Clustering O 0 0.009178581647574902
of O 0 0.0021608532406389713
missense O 0 0.005935074295848608
mutations O 0 0.0005977890104986727
in O 0 0.0003750838804990053
the O 0 0.00193976447917521
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9995536208152771
telangiectasia I-Disease 1 0.9998877048492432
gene O 0 0.00028522219508886337
in O 0 0.00016322359442710876
a O 0 0.0005776904872618616
sporadic B-Disease 0 0.008858910761773586
T I-Disease 1 0.9999492168426514
- I-Disease 1 0.5187333822250366
cell I-Disease 0 0.03589378669857979
leukaemia I-Disease 1 0.9966859221458435
. O 0 0.0013634500792250037

Ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.999291181564331
telangiectasia I-Disease 1 0.9999908208847046
( O 0 0.010924093425273895
A B-Disease 1 0.9999819993972778
- I-Disease 1 0.9994847774505615
T I-Disease 1 0.9999716281890869
) O 0 0.00011518188694026321
is O 0 4.995610288460739e-05
a O 0 0.00017530824698042125
recessive B-Disease 0 0.0022901175543665886
multi I-Disease 1 0.9993426203727722
- I-Disease 1 0.999699592590332
system I-Disease 1 0.7777506113052368
disorder I-Disease 1 1.0
caused O 1 0.9999865293502808
by O 0 0.0002402693935437128
mutations O 0 0.00011995080421911553
in O 0 7.100836228346452e-05
the O 0 0.0002370261208852753
ATM O 0 0.0013257154496386647
gene O 0 0.00018811355403158814
at O 0 0.0006620894419029355
11q22 O 0 0.08885741978883743
- O 0 0.002343281637877226
q23 O 0 0.2705030143260956
( O 0 0.0009291113819926977
ref O 0 0.012050214223563671
. O 0 0.00018665399693418294
3 O 0 0.0005161229055374861
) O 0 0.00026402759249322116
. O 0 0.00039207172812893987

The O 0 0.0036684649530798197
risk O 0 0.002155776135623455
of O 0 0.00488970335572958
cancer B-Disease 1 0.9999909400939941
, O 0 0.0010758860735222697
especially O 0 0.0014643552713096142
lymphoid B-Disease 1 0.9999948740005493
neoplasias I-Disease 1 0.9999972581863403
, O 0 0.0004938271013088524
is O 0 0.00016408074588980526
substantially O 0 0.0006894328398630023
elevated O 0 0.011082137934863567
in O 0 0.0005497658275999129
A B-Disease 1 0.9998403787612915
- I-Disease 1 0.9999130964279175
T I-Disease 1 0.9999995231628418
patients O 0 0.0005879390519112349
and O 0 0.00014096693485043943
has O 0 0.00011586453183554113
long O 0 0.00024238530022557825
been O 0 0.00020063118427060544
associated O 0 0.00021689283312298357
with O 0 0.0003938357112929225
chromosomal O 1 0.9999990463256836
instability O 1 0.9999998807907104
. O 0 0.015546085312962532

By O 0 0.0024145138449966908
analysing O 0 0.01537642627954483
tumour B-Disease 1 0.9999997615814209
DNA O 0 0.002543042879551649
from O 0 0.0005568075575865805
patients O 0 0.00026567952590994537
with O 0 0.00016077836335171014
sporadic B-Disease 0 0.012838281691074371
T I-Disease 1 0.9997922778129578
- I-Disease 0 0.007077464368194342
cell I-Disease 0 0.00551047595217824
prolymphocytic I-Disease 1 0.999705970287323
leukaemia I-Disease 1 0.999983549118042
( O 0 0.0038322503678500652
T B-Disease 1 0.9996349811553955
- I-Disease 0 0.01074365247040987
PLL I-Disease 1 0.9993659853935242
) O 0 0.00021941002341918647
, O 0 0.00015159106987994164
a O 0 0.0003607349353842437
rare O 0 0.001407369039952755
clonal B-Disease 0 0.026889823377132416
malignancy I-Disease 1 0.9879350662231445
with O 0 0.0001863626966951415
similarities O 0 0.00047727502533234656
to O 0 0.0001853147696238011
a O 0 0.0004992463509552181
mature B-Disease 0 0.0030566698405891657
T I-Disease 1 0.9972399473190308
- I-Disease 0 0.004868479911237955
cell I-Disease 0 0.0025510990526527166
leukaemia I-Disease 0 0.26895803213119507
seen O 0 0.0006941093015484512
in O 0 0.00028364366153255105
A B-Disease 1 0.9980481863021851
- I-Disease 1 0.9832984805107117
T I-Disease 1 0.9998987913131714
, O 0 0.00011764784721890464
we O 0 3.862473022309132e-05
demonstrate O 0 0.00011402741802157834
a O 0 8.877013169694692e-05
high O 0 0.00017927993030752987
frequency O 0 4.017517494503409e-05
of O 0 0.0001465748791815713
ATM O 0 0.0025348314084112644
mutations O 0 0.0006382956053130329
in O 0 0.0012192993890494108
T B-Disease 1 0.9991958737373352
- I-Disease 0 0.013179600238800049
PLL I-Disease 1 0.9849475026130676
. O 0 0.0011432698229327798

In O 0 0.0023248714860528708
marked O 0 0.0039014886133372784
contrast O 0 0.00039020617259666324
to O 0 0.00010767075582407415
the O 0 0.00026927419821731746
ATM O 0 0.001510259578935802
mutation O 0 0.00021689532150048763
pattern O 0 0.0005813753232359886
in O 0 0.00035253455280326307
A B-Disease 1 0.9996650218963623
- I-Disease 1 0.9906540513038635
T I-Disease 1 0.9998090863227844
, O 0 6.282129470491782e-05
the O 0 6.324493006104603e-05
most O 0 2.7025476811104454e-05
frequent O 0 0.00010160300007555634
nucleotide O 0 0.00015946090570650995
changes O 0 7.642457785550505e-05
in O 0 7.672132778679952e-05
this O 0 0.00017839558131527156
leukaemia B-Disease 1 0.9940564632415771
were O 0 0.0008607328054495156
missense O 0 0.0065488009713590145
mutations O 0 0.001484135864302516
. O 0 0.0009981337934732437

These O 0 0.00046761613339185715
clustered O 0 0.0010045426897704601
in O 0 0.00013783341273665428
the O 0 0.00017670434317551553
region O 0 0.00020703884365502745
corresponding O 0 0.00010505544196348637
to O 0 5.246177170192823e-05
the O 0 0.0001552742178319022
kinase O 0 0.0003494883712846786
domain O 0 0.00018307377467863262
, O 0 0.00010140108497580513
which O 0 4.4905456888955086e-05
is O 0 4.190854087937623e-05
highly O 0 0.00010171427857130766
conserved O 0 0.00015197273751255125
in O 0 0.00018139247549697757
ATM O 0 0.00218315445818007
- O 0 0.0007173881749622524
related O 0 0.00021099952573422343
proteins O 0 0.00012251829321030527
in O 0 0.00018763150728773326
mouse O 0 0.0009832464857026935
, O 0 0.00017081951955333352
yeast O 0 0.0012301942333579063
and O 0 0.0003598966577555984
Drosophila O 0 0.0031167399138212204
. O 0 0.0006947522051632404

The O 0 0.0034876624122262
resulting O 0 0.003006354672834277
amino O 0 0.0009044635226018727
- O 0 0.001636044355109334
acid O 0 0.0009303638944402337
substitutions O 0 0.0005408808356150985
are O 0 2.295294871146325e-05
predicted O 0 0.00014757958706468344
to O 0 5.335098103387281e-05
interfere O 0 0.000340425583999604
with O 0 0.00011142525909235701
ATP O 1 0.887671947479248
binding O 0 0.0004555739869829267
or O 0 0.0003592988068703562
substrate O 0 0.0010607474250718951
recognition O 0 0.0011568667832762003
. O 0 0.0008943705470301211

Two O 0 0.0007544344407506287
of O 0 0.0011833085445687175
seventeen O 0 0.005026221740990877
mutated O 0 0.011888697743415833
T B-Disease 1 0.9969260096549988
- I-Disease 0 0.004254053346812725
PLL I-Disease 0 0.11511564254760742
samples O 0 0.0002981360303238034
had O 0 0.0002098422555718571
a O 0 0.00016557586786802858
previously O 0 0.0002889753959607333
reported O 0 0.000523837807122618
A B-Disease 0 0.2984558343887329
- I-Disease 0 0.350138783454895
T I-Disease 1 0.99850994348526
allele O 0 0.002546980744227767
. O 0 0.0007276106625795364

In O 0 0.0017829954158514738
contrast O 0 0.0012915577972307801
, O 0 0.000195883956621401
no O 0 0.00021836445375811309
mutations O 0 0.0002166807826142758
were O 0 9.327498264610767e-05
detected O 0 0.0002937520621344447
in O 0 0.00013773642422165722
the O 0 0.00035094510531052947
p53 O 0 0.001737184007652104
gene O 0 0.00025660538813099265
, O 0 7.363211625488475e-05
suggesting O 0 0.0002739325864240527
that O 0 7.063926750561222e-05
this O 0 0.0003113715793006122
tumour B-Disease 1 1.0
suppressor O 1 0.9989203214645386
is O 0 0.00017688085790723562
not O 0 5.0981583626708016e-05
frequently O 0 0.00010009510879172012
altered O 0 0.0003879224241245538
in O 0 0.0001961295201908797
this O 0 0.0002874744823202491
leukaemia B-Disease 1 0.9968589544296265
. O 0 0.001338208676315844

Occasional O 0 0.012175100855529308
missense O 0 0.009362677112221718
mutations O 0 0.0007548417779617012
in O 0 0.000402168050641194
ATM O 0 0.0026670428924262524
were O 0 0.00015703594544902444
also O 0 5.3326974011724815e-05
found O 0 7.265846943482757e-05
in O 0 0.00035955029306933284
tumour B-Disease 1 0.9999984502792358
DNA O 0 0.0011288600508123636
from O 0 0.000449927436420694
patients O 0 0.00027963455067947507
with O 0 0.00015884310414548963
B B-Disease 0 0.0025540515780448914
- I-Disease 0 0.0021854392252862453
cell I-Disease 0 0.0019944251980632544
non I-Disease 0 0.002135088900104165
- I-Disease 0 0.021208208054304123
Hodgkins I-Disease 1 0.9999998807907104
lymphomas I-Disease 1 0.9996225833892822
( O 0 0.0011361677898094058
B B-Disease 0 0.002901434199884534
- I-Disease 0 0.0010674165096133947
NHL I-Disease 0 0.0014717577723786235
) O 0 5.353884262149222e-05
and O 0 4.9633152229944244e-05
a O 0 0.00028914157883264124
B B-Disease 0 0.0020447857677936554
- I-Disease 0 0.0016376558924093843
NHL I-Disease 0 0.00951047521084547
cell O 0 0.002276338404044509
line O 0 0.002316853730008006
. O 0 0.0005688949022442102

The O 0 0.001330150873400271
evidence O 0 0.00045827642315998673
of O 0 0.00035458419006317854
a O 0 0.0002729773405008018
significant O 0 0.00012060592416673899
proportion O 0 0.0001603557902853936
of O 0 0.00021672251750715077
loss O 0 0.030252570286393166
- O 0 0.0007376461289823055
of O 0 0.0005136322579346597
- O 0 0.0013031057314947248
function O 0 0.00013677420793101192
mutations O 0 7.759246364003047e-05
and O 0 4.003554204246029e-05
a O 0 9.946542559191585e-05
complete O 0 0.00047964794794097543
absence O 0 0.0007857741438783705
of O 0 0.0003300667740404606
the O 0 0.0005364172393456101
normal O 0 0.0003810798516497016
copy O 0 0.00035583070712164044
of O 0 0.00028966442914679646
ATM O 0 0.0014778851764276624
in O 0 0.00013444437354337424
the O 0 0.0002129423664882779
majority O 0 0.00010872114216908813
of O 0 0.0005699418252333999
mutated O 0 0.012068619951605797
tumours B-Disease 1 0.9999957084655762
establishes O 0 0.009170952253043652
somatic O 0 0.005089389625936747
inactivation O 0 0.007762724533677101
of O 0 0.0004757762944791466
this O 0 8.063977293204516e-05
gene O 0 9.559167665429413e-05
in O 0 7.350135274464265e-05
the O 0 0.0002326910471310839
pathogenesis O 0 0.008443862199783325
of O 0 0.0014003715477883816
sporadic B-Disease 1 0.996488094329834
T I-Disease 1 0.9999970197677612
- I-Disease 0 0.1980280727148056
PLL I-Disease 1 0.997471809387207
and O 0 0.0002616130223032087
suggests O 0 0.000281267159152776
that O 0 7.736564293736592e-05
ATM O 0 0.0016058969777077436
acts O 0 0.0006168942782096565
as O 0 0.0005339726922102273
a O 0 0.003614182351157069
tumour B-Disease 1 1.0
suppressor O 1 0.9998220801353455
. O 0 0.002587247872725129

As O 0 0.0012234557652845979
constitutional O 0 0.0020174963865429163
DNA O 0 0.001279256190173328
was O 0 0.000893580901902169
not O 0 6.831125938333571e-05
available O 0 2.749386476352811e-05
, O 0 3.494775228318758e-05
a O 0 0.00020353018771857023
putative O 0 0.003263713326305151
hereditary O 1 0.996791660785675
predisposition O 1 0.9993890523910522
to O 1 0.5136808156967163
T B-Disease 1 0.9999997615814209
- I-Disease 1 0.6712425351142883
PLL I-Disease 1 0.9907903671264648
will O 0 0.00019236061780247837
require O 0 4.546736090560444e-05
further O 0 8.436730422545224e-05
investigation O 0 0.00035907141864299774
. O 0 0.00014500375255011022
. O 0 0.0004029693373013288

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.2154487669467926
kinase O 0 0.003038510913029313
is O 0 0.00015502078167628497
involved O 0 0.00014148607442621142
in O 0 9.730618330650032e-05
the O 0 0.0001686048344708979
modulation O 0 0.0002828057622537017
of O 0 0.0002812623279169202
the O 0 0.0009845804888755083
Ca2 O 0 0.08155746757984161
+ O 0 0.008561684750020504
homeostasis O 1 0.9112452864646912
in O 0 0.003218678990378976
skeletal O 1 0.9999998807907104
muscle O 1 0.9999998807907104
cells O 1 0.705133855342865
. O 0 0.0014990766067057848

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999982476234436
DM B-Disease 1 1.0
) O 0 0.0014791495632380247
, O 0 0.00023018916544970125
the O 0 0.0003999672771897167
most O 0 0.0006346112350001931
prevalent O 1 0.9981974959373474
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9971663355827332
adults O 0 0.0006319808890111744
, O 0 0.00013703203876502812
is O 0 9.885949839372188e-05
caused O 0 0.0010071343276649714
by O 0 0.00014293253479991108
( O 0 0.00041410388075746596
CTG O 1 0.9040533304214478
) O 0 0.00018381750851403922
n O 0 0.00041269895154982805
- O 0 0.0004959619836881757
repeat O 0 0.0008469577878713608
expansion O 0 0.0004866773379035294
in O 0 5.753729783464223e-05
a O 0 9.142752969637513e-05
gene O 0 6.302344263531268e-05
encoding O 0 4.3576001189649105e-05
a O 0 0.00012216853792779148
protein O 0 0.00039972321246750653
kinase O 0 0.00103450333699584
( O 0 0.0005644928314723074
DM B-Disease 1 0.9999284744262695
protein O 0 0.0013065631501376629
kinase O 0 0.0014782199868932366
; O 0 0.00033323271782137454
DMPK O 1 0.9983661770820618
) O 0 0.0001977681677090004
and O 0 0.00012245429388713092
involves O 0 0.00038704712642356753
changes O 0 0.00027223609504289925
in O 0 0.0005650327075272799
cytoarchitecture O 1 0.9991536140441895
and O 0 0.0017000604420900345
ion O 0 0.11086607724428177
homeostasis O 1 0.9964166879653931
. O 0 0.002773262793198228

To O 0 0.0006221220246516168
obtain O 0 0.0003408581833355129
clues O 0 0.0003882011806126684
to O 0 0.00014031652244739234
the O 0 0.00026153147337026894
normal O 0 0.00047483955859206617
biological O 0 0.0004243332950863987
role O 0 0.0005173089448362589
of O 0 0.000748875958379358
DMPK O 1 0.9999911785125732
in O 0 0.0015263522509485483
cellular O 0 0.01620592549443245
ion O 0 0.01045703049749136
homeostasis O 1 0.9898499250411987
, O 0 0.00017399498028680682
we O 0 6.300631503108889e-05
have O 0 2.0806943211937323e-05
compared O 0 7.439777255058289e-05
the O 0 0.00020350496924947947
resting O 0 0.008708000183105469
[ O 0 0.0029453181196004152
Ca2 O 0 0.007196260616183281
+ O 0 0.002268120413646102
] O 0 0.0014151480281725526
i O 0 0.0003491547249723226
, O 0 6.561332702403888e-05
the O 0 0.00011388236453058198
amplitude O 0 0.00025739119155332446
and O 0 0.0001081716109183617
shape O 0 0.0007515111356042325
of O 0 0.001765631721355021
depolarization O 1 0.9995681643486023
- O 0 0.14774388074874878
induced O 1 0.9495734572410583
Ca2 O 0 0.013028237968683243
+ O 0 0.002745741279795766
transients O 0 0.003943576477468014
, O 0 0.00011142419680254534
and O 0 7.126553100533783e-05
the O 0 0.00017290524556301534
content O 0 8.634899859316647e-05
of O 0 0.00027697370387613773
ATP O 1 0.9999080896377563
- O 0 0.004325969610363245
driven O 0 0.0034802076406776905
ion O 0 0.0032804515212774277
pumps O 0 0.0033571396488696337
in O 0 0.0005161360022611916
cultured O 0 0.016404008492827415
skeletal O 1 0.999984860420227
muscle O 1 0.9999364614486694
cells O 0 0.0010467895772308111
of O 0 0.0005186412599869072
wild O 0 0.001102508744224906
- O 0 0.0008387242560274899
type O 0 0.0003634063759818673
and O 0 0.00024358491646125913
DMPK O 1 0.9997496008872986
[ O 0 0.002966826083138585
- O 0 0.0026687595527619123
/ O 0 0.0037375378888100386
- O 0 0.0029300637543201447
] O 0 0.0057360390201210976
knockout O 0 0.41869214177131653
mice O 0 0.004079106729477644
. O 0 0.0006371265626512468

In O 0 0.0038135808426886797
vitro O 0 0.005049051251262426
- O 0 0.0025940751656889915
differentiated O 0 0.0039034641813486814
DMPK O 1 0.9993481040000916
[ O 0 0.005909185856580734
- O 0 0.004473146982491016
/ O 0 0.004311174154281616
- O 0 0.0022871065884828568
] O 0 0.0027048522606492043
myotubes O 0 0.010434859432280064
exhibit O 0 0.0011547122849151492
a O 0 0.00042713701259344816
higher O 0 0.0006058883154764771
resting O 0 0.005002488382160664
[ O 0 0.0016824356280267239
Ca2 O 0 0.004286998882889748
+ O 0 0.0017367209075018764
] O 0 0.000958296877797693
i O 0 0.0002509273181203753
than O 0 5.282699203235097e-05
do O 0 5.734273872803897e-05
wild O 0 0.00024572323309257627
- O 0 0.0005203553009778261
type O 0 0.0007567778811790049
myotubes O 0 0.1116103082895279
because O 0 0.0001161069594672881
of O 0 0.00012238422641530633
an O 0 0.00012999959290027618
altered O 0 0.0003428446943871677
open O 0 0.0002497803943697363
probability O 0 4.1138733649859205e-05
of O 0 0.00017972580099012703
voltage O 0 0.0015485413605347276
- O 0 0.000798572029452771
dependent O 0 0.00046004075556993484
l O 0 0.0017571417847648263
- O 0 0.0007376418798230588
type O 0 0.0006394229712896049
Ca2 O 0 0.003992744255810976
+ O 0 0.0013929191045463085
and O 0 0.00037486350629478693
Na O 0 0.3677968382835388
+ O 0 0.002171733882278204
channels O 0 0.0006026704795658588
. O 0 0.000291483971523121

The O 0 0.006823339965194464
mutant O 0 0.03188684210181236
myotubes O 1 0.9829055070877075
exhibit O 0 0.00378641439601779
smaller O 0 0.0006343228742480278
and O 0 0.00027001561829820275
slower O 0 0.0015281992964446545
Ca2 O 0 0.0021344968117773533
+ O 0 0.0009312694310210645
responses O 0 0.00010178743832511827
upon O 0 0.0002673413255251944
triggering O 0 0.0019180867820978165
by O 0 0.00021813763305544853
acetylcholine O 0 0.004592182580381632
or O 0 0.0005073436768725514
high O 0 0.0013071347493678331
external O 0 0.001023980905301869
K O 0 0.0045706480741500854
+ O 0 0.0029321846086531878
. O 0 0.000599000952206552

In O 0 0.0017682018224149942
addition O 0 0.00044648832408711314
, O 0 0.00015081728633958846
we O 0 0.0001012651264318265
observed O 0 8.716603770153597e-05
that O 0 3.1339088309323415e-05
these O 0 6.97989744367078e-05
Ca2 O 0 0.005171448457986116
+ O 0 0.0037242199759930372
transients O 0 0.009483258239924908
partially O 0 0.0019867585506290197
result O 0 0.00018190864648204297
from O 0 7.278892007889226e-05
an O 0 8.858639193931594e-05
influx O 0 0.0005874987691640854
of O 0 0.00034423681790940464
extracellular O 0 0.0022108382545411587
Ca2 O 0 0.002242121146991849
+ O 0 0.00046754235518164933
through O 0 0.0001131374592659995
the O 0 0.00035023654345422983
l O 0 0.0023770874831825495
- O 0 0.00099477160256356
type O 0 0.0009136651642620564
Ca2 O 0 0.004531519953161478
+ O 0 0.0016497436445206404
channel O 0 0.0006169942207634449
. O 0 0.0002294027799507603

Neither O 0 0.003511798568069935
the O 0 0.0008704884094186127
content O 0 0.00022101541981101036
nor O 0 0.00020221232261974365
the O 0 0.00013866879453416914
activity O 0 0.00020136631792411208
of O 0 0.0005112013895995915
Na O 1 0.9935458302497864
+ O 0 0.003124399809166789
/ O 0 0.0027699668426066637
K O 0 0.0028497211169451475
+ O 0 0.0019906889647245407
ATPase O 0 0.005113151855766773
and O 0 0.0007484593661502004
sarcoplasmic O 1 0.8949211835861206
reticulum O 0 0.16477730870246887
Ca2 O 0 0.033867109566926956
+ O 0 0.006348828785121441
- O 0 0.002771449275314808
ATPase O 0 0.0041923243552446365
are O 0 9.189384581986815e-05
affected O 0 0.00054307741811499
by O 0 0.0003810689377132803
DMPK O 1 0.9999674558639526
absence O 0 0.022444652393460274
. O 0 0.0018933319952338934

In O 0 0.001438757055439055
conclusion O 0 0.0010956937912851572
, O 0 0.0001406927331117913
our O 0 0.00014604127500206232
data O 0 5.0165770517196506e-05
suggest O 0 9.81178309302777e-05
that O 0 8.288132812594995e-05
DMPK O 1 0.9984747767448425
is O 0 0.00017718554590828717
involved O 0 0.00016726585454307497
in O 0 0.00015937897842377424
modulating O 0 0.0013973702443763614
the O 0 0.0001926803815877065
initial O 0 0.00024078173737507313
events O 0 0.00016565197438467294
of O 0 0.0002468360180500895
excitation O 0 0.004340530373156071
- O 0 0.004889441188424826
contraction O 0 0.3739626705646515
coupling O 0 0.005041827447712421
in O 0 0.0016252734931185842
skeletal O 1 0.9999997615814209
muscle O 1 0.9999994039535522
. O 0 0.0015303603140637279
. O 0 0.0007572846952825785

Constitutional O 0 0.06531071662902832
RB1 O 1 0.9999932050704956
- O 0 0.029530679807066917
gene O 0 0.000834411010146141
mutations O 0 0.0003596754395402968
in O 0 0.0002579513529781252
patients O 0 0.0003363136784173548
with O 0 0.00018368505698163062
isolated O 0 0.007268927060067654
unilateral B-Disease 0 0.01471731811761856
retinoblastoma I-Disease 1 0.9998210072517395
. O 0 0.0030542933382093906

In O 0 0.0018656133906915784
most O 0 0.0004121192323509604
patients O 0 0.0004019005282316357
with O 0 0.00013562575622927397
isolated O 0 0.0029359355103224516
unilateral B-Disease 0 0.029797105118632317
retinoblastoma I-Disease 1 0.9999909400939941
, O 0 0.0032894862815737724
tumor B-Disease 1 0.9999827146530151
development O 0 0.0013279684353619814
is O 0 0.0002475444634910673
initiated O 0 0.0010015784064307809
by O 0 8.553160296287388e-05
somatic O 0 0.0011741045163944364
inactivation O 0 0.00394352525472641
of O 0 0.00039980036672204733
both O 0 0.00012587194214574993
alleles O 0 0.00013369253429118544
of O 0 0.0003396571264602244
the O 0 0.002034174045547843
RB1 O 1 0.9999843835830688
gene O 0 0.001949459663592279
. O 0 0.0008178724092431366

However O 0 0.0012094710255041718
, O 0 0.00017955093062482774
some O 0 7.772592653054744e-05
of O 0 0.00027296438929624856
these O 0 0.00015507459465879947
patients O 0 0.0007414998253807425
can O 0 0.0002128702908521518
transmit O 0 0.002882785629481077
retinoblastoma B-Disease 1 0.995776355266571
predisposition O 0 0.14183199405670166
to O 0 0.0007537394994869828
their O 0 0.0005362827796489
offspring O 0 0.002113176044076681
. O 0 0.0006633552839048207

To O 0 0.0005020021344535053
determine O 0 0.0001399592001689598
the O 0 0.0001958559441845864
frequency O 0 0.00010945597023237497
and O 0 5.139151107869111e-05
nature O 0 0.00025440199533477426
of O 0 0.00034700933611020446
constitutional O 0 0.007253747899085283
RB1 O 1 0.9999994039535522
- O 0 0.00610760971903801
gene O 0 0.0004379990277811885
mutations O 0 0.00018212123541161418
in O 0 0.00012878674897365272
patients O 0 0.00016101586516015232
with O 0 9.808480535866693e-05
isolated O 0 0.0029164787847548723
unilateral B-Disease 0 0.006073150783777237
retinoblastoma I-Disease 1 0.9989331364631653
, O 0 0.0002334229793632403
we O 0 8.065837755566463e-05
analyzed O 0 0.00011565723252715543
DNA O 0 0.0002744991797953844
from O 0 0.0003480372251942754
peripheral O 1 0.9881742000579834
blood O 1 0.7445659637451172
and O 0 0.0014117230894044042
from O 0 0.3746248483657837
tumor B-Disease 1 0.9999998807907104
tissue O 1 0.9998964071273804
. O 0 0.0014197105774655938

The O 0 0.001295470050536096
analysis O 0 0.00014798203483223915
of O 0 0.000744796940125525
tumors B-Disease 1 0.9998879432678223
from O 0 0.00043994776206091046
54 O 0 0.001116761821322143
( O 0 0.00020057609071955085
71 O 0 0.0005877575022168458
% O 0 8.282807539217174e-05
) O 0 3.7029334635008126e-05
of O 0 0.00015683720994275063
76 O 0 0.0012709298171103
informative O 0 0.0007474628509953618
patients O 0 0.0003218204656150192
showed O 0 0.00040014120168052614
loss O 0 0.0008790046558715403
of O 0 0.00042541269795037806
constitutional O 0 0.003954930230975151
heterozygosity O 1 0.9999886751174927
( O 0 0.02879537083208561
LOH O 1 0.9999988079071045
) O 0 0.0007743912283331156
at O 0 0.002331168856471777
intragenic O 0 0.26833057403564453
loci O 0 0.009349514730274677
. O 0 0.0011152629740536213

Three O 0 0.0012461317237466574
of O 0 0.0012850159546360373
13 O 0 0.006936653982847929
uninformative O 1 0.9921694397926331
patients O 0 0.0015328030567616224
had O 0 0.0013410213869065046
constitutional O 0 0.003298920812085271
deletions O 0 0.011532910168170929
. O 0 0.001732186647132039

For O 0 0.0006145673687569797
39 O 0 0.001331806997768581
randomly O 0 0.0005055773071944714
selected O 0 0.002077916171401739
tumors B-Disease 1 0.9999531507492065
, O 0 0.0010185723658651114
SSCP O 1 0.9999935626983643
, O 0 0.0012213254813104868
hetero O 0 0.05082001909613609
- O 0 0.0018973677651956677
duplex O 0 0.0037098461762070656
analysis O 0 5.8332752814749256e-05
, O 0 8.918393723433837e-05
sequencing O 0 0.0002196832065237686
, O 0 8.31655488582328e-05
and O 0 8.98409343790263e-05
Southern O 0 0.001116050872951746
blot O 0 0.0030590335372835398
analysis O 0 0.00010309425124432892
were O 0 0.00011662449833238497
used O 0 9.47110092965886e-05
to O 0 0.00011469317541923374
identify O 0 0.0003985727089457214
mutations O 0 0.0008315163431689143
. O 0 0.0005258309538476169

Mutations O 0 0.002087556989863515
were O 0 0.00043820487917400897
detected O 0 0.000740094284992665
in O 0 0.0001486889668740332
21 O 0 0.00042270650737918913
( O 0 0.00012994903954677284
91 O 0 0.000534786086063832
% O 0 6.359910912578925e-05
) O 0 5.337535185390152e-05
of O 0 0.0005270898691378534
23 O 1 0.6294541358947754
tumors B-Disease 1 0.9999998807907104
with O 0 0.07789093255996704
LOH O 1 1.0
. O 0 0.003036726266145706

In O 0 0.0006354007055051625
6 O 0 0.0007585329585708678
( O 0 0.00011388485290808603
38 O 0 0.00020189349015709013
% O 0 4.002115019829944e-05
) O 0 3.1421979656443e-05
of O 0 0.0002661823236849159
16 O 1 0.5889905691146851
tumors B-Disease 1 1.0
without O 0 0.010394532233476639
LOH O 1 0.9999998807907104
, O 0 0.00029166691820137203
one O 0 0.00018578679009806365
mutation O 0 0.00022210503811948001
was O 0 0.0005082593997940421
detected O 0 0.00034750692429952323
, O 0 4.0447735955240205e-05
and O 0 3.3552609238540754e-05
in O 0 6.411928916350007e-05
9 O 0 0.00037375197280198336
( O 0 9.738962398841977e-05
56 O 0 0.00021909186034463346
% O 0 5.586887709796429e-05
) O 0 5.709016477339901e-05
of O 0 0.0002083090803353116
the O 0 0.006463988684117794
tumors B-Disease 1 1.0
without O 0 0.3010922074317932
LOH O 1 1.0
, O 0 0.00047349624219350517
both O 0 0.0001654814841458574
mutations O 0 0.00028300806297920644
were O 0 0.00024663700605742633
found O 0 0.00031366574694402516
. O 0 0.000576728256419301

Thus O 0 0.001531953806988895
, O 0 0.00014235310663934797
a O 0 8.14927407191135e-05
total O 0 7.382829062407836e-05
of O 0 0.0001331401726929471
45 O 0 0.00031824217876419425
mutations O 0 0.00014137616381049156
were O 0 7.609122985741124e-05
identified O 0 0.0001749637449393049
in O 0 0.0003269072622060776
tumors B-Disease 1 0.9999027252197266
of O 0 0.0024983978364616632
36 O 0 0.01189357414841652
patients O 0 0.002497847890481353
. O 0 0.0009439007262699306

Thirty O 0 0.007138576824218035
- O 0 0.0013004463398829103
nine O 0 0.00034791696816682816
of O 0 0.00019024801440536976
the O 0 0.0003389034536667168
mutations O 0 0.0002883517590817064
- O 0 0.0004342925385572016
including O 0 9.857200348051265e-05
34 O 0 0.00036178139271214604
small O 0 0.00014927297888789326
mutations O 0 0.00015696021728217602
, O 0 0.00011080414697062224
2 O 0 0.00041989938472397625
large O 0 0.0003725261485669762
structural O 0 0.44630444049835205
alterations O 1 0.6815578937530518
, O 0 0.00031747546745464206
and O 0 0.0001780183520168066
hypermethylation O 0 0.1749744862318039
in O 0 0.000595139863435179
3 O 0 0.007362465374171734
tumors O 1 0.9999984502792358
- O 0 0.0009138837340287864
were O 0 8.747562969801947e-05
not O 0 2.4648230464663357e-05
detected O 0 0.0001479440979892388
in O 0 5.7396016927668825e-05
the O 0 0.0002791561128105968
corresponding O 0 0.0010077337501570582
peripheral O 1 0.9988048076629639
blood O 1 0.9182949662208557
DNA O 0 0.005059521179646254
. O 0 0.001333488617092371

In O 0 0.0010383614571765065
6 O 0 0.0014020790113136172
( O 0 0.00025835298583842814
17 O 0 0.0005832990282215178
% O 0 5.580940342042595e-05
) O 0 2.4191196644096635e-05
of O 0 5.575588875217363e-05
the O 0 0.0002084354346152395
36 O 0 0.0005569805507548153
patients O 0 0.00020586485334206372
, O 0 8.797722693998367e-05
a O 0 0.000193630694411695
mutation O 0 0.0002679853932932019
was O 0 0.0004413940478116274
detected O 0 0.00029321707552298903
in O 0 6.265855336096138e-05
constitutional O 0 0.00022817659191787243
DNA O 0 0.00023420951038133353
, O 0 5.8377547247800976e-05
and O 0 5.188512659515254e-05
1 O 0 0.00013116707850713283
of O 0 0.00014991514035500586
these O 0 4.2271309212083e-05
mutations O 0 0.00012943358160555363
is O 0 6.0321759519865736e-05
known O 0 0.00018304758123122156
to O 0 0.00010723476589191705
be O 0 7.962158997543156e-05
associated O 0 0.000138339790282771
with O 0 0.0001569760643178597
reduced O 0 0.001707791700027883
expressivity O 1 0.7386200428009033
. O 0 0.001617790199816227

The O 0 0.00202769017778337
presence O 0 0.0008378959028050303
of O 0 0.00029136339435353875
a O 0 0.0005168219795450568
constitutional O 0 0.0009912315290421247
mutation O 0 0.0004465657693799585
was O 0 0.0005178331630304456
not O 0 4.4974545744480565e-05
associated O 0 3.9219714381033555e-05
with O 0 2.236010186607018e-05
an O 0 9.240984945790842e-05
early O 0 0.000499913701787591
age O 0 0.0011654144618660212
at O 0 0.0038518928922712803
treatment O 0 0.00402219919487834
. O 0 0.0010150799062103033

In O 0 0.002291196258738637
1 O 0 0.002491152612492442
patient O 0 0.001429036259651184
, O 0 0.0005844002589583397
somatic O 0 0.0059733642265200615
mosaicism O 1 0.9984696507453918
was O 0 0.00286487746052444
demonstrated O 0 0.0007043109508231282
by O 0 4.784471093444154e-05
molecular O 0 0.00012372068886179477
analysis O 0 1.7191949154948816e-05
of O 0 0.00010372169344918802
DNA O 0 0.00044591454206965864
and O 0 0.00030329011497087777
RNA O 0 0.0015056731645017862
from O 0 0.0011272728443145752
peripheral O 1 0.9992082715034485
blood O 1 0.8967186808586121
. O 0 0.0015493539394810796

In O 0 0.002176855457946658
2 O 0 0.0021380202379077673
patients O 0 0.0007034909212961793
without O 0 0.0001268072664970532
a O 0 0.0002965310122817755
detectable O 0 0.0031523590441793203
mutation O 0 0.0004010787815786898
in O 0 0.0005082183051854372
peripheral O 1 0.9992455244064331
blood O 1 0.9270621538162231
, O 0 0.0008017060463316739
mosaicism O 1 0.9986717700958252
was O 0 0.001549183507449925
suggested O 0 0.0001976460189325735
because O 0 4.10091997764539e-05
1 O 0 7.78330213506706e-05
of O 0 0.00011265216016909108
the O 0 0.0006054161349311471
patients O 0 0.004357590340077877
showed O 1 0.9943357110023499
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.0008650622330605984
the O 0 0.0005938538233749568
other O 0 9.713151666801423e-05
later O 0 0.0006273919716477394
developed O 0 0.0009744091075845063
bilateral B-Disease 0 0.006719181779772043
retinoblastoma I-Disease 1 0.9994725584983826
. O 0 0.002414775313809514

In O 0 0.0026419884525239468
conclusion O 0 0.001529894070699811
, O 0 0.00024775316705927253
our O 0 0.0002090590278385207
results O 0 0.00013740232679992914
emphasize O 0 0.0003735253994818777
that O 0 6.184927769936621e-05
the O 0 0.0003855892864521593
manifestation O 0 0.47835344076156616
and O 0 0.0008384885150007904
transmissibility O 1 0.5661702156066895
of O 0 0.0016744367312639952
retinoblastoma B-Disease 1 0.8829582333564758
depend O 0 0.00022731153876520693
on O 0 0.00018565045320428908
the O 0 0.00013123110693413764
nature O 0 0.00017753390420693904
of O 0 0.00012968758528586477
the O 0 0.0002302888169651851
first O 0 0.000265090522589162
mutation O 0 9.795003279577941e-05
, O 0 3.588226900319569e-05
its O 0 2.1793579435325228e-05
time O 0 3.488967558951117e-05
in O 0 7.534089672844857e-05
development O 0 0.0001926733966683969
, O 0 6.40692887827754e-05
and O 0 3.531955007929355e-05
the O 0 7.1181588282343e-05
number O 0 3.0667317332699895e-05
and O 0 4.963547326042317e-05
types O 0 0.00010035258310381323
of O 0 0.0005550258792936802
cells O 0 0.001432409742847085
that O 0 5.743664951296523e-05
are O 0 2.7147190849063918e-05
affected O 0 0.00023751793196424842
. O 0 0.0001716482947813347
. O 0 0.0003256245399825275

Hereditary B-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999998807907104
of I-Disease 1 0.5060142278671265
the I-Disease 0 0.13165611028671265
fifth I-Disease 1 0.9915844202041626
component I-Disease 0 0.0017364431405439973
of I-Disease 0 0.0004800976312253624
complement I-Disease 0 0.0009454055689275265
in O 0 0.0005119047709740698
man O 0 0.0037510774563997984
. O 0 0.00048400243395008147

I O 0 0.14018848538398743
. O 0 0.0032061280217021704

Clinical O 0 0.011523650959134102
, O 0 0.001978919841349125
immunochemical O 1 0.9998323917388916
, O 0 0.0007234903750941157
and O 0 0.00032657990232110023
family O 0 0.0007180515676736832
studies O 0 0.0004171471227891743
. O 0 0.0005731471464969218

The O 0 0.002418320393189788
first O 0 0.0012772133341059089
recognized O 0 0.0012133537093177438
human O 0 0.0008608218631707132
kindred O 1 0.7344648241996765
with O 0 0.0014064633287489414
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.995974600315094
the I-Disease 0 0.4682195484638214
fifth I-Disease 1 0.8556897640228271
component I-Disease 0 0.001373858074657619
of I-Disease 0 0.0004545380943454802
complement I-Disease 0 0.0018494396936148405
( O 0 0.001384612638503313
C5 O 1 0.9999650716781616
) O 0 0.00033323653042316437
is O 0 0.00017989485058933496
described O 0 0.000788727542385459
. O 0 0.0005320836789906025

The O 0 0.0031287171877920628
proband O 0 0.07736565172672272
, O 0 0.00023366612731479108
a O 0 0.0002919103135354817
20 O 0 0.000625795335508883
- O 0 0.0008477419032715261
year O 0 0.0003404513990972191
- O 0 0.0010148981818929315
old O 0 0.0020456130150705576
black O 0 0.003286270424723625
female O 0 0.003745993599295616
with O 0 0.004144239705055952
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999927282333374
age O 1 0.9632579684257507
11 O 0 0.2020415961742401
, O 0 0.0005624820478260517
lacked O 0 0.016093244776129723
serum O 1 0.9974931478500366
hemolytic O 1 0.9999998807907104
complement O 0 0.013555120676755905
activity O 0 0.001950352336280048
, O 0 0.00017485734133515507
even O 0 0.00031876200227998197
during O 0 0.002166346414014697
remission O 0 0.009456832893192768
. O 0 0.0013696872629225254

C5 O 1 0.9999940395355225
was O 0 0.10740063339471817
undetectable O 0 0.12898512184619904
in O 0 0.0005733821308240294
her O 0 0.0006874193786643445
serum O 0 0.0045117540284991264
by O 0 0.00017935995128937066
both O 0 0.0002991548099089414
immunodiffusion O 1 0.9997770190238953
and O 0 0.0032111683394759893
hemolytic O 1 1.0
assays O 0 0.006111976224929094
. O 0 0.0012155482545495033

Other O 0 0.0008744834922254086
complement O 0 0.0016956450417637825
components O 0 0.001046558259986341
were O 0 0.00014214747352525592
normal O 0 0.0004593573685269803
during O 0 0.0007537606870755553
remission O 0 0.002930357586592436
of O 0 0.0028296136297285557
lupus O 1 1.0
, O 0 0.0016994276084005833
but O 0 0.0006990786641836166
C1 O 1 0.9999502897262573
, O 0 0.0008122968720272183
C4 O 1 0.999962568283081
, O 0 0.0012166568776592612
C2 O 1 0.9994875192642212
, O 0 0.00046755169751122594
and O 0 0.0008970350027084351
C3 O 1 0.9999791383743286
levels O 0 0.0122290700674057
fell O 1 0.7997414469718933
during O 0 0.009172824211418629
exacerbations O 1 0.9714293479919434
. O 0 0.002282045315951109

A O 0 0.008073218166828156
younger O 0 0.003896754700690508
half O 0 0.0011093619978055358
- O 0 0.0017783676739782095
sister O 0 0.001035185414366424
, O 0 0.0001192940108012408
who O 0 0.00014485229621641338
had O 0 0.0005190158844925463
no O 0 0.0008103557047434151
underlying O 1 0.9999799728393555
disease O 1 1.0
, O 0 0.0021911049261689186
was O 0 0.009556962177157402
also O 0 0.00013020230107940733
found O 0 0.00018289648869540542
to O 0 0.0002340545761398971
lack O 0 0.0030177037697285414
immunochemically O 1 0.9999715089797974
detectable O 1 0.9993871450424194
C5 O 1 0.999981164932251
. O 0 0.00210758694447577

By O 0 0.005490391049534082
hemolytic O 1 0.9999997615814209
assay O 0 0.005133525002747774
, O 0 0.00033621734473854303
she O 0 0.00026724193594418466
exhibited O 0 0.0009881241712719202
1 O 0 0.00040074094431474805
- O 0 0.00031754811061546206
2 O 0 0.00011005860869772732
% O 0 2.8024704079143703e-05
of O 0 7.839257159503177e-05
the O 0 0.00028543491498567164
normal O 0 0.001519753597676754
serum O 1 0.7907279133796692
C5 O 1 0.9999349117279053
level O 0 0.0008424957632087171
and O 0 0.00011681948672048748
normal O 0 0.00020498051890172064
concentrations O 0 0.00035549839958548546
of O 0 0.00016569557192269713
other O 0 0.00010870954429265112
complement O 0 0.0015437403926625848
components O 0 0.0026097141671925783
. O 0 0.0009875387186184525

C5 O 1 0.9998728036880493
levels O 0 0.001847437466494739
of O 0 0.0004068043199367821
other O 0 7.548573921667412e-05
family O 0 0.0002202660689363256
members O 0 7.062358054099604e-05
were O 0 7.086191908456385e-05
either O 0 6.625818059546873e-05
normal O 0 0.00013815207057632506
or O 0 7.337935676332563e-05
approximately O 0 0.00012629223056137562
half O 0 0.00022464393987320364
- O 0 0.0005154177197255194
normal O 0 0.00020057684741914272
, O 0 5.877823423361406e-05
consistent O 0 0.00016853123088367283
with O 0 8.141864236677065e-05
autosomal O 0 0.003420047229155898
codominant O 1 0.9988312125205994
inheritance O 0 0.002277119318023324
of O 0 0.0008319759508594871
the O 0 0.001965120667591691
gene O 0 0.001821628538891673
determining O 0 0.012955494225025177
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.00624653697013855

Normal O 1 0.6830645203590393
hemolytic O 1 0.9999997615814209
titers O 1 0.9975438714027405
were O 0 0.0011690201936289668
restored O 0 0.0034175647888332605
to O 0 0.00017565360758453608
both O 0 0.0002969242341350764
homozygous O 0 0.004860820714384317
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9978971481323242
deficient I-Disease 1 0.9999880790710449
( O 0 0.005216768942773342
C5D B-Disease 1 1.0
) O 0 0.0011334295850247145
sera O 0 0.008821176365017891
by O 0 0.00013709385530091822
addition O 0 0.00021572672994807363
of O 0 0.0005169932264834642
highly O 0 0.0023643102031201124
purified O 0 0.40325790643692017
human O 0 0.006361089646816254
C5 O 1 0.9999645948410034
. O 0 0.0019277984974905849

In O 0 0.002637529978528619
specific O 0 0.0009073101100511849
C5 O 1 0.9999731779098511
titrations O 1 0.7166343927383423
, O 0 0.00047447215183638036
however O 0 0.00010529524297453463
, O 0 5.855713607161306e-05
it O 0 3.8529193261638284e-05
was O 0 0.000323709798976779
noted O 0 0.0001306906488025561
that O 0 3.2733278203522786e-05
when O 0 0.00010076741455122828
limited O 0 5.847716602147557e-05
amounts O 0 9.11883544176817e-05
of O 0 0.00030446084565483034
C5 O 1 0.999967098236084
were O 0 0.0003674424078781158
assayed O 0 0.0011706026270985603
in O 0 0.00010239901166642085
the O 0 8.933033677749336e-05
presence O 0 0.00019157207862008363
of O 0 0.0003055218840017915
low O 0 0.0006326701841317117
dilutions O 0 0.004459543153643608
of O 0 0.0007530467119067907
either O 0 0.0020774691365659237
C5D B-Disease 1 1.0
serum O 1 0.9952475428581238
, O 0 0.0003960143949370831
curving O 0 0.0021146165672689676
rather O 0 0.00012642114597838372
than O 0 6.729446613462642e-05
linear O 0 0.00021071884839329869
dose O 0 0.001210286864079535
- O 0 0.0006429373170249164
response O 0 0.0001755931443767622
plots O 0 0.00044225278543308377
were O 0 0.00010309011850040406
consistently O 0 0.00021071119408588856
obtained O 0 9.0443754743319e-05
, O 0 8.483756391797215e-05
suggesting O 0 0.00036113819805905223
some O 0 0.00010944396490231156
inhibitory O 0 0.002103132661432028
effect O 0 0.0016981805674731731
. O 0 0.0007195186335593462

Further O 0 0.002397379605099559
studies O 0 0.00032000496867112815
suggested O 0 0.00031335465610027313
that O 0 8.193410030798987e-05
low O 0 0.0004342656466178596
dilutions O 0 0.0054292138665914536
of O 0 0.0018892112420871854
C5D B-Disease 1 1.0
serum O 0 0.24833647906780243
contain O 0 0.0005924959550611675
a O 0 0.00028504329384304583
factor O 0 0.0003283966798335314
( O 0 0.00012425699969753623
or O 0 0.00011169312347192317
factors O 0 0.00011146946781082079
) O 0 8.229021477745846e-05
interfering O 0 0.0004131831228733063
at O 0 0.00026623535086400807
some O 0 4.567718497128226e-05
step O 0 0.00025453203124925494
in O 0 9.980042523238808e-05
the O 0 0.000564382818993181
hemolytic O 1 0.9999977350234985
assay O 0 0.002113200258463621
of O 0 0.0033485672902315855
C5 O 1 0.9999986886978149
, O 0 0.00025214633205905557
rather O 0 0.00012868043268099427
than O 0 4.1494913602946326e-05
a O 0 0.000212614715564996
true O 0 0.0015264300163835287
C5 O 1 0.9999676942825317
inhibitor O 1 0.8761101961135864
or O 0 0.0017111573833972216
inactivator O 1 0.9708803296089172
. O 0 0.0010490382555872202

Of O 0 0.0031489564571529627
clinical O 0 0.0016656828811392188
interest O 0 0.00022909612744115293
are O 0 2.573485835455358e-05
( O 0 0.00010713521623983979
a O 0 0.00013418706657830626
) O 0 4.7574867494404316e-05
the O 0 0.0001583788252901286
documentation O 0 0.0006681194645352662
of O 0 0.0025263135321438313
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999947547912598
vasculitis B-Disease 1 1.0
, O 1 0.986108124256134
and O 1 0.8344223499298096
arthritis B-Disease 1 1.0
in O 0 0.003214993979781866
an O 0 0.00045870273606851697
individual O 0 0.0003724128764588386
lacking O 1 0.8390758633613586
C5 O 1 0.9999996423721313
( O 0 0.0003101636248175055
and O 0 7.482295768568292e-05
its O 0 8.925625297706574e-05
biologic O 0 0.006637700367718935
functions O 0 0.0001634740474401042
) O 0 6.311419565463439e-05
, O 0 5.088522084406577e-05
and O 0 6.681578088318929e-05
( O 0 0.00013681869313586503
b O 0 0.00020297862647566944
) O 0 4.541709495242685e-05
a O 0 0.00014842832752037793
remarkable O 0 0.0008885821443982422
propensity O 0 0.0036368144210428
to O 0 0.0009549582609906793
bacterial B-Disease 1 0.9999996423721313
infections I-Disease 1 0.9999994039535522
in O 0 0.0008030621684156358
the O 0 0.0014099354157224298
proband O 1 0.9989922642707825
, O 0 0.00013031855633016676
even O 0 6.947484507691115e-05
during O 0 0.0002379528887104243
periods O 0 0.00020969746401533484
of O 0 0.00019957417680416256
low O 0 0.0005146546172909439
- O 0 0.000557094463147223
dose O 0 0.0004905421519652009
or O 0 0.00010357215069234371
alternate O 0 0.0004186158475931734
- O 0 0.0014054111670702696
day O 0 0.0024310434237122536
corticosteroid O 1 0.9855504035949707
therapy O 0 0.02017483115196228
. O 0 0.000954386021476239

Other O 0 0.0005441416869871318
observations O 0 0.00039761181687936187
indicate O 0 0.0003385301970411092
that O 0 8.448130392935127e-05
the O 0 0.0005085536395199597
C5D B-Disease 1 0.9999988079071045
state O 0 0.0003282867546658963
is O 0 0.00010170944005949423
compatible O 0 0.00020730750111397356
with O 0 0.0001144724665209651
normal O 0 0.0007504054228775203
coagulation O 0 0.013104363344609737
function O 0 0.00027115747798234224
and O 0 0.0001330084487562999
the O 0 0.000306592759443447
capacity O 0 0.0005827367422170937
to O 0 0.00015323064872063696
mount O 0 0.0068673025816679
a O 0 0.001641169423237443
neutrophilic O 1 0.9998095631599426
leukocytosis O 1 0.999893069267273
during O 1 0.9930558800697327
pyogenic B-Disease 1 0.9999756813049316
infection I-Disease 1 0.9997981190681458
. O 0 0.0006282730028033257
. O 0 0.0007480478961952031

Susceptibility O 1 0.7342978715896606
to O 0 0.019444096833467484
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9947992563247681
twins O 1 0.5045261979103088
: O 0 0.0001761890307534486
the O 0 0.00012669632269535214
role O 0 0.0002967875334434211
of O 0 0.00031795830000191927
genes O 0 0.00044040640932507813
, O 0 0.0004282188310753554
HLA O 1 0.9999775886535645
, O 0 0.00035591787309385836
and O 0 0.0002318172191735357
the O 0 0.0009812337812036276
environment O 0 0.0017533529317006469
. O 0 0.0010034991428256035

OBJECTIVE O 0 0.008314182981848717
To O 0 0.0003353830543346703
determine O 0 0.00015546770009677857
the O 0 0.00026614146190695465
relative O 0 0.0005307116080075502
effects O 0 0.0008505064761266112
of O 0 0.0005292620626278222
genetic O 0 0.0005833524628542364
and O 0 0.0002963334263768047
environmental O 0 0.0008740228367969394
factors O 0 0.00023036477796267718
in O 0 0.00043350295163691044
susceptibility O 0 0.017992476001381874
to O 0 0.0206634309142828
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999905824661255
AS B-Disease 1 0.9999938011169434
) O 0 0.0014068573946133256
. O 0 0.0006382287247106433

METHODS O 0 0.004754766821861267
Twins O 0 0.009775933809578419
with O 0 0.00031920234323479235
AS B-Disease 0 0.0072647822089493275
were O 0 0.00014471838949248195
identified O 0 0.0001297494163736701
from O 0 8.924654684960842e-05
the O 0 0.00026913665351457894
Royal O 0 0.008289073593914509
National O 1 0.6363415718078613
Hospital O 1 0.9999861717224121
for O 0 0.03184697404503822
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.18185681104660034
. O 0 0.0015957292634993792

Clinical O 0 0.007774184923619032
and O 0 0.0015725099947303534
radiographic O 0 0.016164734959602356
examinations O 0 0.00167184101883322
were O 0 0.00030142912873998284
performed O 0 0.0004784930788446218
to O 0 0.00014494266360998154
establish O 0 0.0007717376574873924
diagnoses O 0 0.011393890716135502
, O 0 0.0005626830388791859
and O 0 0.001005693688057363
disease O 1 0.9999994039535522
severity O 1 0.9998869895935059
was O 1 0.8349478244781494
assessed O 0 0.00035376555752009153
using O 0 4.0202121454058215e-05
a O 0 7.661239942535758e-05
combination O 0 0.0001708017662167549
of O 0 0.0002529206976760179
validated O 0 0.0013231742195785046
scoring O 0 0.0007352564134635031
systems O 0 0.0010990843875333667
. O 0 0.0005659525631926954

HLA O 1 0.9791011810302734
typing O 0 0.008246137760579586
for O 0 0.0009828933980315924
HLA O 1 0.9998306035995483
- O 0 0.010897839441895485
B27 O 1 0.9804056882858276
, O 0 0.0012265198165550828
HLA O 1 0.9996726512908936
- O 0 0.006243876647204161
B60 O 1 0.7893681526184082
, O 0 0.00039805236156098545
and O 0 0.0006347267189994454
HLA O 1 0.999976634979248
- O 0 0.07605627924203873
DR1 O 1 0.9985529780387878
was O 0 0.0013495775638148189
performed O 0 0.0004670029738917947
by O 0 0.00010184375423705205
polymerase O 0 0.000883315980900079
chain O 0 0.0005989946657791734
reaction O 0 0.00018685201939661056
with O 0 3.022269629582297e-05
sequence O 0 8.053402416408062e-05
- O 0 0.0002750443236436695
specific O 0 3.507445944705978e-05
primers O 0 0.0006263165269047022
, O 0 9.247312846127898e-05
and O 0 0.0001950449077412486
zygosity O 1 0.5895768404006958
was O 0 0.002120629884302616
assessed O 0 0.0011094253277406096
using O 0 0.0004440879565663636
microsatellite O 0 0.01130084227770567
markers O 0 0.007910449057817459
. O 0 0.001576241455040872

Genetic O 0 0.0041914270259439945
and O 0 0.0007591292960569263
environmental O 0 0.0007725426112301648
variance O 0 0.00024722982197999954
components O 0 0.0007063089869916439
were O 0 0.0001192369163618423
assessed O 0 0.00017879203369375318
with O 0 3.0119463190203533e-05
the O 0 0.00015903741586953402
program O 0 0.0002986017207149416
Mx O 0 0.005268463399261236
, O 0 7.907536200946197e-05
using O 0 2.1746827769675292e-05
data O 0 1.5005444765847642e-05
from O 0 1.948139470187016e-05
this O 0 1.7523736460134387e-05
and O 0 2.755155583145097e-05
previous O 0 6.073903205106035e-05
studies O 0 3.291012762929313e-05
of O 0 0.00017312861746177077
twins O 0 0.004287310875952244
with O 0 0.00023391311697196215
AS B-Disease 1 0.9216538667678833
. O 0 0.0008239366579800844

RESULTS O 0 0.001853171386756003
Six O 0 0.00040224374970421195
of O 0 0.0004623767745215446
8 O 0 0.0029970845207571983
monozygotic O 0 0.20969657599925995
( O 0 0.002370859496295452
MZ O 1 0.9999618530273438
) O 0 0.0006366193993017077
twin O 0 0.004483717028051615
pairs O 0 0.000807584379799664
were O 0 0.0006856729160062969
disease O 1 0.9993000030517578
concordant O 0 0.01716790534555912
, O 0 0.00027910128119401634
compared O 0 0.00013141505769453943
with O 0 4.468874249141663e-05
4 O 0 0.00020617146219592541
of O 0 0.00022102762886788696
15 O 0 0.0007739212596789002
B27 O 1 0.6048386096954346
- O 0 0.0014479898381978273
positive O 0 0.0003533973067533225
dizygotic O 0 0.013005527667701244
( O 0 0.0007748639909550548
DZ O 1 0.9848076105117798
) O 0 0.000259910972090438
twin O 0 0.001471764757297933
pairs O 0 0.0002176396519644186
( O 0 0.00018610790721140802
27 O 0 0.0007938717026263475
% O 0 0.00010122641833731905
) O 0 4.812723636860028e-05
and O 0 5.278640674077906e-05
4 O 0 0.000260655942838639
of O 0 0.0003818380646407604
32 O 0 0.0023942147381603718
DZ O 1 0.9992786049842834
twin O 0 0.008552518673241138
pairs O 0 0.00039293026202358305
overall O 0 0.0006608759285882115
( O 0 0.00020589544146787375
12 O 0 0.00035854653106071055
. O 0 5.0373582780594006e-05
5 O 0 0.0002159183204639703
% O 0 0.00015817236271686852
) O 0 0.00019660958787426353
. O 0 0.00034868603688664734

Nonsignificant O 1 0.9954767823219299
increases O 0 0.0012556344736367464
in O 0 0.00018422723223920912
similarity O 0 0.00026590406196191907
with O 0 9.658289491198957e-05
regard O 0 0.0003076679422520101
to O 0 0.00017934830975718796
age O 0 0.0010416156146675348
at O 0 0.2581949234008789
disease O 1 0.9999966621398926
onset O 1 0.9999967813491821
and O 0 0.00025475246366113424
all O 0 6.595144077436998e-05
of O 0 0.00028485857183113694
the O 0 0.0019278766121715307
disease O 1 0.9999834299087524
severity O 1 0.7411810159683228
scores O 0 0.0010104043176397681
assessed O 0 0.0004128563159611076
were O 0 0.00013978607603348792
noted O 0 0.00017808169650379568
in O 0 0.0003962281043641269
disease O 1 0.9999508857727051
- O 0 0.05722540616989136
concordant O 1 0.5907906293869019
MZ O 1 0.9999641180038452
twins O 0 0.012418883852660656
compared O 0 0.001374269020743668
with O 0 0.0006630350253544748
concordant O 0 0.16583865880966187
DZ O 1 0.9999854564666748
twins O 0 0.14549891650676727
. O 0 0.0021539446897804737

HLA O 1 0.9999871253967285
- O 0 0.43905866146087646
B27 O 1 0.9978199005126953
and O 0 0.001141097629442811
B60 O 1 0.9476650953292847
were O 0 0.0002483067801222205
associated O 0 0.0001513853931101039
with O 0 9.198984480462968e-05
the O 0 0.0011031111935153604
disease O 1 0.999994158744812
in O 0 0.0034849506337195635
probands O 1 0.9999902248382568
, O 0 0.0001471667201258242
and O 0 6.076232239138335e-05
the O 0 0.00010082950029755011
rate O 0 9.523801418254152e-05
of O 0 0.0002664141356945038
disease O 1 0.9997149109840393
concordance O 0 0.004841167014092207
was O 0 0.002538883127272129
significantly O 0 0.0005874993512406945
increased O 0 0.00022680881374981254
among O 0 0.0001699036656646058
DZ O 1 0.9989917874336243
twin O 0 0.0032457690685987473
pairs O 0 0.00013415788998827338
in O 0 7.748303323751315e-05
which O 0 3.702704270835966e-05
the O 0 0.00016137152852024883
co O 0 0.0014746126253157854
- O 0 0.0016272065695375204
twin O 0 0.004086743574589491
was O 0 0.0010252647334709764
positive O 0 0.00018709055439103395
for O 0 0.0001445108646294102
both O 0 0.00035384466173127294
B27 O 1 0.9969027638435364
and O 0 0.0033894884400069714
DR1 O 1 0.9997320771217346
. O 0 0.0026211815420538187

Additive O 0 0.015876084566116333
genetic O 0 0.002024801215156913
effects O 0 0.0015454919775947928
were O 0 0.0002443977282382548
estimated O 0 0.00015527050709351897
to O 0 5.286030864226632e-05
contribute O 0 0.00019567225535865873
97 O 0 0.0005625278572551906
% O 0 4.70170853077434e-05
of O 0 9.732280159369111e-05
the O 0 0.00023209456412587315
population O 0 9.389852493768558e-05
variance O 0 0.00017543233116157353
. O 0 0.00031863225740380585

CONCLUSION O 0 0.01459941640496254
Susceptibility O 0 0.0056519280187785625
to O 0 0.0006906224298290908
AS B-Disease 0 0.025450324639678
is O 0 0.0002078795077977702
largely O 0 0.00037141283974051476
genetically O 0 0.0002829001459758729
determined O 0 0.00014270238170865923
, O 0 5.0579896196722984e-05
and O 0 4.971728412783705e-05
the O 0 0.00010692721843952313
environmental O 0 0.00035022618249058723
trigger O 0 0.0010399984894320369
for O 0 0.0001594853965798393
the O 0 0.0034599376376718283
disease O 1 0.9999995231628418
is O 0 0.0012674229219555855
probably O 0 0.004556433763355017
ubiquitous O 0 0.009372716769576073
. O 0 0.000545914750546217

HLA O 1 0.9999685287475586
- O 0 0.016388975083827972
B27 O 0 0.02746189571917057
accounts O 0 0.0001607191952643916
for O 0 3.698501313920133e-05
a O 0 8.102516585495323e-05
minority O 0 0.00011305625957902521
of O 0 0.00011913826165255159
the O 0 0.00028495583683252335
overall O 0 0.0018043082673102617
genetic O 0 0.0010641524568200111
susceptibility O 0 0.0065252589993178844
to O 0 0.0008770001586526632
AS B-Disease 1 0.9769867062568665
. O 0 0.0014399182982742786

Cell O 0 0.03462781012058258
cycle O 0 0.008470051921904087
- O 0 0.00233490951359272
dependent O 0 0.0004955786862410605
colocalization O 0 0.010518872179090977
of O 0 0.0017925840802490711
BARD1 O 1 0.9999982118606567
and O 0 0.001166291767731309
BRCA1 O 0 0.007493027951568365
proteins O 0 0.00016620462702121586
in O 0 0.00014411742449738085
discrete O 0 0.0004816809087060392
nuclear O 0 0.0023166390601545572
domains O 0 0.0014878734946250916
. O 0 0.0006340586696751416

Germ O 1 0.999977707862854
- O 0 0.010874314233660698
line O 0 0.0017860813532024622
mutations O 0 0.0001918978668982163
of O 0 0.0002787443809211254
the O 0 0.0008788605337031186
BRCA1 O 1 0.9060623645782471
gene O 0 0.000587215181440115
predispose O 0 0.002643091371282935
women O 0 0.00026957833324559033
to O 0 9.435503307031468e-05
early O 0 0.0009246414410881698
- O 0 0.01946311816573143
onset O 1 0.9999988079071045
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.9998345375061035
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.0005728719406761229
compromising O 0 0.0027075381949543953
the O 0 0.0005757846520282328
genes O 0 0.00029764074133709073
presumptive O 0 0.007962649688124657
function O 0 0.0003577883180696517
as O 0 0.0003990194236394018
a O 0 0.0020142211578786373
tumor B-Disease 1 0.9999915361404419
suppressor O 1 0.9940857887268066
. O 0 0.0020347859244793653

Although O 0 0.000788187375292182
the O 0 0.0007030901615507901
biochemical O 0 0.0029881582595407963
properties O 0 0.001067398232407868
of O 0 0.0014784778468310833
BRCA1 O 1 0.9966532588005066
polypeptides O 0 0.002471389714628458
are O 0 5.0363832997391e-05
not O 0 3.8377045711968094e-05
understood O 0 0.00015760779206175357
, O 0 5.343611701391637e-05
their O 0 4.055557292304002e-05
expression O 0 0.00025342273875139654
pattern O 0 0.001152115990407765
and O 0 0.0005890226457268
subcellular O 0 0.005739158950746059
localization O 0 0.00259713688865304
suggest O 0 0.0002683958155103028
a O 0 0.00012009042256977409
role O 0 0.000381830963306129
in O 0 0.00028490147087723017
cell O 0 0.0017431596061214805
- O 0 0.001696115592494607
cycle O 0 0.0027212321292608976
regulation O 0 0.0012584109790623188
. O 0 0.0003815609961748123

When O 0 0.00874525960534811
resting O 1 0.9359359741210938
cells O 0 0.0017203554743900895
are O 0 0.0001017369722831063
induced O 0 0.0019484726944938302
to O 0 0.0001895826862892136
proliferate O 0 0.0011804023524746299
, O 0 6.404229498002678e-05
the O 0 0.00011238563456572592
steady O 0 0.0006271459278650582
- O 0 0.0002858183579519391
state O 0 5.136682011652738e-05
levels O 0 0.00012926336785312742
of O 0 0.00013419603055808693
BRCA1 O 0 0.0021679282654076815
increase O 0 0.0001539045333629474
in O 0 0.00018352959887124598
late O 0 0.0016065743984654546
G1 O 0 0.4545155167579651
and O 0 8.697805606061593e-05
reach O 0 0.0001150935931946151
a O 0 9.183427755488083e-05
maximum O 0 0.00022724368318449706
during O 0 0.0015075239352881908
S O 0 0.015036866068840027
phase O 0 0.0067723579704761505
. O 0 0.0008479381212964654

Moreover O 0 0.005028055980801582
, O 0 0.0004737680428661406
in O 0 0.0004428744432516396
S O 0 0.06660949438810349
phase O 0 0.3507295846939087
cells O 0 0.001959936460480094
, O 0 0.0002801495138555765
BRCA1 O 0 0.008584251627326012
polypeptides O 0 0.001920853042975068
are O 0 7.904595258878544e-05
hyperphosphorylated O 0 0.0113467862829566
and O 0 0.00022768808412365615
accumulate O 0 0.00038905456312932074
into O 0 0.0003294273919891566
discrete O 0 0.001255701412446797
subnuclear O 1 0.5861994028091431
foci O 0 0.02065722458064556
termed O 0 0.01965942420065403
" O 0 0.004201886709779501
BRCA1 O 1 0.6313736438751221
nuclear O 0 0.011895830743014812
dots O 0 0.007245731074362993
. O 0 0.0010746772168204188

" O 0 0.015711169689893723
BRCA1 O 1 0.5165473818778992
associates O 0 0.002276874613016844
in O 0 0.000504609546624124
vivo O 0 0.0010306714102625847
with O 0 0.00011104180885013193
a O 0 0.0006623690715059638
structurally O 0 0.006304498761892319
related O 0 0.001091950573027134
protein O 0 0.0022028174716979265
termed O 0 0.20212922990322113
BARD1 O 1 0.9999856948852539
. O 0 0.0020790041889995337

Here O 0 0.002640120219439268
we O 0 0.00025699613615870476
show O 0 0.00018205371452495456
that O 0 1.810271351132542e-05
the O 0 8.415999764110893e-05
steady O 0 0.0007001947960816324
- O 0 0.0003014739486388862
state O 0 0.00011417582572903484
levels O 0 0.00030389276798814535
of O 0 0.0002997051924467087
BARD1 O 1 0.9999755620956421
, O 0 0.00022108918346930295
unlike O 0 0.0002684866776689887
those O 0 5.140377106727101e-05
of O 0 0.00037614876055158675
BRCA1 O 1 0.9908083081245422
, O 0 0.00021310668671503663
remain O 0 0.00017362425569444895
relatively O 0 0.00011606024054344743
constant O 0 0.00024580597528256476
during O 0 0.002073003677651286
cell O 0 0.0042226421646773815
cycle O 0 0.006192767061293125
progression O 0 0.037502169609069824
. O 0 0.0009385008597746491

However O 0 0.002740150550380349
, O 0 0.0010538026690483093
immunostaining O 1 0.9481517672538757
revealed O 0 0.005552951712161303
that O 0 0.00045530483475886285
BARD1 O 1 0.9998076558113098
resides O 0 0.003635573899373412
within O 0 0.0011699609458446503
BRCA1 O 0 0.01946963369846344
nuclear O 0 0.002964677521958947
dots O 0 0.0016286774771288037
during O 0 0.0012139363680034876
S O 0 0.0027120893355458975
phase O 0 0.00064155797008425
of O 0 0.00017118507821578532
the O 0 0.00033146722125820816
cell O 0 0.0011245120549574494
cycle O 0 0.0008454399066977203
, O 0 6.369160837493837e-05
but O 0 2.577548184490297e-05
not O 0 1.5143597920541652e-05
during O 0 0.00029228764469735324
the O 0 0.00045992914238013327
G1 O 1 0.9958094358444214
phase O 0 0.0075133261270821095
. O 0 0.0007717516273260117

Nevertheless O 0 0.016629811376333237
, O 0 0.0026771456468850374
BARD1 O 1 0.9996613264083862
polypeptides O 0 0.0027802123222500086
are O 0 5.808395872008987e-05
found O 0 7.005217048572376e-05
exclusively O 0 9.159289766103029e-05
in O 0 7.311896479222924e-05
the O 0 0.00015206301759462804
nuclear O 0 0.0005073219072073698
fractions O 0 0.00020231204689480364
of O 0 0.0001416743907611817
both O 0 0.0002094386873068288
G1 O 1 0.992412269115448
- O 0 0.0012861669529229403
and O 0 0.00026500862441025674
S O 0 0.01658974587917328
- O 0 0.0034406352788209915
phase O 0 0.008870717138051987
cells O 0 0.0019256308441981673
. O 0 0.0005157585255801678

Therefore O 0 0.0031843429896980524
, O 0 0.0006363216089084744
progression O 0 0.0038776667788624763
to O 0 0.00045807010610587895
S O 0 0.012469408102333546
phase O 0 0.0036292881704866886
is O 0 0.00018898276903200895
accompanied O 0 0.0006739480304531753
by O 0 4.1530427552061155e-05
the O 0 0.0001374575076624751
aggregation O 0 0.0002789637364912778
of O 0 0.0005040413234382868
nuclear O 0 0.005824850406497717
BARD1 O 1 0.9993933439254761
polypeptides O 0 0.0028327289037406445
into O 0 0.000930669775698334
BRCA1 O 0 0.04178321361541748
nuclear O 0 0.004930668976157904
dots O 0 0.003230791538953781
. O 0 0.0008130092755891383

This O 0 0.001598913106136024
cell O 0 0.0035656108520925045
cycle O 0 0.0035784589126706123
- O 0 0.001441902364604175
dependent O 0 0.0004549989535007626
colocalization O 0 0.008360694162547588
of O 0 0.001280327676795423
BARD1 O 1 0.9999979734420776
and O 0 0.0011030513560399413
BRCA1 O 0 0.01598571240901947
indicates O 0 0.000502448296174407
a O 0 0.0001925780816236511
role O 0 0.000450666033430025
for O 0 0.0001886727404780686
BARD1 O 1 0.9998923540115356
in O 0 0.0014326594537124038
BRCA1 O 1 0.9991312623023987
- O 0 0.12463171780109406
mediated O 1 0.6411358118057251
tumor B-Disease 1 0.9999933242797852
suppression O 1 0.9997679591178894
. O 0 0.0016704901354387403

Ethnic O 0 0.0029801088385283947
differences O 0 0.0009492497192695737
in O 0 0.0005955909145995975
the O 0 0.0011268358211964369
HFE O 1 0.9612892270088196
codon O 0 0.00563224358484149
282 O 0 0.009855201467871666
( O 0 0.0020477010402828455
Cys O 1 0.9873145818710327
/ O 0 0.0576651468873024
Tyr O 1 0.9136008620262146
) O 0 0.0009540432947687805
polymorphism O 0 0.0016110950382426381
. O 0 0.0006398350233212113

Recent O 0 0.0025149299763143063
studies O 0 0.0002903052663896233
have O 0 8.835876360535622e-05
shown O 0 0.00028975337045267224
that O 0 0.0004004255461040884
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999997615814209
HH B-Disease 1 1.0
) O 0 0.0007758403662592173
is O 0 8.888966112863272e-05
likely O 0 9.449486242374405e-05
to O 0 8.689366222824901e-05
be O 0 7.819972233846784e-05
caused O 0 0.0010026523377746344
by O 0 0.00013893534196540713
homozygosity O 0 0.015448329970240593
for O 0 9.475166734773666e-05
a O 0 0.0003637762274593115
Cys282Tyr O 1 0.786154568195343
mutation O 0 0.0003077533619944006
in O 0 0.00020980526460334659
the O 0 0.0005376851768232882
HFE O 1 0.9948882460594177
gene O 0 0.0004802747571375221
located O 0 0.0012510051019489765
4 O 0 0.001386567484587431
. O 0 0.0006813015788793564

5 O 0 0.007314969785511494
Mb O 0 0.027412667870521545
telomeric O 0 0.037834156304597855
to O 0 0.0019284794107079506
HLA O 1 0.9999014139175415
- O 0 0.0078044855035841465
A O 0 0.004578178282827139
. O 0 0.0012950979871675372

Population O 0 0.0004753069079015404
studies O 0 0.00010250804189126939
of O 0 0.0001729580108076334
this O 0 9.409958147443831e-05
polymorphism O 0 0.0002339689090149477
are O 0 1.670543679210823e-05
facilitated O 0 0.0002679095487110317
by O 0 4.730356522486545e-05
the O 0 0.0001441347412765026
fact O 0 0.00012650231656152755
that O 0 5.927470192546025e-05
the O 0 0.0003631141153164208
Cys282Tyr O 1 0.980558454990387
mutation O 0 0.0008545544114895165
creates O 0 0.0011122729629278183
a O 0 0.0010470657143741846
Rsal O 1 0.9886188507080078
restriction O 0 0.0022499817423522472
site O 0 0.0025268292520195246
. O 0 0.0005184440524317324

We O 0 0.0008195484988391399
have O 0 7.745067705400288e-05
studied O 0 0.0003266817075200379
the O 0 0.0003211706643924117
codon O 0 0.002203972777351737
282 O 0 0.006436808500438929
( O 0 0.0014610778307542205
Cys O 1 0.9906771183013916
/ O 0 0.03791555389761925
Tyr O 1 0.5881479978561401
) O 0 0.0004619269457180053
polymorphism O 0 0.0003711835015565157
in O 0 8.01434725872241e-05
different O 0 2.1997077055857517e-05
ethnic O 0 0.00020461983513087034
groups O 0 0.0001492443698225543
. O 0 0.0003473399847280234

In O 0 0.0013449890539050102
agreement O 0 0.0006374169024638832
with O 0 0.0001266658800886944
previous O 0 0.0004866217204835266
observations O 0 0.0004420823242980987
the O 0 0.0008205151534639299
Tyr O 0 0.4402773082256317
allele O 0 0.0008429491426795721
appeared O 0 0.0005540570709854364
to O 0 0.00011731133417924866
be O 0 9.04714543139562e-05
rare O 0 0.0005599763826467097
or O 0 0.00017609077622182667
absent O 0 0.000615712080616504
in O 0 0.0002183190663345158
Asiatic O 0 0.006581448018550873
( O 0 0.00034193109604530036
Indian O 0 0.0004657270619645715
, O 0 0.00013805896742269397
Chinese O 0 0.0012830168707296252
) O 0 0.0003033702087122947
populations O 0 0.00031746126478537917
. O 0 0.000330321432556957

The O 0 0.0024039207492023706
highest O 0 0.002272013807669282
allele O 0 0.00039130845107138157
frequency O 0 8.264598727691919e-05
( O 0 6.56747943139635e-05
7 O 0 0.00016791846428532153
. O 0 2.0794370357180014e-05
5 O 0 0.00013015091826673597
% O 0 6.245358235901222e-05
) O 0 8.956233796197921e-05
was O 0 0.00045427566510625184
found O 0 0.00014610325160901994
in O 0 0.00028687596204690635
Swedes O 0 0.003999684937298298
. O 0 0.0009123437339439988

Saamis O 1 0.8796789646148682
( O 0 0.0009534299606457353
2 O 0 0.0006366060115396976
% O 0 0.00011170036304974928
) O 0 9.195275197271258e-05
and O 0 0.00010553357424214482
Mordvinians O 0 0.03855905309319496
( O 0 0.00028149064746685326
1 O 0 0.00032493608887307346
. O 0 6.62804304738529e-05
8 O 0 0.0002983120793942362
% O 0 7.765893678879365e-05
) O 0 5.376026820158586e-05
had O 0 0.00017945334548130631
significantly O 0 0.0001820703619159758
lower O 0 0.0002342646475881338
frequencies O 0 4.872814679401927e-05
of O 0 0.0001391214900650084
the O 0 0.0008847580756992102
Tyr O 1 0.8091274499893188
allele O 0 0.0025500424671918154
. O 0 0.0008506466983817518

Comparisons O 0 0.0023106986191123724
with O 0 0.00037102322676219046
allele O 0 0.00044023594819009304
frequencies O 0 9.385994781041518e-05
based O 0 3.853047746815719e-05
on O 0 0.00016396751743741333
prevalence O 0 0.001013362081721425
estimates O 0 0.00017554662190377712
of O 0 0.0006208091508597136
HH B-Disease 1 0.9999946355819702
showed O 0 0.0015224071685224771
some O 0 9.512864926364273e-05
disagreements O 0 0.0008923940476961434
with O 0 0.00012450202484615147
the O 0 0.0005863251863047481
RFLP O 0 0.019021684303879738
data O 0 0.00017757319437805563
, O 0 0.0001131240715039894
particularly O 0 0.00025956923491321504
in O 0 0.00031003355979919434
Finns O 0 0.008920243941247463
. O 0 0.0007198673556558788

The O 0 0.004160880111157894
newly O 0 0.010546626523137093
described O 0 0.005242463201284409
HFE O 1 0.9996278285980225
marker O 0 0.0036490161437541246
provides O 0 0.00018428592011332512
a O 0 0.00014796059986110777
new O 0 7.392995030386373e-05
approach O 0 7.712771184742451e-05
to O 0 4.0411570807918906e-05
the O 0 0.00017787297838367522
screening O 0 0.0002672156842891127
of O 0 0.0005262726335786283
HH B-Disease 1 0.9999978542327881
as O 0 0.0005158092244528234
well O 0 9.547816443955526e-05
as O 0 7.500241190427914e-05
studies O 0 1.9671069821924902e-05
of O 0 9.298290387960151e-05
the O 0 0.00017748652317095548
relationship O 0 0.00034935513394884765
between O 0 0.000404624966904521
the O 0 0.003292661625891924
HFE O 1 0.9999984502792358
Tyr O 1 0.9997181296348572
allele O 0 0.001472783973440528
and O 0 0.0004352366377133876
different O 0 0.0005830787122249603
disorders O 1 0.9999991655349731
including O 1 0.99518221616745
cancer B-Disease 1 0.9999997615814209

Autosomal B-Disease 1 0.9995344877243042
dominant I-Disease 1 0.9999971389770508
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.999995231628418
associated O 0 0.001621987670660019
with O 0 0.00025080845807679
a O 0 0.0007681951974518597
missense O 0 0.0023177433758974075
mutation O 0 0.00035615990054793656
encoding O 0 0.0002792069280985743
Gly23 O 1 0.9621436595916748
- O 0 0.0035023565869778395
- O 0 0.0019615243654698133
> O 0 0.002199030015617609
Val O 0 0.011617888696491718
in O 0 0.0010360329179093242
neurophysin O 1 0.9989792704582214
II O 1 0.9999901056289673
. O 0 0.0026848234701901674

Autosomal B-Disease 1 0.995964527130127
dominant I-Disease 1 0.999975323677063
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 1 0.9738987684249878
ADNDI B-Disease 1 0.9999998807907104
) O 0 0.0004447399405762553
is O 0 0.0002736418682616204
an O 0 0.0011262005427852273
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9409698843955994
progressive O 1 0.9999994039535522
degeneration O 1 1.0
of O 1 0.9970189332962036
the O 1 0.8972086906433105
magnocellular O 1 0.9998840093612671
neurons O 0 0.0017696171998977661
of O 0 0.00035331223625689745
the O 0 0.0005478261155076325
hypothalamus O 0 0.05354089289903641
leading O 0 0.0012942953035235405
to O 0 0.00019300603889860213
decreased O 0 0.0008678619051352143
ability O 0 0.0001128936855820939
to O 0 9.877279808279127e-05
produce O 0 0.00021209049737080932
the O 0 0.0005087296012789011
hormone O 0 0.012463578023016453
arginine O 0 0.008293887600302696
vasopressin O 0 0.0632328912615776
( O 0 0.0015820724656805396
AVP O 1 0.9978285431861877
) O 0 0.0009544960921630263
. O 0 0.0008624643087387085

Affected O 0 0.00555837620049715
individuals O 0 0.00022677639208268374
are O 0 5.067109304945916e-05
not O 0 9.8418902780395e-05
symptomatic O 1 0.9736083745956421
at O 0 0.04899245500564575
birth O 0 0.0020841711666435003
, O 0 0.0002192239189753309
but O 0 0.00012770267494488508
usually O 0 0.00020508332818280905
develop O 0 0.0014851450687274337
diabetes B-Disease 1 0.9995715022087097
insipidus I-Disease 1 0.9986470341682434
at O 0 0.003092436818405986
1 O 0 0.0006621746579185128
- O 0 0.0006430221255868673
6 O 0 0.0010831785621121526
yr O 0 0.010386303998529911
of O 0 0.0006722332909703255
age O 0 0.0012322816764935851
. O 0 0.0008744742954149842

The O 0 0.002193437423557043
genetic O 0 0.0009716146159917116
locus O 0 0.001378609798848629
of O 0 0.0006777571979910135
the O 0 0.004155748523771763
disease O 1 0.9999659061431885
is O 0 0.00036095979157835245
the O 0 0.0009149732068181038
AVP O 1 0.9999747276306152
- O 0 0.005142698530107737
neurophysin O 1 0.9938046932220459
II O 1 0.9999898672103882
( O 0 0.0024850694462656975
NPII O 1 0.9999886751174927
) O 0 0.00033360873931087554
gene O 0 0.00023104535648599267
, O 0 8.588909986428916e-05
and O 0 0.00013612689508590847
mutations O 0 0.00034589922870509326
that O 0 0.0001784515770850703
cause O 1 0.9991409778594971
ADNDI B-Disease 1 1.0
have O 0 0.00017442739044781774
been O 0 6.117483280831948e-05
found O 0 3.622879012254998e-05
in O 0 2.8189175282022916e-05
both O 0 1.5990726751624607e-05
the O 0 6.688501161988825e-05
signal O 0 0.00027542587486095726
peptide O 0 0.00030187430093064904
of O 0 0.0001975973864318803
the O 0 0.0005862832185812294
prepro O 1 0.9993626475334167
- O 0 0.017165418714284897
AVP O 1 0.9999125003814697
- O 0 0.010483460500836372
NPII O 1 0.9994474053382874
precursor O 0 0.008056174963712692
and O 0 0.000412775669246912
within O 0 0.0009798170067369938
NPII O 1 0.9999773502349854
itself O 0 0.0051611945964396
. O 0 0.0012801534030586481

An O 0 0.0024635836016386747
affected O 0 0.0017861758824437857
girl O 0 0.0021014222875237465
who O 0 0.00017042303807102144
presented O 0 0.00036150283995084465
at O 0 0.0004746485501527786
9 O 0 0.00047093688044697046
months O 0 0.00025027981610037386
of O 0 0.0002153880341211334
age O 0 0.0005229234229773283
and O 0 0.00020526919979602098
her O 0 0.0006053358665667474
similarly O 0 0.0008201172458939254
affected O 0 0.0013773482060059905
younger O 0 0.0025576159823685884
brother O 0 0.006279134191572666
and O 0 0.0003442743618506938
father O 0 0.0015031233197078109
were O 0 0.00011752048158086836
all O 0 4.095170879736543e-05
found O 0 4.37543130828999e-05
to O 0 4.643355350708589e-05
have O 0 2.0445415430003777e-05
a O 0 9.414804662810639e-05
novel O 0 0.0004178870003670454
missense O 0 0.0013059449847787619
mutation O 0 0.0003835748939309269
( O 0 0.00043113064020872116
G1758 O 1 0.9892808794975281
- O 0 0.0039779432117938995
- O 0 0.001728889998048544
> O 0 0.0019831443205475807
T O 0 0.002063202206045389
) O 0 4.9630551075097173e-05
encoding O 0 4.39077994087711e-05
the O 0 8.560276182834059e-05
amino O 0 0.00028274429496377707
acid O 0 0.0007921578362584114
substitution O 0 0.0018292920431122184
Gly23 O 1 0.9897757768630981
- O 0 0.004933059681206942
- O 0 0.0023956659715622663
> O 0 0.0028874825220555067
Val O 0 0.01936214789748192
within O 0 0.0020000336226075888
NPII O 1 0.9996607303619385
. O 0 0.0019095268798992038

The O 0 0.002255690051242709
mutation O 0 0.0009983301861211658
was O 0 0.0010980027727782726
confirmed O 0 0.0004785993951372802
by O 0 0.0001072446902981028
restriction O 0 0.0004305135807953775
endonuclease O 0 0.0040155379101634026
analysis O 0 0.00026310933753848076
. O 0 0.0005511550698429346

A O 0 0.022830041125416756
T1 O 1 0.9971330165863037
- O 0 0.00329164182767272
weighted O 0 0.000822612433694303
magnetic O 0 0.0008028394659049809
resonance O 0 0.000765003205742687
imaging O 0 0.000869210809469223
of O 0 0.0006338278762996197
the O 0 0.00257841101847589
fathers O 1 0.8609529137611389
pituitary O 1 0.9999990463256836
gland O 1 0.9999061822891235
demonstrates O 0 0.012804193422198296
an O 0 0.001780015998519957
attenuated O 1 0.9552696943283081
posterior O 1 0.9996433258056641
pituitary O 1 0.9999995231628418
bright O 1 0.9953395128250122
spot O 0 0.01678609661757946
. O 0 0.0016567939892411232

This O 0 0.000870809075422585
mutation O 0 0.001135386759415269
may O 0 0.00022038370661903173
be O 0 5.891077671549283e-05
valuable O 0 0.0003275667841080576
for O 0 6.288254371611401e-05
developing O 0 0.00032776861917227507
models O 0 0.00032435450702905655
of O 0 0.0009038851130753756
dominantly B-Disease 1 0.9999809265136719
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.0009804401779547334
as O 0 0.00022342230658978224
the O 0 0.00019146672275383025
early O 0 0.0001933635794557631
age O 0 0.0001495097385486588
of O 0 0.0002874739293474704
onset O 1 0.9999728202819824
of O 1 0.9585456848144531
symptoms O 1 0.9999980926513672
suggests O 0 0.0007501030340790749
that O 0 4.952540621161461e-05
this O 0 6.346449663396925e-05
mutation O 0 0.00010078720515593886
may O 0 8.934856305131689e-05
be O 0 5.4486506996909156e-05
particularly O 0 0.0001380329194944352
deleterious O 0 0.0006052015232853591
to O 0 0.0001820485049393028
the O 0 0.000948315835557878
magnocellular O 1 0.9992832541465759
neuron O 1 0.9304594993591309
. O 0 0.0008452872862108052
. O 0 0.0006207893020473421

Frequent O 0 0.007046381011605263
inactivation O 0 0.038144491612911224
of O 0 0.010944453068077564
PTEN O 1 0.9999996423721313
/ O 1 0.9985679388046265
MMAC1 O 1 0.9999957084655762
in O 0 0.005797137506306171
primary O 1 0.9988295435905457
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.005021650344133377

Sporadic B-Disease 1 0.9999710321426392
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0014255172573029995
the O 0 0.0005855938070453703
most O 0 0.0001240139827132225
common O 0 0.000278314488241449
male B-Disease 0 0.0009662382071837783
cancer I-Disease 0 0.029714738950133324
in O 0 0.00017915245553012937
the O 0 0.0003400767454877496
Western O 0 0.0007425160147249699
world O 0 0.0005370352300815284
, O 0 6.673885945929214e-05
yet O 0 5.289817272569053e-05
many O 0 1.0725304491643328e-05
of O 0 4.867566894972697e-05
the O 0 0.00019431725377216935
major O 0 0.0011768427211791277
genetic O 0 0.000261171895544976
events O 0 0.0003762303967960179
involved O 0 0.00016325876640621573
in O 0 0.00013325855252332985
the O 0 0.000270455697318539
progression O 0 0.002898783888667822
of O 0 0.00041402431088499725
this O 0 0.00025086416280828416
often O 0 0.0004803198971785605
fatal O 1 0.9999998807907104
cancer B-Disease 1 0.9999849796295166
remain O 0 0.0008124192245304585
to O 0 0.0003841486759483814
be O 0 0.0002920809492934495
elucidated O 0 0.009661278687417507
. O 0 0.0010329029755666852

Numerous O 0 0.008893020451068878
cytogenetic O 1 0.8679609298706055
and O 0 0.0022731944918632507
allelotype O 1 0.9990723133087158
studies O 0 0.0003668779390864074
have O 0 0.00010901139467023313
reported O 0 0.0002488317550159991
frequent O 0 0.00026632522349245846
loss O 0 0.001245704828761518
of O 0 0.0010946086840704083
heterozygosity O 1 0.9987492561340332
on O 0 0.003390698228031397
chromosomal O 1 0.9970172643661499
arm O 1 0.9998034834861755
10q O 1 0.9999923706054688
in O 0 0.04188394173979759
sporadic B-Disease 1 0.9999903440475464
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.003802882507443428

Deletion O 0 0.010368000715970993
mapping O 0 0.0023773284628987312
studies O 0 0.00015227080439217389
have O 0 5.559713827096857e-05
unambiguously O 0 0.000520248431712389
identified O 0 0.00014022183313500136
a O 0 0.00015347046428360045
region O 0 0.000367351109161973
of O 0 0.00045783346286043525
chromosome O 0 0.003655057866126299
10q23 O 1 0.9993681311607361
to O 0 0.0002038121601799503
be O 0 6.837257387815043e-05
the O 0 0.00012510514352470636
minimal O 0 0.0003653968160506338
area O 0 0.00036319479113444686
of O 0 0.0006384963635355234
loss O 0 0.1907087117433548
. O 0 0.0009455478866584599

A O 0 0.006177467294037342
new O 0 0.002228629309684038
tumor B-Disease 1 0.9998262524604797
suppressor O 1 0.705075740814209
gene O 0 0.0011816584737971425
, O 0 0.0006524684140458703
PTEN O 1 0.9999864101409912
/ O 1 0.9892007112503052
MMAC1 O 1 0.9999974966049194
, O 0 0.0006647725240327418
was O 0 0.0010509303538128734
isolated O 0 0.0010109830182045698
recently O 0 0.0003197838377673179
at O 0 0.00017058805678971112
this O 0 2.0727569790324196e-05
region O 0 0.00014773363363929093
of O 0 0.00031099983607418835
chromosome O 0 0.0039682816714048386
10q23 O 1 0.9998451471328735
and O 0 0.000309516181005165
found O 0 0.00012172317656222731
to O 0 6.97676368872635e-05
be O 0 3.712140824063681e-05
inactivated O 0 0.0007118589128367603
by O 0 3.8129855965962633e-05
mutation O 0 8.964838343672454e-05
in O 0 0.0001907871337607503
three O 0 0.0015157604357227683
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9983645081520081
lines O 0 0.005275980569422245
. O 0 0.0012358586536720395

We O 0 0.002895538927987218
screened O 0 0.007172065787017345
80 O 0 0.028827475383877754
prostate B-Disease 1 0.9999996423721313
tumors I-Disease 1 0.999996542930603
by O 0 0.0004529659345280379
microsatellite O 0 0.003045466961339116
analysis O 0 6.822506838943809e-05
and O 0 8.784426609054208e-05
found O 0 0.0001857703027781099
chromosome O 0 0.001034090295433998
10q23 O 1 0.8190793991088867
to O 0 0.0001854862493928522
be O 0 0.00011884213017765433
deleted O 0 0.00039448332972824574
in O 0 0.00012264534598216414
23 O 0 0.0008844638359732926
cases O 0 0.0004470236017368734
. O 0 0.0006706878775730729

We O 0 0.000899351725820452
then O 0 0.0003977394080720842
proceeded O 0 0.0006728791049681604
with O 0 2.838823820638936e-05
sequence O 0 5.53188547200989e-05
analysis O 0 2.094792580464855e-05
of O 0 0.00013530180149246007
the O 0 0.0005068153841421008
entire O 0 0.016418827697634697
PTEN O 1 0.9999946355819702
/ O 1 0.5210332870483398
MMAC1 O 1 0.999944806098938
coding O 0 0.0024864431470632553
region O 0 0.0005939747206866741
and O 0 0.00020009835134260356
tested O 0 0.00046145913074724376
for O 0 0.00010547843703534454
homozygous O 0 0.00043391843792051077
deletion O 0 0.00035924706025980413
with O 0 6.739413947798312e-05
new O 0 0.0003261803649365902
intragenic O 1 0.876067578792572
markers O 0 0.0011023784754797816
in O 0 0.00013109116116538644
these O 0 3.216938057448715e-05
23 O 0 0.00029849892598576844
cases O 0 0.00013480649795383215
with O 0 0.0001876229071058333
10q23 O 1 0.9996826648712158
loss O 0 0.3549351692199707
of O 0 0.003748357528820634
heterozygosity O 1 0.999903678894043
. O 0 0.0022423516493290663

The O 0 0.0011074361391365528
identification O 0 0.00019578200590331107
of O 0 0.00026504401466809213
the O 0 0.0005090201739221811
second O 0 0.0011729313991963863
mutational O 0 0.0046403477899730206
event O 0 0.000678961630910635
in O 0 7.870853005442768e-05
10 O 0 0.00011999816342722625
( O 0 6.818726978963241e-05
43 O 0 0.00032106228172779083
% O 0 0.00019832031102851033
) O 0 0.0005135799292474985
tumors B-Disease 1 0.9999754428863525
establishes O 1 0.5535910725593567
PTEN O 1 0.9999991655349731
/ O 1 0.8896175026893616
MMAC1 O 1 0.9998400211334229
as O 0 0.000374459195882082
a O 0 0.0002454956411384046
main O 0 0.0006703153485432267
inactivation O 0 0.0025561575312167406
target O 0 0.00019150925800204277
of O 0 0.0002742354990914464
10q O 1 0.9985018968582153
loss O 0 0.3203541040420532
in O 0 0.0021806785371154547
sporadic B-Disease 1 0.9999884366989136
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0014781313948333263
. O 0 0.0008088793838396668

Risk O 0 0.008311878889799118
reversals O 0 0.014604466035962105
in O 0 0.001093038241378963
predictive O 0 0.0014731010887771845
testing O 0 0.0013293972006067634
for O 0 0.0015050368383526802
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.005495814606547356

The O 0 0.001850116765126586
first O 0 0.0008121088612824678
predictive O 0 0.0008009863668121397
testing O 0 0.0004774515691678971
for O 0 0.0005200598388910294
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.7031364440917969
HD B-Disease 1 0.9932252764701843
) O 0 0.00010960657527903095
was O 0 0.00019018813327420503
based O 0 2.0479918021010235e-05
on O 0 3.522181214066222e-05
analysis O 0 2.0770705305039883e-05
of O 0 0.00017548118194099516
linked O 0 0.0009539296734146774
polymorphic O 0 0.0012765104183927178
DNA O 0 0.0005060345865786076
markers O 0 0.0005701488698832691
to O 0 8.412156603299081e-05
estimate O 0 6.425112951546907e-05
the O 0 7.845658547012135e-05
likelihood O 0 0.0001908855774672702
of O 0 0.00020681491878349334
inheriting O 0 0.0034374191891402006
the O 0 0.0008091327035799623
mutation O 0 0.0005982842994853854
for O 0 0.00031476790900342166
HD B-Disease 0 0.01731361262500286
. O 0 0.0005830277223140001

Limits O 0 0.0010707654291763902
to O 0 0.0003020170843228698
accuracy O 0 0.00022885050566401333
included O 0 0.0001873958681244403
recombination O 0 0.0003720234672073275
between O 0 0.00014735911099705845
the O 0 0.00029596866806969047
DNA O 0 0.000422088400227949
markers O 0 0.0006542343180626631
and O 0 0.00011332758731441572
the O 0 0.00033823889680206776
mutation O 0 0.00025290113990195096
, O 0 0.00015741823881398886
pedigree O 0 0.0015171495033428073
structure O 0 0.0011811829172074795
, O 0 0.00016405807400587946
and O 0 6.437427509808913e-05
whether O 0 6.431451038224623e-05
DNA O 0 0.0001822270278353244
samples O 0 0.00011083204299211502
were O 0 7.511335570598021e-05
available O 0 2.7106734705739655e-05
from O 0 6.386859604390338e-05
family O 0 0.00022433206322602928
members O 0 0.00022324814926832914
. O 0 0.00037849732325412333

With O 0 0.0006194961024448276
direct O 0 0.00024860596749931574
tests O 0 0.00010725378524512053
for O 0 6.731051689712331e-05
the O 0 0.0005726818926632404
HD B-Disease 0 0.33197885751724243
mutation O 0 0.0003883229219354689
, O 0 8.358326886082068e-05
we O 0 4.5431563194142655e-05
have O 0 1.4654914593847934e-05
assessed O 0 5.415616396931e-05
the O 0 5.4172644013306126e-05
accuracy O 0 7.71356571931392e-05
of O 0 9.501441672910005e-05
results O 0 9.18045116122812e-05
obtained O 0 7.691222708672285e-05
by O 0 6.622230284847319e-05
linkage O 0 0.0009241328225471079
approaches O 0 0.0005089318729005754
when O 0 0.00019613832409959286
requested O 0 0.00021268871205393225
to O 0 8.088513277471066e-05
do O 0 4.676542084780522e-05
so O 0 3.2188589102588594e-05
by O 0 2.4007798856473528e-05
the O 0 0.00014693831326439977
test O 0 0.00026521767722442746
individuals O 0 0.00010917930922005326
. O 0 0.0003953780105803162

For O 0 0.0005566382315009832
six O 0 0.0004160801472608
such O 0 7.246321183629334e-05
individuals O 0 7.519448263337836e-05
, O 0 0.00010011401172960177
there O 0 0.00012418261030688882
was O 0 0.0007009165128692985
significant O 0 0.00040226656710729003
disparity O 0 0.0018942488823086023
between O 0 0.0003881693701259792
the O 0 0.0007831025868654251
tests O 0 0.000586751732043922
. O 0 0.0006011903751641512

Three O 0 0.000671599933411926
went O 0 0.0010984082473441958
from O 0 0.00022374508262146264
a O 0 0.0004707519256044179
decreased O 0 0.0019494857406243682
risk O 0 0.00014489733439404517
to O 0 5.628970393445343e-05
an O 0 0.00014754553558304906
increased O 0 0.0003498560981824994
risk O 0 0.00020186616166029125
, O 0 5.1674382120836526e-05
while O 0 3.144410584354773e-05
in O 0 3.178848419338465e-05
another O 0 8.60299332998693e-05
three O 0 7.261781138367951e-05
the O 0 0.0003409675264265388
risk O 0 0.0007507524569518864
was O 0 0.006026820279657841
decreased O 0 0.02964463084936142
. O 0 0.0008892678888514638

Knowledge O 0 0.003661360824480653
of O 0 0.0013870905386283994
the O 0 0.0010613686172291636
potential O 0 0.0008586461190134287
reasons O 0 0.0002187441277783364
for O 0 4.497441841522232e-05
these O 0 2.2358268324751407e-05
changes O 0 4.9465266783954576e-05
in O 0 8.466526924166828e-05
results O 0 9.900797886075452e-05
and O 0 6.473082612501457e-05
impact O 0 0.00025306950556114316
of O 0 0.00016969737771432847
these O 0 5.9632788179442286e-05
risk O 0 0.0003466760681476444
reversals O 0 0.009171412326395512
on O 0 0.0005550743080675602
both O 0 0.0002278542087879032
patients O 0 0.00024574314011260867
and O 0 0.00013528902491088957
the O 0 0.0004249461635481566
counseling O 0 0.0009534767596051097
team O 0 0.00035432400181889534
can O 0 4.709965651272796e-05
assist O 0 0.000219460460357368
in O 0 8.563689334550872e-05
the O 0 0.0002079467085422948
development O 0 0.00016819442680571228
of O 0 0.00013857969315722585
strategies O 0 0.00028105912497267127
for O 0 6.353715434670448e-05
the O 0 0.00034497235901653767
prevention O 1 0.7793835997581482
and O 0 0.00018665862444322556
, O 0 0.00010191951878368855
where O 0 0.00011508559691719711
necessary O 0 0.00018370292673353106
, O 0 7.597696094308048e-05
management O 0 0.00020372435392346233
of O 0 0.00018171031842939556
a O 0 0.0004973718314431608
risk O 0 0.00040091562550514936
reversal O 0 0.0020992576610296965
in O 0 0.0001956043706741184
any O 0 0.0001720074360491708
predictive O 0 0.0006357287638820708
testing O 0 0.00046127752284519374
program O 0 0.00039554995601065457
. O 0 0.00017905374988913536
. O 0 0.0003695623017847538

A O 0 0.007299107499420643
novel O 0 0.0025047757662832737
common O 0 0.0007979741785675287
missense O 0 0.002793141407892108
mutation O 0 0.0006277499487623572
G301C O 0 0.007793239783495665
in O 0 0.00017498810484539717
the O 0 0.0003687755379360169
N O 0 0.0014906880678609014
- O 0 0.0010927146067842841
acetylgalactosamine O 0 0.05005962774157524
- O 0 0.0012657667975872755
6 O 0 0.001604799646884203
- O 0 0.002048895927146077
sulfate O 0 0.014493019320070744
sulfatase O 1 0.6788293123245239
gene O 0 0.000724787067156285
in O 0 0.0012656713370233774
mucopolysaccharidosis B-Disease 1 0.9998750686645508
IVA I-Disease 1 0.9999896287918091
. O 0 0.0038400732446461916

Mucopolysaccharidosis B-Disease 1 0.9999617338180542
IVA I-Disease 1 0.9999990463256836
( O 0 0.11311382055282593
MPS B-Disease 1 0.999925971031189
IVA I-Disease 1 0.9999998807907104
) O 0 0.0010471800342202187
is O 0 0.00022528678528033197
an O 0 0.0003943533811252564
autosomal B-Disease 0 0.028679396957159042
recessive I-Disease 1 0.9999732971191406
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999996423721313
by O 0 0.0004345720517449081
a O 0 0.0009153869468718767
genetic B-Disease 0 0.005042946897447109
defect I-Disease 1 0.999975323677063
in O 0 0.0007124248659238219
N O 0 0.0033286481630057096
- O 0 0.0013017712626606226
acetylgalactosamine O 0 0.017638184130191803
- O 0 0.0011359150521457195
6 O 0 0.0018310638843104243
- O 0 0.002807160373777151
sulfate O 0 0.2736057639122009
sulfatase O 1 0.9994422793388367
( O 0 0.0043729133903980255
GALNS O 1 0.9999922513961792
) O 0 0.0012057842686772346
. O 0 0.000723180128261447

In O 0 0.0013276960235089064
previous O 0 0.0009745325660333037
studies O 0 0.00014883406402077526
, O 0 0.0001070583239197731
we O 0 5.144417445990257e-05
have O 0 2.026774745900184e-05
found O 0 3.164505324093625e-05
two O 0 4.7590703616151586e-05
common O 0 0.0001538226642878726
mutations O 0 0.00022106600226834416
in O 0 0.0002941085258498788
Caucasians O 0 0.008170363493263721
and O 0 0.0004017381288576871
Japanese O 0 0.009082796983420849
, O 0 0.0004395568394102156
respectively O 0 0.0009515595738776028
. O 0 0.0004721977165900171

To O 0 0.0019184822449460626
characterize O 0 0.005621669813990593
the O 0 0.0013930000131949782
mutational O 0 0.010573964565992355
spectrum O 0 0.0011436428176239133
in O 0 0.0001202478670165874
various O 0 6.35167962173e-05
ethnic O 0 0.00011320803605485708
groups O 0 3.8410256820498034e-05
, O 0 7.94461666373536e-05
mutations O 0 7.201358675956726e-05
in O 0 9.92612331174314e-05
the O 0 0.0004191433254163712
GALNS O 1 0.9998470544815063
gene O 0 0.0003722008259501308
in O 0 0.00020835197938140482
Colombian O 0 0.007038878742605448
MPS B-Disease 1 0.9993625283241272
IVA I-Disease 1 1.0
patients O 0 0.002371762879192829
were O 0 0.00033462163992226124
investigated O 0 0.001579493866302073
, O 0 0.00022798914869781584
and O 0 0.0001931695151142776
genetic O 0 0.00029712330433540046
backgrounds O 0 0.0003951606049668044
were O 0 0.00018292266759090126
extensively O 0 0.00031121791107580066
analyzed O 0 0.00012965122004970908
to O 0 4.4722975871991366e-05
identify O 0 7.46013829484582e-05
racial O 0 0.0003475011035334319
origin O 0 7.431935227941722e-05
, O 0 3.7229143345030025e-05
based O 0 1.3113693967170548e-05
on O 0 6.390862836269662e-05
mitochondrial O 0 0.0005046968581154943
DNA O 0 0.00043173664016649127
( O 0 0.0002662069455254823
mtDNA O 0 0.0003192611038684845
) O 0 0.00013363061589188874
lineages O 0 0.0011924186255782843
. O 0 0.0007873210706748068

Three O 0 0.0022362894378602505
novel O 0 0.003248537890613079
missense O 0 0.006814157124608755
mutations O 0 0.000570772506762296
never O 0 0.0006639640196226537
identified O 0 0.00014062380068935454
previously O 0 0.0001749644143274054
in O 0 6.910350202815607e-05
other O 0 3.305550853838213e-05
populations O 0 5.065872392151505e-05
and O 0 4.2755986214615405e-05
found O 0 3.541226396919228e-05
in O 0 5.6602657423354685e-05
16 O 0 0.00022715009981766343
out O 0 9.059844887815416e-05
of O 0 0.00027119883452542126
19 O 0 0.002076328732073307
Colombian O 0 0.009507807902991772
MPS B-Disease 1 0.9915456175804138
IVA I-Disease 1 0.999996542930603
unrelated O 0 0.00420520780608058
alleles O 0 0.0005694936262443662
account O 0 0.00012175463052699342
for O 0 0.00015049017383717
84 O 0 0.003195691155269742
. O 0 0.0008499118266627192

2 O 0 0.0017514392966404557
% O 0 0.00015119956515263766
of O 0 0.00023056825739331543
the O 0 0.0005090652266517282
alleles O 0 0.0002875956706702709
in O 0 0.00014243891928344965
this O 0 0.00010624868446029723
study O 0 0.0002065683511318639
. O 0 0.00040602294029667974

The O 0 0.00825067050755024
G301C O 1 0.9955009818077087
and O 0 0.0015121432952582836
S162F O 1 0.9594825506210327
mutations O 0 0.00045896213850937784
account O 0 0.00016336575208697468
for O 0 0.00018413325597066432
68 O 0 0.0022072645369917154
. O 0 0.0008044270216487348

4 O 0 0.0034377428237348795
% O 0 0.0003918510628864169
and O 0 0.0002929851762019098
10 O 0 0.0008854091283865273
. O 0 0.000758164853323251

5 O 0 0.0017863594694063067
% O 0 0.0003403735172469169
of O 0 0.0004066449764650315
mutations O 0 0.0005416944622993469
, O 0 0.00018603425996843725
respectively O 0 0.0004066626133862883
, O 0 0.00011095259833382443
whereas O 0 0.000169259452377446
the O 0 0.00021414138609543443
remaining O 0 0.0008721132180653512
F69V O 1 0.999618411064148
is O 0 0.0001720735162962228
limited O 0 6.119946192484349e-05
to O 0 4.358610021881759e-05
a O 0 0.0002262317284476012
single O 0 0.0003786012530326843
allele O 0 0.0008725691004656255
. O 0 0.00042833539191633463

The O 0 0.0024268850684165955
skewed O 0 0.0029443521052598953
prevalence O 0 0.0020824475213885307
of O 0 0.0007201541448011994
G301C O 1 0.9956339001655579
in O 0 0.000386557454476133
only O 0 0.0001551541790831834
Colombian O 0 0.0015424223383888602
patients O 0 0.000205209493287839
and O 0 7.848278619349003e-05
haplotype O 0 0.0004302753950469196
analysis O 0 4.626585723599419e-05
by O 0 7.108499994501472e-05
restriction O 0 0.00016442248306702822
fragment O 0 0.0005114874802529812
length O 0 0.00015840599371585995
polymorphisms O 0 0.00030378616065718234
in O 0 0.00014197219570633024
the O 0 0.0005356380715966225
GALNS O 1 0.9998249411582947
gene O 0 0.0003795640077441931
suggest O 0 0.0002852276375051588
that O 0 0.00012854210217483342
G301C O 0 0.013412092812359333
originated O 0 0.0013696019304916263
from O 0 0.0002777845656964928
a O 0 0.00041751429671421647
common O 0 0.0005387363489717245
ancestor O 0 0.006422504782676697
. O 0 0.00171303516253829

Investigation O 0 0.0026799566112458706
of O 0 0.0006728252046741545
the O 0 0.0006014834507368505
genetic O 0 0.00025066238595172763
background O 0 0.0003677035856526345
by O 0 7.474608719348907e-05
means O 0 0.00012558061280287802
of O 0 0.00012981453619431704
mtDNA O 0 0.00018659669149201363
lineages O 0 0.00020249112276360393
indicate O 0 0.00011981054558418691
that O 0 3.454239049460739e-05
all O 0 4.8901787522481754e-05
our O 0 0.00021081730665173382
patients O 0 0.00012135347060393542
are O 0 1.8353182895225473e-05
probably O 0 0.00021168908278923482
of O 0 0.00022476111189462245
native O 0 0.0007946243858896196
American O 0 0.0023752881679683924
descent O 0 0.00993034616112709

Low O 0 0.004053313750773668
frequency O 0 0.0004963343380950391
of O 0 0.0007459272746928036
BRCA1 O 0 0.1291726529598236
germline O 0 0.01377023570239544
mutations O 0 0.00040532948332838714
in O 0 0.00023614145175088197
45 O 0 0.0010092261945828795
German O 1 0.9986642599105835
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0034755391534417868
. O 0 0.0011050860630348325

In O 0 0.0008174178074114025
this O 0 0.00011485152208479121
study O 0 4.549824006971903e-05
we O 0 4.131253808736801e-05
investigated O 0 0.0003551984264049679
45 O 0 0.0007450697594322264
German O 1 0.9516751170158386
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.0005941621493548155
for O 0 0.00023309073003474623
germline O 0 0.013398156501352787
mutations O 0 0.00018024459131993353
in O 0 0.00014228660438675433
the O 0 0.0005238692974671721
BRCA1 O 0 0.36710724234580994
gene O 0 0.0012995549477636814
. O 0 0.0008481547120027244

We O 0 0.0007841411861591041
identified O 0 0.0005654270644299686
four O 0 0.0004227582539897412
germline O 0 0.005118756089359522
mutations O 0 0.00029339492903091013
in O 0 0.00018679590721148998
three O 0 0.0005045013385824859
breast B-Disease 1 0.9999114274978638
cancer I-Disease 1 0.9458087086677551
families O 0 0.00014297437155619264
and O 0 0.0001108087963075377
in O 0 0.0002389872242929414
one O 0 0.001331035397015512
breast B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0028665317222476006
. O 0 0.00014574482338503003
among O 0 9.041849989444017e-05
these O 0 1.9302196960779838e-05
were O 0 7.546248525613919e-05
one O 0 0.00012589689868036658
frameshift O 0 0.0027988723013550043
mutation O 0 0.0002483610005583614
, O 0 0.00010990349255735055
one O 0 0.0001873229630291462
nonsense O 0 0.0027093039825558662
mutation O 0 0.000366810621926561
, O 0 9.594107541488484e-05
one O 0 7.827006629668176e-05
novel O 0 0.00036716522299684584
splice O 0 0.0032921198289841413
site O 0 0.0011258358135819435
mutation O 0 0.0002813196915667504
, O 0 9.597402095096186e-05
and O 0 8.835842891130596e-05
one O 0 0.000279073603451252
missense O 0 0.0036276644095778465
mutation O 0 0.0013278843834996223
. O 0 0.0006125041400082409

The O 0 0.0032407469116151333
missense O 0 0.006922363303601742
mutation O 0 0.00086412881501019
was O 0 0.000787781085819006
also O 0 0.00011650533997453749
found O 0 7.9774581536185e-05
in O 0 0.0002092372888000682
2 O 0 0.0007082008523866534
. O 0 0.0004702119913417846

8 O 0 0.0023769971448928118
% O 0 0.0001427490497007966
of O 0 0.0001574077468831092
the O 0 0.00016278884140774608
general O 0 0.0003533417184371501
population O 0 6.154429138405249e-05
, O 0 4.8935835366137326e-05
suggesting O 0 0.00016988163406495005
that O 0 3.5438279155641794e-05
it O 0 6.93518013576977e-05
is O 0 0.0001172182965092361
not O 0 0.00022033201821614057
disease O 1 0.9996237754821777
associated O 0 0.0015831519849598408
. O 0 0.0009288997971452773

The O 0 0.0021913417149335146
average O 0 0.0010285107418894768
age O 0 0.0007059986819513142
of O 0 0.0013222326524555683
disease O 1 0.9999998807907104
onset O 1 0.9999998807907104
in O 0 0.0027023570146411657
those O 0 0.00022306428581941873
families O 0 0.00039102096343412995
harbouring O 1 0.996620774269104
causative O 1 0.789034903049469
mutations O 0 0.0008410740410909057
was O 0 0.0015972279943525791
between O 0 0.0008325097151100636
32 O 0 0.0018173747230321169
. O 0 0.0007890937849879265

3 O 0 0.004211174789816141
and O 0 0.001011642045341432
37 O 0 0.003132163779810071
. O 0 0.0011125298915430903

4 O 0 0.004833591636270285
years O 0 0.000825301103759557
, O 0 0.00018917821580544114
whereas O 0 0.0003469795628916472
the O 0 0.00038563416455872357
family O 0 0.0005591596127487719
harbouring O 1 0.8861649036407471
the O 0 0.0013283746084198356
missense O 0 0.0019694131333380938
mutation O 0 0.00018859001283999532
had O 0 0.00013971066800877452
an O 0 8.841674571158364e-05
average O 0 0.00010482288780622184
age O 0 0.00016704176960047334
of O 0 0.0004621328553184867
onset O 1 0.999014139175415
of O 0 0.006459473632276058
51 O 0 0.013357103802263737
. O 0 0.0011475476203486323

2 O 0 0.0060743484646081924
years O 0 0.002474660985171795
. O 0 0.001036906847730279

These O 0 0.0005685111391358078
findings O 0 0.0005751615390181541
show O 0 0.0006248728022910655
that O 0 0.00021372038463596255
BRCA1 O 0 0.005204919725656509
is O 0 0.00015432496729772538
implicated O 0 0.0015082634054124355
in O 0 0.00012935239647049457
a O 0 0.0001430143165634945
small O 0 8.85110639501363e-05
fraction O 0 0.000417459785239771
of O 0 0.003090223763138056
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.0004839793546125293
suggesting O 0 0.000356351985828951
the O 0 0.00012178120960015804
involvement O 0 0.00033325652475468814
of O 0 0.000266709947027266
another O 0 0.0010565891861915588
susceptibility O 0 0.007163676433265209
gene O 0 0.0007331894594244659
( O 0 0.0007466423558071256
s O 0 0.005556742660701275
) O 0 0.001067799050360918

Paternal O 1 0.9743033647537231
transmission O 1 0.9999362230300903
of O 1 0.9999966621398926
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999232292175293

We O 0 0.0010860529728233814
report O 0 0.00024376474902965128
a O 0 0.00022264699509833008
rare O 0 0.0005663990741595626
case O 0 0.0006116824806667864
of O 0 0.0022181575186550617
paternally O 1 0.9999948740005493
transmitted O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.003311427542939782
. O 0 0.0008379686623811722

The O 0 0.002905777422711253
proband O 0 0.12182985991239548
is O 0 0.00019966553372796625
a O 0 0.00029357627499848604
23 O 0 0.0008741298806853592
year O 0 0.0007291223737411201
old O 0 0.004171509761363268
, O 0 0.0016207849839702249
mentally B-Disease 1 0.9999992847442627
retarded I-Disease 1 0.9999985694885254
male O 0 0.25909876823425293
who O 0 0.3879026472568512
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9982617497444153

He O 0 0.004613956436514854
presented O 0 0.0030928056221455336
with O 0 0.0012689176946878433
respiratory O 1 1.0
and O 0 0.3895399868488312
feeding O 1 0.7533247470855713
difficulties O 1 0.9940096139907837
at O 1 0.9131943583488464
birth O 0 0.008427117951214314
. O 0 0.0012644964735955

His O 0 0.009038182906806469
two O 0 0.0031779694836586714
sibs O 1 0.9994788765907288
suffer O 1 0.9013164639472961
from O 0 0.005100747104734182
childhood O 1 0.9999555349349976
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.01204228587448597

Their O 0 0.0008375518955290318
late O 0 0.002785715740174055
father O 0 0.0023826120886951685
had O 0 0.00036633381387218833
the O 0 0.0002858069201465696
adult O 0 0.00017638788267504424
type O 0 0.00044502850505523384
of O 0 0.0014504891587421298
DM B-Disease 1 1.0
, O 0 0.00041383469942957163
with O 0 0.00013692140055354685
onset O 1 0.9923061728477478
around O 0 0.0014110879274085164
30 O 0 0.0013188241282477975
years O 0 0.0008191051310859621
. O 0 0.0003958385204896331

Only O 0 0.0006117331213317811
six O 0 0.00030382873956114054
other O 0 6.190900603542104e-05
cases O 0 9.297262295149267e-05
of O 0 0.000614078831858933
paternal O 1 0.8457430601119995
transmission O 1 0.9999186992645264
of O 1 0.9999920129776001
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.008056250400841236
been O 0 0.0006723986589349806
reported O 0 0.000526498188264668
recently O 0 0.0007380644092336297
. O 0 0.00035349451354704797

We O 0 0.0008372710435651243
review O 0 0.00026782581699080765
the O 0 0.0003016326518263668
sex O 0 0.0005636675632558763
related O 0 0.0004830635734833777
effects O 0 0.0017938405508175492
on O 0 0.0017799853812903166
transmission O 1 0.9966679215431213
of O 1 0.9997362494468689
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.3483956456184387

Decreased O 0 0.33609896898269653
fertility O 0 0.005739659070968628
of O 0 0.00055223039817065
males O 0 0.0001338065485469997
with O 0 0.00012094636622350663
adult O 0 0.0007648234604857862
onset O 1 0.9999973773956299
DM B-Disease 1 1.0
and O 0 0.0008929123869165778
contraction O 0 0.003957943990826607
of O 0 0.0002914278593380004
the O 0 0.0003412228252273053
repeat O 0 0.0012775382492691278
upon O 0 0.0006408157641999424
male O 0 0.0007719421410001814
transmission O 0 0.0007516242330893874
contribute O 0 0.00021280290093272924
to O 0 6.959593156352639e-05
the O 0 0.00016783330647740513
almost O 0 0.00021391607879195362
absent O 0 0.000787540222518146
occurrence O 0 0.0006394073716364801
of O 0 0.0006362457643263042
paternal O 0 0.14474157989025116
transmission O 1 0.9994159936904907
of O 1 0.999910831451416
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8398382663726807

Also O 0 0.001064246753230691
the O 0 0.0005920733674429357
fathers O 0 0.0007270775968208909
of O 0 0.00041175525984726846
the O 0 0.0009457911364734173
reported O 0 0.00242811581119895
congenitally O 1 0.9931700229644775
affected O 0 0.0011023636907339096
children O 0 0.0002729195693973452
showed O 0 0.0006476491689682007
, O 0 8.15477833384648e-05
on O 0 0.00020637166744563729
average O 0 0.0003030490770470351
, O 0 0.000218348199268803
shorter O 0 0.0008888891898095608
CTG O 1 0.8373962640762329
repeat O 0 0.004129236098378897
lengths O 0 0.0020992576610296965
and O 0 0.0002584574685897678
hence O 0 0.0006542911869473755
less O 0 0.0004968076827935874
severe O 1 0.9997939467430115
clinical O 1 0.7307623624801636
symptoms O 1 0.9999842643737793
than O 0 0.000740984920412302
the O 0 0.0010834581917151809
mothers O 0 0.0007604702259413898
of O 0 0.0004718886048067361
children O 0 0.0011093155480921268
with O 0 0.03404378145933151
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.6370754241943359

We O 0 0.0014166595647111535
conclude O 0 0.0021378202363848686
that O 0 0.0002394095790805295
paternal O 0 0.006018407642841339
transmission O 1 0.7744317054748535
of O 1 0.9993910789489746
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.42530331015586853
rare O 0 0.0033966863993555307
and O 0 0.0003041356394533068
preferentially O 0 0.000484009797219187
occurs O 0 0.00014492165064439178
with O 0 5.6805758504197e-05
onset O 1 0.7386670708656311
of O 0 0.004861856810748577
DM B-Disease 1 1.0
past O 0 0.0013197653461247683
30 O 0 0.0003738677769433707
years O 0 9.811062773223966e-05
in O 0 6.665643741143867e-05
the O 0 0.00020998156105633825
father O 0 0.001473830547183752
. O 0 0.00035982803092338145
. O 0 0.000455470202723518

The O 0 0.008312121964991093
RB1 O 1 0.9996716976165771
gene O 0 0.0011140168644487858
mutation O 0 0.0004074668977409601
in O 0 0.00023290990793611854
a O 0 0.0005580383003689349
child O 0 0.002753342967480421
with O 0 0.001194562646560371
ectopic B-Disease 1 0.9999946355819702
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999985694885254
. O 0 0.005056400317698717

The O 0 0.009576642885804176
RB1 O 1 0.9999017715454102
gene O 0 0.001403581234626472
mutation O 0 0.0004800365713890642
was O 0 0.0007761665037833154
investigated O 0 0.0007586234132759273
in O 0 0.0002837610663846135
a O 0 0.00045305961975827813
child O 0 0.0017471285536885262
with O 0 0.0007171216420829296
ectopic B-Disease 1 0.9996243715286255
intracranial I-Disease 1 0.9999867677688599
retinoblastoma I-Disease 1 0.9988125562667847
using O 0 0.0003332549531478435
DNA O 0 0.00034585126559250057
obtained O 0 8.888270531315356e-05
from O 0 8.647507638670504e-05
both O 0 0.0001137485378421843
the O 0 0.0006281293462961912
pineal B-Disease 1 0.9994799494743347
and I-Disease 0 0.0033904598094522953
retinal I-Disease 1 0.9999991655349731
tumours I-Disease 1 1.0
of O 1 0.9467447400093079
the O 1 0.9059551358222961
patient O 0 0.04743082821369171
. O 0 0.0010653724893927574

A O 0 0.007259543519467115
nonsense O 0 0.008179712109267712
mutation O 0 0.0005159119609743357
in O 0 0.00021613604621961713
exon O 0 0.0018293869215995073
17 O 0 0.0010829917155206203
( O 0 0.00025513459695503116
codon O 0 0.0009343178826384246
556 O 0 0.0018755203345790505
) O 0 5.9902373322984204e-05
of O 0 0.00020317651797086
the O 0 0.0008202973986044526
RB1 O 1 0.9999843835830688
gene O 0 0.000460631592432037
was O 0 0.0004931159201078117
found O 0 5.924288052483462e-05
to O 0 4.717967749456875e-05
be O 0 4.799917223863304e-05
present O 0 0.00023422023514285684
homozygously O 0 0.00594311160966754
in O 0 0.00016961230721790344
both O 0 0.0001386973453918472
the O 0 0.0007464392692781985
retinal B-Disease 1 0.9994608759880066
and I-Disease 0 0.0012655931059271097
the I-Disease 0 0.29212942719459534
pineal I-Disease 1 0.9999988079071045
tumours I-Disease 1 0.9999998807907104
. O 0 0.003877611830830574

The O 0 0.0019449337851256132
same O 0 0.0005243213381618261
mutation O 0 0.0003625143726821989
was O 0 0.0005864179693162441
present O 0 0.0004063452361151576
heterozygously O 0 0.006941069848835468
in O 0 0.00011185342737007886
the O 0 0.00012487130879890174
DNA O 0 0.00014931966143194586
from O 0 6.326031871140003e-05
the O 0 0.00013527392002288252
constitutional O 0 0.00043886579805985093
cells O 0 0.0001716875849524513
of O 0 0.0001296506088692695
the O 0 0.00029927006107755005
patient O 0 0.0007600341341458261
, O 0 0.0001534374023322016
proving O 0 0.0012203509686514735
it O 0 4.006522067356855e-05
to O 0 3.834214658127166e-05
be O 0 4.05491518904455e-05
of O 0 0.0003035383124370128
germline O 0 0.009332755580544472
origin O 0 0.0009619412012398243
. O 0 0.0008374297758564353

The O 0 0.0024554713163524866
initial O 0 0.001055752974934876
mutation O 0 0.000562051369342953
was O 0 0.0006726235733367503
shown O 0 0.0001582909608259797
to O 0 5.808828063891269e-05
have O 0 3.242118327762e-05
occurred O 0 0.0004982617683708668
in O 0 0.0001267920306418091
the O 0 0.00038324121851474047
paternally O 0 0.010126272216439247
derived O 0 0.002935761120170355
RB1 O 1 0.9988400340080261
allele O 0 0.003326690522953868
. O 0 0.0006752337794750929

The O 0 0.00200752099044621
mutation O 0 0.00032158519024960697
is O 0 5.1243521738797426e-05
in O 0 4.959014768246561e-05
an O 0 3.767350426642224e-05
area O 0 0.00012116383004467934
of O 0 0.0001046854376909323
the O 0 0.0001769976079231128
gene O 0 6.625590322073549e-05
that O 0 1.6182952094823122e-05
encodes O 0 5.83106157137081e-05
the O 0 6.055101766833104e-05
protein O 0 0.00010427714005345479
- O 0 0.00021319529332686216
binding O 0 6.928245420567691e-05
region O 0 0.0001203869323944673
known O 0 0.00013458995090331882
as O 0 0.000123588863061741
the O 0 0.0002636572753544897
pocket O 0 0.0024893581867218018
region O 0 0.0005394030013121665
and O 0 0.00011139550770167261
has O 0 6.987016968196258e-05
been O 0 8.794468158157542e-05
detected O 0 0.00030450234771706164
in O 0 8.041538967518136e-05
other O 0 4.607863229466602e-05
cases O 0 9.245092223864049e-05
of O 0 0.0008979406557045877
retinoblastoma B-Disease 1 0.9999790191650391
. O 0 0.0009144960204139352
. O 0 0.0008664329070597887

Low O 0 0.0033240735065191984
levels O 0 0.0007517868652939796
of O 0 0.00043185518006794155
beta O 0 0.0010468179825693369
hexosaminidase O 0 0.040877655148506165
A O 0 0.0010804464109241962
in O 0 0.0003970084944739938
healthy O 0 0.0005685992655344307
individuals O 0 5.0202048441860825e-05
with O 0 0.00014012050814926624
apparent O 1 0.9993112087249756
deficiency O 1 1.0
of O 1 0.9939864873886108
this O 0 0.0015056446427479386
enzyme O 0 0.00305764377117157
. O 0 0.0006006359471939504

Appreciable O 0 0.03394460678100586
beta O 0 0.00432989839464426
hexosaminidase O 0 0.02464289963245392
A O 0 0.001714270911179483
( O 0 0.00039341780939139426
hex O 0 0.00275282165966928
A O 0 0.0007910101558081806
) O 0 9.412506187800318e-05
activity O 0 0.00017211078375112265
has O 0 4.1300176235381514e-05
been O 0 7.028342224657536e-05
detected O 0 0.0005624488112516701
in O 0 0.000413184316130355
cultured O 1 0.6305450797080994
skin O 1 0.9999945163726807
fibroblasts O 1 0.9999562501907349
and O 1 0.8193707466125488
melanoma B-Disease 1 1.0
tissue O 1 0.9999974966049194
from O 0 0.009658478200435638
healthy O 0 0.0018655777676030993
individuals O 0 5.200510349823162e-05
previously O 0 0.0001361225004075095
reported O 0 0.0002139899443136528
as O 0 0.00019300088752061129
having O 0 0.0007519108476117253
deficiency B-Disease 1 0.99998939037323
of I-Disease 0 0.013135042041540146
hex I-Disease 1 0.969622790813446
A I-Disease 0 0.003971026744693518
activity O 0 0.0008862472022883594
indistinguishable O 0 0.00047528330469504
from O 0 8.224486373364925e-05
that O 0 2.8305788873694837e-05
of O 0 0.00019704012083821
patients O 0 0.0003275399503763765
with O 0 0.0009870355715975165
Tay B-Disease 1 1.0
- I-Disease 1 0.9999983310699463
Sachs I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
( O 1 0.8366028666496277
TSD B-Disease 1 0.9999996423721313
) O 0 0.0012060145381838083
. O 0 0.0007218646933324635

Identification O 0 0.0014603912131860852
and O 0 0.0007301709265448153
quantitation O 0 0.008779970929026604
of O 0 0.0010493696900084615
hex O 0 0.00986199639737606
A O 0 0.001538895652629435
, O 0 0.00018350264872424304
amounting O 0 0.0010352343088015914
to O 0 0.000137203314807266
3 O 0 0.0006920580635778606
. O 0 0.000604358734562993

5 O 0 0.003191710915416479
% O 0 0.0007867256063036621
- O 0 0.0020866114646196365
6 O 0 0.0022978398483246565
. O 0 0.0007617438095621765

9 O 0 0.00285593094304204
% O 0 0.00015796799561940134
of O 0 0.00022325835016090423
total O 0 0.0003848774067591876
beta O 0 0.0013208430027589202
hexosaminidase O 0 0.21787983179092407
activity O 0 0.0006172542343847454
, O 0 8.428312139585614e-05
has O 0 4.090494985575788e-05
been O 0 5.48260759387631e-05
obtained O 0 7.593769259983674e-05
by O 0 0.00020568864420056343
cellulose O 1 0.6381809711456299
acetate O 0 0.3817782700061798
gel O 0 0.15263736248016357
electrophoresis O 0 0.0046551586128771305
, O 0 0.0005932369967922568
DEAE O 1 0.9998742341995239
- O 0 0.004648570436984301
cellulose O 0 0.012498577125370502
ion O 0 0.0029220087453722954
- O 0 0.0014404782559722662
exchange O 0 0.0011302381753921509
chromatography O 0 0.006686070468276739
, O 0 0.000772689119912684
radial O 0 0.028450289741158485
immunodiffusion O 1 0.9998432397842407
, O 0 0.0009781999979168177
and O 0 0.0009258539648726583
radioimmunoassay O 1 0.998206377029419
. O 0 0.001421517925336957

Previous O 0 0.004258426837623119
family O 0 0.0010463917860761285
studies O 0 0.0001548365835333243
suggested O 0 0.00021666567772626877
that O 0 3.1080740882316604e-05
these O 0 2.7712272640201263e-05
individuals O 0 7.000115874689072e-05
may O 0 0.00021290339645929635
be O 0 0.0001347322395304218
compound O 0 0.004156126640737057
heterozygotes O 0 0.0018961941823363304
for O 0 7.372136315098032e-05
the O 0 0.00030263164080679417
common O 0 0.0004783909535035491
mutant O 0 0.01359532866626978
TSD B-Disease 1 0.9999246597290039
gene O 0 0.0006113690906204283
and O 0 0.00018196726159658283
a O 0 0.0003068205260206014
rare O 0 0.000941795005928725
( O 0 0.00063397764461115
allelic O 0 0.0064357272349298
) O 0 0.0006253386382013559
mutant O 0 0.005633611232042313
gene O 0 0.0013538810890167952
. O 0 0.0009107773657888174

Thus O 0 0.0020508216693997383
, O 0 0.00029225871548987925
the O 0 0.0003281898098066449
postulated O 0 0.002417462645098567
rate O 0 0.000486103817820549
mutant O 0 0.0008235680870711803
gene O 0 0.0001824326755013317
appears O 0 0.00021354967611841857
to O 0 3.289117739768699e-05
code O 0 3.260196899645962e-05
for O 0 1.6653961210977286e-05
the O 0 6.989496614551172e-05
expression O 0 0.00011065980652347207
of O 0 0.00014436857600230724
low O 0 0.00028200342785567045
amounts O 0 0.0001335760607616976
of O 0 0.0002681515470612794
hex O 0 0.005261705722659826
A O 0 0.002836567349731922
. O 0 0.0006212741136550903

Heterozygotes O 0 0.020082931965589523
for O 0 0.0003887835191562772
the O 0 0.0006479312432929873
rare O 0 0.0018376276129856706
mutant O 0 0.005671677179634571
may O 0 0.000267099792836234
be O 0 5.3885451052337885e-05
indistinguishable O 0 0.00045848070294596255
from O 0 0.00015585686196573079
heterozygotes O 0 0.001463256194256246
for O 0 8.684561908012256e-05
the O 0 0.0005257276934571564
common O 0 0.0013547621201723814
TSD B-Disease 1 0.9999938011169434
mutant O 0 0.10879441350698471
. O 0 0.0013142331736162305

However O 0 0.0019312798976898193
, O 0 0.00043213600292801857
direct O 0 0.00038529332960024476
visualization O 0 0.0022351618390530348
and O 0 0.00032216275576502085
quantitation O 0 0.011521000415086746
of O 0 0.0008077071397565305
hex O 0 0.006770709529519081
A O 0 0.0006341130356304348
by O 0 4.593779885908589e-05
the O 0 0.00011195267143193632
methods O 0 0.00012435064127203077
described O 0 0.00033838723902590573
may O 0 0.00026955624343827367
prevent O 0 0.0008874852792359889
false O 0 0.0011804754612967372
- O 0 0.001892843865789473
positive O 0 0.0005980804562568665
prenatal O 0 0.004052503500133753
diagnosis O 0 0.0036691988352686167
of O 0 0.0037455998826771975
TSD B-Disease 1 0.9999996423721313
in O 0 0.0018093325197696686
fetuses O 0 0.003147268434986472
having O 0 0.00020428902644198388
the O 0 0.00023127325403038412
incomplete O 0 0.001062982133589685
hex B-Disease 0 0.00803426280617714
A I-Disease 0 0.01845221035182476
deficiency I-Disease 1 0.9999918937683105
of O 0 0.0012698263162747025
the O 0 0.001653516897931695
type O 0 0.0011469529708847404
described O 0 0.0003462877357378602
in O 0 0.00010029021359514445
the O 0 0.0002588308125268668
four O 0 0.0004109202418476343
healthy O 0 0.0016642640111967921
individuals O 0 0.0003610829880926758

The O 0 0.012469818815588951
tumor B-Disease 1 0.9999597072601318
suppressor O 1 0.9916911125183105
gene O 0 0.005520131904631853
Smad4 O 1 0.9998753070831299
/ O 0 0.27648285031318665
Dpc4 O 1 0.9854872226715088
is O 0 0.00026185408933088183
required O 0 0.00014157418627291918
for O 0 0.00010714869858929887
gastrulation O 0 0.3362029194831848
and O 0 0.0002921383420471102
later O 0 0.0005499276448972523
for O 0 0.00017507921438664198
anterior O 0 0.03357542306184769
development O 0 0.0008768384577706456
of O 0 0.0011675235582515597
the O 0 0.0032628944609314203
mouse O 0 0.0078805610537529
embryo O 0 0.003360158298164606
. O 0 0.0007015332812443376

Mutations O 0 0.0023429072462022305
in O 0 0.0009191047865897417
the O 0 0.0025926532689481974
SMAD4 O 1 0.9999991655349731
/ O 1 0.9990666508674622
DPC4 O 1 0.9999997615814209
tumor B-Disease 1 0.9999983310699463
suppressor O 1 0.9608949422836304
gene O 0 0.0006478923605754972
, O 0 0.00011251280375290662
a O 0 0.0001603736891411245
key O 0 0.0009243995882570744
signal O 0 0.00088430882897228
transducer O 0 0.0019178458023816347
in O 0 0.00024225821834988892
most O 0 0.0003045436169486493
TGFbeta O 1 0.9992997646331787
- O 0 0.005346424877643585
related O 0 0.0010753435781225562
pathways O 0 0.004057203885167837
, O 0 0.00011403045937186107
are O 0 1.4087911040405743e-05
involved O 0 6.783995922887698e-05
in O 0 6.634898454649374e-05
50 O 0 0.0002056859084405005
% O 0 0.0001812201226130128
of O 0 0.003577495226636529
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999969005584717
. O 0 0.0028598117642104626

Homozygous O 0 0.028791118413209915
Smad4 O 1 0.9955449104309082
mutant O 0 0.22626352310180664
mice O 0 0.006972551811486483
die O 0 0.003594625275582075
before O 0 0.0004296200640965253
day O 0 0.0006979076424613595
7 O 0 0.0009971680119633675
. O 0 0.0003951899998355657

5 O 0 0.004797929897904396
of O 0 0.0030065577011555433
embryogenesis O 0 0.16856813430786133
. O 0 0.0028677720110863447

Mutant O 0 0.02459283359348774
embryos O 0 0.0018426495371386409
have O 0 9.251230221707374e-05
reduced O 0 0.00027139385929331183
size O 0 0.0001533496251795441
, O 0 0.00011883238039445132
fail O 0 0.0003355646913405508
to O 0 0.00015062080638017505
gastrulate O 0 0.05788952112197876
or O 0 0.00025846881908364594
express O 0 0.00034271791810169816
a O 0 0.00037545643863268197
mesodermal O 1 0.8292328119277954
marker O 0 0.009006718173623085
, O 0 0.0003102801856584847
and O 0 0.00029257035930640996
show O 0 0.0020027814898639917
abnormal O 0 0.4536898732185364
visceral O 1 0.9998606443405151
endoderm O 1 0.9999833106994629
development O 0 0.005404244177043438
. O 0 0.0013532380107790232

Growth B-Disease 1 0.9989263415336609
retardation I-Disease 1 0.9999734163284302
of O 0 0.0034375744871795177
the O 0 0.3741052746772766
Smad4 O 1 0.9999996423721313
- O 1 0.7273930311203003
deficient O 0 0.007676379289478064
embryos O 0 0.0003221166552975774
results O 0 7.718650886090472e-05
from O 0 0.00014474819181486964
reduced O 0 0.0007266502361744642
cell O 0 0.0010697304969653487
proliferation O 0 0.0014346130192279816
rather O 0 0.00017572565411683172
than O 0 0.00014795383322052658
increased O 0 0.0005904391291551292
apoptosis O 0 0.006388039793819189
. O 0 0.0006369713810272515

Aggregation O 0 0.004047037102282047
of O 0 0.002720881486311555
mutant O 0 0.1360727697610855
Smad4 O 1 0.9999922513961792
ES O 1 0.999561607837677
cells O 0 0.0012503784382715821
with O 0 9.129833051702008e-05
wild O 0 0.0006214896566234529
- O 0 0.0009522565524093807
type O 0 0.0015915303956717253
tetraploid O 0 0.017157763242721558
morulae O 1 0.9818666577339172
rescues O 0 0.026997912675142288
the O 0 0.0035322504118084908
gastrulation B-Disease 1 0.9999375343322754
defect I-Disease 1 0.9998958110809326
. O 0 0.002633764874190092

These O 0 0.0007412384147755802
results O 0 0.0004641166015062481
indicate O 0 0.00042357732309028506
that O 0 0.00015828431060072035
Smad4 O 1 0.7946845293045044
is O 0 0.0002215346321463585
initially O 0 0.00016319029964506626
required O 0 3.8314374251058325e-05
for O 0 2.0065372154931538e-05
the O 0 0.0001256977702723816
differentiation O 0 0.00042745398241095245
of O 0 0.0003953654086217284
the O 0 0.0013897786848247051
visceral O 1 0.9995748400688171
endoderm O 1 0.9997610449790955
and O 0 0.00029411722789518535
that O 0 8.41427463456057e-05
the O 0 0.0004395987489260733
gastrulation B-Disease 1 0.996393620967865
defect I-Disease 1 0.9927599430084229
in O 0 0.000743137497920543
the O 0 0.001381922629661858
epiblast O 1 0.9995238780975342
is O 0 0.0003324013960082084
secondary O 0 0.001118192565627396
and O 0 0.0003080683236476034
non O 0 0.0013212683843448758
- O 0 0.0026534898206591606
cell O 0 0.001793565577827394
autonomous O 0 0.0020190195646137
. O 0 0.0007084318203851581

Rescued O 0 0.18618017435073853
embryos O 0 0.009763851761817932
show O 0 0.0050825150683522224
severe O 1 0.9998764991760254
anterior O 1 0.9999974966049194
truncations O 1 0.999988317489624
, O 0 0.0012962642358615994
indicating O 0 0.0009623372461646795
a O 0 0.00036051819915883243
second O 0 0.0006483780452981591
important O 0 0.00025455726427026093
role O 0 0.0005075773224234581
for O 0 0.00020094496721867472
Smad4 O 1 0.9984757304191589
in O 0 0.0018823400605469942
anterior O 1 0.9999264478683472
patterning O 1 0.9997938275337219
during O 1 0.9660751223564148
embryogenesis O 1 0.9551428556442261
. O 0 0.0019992010202258825

Prevalence O 0 0.015843747183680534
of O 0 0.003530891379341483
p16 O 1 0.9659408330917358
and O 0 0.002161388285458088
CDK4 O 1 0.9999971389770508
germline O 0 0.3177645802497864
mutations O 0 0.000509527453687042
in O 0 0.0004068206180818379
48 O 0 0.005975518375635147
melanoma B-Disease 1 1.0
- O 0 0.43132323026657104
prone O 0 0.022543447092175484
families O 0 0.0004166161816101521
in O 0 0.0005050678737461567
France O 0 0.003037740010768175
. O 0 0.0009839709382504225

The O 0 0.007320709992200136
French O 0 0.11355967074632645
Familial B-Disease 1 0.9999803304672241
Melanoma I-Disease 1 1.0
Study O 0 0.004429330118000507
Group O 0 0.0018011968350037932
. O 0 0.000967030122410506

Germline O 1 0.7234437465667725
mutations O 0 0.0011602102313190699
in O 0 0.00037524590152315795
the O 0 0.0010821023024618626
p16 O 0 0.052378326654434204
and O 0 0.0009531621471978724
CDK4 O 1 0.999983549118042
genes O 0 0.0003012527304235846
have O 0 4.7132998588494956e-05
been O 0 4.888705370831303e-05
reported O 0 5.327380131348036e-05
in O 0 3.466574344201945e-05
a O 0 0.00010496311006136239
subset O 0 0.0003828179615084082
of O 0 0.0010338982101529837
melanoma B-Disease 1 0.9999998807907104
pedigrees O 0 0.4493589699268341
, O 0 0.0003045462362933904
but O 0 7.828365050954744e-05
their O 0 4.194460416329093e-05
prevalence O 0 0.00060024403501302
is O 0 8.292733400594443e-05
not O 0 6.622514774790034e-05
well O 0 0.00015736272325739264
known O 0 0.0008212004322558641
. O 0 0.0006811233470216393

We O 0 0.001260494813323021
searched O 0 0.0015523229958489537
for O 0 0.0002125842875102535
such O 0 0.00021833674691151828
germline O 0 0.004987233784049749
mutations O 0 0.0003230506554245949
in O 0 0.00025145275867544115
48 O 0 0.0013901346828788519
French O 1 0.9576103091239929
melanoma B-Disease 1 1.0
- O 0 0.30746492743492126
prone O 0 0.005443620961159468
families O 0 0.00015420449199154973
selected O 0 9.719443187350407e-05
according O 0 2.0647588826250285e-05
to O 0 2.2810458176536486e-05
two O 0 3.368430770933628e-05
major O 0 0.00031984085217118263
criteria O 0 9.670823783380911e-05
families O 0 5.472197517519817e-05
with O 0 4.7231897042365745e-05
at O 0 0.00035634892992675304
least O 0 8.690510003361851e-05
three O 0 5.027793304179795e-05
affected O 0 9.915679402183741e-05
members O 0 4.078860365552828e-05
( O 0 7.497624028474092e-05
n O 0 0.000279173138551414
= O 0 0.00034845308982767165
20 O 0 0.00023982333368621767
) O 0 4.770020314026624e-05
or O 0 4.632810305338353e-05
families O 0 3.664429459604435e-05
with O 0 2.6058994990307838e-05
two O 0 5.064442666480318e-05
affected O 0 0.00024535125703550875
members O 0 5.459542080643587e-05
, O 0 4.4784945202991366e-05
one O 0 3.847936386591755e-05
of O 0 7.968804857227951e-05
them O 0 4.905825699097477e-05
affected O 0 0.00014393668971024454
before O 0 8.612366946181282e-05
the O 0 7.58632886572741e-05
age O 0 4.657315366785042e-05
of O 0 7.295070099644363e-05
50 O 0 0.00012768502347171307
( O 0 7.299550634343177e-05
n O 0 0.0002011559990933165
= O 0 0.00021907806512899697
28 O 0 0.0003995195438619703
) O 0 5.259541649138555e-05
, O 0 4.222651114105247e-05
and O 0 3.72251306544058e-05
one O 0 7.981992530403659e-05
additional O 0 0.00018687946430873126
minor O 0 0.004005420487374067
criterion O 0 0.007385850418359041
. O 0 0.0019179644295945764

Sixteen O 0 0.01316804438829422
different O 0 0.000990017200820148
p16 O 0 0.3150174021720886
germline O 0 0.09334691613912582
mutations O 0 0.0003014514804817736
were O 0 7.091207226039842e-05
found O 0 5.229055022937246e-05
in O 0 7.532107701990753e-05
21 O 0 0.00034818475251086056
families O 0 8.328935655299574e-05
, O 0 5.8081186580238864e-05
while O 0 7.901460048742592e-05
one O 0 0.00018148522940464318
germline O 0 0.00850057415664196
mutation O 0 0.00040635824552737176
, O 0 0.0002301443601027131
Arg24His O 1 0.9967679977416992
, O 0 0.0003744807618204504
was O 0 0.0008980158600024879
detected O 0 0.0004481055948417634
in O 0 0.00019000978500116616
the O 0 0.0012272063177078962
CDK4 O 1 0.9999173879623413
gene O 0 0.002471971558406949
. O 0 0.0006303789559751749

The O 0 0.00188583810813725
frequency O 0 0.00032859615748748183
of O 0 0.00048016331857070327
p16 O 0 0.010773751884698868
gene O 0 0.0003708801814354956
mutation O 0 8.25025126687251e-05
in O 0 5.959958798484877e-05
our O 0 8.344087837031111e-05
sample O 0 3.5036115150433034e-05
( O 0 7.175139035098255e-05
44 O 0 0.00020884386321995407
% O 0 6.78137585055083e-05
) O 0 3.928773003281094e-05
is O 0 2.8052647394360974e-05
among O 0 3.115796789643355e-05
the O 0 0.00014341923815663904
highest O 0 0.0006477540591731668
rates O 0 0.00011539141269167885
yet O 0 8.464806887786835e-05
reported O 0 0.00010358923464082181
and O 0 5.89058363402728e-05
the O 0 0.00032078169169835746
CDK4 O 1 0.9999247789382935
mutation O 0 0.0002224784839199856
is O 0 5.5205440730787814e-05
the O 0 0.00016059449990279973
second O 0 0.0004728318890556693
mutation O 0 0.0001219199548359029
detected O 0 0.0002623868640512228
in O 0 9.989372483687475e-05
this O 0 0.0001055082175298594
gene O 0 0.0003357386449351907
worldwide O 0 0.00033703408553265035
. O 0 0.00040170058491639793

In O 0 0.001790424226783216
summary O 0 0.0022575645707547665
, O 0 0.0003477508726064116
our O 0 0.0003454013494774699
results O 0 0.00017115831724368036
show O 0 0.00033968192292377353
frequent O 0 0.00035564994323067367
involvement O 0 0.0008680322207510471
of O 0 0.0005595874390564859
the O 0 0.0015820529079064727
p16 O 1 0.7316929697990417
gene O 0 0.0007130756275728345
in O 0 0.0006080119055695832
familial B-Disease 1 0.9994726777076721
melanoma I-Disease 1 1.0
and O 0 0.0007717655971646309
confirm O 0 0.0003783981373999268
the O 0 0.00013319654681254178
role O 0 0.00023763753415551037
of O 0 0.00019784549658652395
the O 0 0.0005354492459446192
CDK4 O 1 0.9999406337738037
gene O 0 0.00042219425085932016
as O 0 0.00020211921946611255
a O 0 0.0008066951995715499
melanoma B-Disease 1 0.999998927116394
- O 0 0.041582681238651276
predisposing O 0 0.0330859012901783
gene O 0 0.0009577642194926739
. O 0 0.00029765148065052927
. O 0 0.0005087193567305803

Progression O 0 0.09745542705059052
of O 0 0.006287219934165478
somatic O 0 0.06419145315885544
CTG O 1 0.9973541498184204
repeat O 0 0.0035503290127962828
length O 0 0.00032061265665106475
heterogeneity O 0 0.0008484384743496776
in O 0 0.00020271714311093092
the O 0 0.0009485444170422852
blood O 0 0.2539098262786865
cells O 0 0.016537310555577278
of O 1 0.8820043802261353
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999489784240723
. O 0 0.004271768033504486

The O 0 0.0017520171822980046
genetic O 0 0.0008397751953452826
basis O 0 0.000280167703749612
of O 0 0.004586711060255766
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999997615814209
DM B-Disease 1 1.0
) O 0 0.0005421909154392779
is O 0 9.680520452093333e-05
the O 0 0.00017346025560982525
expansion O 0 0.0004986842395737767
of O 0 0.0001715746329864487
an O 0 0.0002775193133857101
unstable O 1 0.9702659845352173
CTG O 1 0.9995548129081726
repeat O 0 0.0020938303787261248
in O 0 0.00014406231639441103
the O 0 0.00021910482610110193
34 O 0 0.000420332740759477
UTR O 0 0.0040671429596841335
of O 0 0.00023030154989100993
the O 0 0.0008918257080949843
DM B-Disease 1 0.9999701976776123
protein O 0 0.001200026017613709
kinase O 0 0.0005408154102042317
gene O 0 0.000184704054845497
on O 0 0.000242532099946402
chromosome O 0 0.0010734626557677984
19 O 0 0.00234372541308403
. O 0 0.0009354552021250129

One O 0 0.0008976857061497867
of O 0 0.0006148529937490821
the O 0 0.00038872630102559924
principal O 0 0.0006364586879499257
features O 0 0.00012717368372250348
of O 0 0.00029226066544651985
the O 0 0.0023421496152877808
DM B-Disease 1 1.0
mutation O 0 0.00046119678881950676
is O 0 8.380977669730783e-05
an O 0 9.77589370450005e-05
extraordinarily O 0 0.001114998827688396
high O 0 0.0004963286919519305
level O 0 0.0004815124557353556
of O 0 0.0004885524394921958
somatic O 0 0.009476466104388237
mosaicism O 1 0.9994315505027771
, O 0 0.0003314548812340945
due O 0 0.0003108812670689076
to O 0 8.555722160963342e-05
an O 0 9.502031025476754e-05
extremely O 0 0.0002528755576349795
high O 0 0.00038513177423737943
degree O 0 0.0002177104033762589
of O 0 0.0005632191896438599
somatic O 0 0.004867666866630316
instability O 0 0.038353756070137024
both O 0 0.0001554109330754727
within O 0 0.00022051781706977636
and O 0 0.00016800782759673893
between O 0 0.0004930924042128026
different O 0 0.00026231384254060686
tissues O 0 0.011019155383110046
. O 0 0.0013780145673081279

This O 0 0.0018372706836089492
instability O 0 0.03936489671468735
appears O 0 0.00081114680506289
to O 0 0.0001265446626348421
be O 0 4.489783532335423e-05
biased O 0 0.00016403445624746382
towards O 0 0.0003469058428891003
further O 0 0.0002043821441475302
expansion O 0 0.0006987082888372242
and O 0 6.485316407633945e-05
continuous O 0 0.00023661293380428106
throughout O 0 9.820506966207176e-05
the O 0 0.00012192181020509452
life O 0 0.0001384856441291049
of O 0 0.00011024093691958115
an O 0 0.00010509009734960273
individual O 0 5.175180558580905e-05
, O 0 6.960980681469664e-05
features O 0 0.00011318233737256378
that O 0 3.798207762883976e-05
could O 0 8.358040213352069e-05
be O 0 3.2433988963020965e-05
associated O 0 4.3259671656414866e-05
with O 0 2.9889410143368877e-05
the O 0 0.00035336631117388606
progressive O 0 0.016282333061099052
nature O 0 0.001036910805851221
of O 0 0.004976528696715832
the O 1 0.9946858882904053
disease O 1 0.9999996423721313
. O 0 0.001988915493711829

Although O 0 0.0011492245830595493
increasing O 0 0.000551795877981931
measured O 0 0.0002894220524467528
allele O 0 0.00024422910064458847
size O 0 0.00018276594346389174
between O 0 0.00024387214216403663
patients O 0 0.00019794850959442556
clearly O 0 0.00023073452757671475
correlates O 0 0.00033380661625415087
with O 0 4.2357747588539496e-05
an O 0 9.166996460407972e-05
increased O 0 0.00025967121473513544
severity O 0 0.0015510116936638951
of O 0 0.0014549894258379936
symptoms O 1 0.9999046325683594
and O 0 0.00042309064883738756
an O 0 0.00020185844914522022
earlier O 0 0.00040283086127601564
age O 0 0.00030356005299836397
of O 0 0.0005535695236176252
onset O 1 0.9999862909317017
, O 0 0.00033151492243632674
this O 0 7.188405288616195e-05
correlation O 0 9.056147246155888e-05
is O 0 3.885073965648189e-05
not O 0 1.693864214757923e-05
precise O 0 0.0001121385648730211
and O 0 6.876589031890035e-05
measured O 0 0.0002740700147114694
allele O 0 0.0001831401023082435
length O 0 0.00010537890921114013
cannot O 0 6.283471157075837e-05
be O 0 2.25758230953943e-05
used O 0 2.7143618353875354e-05
as O 0 3.6683450161945075e-05
an O 0 2.925367880379781e-05
accurate O 0 0.00011295785952825099
predictor O 0 0.0007870769477449358
of O 0 0.0003579786862246692
age O 0 0.000864282890688628
of O 0 0.004238951951265335
onset O 1 0.9999997615814209
. O 0 0.0037252341862767935

In O 0 0.0010314466198906302
order O 0 0.0003710389428306371
to O 0 8.953108044806868e-05
further O 0 0.00016460713231936097
characterize O 0 0.0009359607356600463
the O 0 0.00029757889569737017
dynamics O 0 0.001612350344657898
of O 0 0.0026864507235586643
DM B-Disease 1 1.0
CTG O 1 0.999992847442627
repeat O 0 0.10729426145553589
somatic O 0 0.015279699116945267
instability O 0 0.2242927998304367
, O 0 0.00016789381334092468
we O 0 6.01357824052684e-05
have O 0 2.096681419061497e-05
studied O 0 0.0001594890491105616
repeat O 0 0.0005659269518218935
length O 0 7.37992231734097e-05
changes O 0 7.506008114432916e-05
over O 0 8.244163473136723e-05
time O 0 9.821415005717427e-05
in O 0 0.0003477401041891426
111 O 1 0.9458237290382385
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9109484553337097
with O 0 0.0005511359195224941
varying O 0 0.0006510745733976364
clinical O 0 0.002319643972441554
severity O 0 0.0969042181968689
and O 0 0.0008634768892079592
CTG O 1 0.9983521699905396
repeat O 0 0.0011870289454236627
size O 0 0.00012144166976213455
over O 0 5.320628042682074e-05
time O 0 2.1539473891607486e-05
intervals O 0 3.870585351251066e-05
of O 0 5.7093486248049885e-05
1 O 0 0.0003201062500011176
- O 0 0.000615480646956712
7 O 0 0.0007388097001239657
years O 0 0.0005266465013846755
. O 0 0.0004089873400516808

We O 0 0.0011214441619813442
have O 0 6.515622226288542e-05
found O 0 6.477961142081767e-05
a O 0 0.00010725655010901392
direct O 0 0.00015109579544514418
progression O 0 0.0014695728896185756
of O 0 0.0003860897268168628
the O 0 0.00046197010669857264
size O 0 0.00022492598509415984
heterogeneity O 0 0.0005800732178613544
over O 0 0.00015745637938380241
time O 0 5.8192403230350465e-05
related O 0 6.75809642416425e-05
to O 0 8.408243593294173e-05
initial O 0 0.0006411584326997399
CTG O 1 0.6978216767311096
repeat O 0 0.0015119877643883228
size O 0 0.00018511273083277047
and O 0 6.309325544862077e-05
the O 0 0.0001462383079342544
time O 0 0.00016861478798091412
interval O 0 0.00033850225736387074
and O 0 0.00013184042472857982
always O 0 0.0001856423041317612
biased O 0 0.0003614814777392894
towards O 0 0.0006616851314902306
further O 0 0.0006428319029510021
expansion O 0 0.0033813880290836096
. O 0 0.0007366667850874364

Attempts O 0 0.0036095783580094576
to O 0 0.0004670572525355965
mathematically O 0 0.000563502311706543
model O 0 0.0004709101340267807
the O 0 0.0004892145516350865
dynamics O 0 0.0018078541615977883
have O 0 0.00012355904618743807
proved O 0 0.001116342842578888
only O 0 0.00015759095549583435
partially O 0 0.001126716611906886
successful O 0 0.0003393242659512907
suggesting O 0 0.00024027076142374426
that O 0 2.593938734207768e-05
individual O 0 1.7362015569233336e-05
specific O 0 4.664471998694353e-05
genetic O 0 0.00023747219529468566
and O 0 0.00044660712592303753
/ O 1 0.60105961561203
or O 0 0.00042143824975937605
environmental O 0 0.0005116162355989218
factors O 0 0.00015861941210459918
also O 0 7.712094520684332e-05
play O 0 0.0001207235109177418
a O 0 0.00018171794363297522
role O 0 0.0004965880070813
in O 0 0.0005957719986326993
somatic O 0 0.010840412229299545
mosaicism O 1 0.999609649181366
. O 0 0.0010297386907041073
. O 0 0.001058767200447619

Aspartylglucosaminuria B-Disease 1 0.9999765157699585
among O 0 0.0037507857196033
Palestinian O 0 0.010300902649760246
Arabs O 0 0.009678530506789684
. O 0 0.0022560940124094486

Aspartylglucosaminuria B-Disease 1 0.9999997615814209
( O 1 0.9886422753334045
AGU B-Disease 1 0.9999998807907104
) O 0 0.0006157546304166317
is O 0 0.0001975060295080766
a O 0 0.000513444363605231
rare O 0 0.004725306760519743
disorder B-Disease 1 0.9999995231628418
of I-Disease 1 0.9999188184738159
glycoprotein I-Disease 1 0.9999998807907104
metabolism I-Disease 1 0.999994158744812
caused O 1 0.9938238859176636
by O 0 0.00012987828813493252
the O 0 0.0005248283850960433
deficiency B-Disease 1 0.9998993873596191
of I-Disease 0 0.0009363738354295492
the I-Disease 0 0.0035382271744310856
lysosomal I-Disease 1 0.9994027614593506
enzyme I-Disease 0 0.007132604252547026
aspartylglucosaminidase I-Disease 1 0.999894380569458
( O 0 0.0017303588101640344
AGA O 1 0.9988290667533875
) O 0 0.0007474814192391932
. O 0 0.0005409265286289155

AGU B-Disease 1 0.999998927116394
is O 0 0.004222656134516001
inherited O 1 0.9920806288719177
as O 0 0.0010643410496413708
an O 0 0.0009444628958590329
autosomal O 1 0.7732408046722412
recessive O 1 0.9998757839202881
trait O 1 0.9942671656608582
and O 0 0.0008187044295482337
occurs O 0 0.0002797454653773457
with O 0 4.506117693381384e-05
a O 0 0.0001782361214281991
high O 0 0.00027476466493681073
frequency O 0 4.458866533241235e-05
in O 0 3.56417331204284e-05
Finland O 0 0.000252480007475242
because O 0 3.139442560495809e-05
of O 0 0.00010741438018158078
a O 0 0.0004289495409466326
founder O 0 0.005435461178421974
effect O 0 0.0013407249934971333
. O 0 0.0007152672042138875

While O 0 0.002139359014108777
very O 0 0.0005038741510361433
few O 0 0.0004802921903319657
patients O 0 0.0004790065286215395
with O 0 0.0002976753457915038
AGU B-Disease 1 1.0
have O 0 0.00019448407692834735
been O 0 0.00014985812595114112
reported O 0 0.00012819445692002773
from O 0 0.00014560201088897884
non O 0 0.0004749423242174089
- O 0 0.0007192179327830672
Finnish O 0 0.0024729676079005003
origin O 0 0.00027466699248179793
, O 0 0.00017713048146106303
we O 0 0.00022499010083265603
diagnosed O 1 0.9588673710823059
the O 0 0.0015397195238620043
disorder O 1 0.9999973773956299
in O 0 0.0025171011220663786
8 O 0 0.0051753162406384945
patients O 0 0.00020937698718626052
originating O 0 0.00024114333791658282
from O 0 0.00013095259782858193
3 O 0 0.00028251309413462877
unrelated O 0 0.0003912525426130742
families O 0 6.233612657524645e-05
, O 0 3.9470920455642045e-05
all O 0 3.134575308649801e-05
Palestinian O 0 0.0004845320654567331
Arabs O 0 0.0004593078629113734
from O 0 8.737625466892496e-05
the O 0 0.00016036773740779608
region O 0 0.00039061540155671537
of O 0 0.0007123726536519825
Jerusalem O 0 0.1919545978307724
. O 0 0.0016326693585142493

The O 0 0.0034179803915321827
clinical O 0 0.00412876158952713
diagnosis O 1 0.7377084493637085
of O 1 0.9935309290885925
AGU B-Disease 1 1.0
is O 0 0.001034799963235855
often O 0 0.00014199766155797988
difficult O 0 0.00018989352975040674
, O 0 6.656445475528017e-05
in O 0 5.174805846763775e-05
particular O 0 3.8012844015611336e-05
early O 0 8.217775757657364e-05
in O 0 3.969722456531599e-05
the O 0 0.00010139335063286126
course O 0 0.00038567272713407874
of O 0 0.0003275580529589206
the O 0 0.009201541543006897
disease O 1 0.9999988079071045
, O 0 0.0002116664545610547
and O 0 5.9515416069189087e-05
most O 0 4.3956686567980796e-05
of O 0 0.00016073927690740675
the O 0 0.00047998782247304916
patients O 0 0.0004145221028011292
are O 0 5.596203845925629e-05
diagnosed O 1 0.770649254322052
after O 0 0.0004441895289346576
the O 0 0.00025289005134254694
age O 0 0.00021967901557218283
of O 0 0.0002780805516522378
5 O 0 0.0009248384740203619
years O 0 0.0005598189891315997
. O 0 0.000529184122569859

However O 0 0.001895433641038835
, O 0 0.00046516937436535954
since O 0 0.0006589915719814599
these O 0 0.00013092176232021302
patients O 0 0.0003346465528011322
excrete O 0 0.003156470600515604
early O 0 0.0004128518048673868
large O 0 0.0001401263871230185
amounts O 0 0.00011078936950070783
of O 0 0.00024078218848444521
aspartylglucosamine O 1 0.9013417959213257
in O 0 0.0004378708254080266
urine O 0 0.0006816405220888555
, O 0 0.00013606331776827574
biochemical O 0 0.0011641961755231023
screening O 0 0.00038757899892516434
is O 0 9.035634866449982e-05
easy O 0 0.00020244516781531274
by O 0 0.0001729946379782632
urine O 0 0.002796732122078538
chromatography O 0 0.01850130967795849
. O 0 0.00039109328645281494
. O 0 0.0004357842553872615

Detection O 0 0.005600970238447189
of O 0 0.0013896748423576355
heterozygous O 0 0.0007153285550884902
carriers O 0 0.0003849961212836206
of O 0 0.00036064436426386237
the O 0 0.001954717095941305
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9998785257339478
telangiectasia I-Disease 1 0.9999960660934448
( O 0 0.0019306503236293793
ATM O 0 0.004586917348206043
) O 0 0.00016671141202095896
gene O 0 0.00017588269838597625
by O 0 0.00012186115054646507
G2 O 1 0.9707979559898376
phase O 0 0.008486366830766201
chromosomal O 0 0.4128710925579071
radiosensitivity O 1 0.9997609257698059
of O 1 0.8121193051338196
peripheral O 1 0.9999997615814209
blood O 1 0.9999971389770508
lymphocytes O 1 0.9994171857833862
. O 0 0.001746667898260057

In O 0 0.007513339165598154
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.99930739402771
telangiectasia I-Disease 1 0.9999983310699463
( O 0 0.005900643300265074
A B-Disease 1 0.999968409538269
- I-Disease 1 0.9999313354492188
T I-Disease 1 0.9999992847442627
) O 0 0.0003114965802524239
patients O 0 0.00017716256843414158
, O 0 9.813383803702891e-05
mutations O 0 8.3980179624632e-05
in O 0 7.016756717348471e-05
a O 0 0.00014590806677006185
single O 0 0.00017596824909560382
gene O 0 0.00018049498612526804
, O 0 0.00013381535245571285
ATM O 0 0.0015306486748158932
, O 0 0.00010896089224843308
result O 0 0.00015194620937108994
in O 0 0.000199070549570024
an O 0 0.0011051733745262027
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.15054985880851746
embraces O 0 0.012445502914488316
a O 0 0.0004636308294720948
variety O 0 0.00018391077173873782
of O 0 0.00032678202842362225
clinical O 0 0.0011747938115149736
features O 0 0.0007606325089000165
and O 0 0.00037203534157015383
manifests O 0 0.0032886802218854427
extreme O 0 0.11535075306892395
radiosensitivity O 1 0.9997925162315369
and O 0 0.00024402563576586545
a O 0 0.00031066322117112577
strong O 0 0.0005161022418178618
pre O 0 0.0026311681140214205
- O 0 0.0015501684974879026
disposition O 0 0.003915675450116396
to O 0 0.0007391646504402161
malignancy B-Disease 1 0.9992402791976929
. O 0 0.0011214023688808084

Heterozygotes O 0 0.017339926213026047
for O 0 0.000451444648206234
the O 0 0.0006490226951427758
ATM O 0 0.005120779387652874
gene O 0 0.00026584372972138226
have O 0 2.9267181162140332e-05
no O 0 7.582359103253111e-05
clinical O 0 0.00016953695740085095
expression O 0 0.00012296397471800447
of O 0 0.0003068907535634935
A B-Disease 1 0.9999852180480957
- I-Disease 1 0.9997389912605286
T I-Disease 1 0.9999921321868896
but O 0 0.00018715907935984433
may O 0 0.0003384914598427713
be O 0 0.00015387606981676072
cancer B-Disease 0 0.022852040827274323
prone O 0 0.002632026793435216
with O 0 9.731583122629672e-05
a O 0 0.00032157573150470853
moderate O 0 0.0007049855776131153
increase O 0 0.00010099810606334358
in O 0 0.00015522180183324963
in O 0 0.00036814523627981544
vitro O 0 0.0028466794174164534
radiosensitivity O 0 0.19872641563415527
. O 0 0.0010878464672714472

We O 0 0.0015566531801596284
performed O 0 0.0021601729094982147
a O 0 0.0009299031225964427
blind O 0 0.004480521660298109
chromosomal O 0 0.0026708405930548906
analysis O 0 0.0001861415948951617
on O 0 0.0005837250500917435
G2 O 1 0.999406099319458
- O 0 0.0014891484752297401
phase O 0 0.0018781208200380206
lymphocytes O 0 0.0008791432483121753
from O 0 0.000103385464171879
7 O 0 0.0005438673542812467
unrelated O 0 0.0011029393645003438
A B-Disease 1 0.9988228678703308
- I-Disease 1 0.9988454580307007
T I-Disease 1 0.9999970197677612
patients O 0 0.0003448603965807706
, O 0 9.65064755291678e-05
13 O 0 0.0006992478738538921
obligate O 0 0.002138473792001605
A B-Disease 1 0.9985917210578918
- I-Disease 1 0.9859841465950012
T I-Disease 1 0.9999758005142212
heterozygotes O 0 0.004339928738772869
( O 0 0.00018292544700670987
parents O 0 4.2852654587477446e-05
of O 0 0.00011467830336187035
the O 0 0.00041551952017471194
patients O 0 0.00039993206155486405
) O 0 7.410343823721632e-05
, O 0 6.239732465473935e-05
and O 0 5.465183494379744e-05
14 O 0 0.0003203905071131885
normal O 0 0.00025388976791873574
controls O 0 0.0001978294603759423
following O 0 0.0002629548835102469
X O 0 0.0010810054372996092
- O 0 0.000639048870652914
irradiation O 0 0.0006664151442237198
with O 0 7.700645073782653e-05
1 O 0 0.0003792590578086674
Gy O 0 0.005489076487720013
in O 0 5.847409556736238e-05
order O 0 5.0562008254928514e-05
to O 0 3.02434873447055e-05
evaluate O 0 0.00012930430239066482
this O 0 6.264624244067818e-05
cytogenetic O 0 0.0018418235704302788
method O 0 0.00013934067101217806
as O 0 0.00012643911759369075
a O 0 0.00016458200116176158
tool O 0 0.0006156953750178218
for O 0 0.00011135601380374283
detection O 0 0.0007812116527929902
of O 0 0.0009449048084206879
ATM O 0 0.12726396322250366
carriers O 0 0.002153996145352721
. O 0 0.0007507230620831251

Both O 0 0.002663121558725834
A B-Disease 1 0.9996827840805054
- I-Disease 1 0.9998350143432617
T I-Disease 1 0.9999902248382568
homozygotes O 0 0.02313341200351715
and O 0 0.0007113089668564498
heterozygotes O 0 0.006305281538516283
showed O 0 0.001021902309730649
significantly O 0 0.00037036521825939417
increased O 0 0.00017860851949080825
levels O 0 0.00023054321354720742
of O 0 0.0003903585602529347
radiation O 1 0.674673855304718
- O 0 0.019694320857524872
induced O 1 0.9808366894721985
chromatid O 1 0.9988999366760254
damage O 1 0.7043845057487488
relative O 0 0.0002905168221332133
to O 0 0.00010062856017611921
that O 0 4.3289594032103196e-05
of O 0 0.00026615362730808556
normal O 0 0.0008789008134044707
controls O 0 0.0014659878797829151
. O 0 0.00048602093011140823

These O 0 0.00047510580043308437
results O 0 0.0003324416175018996
show O 0 0.0002341219806112349
that O 0 7.23089324310422e-05
the O 0 0.00030854804208502173
G2 O 1 0.9981127977371216
- O 0 0.0024843320716172457
phase O 0 0.004722468554973602
chromosomal O 0 0.07896075397729874
radiosensitivity O 1 0.9984796643257141
assay O 0 0.0008052702178247273
can O 0 3.4779917768901214e-05
be O 0 1.9249771867180243e-05
used O 0 1.6256084563792683e-05
for O 0 1.399571465299232e-05
the O 0 6.059700172045268e-05
detection O 0 0.00025898980675265193
of O 0 0.0004394041025079787
A B-Disease 1 0.9999837875366211
- I-Disease 1 0.9997988343238831
T I-Disease 1 0.9999877214431763
heterozygotes O 0 0.01873963326215744
. O 0 0.0008443776168860495

In O 0 0.0016686065355315804
combination O 0 0.0008972623618319631
with O 0 0.00016698092804290354
molecular O 0 0.0005082560237497091
genetic O 0 0.0002007465809583664
analyses O 0 0.00012029948993586004
, O 0 6.554640276590362e-05
this O 0 4.3779185944003984e-05
test O 0 0.00010752341768238693
may O 0 5.491979027283378e-05
be O 0 1.1906578947673552e-05
of O 0 3.733566336450167e-05
value O 0 3.1410803785547614e-05
in O 0 4.141845784033649e-05
studies O 0 3.37553137796931e-05
of O 0 0.00016570885782130063
familial B-Disease 0 0.3452337384223938
and I-Disease 0 0.002612294629216194
sporadic I-Disease 1 0.998832643032074
cancers I-Disease 1 0.9994692206382751
aimed O 0 0.0016111485892906785
at O 0 0.0008125307504087687
determination O 0 0.0005264903884381056
of O 0 0.0001906720281112939
the O 0 0.0002730497217271477
potential O 0 0.0002781317161861807
involvement O 0 0.0008443035185337067
of O 0 0.0005630360683426261
ATM O 0 0.0830993726849556
mutations O 0 0.000568824470974505
in O 0 0.0011666296049952507
tumor B-Disease 1 0.9999991655349731
risk O 0 0.0025935140438377857
or O 0 0.0004672273644246161
development O 0 0.0007937930058687925
. O 0 0.00023603385488968343
. O 0 0.0004339163424447179

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999294281005859
telangiectasia I-Disease 1 0.9999815225601196
: O 0 0.0007185746217146516
identification O 0 0.0002036388759734109
and O 0 0.0001526866399217397
detection O 0 0.00046954170102253556
of O 0 0.00047637667739763856
founder O 1 0.8939454555511475
- O 0 0.002214132808148861
effect O 0 0.00046688190195709467
mutations O 0 0.00011462231486802921
in O 0 7.925154932308942e-05
the O 0 0.000316527730319649
ATM O 0 0.0022604106925427914
gene O 0 0.00020073182531632483
in O 0 0.00012422501458786428
ethnic O 0 0.00032960204407572746
populations O 0 0.00041683748713694513
. O 0 0.0004220807459205389

To O 0 0.0008454524213448167
facilitate O 0 0.0008242916665039957
the O 0 0.0003667749697342515
evaluation O 0 0.0005268389941193163
of O 0 0.0008114571683108807
ATM O 0 0.00811692699790001
heterozygotes O 0 0.005256013013422489
for O 0 0.00017265763017348945
susceptibility O 0 0.001012452063150704
to O 0 0.00018716836348176003
other O 0 0.00022190013260114938
diseases O 1 0.9999474287033081
, O 0 0.0002992238150909543
such O 0 0.00019891570264007896
as O 0 0.07371806353330612
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.999995231628418
, O 0 0.00021397873933892697
we O 0 6.915262201800942e-05
have O 0 1.772860559867695e-05
attempted O 0 0.0002517187676858157
to O 0 4.152290421188809e-05
define O 0 0.00013353915710467845
the O 0 0.00021313715842552483
most O 0 8.884526323527098e-05
common O 0 0.00010256143286824226
mutations O 0 0.00011233689292566851
and O 0 9.404216689290479e-05
their O 0 6.110987305874005e-05
frequencies O 0 9.96332528302446e-05
in O 0 0.00025412370450794697
ataxia B-Disease 1 0.999985933303833
- I-Disease 1 0.9576914310455322
telangiectasia I-Disease 1 0.99998939037323
( O 0 0.0022309506312012672
A B-Disease 1 0.99985671043396
- I-Disease 1 0.9891877770423889
T I-Disease 1 0.9996315240859985
) O 0 0.00015835916565265507
homozygotes O 0 0.001492905430495739
from O 0 0.00013328522618394345
10 O 0 0.00019254485960118473
ethnic O 0 0.0002309239935129881
populations O 0 0.0004047258698847145
. O 0 0.000423462683102116

Both O 0 0.0010164609411731362
genomic O 0 0.0014172532828524709
mutations O 0 0.0004237934190314263
and O 0 0.00014095564256422222
their O 0 0.00011606999032665044
effects O 0 0.0006913300021551549
on O 0 0.0004883224028162658
cDNA O 0 0.0022040619514882565
were O 0 0.00038644473534077406
characterized O 0 0.0016987021081149578
. O 0 0.0006589755648747087

Protein O 0 0.0040272874757647514
- O 0 0.0022073527798056602
truncation O 0 0.00357017177157104
testing O 0 0.0002955634845420718
of O 0 0.0001647116878302768
the O 0 0.00018217161414213479
entire O 0 0.0010448357788845897
ATM O 0 0.001917995628900826
cDNA O 0 0.0010906257666647434
detected O 0 0.0005880538956262171
92 O 0 0.0008590143406763673
( O 0 0.00017766973178368062
66 O 0 0.0009407232864759862
% O 0 0.00017581631254870445
) O 0 0.0001402803900418803
truncating O 0 0.0029333641286939383
mutations O 0 0.00023830845020711422
in O 0 0.0002383345999987796
140 O 0 0.0018174699507653713
mutant O 0 0.004087033681571484
alleles O 0 0.0009160178015008569
screened O 0 0.0015741669340059161
. O 0 0.0005630392697639763

The O 0 0.004568912088871002
haplotyping O 1 0.939974844455719
of O 0 0.001885016798041761
patients O 0 0.0008603163878433406
with O 0 0.00019820254237856716
identical O 0 0.0004897371982224286
mutations O 0 0.0002604236942715943
indicates O 0 0.0002505331067368388
that O 0 2.875959216908086e-05
almost O 0 5.2935367421014234e-05
all O 0 2.1463238226715475e-05
of O 0 8.150268695317209e-05
these O 0 2.2103398805484176e-05
represent O 0 0.0001270115317311138
common O 0 0.00017005405970849097
ancestry O 0 0.00033240235643461347
and O 0 0.00018221625941805542
that O 0 9.721027163323015e-05
very O 0 0.00021143167396076024
few O 0 0.00031914637656882405
spontaneously O 0 0.00614475691691041
recurring O 1 0.5306481122970581
ATM O 1 0.9111234545707703
mutations O 0 0.0018783932318910956
exist O 0 0.0005398605135269463
. O 0 0.0006253108731471002

Assays O 0 0.004496291745454073
requiring O 0 0.0008582788286730647
minimal O 0 0.0007440657936967909
amounts O 0 0.0003249682777095586
of O 0 0.00028123066294938326
genomic O 0 0.0005727026727981865
DNA O 0 0.0005147586343809962
were O 0 0.00016808586951810867
designed O 0 0.00027675015735439956
to O 0 6.174591544549912e-05
allow O 0 0.00011765974340960383
rapid O 0 0.000923318206332624
screening O 0 0.00030344692640937865
for O 0 7.348202052526176e-05
common O 0 0.0001907980622490868
ethnic O 0 0.0006948803784325719
mutations O 0 0.0016983228269964457
. O 0 0.0010279944399371743

These O 0 0.0007434540893882513
rapid O 0 0.00525944959372282
assays O 0 0.00117112894076854
detected O 0 0.0008732486166991293
mutations O 0 0.00012951901589985937
in O 0 9.472708916291595e-05
76 O 0 0.0005651033716276288
% O 0 5.5237887863768265e-05
of O 0 0.00015702338714618236
Costa O 0 0.0009216856560669839
Rican O 0 0.0025128803681582212
patients O 0 0.0002626454224810004
( O 0 0.00014516203373204917
3 O 0 0.00022605578124057502
) O 0 4.4106334826210514e-05
, O 0 3.529399691615254e-05
50 O 0 6.236402259673923e-05
% O 0 2.9131295377737843e-05
of O 0 0.0001399092870997265
Norwegian O 0 0.0009774547070264816
patients O 0 0.000313903292408213
( O 0 0.00011744105722755194
1 O 0 0.00023560797853861004
) O 0 3.45667103829328e-05
, O 0 2.463671626173891e-05
25 O 0 7.706155156483874e-05
% O 0 2.7926873372052796e-05
of O 0 0.00015459109272342175
Polish O 1 0.9968480467796326
patients O 0 0.00204898021183908
( O 0 0.0003242886741645634
4 O 0 0.0006981597980484366
) O 0 4.425274164532311e-05
, O 0 2.461091207806021e-05
and O 0 3.50112677551806e-05
14 O 0 0.0001882138312794268
% O 0 5.136388062965125e-05
of O 0 0.00013884290819987655
Italian O 0 0.004742538556456566
patients O 0 0.0009840750135481358
( O 0 0.0002706927771214396
1 O 0 0.0004144257109146565
) O 0 7.933154120109975e-05
, O 0 4.890029595117085e-05
as O 0 7.779168663546443e-05
well O 0 7.637948147021234e-05
as O 0 0.00011464265116956085
in O 0 0.000176694942638278
patients O 0 0.00028781068976968527
of O 0 0.0008212481043301523
Amish O 0 0.3906703293323517
/ O 0 0.009562496095895767
Mennonite O 0 0.00996409635990858
and O 0 0.0005325467209331691
Irish O 0 0.002995430724695325
English O 0 0.0011763059301301837
backgrounds O 0 0.0009469732758589089
. O 0 0.0006520687020383775

Additional O 0 0.0020849183201789856
mutations O 0 0.0004842650378122926
were O 0 0.00020576457609422505
observed O 0 0.00013509398559108377
in O 0 0.000200182301341556
Japanese O 0 0.0020694436971098185
, O 0 0.0002426692662993446
Utah O 0 0.0025852802209556103
Mormon O 0 0.0025584918912500143
, O 0 0.0002597499405965209
and O 0 0.00028529451810754836
African O 0 0.0020576524548232555
American O 0 0.0036725546233356
patients O 0 0.0018489962676540017
. O 0 0.0009550442337058485

These O 0 0.0005768799455836415
assays O 0 0.0005047803279012442
should O 0 6.21308499830775e-05
facilitate O 0 0.00021581273176707327
screening O 0 0.00015187232929747552
for O 0 0.00010271371138514951
A B-Disease 1 0.7070596218109131
- I-Disease 1 0.7716674208641052
T I-Disease 1 0.9996391534805298
heterozygotes O 0 0.002441606717184186
in O 0 0.00013049847621005028
the O 0 0.00022061960771679878
populations O 0 0.00010019155160989612
studied O 0 0.0004069967253599316
. O 0 0.00017576667596586049
. O 0 0.000347889174008742

The O 0 0.004256488289684057
von B-Disease 0 0.12765085697174072
Hippel I-Disease 1 0.9989728927612305
- I-Disease 0 0.3568389415740967
Lindau I-Disease 1 0.9995911717414856
tumor I-Disease 1 0.9999861717224121
suppressor O 1 0.8365229964256287
gene O 0 0.0003735247009899467
is O 0 6.445948383770883e-05
required O 0 6.69155124342069e-05
for O 0 7.924005331005901e-05
cell O 0 0.0007549284491688013
cycle O 0 0.0010194577043876052
exit O 0 0.0012351307086646557
upon O 0 0.0012914163526147604
serum O 0 0.018454255536198616
withdrawal O 0 0.009647920727729797
. O 0 0.0009843441657721996

The O 0 0.0025816357228904963
inactivation O 0 0.012643829919397831
of O 0 0.0009441488073207438
the O 0 0.0012463061138987541
von B-Disease 0 0.4425128400325775
Hippel I-Disease 1 0.9993606209754944
- I-Disease 0 0.04630855470895767
Lindau I-Disease 1 0.9933933615684509
( I-Disease 0 0.002999052871018648
VHL I-Disease 1 0.9999784231185913
) I-Disease 0 0.003297441639006138
tumor I-Disease 1 0.9999545812606812
suppressor O 1 0.9972975850105286
gene O 0 0.0016886210069060326
predisposes O 0 0.32642796635627747
affected O 0 0.0005683962372131646
individuals O 0 5.902639895793982e-05
to O 0 0.00011802450171671808
the O 0 0.0010232252534478903
human O 1 0.997798502445221
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.20354080200195312
is O 0 0.00033487408654764295
associated O 0 0.0003687656717374921
with O 0 0.0003166484530083835
sporadic B-Disease 1 0.9966326355934143
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9996286630630493
RCC B-Disease 1 1.0
) O 0 0.0012741356622427702
and O 0 0.0007925708196125925
brain B-Disease 1 0.9998121857643127
hemangioblastomas I-Disease 1 0.9999594688415527
. O 0 0.0020233257673680782

VHL O 1 0.998257577419281
- O 0 0.006564696319401264
negative O 0 0.0008455427014268935
786 O 0 0.0228715930134058
- O 0 0.004532339051365852
0 O 0 0.0032579016406089067
RCC B-Disease 1 0.9999966621398926
cells O 0 0.0015638533513993025
are O 0 0.00010264165757689625
tumorigenic O 0 0.049481846392154694
in O 0 0.001220391714014113
nude O 0 0.09535177052021027
mice O 0 0.0016167853027582169
which O 0 9.592003334546462e-05
is O 0 0.0001050291903084144
suppressed O 0 0.0011462047696113586
by O 0 4.4068117858842015e-05
the O 0 0.00023587390023749322
reintroduction O 0 0.002844385104253888
of O 0 0.0017746184021234512
VHL B-Disease 1 0.9999865293502808
. O 0 0.002555153565481305

Remarkably O 0 0.016443239524960518
, O 0 0.0005801561055704951
this O 0 0.0001786114153219387
occurs O 0 0.0003732370969373733
without O 0 0.00013838928134646267
affecting O 0 0.0005293394206091762
the O 0 0.0002717807365115732
growth O 0 0.0005775032914243639
rate O 0 0.00011755029117921367
and O 0 7.336089765885845e-05
cell O 0 0.0004610869218595326
cycle O 0 0.0006181475473567843
profile O 0 0.00021476666734088212
of O 0 0.00030524880276061594
these O 0 0.00013187764852773398
cells O 0 0.0005446086870506406
in O 0 0.0003637136542238295
culture O 0 0.0018952632090076804
. O 0 0.000634162628557533

The O 0 0.002730610780417919
786 O 0 0.02705545164644718
- O 0 0.002013386692851782
0 O 0 0.000652380520477891
cell O 0 0.0011553240474313498
line O 0 0.0007440555491484702
, O 0 0.00011862519750138745
like O 0 0.00038635556120425463
many O 0 0.000344542961101979
cancer B-Disease 1 0.9995763897895813
cells O 0 0.002184016862884164
, O 0 0.00021540075249504298
fails O 0 0.0006730618770234287
to O 0 8.943791181081906e-05
exit O 0 0.0006987768574617803
the O 0 0.0005406488780863583
cell O 0 0.0018753920448943973
cycle O 0 0.002030131872743368
upon O 0 0.0011031863978132606
serum O 0 0.019041214138269424
withdrawal O 0 0.008787743747234344
. O 0 0.0010067864786833525

Here O 0 0.0042044054716825485
, O 0 0.000534352264367044
it O 0 8.424816041951999e-05
is O 0 7.466216629836708e-05
shown O 0 9.851956565398723e-05
that O 0 3.6380883102538064e-05
reintroduction O 0 0.0005463436245918274
of O 0 0.00015673707821406424
the O 0 0.0003603489603847265
wild O 0 0.0009580585756339133
- O 0 0.0012309817830100656
type O 0 0.001975149614736438
VHL B-Disease 1 0.999595582485199
gene O 0 0.0005812761373817921
restores O 0 0.0025155257899314165
the O 0 0.00017565276357345283
ability O 0 0.00013449937978293747
of O 0 0.0006173335714265704
VHL O 1 0.9999988079071045
- O 1 0.8118975162506104
negative O 0 0.005660487804561853
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9996743202209473
cells O 0 0.0004258715780451894
to O 0 0.0001052982552209869
exit O 0 0.0007057411130517721
the O 0 0.0005538197001442313
cell O 0 0.001197344739921391
cycle O 0 0.001208077883347869
and O 0 0.00021181427291594446
enter O 0 0.0025102642830461264
G0 O 1 0.9978219270706177
/ O 0 0.00725657818838954
quiescence O 0 0.013984656892716885
in O 0 0.0011830627918243408
low O 0 0.002276221290230751
serum O 0 0.014702776446938515
. O 0 0.0009606301900930703

Both O 0 0.004927324131131172
VHL O 1 0.9999475479125977
- O 0 0.005336853209882975
positive O 0 0.0005552626680582762
and O 0 0.0005243376363068819
VHL O 1 0.9999908208847046
- O 0 0.008275404572486877
negative O 0 0.001300421659834683
RCC B-Disease 1 0.9999972581863403
cells O 0 0.0008764697122387588
exit O 0 0.0007605187129229307
the O 0 0.0004061456711497158
cell O 0 0.0008197305141948164
cycle O 0 0.0008722893544472754
by O 0 0.00014482991537079215
contact O 0 0.0008143484010361135
inhibition O 0 0.0038808875251561403
. O 0 0.0009413984953425825

The O 0 0.005120070185512304
cyclin O 0 0.012162892147898674
- O 0 0.002086671069264412
dependent O 0 0.0007308567292056978
kinase O 0 0.0018639082554727793
inhibitor O 0 0.007514371536672115
, O 0 0.00042955309618264437
p27 O 0 0.030223462730646133
, O 0 0.0002781502844300121
accumulates O 0 0.0024394034408032894
upon O 0 0.000737293332349509
serum O 0 0.0074054705910384655
withdrawal O 0 0.001233042567037046
, O 0 7.481411012122408e-05
only O 0 2.128605956386309e-05
in O 0 3.433784513617866e-05
the O 0 8.824122051009908e-05
presence O 0 0.0002227223594672978
of O 0 0.0004318135615903884
VHL B-Disease 1 0.9999996423721313
, O 0 0.00024998123990371823
as O 0 9.163028880720958e-05
a O 0 8.248079393524677e-05
result O 0 6.675241456832737e-05
of O 0 8.162044105120003e-05
the O 0 0.0001864736113930121
stabilization O 0 0.0013232700293883681
of O 0 0.0004602975968737155
the O 0 0.000969258660916239
protein O 0 0.001057844259776175
. O 0 0.0005381656810641289

We O 0 0.0009313590708188713
propose O 0 0.0007845104555599391
that O 0 6.189884879859164e-05
the O 0 0.00011700321192620322
loss O 0 0.00044163945131003857
of O 0 0.00023880500521045178
wild O 0 0.0010409014066681266
- O 0 0.0015443889424204826
type O 0 0.0013870338443666697
VHL B-Disease 1 0.9999394416809082
gene O 0 0.00022803830506745726
results O 0 4.9396167014492676e-05
in O 0 3.2293988624587655e-05
a O 0 8.023706323001534e-05
specific O 0 6.66038176859729e-05
cellular O 0 0.0016761026345193386
defect O 1 0.9910877346992493
in O 0 0.0009421926224604249
serum O 1 0.7685909271240234
- O 0 0.0014904019189998507
dependent O 0 0.00035629316698759794
growth O 0 0.0003468609938863665
control O 0 0.00024198908067774028
, O 0 0.00012338164378888905
which O 0 0.00010448606917634606
may O 0 0.0002732194843702018
initiate O 0 0.003691328689455986
tumor B-Disease 1 0.9999867677688599
formation O 1 0.9976613521575928
. O 0 0.0016138323117047548

This O 0 0.000822730828076601
is O 0 0.0003255056799389422
corrected O 0 0.0012691142037510872
by O 0 5.313493238645606e-05
the O 0 0.0001287179911741987
reintroduction O 0 0.0009361730189993978
of O 0 0.0002501772250980139
wild O 0 0.0011928798630833626
- O 0 0.0019507041433826089
type O 0 0.002761590527370572
VHL B-Disease 1 0.9999949932098389
, O 0 0.000959609227720648
implicating O 1 0.9979198575019836
VHL B-Disease 1 0.9999514818191528
as O 0 0.0005600244621746242
the O 0 0.0004771580861415714
first O 0 0.0011257489677518606
tumor B-Disease 1 0.9990631937980652
suppressor O 0 0.00946070160716772
involved O 0 0.00029997905949130654
in O 0 0.00011448403529357165
the O 0 0.0001297224807785824
regulation O 0 0.0001423894864274189
of O 0 0.00018262954836245626
cell O 0 0.001142536522820592
cycle O 0 0.0014565434539690614
exit O 0 0.0008349860436283052
, O 0 0.00012162084749434143
which O 0 3.86938190786168e-05
is O 0 2.6833049560082145e-05
consistent O 0 0.00010526683036005124
with O 0 3.9628157537663355e-05
its O 0 0.00014411496522370726
gatekeeper O 0 0.012902854941785336
function O 0 0.0003491260576993227
in O 0 0.00040892374818213284
the O 0 0.002213426399976015
kidney O 1 0.9999997615814209
. O 0 0.0008167388150468469
. O 0 0.0009657913469709456

Piebaldism B-Disease 1 0.9999986886978149
with O 0 0.0584392249584198
deafness B-Disease 1 1.0
: O 0 0.001821171841584146
molecular O 0 0.0010507040424272418
evidence O 0 0.0005392290186136961
for O 0 0.00015706515114288777
an O 0 0.0004434815200511366
expanded O 0 0.011700637638568878
syndrome O 1 0.9999996423721313
. O 0 0.0024647682439535856

In O 0 0.0012160264886915684
a O 0 0.0006892876117490232
South O 0 0.0018990491516888142
African O 0 0.0021953375544399023
girl O 0 0.0027989300433546305
of O 0 0.0008931737393140793
Xhosa O 1 0.9919060468673706
stock O 0 0.00239300774410367
with O 0 0.0005920327384956181
severe O 1 0.9999985694885254
piebaldism B-Disease 1 1.0
and O 1 0.9992294311523438
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.43557658791542053
identified O 0 0.0006626526010222733
a O 0 0.00033385975984856486
novel O 0 0.00040811332291923463
missense O 0 0.0011721390765160322
substitution O 0 0.0006930301897227764
at O 0 0.000353932729922235
a O 0 0.0001542468526167795
highly O 0 0.00018690922297537327
conserved O 0 0.0002706708328332752
residue O 0 0.0008603355963714421
in O 0 0.00010961994848912582
the O 0 0.00018967418873216957
intracellular O 0 0.0007940484210848808
kinase O 0 0.0003535597352311015
domain O 0 0.00015710396110080183
of O 0 0.0002970986533910036
the O 0 0.0011063350830227137
KIT O 1 0.6423555016517639
proto O 1 0.9595264196395874
- O 0 0.01149651501327753
oncogene O 1 0.63789302110672
, O 0 0.0012075589038431644
R796G O 0 0.4197816252708435
. O 0 0.001292197615839541

Though O 0 0.00759414816275239
auditory B-Disease 1 0.9800181984901428
anomalies I-Disease 0 0.48206114768981934
have O 0 0.00021170926629565656
been O 0 0.00015739123045932502
observed O 0 0.00017896940698847175
in O 0 0.00015980993339326233
mice O 0 0.00034081091871485114
with O 0 8.056552178459242e-05
dominant O 0 0.0011775066377595067
white O 0 0.0023656769189983606
spotting O 0 0.18369723856449127
( O 0 0.0011870565358549356
W O 1 0.8442412614822388
) O 0 0.00021684406965505332
due O 0 0.000371182948583737
to O 0 0.00047187734162434936
KIT O 1 0.9973135590553284
mutations O 0 0.002350908936932683
, O 0 0.0011991456849500537
deafness B-Disease 1 1.0
is O 0 0.000590310781262815
not O 0 0.00012403442815411836
typical O 0 0.0005629485822282732
in O 0 0.0003637384797912091
human O 0 0.0008823233656585217
piebaldism B-Disease 1 0.9980424642562866
. O 0 0.0016963481903076172

Thus O 0 0.0016588869038969278
, O 0 0.0002872323093470186
the O 0 0.0004579543601721525
occurrence O 0 0.0025218534283339977
of O 0 0.007923198863863945
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.2348203808069229
this O 0 0.00048422947293147445
patient O 0 0.0007122216047719121
extends O 0 0.0006661426741629839
considerably O 0 0.00030388490995392203
the O 0 0.00013265569577924907
phenotypic O 0 0.000532918144017458
range O 0 0.00013683435099665076
of O 0 0.00033458080724813044
piebaldism B-Disease 1 0.8515004515647888
due O 0 0.0009289475856348872
to O 0 0.0003497600555419922
KIT O 0 0.015669958665966988
gene O 0 0.0002882028347812593
mutation O 0 0.00019206554861739278
in O 0 0.00013579580991063267
humans O 0 0.00029516525682993233
and O 0 0.00014747382374480367
tightens O 0 0.0016303794691339135
the O 0 0.0003127607051283121
clinical O 0 0.00049682951066643
similarity O 0 0.0009209939162246883
between O 0 0.0014758053002879024
piebaldism B-Disease 1 0.9986913800239563
and O 0 0.00030491952202282846
the O 0 0.0002559415006544441
various O 0 0.0001472414005547762
forms O 0 0.0009302960825152695
of O 1 0.9976129531860352
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.009594406932592392
. O 0 0.0021288697607815266

Cycloheximide O 1 0.9624459743499756
facilitates O 0 0.004373067524284124
the O 0 0.0006996628362685442
identification O 0 0.00036322299274615943
of O 0 0.0006633336888626218
aberrant O 0 0.005242707207798958
transcripts O 0 0.0009499742882326245
resulting O 0 0.0003488444781396538
from O 0 0.00010155668860534206
a O 0 0.00018995688878931105
novel O 0 0.00038600104744546115
splice O 0 0.002764388918876648
- O 0 0.000775460503064096
site O 0 0.0005525900050997734
mutation O 0 0.0002051058254437521
in O 0 0.00016337883425876498
COL17A1 O 1 0.998904824256897
in O 0 0.00035952491452917457
a O 0 0.0005513636278919876
patient O 0 0.001050720107741654
with O 0 0.0007139103254303336
generalized O 1 0.9977854490280151
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999978542327881
. O 0 0.0068895104341208935

Patients O 0 0.011133762076497078
with O 0 0.0019374440889805555
generalized O 1 0.9998350143432617
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999986886978149
often O 0 0.000811173056717962
show O 0 0.0005924820434302092
decreased O 0 0.000879175029695034
expression O 0 0.00014700277824886143
of O 0 0.00041984778363257647
type O 0 0.23579111695289612
XVII O 1 1.0
collagen O 1 0.9999945163726807
, O 0 0.000496567867230624
a O 0 0.0005483014974743128
transmembrane O 0 0.004394182004034519
hemidesmosomal O 0 0.01895574852824211
protein O 0 0.00047749714576639235
encoded O 0 0.0002450295723974705
by O 0 0.0002730812120717019
COL17A1 O 1 0.9943722486495972
. O 0 0.0010135946795344353

This O 0 0.0005744739901274443
report O 0 0.00018190864648204297
documents O 0 0.00016809822409413755
a O 0 0.00020739369210787117
novel O 0 0.000785167096182704
splice O 0 0.004259879235178232
- O 0 0.0011458380613476038
site O 0 0.0006839503184892237
mutation O 0 0.0002035509533016011
in O 0 0.00015910535876173526
COL17A1 O 1 0.9956285953521729
in O 0 0.00028055423172190785
a O 0 0.0005605040350928903
patient O 0 0.0009091641986742616
with O 0 0.00046783441212028265
generalized O 1 0.999058187007904
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 0.0008606693590991199
and O 0 0.000223140450543724
applies O 0 7.655368244741112e-05
a O 0 0.00010759582073660567
new O 0 9.090054663829505e-05
methodology O 0 0.00010131584713235497
to O 0 6.0447579016909e-05
define O 0 0.0002763897064141929
and O 0 0.00015741944662295282
characterize O 0 0.0018898398848250508
the O 0 0.0007008216343820095
resulting O 0 0.0012639330234378576
mRNA O 0 0.0011569693451747298
splice O 0 0.005790167022496462
variants O 0 0.0012003633892163634
. O 0 0.00048281316412612796

Mutational O 0 0.02414555847644806
analysis O 0 0.00042724088416434824
of O 0 0.0010631897021085024
COL17A1 O 1 0.9997585415840149
identified O 0 0.0008599405409768224
a O 0 0.0006378936814144254
maternally O 0 0.005559489130973816
inherited O 0 0.4193207025527954
G O 0 0.028066033497452736
- O 0 0.001439049025066197
to O 0 0.0002715036098379642
- O 0 0.001091195154003799
T O 0 0.005686904303729534
transversion O 0 0.00568609032779932
at O 0 0.0003147871175315231
the O 0 0.00018245374667458236
- O 0 0.00035733202821575105
1 O 0 0.0001815257128328085
position O 0 0.0001588193408679217
of O 0 0.00030159580637700856
exon O 0 0.005448279902338982
32 O 0 0.0024610746186226606
. O 0 0.000957452692091465

This O 0 0.000906405970454216
acceptor O 0 0.0016526569379493594
splice O 0 0.006906774826347828
- O 0 0.001849067397415638
site O 0 0.000862273620441556
mutation O 0 0.00012283014075364918
led O 0 0.00025323170120827854
to O 0 6.670430593658239e-05
the O 0 0.00017919158563017845
formation O 0 0.0012813073117285967
of O 0 0.0007151516620069742
aberrant O 0 0.011428418569266796
transcripts O 0 0.0018114643171429634
present O 0 0.0006409626803360879
at O 0 0.0013735126703977585
extremely O 0 0.0011434751795604825
low O 0 0.0010670028859749436
levels O 0 0.00106491195037961
. O 0 0.00036657904274761677

Based O 0 0.0007094837492331862
on O 0 0.0004185747529845685
our O 0 0.00036475484375841916
recent O 0 0.00024030743225011975
finding O 0 0.00037312504719011486
that O 0 0.00031343859154731035
cycloheximide O 1 0.8153895139694214
stabilized O 0 0.4586162269115448
mutant O 0 0.014586231671273708
COL17A1 O 1 0.9990049004554749
transcripts O 0 0.002531746868044138
in O 0 0.0004148522566538304
keratinocytes O 0 0.004958244040608406
homozygous O 0 0.0005067523452453315
for O 0 7.739132706774399e-05
a O 0 0.00028514876612462103
frameshift O 0 0.0033312980085611343
mutation O 0 0.00023235891421791166
, O 0 5.862395846634172e-05
the O 0 0.0001503337116446346
effects O 0 0.00033056907705031335
of O 0 0.00023923344269860536
the O 0 0.000584055611398071
splice O 0 0.004557491280138493
- O 0 0.001034751650877297
site O 0 0.0004629505565389991
mutation O 0 0.0001005790545605123
on O 0 7.81779526732862e-05
splicing O 0 0.0003638463094830513
of O 0 0.00038527845754288137
COL17A1 O 1 0.9995203018188477
transcripts O 0 0.001197290956042707
were O 0 0.00014636343985330313
determined O 0 0.00013172357284929603
using O 0 7.204587745945901e-05
reverse O 0 0.0005613326793536544
transcriptase O 0 0.001431976561434567
polymerase O 0 0.0008372060256078839
chain O 0 0.0005485171568579972
reaction O 0 0.00015550268290098757
of O 0 0.00011516452650539577
total O 0 0.00020110270997975022
RNA O 0 0.0003027539642062038
from O 0 0.00018124778580386192
keratinocytes O 0 0.0026176483370363712
incubated O 0 0.0010018922621384263
for O 0 0.00011973275104537606
2 O 0 0.0006580000626854599
. O 0 0.0003925898636225611

5 O 0 0.0035593719221651554
h O 0 0.001932807150296867
in O 0 0.00020965248404536396
the O 0 0.00031898877932690084
presence O 0 0.0005913086934015155
or O 0 0.00018867039761971682
absence O 0 0.0005514546064659953
of O 0 0.000425387523137033
10 O 0 0.0015433619264513254
microg O 1 0.9931633472442627
cycloheximide O 1 0.9585108757019043
per O 0 0.0014870648737996817
ml O 0 0.007671622559428215
. O 0 0.0007015751325525343

Using O 0 0.0004972544847987592
this O 0 0.00017908241716213524
approach O 0 0.00032123251003213227
, O 0 9.506262722425163e-05
an O 0 0.00017980359552893788
abnormally O 0 0.0027996087446808815
spliced O 0 0.0016648154705762863
transcript O 0 0.0008155415998771787
was O 0 0.00036943162558600307
identified O 0 0.00011618892312981188
that O 0 2.4743236281210557e-05
contains O 0 2.7654506993712857e-05
an O 0 3.013261994055938e-05
extra O 0 7.783034379826859e-05
264 O 0 0.000514154729899019
bases O 0 0.00027779146330431104
upstream O 0 0.0007490194402635098
from O 0 0.00013898569159209728
exon O 0 0.0009806533344089985
32 O 0 0.00044368591625243425
, O 0 7.664017175557092e-05
resulting O 0 0.0001641738781472668
in O 0 8.747212268644944e-05
a O 0 0.0004047136753797531
premature O 0 0.0031896301079541445
termination O 0 0.0016880367184057832
codon O 0 0.0016605035634711385
27 O 0 0.00159037159755826
bp O 0 0.0031065174844115973
downstream O 0 0.001273252652026713
from O 0 0.00025681269471533597
the O 0 0.000575559155549854
cryptic O 0 0.005416637286543846
splice O 0 0.00958395004272461
site O 0 0.0057394797913730145
. O 0 0.0009325916180387139

Three O 0 0.0009960647439584136
other O 0 0.0002591024385765195
splice O 0 0.0030966512858867645
variants O 0 0.0004844963550567627
, O 0 0.00012142314517404884
including O 0 6.585930532310158e-05
one O 0 4.770343002746813e-05
derived O 0 4.700596764450893e-05
from O 0 6.225617107702419e-05
the O 0 0.0001823685015551746
skipping O 0 0.0009805718436837196
of O 0 0.00030331965535879135
exon O 0 0.0020062888506799936
32 O 0 0.0007216876256279647
, O 0 0.00016740511637181044
were O 0 0.00015659542987123132
also O 0 0.00015434453962370753
identified O 0 0.00047697214176878333
. O 0 0.0006914469413459301

These O 0 0.0007522989762946963
results O 0 0.0003682973620016128
indicate O 0 0.00030515334219671786
the O 0 0.0003100548346992582
usefulness O 0 0.0018248012056574225
of O 0 0.0010407675290480256
cycloheximide O 1 0.998247504234314
treatment O 0 0.002585305832326412
in O 0 0.0002763396187219769
evaluating O 0 0.00027107264031656086
the O 0 0.00021645486413035542
abnormal O 0 0.001064608688466251
processing O 0 0.0004531278391368687
of O 0 0.00019324026652611792
mRNA O 0 0.0002615945413708687
due O 0 0.00015774881467223167
to O 0 6.528315861942247e-05
splice O 0 0.0017326204106211662
- O 0 0.0005036946386098862
site O 0 0.0005652536056004465
mutations O 0 0.00020410658908076584
, O 0 0.00011647190694930032
because O 0 0.00011039643140975386
( O 0 0.00023827803670428693
i O 0 0.0007368296501226723
) O 0 0.0002075733063975349
aberrant O 0 0.0020533427596092224
splicing O 0 0.0008389768772758543
often O 0 6.917274004081264e-05
generates O 0 0.00014298484893515706
a O 0 0.00032031137379817665
premature O 0 0.00221319985575974
termination O 0 0.0015955147100612521
codon O 0 0.0009871578076854348
, O 0 0.00016919587505981326
( O 0 0.00018675174214877188
ii O 0 0.009605450555682182
) O 0 0.00015094116679392755
transcripts O 0 0.0005782504449598491
with O 0 0.00012390110350679606
premature O 0 0.002580008003860712
termination O 0 0.0020269802771508694
codons O 0 0.0010842387564480305
can O 0 6.511474202852696e-05
occur O 0 0.00010798053699545562
at O 0 0.0003549912653397769
low O 0 0.0005319219781085849
or O 0 0.00023696987773291767
undetectable O 0 0.006388036534190178
levels O 0 0.00039184698835015297
due O 0 0.00018496222037356347
to O 0 8.283794159069657e-05
nonsense O 0 0.0011299658799543977
- O 0 0.0005493634380400181
mediated O 0 0.0006414343952201307
mRNA O 0 0.0004543704853858799
decay O 0 0.0008166093030013144
, O 0 7.927716796984896e-05
and O 0 0.00010176802607020363
( O 0 0.00020433052850421518
iii O 0 0.0028846818022429943
) O 0 9.556305303703994e-05
the O 0 0.00013392117398325354
levels O 0 0.00020629398932214826
of O 0 8.619638538220897e-05
these O 0 2.406450585112907e-05
transcripts O 0 0.00022044086654204875
can O 0 2.3920085368445143e-05
be O 0 3.783451393246651e-05
increased O 0 0.00012855534441769123
by O 0 0.00019414760754443705
cycloheximide O 0 0.12667691707611084
. O 0 0.0011094581568613648

A O 0 0.006406009197235107
deletion O 0 0.0035127815790474415
mutation O 0 0.0007300596334971488
in O 0 0.000534200225956738
COL17A1 O 1 0.9991828799247742
in O 0 0.00042125993059016764
five O 0 0.0003237869532313198
Austrian O 0 0.0030738336499780416
families O 0 0.0003189784474670887
with O 0 0.00047159226960502565
generalized O 1 0.970311164855957
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999914169311523
represents O 0 0.004655680153518915
propagation O 0 0.0012164388317614794
of O 0 0.0003712180186994374
an O 0 0.0003442743618506938
ancestral O 0 0.010533438064157963
allele O 0 0.00173800194170326
. O 0 0.0004290240176487714

Patients O 0 0.010046632960438728
with O 0 0.0029035168699920177
generalized O 1 0.999413013458252
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
, O 0 0.0016177492216229439
a O 0 0.0008619659929536283
usually O 0 0.0002643005864229053
nonlethal O 0 0.003242182545363903
form O 0 0.0005339778144843876
of O 0 0.0023609944619238377
junctional B-Disease 1 0.9999995231628418
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999938011169434
, O 0 0.0006685499683953822
have O 0 0.0001951111335074529
generalized O 0 0.0016909713158383965
blistering B-Disease 1 0.9984259605407715
, O 0 0.005671421531587839
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.8533033728599548
patchy B-Disease 1 0.9999995231628418
alopecia I-Disease 1 1.0
, O 1 0.9218984842300415
and O 1 0.7179177403450012
dental B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 0.9999996423721313
. O 0 0.0054133301600813866

Skin B-Disease 1 0.9999978542327881
fragility I-Disease 1 0.999983549118042
in O 0 0.001322358613833785
most O 0 0.0002561924629844725
cases O 0 0.00013401189062278718
is O 0 7.719791028648615e-05
due O 0 0.00023346906527876854
to O 0 0.00011244803317822516
mutations O 0 9.008732013171539e-05
in O 0 6.847169424872845e-05
the O 0 0.00016663482529111207
gene O 0 0.00016808364307507873
encoding O 0 0.0003027276834473014
type O 0 0.0035874044988304377
XVII O 1 1.0
collagen O 1 0.9999998807907104
( O 0 0.38591840863227844
COL17A1 O 1 0.9999978542327881
) O 0 0.0010948198614642024
. O 0 0.0006134590366855264

Recently O 0 0.006551012862473726
, O 0 0.000467934733023867
we O 0 0.00022613881446886808
reported O 0 0.00020264332124497741
five O 0 0.00014088577881921083
Austrian O 0 0.002730016130954027
families O 0 0.0005265295621939003
with O 0 0.0007208744646050036
generalized O 1 0.9975330829620361
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999948740005493
who O 0 0.0014814218739047647
share O 0 0.0004689791821874678
the O 0 0.0005074529908597469
same O 0 0.0005867030122317374
COL17A1 O 1 0.9999563694000244
mutation O 0 0.0019516391912475228
. O 0 0.0007444561924785376

Affected O 0 0.004066293127834797
individuals O 0 0.00013321838923729956
in O 0 0.00015831903147045523
three O 0 0.00011712264677044004
families O 0 7.090166036505252e-05
are O 0 2.5891988116200082e-05
homozygous O 0 0.00033687747782096267
for O 0 0.0001325096673099324
4003delTC O 1 0.9436489343643188
, O 0 0.00047376216389238834
whereas O 0 0.0002741949865594506
those O 0 3.826215834124014e-05
in O 0 8.4118997619953e-05
two O 0 7.258071127580479e-05
others O 0 0.00018874596571549773
are O 0 7.646809535799548e-05
compound O 0 0.01370768342167139
heterozygotes O 0 0.019559547305107117
. O 0 0.0015909775393083692

To O 0 0.000545905320905149
determine O 0 0.0002224449854111299
if O 0 7.474957237718627e-05
the O 0 0.00019464362412691116
occurrence O 0 0.0006064041517674923
of O 0 0.00041431785211898386
4003delTC O 1 0.9930263757705688
in O 0 0.0004202407435514033
these O 0 6.69042783556506e-05
unrelated O 0 0.0006383421132341027
families O 0 0.0002625748165883124
signifies O 0 0.003042390337213874
propagation O 0 0.0006361766718327999
of O 0 0.000262347370153293
an O 0 0.00029026102856732905
ancestral O 0 0.005563544575124979
allele O 0 0.0005908534512855113
or O 0 0.000165175020811148
a O 0 0.0003443160967435688
mutational O 0 0.01493138074874878
hot O 0 0.008420395664870739
spot O 0 0.0024909486528486013
, O 0 0.00023338072060141712
haplotypes O 0 0.0008659161394461989
were O 0 0.00016312308434862643
determined O 0 0.0002204488409915939
for O 0 0.00011058501695515588
polymorphisms O 0 0.0004905093810521066
both O 0 8.707000961294398e-05
within O 0 0.0002673397830221802
and O 0 0.00047109214938245714
flanking O 1 0.9998065829277039
COL17A1 O 1 0.9999996423721313
. O 0 0.002623044652864337

Five O 0 0.005684138275682926
intragenic O 1 0.9146554470062256
polymorphisms O 0 0.0021527500357478857
were O 0 0.0002386829728493467
chosen O 0 0.00017807168478611857
based O 0 4.804442141903564e-05
on O 0 0.00017096128431148827
their O 0 0.00028720658156089485
informativeness O 1 0.8204748034477234
. O 0 0.0015898675192147493

One O 0 0.0007099646027199924
of O 0 0.00043190602445974946
these O 0 7.764628389850259e-05
, O 0 5.181362939765677e-05
not O 0 2.7132931791129522e-05
previously O 0 0.00013709267659578472
reported O 0 0.00013795422273688018
, O 0 7.215890946099535e-05
was O 0 0.0005337228067219257
2988 O 0 0.29254627227783203
A O 0 0.0019892200361937284
or O 0 0.00036961690057069063
C O 0 0.000669317611027509
that O 0 4.394440838950686e-05
introduces O 0 0.0003558123717084527
a O 0 0.0001201591658173129
new O 0 0.00015791377518326044
restriction O 0 0.000209678866667673
site O 0 0.0006566030788235366
for O 0 0.00019352143863216043
Eco0109 O 1 0.9904643297195435
I O 0 0.017480067908763885
. O 0 0.0012162099592387676

All O 0 0.0010687235044315457
the O 0 0.0014210239751264453
4003delTC O 0 0.060235802084207535
alleles O 0 0.0008302487549372017
showed O 0 0.0005876029608771205
the O 0 0.00020156515529379249
same O 0 0.0001331137609668076
haplotype O 0 0.0005103445146232843
for O 0 5.988775592413731e-05
these O 0 4.986514613847248e-05
five O 0 0.00021906763140577823
polymorphic O 0 0.002196695888414979
markers O 0 0.005931417923420668
. O 0 0.0011269098613411188

Fourteen O 0 0.018645169213414192
microsatellite O 0 0.024523667991161346
polymorphisms O 0 0.002918085316196084
were O 0 0.0002920152619481087
selected O 0 0.00013452219718601555
based O 0 3.166352689731866e-05
on O 0 8.667097426950932e-05
their O 0 6.672574818367139e-05
high O 0 0.0006501585012301803
heterozygosity O 0 0.01670736074447632
and O 0 0.00015013443771749735
their O 0 5.4663036280544475e-05
location O 0 0.0003032250970136374
within O 0 0.00048431759933009744
10q23 O 1 0.9936836957931519
- O 0 0.006567203905433416
q25 O 1 0.9764299392700195
near O 0 0.32407650351524353
COL17A1 O 1 0.9998493194580078
. O 0 0.002443052129819989

Three O 0 0.0013559211511164904
families O 0 0.0004553506150841713
shared O 0 0.0005994178936816752
microsatellite O 0 0.007014305330812931
polymorphisms O 0 0.0013609695015475154
covering O 0 0.0021486158948391676
at O 0 0.0006706342683173716
most O 0 0.00012687561684288085
19 O 0 0.000677627045661211
cM O 0 0.0007572536123916507
, O 0 0.00013421061157714576
whereas O 0 0.00019604538101702929
the O 0 0.00017114852380473167
others O 0 0.00010273507359670475
shared O 0 0.00014387781266123056
smaller O 0 0.0001118214349844493
regions O 0 0.0001473242591600865
consistent O 0 0.00021684654348064214
with O 0 8.515083027305081e-05
cross O 0 0.0006040966836735606
- O 0 0.0005523941363207996
over O 0 0.00015488812641706318
events O 0 0.0001361313188681379
during O 0 0.0002917831589002162
passage O 0 0.0002645254717208445
of O 0 0.00011227273353142664
this O 0 5.4892152547836304e-05
mutation O 0 7.132386963348836e-05
through O 0 0.0001488997950218618
several O 0 0.00018771040777210146
generations O 0 0.001441408065147698
. O 0 0.0006597859901376069

These O 0 0.0005490996409207582
results O 0 0.00037591453292407095
indicate O 0 0.00032176950480788946
that O 0 9.617392061045393e-05
4003delTC O 0 0.014194793999195099
occurs O 0 0.0002832374884746969
on O 0 0.0002037843514699489
a O 0 0.00020981786656193435
single O 0 0.0003006363695021719
ancestral O 0 0.005208313465118408
allele O 0 0.0010926187969744205
. O 0 0.0003503875050228089
. O 0 0.0004762281896546483

The O 0 0.0051674810238182545
haptoglobin O 0 0.056629590690135956
- O 0 0.0032628944609314203
gene O 0 0.0005310248234309256
deletion O 0 0.0010570714948698878
responsible O 0 0.0010264007141813636
for O 0 0.0004991766763851047
anhaptoglobinemia B-Disease 1 0.9975270628929138
. O 0 0.002067589433863759

We O 0 0.0008914294303394854
have O 0 9.435620449949056e-05
found O 0 8.777411130722612e-05
an O 0 9.390076593263075e-05
allelic O 0 0.0017413151217624545
deletion O 0 0.00045041731209494174
of O 0 0.0002726153179537505
the O 0 0.0008725150837562978
haptoglobin O 1 0.9810514450073242
( O 0 0.0004850698169320822
Hp O 0 0.0025216892827302217
) O 0 9.181116911349818e-05
gene O 0 6.43043385935016e-05
from O 0 6.158783799037337e-05
an O 0 6.312978803180158e-05
individual O 0 7.896158058429137e-05
with O 0 0.0002254896389786154
anhaptoglobinemia B-Disease 1 0.9995476603507996
. O 0 0.001330281374976039

The O 0 0.0045959679409861565
Hp O 0 0.010369213297963142
gene O 0 0.0005971173522993922
cluster O 0 0.0008476981893181801
consists O 0 0.0002472095366101712
of O 0 0.0002444033161737025
coding O 0 0.00046176143223419785
regions O 0 0.00011554919910850003
of O 0 0.00020382655202411115
the O 0 0.0005662717157974839
alpha O 0 0.0009178616455756128
chain O 0 0.0003976222360506654
and O 0 7.924202509457245e-05
beta O 0 0.00019667430024128407
chain O 0 0.00014967245806474239
of O 0 9.147803211817518e-05
the O 0 0.0002982491860166192
haptoglobin O 0 0.011027347296476364
gene O 0 0.0003912705578841269
( O 0 0.00028129719430580735
Hp O 0 0.001661015790887177
) O 0 6.470304651884362e-05
and O 0 3.531022593961097e-05
of O 0 0.0001511403388576582
the O 0 0.0004893325385637581
alpha O 0 0.001332015497609973
chain O 0 0.0008636752609163523
and O 0 0.00014047931472305208
beta O 0 0.0003832251240964979
chain O 0 0.0003874886897392571
of O 0 0.00021778287191409618
the O 0 0.00045297795441001654
haptoglobin O 0 0.017538078129291534
- O 0 0.0008347250986844301
related O 0 0.0003374021907802671
gene O 0 0.00020735868019983172
( O 0 0.00021265404939185828
Hpr O 0 0.012391502968966961
) O 0 0.00011467655713204294
, O 0 5.531758870347403e-05
in O 0 9.32216426008381e-05
tandem O 0 0.001244699233211577
from O 0 0.00019202324619982392
the O 0 0.00039481910062022507
5 O 0 0.0008719732286408544
side O 0 0.0010361731983721256
. O 0 0.0004560149973258376

Southern O 0 0.022412722930312157
blot O 0 0.0275128111243248
and O 0 0.0013140968512743711
PCR O 0 0.0036936532706022263
analyses O 0 0.00036887224996462464
have O 0 4.632642230717465e-05
indicated O 0 0.00014793533773627132
that O 0 3.394874875084497e-05
the O 0 9.779976971913129e-05
individual O 0 5.9667137975338846e-05
with O 0 9.860848513199016e-05
anhaptoglobinemia B-Disease 1 0.985355019569397
was O 0 0.0022114019375294447
homozygous O 0 0.0003143147914670408
for O 0 3.710339296958409e-05
the O 0 0.00017158265109173954
gene O 0 0.00016852478438522667
deletion O 0 0.0003578978357836604
and O 0 6.983480125200003e-05
that O 0 2.8302602004259825e-05
the O 0 8.250550308730453e-05
gene O 0 0.00012437600526027381
deletion O 0 0.0004102393868379295
was O 0 0.0004153040936216712
included O 0 0.00011791177530540153
at O 0 0.00013987155398353934
least O 0 4.7101813834160566e-05
from O 0 8.258216257672757e-05
the O 0 0.00024521886371076107
promoter O 0 0.003684353781864047
region O 0 0.0005597546696662903
of O 0 0.0006527387304231524
Hp O 0 0.004025747999548912
to O 0 0.00039635502616874874
Hpr O 0 0.01987873949110508
alpha O 0 0.0006006874609738588
but O 0 2.346361543459352e-05
not O 0 1.1692089174175635e-05
to O 0 5.4993535741232336e-05
Hpr O 0 0.009864711202681065
beta O 0 0.0017305316869169474
( O 0 0.0007586476276628673
Hpdel O 1 0.9196653366088867
) O 0 0.0005272948765195906
. O 0 0.0004754671244882047

In O 0 0.0023914899211376905
addition O 0 0.0005776241305284202
, O 0 0.00018443480075802654
we O 0 5.0677666877163574e-05
found O 0 5.4247600928647444e-05
seven O 0 9.87701496342197e-05
individuals O 0 3.869832289637998e-05
with O 0 9.47621520026587e-05
hypohaptoglobinemia B-Disease 1 0.9717733263969421
in O 0 0.00028526244568638504
three O 0 0.00017803059017751366
families O 0 0.00010735774412751198
, O 0 7.257365359691903e-05
and O 0 6.122186459833756e-05
the O 0 0.00012579227040987462
genotypes O 0 0.0005432016914710402
of O 0 0.0002527492761146277
six O 0 0.0002764228847809136
of O 0 0.00022039507166482508
the O 0 0.0003318592789582908
seven O 0 0.0003242354723624885
individuals O 0 3.910316081601195e-05
were O 0 7.009547698544338e-05
found O 0 9.405149467056617e-05
to O 0 0.000137158582219854
be O 0 0.00030294220778159797
Hp2 O 1 0.9996836185455322
/ O 0 0.4653030335903168
Hpdel O 1 0.998910665512085
. O 0 0.0031608338467776775

The O 0 0.003578360192477703
phenotypes O 0 0.006361409090459347
and O 0 0.0003892035165335983
genotypes O 0 0.001222042366862297
in O 0 0.00012493360554799438
one O 0 5.349765342543833e-05
of O 0 8.850903395796195e-05
these O 0 1.9316008547320962e-05
three O 0 5.2080438763368875e-05
families O 0 5.311314816935919e-05
showed O 0 0.00018051840015687048
the O 0 0.00015472265658900142
father O 0 0.0006435132236219943
to O 0 0.0001400279434164986
be O 0 0.00018218602053821087
hypohaptoglobinemic B-Disease 1 0.584461510181427
( O 0 0.0008424423867836595
Hp2 O 1 0.9750657677650452
) O 0 0.0004279713029973209
and O 0 0.0004537152126431465
Hp2 O 1 0.9997743964195251
/ O 1 0.7200038433074951
Hpdel O 1 0.9997500777244568
, O 0 0.0003754532372113317
the O 0 0.00029059607186354697
mother O 0 0.0006140844197943807
to O 0 0.00015830060874577612
be O 0 0.000117122421215754
Hp2 O 0 0.018347151577472687
- O 0 0.0008780829957686365
1 O 0 0.0004233091603964567
and O 0 0.0002834447077475488
Hp1 O 1 0.9991878867149353
/ O 0 0.18327128887176514
Hp2 O 1 0.9988157749176025
, O 0 0.00013052001304458827
one O 0 4.4873999286210164e-05
of O 0 9.805581794353202e-05
the O 0 0.00018131347314920276
two O 0 7.518558413721621e-05
children O 0 0.00010929544805549085
to O 0 0.00011867394641740248
be O 0 0.00016971290460787714
hypohaptoglobinemic B-Disease 0 0.35316452383995056
( O 0 0.0011374782770872116
Hp2 O 1 0.9275261759757996
) O 0 0.0004194395150989294
and O 0 0.0005085012526251376
Hp2 O 1 0.9999525547027588
/ O 1 0.9923772811889648
Hpdel O 1 0.9999843835830688
, O 0 0.000277194834779948
and O 0 7.549963629571721e-05
the O 0 0.0001397975574946031
other O 0 5.637092181132175e-05
child O 0 0.0003012073284480721
to O 0 0.00012038968998240307
be O 0 0.00019863538909703493
Hp1 O 1 0.6470136046409607
and O 0 0.0008478726376779377
Hp1 O 1 0.999972939491272
/ O 1 0.8993636965751648
Hpdel O 1 0.9997579455375671
, O 0 0.0005973168299533427
showing O 0 0.0007792487740516663
an O 0 0.0002987466286867857
anomalous O 0 0.0033725774846971035
inheritance O 0 0.002133349422365427
of O 0 0.002095006639137864
Hp O 1 0.9268108606338501
phenotypes O 0 0.002445533173158765
in O 0 0.0002575416583567858
the O 0 0.0007553854957222939
child O 0 0.001443776418454945
with O 0 0.0004932123119942844
Hp1 O 1 0.9999359846115112
. O 0 0.0020558498799800873

The O 0 0.007974320091307163
Hp2 O 1 0.9999743700027466
/ O 1 0.9957045912742615
Hpdel O 1 0.9996856451034546
individuals O 0 0.00025271959020756185
had O 0 0.0002964015875477344
an O 0 0.00015384319704025984
extremely O 0 0.0003382685245014727
low O 0 0.00021772785112261772
level O 0 0.0002355666656512767
of O 0 0.00021820417896378785
Hp O 0 0.0025034849531948566
( O 0 0.00023734793649055064
mean O 0 0.00031593619496561587
+ O 0 0.0004950746661052108
/ O 0 0.0006320646498352289
- O 0 0.0004523018142208457
SD O 0 0.002197108929976821
= O 0 0.0003027946804650128
0 O 0 8.892866026144475e-05
. O 0 4.9456684791948646e-05
049 O 0 0.004234871827065945
+ O 0 0.000762249284889549
/ O 0 0.0007527191773988307
- O 0 0.0004962013917975128
0 O 0 0.00016309198690578341
. O 0 0.00011232896940782666
043 O 0 0.008696770295500755
mg O 0 0.0057790325954556465
/ O 0 0.0018254851456731558
ml O 0 0.00164793839212507
; O 0 6.716342613799497e-05
n O 0 0.0002667160297278315
= O 0 0.0003532125847414136
6 O 0 0.0003515113203320652
) O 0 3.860138531308621e-05
, O 0 3.070564707741141e-05
compared O 0 3.697404463309795e-05
with O 0 1.1180874025740195e-05
the O 0 8.835909829940647e-05
level O 0 0.00021364132408052683
( O 0 7.441708294209093e-05
1 O 0 9.695015614852309e-05
. O 0 2.3466660422855057e-05
64 O 0 0.00028463409398682415
+ O 0 0.00045609541120938957
/ O 0 0.0004618137900251895
- O 0 0.00031353661324828863
1 O 0 0.00021812389604747295
. O 0 6.895270780660212e-05
07 O 0 0.003971935715526342
mg O 0 0.0035670564975589514
/ O 0 0.00176669517531991
ml O 0 0.001926644705235958
) O 0 7.355548586929217e-05
obtained O 0 5.1459679525578395e-05
from O 0 0.00014181308506522328
52 O 0 0.000908535614144057
healthy O 0 0.00113832694478333
volunteers O 0 0.001164849498309195
having O 0 0.0009879664285108447
phenotype O 0 0.002258297288790345
Hp2 O 1 0.995970606803894
, O 0 0.0003787438909057528
whereas O 0 0.0002818483335431665
the O 0 0.0003615512396208942
serum O 0 0.005518912337720394
Hp O 0 0.002403757069259882
level O 0 0.00034165213583037257
of O 0 0.00012276493362151086
an O 0 8.705838990863413e-05
individual O 0 5.7935041695600376e-05
with O 0 0.00015894735406618565
Hp1 O 1 0.9999606609344482
/ O 1 0.6684014797210693
Hpdel O 1 0.9996827840805054
was O 0 0.007225830107927322
0 O 0 0.0012330289464443922
. O 0 0.0006590249249711633

50 O 0 0.005098385736346245
mg O 0 0.022529451176524162
/ O 0 0.0063974070362746716
ml O 0 0.0043774754740297794
, O 0 0.00011774997983593494
which O 0 3.633327651186846e-05
was O 0 0.00015189871191978455
approximately O 0 7.584622653666884e-05
half O 0 5.377180059440434e-05
the O 0 9.114140993915498e-05
level O 0 0.00022233474010135978
of O 0 0.00022514504962600768
Hp O 0 0.002479201415553689
in O 0 0.0002940468839369714
control O 0 0.0006928558577783406
sera O 0 0.004368199966847897
from O 0 0.0001503582316217944
the O 0 0.00044624111615121365
Hp1 O 1 0.8329397439956665
phenotype O 0 0.0008116350509226322
( O 0 0.00012368317402433604
1 O 0 0.00022066483506932855
. O 0 4.1862167563522235e-05
26 O 0 0.0003995694569312036
+ O 0 0.0005592686356976628
/ O 0 0.0005616757553070784
- O 0 0.00026413085288368165
0 O 0 8.405565313296393e-05
. O 0 4.023721339763142e-05
33 O 0 0.0004213221836835146
mg O 0 0.001907840953208506
/ O 0 0.0011029173620045185
ml O 0 0.001346156350336969
; O 0 6.959446909604594e-05
n O 0 0.00029115044162608683
= O 0 0.00041824232903309166
9 O 0 0.00046894856495782733
) O 0 6.220334762474522e-05
, O 0 4.893765799351968e-05
showing O 0 0.00026920693926513195
a O 0 0.00035517726792022586
gene O 0 0.0006911675445735455
- O 0 0.0016886347439140081
dosage O 0 0.0030997954308986664
effect O 0 0.0013839435996487737
. O 0 0.0006183724035508931

The O 0 0.002330917166545987
other O 0 0.0005060675903223455
allele O 0 0.0012933156685903668
( O 0 0.0007148174336180091
Hp2 O 1 0.6953546404838562
) O 0 0.00019268662435933948
of O 0 0.00019971845904365182
individuals O 0 9.167311509372666e-05
with O 0 0.0002857001090887934
Hp2 O 1 0.9999990463256836
/ O 1 0.9995359182357788
Hpdel O 1 0.9999860525131226
was O 0 0.0031844251789152622
found O 0 0.00013068417320027947
to O 0 5.661647810484283e-05
have O 0 3.274402115494013e-05
, O 0 3.403633672860451e-05
in O 0 5.3714604291599244e-05
all O 0 5.800347207696177e-05
exons O 0 0.0009173410362564027
, O 0 0.00013655332440976053
no O 0 0.0001801978360163048
mutation O 0 0.00018798714154399931
, O 0 8.089917537290603e-05
by O 0 7.958492642501369e-05
DNA O 0 0.0008602331508882344
sequencing O 0 0.0012712011812254786
. O 0 0.0004255564708728343

On O 0 0.0010409014066681266
the O 0 0.00022947433171793818
basis O 0 4.8472964408574626e-05
of O 0 0.00012662493099924177
the O 0 0.0001812434638850391
present O 0 0.00015962019097059965
study O 0 7.41578041925095e-05
, O 0 4.443534271558747e-05
the O 0 0.00013568461872637272
mechanism O 0 0.00039034048677422106
of O 0 0.0005218998994678259
anhaptoglobinemia B-Disease 1 0.9982695579528809
and O 0 0.00025142685626633465
the O 0 0.0004046834073960781
mechanism O 0 0.0005606765625998378
of O 0 0.0005652336985804141
anomalous O 0 0.009057454764842987
inheritance O 0 0.0034069016110152006
of O 0 0.009106194600462914
Hp O 1 0.9986157417297363
phenotypes O 0 0.005717226769775152
were O 0 0.0007037065224722028
well O 0 0.000692203757353127
explained O 0 0.0015286767156794667
. O 0 0.0005390378646552563

However O 0 0.0013634461211040616
, O 0 0.00027871940983459353
the O 0 0.0003943543415516615
mechanism O 0 0.0008107484318315983
of O 0 0.0016727803740650415
hypohaptoglobinemia B-Disease 1 0.9999220371246338
remains O 0 0.017379017546772957
unknown O 0 0.010099397972226143

ATM O 0 0.05579022318124771
mutations O 0 0.0018636768218129873
and O 0 0.0006192434229888022
phenotypes O 0 0.003630678867921233
in O 0 0.0018262836383655667
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999703168869019
telangiectasia I-Disease 1 0.9999856948852539
families O 0 0.0003191622090525925
in O 0 0.00011350832210155204
the O 0 0.00027448005857877433
British O 0 0.0008603495662100613
Isles O 0 0.001333071500994265
: O 0 0.00014910042227711529
expression O 0 0.00012434044037945569
of O 0 0.0002299381885677576
mutant O 0 0.002405198523774743
ATM O 0 0.0021559791639447212
and O 0 0.0001390578254358843
the O 0 0.00026173825608566403
risk O 0 0.000342388404533267
of O 0 0.0041804532520473
leukemia B-Disease 1 1.0
, O 1 0.9999401569366455
lymphoma B-Disease 1 1.0
, O 1 0.9939769506454468
and O 1 0.9947680234909058
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.0023676555138081312

We O 0 0.0008043737034313381
report O 0 0.00018859181727748364
the O 0 0.00016892280837055296
spectrum O 0 0.0003047887294087559
of O 0 0.0003005871258210391
59 O 0 0.00198027933947742
ATM O 0 0.003953901119530201
mutations O 0 0.0002663790655788034
observed O 0 0.00019983999663963914
in O 0 0.00030901137506589293
ataxia B-Disease 1 0.9999953508377075
- I-Disease 1 0.9862769246101379
telangiectasia I-Disease 1 0.9999920129776001
( O 0 0.0019504505908116698
A B-Disease 1 0.9999593496322632
- I-Disease 1 0.9995459914207458
T I-Disease 1 0.9999966621398926
) O 0 0.00019382227037567645
patients O 0 0.00014950288459658623
in O 0 0.0001042181029333733
the O 0 0.0003206771216355264
British O 0 0.0025853465776890516
Isles O 0 0.007860900834202766
. O 0 0.0011738830944523215

Of O 0 0.003283766098320484
51 O 0 0.006043771747499704
ATM O 0 0.014307640492916107
mutations O 0 0.0005347779951989651
identified O 0 0.00015074638940859586
in O 0 7.857668970245868e-05
families O 0 6.28771522315219e-05
native O 0 0.00014460444799624383
to O 0 8.137058466672897e-05
the O 0 0.00022204109700396657
British O 0 0.0006835433305241168
Isles O 0 0.0015320255188271403
, O 0 0.00019084938685409725
11 O 0 0.0006372786592692137
were O 0 0.00019865945796482265
founder O 0 0.0035426062531769276
mutations O 0 0.00024489176576025784
, O 0 7.065523823257536e-05
and O 0 5.637092181132175e-05
2 O 0 0.00013912624854128808
of O 0 0.00012631076970137656
these O 0 3.911610474460758e-05
11 O 0 0.00042526284232735634
conferred O 0 0.001010444830171764
a O 0 0.0005872238543815911
milder O 0 0.0022599201183766127
clinical O 0 0.0009986716322600842
phenotype O 0 0.0008145452011376619
with O 0 9.717422653920949e-05
respect O 0 0.0002694123541004956
to O 0 0.00044838033500127494
both O 0 0.0014707966474816203
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9997387528419495
cellular O 1 0.9983254075050354
features O 0 0.0023442653473466635
. O 0 0.0007433021673932672

We O 0 0.0011269678361713886
report O 0 0.00021708734857384115
, O 0 5.2519430028041825e-05
in O 0 5.803783642477356e-05
two O 0 6.549261888721958e-05
A B-Disease 1 0.5906152129173279
- I-Disease 1 0.6627631783485413
T I-Disease 1 0.9993605017662048
families O 0 0.00015283143147826195
, O 0 8.635097037767991e-05
an O 0 0.0001250770001206547
ATM O 0 0.0022529596462845802
mutation O 0 0.00040196796180680394
( O 0 0.000286296708509326
7271T O 1 0.7421647310256958
- O 0 0.0013646269217133522
- O 0 0.0007080311770550907
> O 0 0.0009251702576875687
G O 0 0.0012494487455114722
) O 0 6.886668415972963e-05
that O 0 3.5415912861935794e-05
may O 0 5.906220758333802e-05
be O 0 3.386871685506776e-05
associated O 0 4.659172554966062e-05
with O 0 3.6653102142736316e-05
an O 0 0.0001289328356506303
increased O 0 0.0004716291150543839
risk O 0 0.0005545676103793085
of O 0 0.1230018213391304
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999910593032837
in O 0 0.0006854789098724723
both O 0 0.0003752049233298749
homozygotes O 0 0.009151277132332325
and O 0 0.00028225628193467855
heterozygotes O 0 0.0032924425322562456
( O 0 0.0001800961617846042
relative O 0 0.0002385546686127782
risk O 0 0.00017014553304761648
12 O 0 0.00027088174829259515
. O 0 5.146605326444842e-05
7 O 0 0.00038640896673314273
; O 0 5.998160122544505e-05
P O 0 0.0020257101859897375
= O 0 0.0006740160752087831
. O 0 0.00017315107106696814
0025 O 1 0.505721390247345
) O 0 9.084951307158917e-05
, O 0 4.458492185221985e-05
although O 0 2.9718874429818243e-05
there O 0 2.604404289741069e-05
is O 0 2.993802263517864e-05
a O 0 0.00012426337343640625
less O 0 0.00020610998035408556
severe O 1 0.9997166991233826
A B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999463558197021
T I-Disease 1 0.9999788999557495
phenotype O 0 0.0005397447966970503
in O 0 7.21317992429249e-05
terms O 0 3.59037694579456e-05
of O 0 8.80267471075058e-05
the O 0 0.0002687827800400555
degree O 0 0.0014641225570812821
of O 1 0.8266244530677795
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9355285167694092

This O 0 0.0006844945019111037
mutation O 0 0.0006271124584600329
( O 0 0.0005762515938840806
7271T O 1 0.6993018388748169
- O 0 0.003285184968262911
- O 0 0.001744062639772892
> O 0 0.0022153754252940416
G O 0 0.0021347671281546354
) O 0 7.626935257576406e-05
also O 0 4.592255936586298e-05
allows O 0 1.8897662812378258e-05
expression O 0 3.949852180085145e-05
of O 0 9.201397188007832e-05
full O 0 0.00024368525191675872
- O 0 0.00039912405190989375
length O 0 0.00013113179011270404
ATM O 0 0.0007159961969591677
protein O 0 0.00011284513311693445
at O 0 0.0001398002204950899
a O 0 8.961487765191123e-05
level O 0 0.0001944775867741555
comparable O 0 0.0002266160154249519
with O 0 4.607073060469702e-05
that O 0 5.3205822041491047e-05
in O 0 0.00024771495372988284
unaffected O 0 0.003624201752245426
individuals O 0 0.000317309342790395
. O 0 0.0006186718237586319

In O 0 0.0015600929036736488
addition O 0 0.0005899093230254948
, O 0 0.00010373543773312122
we O 0 4.510916187427938e-05
have O 0 1.9854105630656704e-05
studied O 0 0.00017004659457597882
18 O 0 0.000760655733756721
A B-Disease 1 0.9974865913391113
- I-Disease 1 0.9993731379508972
T I-Disease 1 0.9999964237213135
patients O 0 0.0002478592505212873
, O 0 5.47017298231367e-05
in O 0 6.713179755024612e-05
15 O 0 0.0002746117243077606
families O 0 0.00010192982881562784
, O 0 0.00010949771240120754
who O 0 0.00034576590405777097
developed O 0 0.0790172889828682
leukemia B-Disease 1 1.0
, O 1 0.9992666840553284
lymphoma B-Disease 1 1.0
, O 0 0.2504163086414337
preleukemic O 1 0.9999997615814209
T O 1 0.999997615814209
- O 0 0.05119704082608223
cell O 0 0.00445445254445076
proliferation O 0 0.01491106953471899
, O 0 0.0005249062087386847
or O 1 0.5234332084655762
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.010179558768868446
mostly O 0 0.0006600645720027387
in O 0 0.0010543770622462034
childhood O 0 0.10350071638822556
. O 0 0.001698345527984202

A O 0 0.005365084856748581
wide O 0 0.0014391696313396096
variety O 0 0.0005317323957569897
of O 0 0.0006976872100494802
ATM O 0 0.01745804212987423
mutation O 0 0.00045495168888010085
types O 0 0.00016308389604091644
, O 0 9.570404654368758e-05
including O 0 0.00015260571672115475
missense O 0 0.0015247601550072432
mutations O 0 0.00020854019385296851
and O 0 8.837562199914828e-05
in O 0 0.00027972518000751734
- O 0 0.0011922279372811317
frame O 0 0.0028212442994117737
deletions O 0 0.0016480513149872422
, O 0 0.00010318295244360343
were O 0 0.00010994909825967625
seen O 0 0.00038424230297096074
in O 0 0.0001713851379463449
these O 0 0.00015727734717074782
patients O 0 0.0008390441071242094
. O 0 0.0006230776198208332

We O 0 0.0007709100027568638
also O 0 0.00013081009092275053
show O 0 0.00011495244689285755
that O 0 2.060946098936256e-05
25 O 0 5.308732943376526e-05
% O 0 2.5663392079877667e-05
of O 0 8.867766155162826e-05
all O 0 0.0001405870571034029
A B-Disease 1 0.9997199177742004
- I-Disease 1 0.9989861845970154
T I-Disease 1 0.9999351501464844
patients O 0 0.00034793323720805347
carried O 0 0.00022683435236103833
in O 0 0.00017385798855684698
- O 0 0.001192665658891201
frame O 0 0.0031221818644553423
deletions O 0 0.002160495612770319
or O 0 0.0004318665014579892
missense O 0 0.0019968305714428425
mutations O 0 0.00020405287796165794
, O 0 7.044943049550056e-05
many O 0 2.8305412342888303e-05
of O 0 0.0001571477041579783
which O 0 7.91390921222046e-05
were O 0 8.367529517272487e-05
also O 0 5.3991516324458644e-05
associated O 0 5.42854868399445e-05
with O 0 5.525695451069623e-05
expression O 0 0.00021855649538338184
of O 0 0.000842717825435102
mutant O 0 0.01826927252113819
ATM O 0 0.015398909337818623
protein O 0 0.0011221622116863728
. O 0 0.0004913386073894799

The O 0 0.007857434451580048
DMPK O 1 0.9999551773071289
gene O 0 0.002164234407246113
of O 0 0.004826560616493225
severely O 1 0.9999995231628418
affected O 1 0.9999762773513794
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999827146530151
is O 0 0.009142079390585423
hypermethylated O 1 0.9999929666519165
proximal O 1 0.9995711445808411
to O 0 0.0005182316526770592
the O 0 0.0005920986877754331
largely O 0 0.0008803411037661135
expanded O 0 0.002463602228090167
CTG O 1 0.9466409683227539
repeat O 0 0.0075267706997692585
. O 0 0.0010083885863423347

Using O 0 0.001334958360530436
methylation O 0 0.0016464594518765807
- O 0 0.0013285264139994979
sensitive O 0 0.002237236825749278
restriction O 0 0.0008475261274725199
enzymes O 0 0.000472034327685833
, O 0 0.00011932176857953891
we O 0 8.10604979051277e-05
characterized O 0 0.0002912808849941939
the O 0 0.00018378859385848045
methylation O 0 0.00037999104824848473
pattern O 0 0.00042949742055498064
on O 0 0.0001916987239383161
the O 0 0.00024530026712454855
5 O 0 0.00024227208632510155
side O 0 0.00016386139031965286
of O 0 0.00018686697876546532
the O 0 0.0006400999845936894
CTG O 1 0.9808556437492371
repeat O 0 0.0012126448564231396
in O 0 0.00020609777129720896
the O 0 0.0003710748569574207
DMPK O 1 0.9966417551040649
gene O 0 0.00024301913799718022
of O 0 0.00023389040143229067
normal O 0 0.0003523887135088444
individuals O 0 5.345359750208445e-05
and O 0 0.0001006323000183329
of O 0 0.0005332113360054791
patients O 0 0.0032104188576340675
affected O 0 0.030005374923348427
with O 0 0.08943197876214981
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.00811414048075676
showing O 0 0.0037466713692992926
expansions O 0 0.002522538648918271
of O 0 0.0003804060397669673
the O 0 0.000769336533267051
repetitive O 0 0.004840937443077564
sequence O 0 0.0006804131553508341
. O 0 0.0005040894029662013

The O 0 0.002942930208519101
gene O 0 0.000835668935906142
segment O 0 0.000979811418801546
analyzed O 0 0.0002121683646691963
corresponds O 0 0.0002639875456225127
to O 0 5.424543269327842e-05
the O 0 0.0002449449966661632
genomic O 0 0.000938695389777422
SacI O 0 0.49806705117225647
- O 0 0.002152262721210718
HindIII O 0 0.01309722289443016
fragment O 0 0.001232741866260767
carrying O 0 0.0006355966324917972
exons O 0 0.0017534955404698849
11 O 0 0.0012979902094230056
- O 0 0.00145056308247149
15 O 0 0.0014096858212724328
. O 0 0.0005631358944810927

There O 0 0.0012459168210625648
is O 0 0.0003372629580553621
constitutive O 0 0.0021837137173861265
methylation O 0 0.0004230711201671511
in O 0 0.00022718196851201355
intron O 0 0.002558032050728798
12 O 0 0.0005722405039705336
at O 0 0.00037664358387701213
restriction O 0 0.00012152229464845732
sites O 0 9.240456711268052e-05
of O 0 0.0002360307116759941
SacII O 1 0.9952753782272339
and O 0 0.0009835538221523166
HhaI O 1 0.9978803396224976
, O 0 0.0004738872521556914
localized O 0 0.0011526336893439293
1 O 0 0.00033513663220219314
, O 0 9.286709246225655e-05
159 O 0 0.0005065328441560268
- O 0 0.00040508847450837493
1 O 0 0.00019439806055743247
, O 0 7.090625877026469e-05
232 O 0 0.0007676598615944386
bp O 0 0.0015549799427390099
upstream O 0 0.0009371319320052862
of O 0 0.000318714912282303
the O 0 0.0006914857076480985
CTG O 1 0.9989483952522278
repeat O 0 0.0034603322856128216
, O 0 0.00016006095393095165
whereas O 0 0.00018006283789873123
most O 0 5.766451795352623e-05
, O 0 6.134353316156194e-05
if O 0 3.6103108868701383e-05
not O 0 1.285783582716249e-05
all O 0 1.4429722796194255e-05
, O 0 2.1384579667937942e-05
of O 0 5.05309144500643e-05
the O 0 7.49542232370004e-05
other O 0 2.4826580556691624e-05
sites O 0 0.00010912600555457175
of O 0 0.00027544109616428614
SacII O 1 0.9999372959136963
, O 0 0.0005943722790107131
HhaI O 1 0.9997474551200867
, O 0 0.00024655918241478503
and O 0 0.0002068734756903723
HpaII O 1 0.8963990211486816
in O 0 0.00018128148803953081
this O 0 7.779947918606922e-05
region O 0 0.0003352973435539752
are O 0 3.5334680433152243e-05
unmethylated O 0 0.00387486070394516
, O 0 0.00013337904238142073
in O 0 0.00017876099445857108
normal O 0 0.0002688524837139994
individuals O 0 3.078220470342785e-05
and O 0 5.422194954007864e-05
most O 0 6.820509588578716e-05
of O 0 0.00037151077413000166
the O 0 0.002329204697161913
patients O 0 0.002028440358117223
. O 0 0.0008823482203297317

In O 0 0.0009110824321396649
a O 0 0.00043713056948035955
number O 0 0.00010006943921325728
of O 0 0.00031631835736334324
young O 0 0.0013455208390951157
and O 0 0.0006581248599104583
severely O 1 0.9999676942825317
affected O 0 0.03719160705804825
patients O 0 0.0007686276221647859
, O 0 0.00010765730257844552
however O 0 7.46926452848129e-05
, O 0 4.2722938815131783e-05
complete O 0 0.00015881496074143797
methylation O 0 0.00013040208432357758
of O 0 0.0001797060831449926
these O 0 3.811894930549897e-05
restriction O 0 0.00019827303185593337
sites O 0 0.0001578523515490815
was O 0 0.0002977466501761228
found O 0 7.451728015439585e-05
in O 0 0.00010020971240010113
the O 0 0.0003692532773129642
mutated O 0 0.0025646102149039507
allele O 0 0.0016707653412595391
. O 0 0.0005959327681921422

In O 0 0.0009513483382761478
most O 0 0.00020486423454713076
of O 0 0.0001975118793779984
these O 0 9.177115862257779e-05
patients O 0 0.000244843220571056
, O 0 8.902385889086872e-05
the O 0 0.0003644583630375564
onset O 1 0.9978554844856262
of O 0 0.05159662663936615
the O 1 0.9999188184738159
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.7833256721496582

Preliminary O 0 0.003543784376233816
in O 0 0.0018004629528149962
vivo O 0 0.006149642635136843
footprinting O 0 0.017245659604668617
data O 0 9.937137656379491e-05
gave O 0 0.000152483960846439
evidence O 0 0.00010620187822496518
for O 0 4.4433054426917806e-05
protein O 0 0.0002588248753454536
- O 0 0.00042365328408777714
DNA O 0 0.0002561551227699965
contact O 0 0.00015335225907620043
in O 0 8.093058568192646e-05
normal O 0 0.00020406300609465688
genes O 0 9.528507507639006e-05
at O 0 0.0003062918549403548
an O 0 0.00012803077697753906
Sp1 O 0 0.008510876446962357
consensus O 0 0.0003393779625184834
binding O 0 0.00011519869440235198
site O 0 0.0002767314144875854
upstream O 0 0.000463635049527511
of O 0 0.00022645379067398608
the O 0 0.000736866204533726
CTG O 1 0.9981492757797241
repeat O 0 0.001578527968376875
and O 0 6.748095620423555e-05
for O 0 2.7204367142985575e-05
a O 0 9.508275252301246e-05
significant O 0 0.00016848670202307403
reduction O 0 0.00024915457470342517
of O 0 0.00011668388469843194
this O 0 5.81394815526437e-05
interaction O 0 7.406755321426317e-05
in O 0 0.0001356630091322586
cells O 0 0.00015581230400130153
with O 0 4.6609235141659155e-05
a O 0 0.0005579694407060742
hypermethylated O 1 0.9997450709342957
DMPK O 1 0.999992847442627
gene O 0 0.0014946095179766417
. O 0 0.00031332895741797984
. O 0 0.000414432433899492

The O 0 0.016851019114255905
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.0027855492662638426
product O 0 0.0008052472840063274
complexes O 0 0.0012302820105105639
with O 0 0.00012724574480671436
the O 0 0.0006878215936012566
transferrin O 0 0.3807964026927948
receptor O 0 0.0004891378921456635
and O 0 0.000135877649881877
lowers O 0 0.0009584702784195542
its O 0 5.858294025529176e-05
affinity O 0 0.00015151406114455312
for O 0 8.397913916269317e-05
ligand O 0 0.0014160405844449997
binding O 0 0.0006008169148117304
. O 0 0.0007215754594653845

We O 0 0.0012143017956987023
recently O 0 0.0012656569015234709
reported O 0 0.0003467244387138635
the O 0 0.00023020450316835195
positional O 0 0.002460069488734007
cloning O 0 0.0005797938210889697
of O 0 0.00017796507745515555
a O 0 0.00025028124218806624
candidate O 0 0.0004328063514549285
gene O 0 0.00038351878174580634
for O 0 0.0004939127829857171
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999960660934448
HFE O 1 0.9999994039535522
. O 0 0.005322162061929703

The O 0 0.0031719317194074392
gene O 0 0.0008208936196751893
product O 0 0.0003690113371703774
, O 0 6.157785537652671e-05
a O 0 6.933480472071096e-05
member O 0 0.0001040752831613645
of O 0 0.0001234795490745455
the O 0 0.00039223802741616964
major O 0 0.008991298265755177
histocompatibility O 1 0.9999996423721313
complex O 0 0.4287256598472595
class O 0 0.0025405525229871273
I O 0 0.05341142416000366
- O 0 0.000655690731946379
like O 0 0.0001480540377087891
family O 0 0.00017110345652326941
, O 0 8.069947216426954e-05
was O 0 0.00028275290969759226
found O 0 5.030436295783147e-05
to O 0 3.806526365224272e-05
have O 0 1.6440095350844786e-05
a O 0 0.00012004142627120018
mutation O 0 0.00018523722246754915
, O 0 0.00021364375425036997
Cys O 0 0.02201457880437374
- O 0 0.0020401417277753353
282 O 0 0.0037285801954567432
- O 0 0.0013688832987099886
- O 0 0.0011215348495170474
> O 0 0.0023127547465264797
Tyr O 0 0.02640945091843605
( O 0 0.000655690033454448
C282Y O 0 0.0743064433336258
) O 0 0.0001475097960792482
, O 0 5.185080226510763e-05
in O 0 6.720257078995928e-05
85 O 0 0.00029659661231562495
% O 0 0.00010674200166249648
of O 0 0.00043380551505833864
patient O 0 0.0026527540758252144
chromosomes O 0 0.002368903486058116
. O 0 0.0010311100631952286

This O 0 0.0013359744334593415
mutation O 0 0.0008711652480997145
eliminates O 0 0.0014705319190397859
the O 0 0.00037178854108788073
ability O 0 0.0002826071286108345
of O 0 0.000510579498950392
HFE O 1 0.9951009154319763
to O 0 0.00025708856992423534
associate O 0 0.00046698961523361504
with O 0 0.0001874013978522271
beta2 O 1 0.9976081848144531
- O 0 0.00639383215457201
microglobulin O 1 0.9972403049468994
( O 0 0.0009512305841781199
beta2m O 1 0.9434385895729065
) O 0 0.00024751233286224306
and O 0 0.00023031473392620683
prevents O 0 0.0017153051448985934
cell O 0 0.0077539109624922276
- O 0 0.002970334840938449
surface O 0 0.0020779890473932028
expression O 0 0.0009590074187144637
. O 0 0.00040727542364038527

A O 0 0.006269590929150581
second O 0 0.002567189047113061
mutation O 0 0.000273309153271839
that O 0 6.057239443180151e-05
has O 0 6.381673301802948e-05
no O 0 7.526607805630192e-05
effect O 0 0.00020345023949630558
on O 0 0.0005939002730883658
beta2m O 1 0.9988893866539001
association O 0 0.0011188234202563763
, O 0 0.00045946199679747224
H63D O 1 0.999992847442627
, O 0 0.0002955042873509228
was O 0 0.00037958353641442955
found O 0 6.320929969660938e-05
in O 0 5.936922752880491e-05
eight O 0 9.646673424867913e-05
out O 0 5.832262468175031e-05
of O 0 0.0002048550668405369
nine O 0 0.0007166318246163428
patients O 0 0.0004081547958776355
heterozygous O 0 0.0002246852673124522
for O 0 8.655789133626968e-05
the O 0 0.000669626984745264
C282Y O 1 0.9979695677757263
mutant O 0 0.012069096788764
. O 0 0.0009535893914289773

In O 0 0.0013126387493684888
this O 0 0.00024114150437526405
report O 0 0.0001700342691037804
, O 0 8.108763722702861e-05
we O 0 6.45397522021085e-05
demonstrate O 0 0.0002896268852055073
in O 0 0.0001894435699796304
cultured O 0 0.002886067144572735
293 O 0 0.006361161824315786
cells O 0 0.001120886649005115
overexpressing O 0 0.006633054930716753
wild O 0 0.0006868279888294637
- O 0 0.0006864500464871526
type O 0 0.0006458270945586264
or O 0 0.00034373984090052545
mutant O 0 0.004619254730641842
HFE O 1 0.9754272699356079
proteins O 0 0.0002026371512329206
that O 0 2.6754609280033037e-05
both O 0 1.8547218132880516e-05
the O 0 0.00010690315684769303
wild O 0 0.00045096786925569177
- O 0 0.001015408313833177
type O 0 0.000827897631097585
and O 0 0.0006516456487588584
H63D O 1 0.9999972581863403
HFE O 1 0.9999570846557617
proteins O 0 0.0007955171749927104
form O 0 0.00038108022999949753
stable O 0 0.0012024127645418048
complexes O 0 0.000925210362765938
with O 0 8.728090324439108e-05
the O 0 0.0005893975612707436
transferrin O 1 0.7627038955688477
receptor O 0 0.0013667241437360644
( O 0 0.0007053646259009838
TfR O 0 0.2266441434621811
) O 0 0.0006133005954325199
. O 0 0.0005328435217961669

The O 0 0.005164733622223139
C282Y O 1 0.9927178621292114
mutation O 0 0.0019715672824531794
nearly O 0 0.0014980507548898458
completely O 0 0.0020796689204871655
prevents O 0 0.00048764742678031325
the O 0 0.0002495901717338711
association O 0 0.00016370133380405605
of O 0 0.00021927909983787686
the O 0 0.0008681265753693879
mutant O 0 0.007767362054437399
HFE O 1 0.9987215399742126
protein O 0 0.0007146038697101176
with O 0 0.00021404850122053176
the O 0 0.0019011435797438025
TfR O 1 0.9955505132675171
. O 0 0.0018846294842660427

Studies O 0 0.0007426822558045387
on O 0 0.0010092883603647351
cell O 0 0.0025711271446198225
- O 0 0.0009471320081502199
associated O 0 0.00036149233346804976
transferrin O 0 0.0053493366576731205
at O 0 0.0004623542772606015
37 O 0 0.0003959940222557634
degrees O 0 0.0002015765057876706
C O 0 0.0006315446808002889
suggest O 0 0.00012908810458611697
that O 0 3.439420834183693e-05
the O 0 0.0002448441518936306
overexpressed O 0 0.004494242835789919
wild O 0 0.0011565451277419925
- O 0 0.001459920546039939
type O 0 0.0013838091399520636
HFE O 1 0.9605979323387146
protein O 0 0.0009188398253172636
decreases O 0 0.0005679603200405836
the O 0 0.00019552365120034665
affinity O 0 0.0002112942311214283
of O 0 0.00036438798997551203
the O 0 0.0013390075182542205
TfR O 1 0.9911899566650391
for O 0 0.0013110731961205602
transferrin O 1 0.9822039604187012
. O 0 0.0017708619125187397

The O 0 0.008026164956390858
overexpressed O 1 0.5263642072677612
H63D O 1 0.9999566078186035
protein O 0 0.0010967024136334658
does O 0 9.028925705933943e-05
not O 0 1.697847619652748e-05
have O 0 9.853897608991247e-06
this O 0 1.9279383195680566e-05
effect O 0 8.170953515218571e-05
, O 0 5.0180657126475126e-05
providing O 0 5.6111766753019765e-05
the O 0 7.73652718635276e-05
first O 0 0.00010164097329834476
direct O 0 5.168610732653178e-05
evidence O 0 0.0001120899323723279
for O 0 5.943034193478525e-05
a O 0 0.0001846857339842245
functional O 0 0.0006125210784375668
consequence O 0 0.001266087987460196
of O 0 0.0006406813627108932
the O 0 0.0029196867253631353
H63D O 1 0.9999997615814209
mutation O 0 0.002384476363658905
. O 0 0.000592107477132231

Addition O 0 0.0022842977195978165
of O 0 0.001373058883473277
soluble O 0 0.006889082957059145
wild O 0 0.0019114381866529584
- O 0 0.0020601546857506037
type O 0 0.0032972199842333794
HFE O 1 0.9999803304672241
/ O 0 0.1596543788909912
beta2m O 1 0.9678479433059692
heterodimers O 0 0.014403852634131908
to O 0 0.0005580135039053857
cultured O 0 0.005543651524931192
cells O 0 0.0008848347933962941
also O 0 0.00015863816952332854
decreased O 0 0.0005768104456365108
the O 0 0.0001427683891961351
apparent O 0 0.0007988543366082013
affinity O 0 0.0002552995574660599
of O 0 0.0002475024084560573
the O 0 0.0007665440789423883
TfR O 0 0.033071354031562805
for O 0 8.251934923464432e-05
its O 0 5.1008428272325546e-05
ligand O 0 0.00030624071951024234
under O 0 0.0002460232935845852
steady O 0 0.0011400252114981413
- O 0 0.0003527658700477332
state O 0 0.00010602238035062328
conditions O 0 0.00026334324502386153
, O 0 4.805440767086111e-05
both O 0 5.340783900464885e-05
in O 0 0.00016873284766916186
293 O 0 0.0058122663758695126
cells O 0 0.0006925991037860513
and O 0 0.0002349690767005086
in O 0 0.0007751273224130273
HeLa O 1 0.9998587369918823
cells O 0 0.0035984686110168695
. O 0 0.0005950910272076726

Furthermore O 0 0.002337923739105463
, O 0 0.0002844656119123101
at O 0 0.0003165247035212815
4 O 0 0.00032052304595708847
degrees O 0 0.00016045583470258862
C O 0 0.0005153511883690953
, O 0 0.00010088029375765473
the O 0 0.00025822396855801344
added O 0 0.0005306306411512196
soluble O 0 0.001959179062396288
complex O 0 0.0015999068273231387
of O 0 0.0018829817418009043
HFE O 1 0.9999896287918091
/ O 1 0.5249376893043518
beta2m O 1 0.8373972177505493
inhibited O 0 0.0031003495678305626
binding O 0 0.0003007430350407958
of O 0 0.0006764459540136158
transferrin O 0 0.13773663341999054
to O 0 0.0011457843938842416
HeLa O 1 0.996324360370636
cell O 0 0.002934348536655307
TfR O 0 0.014823909848928452
in O 0 0.0002455110370647162
a O 0 0.0005939651164226234
concentration O 0 0.011376469396054745
- O 0 0.0020902655087411404
dependent O 0 0.0006400006241165102
manner O 0 0.0012714032782241702
. O 0 0.0005770674906671047

Scatchard O 0 0.01803244650363922
plots O 0 0.0023453827016055584
of O 0 0.00040596717735752463
these O 0 6.623531953664497e-05
data O 0 5.8127505326410756e-05
indicate O 0 0.00010663914872566238
that O 0 3.074963387916796e-05
the O 0 0.0002547281910665333
added O 0 0.0005712296115234494
heterodimer O 0 0.004249689169228077
substantially O 0 0.000824355985969305
reduced O 0 0.00015657722542528063
the O 0 0.00011426524724811316
affinity O 0 0.00023041092208586633
of O 0 0.0007885292288847268
TfR O 1 0.995465099811554
for O 0 0.001130384742282331
transferrin O 1 0.9909374713897705
. O 0 0.0013636407675221562

These O 0 0.00039499130798503757
results O 0 0.00030454996158368886
establish O 0 0.0003180198254995048
a O 0 0.00027104062610305846
molecular O 0 0.0005529794143512845
link O 0 0.0011974540539085865
between O 0 0.0010653878562152386
HFE O 1 0.9993396401405334
and O 0 0.0003157832252327353
a O 0 0.0003501213504932821
key O 0 0.0007039550109766424
protein O 0 0.00023012638848740608
involved O 0 0.00026861033984459937
in O 0 0.00043639636714942753
iron O 1 0.9999942779541016
transport O 0 0.008718502707779408
, O 0 0.0003088043595198542
the O 0 0.0007089821738190949
TfR O 1 0.996752917766571
, O 0 0.0002609379298519343
and O 0 0.00010444832150824368
raise O 0 0.00019266385061200708
the O 0 0.00014057982480153441
possibility O 0 0.0002925904409494251
that O 0 5.6527354900026694e-05
alterations O 0 0.0011730280239135027
in O 0 0.00011368075502105057
this O 0 4.3466847273521125e-05
regulatory O 0 0.0004048365808557719
mechanism O 0 0.0006187691469676793
may O 0 0.00015887583140283823
play O 0 0.00011747968528652564
a O 0 9.59099706960842e-05
role O 0 0.00021440247655846179
in O 0 0.00012465646432247013
the O 0 0.0006576227024197578
pathogenesis O 1 0.9997642636299133
of O 1 0.9981120824813843
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9921920895576477
. O 0 0.00250788452103734

Genomic O 0 0.003915262408554554
organization O 0 0.0004857060266658664
of O 0 0.0005771021824330091
the O 0 0.001647404977120459
UBE3A O 1 0.9999793767929077
/ O 1 0.8416469693183899
E6 O 1 0.9999370574951172
- O 0 0.005123767536133528
AP O 0 0.004154414404183626
gene O 0 0.0004326667112763971
and O 0 0.0002269070246256888
related O 0 0.0009437748230993748
pseudogenes O 0 0.013616452924907207
. O 0 0.0015317868674173951

The O 0 0.005910228472203016
UBE3A O 0 0.3972266614437103
gene O 0 0.0007187629817053676
encodes O 0 0.000474575295811519
the O 0 0.0005496992380358279
E6 O 1 0.8964353203773499
- O 0 0.0021143793128430843
AP O 0 0.0031851185485720634
ubiquitin O 0 0.004469092935323715
- O 0 0.0010461235651746392
protein O 0 0.0004325691843405366
ligase O 0 0.0021999531891196966
and O 0 0.00011608746717683971
has O 0 9.651733853388578e-05
recently O 0 0.00024267622211482376
been O 0 8.290835830848664e-05
shown O 0 6.571251287823543e-05
to O 0 6.6543128923513e-05
be O 0 0.00013335171388462186
mutated O 0 0.0028236343059688807
in O 0 0.04195433855056763
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9997914433479309
who O 0 0.01621394231915474
lack O 1 0.8592460751533508
15q11 O 1 0.9999983310699463
- O 0 0.40331411361694336
q13 O 1 0.9834422469139099
deletions O 0 0.0038472446613013744
or O 0 0.0005166244809515774
chromosome O 0 0.0017098496900871396
15 O 0 0.0024398688692599535
paternal O 0 0.08324281871318817
uniparental B-Disease 1 0.9999885559082031
disomy I-Disease 1 0.9999585151672363
. O 0 0.005353458225727081

Previous O 0 0.01676139421761036
UBE3A O 1 0.8684737682342529
cDNA O 0 0.004626972135156393
analysis O 0 0.00018727921997196972
has O 0 5.1740407798206434e-05
shown O 0 6.456670962506905e-05
a O 0 0.00010841014591278508
coding O 0 0.00026382325449958444
region O 0 0.00019788663485087454
of O 0 0.0002023880515480414
approximately O 0 0.0004960439982824028
2 O 0 0.0009427349432371557
. O 0 0.000361034763045609

6 O 0 0.006840527523308992
kb O 0 0.005383704323321581
and O 0 0.00020686874631792307
a O 0 0.0002597116108518094
3 O 0 0.000453663757070899
- O 0 0.0006928955554030836
untranslated O 0 0.0031460868194699287
region O 0 0.000514846935402602
( O 0 0.0002190375525970012
UTR O 0 0.006801936775445938
) O 0 5.40125256520696e-05
of O 0 0.00015443463053088635
< O 0 0.0014729901449754834
50 O 0 0.0003808338369708508
bp O 0 0.0014429145958274603
, O 0 8.755825547268614e-05
whereas O 0 7.444809307344258e-05
Northern O 0 0.0001963948889169842
analysis O 0 2.5504657969577238e-05
has O 0 2.064936052192934e-05
indicated O 0 5.5254738981602713e-05
mRNA O 0 4.616097066900693e-05
sizes O 0 1.858234463725239e-05
of O 0 6.797698006266728e-05
5 O 0 0.0003189164272043854
- O 0 0.0007543524261564016
8 O 0 0.0011491160839796066
kb O 0 0.006578823551535606
. O 0 0.0007170750759541988

We O 0 0.0008771455613896251
have O 0 0.00012844297452829778
analyzed O 0 0.00017838265921454877
additional O 0 0.00014479954552371055
cDNA O 0 0.0019823708571493626
clones O 0 0.001367039978504181
and O 0 8.294077997561544e-05
provide O 0 5.2526946092257276e-05
evidence O 0 7.818458834663033e-05
for O 0 3.25873916153796e-05
an O 0 6.348772876663134e-05
additional O 0 0.00021372406627051532
0 O 0 0.0003467705682851374
. O 0 0.00036604490014724433

5 O 0 0.002778091235086322
kb O 0 0.003302149008959532
of O 0 0.0005847153952345252
5 O 0 0.0010241791605949402
- O 0 0.0014024749398231506
UTR O 0 0.008003145456314087
and O 0 0.00020115925872232765
> O 0 0.00059882941422984
2 O 0 0.00035218047560192645
kb O 0 0.0011277168523520231
of O 0 0.0004055662138853222
3 O 0 0.0016250887420028448
- O 0 0.004374637268483639
UTR O 0 0.11844602227210999
. O 0 0.0010974104516208172

We O 0 0.0010611831676214933
have O 0 7.585606363136321e-05
established O 0 0.00022214527416508645
the O 0 0.00020595750538632274
genomic O 0 0.00038198824040591717
organization O 0 0.0002658492885529995
of O 0 0.0006169165717437863
UBE3A O 1 0.9965558052062988
and O 0 0.00020406339899636805
the O 0 0.00022123806411400437
sequence O 0 0.0001384133065585047
of O 0 0.00039944914169609547
intron O 0 0.14426931738853455
- O 0 0.00317550846375525
exon O 0 0.003910944797098637
borders O 0 0.0008128746412694454
. O 0 0.0004862094938289374

We O 0 0.0014337982283905149
have O 0 0.00014472032489720732
also O 0 9.333522757515311e-05
mapped O 0 0.00028455484425649047
two O 0 9.510525705991313e-05
highly O 0 0.00044801674084737897
homologous O 0 0.002222295617684722
processed O 0 0.001954849809408188
pseudogenes O 0 0.005789195187389851
, O 0 0.00047870021080598235
UBE3AP1 O 1 0.9997319579124451
and O 0 0.0009275112533941865
UBE3AP2 O 1 0.9998724460601807
, O 0 0.00019585333939176053
to O 0 9.073990804608911e-05
chromosomes O 0 0.00018948872457258403
2 O 0 0.00018892639491241425
and O 0 9.554420103086159e-05
21 O 0 0.0006099775200709701
, O 0 0.00016034570580814034
respectively O 0 0.0003105746873188764
, O 0 7.667642057640478e-05
and O 0 8.281685586553067e-05
determined O 0 0.0001651246566325426
their O 0 7.263720908667892e-05
genomic O 0 0.0006875270628370345
organization O 0 0.0007058298797346652
. O 0 0.0006058868602849543

These O 0 0.00042495669913478196
results O 0 0.000294219033094123
will O 0 7.863185601308942e-05
form O 0 6.286683492362499e-05
the O 0 6.872654921608046e-05
basis O 0 3.0496526960632764e-05
for O 0 2.6788995455717668e-05
studies O 0 3.0238668841775507e-05
of O 0 0.00025034425198100507
mutation O 0 0.0003719370870385319
and O 0 0.0003315408539492637
imprinting O 0 0.011614865623414516
of O 0 0.006157136522233486
UBE3A O 1 0.9999926090240479
. O 0 0.0030242486391216516

Mutation O 0 0.00618007592856884
spectrum O 0 0.003916761837899685
and O 0 0.0008159978897310793
genotype O 0 0.0035389766562730074
- O 0 0.0022424794733524323
phenotype O 0 0.0012822590069845319
analyses O 0 0.00040079618338495493
in O 0 0.0010767042404040694
Cowden B-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999996423721313
and O 1 0.5325616002082825
Bannayan B-Disease 1 1.0
- I-Disease 1 0.999998927116394
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.001594080007635057
two O 0 0.0014801302459090948
hamartoma B-Disease 1 0.9999986886978149
syndromes I-Disease 1 0.9999986886978149
with O 1 0.6030982136726379
germline O 1 0.9999995231628418
PTEN O 1 0.9999997615814209
mutation O 0 0.0047803008928895
. O 0 0.0009966522920876741

The O 0 0.021634314209222794
tumour B-Disease 1 1.0
suppressor O 1 0.9999635219573975
gene O 0 0.010549857281148434
PTEN O 1 0.9999549388885498
, O 0 0.00032091813045553863
which O 0 0.00010103952081408352
maps O 0 0.00029715648270212114
to O 0 0.0004326999478507787
10q23 O 1 0.7743993401527405
. O 0 0.001392288482747972

3 O 0 0.0029693690594285727
and O 0 0.00038245972245931625
encodes O 0 0.00030601397156715393
a O 0 0.00024267435946967453
403 O 0 0.0011035657953470945
amino O 0 0.00028425903292372823
acid O 0 0.0004810458922293037
dual O 0 0.0003903844626620412
specificity O 0 0.0005019623786211014
phosphatase O 0 0.009400911629199982
( O 0 0.00040827953489497304
protein O 0 0.0005426071002148092
tyrosine O 0 0.0018140682950615883
phosphatase O 0 0.014061379246413708
; O 0 0.0002598267456050962
PTPase O 1 0.9848644137382507
) O 0 0.0002884028945118189
, O 0 0.00020095548825338483
was O 0 0.0006077656871639192
shown O 0 0.0001437858009012416
recently O 0 0.00017179074347950518
to O 0 5.2397317631402984e-05
play O 0 0.0001114712722483091
a O 0 0.00012373272329568863
broad O 0 0.0004899725317955017
role O 0 0.0009557830053381622
in O 0 0.0006815086817368865
human O 0 0.003831276437267661
malignancy B-Disease 1 0.9999877214431763
. O 0 0.0015947280917316675

Somatic O 1 0.9606581330299377
PTEN O 1 0.9998974800109863
deletions O 0 0.018482031300663948
and O 0 0.0007314441027119756
mutations O 0 0.0004556323983706534
were O 0 0.0001817664597183466
observed O 0 0.00019516062457114458
in O 0 0.00020314262656029314
sporadic B-Disease 0 0.02097223699092865
breast I-Disease 1 0.9999873638153076
, I-Disease 0 0.004314442165195942
brain I-Disease 1 0.9999991655349731
, I-Disease 0 0.020387962460517883
prostate I-Disease 1 1.0
and I-Disease 1 0.9998430013656616
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9993429780006409
lines O 0 0.0006563002825714648
and O 0 7.750713120913133e-05
in O 0 7.40831601433456e-05
several O 0 0.00013983540702611208
primary O 0 0.001437873812392354
tumours B-Disease 1 0.9999957084655762
such O 0 0.0005631724488921463
as O 0 0.11412118375301361
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 1 0.9999933242797852
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.10279323160648346

In O 0 0.0013454131549224257
addition O 0 0.0007935608737170696
, O 0 0.000526015879586339
PTEN O 1 0.9995169639587402
was O 0 0.001271772664040327
identified O 0 0.00021719789947383106
as O 0 0.00013653146743308753
the O 0 0.000297692371532321
susceptibility O 0 0.0011213645339012146
gene O 0 0.00023361046623904258
for O 0 0.0001611831394257024
two O 0 0.0005608721985481679
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9988806843757629
CD B-Disease 1 0.9944508671760559
; O 0 0.0005536967073567212
MIM O 1 0.9993411898612976
158350 O 1 0.9836046099662781
) O 0 0.00022554793395102024
and O 0 0.0002976288378704339
Bannayan B-Disease 1 0.999011754989624
- I-Disease 0 0.0188148096203804
Zonana I-Disease 1 0.9978165626525879
( I-Disease 0 0.0015620205085724592
BZS I-Disease 1 0.9860284924507141
) I-Disease 0 0.0005068385507911444
or I-Disease 0 0.000563091947697103
Ruvalcaba I-Disease 1 0.9203281402587891
- I-Disease 0 0.007306080311536789
Riley I-Disease 1 0.7589923143386841
- I-Disease 0 0.16050682961940765
Smith I-Disease 1 0.7685600519180298
syndrome I-Disease 1 1.0
( O 1 0.8848389983177185
MIM O 1 0.9999994039535522
153480 O 1 0.9999749660491943
) O 0 0.0016559172654524446
. O 0 0.0010691549396142364

Constitutive O 0 0.03069940209388733
DNA O 0 0.00227642385289073
from O 0 0.0005956193781457841
37 O 0 0.0022074382286518812
CD B-Disease 0 0.002190058585256338
families O 0 0.00012224660895299166
and O 0 0.00013071903958916664
seven O 0 0.00045953603694215417
BZS B-Disease 1 0.9334170818328857
families O 0 0.0004038710321765393
was O 0 0.0009576761513017118
screened O 0 0.0010418308665975928
for O 0 0.000419903575675562
germline O 1 0.9959663152694702
PTEN O 1 0.9999876022338867
mutations O 0 0.0029176385141909122
. O 0 0.0008508311584591866

PTEN O 1 0.9997891783714294
mutations O 0 0.001402360270731151
were O 0 0.00021849565382581204
identified O 0 0.00011300278856651857
in O 0 6.898236460983753e-05
30 O 0 0.00013402799959294498
of O 0 0.0001167597874882631
37 O 0 0.0004993455950170755
( O 0 0.00020913795742671937
81 O 0 0.001131539698690176
% O 0 0.00014909301535226405
) O 0 0.00014619313878938556
CD B-Disease 0 0.0013784781331196427
families O 0 0.00010483188088983297
, O 0 8.400412480114028e-05
including O 0 0.00012562227493617684
missense O 0 0.0016672313213348389
and O 0 0.0003462890745140612
nonsense O 0 0.008582495152950287
point O 0 0.0015870543429628015
mutations O 0 0.00039484596345573664
, O 0 0.0001938435307238251
deletions O 0 0.0015870437491685152
, O 0 0.00026521238032728434
insertions O 0 0.0021080924198031425
, O 0 0.00016790887457318604
a O 0 0.0005159094580449164
deletion O 0 0.002062560059130192
/ O 0 0.0031722048297524452
insertion O 0 0.002912049414590001
and O 0 0.0005310111446306109
splice O 0 0.009994547814130783
site O 0 0.004060002509504557
mutations O 0 0.0014188360655680299
. O 0 0.0006907284259796143

These O 0 0.0009069432853721082
mutations O 0 0.0004775535489898175
were O 0 0.00012933413381688297
scattered O 0 0.0002739299670793116
over O 0 0.00016024880460463464
the O 0 0.00015768715820740908
entire O 0 0.0006379957776516676
length O 0 0.00015455322863999754
of O 0 0.0005072223138995469
PTEN O 1 0.9998911619186401
, O 0 0.00014563422882929444
with O 0 3.8572274206671864e-05
the O 0 0.0001277773262700066
exception O 0 0.00011705007636919618
of O 0 0.00011509809701237828
the O 0 0.00018631687271408737
first O 0 0.00032825206289999187
, O 0 0.0001414905273122713
fourth O 0 0.0013057049363851547
and O 0 0.00019060223712585866
last O 0 0.0009814552031457424
exons O 0 0.004846536088734865
. O 0 0.000834729871712625

A O 0 0.008187676779925823
hot O 0 0.008414903655648232
spot O 0 0.002818913431838155
for O 0 0.00040577995241619647
PTEN O 1 0.9960663914680481
mutation O 0 0.00056068244157359
in O 0 0.0002951067581307143
CD B-Disease 0 0.001607679296284914
was O 0 0.00047958767390809953
identified O 0 0.00011939415708184242
in O 0 0.00010236698290100321
exon O 0 0.0012022724840790033
5 O 0 0.00022168444411363453
that O 0 3.779296821448952e-05
contains O 0 6.56410411465913e-05
the O 0 0.0002618580765556544
PTPase O 1 0.5460677742958069
core O 0 0.00419131712988019
motif O 0 0.0008789476123638451
, O 0 7.360235758824274e-05
with O 0 2.5448511223657988e-05
13 O 0 0.00016948490520007908
of O 0 0.00013854402641300112
30 O 0 0.0003908103972207755
( O 0 0.00015574721328448504
43 O 0 0.00044029284617863595
% O 0 0.0001588435552548617
) O 0 0.00016520779172424227
CD B-Disease 0 0.001307942788116634
mutations O 0 0.00015063777391333133
identified O 0 0.00013750586367677897
in O 0 0.00010976450721500441
this O 0 0.00016252393834292889
exon O 0 0.0036881258711218834
. O 0 0.0006294717313721776

Seven O 0 0.001226867432706058
of O 0 0.0005868742009624839
30 O 0 0.0006826833123341203
( O 0 0.0002468699240125716
23 O 0 0.0005234110867604613
% O 0 7.235763041535392e-05
) O 0 2.655377465998754e-05
were O 0 3.524966450640932e-05
within O 0 5.856171264895238e-05
the O 0 0.00015248556155711412
core O 0 0.0011018040822818875
motif O 0 0.0007373835542239249
, O 0 6.45662221359089e-05
the O 0 7.056064350763336e-05
majority O 0 2.8159000066807494e-05
( O 0 3.5384651710046455e-05
five O 0 6.071592724765651e-05
of O 0 8.624726615380496e-05
seven O 0 0.00023515868815593421
) O 0 4.1205519664799795e-05
of O 0 0.0001272103254450485
which O 0 7.980364171089604e-05
were O 0 0.00013444667274598032
missense O 0 0.0015559432795271277
mutations O 0 0.000308061862597242
, O 0 0.00012562383199110627
possibly O 0 0.0003759360406547785
pointing O 0 0.0003872652887366712
to O 0 7.065301906550303e-05
the O 0 0.00012412034266162664
functional O 0 0.00020297009905334562
significance O 0 0.00030689575942233205
of O 0 0.00035880040377378464
this O 0 0.00016406152280978858
region O 0 0.0009055789560079575
. O 0 0.0006233393214643002

Germline O 1 0.9998577833175659
PTEN O 1 0.9999408721923828
mutations O 0 0.0009986921213567257
were O 0 0.0002526683092582971
identified O 0 0.00011427438585087657
in O 0 4.5196742576081306e-05
four O 0 3.4035168937407434e-05
of O 0 9.77089730440639e-05
seven O 0 0.0002269269316457212
( O 0 0.00012399139814078808
57 O 0 0.0007244804291985929
% O 0 0.00019094001618213952
) O 0 0.00034006472560577095
BZS B-Disease 0 0.3381471633911133
families O 0 0.0005675684660673141
studied O 0 0.0014123221626505256
. O 0 0.0005917783128097653

Interestingly O 0 0.009028799831867218
, O 0 0.0004013077123090625
none O 0 0.00021150888642296195
of O 0 0.00017014342301990837
these O 0 4.747212733491324e-05
mutations O 0 0.00013327327906154096
was O 0 0.0005045647849328816
observed O 0 0.00011814001481980085
in O 0 0.00012396657257340848
the O 0 0.0005172320525161922
PTPase O 1 0.997260570526123
core O 0 0.03118843585252762
motif O 0 0.008631608448922634
. O 0 0.0009485588525421917

It O 0 0.0008577681728638709
is O 0 0.00022815358533989638
also O 0 8.595178951509297e-05
worthy O 0 0.00033311199513264
of O 0 0.00016163485997822136
note O 0 0.00011456790525699034
that O 0 2.4916544134612195e-05
a O 0 0.0001097302811103873
single O 0 0.0002118926349794492
nonsense O 0 0.001771167037077248
point O 0 0.0006887727649882436
mutation O 0 0.00046103709610179067
, O 0 0.0002077326935250312
R233X O 0 0.40878528356552124
, O 0 0.00028770972858183086
was O 0 0.0005056372610852122
observed O 0 0.00011975833331234753
in O 0 8.176136179827154e-05
the O 0 0.00021759212540928274
germline O 0 0.0029558727983385324
DNA O 0 0.0002899733663070947
from O 0 0.0001354520645691082
two O 0 0.0001236528914887458
unrelated O 0 0.0013320117723196745
CD B-Disease 0 0.002034323289990425
families O 0 0.00020182998559903353
and O 0 0.00017231784295290709
one O 0 0.0004901401116512716
BZS B-Disease 1 0.9987369179725647
family O 0 0.0024920625146478415
. O 0 0.0011135711101815104

Genotype O 0 0.019700121134519577
- O 0 0.005529400892555714
phenotype O 0 0.0014744250802323222
studies O 0 0.00010566609853412956
were O 0 7.200726395240054e-05
not O 0 2.360728285566438e-05
performed O 0 0.00018383715359959751
on O 0 9.278619108954445e-05
this O 0 3.914453918696381e-05
small O 0 7.349960651481524e-05
group O 0 8.198207797249779e-05
of O 0 0.0006582992500625551
BZS B-Disease 1 0.9996742010116577
families O 0 0.0012506869388744235
. O 0 0.0008777867769822478

However O 0 0.0028782356530427933
, O 0 0.0008566545438952744
genotype O 0 0.00286899134516716
- O 0 0.0015602442435920238
phenotype O 0 0.000857186911161989
analysis O 0 0.0001304568286286667
inthe O 0 0.005881397519260645
group O 0 0.0001816102012526244
of O 0 0.0003902242169715464
CD B-Disease 0 0.003071807324886322
families O 0 0.00012978307495359331
revealed O 0 0.0004287533229216933
two O 0 4.732206434709951e-05
possible O 0 0.00012173269351478666
associations O 0 8.785867976257578e-05
worthy O 0 0.000555859471205622
of O 0 0.00025699639809317887
follow O 0 0.00025496562011539936
- O 0 0.000627986853942275
up O 0 0.0002587412600405514
in O 0 0.00017703388584777713
independent O 0 0.00012317311484366655
analyses O 0 0.00036101756268180907
. O 0 0.0003231911105103791

The O 0 0.0016230365727096796
first O 0 0.0009442955488339067
was O 0 0.000942082260735333
an O 0 0.0001644380099605769
association O 0 0.0002552452788222581
noted O 0 0.00010147034481633455
in O 0 6.578423199243844e-05
the O 0 0.00013004969514440745
group O 0 7.583075057482347e-05
of O 0 0.00027618318563327193
CD B-Disease 0 0.004991656169295311
families O 0 0.00036046956665813923
with O 0 0.0012378412066027522
breast B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 0.004600995220243931

A O 0 0.004017270170152187
correlation O 0 0.0006528896628879011
was O 0 0.0007605303544551134
observed O 0 0.000227039898163639
between O 0 0.00015300785889849067
the O 0 0.00024249624402727932
presence O 0 0.0006677709752693772
/ O 0 0.0011824492830783129
absence O 0 0.0005572662921622396
of O 0 0.0004295522812753916
a O 0 0.0018684567185118794
PTEN O 1 0.9999629259109497
mutation O 0 0.0003638397320173681
and O 0 0.00010684508015401661
the O 0 0.0002670717949513346
type O 0 0.0006567564560100436
of O 0 0.0014870775630697608
breast O 1 0.9993708729743958
involvement O 1 0.806954562664032
( O 0 0.0020159666892141104
unaffected O 0 0.0370795764029026
versus O 0 0.26462066173553467
benign O 1 0.9999405145645142
versus O 1 0.9992735981941223
malignant O 1 1.0
) O 0 0.0016283798031508923
. O 0 0.0010857151355594397

Specifically O 0 0.0015080930897966027
and O 0 0.00020828821288887411
more O 0 5.682651317329146e-05
directly O 0 8.675241406308487e-05
, O 0 6.159348413348198e-05
an O 0 0.00013466234668157995
association O 0 0.0003064420016016811
was O 0 0.0005650650127790868
also O 0 8.785365935182199e-05
observed O 0 5.564688763115555e-05
between O 0 7.737228588666767e-05
the O 0 0.00013679078256245703
presence O 0 0.0002590485673863441
of O 0 0.0003961784241255373
a O 0 0.0016603580443188548
PTEN O 1 0.9999988079071045
mutation O 0 0.012361188419163227
and O 0 0.20597390830516815
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.014372963458299637

Secondly O 0 0.08898710459470749
, O 0 0.0006790987681597471
there O 0 0.00028446398209780455
appeared O 0 0.000718441151548177
to O 0 8.392414019908756e-05
be O 0 7.684565207455307e-05
an O 0 0.0001581874385010451
interdependent O 0 0.00336659187451005
association O 0 0.0008222096366807818
between O 0 0.0006979323225095868
mutations O 0 0.0004927029949612916
upstream O 0 0.0012335522333160043
and O 0 0.00010996795754181221
within O 0 0.00010341582674300298
the O 0 0.0004916478646919131
PTPase O 1 0.9957892298698425
core O 0 0.007495273370295763
motif O 0 0.0016120356740429997
, O 0 0.00012922541645821184
the O 0 0.0002442705153953284
core O 0 0.0017525751609355211
motif O 0 0.0008314009755849838
containing O 0 0.0002173141110688448
the O 0 8.650615927763283e-05
majority O 0 5.018587035010569e-05
of O 0 0.00019896125013474375
missense O 0 0.002862878143787384
mutations O 0 0.0002689178509172052
, O 0 9.000584395835176e-05
and O 0 6.239161302801222e-05
the O 0 0.00014913440099917352
involvement O 0 0.0007582436664961278
of O 0 0.0003116692241746932
all O 0 0.00019027956295758486
major O 0 0.04544255509972572
organ O 1 0.9999432563781738
systems O 0 0.1424327790737152
( O 0 0.0008994468371383846
central O 0 0.004484325181692839
nervous O 1 0.932079553604126
system O 0 0.002492425264790654
, O 0 0.0022041993215680122
thyroid O 1 1.0
, O 1 0.80880206823349
breast O 1 0.9999997615814209
, O 1 0.7028552889823914
skin O 1 1.0
and O 1 0.9999562501907349
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 0.013444777578115463
. O 0 0.0015760072274133563

However O 0 0.0013197539374232292
, O 0 0.00019626852008514106
these O 0 4.30722939199768e-05
observations O 0 0.00013697717804461718
would O 0 6.552878767251968e-05
need O 0 5.082925417809747e-05
to O 0 4.633535354514606e-05
be O 0 2.7603889975580387e-05
confirmed O 0 7.463966903742403e-05
by O 0 2.5585826733731665e-05
studying O 0 7.734794780844823e-05
a O 0 6.532700354000553e-05
larger O 0 6.96052229613997e-05
number O 0 3.7294415960786864e-05
of O 0 0.00031156642944552004
CD B-Disease 0 0.003389934543520212
families O 0 0.0003086650976911187
. O 0 0.00041341266478411853

Molecular O 1 0.891225278377533
defects O 1 0.999985933303833
leading O 0 0.017944347113370895
to O 0 0.0008183507598005235
human O 0 0.0011360753560438752
complement B-Disease 0 0.015242036432027817
component I-Disease 1 0.9999916553497314
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0010612781625241041
an O 0 0.00035801096237264574
African O 0 0.0013563513057306409
- O 0 0.0014411939773708582
American O 0 0.0007531270966865122
family O 0 0.0008488200837746263
. O 0 0.0005014765192754567

Complement B-Disease 0 0.06471344083547592
component I-Disease 1 0.9999821186065674
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9980496168136597
C6D B-Disease 1 1.0
) O 0 0.0007285778992809355
was O 0 0.0022434082347899675
diagnosed O 0 0.011410171166062355
in O 0 0.00011667142825899646
a O 0 0.00016948103439062834
16 O 0 0.0005161873996257782
- O 0 0.00044284050818532705
year O 0 0.0002122679288731888
- O 0 0.0004239714180584997
old O 0 0.0011046627769246697
African O 0 0.0012483139289543033
- O 0 0.0009241196094080806
American O 0 0.0008690104587003589
male O 0 0.0016187276924028993
with O 0 0.001450352487154305
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.014183936640620232

The O 0 0.005613319575786591
patients O 0 0.0018684692913666368
father O 0 0.0030774157494306564
and O 0 0.00034339193371124566
two O 0 0.00025869463570415974
brothers O 0 0.0017734634457156062
also O 0 0.00030958521529100835
had O 0 0.0009867656044661999
C6D B-Disease 1 0.9999982118606567
, O 0 0.0002742467331700027
but O 0 5.943810538155958e-05
gave O 0 0.0001650500053074211
no O 0 7.588665903313085e-05
history O 0 0.00037225245614536107
of O 0 0.0018569156527519226
meningitis B-Disease 1 1.0
or O 0 0.44995206594467163
other O 0 0.001485249842517078
neisserial B-Disease 1 0.9999995231628418
infection I-Disease 1 0.9999817609786987
. O 0 0.0027160104364156723

By O 0 0.0009523069602437317
using O 0 0.00029587530298158526
exon O 0 0.0024078781716525555
- O 0 0.000322840380249545
specific O 0 7.794844714226201e-05
polymerase O 0 0.0007327236235141754
chain O 0 0.0005495263612829149
reaction O 0 0.0003787605091929436
( O 0 0.00014515967632178217
PCR O 0 0.0009290461894124746
) O 0 0.0001234496448887512
/ O 0 0.0004918010672554374
single O 0 0.00023322143533732742
- O 0 0.0004828393866773695
strand O 0 0.0006879507564008236
conformation O 0 0.0006013536476530135
polymorphism O 0 0.00022992331651039422
as O 0 7.769493822706863e-05
a O 0 0.00014435729826800525
screening O 0 0.00015275931218639016
step O 0 0.00029907008865848184
and O 0 7.341687887674198e-05
nucleotide O 0 0.00016562070231884718
sequencing O 0 0.00010282130824634805
of O 0 9.650629363022745e-05
target O 0 0.0001791955146472901
exons O 0 0.0008182922028936446
, O 0 9.791959746507928e-05
we O 0 5.153162419446744e-05
determined O 0 8.649097435409203e-05
that O 0 4.259532215655781e-05
the O 0 0.000295546866254881
proband O 0 0.025424223393201828
was O 0 0.0010861430782824755
a O 0 0.0004642962303478271
compound O 0 0.004648543894290924
heterozygote O 0 0.0034868689253926277
for O 0 0.00015498044376727194
two O 0 0.00048427240108139813
C6 O 1 0.9999940395355225
gene O 0 0.002127330517396331
mutations O 0 0.0015339215751737356
. O 0 0.0009260564111173153

The O 0 0.00180210848338902
first O 0 0.0008068244205787778
, O 0 0.00021878164261579514
1195delC O 0 0.005998993292450905
located O 0 0.0006573096616193652
in O 0 0.00020005465194117278
exon O 0 0.0021056602708995342
7 O 0 0.0005481076659634709
, O 0 9.161525667877868e-05
is O 0 5.298450923874043e-05
a O 0 0.00012428898480720818
novel O 0 0.0003494089760351926
mutation O 0 0.00015693384921178222
, O 0 8.4416322351899e-05
while O 0 6.581272464245558e-05
the O 0 0.0001241132413269952
second O 0 0.000453960063168779
, O 0 0.0001320022129220888
1936delG O 0 0.004215728025883436
in O 0 0.0002558771229814738
exon O 0 0.0022068426478654146
12 O 0 0.0005661273025907576
, O 0 9.385243174619973e-05
has O 0 4.912028816761449e-05
been O 0 4.6133241994539276e-05
described O 0 0.000208658937481232
before O 0 0.00019014228018932045
to O 0 0.00016884776414372027
cause O 0 0.03187640756368637
C6D B-Disease 1 0.9999901056289673
in O 0 0.0003978808526881039
an O 0 0.0002142880402971059
unrelated O 0 0.0010615481296554208
African O 0 0.0021603575441986322
- O 0 0.0022817477583885193
American O 0 0.0009464735630899668
individual O 0 0.00023616192629560828
. O 0 0.0003702492394950241

Both O 0 0.0017297163140028715
mutations O 0 0.0007727867341600358
result O 0 0.0004468621627893299
in O 0 0.0005291586276143789
premature O 0 0.008359205909073353
termination O 0 0.00694292364642024
codons O 0 0.004678304307162762
and O 0 0.0008401072700507939
C6 O 1 0.9999585151672363
null O 0 0.005008629988878965
alleles O 0 0.001865290105342865
. O 0 0.0006214694585651159

Allele O 0 0.004473720211535692
- O 0 0.0015393088106065989
specific O 0 0.00021912068768870085
PCR O 0 0.0012439199490472674
indicated O 0 0.00030039515695534647
that O 0 4.992000322090462e-05
the O 0 0.000216119151446037
probands O 0 0.024276424199342728
two O 0 0.00027361573302187026
brothers O 0 0.001277748728170991
also O 0 0.00033137333230115473
inherited O 0 0.09328650683164597
the O 0 0.0017678213771432638
1195delC O 1 0.9996355772018433
mutation O 0 0.00038134027272462845
from O 0 0.0001618505921214819
their O 0 6.883930473122746e-05
heterozygous O 0 0.00027138093719258904
mother O 0 0.00036795486812479794
and O 0 0.00010539780487306416
the O 0 0.0005305310478433967
1936delG O 1 0.9018632769584656
mutation O 0 0.00021038559498265386
from O 0 0.00014000418013893068
their O 0 0.0001112009776988998
homozygous O 0 0.0013448187382891774
father O 0 0.0028992691077291965
. O 0 0.0003701892273966223
. O 0 0.00039364502299577

PAX6 O 1 0.9991858601570129
mutations O 0 0.0075630368664860725
reviewed O 0 0.004541230853646994
. O 0 0.0015286634443327785

Mutations O 0 0.0052609071135520935
in O 0 0.0020354154985398054
PAX6 O 1 0.9983559250831604
are O 0 8.941513078752905e-05
responsible O 0 0.0003813620423898101
for O 0 0.00015454924141522497
human O 0 0.0020700120367109776
aniridia B-Disease 1 0.9999998807907104
and O 0 0.00041254988173022866
have O 0 6.004042734275572e-05
also O 0 4.4445852836361155e-05
been O 0 5.799981954623945e-05
found O 0 6.590365956071764e-05
in O 0 0.00012060200970154256
patients O 0 0.00030733225867152214
with O 0 0.00027534685796126723
Peters B-Disease 1 0.9999994039535522
anomaly I-Disease 1 0.9999998807907104
, O 0 0.31367242336273193
with O 1 0.9996781349182129
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999656677246094
with O 0 0.13726195693016052
autosomal B-Disease 1 0.9999809265136719
dominant I-Disease 1 0.9999997615814209
keratitis I-Disease 1 1.0
, O 0 0.0031387258786708117
and O 0 0.0005605483311228454
with O 0 0.0009132892009802163
isolated B-Disease 1 0.999796450138092
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.010687372647225857

No O 0 0.002113948343321681
locus O 0 0.002427025930956006
other O 0 0.00016057092580012977
than O 0 0.0003091899852734059
chromosome O 0 0.0019826535135507584
11p13 O 1 0.9987825751304626
has O 0 0.0003070874372497201
been O 0 0.00020553379727061838
implicated O 0 0.005209909286350012
in O 0 0.0010046010138466954
aniridia B-Disease 1 0.9999997615814209
, O 0 0.0006258717039600015
and O 0 0.0005667657824233174
PAX6 O 1 0.9998408555984497
is O 0 0.0002917375531978905
clearly O 0 0.00020126842719037086
the O 0 0.00014977468526922166
major O 0 0.001035840017721057
, O 0 0.00012686023546848446
if O 0 4.305081893107854e-05
not O 0 2.6815734599949792e-05
only O 0 4.9539285100763664e-05
, O 0 9.030517685459927e-05
gene O 0 0.0004018685722257942
responsible O 0 0.0009345574071630836
. O 0 0.0008706601802259684

Twenty O 0 0.005172439385205507
- O 0 0.001315195462666452
eight O 0 0.00035447333357296884
percent O 0 0.0001927718985825777
of O 0 0.000196283872355707
identified O 0 0.0008019235101528466
PAX6 O 1 0.996136486530304
mutations O 0 0.00045147648779675364
are O 0 5.94640732742846e-05
C O 0 0.0013637921074405313
- O 0 0.0012440597638487816
T O 0 0.002707818755879998
changes O 0 0.0001574280031491071
at O 0 0.0005663850461132824
CpG O 0 0.004297142848372459
dinucleotides O 0 0.025900322943925858
, O 0 0.00019354469259269536
20 O 0 0.00036448612809181213
% O 0 6.838660192443058e-05
are O 0 1.954011713678483e-05
splicing O 0 0.00045215911814011633
errors O 0 0.0005490609328262508
, O 0 0.00010226103040622547
and O 0 3.3185955544468015e-05
more O 0 1.3928379303251859e-05
than O 0 2.7449956178315915e-05
30 O 0 0.00013841463078279048
% O 0 3.77081596525386e-05
are O 0 1.396353036398068e-05
deletion O 0 0.00039615013520233333
or O 0 0.00027420592959970236
insertion O 0 0.0024389210157096386
events O 0 0.0015497118001803756
. O 0 0.0007333439425565302

There O 0 0.0010679139522835612
is O 0 0.0002375691256020218
a O 0 0.00037105914088897407
noticeably O 0 0.00353585765697062
elevated O 0 0.0149010568857193
level O 0 0.00030626263469457626
of O 0 0.00013193022459745407
mutation O 0 8.929115574574098e-05
in O 0 5.888842497370206e-05
the O 0 0.00012723120744340122
paired O 0 0.00022777970298193395
domain O 0 0.00013388747174758464
compared O 0 9.202082583215088e-05
with O 0 1.9159588191541843e-05
the O 0 0.00013073027366772294
rest O 0 0.0004202551790513098
of O 0 0.00030099719879217446
the O 0 0.0009202912333421409
gene O 0 0.0007227832684293389
. O 0 0.0005253624403849244

Increased O 0 0.0028311104979366064
mutation O 0 0.00042902049608528614
in O 0 0.00020242782193236053
the O 0 0.0003938779409509152
homeodomain O 0 0.004067592788487673
is O 0 0.00013253824727144092
accounted O 0 0.00029488405562005937
for O 0 4.129521403228864e-05
by O 0 4.54910405096598e-05
the O 0 0.00045906557352282107
hypermutable O 1 0.8268799781799316
CpG O 0 0.018524356186389923
dinucleotide O 0 0.025343969464302063
in O 0 0.0008181491284631193
codon O 0 0.003915523178875446
240 O 0 0.0035188724286854267
. O 0 0.000532782229129225

Very O 0 0.0014911160105839372
nearly O 0 0.0010234309593215585
all O 0 0.00018961560272146016
mutations O 0 0.00036006461596116424
appear O 0 0.0002239021414425224
to O 0 0.00018864450976252556
cause O 0 0.0021362861152738333
loss O 0 0.0016215891810134053
of O 0 0.0003614583984017372
function O 0 0.00017086837033275515
of O 0 0.00030012609204277396
the O 0 0.0005161566659808159
mutant O 0 0.0014468478038907051
allele O 0 0.0003231048467569053
, O 0 3.920625022146851e-05
and O 0 2.85554942820454e-05
more O 0 1.5331457689171657e-05
than O 0 3.470811861916445e-05
80 O 0 0.00018074420222546905
% O 0 5.725050868932158e-05
of O 0 0.00037999608321115375
exonic O 1 0.7508979439735413
substitutions O 0 0.002771159168332815
result O 0 0.0004939761129207909
in O 0 0.00028445853968150914
nonsense O 0 0.0055745914578437805
codons O 0 0.0041749062947928905
. O 0 0.000667316373437643

In O 0 0.0012617933098226786
a O 0 0.0006898553692735732
gene O 0 0.0002611868258100003
with O 0 8.484986756229773e-05
such O 0 8.147176413331181e-05
extraordinarily O 0 0.001624780590645969
high O 0 0.0006100981263443828
sequence O 0 0.00014702171029057354
conservation O 0 0.00015419830742757767
throughout O 0 0.00014469408779405057
evolution O 0 0.0003168713010381907
, O 0 8.810122380964458e-05
there O 0 6.643927190452814e-05
are O 0 3.3042240829672664e-05
presumed O 0 0.0011424642289057374
undiscovered O 0 0.10575412958860397
missense O 0 0.006625226698815823
mutations O 0 0.0005957033718004823
, O 0 0.0001473425218136981
these O 0 2.6204781534033827e-05
are O 0 1.538113247079309e-05
hypothesized O 0 0.000255522143561393
to O 0 5.215916462475434e-05
exist O 0 6.731963367201388e-05
in O 0 9.722659160615876e-05
as O 0 0.0002202055766247213
- O 0 0.0006995071307756007
yet O 0 0.0003503106127027422
unidentified O 0 0.0019390096422284842
phenotypes O 0 0.001717332866974175
. O 0 0.00021602724154945463
. O 0 0.0004689335764851421

Genetic O 0 0.0044386847876012325
heterogeneity O 0 0.005004116799682379
and O 0 0.0005816651973873377
penetrance O 0 0.004138858988881111
analysis O 0 9.774532372830436e-05
of O 0 0.00026406379765830934
the O 0 0.0011603987077251077
BRCA1 O 1 0.8731830716133118
and O 0 0.0007754426915198565
BRCA2 O 1 0.6926642656326294
genes O 0 0.0010556635679677129
in O 0 0.001992384437471628
breast B-Disease 1 0.9999921321868896
cancer I-Disease 1 0.9997065663337708
families O 0 0.0012346009025350213
. O 0 0.0012547068763524294

The O 1 0.9921708106994629
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9995946288108826
Consortium O 0 0.012016920372843742
. O 0 0.00245127035304904

The O 0 0.0025095753371715546
contribution O 0 0.0022633676417171955
of O 0 0.001969271572306752
BRCA1 O 1 0.9969300627708435
and O 0 0.001258285716176033
BRCA2 O 1 0.997174859046936
to O 0 0.005459367763251066
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9898266792297363
assessed O 0 0.000583797984290868
by O 0 8.661700849188492e-05
linkage O 0 0.000723066390492022
and O 0 8.430353773292154e-05
mutation O 0 9.531896648695692e-05
analysis O 0 2.0340145056252368e-05
in O 0 6.91551249474287e-05
237 O 0 0.0008350679418072104
families O 0 6.088621012168005e-05
, O 0 2.9228025596239604e-05
each O 0 8.158997843565885e-06
with O 0 1.961969792318996e-05
at O 0 0.00014085971633903682
least O 0 3.323424971313216e-05
four O 0 5.375190812628716e-05
cases O 0 8.960299601312727e-05
of O 0 0.002527969889342785
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999935626983643
, O 0 0.00020101488917134702
collected O 0 0.00012221561337355524
by O 0 8.779184281593189e-05
the O 0 0.0015373564092442393
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9995953440666199
Consortium O 0 0.006727793253958225
. O 0 0.0007926758262328804

Families O 0 0.0017663863254711032
were O 0 0.00036735148751176894
included O 0 0.0002681886253412813
without O 0 0.00011810261639766395
regard O 0 0.00020017068891320378
to O 0 7.555415504612029e-05
the O 0 0.00024287479755003005
occurrence O 0 0.0015730588929727674
of O 0 0.005325470119714737
ovarian B-Disease 1 1.0
or I-Disease 0 0.12925437092781067
other I-Disease 0 0.001670930883847177
cancers I-Disease 1 0.9997294545173645
. O 0 0.0015586910303682089

Overall O 0 0.27922624349594116
, O 0 0.003791727824136615
disease O 1 0.9999921321868896
was O 1 0.5355145931243896
linked O 0 0.003356299130246043
to O 0 0.0003348909958731383
BRCA1 O 0 0.0023616596590727568
in O 0 9.121948824031278e-05
an O 0 5.37001651537139e-05
estimated O 0 6.946187204448506e-05
52 O 0 0.0001410001568729058
% O 0 3.15441757265944e-05
of O 0 0.00011120171257061884
families O 0 0.00011422080569900572
, O 0 7.410549005726352e-05
to O 0 9.067493374459445e-05
BRCA2 O 0 0.001460169441998005
in O 0 8.789991989033297e-05
32 O 0 0.0002522114955354482
% O 0 5.644526027026586e-05
of O 0 0.0001397173327859491
families O 0 0.00010565581760602072
, O 0 9.242412488674745e-05
and O 0 5.9857378801098093e-05
to O 0 7.100328366504982e-05
neither O 0 0.0002027801820077002
gene O 0 5.5300180974882096e-05
in O 0 4.2204163037240505e-05
16 O 0 0.00020939495880156755
% O 0 5.507325113285333e-05
( O 0 6.819956615800038e-05
95 O 0 0.00029014534084126353
% O 0 5.9227459132671356e-05
confidence O 0 0.0006442192243412137
interval O 0 0.0006156449089758098
[ O 0 0.0009599777404218912
CI O 0 0.02970149554312229
] O 0 0.000885755056515336
6 O 0 0.0003809721674770117
% O 0 5.3130781452637166e-05
- O 0 0.0002252425329061225
28 O 0 0.0003760514664463699
% O 0 9.488386422162876e-05
) O 0 6.616814789595082e-05
, O 0 6.202115764608607e-05
suggesting O 0 0.000392861693399027
other O 0 0.00011759602057281882
predisposition O 0 0.0753331184387207
genes O 0 0.0019505826057866216
. O 0 0.0011967014288529754

The O 0 0.001108513679355383
majority O 0 0.00021373179333750159
( O 0 0.00016498456534463912
81 O 0 0.0005594328395090997
% O 0 5.646781937684864e-05
) O 0 4.844948853133246e-05
of O 0 0.0002772106963675469
the O 0 0.003085216972976923
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.0002043706481344998
were O 0 0.00011936273949686438
due O 0 0.00020528897584881634
to O 0 0.00012745925050694495
BRCA1 O 0 0.007569965440779924
, O 0 7.182114495662972e-05
with O 0 3.321438271086663e-05
most O 0 3.9112375816330314e-05
others O 0 6.041144297341816e-05
( O 0 0.00010162701801164076
14 O 0 0.0004062408988829702
% O 0 0.00011245146743021905
) O 0 9.752429468790069e-05
due O 0 0.0005626173806376755
to O 0 0.0005695676663890481
BRCA2 O 0 0.25762513279914856
. O 0 0.0013048831606283784

Conversely O 0 0.006490021478384733
, O 0 0.0003483679029159248
the O 0 0.00016162284009624273
majority O 0 5.935626177233644e-05
of O 0 0.00012238201452419162
families O 0 0.00011545490269782022
with O 0 0.00014102771820034832
male B-Disease 0 0.001015720423310995
and I-Disease 0 0.0006214245222508907
female I-Disease 1 0.9990398287773132
breast I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999138116836548
were O 0 0.00025568739511072636
due O 0 0.0004315617261454463
to O 0 0.00020798895275220275
BRCA2 O 0 0.008361035026609898
( O 0 0.0003621877694968134
76 O 0 0.0015768537996336818
% O 0 0.000328849971992895
) O 0 0.00029157515382394195
. O 0 0.00047658878611400723

The O 0 0.0018151149852201343
largest O 0 0.0012907793279737234
proportion O 0 0.0003227812412660569
( O 0 0.0001680344284977764
67 O 0 0.00041050754953175783
% O 0 9.936549759004265e-05
) O 0 6.242850940907374e-05
of O 0 0.00015812696074135602
families O 0 0.00012312918261159211
due O 0 0.0002567920892033726
to O 0 9.751759353093803e-05
other O 0 5.5288684961851686e-05
genes O 0 0.00012801050615962595
was O 0 0.000326108856825158
found O 0 8.415927732130513e-05
in O 0 4.793079278897494e-05
families O 0 2.4644941731821746e-05
with O 0 2.16709086089395e-05
four O 0 6.948273221496493e-05
or O 0 7.5509786256589e-05
five O 0 8.407280984101817e-05
cases O 0 9.010819485411048e-05
of O 0 0.0009981014300137758
female O 1 0.9999402761459351
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999878406524658
only O 0 0.0013479948975145817
. O 0 0.0010182695696130395

These O 0 0.0008218453731387854
estimates O 0 0.00035105686401948333
were O 0 0.00020625856996048242
not O 0 0.00010913828737102449
substantially O 0 0.0006773755885660648
affected O 0 0.00024862494319677353
either O 0 7.668571197427809e-05
by O 0 3.987470699939877e-05
changing O 0 0.00012529880041256547
the O 0 0.00023052608594298363
assumed O 0 0.0011569439666345716
penetrance O 0 0.0039313361048698425
model O 0 0.00038603966822847724
for O 0 0.00014653326070401818
BRCA1 O 0 0.009913305751979351
or O 0 0.00019616300414782017
by O 0 6.273238977883011e-05
including O 0 0.0001634494255995378
or O 0 0.0004779993905685842
excluding O 0 0.002191574312746525
BRCA1 O 0 0.32928791642189026
mutation O 0 0.0008296406012959778
data O 0 0.00029279582668095827
. O 0 0.00042990129441022873

Among O 0 0.0011015281779691577
those O 0 0.00016879013855941594
families O 0 0.00021815302898176014
with O 0 0.00034394042450003326
disease O 1 0.9999954700469971
due O 1 0.5378695130348206
to O 0 0.0008582906448282301
BRCA1 O 1 0.5458109378814697
that O 0 7.365375495282933e-05
were O 0 8.062332199187949e-05
tested O 0 0.00014469657617155463
by O 0 2.064494947262574e-05
one O 0 2.848728036042303e-05
of O 0 9.088295337278396e-05
the O 0 0.0002242666232632473
standard O 0 0.00021364886197261512
screening O 0 0.0001412478886777535
methods O 0 9.207050607074052e-05
, O 0 6.96728311595507e-05
mutations O 0 0.00010723026207415387
were O 0 8.777352923061699e-05
detected O 0 0.0002767300757113844
in O 0 9.001450962387025e-05
the O 0 0.00012960575986653566
coding O 0 0.00032593077048659325
sequence O 0 0.00012833108485210687
or O 0 7.116061169654131e-05
splice O 0 0.0005408406723290682
sites O 0 4.783157055499032e-05
in O 0 3.054379703826271e-05
an O 0 3.002130142704118e-05
estimated O 0 7.326657214434817e-05
63 O 0 0.0001926660625031218
% O 0 3.2141841074917465e-05
( O 0 5.715433871955611e-05
95 O 0 0.0002157847338821739
% O 0 7.089097198331729e-05
CI O 0 0.008396596647799015
51 O 0 0.0005349961575120687
% O 0 0.00011201875895494595
- O 0 0.0004414790601003915
77 O 0 0.0007975620683282614
% O 0 0.0002174366090912372
) O 0 0.00020011629385408014
. O 0 0.0004020344349555671

The O 0 0.0021481274161487818
estimated O 0 0.0009172169375233352
sensitivity O 0 0.0006195510504767299
was O 0 0.0006066192290745676
identical O 0 0.00013906153617426753
for O 0 3.590075357351452e-05
direct O 0 0.00011665184865705669
sequencing O 0 0.0003135796869173646
and O 0 0.0001144673369708471
other O 0 9.548107482260093e-05
techniques O 0 0.0008524765144102275
. O 0 0.0007896142196841538

The O 0 0.00417533703148365
penetrance O 0 0.029695875942707062
of O 0 0.0024234058801084757
BRCA2 O 1 0.9500740170478821
was O 0 0.0017427928978577256
estimated O 0 0.0002262274210806936
by O 0 5.9374378906795755e-05
maximizing O 0 0.0004511864681262523
the O 0 0.0002249536628369242
LOD O 0 0.024037132039666176
score O 0 0.00024247358669526875
in O 0 0.0002786710683722049
BRCA2 O 0 0.09249018877744675
- O 0 0.0011056936345994473
mutation O 0 0.0001734263641992584
families O 0 6.36702316114679e-05
, O 0 5.545819294638932e-05
over O 0 0.00011288410314591601
all O 0 7.967073179315776e-05
possible O 0 0.00029330264078453183
penetrance O 0 0.009177601896226406
functions O 0 0.0006439923890866339
. O 0 0.0006322544068098068

The O 0 0.0019370228983461857
estimated O 0 0.0007611331529915333
cumulative O 0 0.001024299650453031
risk O 0 0.0005002652760595083
of O 0 0.001359787886030972
breast B-Disease 1 0.9999948740005493
cancer I-Disease 1 0.9995306730270386
reached O 0 0.0015359895769506693
28 O 0 0.0006012156372889876
% O 0 6.230628787307069e-05
( O 0 5.88655166211538e-05
95 O 0 0.00017079572717193514
% O 0 8.830097794998437e-05
CI O 0 0.009299946017563343
9 O 0 0.00043499565799720585
% O 0 5.081374547444284e-05
- O 0 0.00015065156912896782
44 O 0 0.00012057947606081143
% O 0 3.9401118556270376e-05
) O 0 2.283652975165751e-05
by O 0 1.911482286232058e-05
age O 0 8.134359813993797e-05
50 O 0 0.0001413564896211028
years O 0 0.0001216567907249555
and O 0 5.9321177104720846e-05
84 O 0 0.00036423534038476646
% O 0 6.105349893914536e-05
( O 0 7.735391409369186e-05
95 O 0 0.0003417902917135507
% O 0 8.914652426028624e-05
CI O 0 0.005149705335497856
43 O 0 0.0003276014467701316
% O 0 6.673885945929214e-05
- O 0 0.0003089165547862649
95 O 0 0.00031999152270145714
% O 0 6.704939733026549e-05
) O 0 2.8175923944218084e-05
by O 0 4.383106715977192e-05
age O 0 0.0003273376787547022
70 O 0 0.00108522258233279
years O 0 0.0008075098157860339
. O 0 0.0005352285224944353

The O 0 0.00965710449963808
corresponding O 1 0.9984277486801147
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.4308650493621826
were O 0 0.0009647016413509846
0 O 0 0.0009168866672553122
. O 0 0.000495050335302949

4 O 0 0.0016758504789322615
% O 0 0.00016884904471226037
( O 0 0.00012627420073840767
95 O 0 0.0002580354630481452
% O 0 8.466865256195888e-05
CI O 0 0.005855042953044176
0 O 0 0.00012823750148527324
% O 0 5.073771899333224e-05
- O 0 0.00017313075659330934
1 O 0 0.0001231757050845772
% O 0 3.6618304875446483e-05
) O 0 2.2396445274353027e-05
by O 0 2.2892003471497446e-05
age O 0 0.00011145226017106324
50 O 0 0.00016831987886689603
years O 0 0.00011025072308257222
and O 0 5.5040170991560444e-05
27 O 0 0.0003977255255449563
% O 0 6.903909525135532e-05
( O 0 7.797677244525403e-05
95 O 0 0.0002584816247690469
% O 0 9.05521446838975e-05
CI O 0 0.007257863413542509
0 O 0 0.00016304347082041204
% O 0 5.481541302287951e-05
- O 0 0.000215895488508977
47 O 0 0.00022442791669163853
% O 0 7.492220174754038e-05
) O 0 5.2492796385195106e-05
by O 0 4.9387312174076214e-05
age O 0 0.00031493359711021185
70 O 0 0.0009197004255838692
years O 0 0.0009916281560435891
. O 0 0.000550062395632267

The O 0 0.003083315445110202
lifetime O 0 0.004743047524243593
risk O 0 0.0015966653591021895
of O 0 0.059283073991537094
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999949932098389
appears O 0 0.001195083954371512
similar O 0 9.275133197661489e-05
to O 0 7.615191134391353e-05
the O 0 0.0002922065614257008
risk O 0 0.0002398551005171612
in O 0 0.0002842476242221892
BRCA1 O 1 0.8907243609428406
carriers O 0 0.0005758848274126649
, O 0 8.01434725872241e-05
but O 0 2.8712838684441522e-05
there O 0 5.319953561411239e-05
was O 0 0.0001664272858761251
some O 0 2.67623872787226e-05
suggestion O 0 0.00021710801229346544
of O 0 0.0001408484240528196
a O 0 0.0002947648463305086
lower O 0 0.0014823813689872622
risk O 0 0.00024732458405196667
in O 0 0.0002461732074152678
BRCA2 O 0 0.0053091272711753845
carriers O 0 0.0005806084373034537
< O 0 0.0012797181261703372
50 O 0 0.00020876979397144169
years O 0 0.0001344596385024488
of O 0 0.0003323373675812036
age O 0 0.0012000460410490632
. O 0 0.0008160822908394039

Eye B-Disease 1 0.9999774694442749
movement I-Disease 1 0.9972378015518188
abnormalities I-Disease 1 0.9997510313987732
correlate O 0 0.0034158627968281507
with O 0 0.0005721707129850984
genotype O 0 0.001975027611479163
in O 0 0.0006776487571187317
autosomal O 0 0.38807713985443115
dominant O 1 0.9999680519104004
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999998807907104
I I-Disease 1 0.9999982118606567
. O 0 0.002310876501724124

We O 0 0.0026374361477792263
compared O 0 0.0021347487345337868
horizontal O 0 0.007186857517808676
eye O 0 0.2641228139400482
movements O 0 0.0031842601019889116
( O 0 0.0012650905409827828
visually O 0 0.003261212259531021
guided O 0 0.004012080375105143
saccades O 1 0.9718562960624695
, O 0 0.0008226723875850439
antisaccades O 1 0.9344082474708557
, O 0 0.0002817451604641974
and O 0 0.0001723066670820117
smooth O 0 0.0019256254890933633
pursuit O 0 0.003870269749313593
) O 0 0.00011843405809486285
in O 0 7.970225851750001e-05
control O 0 0.000182318952283822
subjects O 0 0.0002440791722619906
( O 0 0.0001709534553810954
n O 0 0.00039243948413059115
= O 0 0.00048635876737535
14 O 0 0.0005121871363371611
) O 0 0.00013421368203125894
and O 0 0.00013351622328627855
patients O 0 0.00017560152627993375
with O 0 6.449065404012799e-05
three O 0 0.0001577226648805663
forms O 0 0.0003431862860452384
of O 0 0.001973289530724287
autosomal O 1 0.9981542229652405
dominant O 1 0.999993085861206
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9997327923774719
I I-Disease 1 0.9994474053382874
spinocerebellar B-Disease 1 0.9999847412109375
ataxias I-Disease 1 0.994728147983551
1 I-Disease 0 0.0006510081584565341
and I-Disease 0 0.00011949210602324456
2 I-Disease 0 0.00027797109214589
( O 0 0.00021402421407401562
SCA1 B-Disease 0 0.2149467021226883
, O 0 0.00019571818120311946
n O 0 0.0003460953594185412
= O 0 0.00037897666334174573
11 O 0 0.0005653990083374083
; O 0 0.00012802809942513704
SCA2 B-Disease 0 0.39314907789230347
, O 0 0.0001958279317477718
n O 0 0.00039843993727117777
= O 0 0.00046169228153303266
10 O 0 0.000214553001569584
) O 0 0.00012851343490183353
and O 0 0.0002731809508986771
SCA3 B-Disease 1 0.9999995231628418
/ O 0 0.26384758949279785
Machado B-Disease 0 0.1499578058719635
- I-Disease 0 0.006631826516240835
Joseph I-Disease 0 0.27099886536598206
disease I-Disease 1 0.9999939203262329
( O 0 0.006086406297981739
MJD B-Disease 1 1.0
) O 0 0.0003884288016706705
( O 0 0.0002354261087020859
n O 0 0.0005360886570997536
= O 0 0.0006622876389883459
16 O 0 0.0006120509933680296
) O 0 0.000245568691752851
. O 0 0.0002642592880874872

In O 0 0.005449793767184019
SCA1 B-Disease 1 0.9997515082359314
, O 0 0.0013284377055242658
saccade O 0 0.012641037814319134
amplitude O 0 0.0012667978880926967
was O 0 0.0009419390698894858
significantly O 0 0.0004745327460113913
increased O 0 0.00017113937065005302
, O 0 0.00010511094296816736
resulting O 0 0.00036789823207072914
in O 0 0.0003904045152012259
hypermetria B-Disease 1 0.9976902008056641
. O 0 0.0013543544337153435

The O 0 0.0025649615563452244
smooth O 0 0.006542951799929142
pursuit O 0 0.015215620398521423
gain O 0 0.003991269506514072
was O 0 0.006974510382860899
decreased O 0 0.010562711395323277
. O 0 0.000833733007311821

In O 0 0.006820200011134148
SCA2 B-Disease 1 0.9997561573982239
, O 0 0.0013408667873591185
saccade O 0 0.012010801583528519
velocity O 0 0.0013579449150711298
was O 0 0.002946979133412242
markedly O 0 0.010180934332311153
decreased O 0 0.0049154250882565975
. O 0 0.0007309956126846373

The O 0 0.0013279621489346027
percentage O 0 0.0006379230762831867
of O 0 0.0004090060538146645
errors O 0 0.0019568651914596558
in O 0 0.0007000247132964432
antisaccades O 1 0.9999451637268066
was O 0 0.006749418098479509
greatly O 0 0.0009735224884934723
increased O 0 0.0002203479816671461
and O 0 7.495722820749506e-05
was O 0 0.00039044301956892014
significantly O 0 0.0002240567555418238
correlated O 0 0.00013652573397848755
with O 0 6.603477231692523e-05
age O 0 0.0008563970332033932
at O 1 0.9680051803588867
disease O 1 0.9999998807907104
onset O 1 0.9999998807907104
. O 0 0.003724759677425027

In O 0 0.0011249149683862925
addition O 0 0.00043933375854976475
, O 0 0.00012771738693118095
a O 0 0.00020521222904790193
correlation O 0 0.00015479553258046508
between O 0 0.0002604070759844035
smooth O 0 0.0020552698988467455
pursuit O 0 0.006453573238104582
gain O 0 0.000772798084653914
and O 0 8.519102266291156e-05
the O 0 0.00010161635873373598
number O 0 4.949546928401105e-05
of O 0 0.0003493215190246701
trinucleotide O 1 0.9990271329879761
repeats O 0 0.0028459092136472464
was O 0 0.0016897909808903933
found O 0 0.0004913526936434209
. O 0 0.00045049458276480436

In O 0 0.014431274496018887
SCA3 B-Disease 1 0.9999997615814209
, O 0 0.0036630365066230297
gaze B-Disease 1 0.8008447885513306
- I-Disease 0 0.04492662847042084
evoked I-Disease 1 0.6363549828529358
nystagmus I-Disease 1 0.9858819246292114
was O 0 0.0023242172319442034
often O 0 0.00017362921789754182
present O 0 0.0002456199435982853
as O 0 0.00027289509307593107
was O 0 0.0020258817821741104
saccade O 0 0.028535732999444008
hypometria O 1 0.8194397687911987
and O 0 0.0004990503657609224
smooth O 0 0.002657309640198946
pursuit O 0 0.008071714080870152
gain O 0 0.002168544800952077
was O 0 0.003822516417130828
markedly O 0 0.015315569937229156
decreased O 0 0.005732156336307526
. O 0 0.000496626365929842

Three O 0 0.0013807030627503991
major O 0 0.0020333167631179094
criteria O 0 0.00041057387716136873
, O 0 0.00032972556073218584
saccade O 0 0.010037512518465519
amplitude O 0 0.0014352997532114387
, O 0 0.00035793602000921965
saccade O 0 0.007118920795619488
velocity O 0 0.0006682341336272657
, O 0 0.00012806545419152826
and O 0 7.95691303210333e-05
presence O 0 0.0003696222265716642
of O 0 0.0006435536779463291
gaze B-Disease 1 0.9601801633834839
- I-Disease 0 0.03352341055870056
evoked I-Disease 0 0.23859642446041107
nystagmus I-Disease 0 0.17903314530849457
, O 0 0.00027298409258946776
permitted O 0 0.00018317259673494846
the O 0 0.0001533373724669218
correct O 0 0.0002771903236862272
assignment O 0 0.00035724297049455345
of O 0 0.0001553881011204794
90 O 0 0.00020072684856131673
% O 0 4.427402018336579e-05
of O 0 0.00011695156717905775
the O 0 0.0004924522363580763
SCA1 B-Disease 1 0.9997962117195129
, O 0 0.00014659656153526157
90 O 0 9.599599434295669e-05
% O 0 3.1838237191550434e-05
of O 0 0.00011325639934511855
the O 0 0.000529287033714354
SCA2 B-Disease 1 0.9999855756759644
, O 0 0.00020550577028188854
and O 0 0.0001054746171575971
93 O 0 0.0004891313728876412
% O 0 5.403715476859361e-05
of O 0 0.00016388842777814716
the O 0 0.0004718931159004569
patients O 0 0.0005084419390186667
with O 0 0.00022014429850969464
SCA3 B-Disease 1 1.0
to O 0 0.00039983639726415277
their O 0 0.00011632905079750344
genetically O 0 0.00031335046514868736
confirmed O 0 0.00022695332881994545
patient O 0 0.0002570880460552871
group O 0 5.885047357878648e-05
and O 0 6.742679397575557e-05
, O 0 8.627260831417516e-05
therefore O 0 0.00012401504500303417
, O 0 0.00010144925909116864
may O 0 0.00013798645522911102
help O 0 0.0002650197420734912
orient O 0 0.006255041342228651
diagnoses O 0 0.0031596438493579626
of O 0 0.0038832053542137146
SCA1 B-Disease 1 1.0
, O 0 0.003653043881058693
SCA2 B-Disease 1 0.9999971389770508
, O 0 0.000760500377509743
and O 0 0.0005925848381593823
SCA3 B-Disease 1 0.9999986886978149
at O 0 0.0025525360833853483
early O 0 0.0006702977116219699
clinical O 0 0.000471696985187009
stages O 0 0.0012660481734201312
of O 0 0.0008411750313825905
the O 0 0.3394777774810791
diseases O 1 0.9999995231628418
. O 0 0.0009714229381643236
. O 0 0.0009570969850756228

Genetic O 0 0.0026548667810857296
basis O 0 0.0004162763652857393
and O 0 0.00038285847404040396
molecular O 0 0.0014123839791864157
mechanism O 0 0.016544733196496964
for O 0 0.012456590309739113
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.5841404795646667

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999998807907104
causes O 1 0.9974896907806396
more O 0 0.0003149659896735102
than O 0 0.0001601682888576761
300 O 0 0.0003439961583353579
, O 0 8.672181138535962e-05
000 O 0 0.000631284317933023
sudden O 0 0.001573970657773316
deaths O 0 0.000291356147499755
each O 0 2.6839525162358768e-05
year O 0 9.321665856987238e-05
in O 0 8.034985512495041e-05
the O 0 0.0003341788542456925
USA O 0 0.002742090029641986
alone O 0 0.0008546757162548602
. O 0 0.0004452909925021231

In O 0 0.0006778372917324305
approximately O 0 0.00035860686330124736
5 O 0 0.0002708990650717169
- O 0 0.00026506243739277124
12 O 0 0.00019146580598317087
% O 0 3.500402090139687e-05
of O 0 9.248221613233909e-05
these O 0 2.44536240643356e-05
cases O 0 7.837239536456764e-05
, O 0 6.956765719223768e-05
there O 0 6.860999565105885e-05
are O 0 2.2325624740915373e-05
no O 0 0.0002930862829089165
demonstrable O 1 0.9992602467536926
cardiac O 1 0.9999997615814209
or O 1 0.8696889877319336
non O 1 0.9985595345497131
- O 1 0.9992572665214539
cardiac O 1 0.9999903440475464
causes O 0 0.00284028728492558
to O 0 0.00015313921903725713
account O 0 5.0443723011994734e-05
for O 0 2.449970088491682e-05
the O 0 0.00011906751024071127
episode O 0 0.0007929107523523271
, O 0 7.908357656560838e-05
which O 0 5.265146683086641e-05
is O 0 5.9353089454816654e-05
therefore O 0 0.00015233644808176905
classified O 0 0.000760768074542284
as O 0 0.0029673483222723007
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999949932098389
IVF B-Disease 1 0.9999997615814209
) O 0 0.0013113542227074504
. O 0 0.0007100850343704224

A O 0 0.002610127441585064
distinct O 0 0.000516348285600543
group O 0 0.0003423782764002681
of O 0 0.0013384923804551363
IVF B-Disease 1 0.9999997615814209
patients O 0 0.0014160634018480778
has O 0 0.0001485322427470237
been O 0 7.411792466882616e-05
found O 0 5.149443313712254e-05
to O 0 3.8430043787229806e-05
present O 0 9.452010272070765e-05
with O 0 6.101472536101937e-05
a O 0 0.0005038881208747625
characteristic O 0 0.015103735961019993
electrocardiographic O 1 0.9999772310256958
pattern O 1 0.6807852983474731
. O 0 0.0020548617467284203

Because O 0 0.0009089307277463377
of O 0 0.00036954134702682495
the O 0 0.0003090016543865204
small O 0 0.0001554027694510296
size O 0 0.00014136714162304997
of O 0 0.0001633792999200523
most O 0 0.00010574673069640994
pedigrees O 0 0.0007632915512658656
and O 0 8.255515422206372e-05
the O 0 0.00027477488038130105
high O 0 0.0010442276252433658
incidence O 0 0.0016386649804189801
of O 0 0.0012134016724303365
sudden B-Disease 1 0.9999945163726807
death I-Disease 1 0.9993187189102173
, O 0 0.00021250608551781625
however O 0 7.638231909368187e-05
, O 0 6.270948506426066e-05
molecular O 0 0.00021724365069530904
genetic O 0 0.0001366380020044744
studies O 0 0.00012674367462750524
of O 0 0.0008106769528239965
IVF B-Disease 1 0.9999867677688599
have O 0 0.00011414304753998294
not O 0 4.677871402236633e-05
yet O 0 0.00013591861352324486
been O 0 0.00015407954924739897
done O 0 0.0006716966745443642
. O 0 0.000528095755726099

Because O 0 0.016539335250854492
IVF B-Disease 1 0.9999984502792358
causes O 1 0.9999891519546509
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 1.0
, O 0 0.000598579179495573
we O 0 0.00014899011875968426
investigated O 0 0.00048034280189312994
whether O 0 0.00011766960960812867
malfunction O 0 0.027879511937499046
of O 0 0.0005277761374600232
ion O 0 0.001535029150545597
channels O 0 0.00024635964655317366
could O 0 0.00023487948055844754
cause O 0 0.001324190990999341
the O 0 0.0007735755061730742
disorder O 1 0.9999734163284302
by O 0 0.00018027603800874203
studying O 0 0.0005087266326881945
mutations O 0 0.0002030810428550467
in O 0 0.00017480731185059994
the O 0 0.0007184274145402014
cardiac O 1 0.9992578625679016
sodium O 0 0.006364378612488508
channel O 0 0.0013505816459655762
gene O 0 0.0012164585059508681
SCN5A O 1 0.9980384707450867
. O 0 0.0013271492207422853

We O 0 0.0011842477833852172
have O 0 0.00014636553532909602
now O 0 0.00011475617793621495
identified O 0 8.304865332320333e-05
a O 0 0.0001559648080728948
missense O 0 0.001351585378870368
mutation O 0 0.00022233133495319635
, O 0 0.00012214173329994082
a O 0 0.00034569218405522406
splice O 0 0.005183832254260778
- O 0 0.0019144497346132994
donor O 0 0.0006419255514629185
mutation O 0 0.000488393590785563
, O 0 0.0001863769139163196
and O 0 0.00011932814959436655
a O 0 0.00031900187605060637
frameshift O 0 0.004120359197258949
mutation O 0 0.000193050189409405
in O 0 8.562398579670116e-05
the O 0 0.0002539195120334625
coding O 0 0.0004151425964664668
region O 0 0.00043249534792266786
of O 0 0.0005833452451042831
SCN5A O 1 0.9999699592590332
in O 0 0.0007439623004756868
three O 0 0.0006417844560928643
IVF B-Disease 1 0.9832738637924194
families O 0 0.0006882564048282802
. O 0 0.0006195546011440456

We O 0 0.001300388714298606
show O 0 0.0006349222385324538
that O 0 6.286797724897042e-05
sodium O 0 0.00022707715106662363
channels O 0 4.088358036824502e-05
with O 0 1.668327604420483e-05
the O 0 0.00014907096920069307
missense O 0 0.0016579934163019061
mutation O 0 0.0003071992832701653
recover O 0 0.0017850642325356603
from O 0 0.0003310345346108079
inactivation O 0 0.0076276869513094425
more O 0 0.00010075069440063089
rapidly O 0 0.0006511142710223794
than O 0 9.432562364963815e-05
normal O 0 0.00015085379709489644
and O 0 4.393497874843888e-05
that O 0 1.7952195776160806e-05
the O 0 0.000188142410479486
frameshift O 0 0.005116601940244436
mutation O 0 0.00041220057755708694
causes O 0 0.0006467596394941211
the O 0 0.0005157865816727281
sodium O 0 0.000771298015024513
channel O 0 0.0001286833721678704
to O 0 4.6837812988087535e-05
be O 0 6.797412788728252e-05
non O 0 0.00041605395381338894
- O 0 0.0010005367221310735
functional O 0 0.0010433507850393653
. O 0 0.0004210050101391971

Our O 0 0.002498153131455183
results O 0 0.0003857996198348701
indicate O 0 0.0002661125035956502
that O 0 5.735608283430338e-05
mutations O 0 0.00023537671950180084
in O 0 0.00036521063884720206
cardiac O 1 0.9999270439147949
ion O 0 0.027489829808473587
- O 0 0.0017472900217399001
channel O 0 0.00025976134929805994
genes O 0 6.825460150139406e-05
contribute O 0 7.29598687030375e-05
to O 0 3.5880897485185415e-05
the O 0 0.00014931353507563472
risk O 0 0.0001689901400823146
of O 0 0.0005205554771237075
developing O 0 0.030726147815585136
IVF B-Disease 1 0.9999953508377075
. O 0 0.0006041526212356985
. O 0 0.0007522275554947555

Molecular O 0 0.005539515055716038
heterogeneity O 0 0.007245573215186596
in O 0 0.0019228284945711493
mucopolysaccharidosis B-Disease 1 0.9999184608459473
IVA I-Disease 1 0.9999643564224243
in O 0 0.0007372947293333709
Australia O 0 0.0005211422685533762
and O 0 9.870839858194813e-05
Northern O 0 0.0006816363311372697
Ireland O 0 0.0004384334897622466
: O 0 0.00016602168034296483
nine O 0 0.00031870155362412333
novel O 0 0.0005744745722040534
mutations O 0 0.000272207020316273
including O 0 0.0003179998602718115
T312S O 1 0.999480664730072
, O 0 0.00038891308940947056
a O 0 0.0003544189385138452
common O 0 0.0002777628251351416
allele O 0 0.000302083877613768
that O 0 5.456470535136759e-05
confers O 0 0.0011883038096129894
a O 0 0.0011503826826810837
mild O 1 0.8047519326210022
phenotype O 0 0.007405986078083515
. O 0 0.0011718899477273226

Mucopolysaccharidosis B-Disease 1 0.9999632835388184
IVA I-Disease 1 0.9999984502792358
( O 0 0.11221943795681
MPS B-Disease 1 0.9998569488525391
IVA I-Disease 1 0.9999998807907104
) O 0 0.0012624026276171207
is O 0 0.00029683817410841584
an O 0 0.0004258774861227721
autosomal B-Disease 0 0.0551995113492012
recessive I-Disease 1 0.9999873638153076
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999990463256836
by O 0 0.0004272266523912549
a O 0 0.0009705699048936367
genetic B-Disease 0 0.006756237242370844
defect I-Disease 1 0.9999891519546509
in O 0 0.0010059572523459792
N O 0 0.0051813204772770405
- O 0 0.0015096369897946715
acetylgalactosamine O 0 0.03441844880580902
- O 0 0.0011199867585673928
6 O 0 0.0015500076115131378
- O 0 0.0036606634967029095
sulfate O 0 0.15108925104141235
sulfatase O 1 0.9990630745887756
( O 0 0.00556587241590023
GALNS O 1 0.9999823570251465
) O 0 0.0015073945978656411
. O 0 0.0008463161066174507

Previous O 0 0.0018294270848855376
studies O 0 0.0001912992011057213
of O 0 0.0002966645115520805
patients O 0 0.00022112397709861398
from O 0 0.0001631601044209674
a O 0 0.0003960195172112435
British O 0 0.0015210158890113235
- O 0 0.0010125136468559504
Irish O 0 0.0006563121569342911
population O 0 4.1249237256124616e-05
showed O 0 0.00011127001926070079
that O 0 2.312260039616376e-05
the O 0 0.00019455420260783285
I113F O 1 0.9263416528701782
mutation O 0 0.00022491160780191422
is O 0 6.59848446957767e-05
the O 0 0.00012307096039876342
most O 0 6.372403731802478e-05
common O 0 0.00012378182145766914
single O 0 0.0003036790294572711
mutation O 0 0.000493384141009301
among O 0 0.0005523051368072629
MPS B-Disease 1 0.9999417066574097
IVA I-Disease 1 1.0
patients O 0 0.062342867255210876
and O 0 0.0006648533162660897
produces O 0 0.0011594914831221104
a O 0 0.0013436460867524147
severe O 1 0.9999914169311523
clinical O 1 0.9577103853225708
phenotype O 0 0.10993451625108719
. O 0 0.0016606979770585895

We O 0 0.0005620115553028882
studied O 0 0.0006975103751756251
mutations O 0 0.00019648947636596859
in O 0 0.00013078140909783542
the O 0 0.000442562741227448
GALNS O 1 0.9962592124938965
gene O 0 0.0003125976654700935
from O 0 0.0001616536610526964
23 O 0 0.0006640522042289376
additional O 0 0.0003899916191585362
MPS B-Disease 1 0.7761219143867493
IVA I-Disease 1 0.9999996423721313
patients O 0 0.0012203314108774066
( O 0 0.00034074007999151945
15 O 0 0.00027206639060750604
from O 0 0.00014899553207214922
Australia O 0 0.00018995652499143034
, O 0 5.090939157526009e-05
8 O 0 0.0001677405380178243
from O 0 0.00012472184607759118
Northern O 0 0.00045314812450669706
Ireland O 0 0.000584534602239728
) O 0 9.194968151859939e-05
, O 0 4.791886385646649e-05
with O 0 3.9209131500683725e-05
various O 0 0.00010680757986847311
clinical O 0 0.001979131018742919
phenotypes O 1 0.7585490942001343
( O 0 0.00295654428191483
severe O 1 0.9999889135360718
, O 0 0.0003306384023744613
16 O 0 0.0007578805671073496
cases O 0 0.00012508440704550594
; O 0 5.434515333035961e-05
intermediate O 0 0.0005312982248142362
, O 0 7.90906633483246e-05
4 O 0 0.0002365538093727082
cases O 0 5.8236921177012846e-05
; O 0 6.103707710281014e-05
mild O 0 0.001147391158156097
, O 0 0.00012839950795751065
3 O 0 0.00032593822106719017
cases O 0 0.00019971236179117113
) O 0 0.00021839111286681145
. O 0 0.00034730194602161646

We O 0 0.0009084532503038645
found O 0 0.0003432078519836068
two O 0 0.00012714520562440157
common O 0 0.00018147379159927368
mutations O 0 0.0001376480795443058
that O 0 3.4658140066312626e-05
together O 0 0.00014683787594549358
accounted O 0 0.0002688350505195558
for O 0 3.6511290090857074e-05
32 O 0 0.00011504269787110388
% O 0 2.4403025236097164e-05
of O 0 0.00010400979226687923
the O 0 0.00031234114430844784
44 O 0 0.0009491980890743434
unrelated O 0 0.001196973375044763
alleles O 0 0.00046558439498767257
in O 0 0.0003098757879342884
these O 0 0.0002296231541549787
patients O 0 0.000841909961309284
. O 0 0.0008007436990737915

One O 0 0.001116983825340867
is O 0 0.00021333193581085652
the O 0 0.00044507565326057374
T312S O 1 0.9847821593284607
mutation O 0 0.0003794107760768384
, O 0 0.00011982711293967441
a O 0 0.00028983072843402624
novel O 0 0.0006905331392772496
mutation O 0 0.00023278470325749367
found O 0 0.0001615866058273241
exclusively O 0 0.0002697166637517512
in O 0 0.0004939975333400071
milder O 0 0.00782981887459755
patients O 0 0.001794844982214272
. O 0 0.0007502227672375739

The O 0 0.0016644366551190615
other O 0 0.00014688789087813348
is O 0 0.00012752281327266246
the O 0 0.00030852537020109594
previously O 0 0.0005022374098189175
described O 0 0.0008649476803839207
I113F O 1 0.9782081246376038
that O 0 0.0003578439063858241
produces O 0 0.0006555485306307673
a O 0 0.0011005591368302703
severe O 1 0.9999780654907227
phenotype O 1 0.8388095498085022
. O 0 0.0023893634788691998

The O 0 0.008446863852441311
I113F O 1 0.98911452293396
and O 0 0.001410346943885088
T312S O 1 0.6613820791244507
mutations O 0 0.00046469937660731375
accounted O 0 0.00036059535341337323
for O 0 4.568973236018792e-05
8 O 0 0.00026742034242488444
( O 0 8.436504867859185e-05
18 O 0 0.00019379807054065168
% O 0 4.753037865157239e-05
) O 0 3.6105659091845155e-05
and O 0 5.8120025641983375e-05
6 O 0 0.00030555683770217
( O 0 9.867940389085561e-05
14 O 0 0.0002776317414827645
% O 0 4.930185241391882e-05
) O 0 3.4331817005295306e-05
of O 0 0.0001229421905009076
44 O 0 0.0008073712815530598
unrelated O 0 0.0023187946062535048
alleles O 0 0.0009653732413426042
, O 0 0.0003717644140124321
respectively O 0 0.0013645930448547006
. O 0 0.0006768870516680181

The O 0 0.00532448710873723
relatively O 0 0.0018765167333185673
high O 0 0.003067712765187025
residual O 0 0.02194112353026867
GALNS O 1 0.9999294281005859
activity O 0 0.0024740726221352816
seen O 0 0.0010639901738613844
when O 0 0.00022433529375120997
the O 0 0.0004296186089050025
T312S O 0 0.015728464350104332
mutant O 0 0.0032320222817361355
cDNA O 0 0.0024604331701993942
is O 0 0.0002306196984136477
overexpressed O 0 0.0024394337087869644
in O 0 0.0003228425339329988
mutant O 0 0.0023365672677755356
cells O 0 0.0004912998410873115
provides O 0 6.653830496361479e-05
an O 0 3.393476436031051e-05
explanation O 0 9.622511424822733e-05
for O 0 4.380983955343254e-05
the O 0 0.00026979329413734376
mild O 0 0.006600774358958006
phenotype O 0 0.0009526163339614868
in O 0 0.0003021034935954958
patients O 0 0.0002736455062404275
with O 0 9.654182940721512e-05
this O 0 0.00019724010780919343
mutation O 0 0.0004612502525560558
. O 0 0.00037701940163969994

The O 0 0.0022953662555664778
distribution O 0 0.0003272356407251209
and O 0 0.00011862259998451918
relative O 0 0.0002618690486997366
frequencies O 0 9.003897866932675e-05
of O 0 0.00017025037959683686
the O 0 0.0005712307174690068
I113F O 1 0.9969567060470581
and O 0 0.0006525975186377764
T312S O 1 0.996086835861206
mutations O 0 0.0003435917606111616
in O 0 0.00010783936158986762
Australia O 0 0.0002540011191740632
corresponded O 0 0.0003573804278858006
to O 0 5.7698511227499694e-05
those O 0 5.086745659355074e-05
observed O 0 9.360582771478221e-05
in O 0 7.328579522436485e-05
Northern O 0 0.0005150786018930376
Ireland O 0 0.00039120420115068555
and O 0 9.361645788885653e-05
are O 0 1.5156398148974404e-05
unique O 0 5.161360604688525e-05
to O 0 3.1868617952568457e-05
these O 0 1.5486517440876924e-05
two O 0 2.752571163000539e-05
populations O 0 6.213363667484373e-05
, O 0 5.5115287977969274e-05
suggesting O 0 0.00017391885921824723
that O 0 3.783040301641449e-05
both O 0 7.047685357974842e-05
mutations O 0 9.63509883149527e-05
were O 0 8.0895159044303e-05
probably O 0 0.00031936337472870946
introduced O 0 0.0001257354160770774
to O 0 5.072717249277048e-05
Australia O 0 9.265496919397265e-05
by O 0 4.077397534274496e-05
Irish O 0 0.000608361151535064
migrants O 0 0.0002302622451679781
during O 0 0.0005216390127316117
the O 0 0.000439959520008415
19th O 0 0.006999416276812553
century O 0 0.006171088665723801
. O 0 0.0008931502234190702

Haplotype O 0 0.008210734464228153
analysis O 0 0.00036224591895006597
using O 0 0.0002934497897513211
6 O 0 0.0017572471406310797
RFLPs O 0 0.022200150415301323
provides O 0 0.00025006322539411485
additional O 0 9.731082536745816e-05
data O 0 3.5792181733995676e-05
that O 0 3.271446257713251e-05
the O 0 0.00015651274588890374
I113F O 0 0.030341360718011856
mutation O 0 0.0003245138213969767
originated O 0 0.0004089853900950402
from O 0 0.00013645336730405688
a O 0 0.0003103151102550328
common O 0 0.00051926972810179
ancestor O 0 0.004512371029704809
. O 0 0.0012649638811126351

The O 0 0.0011129450285807252
other O 0 0.00013776624109596014
9 O 0 0.0008468964952044189
novel O 0 0.0003435432445257902
mutations O 0 0.0001270299544557929
identified O 0 5.9715188399422914e-05
in O 0 4.83805088151712e-05
these O 0 3.0732251616427675e-05
23 O 0 0.0006640123319812119
patients O 0 0.00017450388986617327
were O 0 5.502474232343957e-05
each O 0 1.6650452380417846e-05
limited O 0 4.403720595291816e-05
to O 0 3.652170198620297e-05
a O 0 0.00015862243890296668
single O 0 0.00036943514714948833
family O 0 0.0007054465240798891
. O 0 0.0005225636414252222

These O 0 0.0006561413174495101
data O 0 0.00012329108722042292
provide O 0 0.00011926556908292696
further O 0 0.00014559950795955956
evidence O 0 0.00018221867503598332
for O 0 7.999000081326813e-05
extensive O 0 0.0011139351408928633
allelic O 0 0.007115430198609829
heterogeneity O 0 0.00383459753356874
in O 0 0.0007753998506814241
MPS B-Disease 1 0.9760718941688538
IVA I-Disease 1 0.9999951124191284
in O 0 0.0012493189424276352
British O 0 0.0032819064799696207
- O 0 0.003186747431755066
Irish O 0 0.003197495825588703
patients O 0 0.00021542212925851345
and O 0 6.388023030012846e-05
provide O 0 5.730632983613759e-05
evidence O 0 9.719786612549797e-05
for O 0 3.9888782339403406e-05
their O 0 4.3921911128563806e-05
transmission O 0 0.0003546946099959314
to O 0 6.455932452809066e-05
Australia O 0 0.00013959627540316433
by O 0 4.832693230127916e-05
British O 0 0.0005799413775093853
- O 0 0.0008566137403249741
Irish O 0 0.0012124977074563503
migrants O 0 0.00046709534944966435
. O 0 0.00016870164836291224
. O 0 0.0003820048295892775

Identification O 0 0.00195959466509521
of O 0 0.0019376203417778015
constitutional O 0 0.032224953174591064
WT1 O 1 0.9999991655349731
mutations O 0 0.0015566102229058743
, O 0 0.0002447503211442381
in O 0 0.0004316160921007395
patients O 0 0.0005418494110926986
with O 0 0.00032154537620954216
isolated O 1 0.9996588230133057
diffuse B-Disease 1 0.9999997615814209
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.003263087011873722
and O 0 0.00031546459649689496
analysis O 0 9.713818872114643e-05
of O 0 0.00046052003744989634
genotype O 0 0.003405836410820484
/ O 0 0.004239615518599749
phenotype O 0 0.0013411050895228982
correlations O 0 0.0004862797213718295
by O 0 5.147292904439382e-05
use O 0 3.579033727874048e-05
of O 0 0.0001518032659078017
a O 0 0.0005473705241456628
computerized O 0 0.0022126229014247656
mutation O 0 0.0004940283834002912
database O 0 0.00044477975461632013
. O 0 0.0005873940535821021

Constitutional O 0 0.0054260422475636005
mutations O 0 0.0009049346554093063
of O 0 0.0007756128325127065
the O 0 0.0019401522586122155
WT1 O 1 0.9996447563171387
gene O 0 0.0003862252342514694
, O 0 9.464908362133428e-05
encoding O 0 0.00011058491509174928
a O 0 0.0003321669646538794
zinc O 1 0.8509929776191711
- O 0 0.0014229501830413938
finger O 0 0.0034815906547009945
transcription O 0 0.0014814847381785512
factor O 0 0.000694506336003542
involved O 0 0.0005001251120120287
in O 0 0.0009032108937390149
renal O 1 1.0
and O 1 0.737779438495636
gonadal O 1 1.0
development O 1 0.752252995967865
, O 0 0.00016509393753949553
are O 0 1.4568826372851618e-05
found O 0 4.1573621274437755e-05
in O 0 8.241146133514121e-05
most O 0 9.943317854776978e-05
patients O 0 0.0001806947257136926
with O 0 0.00030814469209872186
Denys B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999954700469971
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9976896047592163
DDS B-Disease 1 1.0
) O 0 0.0012926241615787148
, O 0 0.0007229155744425952
or O 0 0.0024210140109062195
diffuse B-Disease 1 0.9999381303787231
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999737739562988
DMS B-Disease 1 0.9999998807907104
) O 0 0.000865822599735111
associated O 0 0.0004209668841212988
with O 0 0.0002778534253593534
pseudohermaphroditism B-Disease 1 0.999996542930603
and O 0 0.001495497184805572
/ O 1 0.9727905988693237
or O 0 0.043862588703632355
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 0.14243900775909424
WT B-Disease 1 0.9999935626983643
) O 0 0.0010825266363099217
. O 0 0.0006255523767322302

Most O 0 0.0024256755132228136
mutations O 0 0.0018237392650917172
in O 0 0.002163305878639221
DDS B-Disease 1 0.9999985694885254
patients O 0 0.001800024532712996
lie O 0 0.002543623559176922
in O 0 0.0005517429672181606
exon O 0 0.0030812860932201147
8 O 0 0.000875813071615994
or O 0 0.00018863477453123778
exon O 0 0.0017109327018260956
9 O 0 0.0006957571022212505
, O 0 0.0001212448623846285
encoding O 0 0.0002722454664763063
zinc O 0 0.0075609865598380566
finger O 0 0.0050810156390070915
2 O 0 0.0018338459776714444
or O 0 0.0007006603991612792
zinc O 1 0.5949217081069946
finger O 0 0.02558295428752899
3 O 0 0.0009071058011613786
, O 0 0.00015333399642258883
respectively O 0 0.00021290380391292274
, O 0 3.677003405755386e-05
with O 0 2.7566486096475273e-05
a O 0 0.00021517620189115405
hot O 0 0.002224806696176529
spot O 0 0.0015949119115248322
( O 0 0.000357989250915125
R394W O 0 0.010659126564860344
) O 0 0.000109332766442094
in O 0 0.0001585581776453182
exon O 0 0.003876456758007407
9 O 0 0.002712917746976018
. O 0 0.0007315828697755933

We O 0 0.0007225608569569886
analyzed O 0 0.00018805258150678128
a O 0 8.985455497168005e-05
series O 0 0.00012810429325327277
of O 0 0.00024887704057618976
24 O 0 0.001284884405322373
patients O 0 0.00023685941414441913
, O 0 9.51812689891085e-05
10 O 0 0.000265049806330353
with O 0 0.00017496707732789218
isolated B-Disease 0 0.02213967964053154
DMS I-Disease 1 0.9999985694885254
( O 0 0.0034452355466783047
IDMS B-Disease 1 0.9999864101409912
) O 0 0.00024240727361757308
, O 0 8.372047886950895e-05
10 O 0 0.00021647840912919492
with O 0 0.00013916338502895087
DDS B-Disease 1 0.9999825954437256
, O 0 0.0003662656818050891
and O 0 0.000275953090749681
4 O 0 0.0012167685199528933
with O 0 0.0009757831576280296
urogenital B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 1.0
and O 1 0.9701212048530579
/ O 1 0.9999656677246094
or O 0 0.30549848079681396
WT B-Disease 1 0.999995231628418
. O 0 0.003149068681523204

We O 0 0.0033180692698806524
report O 0 0.0015474034007638693
WT1 O 1 0.6039599180221558
heterozygous O 0 0.0006571480189450085
mutations O 0 0.00020759152539540082
in O 0 0.00013548370043281466
16 O 0 0.000810241443105042
patients O 0 0.00016088172560557723
, O 0 8.502336277160794e-05
4 O 0 0.0002873591147363186
of O 0 0.00024265862884931266
whom O 0 0.0006948502268642187
presented O 0 0.0011811412405222654
with O 0 0.0011101295240223408
IDMS B-Disease 1 0.9999943971633911
. O 0 0.0035213695373386145

One O 0 0.0019874032586812973
male O 0 0.001444400753825903
and O 0 0.00029917049687355757
two O 0 0.0003639500355347991
female O 0 0.0490189790725708
IDMS B-Disease 1 0.9999997615814209
patients O 0 0.00781550444662571
with O 0 0.0021376924123615026
WT1 O 1 0.9999996423721313
mutations O 0 0.0593244843184948
underwent O 1 0.9999971389770508
normal O 1 0.5481576919555664
puberty O 1 0.993907630443573
. O 0 0.0008741801721043885

Two O 0 0.0015892317751422524
mutations O 0 0.001337244757451117
associated O 0 0.0005711973062716424
with O 0 0.00046195625327527523
IDMS B-Disease 1 0.9999874830245972
are O 0 6.996858428465202e-05
different O 0 3.115309664281085e-05
from O 0 0.00010144209954887629
those O 0 6.745920836692676e-05
described O 0 0.0007416889420710504
in O 0 0.00226978724822402
DDS B-Disease 1 0.9999998807907104
patients O 0 0.01381723117083311
. O 0 0.0010785490740090609

No O 0 0.009302557446062565
WT1 O 1 0.9998113512992859
mutations O 0 0.0006822450086474419
were O 0 0.00014741164341103286
detected O 0 0.00023862360103521496
in O 0 4.809154779650271e-05
the O 0 0.00010123984247911721
six O 0 0.0002531539648771286
other O 0 0.00027518701972439885
IDMS B-Disease 1 0.9999997615814209
patients O 0 0.0017592157237231731
, O 0 0.00032586988527327776
suggesting O 0 0.0009618852636776865
genetic O 0 0.0003947682853322476
heterogeneity O 0 0.002089208457618952
of O 0 0.00166808080393821
this O 0 0.002886042697355151
disease O 1 0.999997615814209
. O 0 0.0016717360122129321

We O 0 0.001546560786664486
analyzed O 0 0.0011864070547744632
genotype O 0 0.003617650829255581
/ O 0 0.0032642425503581762
phenotype O 0 0.0011005778796970844
correlations O 0 0.0005447613075375557
, O 0 0.0001013904475257732
on O 0 6.41359220026061e-05
the O 0 7.498324703192338e-05
basis O 0 3.400152854737826e-05
of O 0 7.771368836984038e-05
the O 0 0.00021940332953818142
constitution O 0 0.0002735948655754328
of O 0 0.000382498576072976
a O 0 0.0009644363890402019
WT1 O 1 0.9771904349327087
mutation O 0 0.0002448800951242447
database O 0 8.297115709865466e-05
of O 0 0.00020258265431039035
84 O 0 0.0038126716390252113
germ O 1 0.999996542930603
- O 0 0.016857480630278587
line O 0 0.0016731099458411336
mutations O 0 0.0001498846831964329
, O 0 5.215111741563305e-05
to O 0 3.6633740819524974e-05
compare O 0 8.923055429477245e-05
the O 0 0.00011389211431378499
distribution O 0 6.319615931715816e-05
and O 0 6.33462259429507e-05
type O 0 0.00023946438159327954
of O 0 0.0005664101336151361
mutations O 0 0.00036740981158800423
, O 0 9.352249617222697e-05
according O 0 3.423638190724887e-05
to O 0 5.010600943933241e-05
the O 0 0.0001986533752642572
different O 0 0.0001568384177517146
symptoms O 1 0.7827782034873962
. O 0 0.0017291944241151214

This O 0 0.0006459550932049751
demonstrated O 0 0.001311344327405095
( O 0 0.0002546942268963903
1 O 0 0.00029508143779821694
) O 0 5.7128072512568906e-05
the O 0 0.00012003937445115298
association O 0 0.00011229865049244836
between O 0 8.053986675804481e-05
mutations O 0 0.00010851016850210726
in O 0 0.00015803967835381627
exons O 0 0.001054878463037312
8 O 0 0.0004994786577299237
and O 0 0.00010915307211689651
9 O 0 0.0006719854427501559
and O 0 0.000324768217978999
DMS B-Disease 1 0.9989206790924072
; O 0 0.00023288658121600747
( O 0 0.0002773288870230317
2 O 0 0.00047787363291718066
) O 0 0.00014198409917298704
among O 0 0.000115837792691309
patients O 0 0.00026172478101216257
with O 0 0.00025938666658475995
DMS B-Disease 1 0.9999880790710449
, O 0 0.00026346580125391483
a O 0 0.00020282772311475128
higher O 0 0.00010294767707819119
frequency O 0 3.0527255148626864e-05
of O 0 6.731782923452556e-05
exon O 0 0.0016614318592473865
8 O 0 0.0005086161545477808
mutations O 0 0.00020025810226798058
among O 0 9.355184738524258e-05
46 O 0 0.0006908225477673113
, O 0 0.0005108599434606731
XY O 1 0.986152172088623
patients O 0 0.0006461530574597418
with O 0 0.00016089768905658275
female O 0 0.001789427362382412
phenotype O 0 0.0006822273717261851
than O 0 8.010434248717502e-05
among O 0 9.889682405628264e-05
46 O 0 0.0006919782608747482
, O 0 0.00047353553236462176
XY O 1 0.9931979179382324
patients O 0 0.0007248816546052694
with O 0 0.00017962009587790817
sexual O 0 0.0010248232865706086
ambiguity O 0 0.001807774300687015
or O 0 0.0006312055629678071
male O 0 0.0007671078201383352
phenotype O 0 0.0006356148514896631
; O 0 4.411529880599119e-05
and O 0 9.53686103457585e-05
( O 0 0.00016181280079763383
3 O 0 0.0003400857967790216
) O 0 7.331284723477438e-05
statistically O 0 7.35776629881002e-05
significant O 0 6.969449168536812e-05
evidence O 0 8.299838373204693e-05
that O 0 3.285462298663333e-05
mutations O 0 5.4764208471169695e-05
in O 0 6.512882828246802e-05
exons O 0 0.0011125538730993867
8 O 0 0.0004582123947329819
and O 0 0.00014263694174587727
9 O 0 0.0008422264363616705
preferentially O 0 0.0008667363435961306
affect O 0 0.00032070925226435065
amino O 0 0.00023493952176067978
acids O 0 0.00011682951299007982
with O 0 2.6467714633326977e-05
different O 0 3.2964057027129456e-05
functions O 0 0.0001419155887560919
. O 0 0.00021491723600775003
. O 0 0.0003881297307088971

The O 0 0.008870666846632957
185delAG O 1 0.9977772831916809
BRCA1 O 0 0.44212806224823
mutation O 0 0.0008352784207090735
originated O 0 0.0009529232047498226
before O 0 0.0002767163678072393
the O 0 0.00018723261018749326
dispersion O 0 0.0005939724505878985
of O 0 0.00029279134469106793
Jews O 0 0.0007340333540923893
in O 0 0.00021478181588463485
the O 0 0.00034630211303010583
diaspora O 0 0.0003816613752860576
and O 0 8.79114813869819e-05
is O 0 7.205150905065238e-05
not O 0 4.741733573609963e-05
limited O 0 0.00015135362627916038
to O 0 0.00027005450101569295
Ashkenazim O 0 0.015375993214547634
. O 0 0.0014166288310661912

The O 0 0.003995165228843689
185delAG O 1 0.978008508682251
mutation O 0 0.0011378206545487046
in O 0 0.0006073631811887026
BRCA1 O 0 0.026541883125901222
is O 0 0.00021052363445051014
detected O 0 0.0003092279948759824
in O 0 0.00010790119267767295
Ashkenazi O 0 0.0007723250892013311
Jews O 0 0.00037362193688750267
both O 0 5.6583819969091564e-05
in O 0 0.0001972126483451575
familial B-Disease 1 0.9999003410339355
breast I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0011256899451836944
in O 0 0.00028093645232729614
the O 0 0.0002999956195708364
general O 0 0.0005354704335331917
population O 0 0.00012197146861581132
. O 0 0.00024108632351271808

All O 0 0.0014646642375737429
tested O 0 0.0020392818842083216
Ashkenazi O 0 0.003344781929627061
mutation O 0 0.00040660816011950374
carriers O 0 0.00018440315034240484
share O 0 4.8107089241966605e-05
the O 0 6.805202428949997e-05
same O 0 6.770591426175088e-05
allelic O 0 0.002090748166665435
pattern O 0 0.0011370329884812236
at O 0 0.0013074458111077547
the O 0 0.0012203186051920056
BRCA1 O 0 0.45373955368995667
locus O 0 0.0063046785071492195
. O 0 0.0009526681387796998

Our O 0 0.003340679919347167
previous O 0 0.0012980946339666843
study O 0 0.00018155515135731548
showed O 0 0.0002645461354404688
that O 0 3.237940836697817e-05
this O 0 5.386808334151283e-05
Ashkenazi O 0 0.0013549813302233815
mutation O 0 0.0002371450245846063
also O 0 0.000113495989353396
occurs O 0 0.00014350199489854276
in O 0 9.652986045693979e-05
Iraqi O 0 0.001556407194584608
Jews O 0 0.0004798080772161484
with O 0 7.120270311133936e-05
a O 0 0.0003066620556637645
similar O 0 0.000258370244409889
allelic O 0 0.009809658862650394
pattern O 0 0.0077359736897051334
. O 0 0.002012281445786357

We O 0 0.0009366343729197979
extended O 0 0.0005470330943353474
our O 0 0.0001605164143256843
analysis O 0 2.670670801308006e-05
to O 0 4.3631978769553825e-05
other O 0 4.89195590489544e-05
non O 0 0.00032991491025313735
- O 0 0.00041061945375986397
Ashkenazi O 0 0.0008471934706903994
subsets O 0 0.0004987747524864972
354 O 0 0.0013397946022450924
of O 0 0.0002895766228903085
Moroccan O 0 0.001105251256376505
origin O 0 0.0001766534842317924
, O 0 0.00018760144303087145
200 O 0 0.000702310586348176
Yemenites O 0 0.010239900089800358
and O 0 0.00026657874695956707
150 O 0 0.0007216022931970656
Iranian O 0 0.0016438059974461794
Jews O 0 0.0018719085492193699
. O 0 0.0006365933222696185

Heteroduplex O 0 0.2970966696739197
analysis O 0 0.000507485878188163
complemented O 0 0.0016631297767162323
by O 0 9.07241555978544e-05
direct O 0 9.720324305817485e-05
DNA O 0 0.00027612311532720923
sequencing O 0 0.00034602091182023287
of O 0 0.0003984298964496702
abnormally O 0 0.005686079617589712
migrating O 0 0.0010184305720031261
bands O 0 0.0012917268322780728
were O 0 0.0002891352341976017
employed O 0 0.0012776829535141587
. O 0 0.0006701664533466101

Four O 0 0.0007799872546456754
of O 0 0.0004441290511749685
Moroccan O 0 0.001155987847596407
origin O 0 9.875208343146369e-05
( O 0 7.809129601810127e-05
1 O 0 0.0001063151576090604
. O 0 2.5029499738593586e-05
1 O 0 9.871969814412296e-05
% O 0 3.53374780388549e-05
) O 0 3.7338973925216123e-05
and O 0 4.8693775170249864e-05
none O 0 0.0001529750443296507
of O 0 0.0002380521036684513
the O 0 0.0006572561105713248
Yemenites O 1 0.9914952516555786
or O 0 0.0004828716046176851
Iranians O 0 0.0007910701096989214
was O 0 0.0004029213450849056
a O 0 0.00019941001664847136
carrier O 0 0.0006556244916282594
of O 0 0.0003572194545995444
the O 0 0.0008919230313040316
185delAG O 1 0.9993174076080322
mutation O 0 0.002894591772928834
. O 0 0.0009140177862718701

BRCA1 O 1 0.9237037301063538
allelic O 0 0.03319629654288292
patterns O 0 0.001081972848623991
were O 0 0.00015561154577881098
determined O 0 9.272992610931396e-05
for O 0 2.025696448981762e-05
four O 0 3.289666346972808e-05
of O 0 7.207479939097539e-05
these O 0 1.896514731924981e-05
individuals O 0 1.964875809790101e-05
and O 0 4.821842230740003e-05
for O 0 4.099985380889848e-05
12 O 0 0.0003918613656423986
additional O 0 0.00019347276247572154
non O 0 0.000470935512566939
- O 0 0.0006917289574630558
Ashkenazi O 0 0.002089791465550661
185delAG O 0 0.026726344600319862
mutation O 0 0.00046749424654990435
carriers O 0 0.0002872443583328277
who O 0 0.00022079171321820468
had O 0 0.006039355881512165
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0050499713979661465

Six O 0 0.0038335302378982306
non O 0 0.003421139670535922
- O 0 0.002340173814445734
Ashkenazi O 0 0.0015615879092365503
individuals O 0 6.979358295211568e-05
shared O 0 0.00011007392458850518
the O 0 0.00026156159583479166
common O 0 0.0002452913613524288
Ashkenazi O 0 0.003532727248966694
haplotype O 0 0.0015261415392160416
, O 0 0.00011811320291599259
four O 0 9.004180901683867e-05
had O 0 0.00016441983461845666
a O 0 0.00012595212319865823
closely O 0 0.00012064274051226676
related O 0 0.00028117868350818753
pattern O 0 0.0011006880085915327
, O 0 0.00015258185158018023
and O 0 0.00010578022192930803
the O 0 0.00026144046569243073
rest O 0 0.0007153728511184454
( O 0 0.00020309226238168776
n O 0 0.000494652078486979
= O 0 0.0005513373762369156
6 O 0 0.000652921327855438
) O 0 0.00011598379933275282
displayed O 0 0.0004867128445766866
a O 0 0.00035130680771544576
distinct O 0 0.0008478980744257569
BRCA1 O 0 0.36098724603652954
allelic O 0 0.0376950241625309
pattern O 0 0.014779713936150074
. O 0 0.0017983218422159553

We O 0 0.0011610375950112939
conclude O 0 0.0009511200478300452
that O 0 7.975525659276173e-05
the O 0 0.0004061599320266396
185delAG O 1 0.9769534468650818
BRCA1 O 1 0.6261054277420044
mutation O 0 0.00048696971498429775
occurs O 0 0.0001765241613611579
in O 0 6.705104897264391e-05
some O 0 6.30350477877073e-05
non O 0 0.0002915028599090874
- O 0 0.0003627994447015226
Ashkenazi O 0 0.000730082974769175
populations O 0 7.792525866534561e-05
at O 0 0.0002389961009612307
rates O 0 6.218412454472855e-05
comparable O 0 0.00010514494351809844
with O 0 3.3983669709414244e-05
that O 0 5.295031223795377e-05
of O 0 0.0005757375620305538
Ashkenazim O 0 0.3751498758792877
. O 0 0.002033897442743182

The O 0 0.0013063603546470404
majority O 0 0.00021751911845058203
of O 0 0.00036719569470733404
Jewish O 0 0.00197433028370142
185delAG O 1 0.9993102550506592
mutation O 0 0.0006197066395543516
carriers O 0 0.00027886455063708127
have O 0 3.1606330594513565e-05
a O 0 0.0001408766402164474
common O 0 0.00028573875897563994
allelic O 0 0.00506951566785574
pattern O 0 0.0019351624650880694
, O 0 0.0002914117358159274
supporting O 0 0.0005642814794555306
the O 0 0.00042434968054294586
founder O 0 0.00715603306889534
effect O 0 0.0004478935443330556
notion O 0 0.00046889582881703973
, O 0 8.723522478248924e-05
but O 0 3.6919820558978245e-05
dating O 0 0.000378930737497285
the O 0 0.00014302509953267872
mutations O 0 7.9117133282125e-05
origin O 0 3.0828821763861924e-05
to O 0 3.4231059544254094e-05
an O 0 5.134737511980347e-05
earlier O 0 0.00016686854360159487
date O 0 0.0002312154829269275
than O 0 7.091951556503773e-05
currently O 0 9.891682566376403e-05
estimated O 0 0.000298787112114951
. O 0 0.00037026265636086464

However O 0 0.0013298657722771168
, O 0 0.0002122906007571146
the O 0 0.00018604846263770014
different O 0 5.384209725889377e-05
allelic O 0 0.0024340148083865643
pattern O 0 0.0012918002903461456
at O 0 0.0013042843202129006
the O 0 0.0007321212324313819
BRCA1 O 0 0.14248451590538025
locus O 0 0.0010877966415137053
even O 0 8.843513205647469e-05
in O 0 5.142754889675416e-05
some O 0 4.166780490777455e-05
Jewish O 0 0.0005514892982318997
mutation O 0 0.00043122144415974617
carriers O 0 0.0004006749077234417
, O 0 0.00012544621131382883
might O 0 0.00015162114868871868
suggest O 0 0.00010106236004503444
that O 0 2.882163789763581e-05
the O 0 0.00018371939950156957
mutation O 0 0.00035667739575728774
arose O 0 0.0013159841764718294
independently O 0 0.0002662419865373522
. O 0 0.00022896970040164888
. O 0 0.00037153877201490104

Crystal O 0 0.06484570354223251
structure O 0 0.0040885512717068195
of O 0 0.0017083316342905164
the O 0 0.009852027520537376
hemochromatosis B-Disease 1 1.0
protein O 0 0.14832907915115356
HFE O 1 0.9999345541000366
and O 0 0.0003601508215069771
characterization O 0 0.0007610349566675723
of O 0 0.00017854943871498108
its O 0 0.000139878349727951
interaction O 0 0.00022678999812342227
with O 0 0.00036422631819732487
transferrin O 1 0.9807267785072327
receptor O 0 0.00197049998678267
. O 0 0.0006140799960121512

HFE O 1 0.9976280331611633
is O 0 0.0008642991888336837
an O 0 0.0007542165694758296
MHC O 1 0.7140899300575256
- O 0 0.001885889214463532
related O 0 0.0003141706984024495
protein O 0 0.0001473189186071977
that O 0 2.9777940653730184e-05
is O 0 4.8859179514693096e-05
mutated O 0 0.00022733384685125202
in O 0 0.00017059016681741923
the O 0 0.0009472850360907614
iron B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9991697072982788

HFE O 1 0.9371974468231201
binds O 0 0.005124998278915882
to O 0 0.0013317023403942585
transferrin O 0 0.17751386761665344
receptor O 0 0.001638451125472784
( O 0 0.0007124442490749061
TfR O 0 0.10367295891046524
) O 0 0.00020445486006792635
and O 0 0.00010129902511835098
reduces O 0 0.00027274113381281495
its O 0 6.355472578434274e-05
affinity O 0 0.00023017071362119168
for O 0 0.00015366404841188341
iron O 1 0.9999920129776001
- O 0 0.0070790862664580345
loaded O 0 0.00472848117351532
transferrin O 0 0.03903794661164284
, O 0 0.00045252477866597474
implicating O 1 0.9144465923309326
HFE O 1 0.9999872446060181
in O 0 0.02866986021399498
iron O 1 1.0
metabolism O 1 0.9996501207351685
. O 0 0.0013275733217597008

The O 0 0.004443828947842121
2 O 0 0.004265614785254002
. O 0 0.001146863796748221

6 O 0 0.011454826220870018
A O 0 0.009471113793551922
crystal O 0 0.05540155619382858
structure O 0 0.003206813707947731
of O 0 0.0022287543397396803
HFE O 1 0.9999703168869019
reveals O 0 0.002000256208702922
the O 0 0.0004600365646183491
locations O 0 0.0003763896820601076
of O 0 0.001178004196844995
hemochromatosis B-Disease 1 1.0
mutations O 0 0.0012133554555475712
and O 0 0.000251502642640844
a O 0 0.0008633107645437121
patch O 1 0.9999725818634033
of O 0 0.014365103095769882
histidines O 1 0.9999872446060181
that O 0 0.00015629381232429296
could O 0 0.00010111393203260377
be O 0 3.059641312574968e-05
involved O 0 9.399348346050829e-05
in O 0 0.0001999646337935701
pH O 0 0.007946097292006016
- O 0 0.001837160554714501
dependent O 0 0.0006406798493117094
interactions O 0 0.0003539148601703346
. O 0 0.0004890597192570567

We O 0 0.0025833367835730314
also O 0 0.0007035975577309728
demonstrate O 0 0.0018700697692111135
that O 0 0.00044406845699995756
soluble O 0 0.01964814029633999
TfR O 1 0.9945213794708252
and O 0 0.00147421529982239
HFE O 1 0.9985370635986328
bind O 0 0.0009502721950411797
tightly O 0 0.00045566217158921063
at O 0 0.0004100851365365088
the O 0 0.00020495490753091872
basic O 0 0.00048167354543693364
pH O 0 0.0007262888248078525
of O 0 0.00023462343961000443
the O 0 0.000402859877794981
cell O 0 0.0013215949293226004
surface O 0 0.0007176346844062209
, O 0 8.396080374950543e-05
but O 0 2.4598099116701633e-05
not O 0 1.4430465853365604e-05
at O 0 0.0001244464801857248
the O 0 0.0002133734233211726
acidic O 0 0.00250245351344347
pH O 0 0.004724977537989616
of O 0 0.0023370874114334583
intracellular O 0 0.15346814692020416
vesicles O 0 0.043552812188863754
. O 0 0.0012347341980785131

TfR O 1 0.9886698722839355
HFE O 1 0.9929528832435608
stoichiometry O 0 0.008068803697824478
( O 0 0.0007307439227588475
2 O 0 0.000588692375458777
1 O 0 0.0005446880240924656
) O 0 0.00011839331273222342
differs O 0 0.00024813023628666997
from O 0 0.0003022227610927075
TfR O 0 0.0239939633756876
transferrin O 0 0.01460507046431303
stoichiometry O 0 0.002012941287830472
( O 0 0.00025669101160019636
2 O 0 0.00031490836408920586
2 O 0 0.0002885890717152506
) O 0 5.992579826852307e-05
, O 0 5.3460120398085564e-05
implying O 0 0.00022658727539237589
a O 0 5.959424743195996e-05
different O 0 1.4402076885744464e-05
mode O 0 0.00015428393089678138
of O 0 0.00015111610991880298
binding O 0 0.0001666192547418177
for O 0 0.0002138769195880741
HFE O 1 0.9997246861457825
and O 0 0.0010359876323491335
transferrin O 1 0.8487920165061951
to O 0 0.0008008932927623391
TfR O 1 0.9641010165214539
, O 0 0.0002461708791088313
consistent O 0 0.0002909769827965647
with O 0 7.81820563133806e-05
our O 0 0.00035081731039099395
demonstration O 0 0.0027547418139874935
that O 0 0.00033758123754523695
HFE O 1 0.9998667240142822
, O 0 0.0006319820531643927
transferrin O 1 0.8102807402610779
, O 0 0.00037600271753035486
and O 0 0.00033925293246284127
TfR O 1 0.5083387494087219
form O 0 0.000592028780374676
a O 0 0.0011489158496260643
ternary O 0 0.07938317209482193
complex O 0 0.013228178955614567
. O 0 0.0015837905230000615

Identification O 0 0.0013226595474407077
of O 0 0.0006709976005367935
three O 0 0.0003158618346787989
novel O 0 0.0008627376519143581
mutations O 0 0.00017166859470307827
and O 0 7.72076309658587e-05
a O 0 0.00013880529149901122
high O 0 0.00029247833299450576
frequency O 0 5.163960304344073e-05
of O 0 7.7120064815972e-05
the O 0 0.00038662689621560276
Arg778Leu O 1 0.9968934059143066
mutation O 0 0.00031392814707942307
in O 0 0.00021927407942712307
Korean O 0 0.34727364778518677
patients O 0 0.0005683372728526592
with O 0 0.00043907505460083485
Wilson B-Disease 1 0.9998268485069275
disease I-Disease 1 0.9999983310699463
. O 0 0.002697412623092532

Four O 0 0.00247494806535542
mutations O 0 0.0014843957033008337
- O 0 0.003214572323486209
- O 0 0.0029785281512886286
R778L O 1 0.5345666408538818
, O 0 0.0004997734213247895
A874V O 1 0.6950226426124573
, O 0 0.0004746924969367683
L1083F O 0 0.3622530996799469
, O 0 0.00035596726229414344
and O 0 0.0002851547615136951
2304delC O 1 0.851778507232666
- O 0 0.0017279142048209906
- O 0 0.0005143159651197493
in O 0 0.00014136458048596978
the O 0 0.00032825800008140504
copper O 1 0.5267917513847351
- O 0 0.0007782850880175829
transporting O 0 0.0018353724153712392
enzyme O 0 0.0004522328672464937
, O 0 0.00013450169353745878
P O 0 0.0015301286475732923
- O 0 0.0008104081498458982
type O 0 0.0009871060028672218
ATPase O 0 0.014409004710614681
( O 0 0.0008775681490078568
ATP7B O 1 0.9999408721923828
) O 0 0.00021465428289957345
, O 0 9.591380512574688e-05
were O 0 7.040073251118883e-05
identified O 0 0.00013986689737066627
in O 0 0.00025217660004273057
Korean O 0 0.19592590630054474
Patients O 0 0.0014692237600684166
with O 0 0.0009127185912802815
Wilson B-Disease 1 0.9999904632568359
disease I-Disease 1 0.9999998807907104
. O 0 0.0033910979982465506

Arg778Leu O 1 0.9993879795074463
, O 0 0.0011876565404236317
the O 0 0.0005347009864635766
most O 0 0.00013842148473486304
frequently O 0 0.0001600918039912358
reported O 0 0.00016408496594522148
mutation O 0 6.072554242564365e-05
of O 0 0.00014410671428777277
this O 0 0.00012797229283023626
enzyme O 0 0.0003593409201130271
, O 0 6.0584523453144357e-05
was O 0 0.0001933289022417739
found O 0 3.7487217923626304e-05
in O 0 3.462206950644031e-05
six O 0 7.862631173338741e-05
of O 0 0.00013655579823534936
eight O 0 0.00034590845461934805
unrelated O 0 0.0015287037240341306
patients O 0 0.000240513269091025
studied O 0 0.0004519898211583495
, O 0 0.00014247804938349873
an O 0 8.754581358516589e-05
allele O 0 0.00013821374159306288
frequency O 0 5.689266981789842e-05
of O 0 0.00021147503866814077
37 O 0 0.0015221795765683055
. O 0 0.0006131220725364983

5 O 0 0.002136027906090021
% O 0 0.00022098192130215466
, O 0 0.00010922158980974928
which O 0 4.83681469631847e-05
is O 0 5.340081042959355e-05
considerably O 0 0.0002766886609606445
higher O 0 8.519638504367322e-05
than O 0 2.5255507352994755e-05
those O 0 1.8861834178096615e-05
in O 0 4.196725058136508e-05
other O 0 8.438556687906384e-05
Asian O 0 0.0013272396754473448
populations O 0 0.00038058069185353816
. O 0 0.0004673296061810106

The O 0 0.0021724237594753504
novel O 0 0.0017749833641573787
single O 0 0.00043097385787405074
nucleotide O 0 0.0010093719465658069
deletion O 0 0.0012072462122887373
, O 0 0.00033886084565892816
2304delC O 1 0.9357934594154358
, O 0 0.00032999349059537053
was O 0 0.0004568608128465712
found O 0 9.603187208995223e-05
in O 0 0.00019553797028493136
one O 0 0.0003069899685215205
patient O 0 0.0014018460642546415
. O 0 0.0007563509861938655

Since O 0 0.002302286447957158
a O 0 0.0006910886149853468
mutation O 0 0.000519538123626262
at O 0 0.0007884285296313465
cDNA O 0 0.0019787014462053776
nucleotide O 0 0.002155367750674486
2302 O 0 0.06872790306806564
( O 0 0.0009139786125160754
2302insC O 0 0.14945998787879944
) O 0 0.00031232237233780324
had O 0 0.00029284664196893573
been O 0 8.881763642420992e-05
previously O 0 0.0001716165425023064
described O 0 0.0001681570429354906
, O 0 4.2746203689603135e-05
this O 0 1.784268897608854e-05
region O 0 0.00013183314877096564
of O 0 0.0002492342027835548
the O 0 0.0015987890074029565
ATP7B O 1 0.9999998807907104
gene O 0 0.0011517632519826293
may O 0 0.0002371007140027359
be O 0 8.320472988998517e-05
susceptible O 0 0.0006074963603168726
to O 0 0.00026476793573237956
gene O 0 0.0014455022756010294
rearrangements O 1 0.9993966817855835
causing O 1 0.9999994039535522
Wilson B-Disease 1 0.9999988079071045
disease I-Disease 1 0.9999998807907104
. O 0 0.003706395160406828

Disruption O 0 0.029759706929326057
of O 0 0.001533934031613171
splicing O 0 0.001573838759213686
regulated O 0 0.00030642561614513397
by O 0 5.985321331536397e-05
a O 0 0.00042872020276263356
CUG O 1 0.9990295171737671
- O 0 0.0017566884635016322
binding O 0 0.00045661351759918034
protein O 0 0.001239095232449472
in O 0 0.0019805734045803547
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.012036142870783806

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999948740005493
DM B-Disease 1 1.0
) O 0 0.002157252747565508
is O 0 0.0003457795537542552
caused O 0 0.0019959101919084787
by O 0 0.00017024243425112218
a O 0 0.0005082202260382473
CTG O 1 0.6605305075645447
expansion O 0 0.0010190537432208657
in O 0 8.21539360913448e-05
the O 0 0.00014623593597207218
3 O 0 0.00023153360234573483
untranslated O 0 0.0013723581796512008
region O 0 0.00030156681896187365
of O 0 0.0004502546216826886
the O 0 0.002685847692191601
DM B-Disease 1 0.9999998807907104
gene O 0 0.0030406294390559196
. O 0 0.0008054156205616891

One O 0 0.0021197611931711435
model O 0 0.0019228487508371472
of O 0 0.00279583060182631
DM B-Disease 1 1.0
pathogenesis O 1 0.9999852180480957
suggests O 0 0.0014203502796590328
that O 0 0.00010825458593899384
RNAs O 0 0.0005260659963823855
from O 0 8.353753219125792e-05
the O 0 0.00013785665214527398
expanded O 0 0.0004013840516563505
allele O 0 9.416726243216544e-05
create O 0 6.756517541361973e-05
a O 0 0.00011719304893631488
gain O 0 0.00023329108080361038
- O 0 0.000310105417156592
of O 0 0.00023045770649332553
- O 0 0.00047588968300260603
function O 0 0.00011851959425257519
mutation O 0 5.789019269286655e-05
by O 0 2.232639235444367e-05
the O 0 9.281317034037784e-05
inappropriate O 0 0.0003905206685885787
binding O 0 5.609689105767757e-05
of O 0 0.0001523239625385031
proteins O 0 0.00020931112521793693
to O 0 0.00016198631783481687
the O 0 0.000776901317294687
CUG O 1 0.9998775720596313
repeats O 0 0.006774221546947956
. O 0 0.0006551010301336646

Data O 0 0.0009697010973468423
presented O 0 0.0008174532558768988
here O 0 0.0003310418105684221
indicate O 0 0.00017285086505580693
that O 0 2.7729585781344213e-05
the O 0 0.00018891810032073408
conserved O 0 0.0007554502808488905
heterogeneous O 0 0.003130077151581645
nuclear O 0 0.006871664430946112
ribonucleoprotein O 1 0.6405742168426514
, O 0 0.0006024864269420505
CUG O 1 0.9710540771484375
- O 0 0.000773200299590826
binding O 0 0.00021547327924054116
protein O 0 0.00043339800322428346
( O 0 0.00048496483941562474
CUG O 1 0.9998379945755005
- O 0 0.004877226892858744
BP O 0 0.06699593365192413
) O 0 0.00015862833242863417
, O 0 8.896140207070857e-05
may O 0 0.000124925616546534
mediate O 0 0.0006423245067708194
the O 0 0.0005693602724932134
trans O 0 0.0022507794201374054
- O 0 0.0009939129231497645
dominant O 0 0.0010163505794480443
effect O 0 0.00027448582113720477
of O 0 0.0002809327270369977
the O 0 0.0007188821327872574
RNA O 0 0.002073039300739765
. O 0 0.0005503089050762355

CUG O 1 0.9999914169311523
- O 0 0.40192079544067383
BP O 0 0.4102887511253357
was O 0 0.0012657713377848268
found O 0 0.00011480084504000843
to O 0 8.065422298386693e-05
bind O 0 0.000167488309671171
to O 0 9.336932271253318e-05
the O 0 0.0003372655191924423
human O 0 0.0018928275676444173
cardiac O 1 0.9999997615814209
troponin O 1 0.9999998807907104
T O 1 0.999983549118042
( O 0 0.0008912757621146739
cTNT O 0 0.04856950044631958
) O 0 0.0002667644002940506
pre O 0 0.0019295234233140945
- O 0 0.000905736000277102
messenger O 0 0.0012732124887406826
RNA O 0 0.0004172000044491142
and O 0 0.00011512905621202663
regulate O 0 0.0003518295125104487
its O 0 0.0001282663579331711
alternative O 0 0.00036405620630830526
splicing O 0 0.0016236145747825503
. O 0 0.0004629315226338804

Splicing O 0 0.009039991535246372
of O 0 0.0038124124985188246
cTNT O 1 0.9995455145835876
was O 0 0.01614091917872429
disrupted O 1 0.7510319948196411
in O 0 0.004437087569385767
DM B-Disease 1 1.0
striated O 1 0.9999980926513672
muscle O 1 0.9999892711639404
and O 0 0.0010455676820129156
in O 0 0.0008576696855016053
normal O 0 0.0013812232064083219
cells O 0 0.0005326058599166572
expressing O 0 0.00047833126154728234
transcripts O 0 0.0007453652797266841
that O 0 9.780051914276555e-05
contain O 0 0.0013058988843113184
CUG O 1 0.9990922212600708
repeats O 0 0.006235565524548292
. O 0 0.0010215031215921044

Altered O 0 0.005213345400989056
expression O 0 0.0007929561543278396
of O 0 0.00045334294554777443
genes O 0 0.00038672887603752315
regulated O 0 0.0005913785425946116
posttranscriptionally O 0 0.040036141872406006
by O 0 0.000468518934212625
CUG O 1 0.9999960660934448
- O 0 0.029547251760959625
BP O 0 0.03275136649608612
therefore O 0 0.00036358938086777925
may O 0 0.00021787258447147906
contribute O 0 0.0006939469021745026
to O 0 0.0009245908004231751
DM B-Disease 1 1.0
pathogenesis O 1 0.9999874830245972
. O 0 0.0014829604187980294
. O 0 0.0013384503545239568

Identification O 0 0.001100997906178236
of O 0 0.0007359315059147775
a O 0 0.0007580167148262262
novel O 0 0.0013067087857052684
nonsense O 0 0.00435106223449111
mutation O 0 0.0002889814495574683
and O 0 9.135432628681883e-05
a O 0 0.0002110818022629246
missense O 0 0.0013413630658760667
substitution O 0 0.0005211012903600931
in O 0 0.00017398982890881598
the O 0 0.00042239631875418127
vasopressin O 0 0.009677283465862274
- O 0 0.0017115826485678554
neurophysin O 0 0.4014301598072052
II O 1 0.9986333250999451
gene O 0 0.0003404939197935164
in O 0 0.00010270157508784905
two O 0 6.739376112818718e-05
Spanish O 0 0.0008353950688615441
kindreds O 0 0.005860046949237585
with O 0 0.0005071753403171897
familial B-Disease 1 0.9999940395355225
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999996423721313
. O 0 0.007109714671969414

Familial B-Disease 1 0.9999889135360718
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9995630383491516
FNDI B-Disease 1 1.0
) O 0 0.0005877272342331707
is O 0 0.00015262173837982118
an O 0 0.00025267459568567574
autosomal B-Disease 1 0.6574118733406067
dominant I-Disease 1 0.9999978542327881
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9989633560180664
deficiency O 1 1.0
in O 0 0.012028797529637814
the O 0 0.036533743143081665
antidiuretic O 1 0.9994370341300964
hormone O 0 0.05044877901673317
arginine O 0 0.006498242262750864
vasopressin O 0 0.010610310360789299
( O 0 0.0005613690591417253
AVP O 0 0.16689953207969666
) O 0 8.58835264807567e-05
encoded O 0 3.8668218621751294e-05
by O 0 3.1550614949082956e-05
the O 0 0.0003258524520788342
AVP O 1 0.9971926808357239
- O 0 0.0045417179353535175
neurophysin O 1 0.9895125031471252
II O 1 0.9999935626983643
( O 0 0.003287535859271884
AVP O 1 0.999980092048645
- O 0 0.007341939955949783
NPII O 1 0.9994781613349915
) O 0 0.0002712409768719226
gene O 0 0.0003008055791724473
on O 0 0.0005446585128083825
chromosome O 0 0.0045532644726336
20p13 O 1 0.9952839016914368
. O 0 0.0016000119503587484

In O 0 0.0013934392482042313
this O 0 0.0001824045175453648
study O 0 0.0001064271418727003
, O 0 7.042860670480877e-05
we O 0 3.7684068956878036e-05
analyzed O 0 5.3458079491974786e-05
two O 0 3.059761365875602e-05
families O 0 7.289310451596975e-05
with O 0 0.0001428831892553717
FNDI B-Disease 1 0.9999830722808838
using O 0 0.00037800188874825835
direct O 0 0.00027578428853303194
automated O 0 0.0011586302425712347
fluorescent O 0 0.002005754504352808
, O 0 0.00011478726810310036
solid O 0 0.0008779959171079099
phase O 0 0.001246457570232451
, O 0 9.853262599790469e-05
single O 0 0.00011180587171111256
- O 0 0.00034396699629724026
stranded O 0 0.0004204892029520124
DNA O 0 0.00010368895891588181
sequencing O 0 0.00010534624743741006
of O 0 0.00023134735238272697
PCR O 0 0.0023524314165115356
- O 0 0.0018470627255737782
amplified O 0 0.005414374638348818
AVP O 1 0.9993917942047119
- O 0 0.008190869353711605
NPII O 1 0.9987379908561707
DNA O 0 0.0038915793411433697
. O 0 0.0009482064633630216

In O 0 0.000656007556244731
one O 0 0.00012603888171724975
of O 0 0.00015781050024088472
the O 0 0.000296476180665195
families O 0 0.00019928190158680081
, O 0 0.00018363847630098462
affected O 0 0.0003347419551573694
individuals O 0 6.220245995791629e-05
presented O 0 0.00034891412360593677
a O 0 0.00036406348226591945
novel O 0 0.0007058393093757331
nonsense O 0 0.0017071887850761414
mutation O 0 0.00013217248488217592
in O 0 7.428173557855189e-05
exon O 0 0.0006561463815160096
3 O 0 0.00012321502435952425
of O 0 9.203750232700258e-05
the O 0 0.00010798754374263808
gene O 0 0.00010531592124607414
, O 0 3.691555684781633e-05
consisting O 0 7.795900455676019e-05
in O 0 6.71379457344301e-05
a O 0 0.00022310280473902822
G O 0 0.0013905499363318086
to O 0 0.00023830754798837006
T O 0 0.003206566907465458
transition O 0 0.0013936342438682914
at O 0 0.0009917537681758404
nucleotide O 0 0.001146673341281712
2101 O 0 0.0553935170173645
, O 0 0.00013939051132183522
which O 0 6.58097123960033e-05
produces O 0 0.0001268975029233843
a O 0 0.00012904193135909736
stop O 0 0.000489708676468581
signal O 0 0.00044538138899952173
in O 0 0.0001761359308147803
codon O 0 0.0012021958827972412
82 O 0 0.0018030438804998994
( O 0 0.0007350266096182168
Glu O 1 0.6655578017234802
) O 0 0.0004634198558051139
of O 0 0.0013580755330622196
NPII O 1 0.9999653100967407
. O 0 0.0024179192259907722

The O 0 0.00582027668133378
premature O 0 0.017396746203303337
termination O 0 0.004145293030887842
eliminates O 0 0.0013605211861431599
part O 0 0.0002540451823733747
of O 0 0.00019968838023487478
the O 0 0.00030535185942426324
C O 0 0.001179514336399734
- O 0 0.0005842217360623181
terminal O 0 0.0010692639043554664
domain O 0 0.00017962556739803404
of O 0 0.000299900391837582
NPII O 1 0.9999363422393799
, O 0 0.00017281623149756342
including O 0 0.00012789435277227312
a O 0 0.00018438836559653282
cysteine O 0 0.0003761758853215724
residue O 0 0.0009648637496866286
in O 0 0.0001233898801729083
position O 0 0.0002430981257930398
85 O 0 0.00043822158477269113
, O 0 9.631654393160716e-05
which O 0 3.220394137315452e-05
could O 0 5.13128652528394e-05
be O 0 1.760866871336475e-05
involved O 0 5.851649621035904e-05
in O 0 5.8840094425249845e-05
the O 0 0.0002432008332107216
correct O 0 0.0008213263936340809
folding O 0 0.00336226518265903
of O 0 0.0011795052560046315
the O 0 0.0034740548580884933
prohormone O 1 0.9992578625679016
. O 0 0.001507930806837976

In O 0 0.0010202276753261685
the O 0 0.0007013207650743425
second O 0 0.0009707917924970388
family O 0 0.0002924699510913342
, O 0 0.0001556949719088152
a O 0 0.0003129032556898892
G279A O 0 0.010377167724072933
substitution O 0 0.0007975241169333458
at O 0 0.00040940038161352277
position O 0 0.00023499350936617702
- O 0 0.00016359941218979657
1 O 0 8.639478619443253e-05
of O 0 7.251167698996142e-05
the O 0 0.0002005688293138519
signal O 0 0.0009134241263382137
peptide O 0 0.0008775459136813879
was O 0 0.0004875558370258659
observed O 0 0.00011961510608671233
in O 0 9.20833190320991e-05
all O 0 9.093886910704896e-05
affected O 0 0.0005135309766046703
individuals O 0 0.00018423442088533193
. O 0 0.0004924414097331464

This O 0 0.0012002805015072227
missense O 0 0.005711580626666546
mutation O 0 0.0005307981045916677
, O 0 0.0002471727493684739
which O 0 0.00020954635692760348
replaces O 0 0.014262525364756584
Ala O 1 0.8584548830986023
with O 0 0.0005248093511909246
Thr O 1 0.9997524619102478
, O 0 0.0004386303771752864
is O 0 0.00019740380230359733
frequent O 0 0.0004458528710529208
among O 0 0.0011020462261512876
FNDI B-Disease 1 1.0
patients O 0 0.11549215018749237
and O 0 0.00030597433215007186
is O 0 0.00011092381464550272
thought O 0 0.0003616059257183224
to O 0 7.956156332511455e-05
reduce O 0 0.00014064348943065852
the O 0 0.00017070016474463046
efficiency O 0 0.00047025855747051537
of O 0 0.0003792603383772075
cleavage O 0 0.006937370635569096
by O 0 0.000495279033202678
signal O 0 0.003462289460003376
peptidases O 0 0.014943012036383152
. O 0 0.0004807900986634195
. O 0 0.00043642526725307107

Genetic O 0 0.003683979157358408
heterogeneity O 0 0.007021663244813681
of O 0 0.012916472740471363
Saethre B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999970197677612
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0012604035437107086
due O 0 0.0017967511666938663
to O 0 0.0009264372638426721
TWIST O 1 0.9970692992210388
and O 0 0.002224087016656995
FGFR O 1 0.9999986886978149
mutations O 0 0.004532821010798216
. O 0 0.0011439676163718104

Thirty O 0 0.016636548563838005
- O 0 0.0028341624420136213
two O 0 0.00018864756566472352
unrelated O 0 0.0009443585877306759
patients O 0 0.00020090414909645915
with O 0 8.86949201230891e-05
features O 0 0.0003285695565864444
of O 0 0.0031743510626256466
Saethre B-Disease 1 1.0
- I-Disease 1 0.999998927116394
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0006715577328577638
a O 0 0.0007153302431106567
common O 0 0.000756931840442121
autosomal B-Disease 0 0.19752411544322968
dominant I-Disease 1 0.999466598033905
condition I-Disease 1 0.9998536109924316
of O 1 0.9999454021453857
craniosynostosis B-Disease 1 1.0
and O 1 0.9999972581863403
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999995231628418
, O 0 0.0010145033011212945
were O 0 0.00034654204500839114
screened O 0 0.0003515733405947685
for O 0 6.812117499066517e-05
mutations O 0 0.00013218686217442155
in O 0 0.0003156489983666688
TWIST O 1 0.9741820693016052
, O 0 0.0009123749914579093
FGFR2 O 1 0.999996542930603
, O 0 0.0011906016152352095
and O 0 0.0015734386397525668
FGFR3 O 1 0.9999755620956421
. O 0 0.0027717866469174623

Nine O 0 0.005503774154931307
novel O 0 0.001758905011229217
and O 0 0.0002535365638323128
three O 0 0.0004188799357507378
recurrent O 1 0.974492073059082
TWIST O 1 0.9998849630355835
mutations O 0 0.000643407111056149
were O 0 0.00015672898734919727
found O 0 9.756447252584621e-05
in O 0 0.00014523747086059302
12 O 0 0.0006236946792341769
families O 0 0.0003554818395059556
. O 0 0.000488563789986074

Seven O 0 0.0026772369164973497
families O 0 0.0003368225588928908
were O 0 0.00014102771820034832
found O 0 5.898643939872272e-05
to O 0 5.5746477300999686e-05
have O 0 3.297999865026213e-05
the O 0 0.0005195504636503756
FGFR3 O 1 0.9999898672103882
P250R O 1 0.9998985528945923
mutation O 0 0.0008096417877823114
, O 0 0.0001241898280568421
and O 0 8.509984036209062e-05
one O 0 8.693825657246634e-05
individual O 0 6.267707794904709e-05
was O 0 0.000496980152092874
found O 0 9.253682219423354e-05
to O 0 4.901963620795868e-05
have O 0 3.486120840534568e-05
an O 0 0.0002072331844829023
FGFR2 O 1 0.9998248219490051
VV269 O 1 0.9981910586357117
- O 0 0.004086670465767384
270 O 0 0.004723935388028622
deletion O 0 0.004378992598503828
. O 0 0.0007018616306595504

To O 0 0.0010586869902908802
date O 0 0.0010599945671856403
, O 0 0.0001599016977706924
our O 0 0.000244267750531435
detection O 0 0.00044302959577180445
rate O 0 9.672097075963393e-05
for O 0 7.12023611413315e-05
TWIST O 0 0.010429996065795422
or O 0 0.000724686891771853
FGFR O 1 0.999900221824646
mutations O 0 0.0002461957628838718
is O 0 6.731834582751617e-05
68 O 0 0.00037623828393407166
% O 0 4.2524494347162545e-05
in O 0 9.291289461543784e-05
our O 0 0.0007368394872173667
Saethre B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999648332595825
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.577103316783905
, O 0 0.0002742728975135833
including O 0 0.0002896357327699661
our O 0 0.0003237240307498723
five O 0 0.00025286542950198054
patients O 0 0.0002626028726808727
elsewhere O 0 0.0003674036997836083
reported O 0 0.0003522313490975648
with O 0 0.00023882684763520956
TWIST O 1 0.993787407875061
mutations O 0 0.0013323278399184346
. O 0 0.0006851791404187679

More O 0 0.0002808223944157362
than O 0 0.00012087696086382493
35 O 0 0.00015530975360888988
different O 0 5.601126395049505e-05
TWIST O 0 0.017741434276103973
mutations O 0 0.00023291479737963527
are O 0 1.7120417396654375e-05
now O 0 9.732658509165049e-05
known O 0 0.00016503081133123487
in O 0 9.8736651125364e-05
the O 0 0.00032429146813228726
literature O 0 0.0005029254825785756
. O 0 0.00034215100458823144

The O 0 0.0024996460415422916
most O 0 0.0004974137409590185
common O 0 0.00039403303526341915
phenotypic O 0 0.0016606017015874386
features O 0 0.0002953927614726126
, O 0 6.788971950300038e-05
present O 0 8.28786360216327e-05
in O 0 6.427049811463803e-05
more O 0 2.0082468836335465e-05
than O 0 2.4407818273175508e-05
a O 0 5.685480573447421e-05
third O 0 0.00013658589159604162
of O 0 0.0001430368283763528
our O 0 0.0002892560441978276
patients O 0 0.00019597288337536156
with O 0 0.00010894572915276513
TWIST O 1 0.9995974898338318
mutations O 0 0.0007485085516236722
, O 0 0.00020702621259260923
are O 0 7.743044261587784e-05
coronal B-Disease 1 0.8777549862861633
synostosis I-Disease 1 0.9994133710861206
, O 0 0.0010129952570423484
brachycephaly B-Disease 1 0.9956938028335571
, O 0 0.0010588166769593954
low B-Disease 0 0.005875077564269304
frontal I-Disease 1 0.9999969005584717
hairline I-Disease 1 1.0
, O 1 0.9738338589668274
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999992847442627
, O 1 0.8010878562927246
ptosis B-Disease 1 0.9999983310699463
, O 0 0.0025864162016659975
hypertelorism B-Disease 1 0.9911604523658752
, O 0 0.000849638192448765
broad B-Disease 0 0.001975459046661854
great I-Disease 1 0.9942374229431152
toes I-Disease 1 0.999962329864502
, O 0 0.0010841918410733342
and O 0 0.0010236094240099192
clinodactyly B-Disease 1 0.9999361038208008
. O 0 0.002159343333914876

Significant O 0 0.0094106150791049
intra O 1 0.5381801128387451
- O 0 0.005972319282591343
and O 0 0.0007274892996065319
interfamilial O 0 0.29768645763397217
phenotypic O 0 0.003069197526201606
variability O 0 0.0007026898674666882
is O 0 9.401921124663204e-05
present O 0 0.00019151254673488438
for O 0 6.790047336835414e-05
either O 0 0.0002927478344645351
TWIST O 0 0.20535758137702942
mutations O 0 0.0017262559849768877
or O 0 0.0018206543754786253
FGFR O 1 0.9999973773956299
mutations O 0 0.0025183656252920628
. O 0 0.001038199756294489

The O 0 0.002263936446979642
overlap O 0 0.0009591361158527434
in O 0 0.00041724531911313534
clinical O 0 0.0007158464868552983
features O 0 0.00030365295242518187
and O 0 0.00010752474918263033
the O 0 0.000215712352655828
presence O 0 0.0003737598017323762
, O 0 5.67823663004674e-05
in O 0 3.761118568945676e-05
the O 0 6.486677011707798e-05
same O 0 4.5775384933222085e-05
genes O 0 7.152001489885151e-05
, O 0 3.6275669117458165e-05
of O 0 7.346744678216055e-05
mutations O 0 7.276296673808247e-05
for O 0 2.449377097946126e-05
more O 0 1.604464887350332e-05
than O 0 3.4753124054986984e-05
one O 0 0.00013314600801095366
craniosynostotic B-Disease 1 0.9545888304710388
condition I-Disease 0 0.0023631721269339323
- O 0 0.0006284993723966181
such O 0 8.140714635374025e-05
as O 0 0.0003558688622433692
Saethre B-Disease 1 0.9997203946113586
- I-Disease 0 0.015640417113900185
Chotzen I-Disease 1 0.999423623085022
, I-Disease 0 0.001126767136156559
Crouzon I-Disease 1 0.9986810088157654
, I-Disease 0 0.0007602854166179895
and I-Disease 0 0.0009830892086029053
Pfeiffer I-Disease 1 0.9999994039535522
syndromes I-Disease 1 0.999997615814209
- O 0 0.008936877362430096
support O 0 0.00038352535921148956
the O 0 0.0003410011704545468
hypothesis O 0 0.00038741776370443404
that O 0 8.191823872039095e-05
TWIST O 0 0.009285788983106613
and O 0 0.00034624882391653955
FGFRs O 1 0.6424404978752136
are O 0 5.2916791901225224e-05
components O 0 0.00023536416119895875
of O 0 0.00015160624752752483
the O 0 0.00020982346904929727
same O 0 0.00015436336980201304
molecular O 0 0.00023261627939064056
pathway O 0 0.0005223086336627603
involved O 0 0.00011863696272484958
in O 0 8.385589899262413e-05
the O 0 0.00023575675731990486
modulation O 0 0.000877868733368814
of O 0 0.0021337110083550215
craniofacial O 1 1.0
and O 1 0.999242901802063
limb O 1 1.0
development O 1 0.908663809299469
in O 0 0.0023523150011897087
humans O 0 0.0011203986359760165
. O 0 0.0002527545439079404
. O 0 0.0003196683246642351

Mutation O 0 0.0018918963614851236
analysis O 0 0.00020592923101503402
of O 0 0.0015694840112701058
UBE3A O 1 0.9999996423721313
in O 1 0.9999405145645142
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999854564666748
. O 0 0.0044365148060023785

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9998656511306763
AS B-Disease 1 0.9999966621398926
) O 0 0.0003977799788117409
is O 0 0.0001194716096506454
caused O 0 0.0014472288312390447
by O 0 0.00018807032029144466
chromosome O 0 0.0029025408439338207
15q11 O 1 0.9999344348907471
- O 0 0.007214680314064026
q13 O 0 0.15569373965263367
deletions O 0 0.0016015985747799277
of O 0 0.00044102981337346137
maternal O 0 0.0018229713896289468
origin O 0 0.00025926504167728126
, O 0 0.0001413343707099557
by O 0 0.00011988425103481859
paternal O 0 0.00679547106847167
uniparental B-Disease 1 0.9999949932098389
disomy I-Disease 1 0.9999992847442627
( O 0 0.027965478599071503
UPD B-Disease 1 0.9999985694885254
) O 0 0.0003456228878349066
15 O 0 0.0003832583606708795
, O 0 0.00015322685067076236
by O 0 0.00021489571372512728
imprinting O 1 0.9992615580558777
defects O 1 0.9999997615814209
, O 0 0.0005884886486455798
and O 0 0.00021935772383585572
by O 0 0.00013114153989590704
mutations O 0 0.00023361158673651516
in O 0 0.00024171006225515157
the O 0 0.0013537406921386719
UBE3A O 1 0.9999630451202393
gene O 0 0.001627677702344954
. O 0 0.0005944097065366805

UBE3A O 0 0.21748025715351105
encodes O 0 0.0024252566508948803
a O 0 0.0011790517019107938
ubiquitin O 0 0.006395807024091482
- O 0 0.00152690545655787
protein O 0 0.0007387406658381224
ligase O 0 0.0033935934770852327
and O 0 0.00029120067483745515
shows O 0 0.0006375110824592412
brain O 1 0.7612411379814148
- O 0 0.0012999590253457427
specific O 0 0.0002942016290035099
imprinting O 0 0.007663973607122898
. O 0 0.0012737184297293425

Here O 0 0.003069495316594839
we O 0 0.0004897110047750175
describe O 0 0.0012253918685019016
UBE3A O 1 0.8951327800750732
coding O 0 0.002357400953769684
- O 0 0.0014784187078475952
region O 0 0.0006264789262786508
mutations O 0 0.00031267182203009725
detected O 0 0.0004489074635785073
by O 0 0.00010331804514862597
SSCP O 0 0.2565760314464569
analysis O 0 6.170212145661935e-05
in O 0 9.880690777208656e-05
13 O 0 0.000957829412072897
AS B-Disease 0 0.007718693930655718
individuals O 0 0.00011399469804018736
or O 0 0.0003056369605474174
families O 0 0.0004297869454603642
. O 0 0.0008293999708257616

Two O 0 0.0007838073070161045
identical O 0 0.0010629455791786313
de O 0 0.0028873011469841003
novo O 0 0.0037862074095755816
5 O 0 0.0010076507460325956
- O 0 0.0012288930593058467
bp O 0 0.002663472667336464
duplications O 0 0.002605102490633726
in O 0 0.00022514504962600768
exon O 0 0.0020562002900987864
16 O 0 0.0009103140910156071
were O 0 0.00019993756723124534
found O 0 0.00028946236125193536
. O 0 0.00044341752072796226

Among O 0 0.0011820202926173806
the O 0 0.0002969047345686704
other O 0 7.502130029024556e-05
11 O 0 0.0005650274106301367
unique O 0 0.00026789394905790687
mutations O 0 0.00020445215341169387
, O 0 8.334164158441126e-05
8 O 0 0.0003756073710974306
were O 0 0.00011359840573277324
small O 0 0.0001216567907249555
deletions O 0 0.0011811141157522798
or O 0 0.0003116994630545378
insertions O 0 0.002033026423305273
predicted O 0 0.0005573416710831225
to O 0 0.00019428056839387864
cause O 0 0.0038333702832460403
frameshifts O 1 0.9989953637123108
, O 0 0.00019800402515102178
1 O 0 0.00025125197134912014
was O 0 0.0003063841431867331
a O 0 0.00013633864000439644
mutation O 0 6.750451575499028e-05
to O 0 3.1613861210644245e-05
a O 0 0.00010118780483026057
stop O 0 0.00037600292125716805
codon O 0 0.0005792645970359445
, O 0 5.9497830079635605e-05
1 O 0 0.00018575739522930235
was O 0 0.00028936853050254285
a O 0 0.00018119509331882
missense O 0 0.001045391196385026
mutation O 0 0.0001698647829471156
, O 0 6.122875493019819e-05
and O 0 7.441125490004197e-05
1 O 0 0.00027073381352238357
was O 0 0.0006210959400050342
predicted O 0 0.0004901948268525302
to O 0 0.00011031318717868999
cause O 0 0.0006815158412791789
insertion O 0 0.0008210869273170829
of O 0 0.000414935260778293
an O 0 0.00035815875162370503
isoleucine O 0 0.04239730164408684
in O 0 0.00025802463642321527
the O 0 0.00040764501318335533
hect O 0 0.00435098959133029
domain O 0 0.00019213222549296916
of O 0 0.00021531799575313926
the O 0 0.0007314489921554923
UBE3A O 1 0.9994418025016785
protein O 0 0.0004260999849066138
, O 0 8.29017226351425e-05
which O 0 2.1796531655127183e-05
functions O 0 3.8184520235517994e-05
in O 0 0.00013045284140389413
E2 O 0 0.011328965425491333
binding O 0 0.00027209080872125924
and O 0 0.00021379353711381555
ubiquitin O 0 0.005340397823601961
transfer O 0 0.001348437974229455
. O 0 0.0004621709231287241

Eight O 0 0.002217234345152974
of O 0 0.0008934072684496641
the O 0 0.0006352139171212912
cases O 0 0.0003083371848333627
were O 0 0.0002727028913795948
familial O 0 0.02527875080704689
, O 0 0.0005030386382713914
and O 0 0.00028082451899535954
five O 0 0.0003525502106640488
were O 0 0.00045503972796723247
sporadic O 0 0.0029931620229035616
. O 0 0.0011330853449180722

In O 0 0.0015842822613194585
two O 0 0.00042560839210636914
familial O 0 0.0044890157878398895
cases O 0 0.0004549230507109314
and O 0 0.0002989096101373434
one O 0 0.00033198969322256744
sporadic O 0 0.002356261946260929
case O 0 0.0008288132958114147
, O 0 0.0004090134461876005
mosaicism O 0 0.09976217150688171
for O 0 0.0006561782793141901
UBE3A O 1 0.999902606010437
mutations O 0 0.0006267688586376607
was O 0 0.0008331547724083066
detected O 0 0.00033809931483119726
in O 0 6.669609865639359e-05
the O 0 9.316635259892792e-05
mother O 0 0.0001656192762311548
of O 0 0.0001480472565162927
three O 0 0.00020457693608477712
AS B-Disease 1 0.5730603337287903
sons O 0 0.0039887381717562675
, O 0 7.636963709956035e-05
in O 0 8.588051423430443e-05
the O 0 0.00020657051936723292
maternal O 0 0.0007000469486229122
grandfather O 0 0.0023487054277211428
of O 0 0.00025395414559170604
two O 0 0.00014224428741727024
AS B-Disease 0 0.030264127999544144
first O 0 0.00032668327912688255
cousins O 0 0.0007796364952810109
, O 0 6.604182271985337e-05
and O 0 3.48762005160097e-05
in O 0 4.7647507017245516e-05
the O 0 0.0001662202994339168
mother O 0 0.0005289518157951534
of O 0 0.0003639562928583473
an O 0 0.0005560422432608902
AS B-Disease 1 0.9979544878005981
daughter O 0 0.08033429086208344
. O 0 0.0014487815788015723

The O 0 0.001485344604589045
frequencies O 0 0.00031683110864833
with O 0 9.655858593760058e-05
which O 0 6.419061537599191e-05
we O 0 7.897286559455097e-05
detected O 0 0.0003094135026913136
mutations O 0 6.121894693933427e-05
were O 0 4.3954885768471286e-05
5 O 0 0.00012676978076342493
( O 0 8.112259092740715e-05
14 O 0 0.0002761757932603359
% O 0 5.9169768064748496e-05
) O 0 2.7404732463764958e-05
of O 0 9.026326006278396e-05
35 O 0 0.00024125234631355852
in O 0 0.00015283303218893707
sporadic O 0 0.0006520961178466678
cases O 0 8.57943159644492e-05
and O 0 0.0001048622652888298
8 O 0 0.0003765630244743079
( O 0 0.00012388610048219562
80 O 0 0.00029762997291982174
% O 0 4.926181281916797e-05
) O 0 2.503623181837611e-05
of O 0 8.841084490995854e-05
10 O 0 0.00018157974409405142
in O 0 0.00020986147865187377
familial O 0 0.007333659566938877
cases O 0 0.0011567914625629783
. O 0 0.0005082163843326271
. O 0 0.0006979502504691482

The O 0 0.00889252033084631
hemochromatosis B-Disease 1 1.0
845 O 1 0.9996528625488281
G O 1 0.9879898428916931
- O 0 0.004969634115695953
- O 0 0.0013365987688302994
> O 0 0.0005802766536362469
A O 0 0.00034130411222577095
and O 0 8.08670956757851e-05
187 O 0 0.00044650110066868365
C O 0 0.0009150831028819084
- O 0 0.0007893825531937182
- O 0 0.0009146128431893885
> O 0 0.0012923786416649818
G O 0 0.002641338622197509
mutations O 0 0.000366064632544294
: O 0 0.00022946273384150118
prevalence O 0 0.0006005890318192542
in O 0 0.00029298238223418593
non O 0 0.001220161677338183
- O 0 0.0019016691949218512
Caucasian O 0 0.004443672951310873
populations O 0 0.00044756600982509553
. O 0 0.00046762925921939313

Hemochromatosis B-Disease 1 0.9999997615814209
, O 0 0.0035890056751668453
the O 0 0.022052882239222527
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999998807907104
, O 0 0.0009212352451868355
leads O 0 0.001177541445940733
, O 0 0.00023778305330779403
if O 0 0.00027157971635460854
untreated O 1 0.9897493720054626
, O 0 0.00029309216188266873
to O 0 0.0005628998042084277
progressive O 1 0.9999312162399292
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.5959519743919373
premature B-Disease 1 0.9998639822006226
death I-Disease 0 0.4808608591556549
. O 0 0.0009841874707490206

The O 0 0.02326156012713909
hemochromatosis B-Disease 1 1.0
gene O 0 0.010402362793684006
, O 0 0.0011210297234356403
HFE O 1 0.9999914169311523
, O 0 0.0005371248116716743
recently O 0 0.0004901901702396572
has O 0 7.838606688892469e-05
been O 0 7.942737283883616e-05
identified O 0 8.547469769837335e-05
, O 0 4.9724778364179656e-05
and O 0 5.887494990020059e-05
characterization O 0 0.0005072402418591082
of O 0 0.00025780993746593595
this O 0 0.00011083976278314367
gene O 0 0.00014282925985753536
has O 0 7.011700654402375e-05
shown O 0 5.733037687605247e-05
that O 0 1.4756251403014176e-05
it O 0 1.8005383026320487e-05
contains O 0 3.746499351109378e-05
two O 0 3.02363059745403e-05
mutations O 0 7.857167656766251e-05
that O 0 3.497849320410751e-05
result O 0 0.00010959320206893608
in O 0 0.0001631515333428979
amino O 0 0.00015748733130749315
acid O 0 0.0003430964716244489
substitutions O 0 0.0003561571938917041
- O 0 0.00025088523398153484
cDNA O 0 0.0006684270920231938
nucleotides O 0 0.0004923539236187935
845 O 0 0.0033230544067919254
G O 0 0.001857136725448072
- O 0 0.0007292432710528374
- O 0 0.00045334341120906174
> O 0 0.000540230714250356
A O 0 0.0005856342613697052
( O 0 0.0002804296091198921
C282Y O 0 0.006898334715515375
) O 0 7.411708065774292e-05
and O 0 4.4889446144225076e-05
187 O 0 0.0004108159919269383
C O 0 0.0008505478617735207
- O 0 0.0007991109741851687
- O 0 0.0010529395658522844
> O 0 0.0017560262931510806
G O 0 0.0065431008115410805
( O 0 0.0013795156264677644
H63D O 1 0.9998517036437988
) O 0 0.001210113987326622
. O 0 0.0007202831329777837

Although O 0 0.013003814965486526
hemochromatosis B-Disease 1 1.0
is O 0 0.0009459214052185416
common O 0 0.00041115141357295215
in O 0 0.0004644515865948051
Caucasians O 0 0.004681271500885487
, O 0 0.0002378317731199786
affecting O 0 0.0009565458167344332
> O 0 0.0010964610846713185
= O 0 0.0006653020391240716
1 O 0 0.0004027884569950402
/ O 0 0.0005401272210292518
300 O 0 0.0002011073229368776
individuals O 0 1.7313703210675158e-05
of O 0 0.00010851007391465828
northern O 0 0.00040943396743386984
European O 0 0.00017133857181761414
origin O 0 0.00011480446119094267
, O 0 9.757712541613728e-05
it O 0 4.7658140829298645e-05
has O 0 5.532133218366653e-05
not O 0 3.0016408345545642e-05
been O 0 5.542884537135251e-05
recognized O 0 0.0001681261055637151
in O 0 0.00015674483438488096
other O 0 0.0001655744417803362
populations O 0 0.00041286833584308624
. O 0 0.0005142931477166712

The O 0 0.0016854351852089167
present O 0 0.0005539447884075344
study O 0 0.0001748196518747136
used O 0 0.00013316288823261857
PCR O 0 0.0009397459798492491
and O 0 0.00018309193546883762
restriction O 0 0.0006224796525202692
- O 0 0.000633939343970269
enzyme O 0 0.00045208202209323645
digestion O 0 0.0006324489950202405
to O 0 5.9933969168923795e-05
analyze O 0 8.760100899962708e-05
the O 0 4.137128416914493e-05
frequency O 0 1.5732251995359547e-05
of O 0 4.8354217142332345e-05
the O 0 0.00024393259081989527
845 O 0 0.008360903710126877
G O 0 0.004772671032696962
- O 0 0.0010591151658445597
- O 0 0.0006140746991150081
> O 0 0.000355111580574885
A O 0 0.00025084501248784363
and O 0 5.014472480979748e-05
187 O 0 0.0003257450007367879
C O 0 0.000892746087629348
- O 0 0.0006301131215877831
- O 0 0.0007836146396584809
> O 0 0.001118123414926231
G O 0 0.0014924050774425268
mutations O 0 0.00025198410730808973
in O 0 0.00026885195984505117
HLA O 1 0.9567129015922546
- O 0 0.0005760975764133036
typed O 0 0.00022299370903056115
samples O 0 7.16207578079775e-05
from O 0 0.00012997679004911333
non O 0 0.00046635832404717803
- O 0 0.0006575568113476038
Caucasian O 0 0.001727802213281393
populations O 0 0.00012022219016216695
, O 0 6.986417429288849e-05
comprising O 0 0.00025076803285628557
Australian O 0 0.0012812401400879025
Aboriginal O 0 0.0014165665488690138
, O 0 0.00016530894208699465
Chinese O 0 0.0008285625954158604
, O 0 0.0002369050052948296
and O 0 0.0002723534416873008
Pacific O 0 0.0033926533069461584
Islanders O 0 0.0032073899637907743
. O 0 0.0009109643287956715

Results O 0 0.0017546378076076508
showed O 0 0.0006266195559874177
that O 0 5.030766988056712e-05
the O 0 0.00031566916732117534
845 O 0 0.010455658659338951
G O 0 0.01153580192476511
- O 0 0.002281817141920328
- O 0 0.0008697207667864859
> O 0 0.0007366197532974184
A O 0 0.0006257422501221299
mutation O 0 0.00018736922356765717
was O 0 0.00029503784026019275
present O 0 0.00011016885400749743
in O 0 6.43966268398799e-05
these O 0 2.1648207621183246e-05
populations O 0 3.954819476348348e-05
( O 0 6.230503640836105e-05
allele O 0 7.771776290610433e-05
frequency O 0 2.829097502399236e-05
0 O 0 3.394402301637456e-05
. O 0 1.81945288204588e-05
32 O 0 0.00012593844439834356
% O 0 5.704635623260401e-05
) O 0 5.332488944986835e-05
, O 0 9.062031313078478e-05
and O 0 9.7824857220985e-05
, O 0 0.00012051891098963097
furthermore O 0 0.0003629291313700378
, O 0 9.630386193748564e-05
it O 0 6.328511517494917e-05
was O 0 0.0005096413660794497
always O 0 0.00028240459505468607
seen O 0 0.0004018099280074239
in O 0 0.00016687778406776488
conjunction O 0 0.0008153562666848302
with O 0 0.0003054429544135928
HLA O 1 0.9998779296875
haplotypes O 0 0.00376152154058218
common O 0 0.0005357503541745245
in O 0 0.000465785909909755
Caucasians O 0 0.0034515513107180595
, O 0 0.00019637240620795637
suggesting O 0 0.00043208166607655585
that O 0 6.350129115162417e-05
845 O 0 0.004765221383422613
G O 0 0.004926604218780994
- O 0 0.0014657769352197647
- O 0 0.000945076928474009
> O 0 0.0009708354482427239
A O 0 0.0007075647008605301
may O 0 0.0001436005550203845
have O 0 3.3124961191788316e-05
been O 0 6.0967850004089996e-05
introduced O 0 9.730117017170414e-05
into O 0 8.481232362100855e-05
these O 0 2.8005386411678046e-05
populations O 0 8.241381874540821e-05
by O 0 9.758550731930882e-05
Caucasian O 0 0.004904584027826786
admixture O 0 0.015401598066091537
. O 0 0.0021158766467124224

187 O 0 0.005027480889111757
C O 0 0.003934928681701422
- O 0 0.0013660723343491554
- O 0 0.0010075124446302652
> O 0 0.0011968839680776
G O 0 0.001740942127071321
was O 0 0.0005367931444197893
present O 0 0.00021521722374018282
at O 0 0.000312178599415347
an O 0 8.123159204842523e-05
allele O 0 0.00016003745258785784
frequency O 0 5.4962813010206446e-05
of O 0 0.00020858952484559268
2 O 0 0.0009516520658507943
. O 0 0.000412471272284165

68 O 0 0.004600409884005785
% O 0 0.00026715072453953326
in O 0 0.00014562145224772394
the O 0 0.0001223317376570776
two O 0 7.227211608551443e-05
populations O 0 6.160676275612786e-05
analyzed O 0 0.00011229072697460651
( O 0 0.00013856672740075737
Australian O 0 0.0011681674513965845
Aboriginal O 0 0.002212646184489131
and O 0 0.00039470093906857073
Chinese O 0 0.002507446799427271
) O 0 0.0005417756037786603
. O 0 0.0005604581092484295

In O 0 0.0013471157290041447
the O 0 0.0007855105213820934
Australian O 0 0.0023139931727200747
Aboriginal O 0 0.0014017338398844004
samples O 0 0.00010515686153667048
, O 0 6.112841219874099e-05
187 O 0 0.0002533881925046444
C O 0 0.0008969781920313835
- O 0 0.0006570180994458497
- O 0 0.0006737053045071661
> O 0 0.0009732823236845434
G O 0 0.0017635057447478175
was O 0 0.0004663903673645109
found O 0 9.139466419583187e-05
to O 0 5.616825001197867e-05
be O 0 5.1757331675617024e-05
associated O 0 0.00011641182936728
with O 0 0.00018437781545799226
HLA O 1 0.9999563694000244
haplotypes O 0 0.003290455788373947
common O 0 0.00046279473463073373
in O 0 0.0005838224315084517
Caucasians O 0 0.013593710958957672
, O 0 0.0002056506200460717
suggesting O 0 0.00031213040347211063
that O 0 2.8456051950342953e-05
it O 0 4.6302578994072974e-05
was O 0 0.0003126700466964394
introduced O 0 0.0001993368350667879
by O 0 6.800953269703314e-05
recent O 0 0.0003422843001317233
admixture O 0 0.003427612828090787
. O 0 0.001060763606801629

In O 0 0.0006865501636639237
the O 0 0.00043143954826518893
Chinese O 0 0.0006313349585980177
samples O 0 6.390222551999614e-05
analyzed O 0 6.069994924473576e-05
, O 0 4.49139806733001e-05
187 O 0 0.00022129606804810464
C O 0 0.0005577901611104608
- O 0 0.0005283394129946828
- O 0 0.0005802230443805456
> O 0 0.0010553855681791902
G O 0 0.001305215759202838
was O 0 0.0004951678565703332
present O 0 0.00017150495841633528
in O 0 0.00013068030239082873
association O 0 0.00016157490608748049
with O 0 4.603752677212469e-05
a O 0 0.00022865572827868164
wide O 0 0.0004489161947276443
variety O 0 0.00031724010477773845
of O 0 0.001443871296942234
HLA O 1 0.9999991655349731
haplotypes O 0 0.007050700020045042
, O 0 0.00025322637520730495
showing O 0 0.0005938122631050646
this O 0 7.144708069972694e-05
mutation O 0 9.275486809201539e-05
to O 0 6.896236300235614e-05
be O 0 4.4543612602865323e-05
widespread O 0 0.0002801425871439278
and O 0 0.00012073975813109428
likely O 0 0.0001873955043265596
to O 0 9.22877952689305e-05
predate O 0 0.0014094655634835362
the O 0 0.00017552217468619347
more O 0 4.2531060898909345e-05
genetically O 0 0.00028307014144957066
restricted O 0 0.00016074004815891385
845 O 0 0.005678164307028055
G O 0 0.006494549568742514
- O 0 0.002177674788981676
- O 0 0.0015679389471188188
> O 0 0.0019401126774027944
A O 0 0.0018738036742433906
mutation O 0 0.0012560896575450897
. O 0 0.0006870820070616901

Genotype O 0 0.028485355898737907
- O 0 0.009753148071467876
phenotype O 0 0.004820856265723705
correlations O 0 0.002794756554067135
in O 0 0.002884352346882224
attenuated B-Disease 1 0.9981132745742798
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999995231628418
. O 0 0.0066046155989170074

Germ O 1 0.9999203681945801
- O 0 0.009478986263275146
line O 0 0.0015372664202004671
mutations O 0 0.0001732058881316334
of O 0 0.00032078599906526506
the O 0 0.0029120370745658875
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999749660491943
APC O 1 0.9989594221115112
are O 0 9.785723523236811e-05
implicated O 0 0.003771493211388588
in O 0 0.0010881791822612286
attenuated B-Disease 1 0.9939117431640625
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9984329342842102
AAPC B-Disease 1 0.9999998807907104
) O 0 0.00046653090976178646
, O 0 0.00010966909758280963
a O 0 0.0001703760790405795
variant O 0 0.0008745609666220844
of O 0 0.0012419718550518155
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999938011169434
FAP B-Disease 1 0.9999995231628418
) O 0 0.0031805161852389574
. O 0 0.0014494853094220161

AAPC B-Disease 1 0.999970555305481
is O 0 0.000915459415409714
recognized O 0 0.00031225630664266646
by O 0 6.89486987539567e-05
the O 0 0.00017281723557971418
occurrence O 0 0.000798200024291873
of O 0 0.0008242515614256263
< O 0 0.01440210547298193
100 O 0 0.003496479708701372
colonic B-Disease 1 0.9998210072517395
adenomas I-Disease 1 0.7354646325111389
and O 0 0.00016475615848321468
a O 0 0.00024641508935019374
later O 0 0.0006511881365440786
onset O 1 0.99947589635849
of O 1 0.9999077320098877
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.004728151485323906
age O 0 0.0013274240773171186
> O 0 0.0015555797144770622
40 O 0 0.0006339239189401269
years O 0 0.00041060184594243765
) O 0 0.00020788706024177372
. O 0 0.0003150627308059484

The O 0 0.0022316204849630594
aim O 0 0.0009129758691415191
of O 0 0.00026833670563064516
this O 0 7.479072519345209e-05
study O 0 8.84398614289239e-05
was O 0 0.0003480486629996449
to O 0 0.00011021761019947007
assess O 0 0.00057728320825845
genotype O 0 0.0021331626921892166
- O 0 0.0018470153445377946
phenotype O 0 0.0016456431476399302
correlations O 0 0.0016266829334199429
in O 0 0.0015617996687069535
AAPC B-Disease 1 0.9999912977218628
families O 0 0.0018858532421290874
. O 0 0.0009273866889998317

By O 0 0.0005306556704454124
protein O 0 0.0007680481066927314
- O 0 0.0008271919214166701
truncation O 0 0.004043662454932928
test O 0 0.0006357553647831082
( O 0 0.00040638691280037165
PTT O 0 0.007649796549230814
) O 0 0.00011608193744905293
assay O 0 0.0002889781608246267
, O 0 6.061433668946847e-05
the O 0 0.00010879706678679213
entire O 0 0.000606437970418483
coding O 0 0.00037297068047337234
region O 0 0.00015930224617477506
of O 0 0.00018798283417709172
the O 0 0.0009211237775161862
APC B-Disease 1 0.9982214570045471
gene O 0 0.00044839701149612665
was O 0 0.0008394586620852351
screened O 0 0.00047918138443492353
in O 0 0.00012617619358934462
affected O 0 0.00022385454212781042
individuals O 0 5.6946617405628785e-05
from O 0 0.0005012800684198737
11 O 0 0.05401242896914482
AAPC B-Disease 1 0.9999998807907104
kindreds O 1 0.9752540588378906
, O 0 0.000537540705408901
and O 0 0.00017036747885867953
their O 0 0.00016132413293235004
phenotypic O 0 0.001980215311050415
differences O 0 0.0009137399611063302
were O 0 0.0006381489802151918
examined O 0 0.0027462963480502367
. O 0 0.0012676487676799297

Five O 0 0.0037647378630936146
novel O 0 0.005708380602300167
germ O 1 0.9998393058776855
- O 0 0.015628866851329803
line O 0 0.0060154106467962265
APC B-Disease 1 0.9599088430404663
mutations O 0 0.00038453101296909153
were O 0 0.00015322626859415323
identified O 0 0.00016429727838840336
in O 0 0.0001789962116163224
seven O 0 0.0007688236073590815
kindreds O 0 0.012141197919845581
. O 0 0.0009211343131028116

Mutations O 0 0.0020842179656028748
were O 0 0.00031317066168412566
located O 0 0.00039680645568296313
in O 0 9.207735274685547e-05
three O 0 3.756555452127941e-05
different O 0 6.4648183979443274e-06
regions O 0 2.3394240997731686e-05
of O 0 7.958795322338119e-05
the O 0 0.00029219541465863585
APC B-Disease 1 0.9801533222198486
gene O 0 0.00017475600179750472
( O 0 6.790766201447695e-05
1 O 0 0.00011512653873069212
) O 0 2.4094199034152552e-05
at O 0 0.000105244544101879
the O 0 6.990403198869899e-05
5 O 0 0.00011778603220591322
end O 0 0.00026380765484645963
spanning O 0 0.000616830715443939
exons O 0 0.0005591873778030276
4 O 0 0.00027182837948203087
and O 0 6.453765672631562e-05
5 O 0 0.00014012664905749261
, O 0 4.565619019558653e-05
( O 0 5.328935003490187e-05
2 O 0 0.00012556707952171564
) O 0 3.500158345559612e-05
within O 0 4.9230722652282566e-05
exon O 0 0.0006572852144017816
9 O 0 0.0003764413413591683
, O 0 4.529494617599994e-05
and O 0 4.460873969946988e-05
( O 0 6.844910240033641e-05
3 O 0 0.00014949646720197052
) O 0 3.9588492654729635e-05
at O 0 0.00011845597327919677
the O 0 0.00012264720862731338
3 O 0 0.00034923857310786843
distal O 0 0.004695904441177845
end O 0 0.0012386987218633294
of O 0 0.0005558048724196851
the O 0 0.0010442655766382813
gene O 0 0.0009148350800387561
. O 0 0.0006551909609697759

Variability O 0 0.0038025665562599897
in O 0 0.0003096354193985462
the O 0 0.00035673382808454335
number O 0 0.00014522876881528646
of O 0 0.13972052931785583
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9841527342796326
most O 0 0.00030029378831386566
apparent O 0 0.0010198442032560706
in O 0 0.00012510920350905508
individuals O 0 3.3431333577027544e-05
with O 0 4.784306656802073e-05
mutations O 0 0.00011507353337947279
in O 0 0.0001767990761436522
region O 0 0.0004527530400082469
1 O 0 0.0005224281339906156
, O 0 0.00018253222515340894
and O 0 0.000244811933953315
upper O 1 0.9987012147903442
- O 1 0.9978135824203491
gastrointestinal O 1 0.9999856948852539
manifestations O 1 0.9983805418014526
were O 0 0.0009905871702358127
more O 0 0.0002946212771348655
severe O 1 0.9931812882423401
in O 0 0.0006337100639939308
them O 0 0.0005479933461174369
. O 0 0.0005887391744181514

In O 0 0.0011932936031371355
individuals O 0 0.00017034033953677863
with O 0 0.00012223017984069884
mutations O 0 0.0001937223132699728
in O 0 0.0001231364585692063
either O 0 0.00010616045619826764
region O 0 0.00019847543444484472
2 O 0 0.00016730540664866567
or O 0 5.991168654873036e-05
region O 0 0.0001434158330084756
3 O 0 0.0001476111210649833
, O 0 3.346313314978033e-05
the O 0 5.7675842981552705e-05
average O 0 8.065453585004434e-05
number O 0 4.814835119759664e-05
of O 0 0.0004337092104833573
adenomas B-Disease 1 0.9953615069389343
tended O 0 0.0007188318413682282
to O 0 0.00012974128185305744
be O 0 7.49489336158149e-05
lower O 0 0.00021298479987308383
than O 0 4.2079384002136067e-05
those O 0 2.389254586887546e-05
in O 0 3.7552552385022864e-05
individuals O 0 2.596713420643937e-05
with O 0 3.872505112667568e-05
mutations O 0 0.00010863823990803212
in O 0 0.00010277338878950104
region O 0 0.00033229522523470223
1 O 0 0.00027855951339006424
, O 0 4.8647641960997134e-05
although O 0 5.636242713080719e-05
age O 0 0.00022781704319640994
at O 0 0.001110008917748928
diagnosis O 0 0.0051339673809707165
was O 0 0.0021465641912072897
similar O 0 0.00038746651262044907
. O 0 0.0005785793182440102

In O 0 0.0031494309660047293
all O 0 0.0014962658751755953
AAPC B-Disease 1 0.9999699592590332
kindreds O 0 0.029265159741044044
, O 0 0.0005761692300438881
a O 0 0.000565572117920965
predominance O 0 0.007294697221368551
of O 0 0.002965462626889348
right O 1 0.8935714960098267
- O 1 0.9998015761375427
sided O 1 0.9999986886978149
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9997199177742004
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9963330030441284
was O 0 0.01735980249941349
observed O 0 0.0016975888283923268
. O 0 0.0007080702926032245

No O 0 0.042210012674331665
desmoid B-Disease 1 0.9999994039535522
tumors I-Disease 1 0.9999996423721313
were O 0 0.0005817855126224458
found O 0 0.0003148633404634893
in O 0 0.0002961625868920237
these O 0 0.00014784609084017575
kindreds O 0 0.00997182261198759
. O 0 0.0010278053814545274

Our O 0 0.0029442415107041597
data O 0 0.00021574691345449537
suggest O 0 0.00024686355027370155
that O 0 6.915295671205968e-05
, O 0 0.0001367532240692526
in O 0 0.00037999500636942685
AAPC B-Disease 1 0.9999839067459106
families O 0 0.0002874766942113638
, O 0 7.708683551754802e-05
the O 0 0.00010733952512964606
location O 0 0.00022020011965651065
of O 0 0.0002720062620937824
the O 0 0.0014698648592457175
APC B-Disease 1 0.9999805688858032
mutation O 0 0.0019514219602569938
may O 0 0.0008370939176529646
partially O 0 0.0027456823736429214
predict O 0 0.0008063955465331674
specific O 0 0.00013085524551570415
phenotypic O 0 0.00267409672960639
expression O 0 0.0015312611358240247
. O 0 0.0011043039849027991

This O 0 0.0008470196044072509
should O 0 0.00020304443023633212
help O 0 0.00014856737107038498
in O 0 0.00011413326865294948
the O 0 0.00019426314975135028
design O 0 0.00041411336860619485
of O 0 0.0004038990882690996
tailored O 0 0.001212113187648356
clinical O 0 0.0013296371325850487
- O 0 0.0022750133648514748
management O 0 0.0007802408072166145
protocols O 0 0.0004677790857385844
in O 0 0.00011107009777333587
this O 0 5.7071109040407464e-05
subset O 0 0.00031636690255254507
of O 0 0.0009568962850607932
FAP B-Disease 1 0.9999966621398926
patients O 0 0.003379858797416091
. O 0 0.0005638062139041722
. O 0 0.0007348178187385201

Wilms B-Disease 1 0.9999973773956299
' I-Disease 1 0.7700861692428589
tumor I-Disease 1 0.9973706007003784
1 O 0 0.0013287320034578443
and O 0 0.00039593828842043877
Dax O 1 0.9965531826019287
- O 0 0.0012350325705483556
1 O 0 0.0004404521605465561
modulate O 0 0.0007278317934833467
the O 0 0.00022197040379978716
orphan O 0 0.0031372939702123404
nuclear O 0 0.002035669516772032
receptor O 0 0.0007647144957445562
SF O 1 0.8722227811813354
- O 0 0.000510923215188086
1 O 0 0.00019498875190038234
in O 0 8.563861047150567e-05
sex O 0 0.0002747633552644402
- O 0 0.00034391257213428617
specific O 0 9.278441575588658e-05
gene O 0 0.00043263909174129367
expression O 0 0.0006664164247922599
. O 0 0.0005891629843972623

Products O 0 0.003194439457729459
of O 0 0.0010590673191472888
steroidogenic O 1 0.9542132616043091
factor O 0 0.0013574742479249835
1 O 0 0.000798004271928221
( O 0 0.0004502494412008673
SF O 1 0.995729386806488
- O 0 0.0008813856402412057
1 O 0 0.0002939016558229923
) O 0 9.836337267188355e-05
and O 0 0.00023423631500918418
Wilms B-Disease 1 0.9999858140945435
tumor I-Disease 1 0.9999836683273315
1 O 0 0.004499499220401049
( O 0 0.0012820713454857469
WT1 O 1 0.999729573726654
) O 0 0.00022197166981641203
genes O 0 9.119652531808242e-05
are O 0 1.184047414426459e-05
essential O 0 0.00016052467981353402
for O 0 7.87082317401655e-05
mammalian O 0 0.001928798039443791
gonadogenesis O 0 0.07405693084001541
prior O 0 0.0006487691425718367
to O 0 0.00026876124320551753
sexual O 0 0.0011584559688344598
differentiation O 0 0.0043354155495762825
. O 0 0.0008998729172162712

In O 0 0.0013848982052877545
males O 0 0.00044912530574947596
, O 0 0.00044845917727798223
SF O 1 0.9992660880088806
- O 0 0.0021335340570658445
1 O 0 0.0005887352745048702
participates O 0 0.000570437463466078
in O 0 0.00011544083099579439
sexual O 0 0.00025704220752231777
development O 0 0.00025681022088974714
by O 0 8.296957821585238e-05
regulating O 0 0.0003675178741104901
expression O 0 0.00012345824507065117
of O 0 0.0002867698494810611
the O 0 0.0013012243434786797
polypeptide O 1 0.531797468662262
hormone O 1 0.7578473687171936
Mullerian O 1 0.999200165271759
inhibiting O 0 0.04832000285387039
substance O 1 0.7412660121917725
( O 0 0.00260770577006042
MIS O 1 0.9995311498641968
) O 0 0.000816405052319169
. O 0 0.0006434083334170282

Here O 0 0.003731491742655635
, O 0 0.00039248436223715544
we O 0 0.000172366329934448
show O 0 0.000387453445000574
that O 0 0.00025787754566408694
WT1 O 1 0.9996165037155151
- O 0 0.012933882884681225
KTS O 1 0.9975079298019409
isoforms O 0 0.0012228806735947728
associate O 0 0.0007221155101433396
and O 0 0.0003006444312632084
synergize O 0 0.01337019819766283
with O 0 0.0007863981300033629
SF O 1 0.9999645948410034
- O 0 0.0022412147372961044
1 O 0 0.0005580614670179784
to O 0 0.00031856028363108635
promote O 0 0.0017469757003709674
MIS O 1 0.9971831440925598
expression O 0 0.002508476609364152
. O 0 0.0006803029682487249

In O 0 0.0034283457789570093
contrast O 0 0.002980479970574379
, O 0 0.0010581777896732092
WT1 O 1 0.9998805522918701
missense O 0 0.01721634343266487
mutations O 0 0.0009292679606005549
, O 0 0.00018904083117377013
associated O 0 0.00024008849868550897
with O 0 0.00015694448666181415
male B-Disease 0 0.0021100433077663183
pseudohermaphroditism I-Disease 1 0.9999995231628418
in O 0 0.005615840665996075
Denys B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999814033508301
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0013710837811231613
fail O 0 0.0013837260194122791
to O 0 0.000462910596979782
synergize O 0 0.02634884975850582
with O 0 0.0009653373272158206
SF O 1 0.999995231628418
- O 0 0.006644756533205509
1 O 0 0.002043657237663865
. O 0 0.0007382825133390725

Additionally O 0 0.0028517136815935373
, O 0 0.0003327806480228901
the O 0 0.0005185016780160367
X O 0 0.004768818151205778
- O 0 0.0027548172511160374
linked O 0 0.0013462910428643227
, O 0 0.00015348334272857755
candidate O 0 0.0004209970065858215
dosage O 0 0.0022336142137646675
- O 0 0.001253161346539855
sensitive O 0 0.0012574493885040283
sex O 0 0.000560751068405807
- O 0 0.0006694869371131063
reversal O 0 0.0017689071828499436
gene O 0 0.00034977789619006217
, O 0 0.0002907468006014824
Dax O 1 0.9965630173683167
- O 0 0.0016713119111955166
1 O 0 0.0006890944787301123
, O 0 0.00020102410053368658
antagonizes O 0 0.004759139847010374
synergy O 0 0.0034800029825419188
between O 0 0.0014435674529522657
SF O 1 0.9999951124191284
- O 0 0.0039170109666883945
1 O 0 0.0009456514962948859
and O 0 0.0004482142976485193
WT1 O 1 0.9995513558387756
, O 0 0.00021282238594722003
most O 0 7.534118776675314e-05
likely O 0 9.127639350481331e-05
through O 0 4.457756949705072e-05
a O 0 8.519541734131053e-05
direct O 0 9.622328070690855e-05
interaction O 0 0.00017412011220585555
with O 0 0.0004038434417452663
SF O 1 0.9999973773956299
- O 0 0.008006272837519646
1 O 0 0.002163867698982358
. O 0 0.000673492148052901

We O 0 0.00151722168084234
propose O 0 0.0014942168490961194
that O 0 0.0002738495822995901
WT1 O 1 0.9414347410202026
and O 0 0.0007562857936136425
Dax O 1 0.9999423027038574
- O 0 0.002859556581825018
1 O 0 0.0007898388430476189
functionally O 0 0.0010042197536677122
oppose O 0 0.00014512769121211022
each O 0 1.509204139438225e-05
other O 0 2.8873360861325637e-05
in O 0 0.0001452930155210197
testis O 0 0.0060396078042685986
development O 0 0.0006373971118591726
by O 0 0.00023139544646255672
modulating O 0 0.4376674294471741
SF O 1 0.999994158744812
- O 0 0.0032940986566245556
1 O 0 0.0013344816397875547
- O 0 0.0024414698127657175
mediated O 0 0.005007537081837654
transactivation O 0 0.021404240280389786
. O 0 0.0005640131421387196
. O 0 0.0007873504073359072

A O 0 0.00931638851761818
mouse O 0 0.0036137786228209734
model O 0 0.0009823982836678624
for O 0 0.0006750677130185068
Prader B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999996423721313
- O 1 0.9999113082885742
centre O 1 0.9779520034790039
mutations O 0 0.0016803870676085353
. O 0 0.0008110532653518021

Imprinting O 0 0.01757744513452053
in O 0 0.0011754048755392432
the O 0 0.0018664863891899586
15q11 O 1 0.9949707984924316
- O 0 0.0052808779291808605
q13 O 0 0.02259228751063347
region O 0 0.0008118550758808851
involves O 0 0.0004642046114895493
an O 0 0.0001877281320048496
imprinting O 0 0.0067329308949410915
centre O 0 0.018791092559695244
( O 0 0.0010572497267276049
IC O 1 0.9915561676025391
) O 0 0.00013834837591275573
, O 0 5.989501005387865e-05
mapping O 0 0.0001205334992846474
in O 0 5.8837566029978916e-05
part O 0 0.00017505217692814767
to O 0 7.72848361521028e-05
the O 0 0.0003004409954883158
promoter O 0 0.00585147412493825
and O 0 0.00025122560327872634
first O 0 0.0005256106960587204
exon O 0 0.003404211951419711
of O 0 0.0016520952340215445
SNRPN O 1 0.9999908208847046
. O 0 0.00169325340539217

Deletion O 0 0.006012127734720707
of O 0 0.0016582024982199073
this O 0 0.0011292967246845365
IC O 1 0.6313806176185608
abolishes O 0 0.01791795715689659
local O 0 0.0010219246614724398
paternally O 0 0.005419792607426643
derived O 0 0.0005041038384661078
gene O 0 0.0002745460078585893
expression O 0 0.00019787643395829946
and O 0 9.678619244368747e-05
results O 0 0.000203153642360121
in O 0 0.0007016208837740123
Prader B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999951124191284
PWS B-Disease 1 1.0
) O 0 0.004860359709709883
. O 0 0.0015254863537847996

We O 0 0.001260594348423183
have O 0 0.00014176873082760721
created O 0 0.00038693094393238425
two O 0 0.00011359406926203519
deletion O 0 0.0012100760359317064
mutations O 0 0.00042064880835823715
in O 0 0.0003324765129946172
mice O 0 0.0007626720471307635
to O 0 0.00022125580289866775
understand O 0 0.00104864954482764
PWS B-Disease 1 0.9999996423721313
and O 0 0.00046645215479657054
the O 0 0.00038246868643909693
mechanism O 0 0.0005030756001360714
of O 0 0.00047020975034683943
this O 0 0.0005157310515642166
IC O 1 0.9921334981918335
. O 0 0.0017525652656331658

Mice O 0 0.031738512217998505
harbouring O 1 0.9495658278465271
an O 0 0.0016916661988943815
intragenic O 1 0.9890524744987488
deletion O 0 0.006499393843114376
in O 0 0.001182684674859047
Snrpn O 1 0.9991165995597839
are O 0 0.0002891991753131151
phenotypically O 0 0.006806535180658102
normal O 0 0.0006322104018181562
, O 0 0.00015965533384587616
suggesting O 0 0.0002889993484131992
that O 0 4.839020039071329e-05
mutations O 0 0.00013934998423792422
of O 0 0.00045164008042775095
SNRPN O 1 0.9999984502792358
are O 0 7.246051245601848e-05
not O 0 4.8408845032099634e-05
sufficient O 0 0.0003198414633516222
to O 0 0.0004402879858389497
induce O 0 0.28972598910331726
PWS B-Disease 1 0.9999998807907104
. O 0 0.004592097830027342

Mice O 0 0.005505961831659079
with O 0 0.000228491859161295
a O 0 0.00047377258306369185
larger O 0 0.0005537629476748407
deletion O 0 0.0010261968709528446
involving O 0 0.0005755388992838562
both O 0 0.0002244234347017482
Snrpn O 1 0.9944252967834473
and O 0 0.00040092322160489857
the O 0 0.001098448527045548
putative O 1 0.9622387886047363
PWS O 1 1.0
- O 1 0.9948110580444336
IC O 1 0.9931857585906982
lack O 0 0.0016381144523620605
expression O 0 0.00032489115255884826
of O 0 0.000272242323262617
the O 0 0.0004971455200575292
imprinted O 0 0.006011155899614096
genes O 0 0.000712523702532053
Zfp127 O 1 0.9812120795249939
( O 0 0.0006151065463200212
mouse O 0 0.0010432760464027524
homologue O 0 0.00476133543998003
of O 0 0.0011993112275376916
ZNF127 O 1 0.9999929666519165
) O 0 0.0005837478674948215
, O 0 0.0005922935088165104
Ndn O 1 0.7288301587104797
and O 0 0.0012502212775871158
Ipw O 1 0.9935637712478638
, O 0 0.0006066235364414752
and O 0 0.00031696679070591927
manifest O 0 0.002922083716839552
several O 0 0.00045789629803039134
phenotypes O 0 0.0027420460246503353
common O 0 0.0012001660652458668
to O 0 0.004270593635737896
PWS B-Disease 1 1.0
infants O 1 0.999821126461029
. O 0 0.0019347838824614882

These O 0 0.00037880270974710584
data O 0 0.00012635548773687333
demonstrate O 0 0.0002962433500215411
that O 0 3.7026547943241894e-05
both O 0 3.53487666870933e-05
the O 0 9.779324318515137e-05
position O 0 0.00024073441454675049
of O 0 0.00019010873802471906
the O 0 0.0005265466752462089
IC O 1 0.8931812047958374
and O 0 0.00017433658649679273
its O 0 8.094701479421929e-05
role O 0 0.00016789668006822467
in O 0 4.95902422699146e-05
the O 0 0.00011947559687541798
coordinate O 0 0.0002105017629219219
expression O 0 0.00013567710993811488
of O 0 0.0001290830405196175
genes O 0 0.00010265654418617487
is O 0 4.550839730654843e-05
conserved O 0 0.00019132235320284963
between O 0 0.0002119257696904242
mouse O 0 0.0006410439382307231
and O 0 0.00011551503848750144
human O 0 0.0002420426026219502
, O 0 8.82215317687951e-05
and O 0 6.0661870520561934e-05
indicate O 0 0.00010279387061018497
that O 0 2.8083828510716558e-05
the O 0 0.00020031271560583264
mouse O 0 0.0005305269733071327
is O 0 4.971610178472474e-05
a O 0 0.00011952104978263378
suitable O 0 0.0003904625482391566
model O 0 0.00030615870491601527
system O 0 0.0001338423026027158
in O 0 7.216097583295777e-05
which O 0 4.61697782156989e-05
to O 0 4.536713822744787e-05
investigate O 0 0.0002630441449582577
the O 0 0.00018699176143854856
molecular O 0 0.000324148015351966
mechanisms O 0 0.000269588636001572
of O 0 0.00023276648425962776
imprinting O 0 0.0019210412865504622
in O 0 0.00015763018745929003
this O 0 2.7700223654392175e-05
region O 0 6.822330760769546e-05
of O 0 0.00011631551024038345
the O 0 0.00036229187389835715
genome O 0 0.0004574246995616704
. O 0 0.000142522607347928
. O 0 0.0003540761535987258

Mutations O 0 0.0016834536800161004
of O 0 0.0008154393872246146
the O 0 0.0010322281159460545
ATM O 0 0.004532857798039913
gene O 0 0.00039491071947850287
detected O 0 0.0005667374352924526
in O 0 0.0003329221217427403
Japanese O 0 0.2564920485019684
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999762773513794
telangiectasia I-Disease 1 0.9999992847442627
patients O 0 0.002037600614130497
: O 0 0.00016032796702347696
possible O 0 0.00016007378872018307
preponderance O 0 0.001720959902741015
of O 0 0.0002320025087101385
the O 0 0.00037270234315656126
two O 0 0.0002027229347731918
founder O 0 0.009018966928124428
mutations O 0 0.0020245728082954884
4612del165 O 1 0.9988895058631897
and O 0 0.002312849508598447
7883del5 O 1 0.9992827773094177
. O 0 0.0021974716801196337

The O 0 0.0036026514135301113
ATM O 0 0.00943608395755291
( O 0 0.0013092876179143786
A O 1 0.6237937211990356
- O 0 0.26230475306510925
T O 1 0.9985554814338684
, O 0 0.00023919511295389384
mutated O 0 0.0007294045644812286
) O 0 8.363069355254993e-05
gene O 0 0.00010230804764432833
on O 0 0.0002606713678687811
human O 0 0.0007274525705724955
chromosome O 0 0.0070566944777965546
11q22 O 1 0.999265730381012
. O 0 0.00234381016343832

3 O 0 0.003176805330440402
has O 0 0.00032314055715687573
recently O 0 0.0002996925904881209
been O 0 6.778058741474524e-05
identified O 0 9.90425469353795e-05
as O 0 9.865240281214938e-05
the O 0 0.0001424201764166355
gene O 0 0.0001288728672079742
responsible O 0 0.00024893044610507786
for O 0 9.783913264982402e-05
the O 0 0.0005440563545562327
human O 0 0.004400239791721106
recessive B-Disease 1 0.9999978542327881
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.8010751008987427
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9998331069946289
T I-Disease 1 0.9999544620513916
) O 0 0.0004603888082783669
. O 0 0.00031025742646306753

In O 0 0.001208025962114334
order O 0 0.0003057984577026218
to O 0 8.5404550191015e-05
define O 0 0.00017904759442899376
the O 0 0.00021191322593949735
types O 0 0.00019940412312280387
of O 0 0.0021637259051203728
disease O 1 1.0
- O 1 0.9998764991760254
causing O 1 0.999711811542511
ATM O 0 0.0048513771034777164
mutations O 0 0.00012593869178090245
in O 0 0.00010469023254700005
Japanese O 0 0.0028219767846167088
A B-Disease 1 0.9994755387306213
- I-Disease 1 0.9950854182243347
T I-Disease 1 0.9999836683273315
patients O 0 0.000354212912498042
as O 0 9.229325223714113e-05
well O 0 6.729183223797008e-05
as O 0 6.162568024592474e-05
to O 0 4.585507485899143e-05
look O 0 0.00012249899737071246
for O 0 5.148441778146662e-05
possible O 0 0.000256369385169819
mutational O 0 0.011736169457435608
hotspots O 0 0.013033057563006878
, O 0 0.0003146412782371044
reverse O 0 0.0009541215840727091
- O 0 0.0007006243104115129
transcribed O 0 0.00042516476241871715
RNA O 0 0.00028145761461928487
derived O 0 7.975586777320132e-05
from O 0 5.765186870121397e-05
ten O 0 0.00028294685762375593
patients O 0 0.00012893491657450795
belonging O 0 0.0002873259945772588
to O 0 8.749566040933132e-05
eight O 0 0.0004035413439851254
unrelated O 0 0.0008967939647845924
Japanese O 0 0.009986232966184616
A B-Disease 1 0.9996987581253052
- I-Disease 1 0.9688581228256226
T I-Disease 1 0.9986521601676941
families O 0 0.0001471299765398726
was O 0 0.000403291400289163
analyzed O 0 9.959069575415924e-05
for O 0 3.609767372836359e-05
mutations O 0 0.00010508227569516748
by O 0 3.931434184778482e-05
the O 0 0.00021537365682888776
restriction O 0 0.0005096421227790415
endonuclease O 0 0.0035929467994719744
fingerprinting O 0 0.0016987902345135808
method O 0 0.0003712898469530046
. O 0 0.000419981632148847

As O 0 0.002235594904050231
has O 0 0.0003167057875543833
been O 0 0.0001756299752742052
reported O 0 0.0001778485457180068
by O 0 5.80667910980992e-05
others O 0 0.0001304976176470518
, O 0 0.00011766422539949417
mutations O 0 0.0001590556203154847
that O 0 5.3181880502961576e-05
lead O 0 0.0003194142773281783
to O 0 0.00015335284115280956
exon O 0 0.002690413733944297
skipping O 0 0.0035413154400885105
or O 0 0.0003295684000477195
premature O 0 0.0023396790493279696
protein O 0 0.00030624744249507785
truncation O 0 0.002573987701907754
were O 0 0.00012732380127999932
also O 0 9.426321048522368e-05
predominant O 0 0.0003563110076356679
in O 0 0.0002019654930336401
our O 0 0.000660585006698966
mutants O 0 0.006606317590922117
. O 0 0.0008563493029214442

Six O 0 0.0015759471571072936
different O 0 0.00010371961980126798
mutations O 0 0.00013567750283982605
were O 0 6.227243284229189e-05
identified O 0 5.084185613668524e-05
on O 0 7.613607886014506e-05
12 O 0 0.00019682607671711594
of O 0 0.00016973589663393795
the O 0 0.00035556245711632073
16 O 0 0.0013712880900129676
alleles O 0 0.0008173855603672564
examined O 0 0.0019719284027814865
. O 0 0.0010160397505387664

Four O 0 0.0015854139346629381
were O 0 0.0004077404155395925
deletions O 0 0.0014119631377980113
involving O 0 0.0006491485401056707
a O 0 0.00040101687773130834
loss O 0 0.001366618205793202
of O 0 0.00031077340827323496
a O 0 0.0004929467104375362
single O 0 0.00029959206585772336
exon O 0 0.0015481729060411453
exon O 0 0.001704041613265872
7 O 0 0.0004981838865205646
, O 0 9.831103670876473e-05
exon O 0 0.0012370799668133259
16 O 0 0.0007088835700415075
, O 0 0.00017465004930272698
exon O 0 0.002154313726350665
33 O 0 0.0013819935265928507
or O 0 0.0005272325943224132
exon O 0 0.006136943120509386
35 O 0 0.00208449549973011
. O 0 0.0009452893864363432

The O 0 0.0021490436047315598
others O 0 0.0004537316272035241
were O 0 0.00033209254615940154
minute O 0 0.0006144765648059547
deletions O 0 0.001543101156130433
, O 0 0.00022491547861136496
4649delA O 0 0.010682589374482632
in O 0 0.00045095733366906643
exon O 0 0.003725772025063634
33 O 0 0.0014133702497929335
and O 0 0.0004148312727920711
7883del5 O 0 0.024806076660752296
in O 0 0.000986416474916041
exon O 0 0.007545198313891888
55 O 0 0.0021099508740007877
. O 0 0.0006556700682267547

The O 0 0.00571746239438653
mutations O 0 0.00370306009426713
4612del165 O 1 0.9940525889396667
and O 0 0.001300381263718009
7883del5 O 1 0.9970081448554993
were O 0 0.00026095932116732
found O 0 8.56187689350918e-05
in O 0 3.663632378447801e-05
more O 0 2.253130151075311e-05
than O 0 2.017372207774315e-05
two O 0 2.4076121917460114e-05
unrelated O 0 0.00023071470786817372
families O 0 5.406333366408944e-05
; O 0 2.6067222279380076e-05
44 O 0 0.00014707933587487787
% O 0 6.144904909888282e-05
( O 0 6.637859769398347e-05
7 O 0 0.00020326566300354898
of O 0 0.00020453089382499456
16 O 0 0.0005294018192216754
) O 0 5.291840716381557e-05
of O 0 0.00015788439486641437
the O 0 0.0003636141773313284
mutant O 0 0.001608515391126275
alleles O 0 0.00018302454554941505
had O 0 0.00011867451394209638
one O 0 6.0591919464059174e-05
of O 0 0.00015767272270750254
the O 0 0.00040364370215684175
two O 0 0.0003050253726541996
mutations O 0 0.0008634597179479897
. O 0 0.0006774194771423936

The O 0 0.00650105020031333
4612del165 O 1 0.9867557287216187
mutations O 0 0.00035928544821217656
in O 0 9.553572454024106e-05
three O 0 4.006292510894127e-05
different O 0 1.0565713637333829e-05
families O 0 2.803077040880453e-05
were O 0 3.1393050448969007e-05
all O 0 3.102270784438588e-05
ascribed O 0 0.00038562773261219263
to O 0 8.28738120617345e-05
the O 0 0.00020784305525012314
same O 0 0.00023269593657460064
T O 0 0.10163798183202744
- O 0 0.0008106321329250932
- O 0 0.0006171070854179561
> O 0 0.000373341899830848
A O 0 0.00029762316262349486
substitution O 0 0.0005101655260659754
at O 0 0.00036810539313592017
the O 0 0.0002752066939137876
splice O 0 0.0019981954246759415
donor O 0 0.0005054288194514811
site O 0 0.0005844736006110907
in O 0 0.00027702547959052026
intron O 0 0.008548003621399403
33 O 0 0.002978607313707471
. O 0 0.0008629135554656386

Microsatellite O 0 0.056378740817308426
genotyping O 0 0.010669802315533161
around O 0 0.0013389838859438896
the O 0 0.0007877631578594446
ATM O 0 0.0055889952927827835
locus O 0 0.001633981941267848
also O 0 0.00014031960745342076
indicated O 0 0.00016330392099916935
that O 0 3.387899050721899e-05
a O 0 0.00010530700092203915
common O 0 0.0001166927904705517
haplotype O 0 0.0008627914940007031
was O 0 0.00060257688164711
shared O 0 0.00014951842604205012
by O 0 7.034088048385456e-05
the O 0 0.00021600934269372374
mutant O 0 0.00129076954908669
alleles O 0 0.0002203614276368171
in O 0 0.0001645823213038966
both O 0 0.00021277858468238264
mutations O 0 0.000676854164339602
. O 0 0.0004932127776555717

This O 0 0.0005284048966132104
suggests O 0 0.0004476987523958087
that O 0 4.733537934953347e-05
these O 0 1.988876647374127e-05
two O 0 7.557029312010854e-05
founder O 0 0.005267599131911993
mutations O 0 0.00037220792728476226
may O 0 0.00025511172134429216
be O 0 0.00010481728531885892
predominant O 0 0.0005663267802447081
among O 0 0.00017378655320499092
Japanese O 0 0.003632573178038001
ATM O 0 0.008302957750856876
mutant O 0 0.00788028072565794
alleles O 0 0.002344561740756035
. O 0 0.0008636094280518591

W474C O 0 0.3035942018032074
amino O 0 0.0032109685707837343
acid O 0 0.002991592511534691
substitution O 0 0.001830604742281139
affects O 0 0.0006361317355185747
early O 0 0.00026908121071755886
processing O 0 0.0001720044674584642
of O 0 0.00010572313476586714
the O 0 0.00021108362125232816
alpha O 0 0.00023803416115697473
- O 0 9.301651880377904e-05
subunit O 0 5.8922578318743035e-05
of O 0 0.00012139791942900047
beta O 0 0.00046859466237947345
- O 0 0.0007206971640698612
hexosaminidase O 0 0.010986263863742352
A O 0 0.0007991025922819972
and O 0 0.00013967922131996602
is O 0 6.107830267865211e-05
associated O 0 0.00015899798017926514
with O 0 0.0002605697372928262
subacute O 1 0.9999992847442627
G B-Disease 1 0.9999597072601318
( I-Disease 0 0.01781134493649006
M2 I-Disease 1 0.9999006986618042
) I-Disease 0 0.0014039274537935853
gangliosidosis I-Disease 1 0.5193606019020081
. O 0 0.001025146571919322

Mutations O 0 0.0032915007323026657
in O 0 0.0007285632891580462
the O 0 0.0015952109824866056
HEXA O 1 0.9989529848098755
gene O 0 0.0004127967113163322
, O 0 7.74116997490637e-05
encoding O 0 4.541198359220289e-05
the O 0 7.316631672438234e-05
alpha O 0 0.0002362542727496475
- O 0 0.00011044801794923842
subunit O 0 5.21846413903404e-05
of O 0 0.0001148877854575403
beta O 0 0.0003949218662455678
- O 0 0.0004988929140381515
hexosaminidase O 0 0.005900173913687468
A O 0 0.0011197665007784963
( O 0 0.00039216683944687247
Hex O 0 0.0032299410086125135
A O 0 0.0013325485633686185
) O 0 0.00012003674055449665
, O 0 7.698934496147558e-05
that O 0 7.261816062964499e-05
abolish O 0 0.0019050310365855694
Hex O 0 0.004190267063677311
A O 0 0.0013686591992154717
enzyme O 0 0.0012990438845008612
activity O 0 0.0014157668920233846
cause O 1 0.999312162399292
Tay B-Disease 1 1.0
- I-Disease 1 0.999976396560669
Sachs I-Disease 1 0.999996542930603
disease I-Disease 1 0.9999998807907104
( O 0 0.11335546523332596
TSD B-Disease 1 0.9999997615814209
) O 0 0.0003410663630347699
, O 0 0.00017124612350016832
the O 0 0.0005443621193990111
fatal O 1 0.9997392296791077
infantile B-Disease 1 0.9998509883880615
form I-Disease 0 0.0009431788348592818
of I-Disease 0 0.0057401517406105995
G I-Disease 1 0.9986373782157898
( I-Disease 0 0.001169554889202118
M2 I-Disease 1 0.974007785320282
) I-Disease 0 0.0003621205978561193
gangliosidosis I-Disease 0 0.011230827309191227
, I-Disease 0 0.00021073853713460267
Type I-Disease 0 0.0010704481974244118
1 I-Disease 0 0.0013646971201524138
. O 0 0.0006498025613836944

Less O 0 0.007010693661868572
severe O 1 0.9998723268508911
, O 0 0.0033418110106140375
subacute O 1 0.9999997615814209
( O 0 0.0502433180809021
juvenile O 1 0.9999469518661499
- O 1 0.8847315907478333
onset O 1 0.9999761581420898
) O 0 0.00045093457447364926
and O 0 0.0006040077423676848
chronic O 1 0.9999998807907104
( O 0 0.002741675591096282
adult O 0 0.001407810254022479
- O 0 0.049916237592697144
onset O 1 0.9995918869972229
) O 0 0.00025936393649317324
variants O 0 0.00025106992688961327
are O 0 1.957312815648038e-05
characterized O 0 0.0002485085860826075
by O 0 5.677434819517657e-05
a O 0 0.00017808628035709262
broad O 0 0.0007562180981040001
spectrum O 0 0.0008042514673434198
of O 0 0.00086165068205446
clinical O 0 0.012493705376982689
manifestations O 1 0.9997561573982239
and O 0 0.0005242052138783038
are O 0 4.211350824334659e-05
associated O 0 9.742093970999122e-05
with O 0 7.982738316059113e-05
residual O 0 0.0021897824481129646
levels O 0 0.0009330243919976056
of O 0 0.0004997958312742412
Hex O 0 0.0076697273179888725
A O 0 0.002454463392496109
enzyme O 0 0.00115584849845618
activity O 0 0.0009598026517778635
. O 0 0.0004497038316912949

We O 0 0.0006575026200152934
identified O 0 0.00041866852552630007
a O 0 0.0006317230872809887
1422 O 0 0.10360684245824814
G O 0 0.008257148787379265
- O 0 0.0021658786572515965
- O 0 0.0015184386866167188
> O 0 0.0013735874090343714
C O 0 0.0010013912105932832
( O 0 0.0002166890335502103
amino O 0 0.0003836151445284486
acid O 0 0.0007176118087954819
W474C O 0 0.009290632791817188
) O 0 0.00010128840222023427
substitution O 0 0.00018524056940805167
in O 0 4.6423901949310675e-05
the O 0 6.890176882734522e-05
first O 0 8.464201528113335e-05
position O 0 0.00012078317377017811
of O 0 0.00014071674377191812
exon O 0 0.0017092932248488069
13 O 0 0.000692238099873066
of O 0 0.0006391783244907856
HEXA O 1 0.9988866448402405
of O 0 0.0008420603699050844
a O 0 0.0008669361704960465
non O 0 0.0012893056264147162
- O 0 0.001307600294239819
Jewish O 0 0.0011426247656345367
proband O 1 0.681926429271698
who O 0 0.0004400668549351394
manifested O 0 0.0035497047938406467
a O 0 0.0008263496565632522
subacute O 1 0.9996504783630371
variant O 0 0.0026194769889116287
of O 0 0.003453589044511318
G B-Disease 1 0.9996114373207092
( I-Disease 0 0.003122259397059679
M2 I-Disease 1 0.9995840191841125
) I-Disease 0 0.0012364803114905953
gangliosidosis I-Disease 0 0.11925211548805237
. O 0 0.0013321425067260861

On O 0 0.0015963688492774963
the O 0 0.0008190320804715157
second O 0 0.0026550183538347483
maternally O 0 0.011368609964847565
inherited O 1 0.9899342656135559
allele O 0 0.0009672099258750677
, O 0 0.00014657629071734846
we O 0 5.779410639661364e-05
identified O 0 0.00010378203296568245
the O 0 0.00026180213899351656
common O 0 0.0009655299945734441
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9999728202819824
causing O 1 0.9998058676719666
4 O 0 0.0024281577207148075
- O 0 0.00110916537232697
bp O 0 0.002541768830269575
insertion O 0 0.0009020481957122684
, O 0 0.00024464764283038676
+ O 0 0.0016298014670610428
TATC O 1 0.9996254444122314
1278 O 1 0.9782523512840271
, O 0 0.0003828148473985493
in O 0 0.00033783382968977094
exon O 0 0.004501803778111935
11 O 0 0.0022258739918470383
. O 0 0.0007170430617406964

Pulse O 0 0.03542200103402138
- O 0 0.004321197047829628
chase O 0 0.0019227444427087903
analysis O 0 0.00015054529649205506
using O 0 0.0003346685552969575
proband O 1 0.7234116792678833
fibroblasts O 0 0.014019634574651718
revealed O 0 0.0017380848294124007
that O 0 9.480517474003136e-05
the O 0 0.0003250876034144312
W474C O 0 0.018368730321526527
- O 0 0.0007521215011365712
containing O 0 0.0003563365316949785
alpha O 0 0.0005141819128766656
- O 0 0.0002395497722318396
subunit O 0 0.00021453111548908055
precursor O 0 0.0012359616812318563
was O 0 0.00043697626097127795
normally O 0 0.00027907147887162864
synthesized O 0 0.000598746060859412
, O 0 7.04290796420537e-05
but O 0 2.941407910839189e-05
not O 0 2.1530275262193754e-05
phosphorylated O 0 0.0005940921837463975
or O 0 0.00016884872457012534
secreted O 0 0.0006142681813798845
, O 0 0.00011461335816420615
and O 0 0.0001024077064357698
the O 0 0.00033515581162646413
mature O 0 0.001336240442469716
lysosomal O 0 0.017566870898008347
alpha O 0 0.001534174312837422
- O 0 0.000616291887126863
subunit O 0 0.0004649995535146445
was O 0 0.0005936521338298917
not O 0 0.00012568892270792276
detected O 0 0.0010875645093619823
. O 0 0.00046283623669296503

When O 0 0.0019636875949800014
the O 0 0.0012194267474114895
W474C O 0 0.035196203738451004
- O 0 0.0010787876090034842
containing O 0 0.00034895038697868586
alpha O 0 0.0003156056918669492
- O 0 0.0001861006167018786
subunit O 0 0.00020089111058041453
was O 0 0.0005893621128052473
transiently O 0 0.0036286262329667807
co O 0 0.0005719182663597167
- O 0 0.0002760700008366257
expressed O 0 9.499521547695622e-05
with O 0 3.705483686644584e-05
the O 0 0.00018690084107220173
beta O 0 0.00029475698829628527
- O 0 0.00021235173335298896
subunit O 0 0.00010459980694577098
to O 0 4.451694985618815e-05
produce O 0 0.00021197021123953164
Hex O 0 0.0018828444881364703
A O 0 0.0008819619542919099
( O 0 0.0003451019583735615
alphabeta O 0 0.008829744532704353
) O 0 0.00011957372043980286
in O 0 0.00026114899083040655
COS O 1 0.9961060881614685
- O 0 0.0018618929898366332
7 O 0 0.0013349046930670738
cells O 0 0.00028120065690018237
, O 0 6.493552791653201e-05
the O 0 0.00011341181379975751
mature O 0 0.0002517223765607923
alpha O 0 0.0003303246048744768
- O 0 0.0001944785180967301
subunit O 0 0.00017465905693825334
was O 0 0.00033959903521463275
present O 0 0.00012214755406603217
, O 0 4.242784416419454e-05
but O 0 1.6168265574378893e-05
its O 0 2.8458985980250873e-05
level O 0 0.0002239004388684407
was O 0 0.00031215359922498465
much O 0 0.00011426982382545248
lower O 0 0.00013821454194840044
than O 0 2.0966634110664017e-05
that O 0 1.52640732267173e-05
from O 0 6.299898086581379e-05
normal O 0 0.00018341834947932512
alpha O 0 0.0003370086778886616
- O 0 0.0001912690931931138
subunit O 0 0.00023790323757566512
transfections O 0 0.004227346740663052
, O 0 8.388404967263341e-05
although O 0 3.899134026141837e-05
higher O 0 6.583934737136588e-05
than O 0 1.8372113117948174e-05
in O 0 4.438740143086761e-05
those O 0 4.464112498681061e-05
cells O 0 0.00034684015554375947
transfected O 0 0.0019333554664626718
with O 0 4.583688496495597e-05
an O 0 0.00010920742352027446
alpha O 0 0.0007146563730202615
- O 0 0.0005283126956783235
subunit O 0 0.000441420532297343
associated O 0 0.0004861154011450708
with O 0 0.0006491364911198616
infantile O 1 0.9999653100967407
TSD B-Disease 1 0.9999970197677612
. O 0 0.005806268658488989

Furthermore O 0 0.0033507293555885553
, O 0 0.00031174079049378633
the O 0 0.00038790839607827365
precursor O 0 0.0016322331503033638
level O 0 0.0003742780536413193
of O 0 0.000253957521636039
the O 0 0.0003855402464978397
W474C O 0 0.029738670215010643
alpha O 0 0.000896377139724791
- O 0 0.00027274060994386673
subunit O 0 0.00011453382467152551
was O 0 0.0001854984584497288
found O 0 3.19543105433695e-05
to O 0 2.7112500902148895e-05
accumulate O 0 9.542446787236258e-05
in O 0 5.323271398083307e-05
comparison O 0 5.840566518600099e-05
to O 0 4.4054420868633315e-05
the O 0 0.0001691807119641453
normal O 0 0.0004274129751138389
alpha O 0 0.0004900635685771704
- O 0 0.00041310713277198374
subunit O 0 0.0006298429216258228
precursor O 0 0.003984485752880573
levels O 0 0.0010748585918918252
. O 0 0.00042750607826747

We O 0 0.0007955817272886634
conclude O 0 0.000981066725216806
that O 0 4.744628313346766e-05
the O 0 0.000294151424895972
1422 O 0 0.34863585233688354
G O 0 0.0062787411734461784
- O 0 0.0015127641381695867
- O 0 0.0008447301224805415
> O 0 0.0007573900511488318
C O 0 0.0005158883286640048
mutation O 0 7.48876336729154e-05
is O 0 2.8664522687904537e-05
the O 0 9.996329026762396e-05
cause O 0 0.0006066903006285429
of O 0 0.0006329423049464822
Hex B-Disease 1 0.9733139872550964
A I-Disease 1 0.9928935170173645
enzyme I-Disease 1 0.9996733665466309
deficiency I-Disease 1 1.0
in O 0 0.0016033775173127651
the O 0 0.0035719904117286205
proband O 1 0.9993371367454529
. O 0 0.0014260616153478622

The O 0 0.007620304357260466
resulting O 0 0.005797896068543196
W474C O 1 0.5227745771408081
substitution O 0 0.003060918767005205
clearly O 0 0.0007657066453248262
interferes O 0 0.0009260048973374069
with O 0 5.3978954383637756e-05
alpha O 0 0.00036114492104388773
- O 0 0.0001858702744357288
subunit O 0 0.00014592600928153843
processing O 0 0.0001811727852327749
, O 0 3.68806577171199e-05
but O 0 1.4293148524302524e-05
because O 0 1.4960294720367528e-05
the O 0 5.120658897794783e-05
base O 0 0.00037699565291404724
substitution O 0 0.0007776471902616322
falls O 0 0.0032167916651815176
at O 0 0.0003141053894069046
the O 0 0.0001320480223512277
first O 0 0.00012322314432822168
position O 0 0.00020594612578861415
of O 0 0.00023734972637612373
exon O 0 0.0023457410279661417
13 O 0 0.0009588703978806734
, O 0 0.00022840779274702072
aberrant O 0 0.003157271770760417
splicing O 0 0.0012723058462142944
may O 0 0.000209187637665309
also O 0 5.217687794356607e-05
contribute O 0 0.00020266052160877734
to O 0 0.00023958015663083643
Hex B-Disease 0 0.01742134802043438
A I-Disease 0 0.15073654055595398
deficiency I-Disease 1 0.9999980926513672
in O 0 0.0010339913424104452
this O 0 0.0006360135157592595
proband O 1 0.9979835748672485
. O 0 0.0005226408247835934
. O 0 0.0006115360883995891

Two O 0 0.0018447363981977105
frequent O 0 0.002858327468857169
missense O 0 0.011537151411175728
mutations O 0 0.0032985161524266005
in O 0 0.009917719289660454
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0123568344861269

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.04155075550079346
an O 1 0.5908446311950684
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9938513040542603
early O 1 0.9999836683273315
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999984502792358
goiter B-Disease 1 1.0
. O 0 0.07380392402410507

A O 0 0.004999012686312199
century O 0 0.002079905243590474
after O 0 0.000516989326570183
its O 0 9.813693031901494e-05
recognition O 0 0.00017218825814779848
as O 0 0.0002595464757177979
a O 0 0.0011861840030178428
syndrome O 1 0.9999998807907104
by O 0 0.0005445408751256764
Vaughan O 1 0.9608572125434875
Pendred O 1 0.9999860525131226
, O 0 0.0003904804470948875
the O 0 0.0010672647040337324
disease O 1 0.999988317489624
gene O 0 0.0013780618319287896
( O 0 0.0011080027325078845
PDS O 1 0.9999915361404419
) O 0 0.00028208893490955234
was O 0 0.0006491111125797033
mapped O 0 0.0006074911216273904
to O 0 0.0003503863117657602
chromosome O 0 0.005247387569397688
7q22 O 1 0.9998264908790588
- O 0 0.10383068025112152
q31 O 1 0.9858942031860352
. O 0 0.001512068440206349

1 O 0 0.003155273385345936
and O 0 0.0005051535554230213
, O 0 0.00022664583229925483
recently O 0 0.00037499787868000567
, O 0 7.776787970215082e-05
found O 0 5.395043990574777e-05
to O 0 4.2511761421337724e-05
encode O 0 0.00021541268506553024
a O 0 0.0005659803282469511
putative O 0 0.009516227059066296
sulfate O 1 0.997627317905426
transporter O 1 0.9785720109939575
. O 0 0.0015065852785483003

We O 0 0.0012168735265731812
performed O 0 0.0009188551921397448
mutation O 0 0.00010375582496635616
analysis O 0 1.9883171262335964e-05
of O 0 8.241507748607546e-05
the O 0 0.0004311920201871544
PDS B-Disease 1 0.9999663829803467
gene O 0 0.0005594842368736863
in O 0 0.00024082761956378818
patients O 0 0.0002061789418803528
from O 0 0.00019425092614255846
14 O 0 0.0010674191871657968
Pendred B-Disease 1 0.6725058555603027
families O 0 0.00018266923143528402
originating O 0 0.0002997129049617797
from O 0 0.00013609652523882687
seven O 0 0.00015136113506741822
countries O 0 2.7728105123969726e-05
and O 0 5.398976645665243e-05
identified O 0 0.00016201025573536754
all O 0 0.00019304503803141415
mutations O 0 0.0007763661560602486
. O 0 0.000553219870198518

The O 0 0.002846284070983529
mutations O 0 0.0008128653862513602
include O 0 0.00034281169064342976
three O 0 0.0002051308547379449
single O 0 0.00034119124757125974
base O 0 0.001405832706950605
deletions O 0 0.0016832782421261072
, O 0 0.00014592324441764504
one O 0 0.00019208861340302974
splice O 0 0.0032474847976118326
site O 0 0.0014122911961749196
mutation O 0 0.0003572606947273016
and O 0 0.0001759660808602348
10 O 0 0.0008228515507653356
missense O 0 0.00671002920717001
mutations O 0 0.002071341034024954
. O 0 0.0010095518082380295

One O 0 0.0020584675949066877
missense O 0 0.0065292478539049625
mutation O 0 0.0012992529664188623
( O 0 0.0007069695857353508
L236P O 1 0.9964858293533325
) O 0 0.00027752036112360656
was O 0 0.00043999889749102294
found O 0 8.230840467149392e-05
in O 0 6.84130864101462e-05
a O 0 0.0001519712823210284
homozygous O 0 0.0001906140532810241
state O 0 4.3950272811343893e-05
in O 0 5.377805427997373e-05
two O 0 8.082376734819263e-05
consanguineous O 0 0.0032678793650120497
families O 0 0.0001116241401177831
and O 0 6.55248441034928e-05
in O 0 6.79435397614725e-05
a O 0 0.0001430956181138754
heterozygous O 0 9.635218157200143e-05
state O 0 2.3648406568099745e-05
in O 0 4.412834459799342e-05
five O 0 5.0477985496399924e-05
additional O 0 0.0001287501654587686
non O 0 0.0007082015508785844
- O 0 0.001656066975556314
consanguineous O 0 0.011844114400446415
families O 0 0.0009263610118068755
. O 0 0.0007161463727243245

Another O 0 0.0035432439763098955
missense O 0 0.0054833246394991875
mutation O 0 0.0012306642020121217
( O 0 0.0006710811285302043
T416P O 1 0.9931730628013611
) O 0 0.00026003739912994206
was O 0 0.0003728670417331159
found O 0 6.113424024078995e-05
in O 0 5.759818304795772e-05
a O 0 0.00011359558993717656
homozygous O 0 0.00020433092140592635
state O 0 4.4052656448911875e-05
in O 0 4.3884021579287946e-05
one O 0 6.117436714703217e-05
family O 0 0.0001365983916912228
and O 0 6.110532558523118e-05
in O 0 7.309790089493617e-05
a O 0 0.0001365865464322269
heterozygous O 0 0.00013545696856454015
state O 0 5.0024031224893406e-05
in O 0 8.924859139369801e-05
four O 0 0.00015635789895895869
families O 0 0.00022114231251180172
. O 0 0.0004902744549326599

Pendred B-Disease 1 0.9998102784156799
patients O 0 0.0022742871660739183
in O 0 0.0004987155552953482
three O 0 0.0004857670865021646
non O 0 0.0014836483169347048
- O 0 0.001634513959288597
consanguineous O 0 0.004713172558695078
families O 0 0.00022188806906342506
were O 0 0.00014179604477249086
shown O 0 0.00013137308997102082
to O 0 9.674669854575768e-05
be O 0 0.00015429362247232348
compound O 0 0.004990994930267334
heterozygotes O 0 0.004644918255507946
for O 0 0.00045469263568520546
L236P O 1 0.9925991296768188
and O 0 0.0015951261157169938
T416P O 1 0.997789740562439
. O 0 0.00214375089854002

In O 0 0.0010052770376205444
total O 0 0.0004236644017510116
, O 0 0.00014236371498554945
one O 0 9.331609180662781e-05
or O 0 6.175333692226559e-05
both O 0 4.1643535951152444e-05
of O 0 9.760811371961609e-05
these O 0 4.203189382678829e-05
mutations O 0 8.128071203827858e-05
were O 0 5.407173739513382e-05
found O 0 2.725307786022313e-05
in O 0 3.1174844480119646e-05
nine O 0 7.099624053807929e-05
of O 0 8.834250184008852e-05
the O 0 0.0002264060894958675
14 O 0 0.0006325611029751599
families O 0 0.00024161099281627685
analyzed O 0 0.0006637984770350158
. O 0 0.00042102709994651377

The O 0 0.0015501301968470216
identification O 0 0.00036803996772505343
of O 0 0.0003598386829253286
two O 0 0.0003651872684713453
frequent O 0 0.0015148844104260206
PDS B-Disease 1 0.9999932050704956
mutations O 0 0.0006787416059523821
will O 0 0.0001508542336523533
facilitate O 0 0.0002858145453501493
the O 0 0.0002940984268207103
molecular O 0 0.0009025554172694683
diagnosis O 0 0.2565736770629883
of O 1 0.9993653893470764
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0380757600069046

Insertional O 1 0.9779967665672302
mutation O 0 0.0026567308232188225
by O 0 0.0006047445349395275
transposable O 0 0.029724355787038803
element O 0 0.0044843233190476894
, O 0 0.0007377550937235355
L1 O 0 0.011261059902608395
, O 0 0.0001907456899061799
in O 0 0.00013644646969623864
the O 0 0.0005823097308166325
DMD B-Disease 1 0.9999816417694092
gene O 0 0.0003715959610417485
results O 0 0.00012905178300570697
in O 0 0.00034907052759081125
X B-Disease 0 0.10116457939147949
- I-Disease 0 0.41498714685440063
linked I-Disease 1 0.851106584072113
dilated I-Disease 1 0.9999819993972778
cardiomyopathy I-Disease 1 1.0
. O 0 0.00894180778414011

X B-Disease 1 0.9797797799110413
- I-Disease 1 0.9166900515556335
linked I-Disease 1 0.9764909744262695
dilated I-Disease 1 0.9999969005584717
cardiomyopathy I-Disease 1 1.0
( O 1 0.9998515844345093
XLDCM B-Disease 1 1.0
) O 0 0.0004263397422619164
is O 0 0.00012132199481129646
a O 0 0.00023196800611913204
clinical O 0 0.0005386917036958039
phenotype O 0 0.0011421426897868514
of O 0 0.0014300354523584247
dystrophinopathy B-Disease 1 0.9999834299087524
which O 0 0.000292844430077821
is O 0 0.00012731639435514808
characterized O 0 0.0007868711254559457
by O 0 0.00022670981707051396
preferential O 0 0.004478530026972294
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9973700046539307
without O 0 0.0006974661955609918
any O 0 0.0003090423415414989
overt O 0 0.003511780174449086
clinical O 0 0.005417227745056152
signs O 1 0.9949079155921936
of O 1 0.9996970891952515
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9066261053085327

To O 0 0.0008653936092741787
date O 0 0.000853882113005966
, O 0 0.00015566112415399402
several O 0 9.697325731394812e-05
mutations O 0 0.00023446534760296345
in O 0 0.0004138256481382996
the O 0 0.006179882679134607
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999805688858032
, O 1 0.9760285019874573
DMD O 1 1.0
, O 0 0.0003875655820593238
have O 0 4.416021329234354e-05
been O 0 5.797013363917358e-05
identified O 0 7.151319732656702e-05
in O 0 0.00011769701086450368
patients O 0 0.0002721709606703371
with O 0 0.0002611597010400146
XLDCM B-Disease 1 1.0
, O 0 0.00036087341140955687
but O 0 8.125512977130711e-05
a O 0 0.00014386560360435396
pathogenic O 0 0.0005590330110862851
correlation O 0 0.00013154381304048002
of O 0 0.000292144191917032
these O 0 0.00012499401054810733
cardiospecific O 1 0.9900919198989868
mutations O 0 0.000876092235557735
in O 0 0.0008145293104462326
DMD O 1 0.9999821186065674
with O 0 0.00045523731387220323
the O 0 0.0024443422444164753
XLDCM B-Disease 1 0.9999997615814209
phenotype O 0 0.0021615419536828995
has O 0 0.00019282207358628511
remained O 0 0.0010841593611985445
to O 0 0.0002495668304618448
be O 0 0.0002991085930261761
elucidated O 0 0.012175376527011395
. O 0 0.0014124620938673615

We O 0 0.0013482600916177034
report O 0 0.00020814669551327825
here O 0 0.00011131353676319122
the O 0 8.613039972260594e-05
identification O 0 7.030271808616817e-05
of O 0 0.00012853328371420503
a O 0 0.00032802243367768824
unique O 0 0.0005596285336650908
de O 0 0.002668332075700164
novo O 0 0.00492556719109416
L1 O 0 0.007900516502559185
insertion O 0 0.0009620768832974136
in O 0 0.00018248191918246448
the O 0 0.0003719463129527867
muscle O 0 0.006382621359080076
exon O 0 0.0032180671114474535
1 O 0 0.0006961480248719454
in O 0 0.00039201058098115027
DMD O 1 0.9996719360351562
in O 0 0.0006294594495557249
three O 0 0.0008975607925094664
XLDCM B-Disease 1 0.9999967813491821
patients O 0 0.0006524902419187129
from O 0 0.00017542680143378675
two O 0 0.0001508023269707337
unrelated O 0 0.0015630621928721666
Japanese O 0 0.0054451338946819305
families O 0 0.0005479010287672281
. O 0 0.0006033458630554378

The O 0 0.0017098906682804227
insertion O 0 0.0024520561564713717
was O 0 0.0009778972016647458
a O 0 0.00043634415487758815
5 O 0 0.0004301115404814482
- O 0 0.0005009383312426507
truncated O 0 0.0011419299989938736
form O 0 0.00015621275815647095
of O 0 0.00024644352379254997
human O 0 0.0004474064626265317
L1 O 0 0.011557397432625294
inversely O 0 0.0011712370906025171
integrated O 0 0.0005085085285827518
in O 0 7.019875920377672e-05
the O 0 0.00016506039537489414
5 O 0 0.00025709273177199066
- O 0 0.0003674639156088233
untranslated O 0 0.0014808661071583629
region O 0 0.00021308513532858342
in O 0 0.00011209506919840351
the O 0 0.0005293934955261648
muscle O 0 0.18517178297042847
exon O 0 0.005979984067380428
1 O 0 0.0005863142432644963
, O 0 0.00010956624464597553
which O 0 4.8406353016616777e-05
affected O 0 0.000123625184642151
the O 0 0.00017338534235022962
transcription O 0 0.000459283561212942
or O 0 0.00012043584138154984
the O 0 0.00019731384236365557
stability O 0 0.0008249028469435871
of O 0 0.00045062816934660077
the O 0 0.0014695213176310062
muscle O 1 0.9916509985923767
form O 0 0.0006215636967681348
of O 0 0.0037790704518556595
dystrophin O 1 0.9985523819923401
transcripts O 0 0.0009213985176756978
but O 0 4.287100091460161e-05
not O 0 9.98658924800111e-06
that O 0 8.909820280678105e-06
of O 0 9.466235496802256e-05
the O 0 0.0006170154083520174
brain O 1 0.9999043941497803
or O 0 0.024834463372826576
Purkinje O 1 0.9999996423721313
cell O 0 0.019559437409043312
form O 0 0.00042651573312468827
, O 0 0.0001814329734770581
probably O 0 0.00032106012804433703
due O 0 0.0001402450870955363
to O 0 4.462031211005524e-05
its O 0 5.88464317843318e-05
unique O 0 0.0001487559056840837
site O 0 0.0005416098283603787
of O 0 0.0005925664445385337
integration O 0 0.0022002668119966984
. O 0 0.0008951416821219027

We O 0 0.0011630157241597772
speculate O 0 0.0008068517199717462
that O 0 3.823261067736894e-05
this O 0 2.7869937184732407e-05
insertion O 0 0.00021484408352989703
of O 0 0.00010893908620346338
an O 0 0.00016720921848900616
L1 O 0 0.008045276626944542
sequence O 0 0.00048202063771896064
in O 0 0.0005333953304216266
DMD O 1 0.9999978542327881
is O 0 0.00018688444106373936
responsible O 0 0.00019472009444143623
for O 0 3.0149234589771368e-05
some O 0 1.957581662281882e-05
of O 0 7.772577373543754e-05
the O 0 0.00017811550060287118
population O 0 5.3019026381662115e-05
of O 0 0.00023041068925522268
Japanese O 0 0.011119919829070568
patients O 0 0.0006769109750166535
with O 0 0.00045629701344296336
XLDCM B-Disease 1 0.9999996423721313
. O 0 0.0008737463504076004
. O 0 0.0005916520021855831

Severe O 1 0.999906063079834
early O 1 0.7958089113235474
- O 1 0.9993976354598999
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 1 0.9998792409896851
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999681711196899
red O 1 0.9999998807907104
hair O 1 0.9999994039535522
pigmentation O 1 0.9999997615814209
caused O 1 0.9999957084655762
by O 0 0.001709673902951181
POMC O 1 0.9999966621398926
mutations O 0 0.0010807820362970233
in O 0 0.0004675494856201112
humans O 0 0.0008642708999104798
. O 0 0.0004444385995157063

Sequential O 0 0.008167102932929993
cleavage O 0 0.006998567376285791
of O 0 0.000865092733874917
the O 0 0.0008542112191207707
precursor O 0 0.0036032930947840214
protein O 0 0.000532433798070997
pre O 0 0.002202322008088231
- O 0 0.0007886005914770067
pro O 0 0.002350051188841462
- O 0 0.0020023477263748646
opiomelanocortin O 1 0.5487743616104126
( O 0 0.0012796290684491396
POMC O 1 0.9617049694061279
) O 0 0.0003059841983485967
generates O 0 0.0003726909344550222
the O 0 0.0004530746955424547
melanocortin O 0 0.050620172172784805
peptides O 0 0.0033977667335420847
adrenocorticotrophin O 1 0.9976539015769958
( O 0 0.0032761963084340096
ACTH O 1 0.9987879395484924
) O 0 0.0004950430011376739
, O 0 0.0005900953547097743
melanocyte O 1 0.9916965961456299
- O 0 0.009570610709488392
stimulating O 0 0.20525497198104858
hormones O 0 0.07478297501802444
( O 0 0.0009991765255108476
MSH O 1 0.9915915727615356
) O 0 0.0002537278342060745
alpha O 0 0.0004798203881364316
, O 0 0.00010142429528059438
beta O 0 0.00022698061366099864
and O 0 6.032624514773488e-05
gamma O 0 0.00015590443217661232
as O 0 5.009282540413551e-05
well O 0 2.8783349989680573e-05
as O 0 4.8933598009170964e-05
the O 0 0.00013837264850735664
opioid O 0 0.001192428288049996
- O 0 0.0006534174317494035
receptor O 0 0.000482616713270545
ligand O 0 0.0016769709764048457
beta O 0 0.001731148106046021
- O 0 0.0024495436809957027
endorphin O 0 0.03281942382454872
. O 0 0.0009601272759027779

While O 0 0.00110685545951128
a O 0 0.0004157584044151008
few O 0 0.0003044184995815158
cases O 0 0.00025709494366310537
of O 0 0.002393351634964347
isolated O 1 0.9999980926513672
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.00029007316334173083
been O 0 0.0003294732596259564
reported O 0 0.0006152858841232955
( O 0 0.0009436174295842648
OMIM O 1 0.9998206496238708
201400 O 1 0.9995840191841125
) O 0 0.0003996688756160438
, O 0 0.00020000356016680598
an O 0 0.000432413537055254
inherited O 1 0.9999994039535522
POMC O 1 1.0
defect O 1 1.0
has O 0 0.0013211638433858752
not O 0 0.00010505343379918486
been O 0 0.00015945923223625869
described O 0 0.0003344009746797383
so O 0 0.00018799396639224142
far O 0 0.0004962077946402133
. O 0 0.0005257231532596052

Recent O 0 0.00185005075763911
studies O 0 0.0002406451676506549
in O 0 0.0002449660387355834
animal O 0 0.0007787313079461455
models O 0 0.00033443636493757367
elucidated O 0 0.001468527945689857
a O 0 0.0002139289426850155
central O 0 0.0004224047879688442
role O 0 0.00040266948053613305
of O 0 0.00042873533675447106
alpha O 0 0.002405771752819419
- O 0 0.001930931699462235
MSH O 1 0.6186079978942871
in O 0 0.00014652068784926087
the O 0 0.00020012829918414354
regulation O 0 0.00019888118549715728
of O 0 0.0002904681023210287
food O 0 0.0005386850098147988
intake O 0 0.0004820676986128092
by O 0 3.1027502700453624e-05
activation O 0 0.0001665347517700866
of O 0 0.0001460882049286738
the O 0 0.0005779564962722361
brain O 1 0.8448968529701233
melanocortin O 1 0.9639543294906616
- O 0 0.000712003733497113
4 O 0 0.00039405105053447187
- O 0 0.0004699229320976883
receptor O 0 0.00026025366969406605
( O 0 0.0002547160256654024
MC4 O 0 0.15708987414836884
- O 0 0.0011424614349380136
R O 0 0.0014084443682804704
; O 0 7.056413596728817e-05
refs O 0 0.0021576168946921825
3 O 0 0.00031436121207661927
- O 0 0.0003534254210535437
5 O 0 0.0002092704235110432
) O 0 4.296653423807584e-05
and O 0 3.747706796275452e-05
the O 0 0.00014744428335689008
linkage O 0 0.0013009246904402971
of O 0 0.0009074429399333894
human O 0 0.002568074269220233
obesity B-Disease 1 0.9999481439590454
to O 0 0.0002845382841769606
chromosome O 0 0.00039745212416164577
2 O 0 0.00022545158572029322
in O 0 6.769313040422276e-05
close O 0 0.00016570663137827069
proximity O 0 0.0002217948203906417
to O 0 9.365904406877235e-05
the O 0 0.0006311290781013668
POMC O 1 0.9990234375
locus O 0 0.002649797359481454
, O 0 0.00016019011673051864
led O 0 0.0005527770263142884
to O 0 6.401017890311778e-05
the O 0 0.00010158885561395437
proposal O 0 0.00010422137711429968
of O 0 0.00011417996574891731
an O 0 0.00013613144983537495
association O 0 0.0005193621036596596
of O 0 0.0012590463738888502
POMC O 1 0.9999994039535522
with O 0 0.0032531111501157284
human O 1 0.9508894681930542
obesity B-Disease 1 0.9999992847442627
. O 0 0.0014892052859067917

The O 0 0.0017582144355401397
dual O 0 0.0012075278209522367
role O 0 0.0010690672788769007
of O 0 0.001369360601529479
alpha O 0 0.00546334870159626
- O 0 0.004229947924613953
MSH O 1 0.9793093204498291
in O 0 0.00040133067523129284
regulating O 0 0.0015183838550001383
food O 0 0.0011066830484196544
intake O 0 0.0020974362269043922
and O 0 0.0002700120094232261
influencing O 0 0.0026545641012489796
hair O 1 0.9754807949066162
pigmentation O 1 0.9999234676361084
predicts O 0 0.0025530033744871616
that O 0 7.453369471477345e-05
the O 0 0.0002668282249942422
phenotype O 0 0.000480789429275319
associated O 0 0.00010630947508616373
with O 0 7.217529491754249e-05
a O 0 0.0009104394703172147
defect O 1 0.9999645948410034
in O 0 0.0025420079473406076
POMC O 1 0.9999963045120239
function O 0 0.0005847770371474326
would O 0 0.00037192998570390046
include O 0 0.0005936193047091365
obesity B-Disease 1 0.9996275901794434
, O 0 0.0005693293642252684
alteration O 1 0.9841768741607666
in O 0 0.024106163531541824
pigmentation O 1 0.9999995231628418
and O 1 0.9997532963752747
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.005614517722278833

The O 0 0.0021271868608891964
observation O 0 0.0021002907305955887
of O 0 0.000777015695348382
these O 0 0.0001915107131935656
symptoms O 0 0.02330622635781765
in O 0 0.00029810480191372335
two O 0 0.00019724387675523758
probands O 1 0.9251883625984192
prompted O 0 0.0010853925487026572
us O 0 0.0001942179660545662
to O 0 4.6069322706898674e-05
search O 0 8.861815149430186e-05
for O 0 5.702150156139396e-05
mutations O 0 0.00013355215196497738
within O 0 0.00024295030743815005
their O 0 0.0004320346633903682
POMC O 1 0.999721348285675
genes O 0 0.001619870075955987
. O 0 0.0006954584387131035

Patient O 0 0.009921652264893055
1 O 0 0.0018706244882196188
was O 0 0.0012997741578146815
found O 0 0.00011474808707134798
to O 0 7.565083069493994e-05
be O 0 4.34805297118146e-05
a O 0 0.00015255071048159152
compound O 0 0.001884986413642764
heterozygote O 0 0.0021656074095517397
for O 0 3.939792441087775e-05
two O 0 4.579101732815616e-05
mutations O 0 7.926772377686575e-05
in O 0 0.0001065254255081527
exon O 0 0.001676661311648786
3 O 0 0.0006657971534878016
( O 0 0.0004268171323928982
G7013T O 1 0.8359977602958679
, O 0 0.0005760305793955922
C7133delta O 1 0.9966663718223572
) O 0 0.0002732007415033877
which O 0 6.759946700185537e-05
interfere O 0 0.00026056900969706476
with O 0 5.827147833770141e-05
appropriate O 0 0.0002377683122176677
synthesis O 0 0.0009752789046615362
of O 0 0.0014019914669916034
ACTH O 1 0.9991499185562134
and O 0 0.0010796963470056653
alpha O 0 0.005174889229238033
- O 0 0.006312420126050711
MSH O 1 0.9912774562835693
. O 0 0.001066291588358581

Patient O 0 0.008876681327819824
2 O 0 0.002633561845868826
was O 0 0.0021976460702717304
homozygous O 0 0.0006778081879019737
for O 0 7.043465302558616e-05
a O 0 0.00012125816283514723
mutation O 0 9.735703497426584e-05
in O 0 0.0001612939959159121
exon O 0 0.002022368833422661
2 O 0 0.0008805571706034243
( O 0 0.0005002619000151753
C3804A O 0 0.06408244371414185
) O 0 0.0004802024341188371
which O 0 0.0004287745978217572
abolishes O 0 0.043617624789476395
POMC O 1 0.9992388486862183
translation O 0 0.00421785656362772
. O 0 0.0013610563473775983

These O 0 0.00046603617374785244
findings O 0 0.0002057859383057803
represent O 0 0.00015447514306288213
the O 0 0.00013115729962009937
first O 0 0.0001662563008721918
examples O 0 0.0001589697931194678
of O 0 0.00021212872525211424
a O 0 0.0010462491773068905
genetic B-Disease 1 0.6991487145423889
defect I-Disease 1 0.9999997615814209
within O 0 0.002179035684093833
the O 0 0.005739839281886816
POMC O 1 0.9999850988388062
gene O 0 0.00027187555679120123
and O 0 5.78034196223598e-05
define O 0 0.00017200464208144695
a O 0 0.00026236288249492645
new O 0 0.0011493066558614373
monogenic B-Disease 1 0.9999998807907104
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.9777257442474365
in O 0 0.0017648938810452819
early O 0 0.008435984142124653
- O 1 0.7196223139762878
onset O 1 0.9999982118606567
obesity B-Disease 1 1.0
, O 1 0.9843243360519409
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999594688415527
red O 1 0.9999998807907104
hair O 1 0.9999990463256836
pigmentation O 1 0.9999959468841553
. O 0 0.0008746034582145512
. O 0 0.0006448787171393633

A O 0 0.006680530961602926
European O 0 0.0014576299581676722
multicenter O 0 0.004576036240905523
study O 0 0.00030429227626882493
of O 0 0.0018443043809384108
phenylalanine B-Disease 1 0.9999921321868896
hydroxylase I-Disease 1 0.9999935626983643
deficiency I-Disease 1 1.0
: O 0 0.0006608783733099699
classification O 0 0.0003484560875222087
of O 0 0.00047818172606639564
105 O 0 0.0018238774500787258
mutations O 0 0.00018572641420178115
and O 0 8.122585859382525e-05
a O 0 0.00012730267189908773
general O 0 0.0003051274979952723
system O 0 0.00014110653137322515
for O 0 7.37687514629215e-05
genotype O 0 0.00046061884495429695
- O 0 0.0003722302499227226
based O 0 6.18346530245617e-05
prediction O 0 0.0009337216033600271
of O 0 0.0008862269460223615
metabolic O 1 0.9999207258224487
phenotype O 0 0.024915000423789024
. O 0 0.0017738700844347477

Phenylketonuria B-Disease 1 0.999995231628418
( O 1 0.7612787485122681
PKU B-Disease 1 0.999998927116394
) O 0 0.0018491193186491728
and O 0 0.0011132662184536457
mild B-Disease 1 0.9991244673728943
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9984927177429199
MHP B-Disease 1 1.0
) O 0 0.0008969461196102202
are O 0 0.00021390957408584654
allelic B-Disease 1 0.9962322115898132
disorders I-Disease 1 0.9999998807907104
caused O 1 0.9999892711639404
by O 0 0.0004985653795301914
mutations O 0 0.00021665926033165306
in O 0 0.00010834524437086657
the O 0 0.00029973548953421414
gene O 0 0.00020604078599717468
encoding O 0 0.0003252497117500752
phenylalanine O 0 0.009049207903444767
hydroxylase O 1 0.606040894985199
( O 0 0.005589964333921671
PAH O 1 0.9999996423721313
) O 0 0.001339466660283506
. O 0 0.0009197228355333209

Previous O 0 0.0030040147248655558
studies O 0 0.00016883519128896296
have O 0 4.408055974636227e-05
suggested O 0 0.00013264773588161916
that O 0 2.3268286895472556e-05
the O 0 0.00016258005052804947
highly O 0 0.00046340859262272716
variable O 0 0.0002735713787842542
metabolic O 1 0.9882748126983643
phenotypes O 1 0.80866539478302
of O 1 0.9999815225601196
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9968833327293396
with O 1 0.5400388240814209
PAH O 1 1.0
genotypes O 1 0.674780011177063
. O 0 0.002301498083397746

We O 0 0.0011844433611258864
identified O 0 0.0005348941776901484
both O 0 0.0002315503661520779
causative O 0 0.005249022506177425
mutations O 0 0.0006648200214840472
in O 0 0.000695803842972964
686 O 1 0.986042857170105
patients O 0 0.0004890949930995703
from O 0 0.00025688615278340876
seven O 0 0.0006034752586856484
European O 0 0.0006066122441552579
centers O 0 0.001009944244287908
. O 0 0.0004607842129189521

On O 0 0.0009380977135151625
the O 0 0.00031102891080081463
basis O 0 6.443716847570613e-05
of O 0 0.00013650568143930286
the O 0 0.00027831605984829366
phenotypic O 0 0.0012145418440923095
characteristics O 0 0.00046487239887937903
of O 0 0.0010162905091419816
297 O 1 0.9547571539878845
functionally O 1 0.9144593477249146
hemizygous O 1 0.999710738658905
patients O 0 0.0003124596842098981
, O 0 8.936492667999119e-05
105 O 0 0.00034008806687779725
of O 0 0.00017316511366516352
the O 0 0.00018655169697012752
mutations O 0 9.838569530984387e-05
were O 0 4.6783174184383824e-05
assigned O 0 9.224397217622027e-05
to O 0 2.8925001970492303e-05
one O 0 3.307215956738219e-05
of O 0 9.902932652039453e-05
four O 0 0.0001798106386559084
arbitrary O 0 0.00047753576654940844
phenotype O 0 0.0017783407820388675
categories O 0 0.0011436996283009648
. O 0 0.0008384422399103642

We O 0 0.0008972518262453377
proposed O 0 0.0004944531247019768
and O 0 0.00019192349282093346
tested O 0 0.0002949368499685079
a O 0 0.00019289932970423251
simple O 0 0.00017953687347471714
model O 0 0.00015990382235031575
for O 0 5.76313141209539e-05
correlation O 0 9.545103966956958e-05
between O 0 0.00036308576818555593
genotype O 0 0.0009980235481634736
and O 0 0.0002407208812655881
phenotypic O 0 0.0025794978719204664
outcome O 0 0.0014961987035349011
. O 0 0.000635061354842037

The O 0 0.004507523961365223
observed O 0 0.0017571067437529564
phenotype O 0 0.0015014188829809427
matched O 0 0.0005543139413930476
the O 0 0.000356504344381392
predicted O 0 0.0007426072261296213
phenotype O 0 0.0002977412659674883
in O 0 8.437945507466793e-05
79 O 0 0.00020907178986817598
% O 0 3.5046272387262434e-05
of O 0 8.117179822875187e-05
the O 0 0.00021986235515214503
cases O 0 0.00012456663534976542
, O 0 5.779146158602089e-05
and O 0 2.9288514269865118e-05
in O 0 4.365049608168192e-05
only O 0 2.992386362166144e-05
5 O 0 0.00013644321006722748
of O 0 0.00020051567116752267
184 O 0 0.0012567209778353572
patients O 0 0.0003941470349673182
was O 0 0.0008025687420740724
the O 0 0.0003578858741093427
observed O 0 0.0002222745242761448
phenotype O 0 0.00021991269022691995
more O 0 2.394176772213541e-05
than O 0 2.6105384677066468e-05
one O 0 3.636801557149738e-05
category O 0 0.00011141739378217608
away O 0 0.0001340783346677199
from O 0 0.00012020271242363378
that O 0 8.357386104762554e-05
expected O 0 0.00051203987095505
. O 0 0.0003255615010857582

Among O 0 0.0008007726864889264
the O 0 0.0004274080856703222
seven O 0 0.0006012975354678929
contributing O 0 0.0008127355249598622
centers O 0 0.00043187473784200847
, O 0 0.00011107284808531404
the O 0 0.00021800560352858156
proportion O 0 0.00021097717399243265
of O 0 0.00028506777016445994
patients O 0 0.00036958311102353036
for O 0 0.00010558107896940783
whom O 0 0.000438698916696012
the O 0 0.0006238524802029133
observed O 0 0.0006538759334944189
phenotype O 0 0.0008042184635996819
did O 0 0.0001537898206152022
not O 0 3.479723818600178e-05
match O 0 0.0001259780692635104
the O 0 0.00011980837734881788
predicted O 0 0.0003368434263393283
phenotype O 0 0.00027664992376230657
was O 0 0.0002571201475802809
4 O 0 0.00022220418031793088
% O 0 4.5426797441905364e-05
- O 0 0.00018938866560347378
23 O 0 0.00040002723108045757
% O 0 0.00010299726272933185
( O 0 0.00019290098862256855
P O 0 0.0030164390336722136
< O 0 0.003086584387347102
. O 0 0.0003720809181686491
0001 O 0 0.027161987498402596
) O 0 0.00018475302204024047
, O 0 0.0001095934203476645
suggesting O 0 0.0002470554318279028
that O 0 2.8758164262399077e-05
differences O 0 8.767171675572172e-05
in O 0 6.810792547184974e-05
methods O 0 5.835477713844739e-05
used O 0 5.764923116657883e-05
for O 0 4.594603524310514e-05
mutation O 0 0.00020063194097019732
detection O 0 0.0004829944809898734
or O 0 0.00026866389089263976
phenotype O 0 0.0010850612306967378
classification O 0 0.00039302351069636643
may O 0 0.0002100560668623075
account O 0 6.696887430734932e-05
for O 0 2.5629984520492144e-05
a O 0 9.457636042498052e-05
considerable O 0 0.00047330179950222373
proportion O 0 0.0003935236600227654
of O 0 0.0009053800604306161
genotype O 0 0.00752743287011981
- O 0 0.008539557456970215
phenotype O 0 0.00400133291259408
inconsistencies O 0 0.006045909132808447
. O 0 0.0012199792545288801

Our O 0 0.001866660313680768
data O 0 0.00020970623882021755
indicate O 0 0.00016942190995905548
that O 0 8.28979245852679e-05
the O 0 0.0011040862882509828
PAH O 1 1.0
- O 0 0.004914035089313984
mutation O 0 0.00033989004441536963
genotype O 0 0.0002480041584931314
is O 0 5.196088386583142e-05
the O 0 0.0001608117891009897
main O 0 0.0009818656835705042
determinant O 0 0.0030958433635532856
of O 0 0.0024037023540586233
metabolic O 1 0.999897837638855
phenotype O 0 0.0019528338452801108
in O 0 0.0003483427863102406
most O 0 0.0004869478871114552
patients O 0 0.006891481578350067
with O 1 0.9943658113479614
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.016257142648100853

In O 0 0.0015393632929772139
the O 0 0.0005467598675750196
present O 0 0.0004589205782394856
study O 0 7.795015699230134e-05
, O 0 4.5029733882984146e-05
the O 0 7.835371798137203e-05
classification O 0 0.00031616276828572154
of O 0 0.0008831737795844674
105 O 1 0.9906376004219055
PAH O 1 1.0
mutations O 0 0.0008863126859068871
may O 0 0.00019017599697690457
allow O 0 4.3908301449846476e-05
the O 0 7.436628948198631e-05
prediction O 0 0.00024542282335460186
of O 0 0.00010202434350503609
the O 0 0.00036419942625798285
biochemical O 0 0.002369679743424058
phenotype O 0 0.0007137650391086936
in O 0 0.00023529505415353924
> O 0 0.0007384521304629743
10 O 0 0.00022541312500834465
, O 0 0.00011366840044502169
000 O 0 0.0009958879090845585
genotypes O 0 0.001616662833839655
, O 0 0.00018075124535243958
which O 0 8.080588304437697e-05
may O 0 0.00012212683213874698
be O 0 3.620630013756454e-05
useful O 0 7.291584188351408e-05
for O 0 3.574354195734486e-05
the O 0 0.00015066204650793225
management O 0 0.000548283162061125
of O 0 0.0018992676632478833
hyperphenylalaninemia B-Disease 1 0.9999998807907104
in O 0 0.007819654420018196
newborns O 0 0.0199295561760664
. O 0 0.0009427403565496206

Somatic O 0 0.01832008734345436
instability O 0 0.010406133718788624
of O 0 0.0021027184557169676
the O 0 0.004637120757251978
CTG O 1 0.9998600482940674
repeat O 0 0.004034876357764006
in O 0 0.0005644167540594935
mice O 0 0.0005427216528914869
transgenic O 0 0.0007564350380562246
for O 0 9.854117524810135e-05
the O 0 0.0013722431613132358
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9988678693771362
is O 0 0.0007768524228595197
age O 0 0.00075156131060794
dependent O 0 0.0002109556517098099
but O 0 4.582941619446501e-05
not O 0 1.7683169062365778e-05
correlated O 0 8.632519893581048e-05
to O 0 4.103161336388439e-05
the O 0 0.00018392200581729412
relative O 0 0.0007432808633893728
intertissue O 0 0.3843521475791931
transcription O 0 0.0045457580126821995
levels O 0 0.0028552657458931208
and O 0 0.0010141152888536453
proliferative O 1 0.9999128580093384
capacities O 0 0.05386333912611008
. O 0 0.0015610349364578724

A O 0 0.011174580082297325
( O 0 0.00236664735712111
CTG O 1 0.988760232925415
) O 0 0.000473526946734637
nexpansion O 0 0.0053644124418497086
in O 0 0.00015405751764774323
the O 0 0.00027742088423110545
3 O 0 0.0004332104290369898
- O 0 0.0005230545066297054
untranslated O 0 0.0029895880725234747
region O 0 0.00042440954712219536
( O 0 0.00021903630113229156
UTR O 0 0.007252093404531479
) O 0 6.439957360271364e-05
of O 0 0.0001739535218803212
the O 0 0.0007253276999108493
DM O 1 0.9999904632568359
protein O 0 0.0012950141681358218
kinase O 0 0.0013165139826014638
gene O 0 0.0004877164610661566
( O 0 0.0004557434003800154
DMPK O 1 0.9996473789215088
) O 0 0.0002719032927416265
is O 0 0.00010521845251787454
responsible O 0 0.0006300978129729629
for O 0 0.0005488160531967878
causing O 1 0.9999990463256836
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.003581626107916236
. O 0 0.0011577720288187265

Major O 1 0.9637473225593567
instability O 1 0.9982494115829468
, O 0 0.0006684347172267735
with O 0 0.00025185514823533595
very O 0 0.00021502093295566738
large O 0 0.0003541642799973488
expansions O 0 0.001873693079687655
between O 0 0.000350276124663651
generations O 0 0.0005658611189574003
and O 0 0.00010786384518723935
high O 0 0.0005907734157517552
levels O 0 0.00024011090863496065
of O 0 0.00037242850521579385
somatic O 0 0.0062382458709180355
mosaicism O 1 0.9995970129966736
, O 0 0.00035057959030382335
is O 0 0.00016184952983167022
observed O 0 0.000292265962343663
in O 0 0.0002949205518234521
patients O 0 0.0008152017253451049
. O 0 0.0006404661107808352

There O 0 0.0011324669467285275
is O 0 0.00022647561854682863
a O 0 0.0002221033355453983
good O 0 0.0001987011346500367
correlation O 0 9.221970685757697e-05
between O 0 0.0001639092224650085
repeat O 0 0.0006820135749876499
size O 0 0.00021757032664027065
( O 0 8.269319368992001e-05
at O 0 0.00011955034278798848
least O 0 6.882283196318895e-05
in O 0 0.00010185869177803397
leucocytes O 1 0.6625972986221313
) O 0 0.00011160422582179308
, O 0 0.00012204126687720418
clinical O 0 0.0006020647706463933
severity O 0 0.0030623814091086388
and O 0 0.0005034361383877695
age O 0 0.0016792621463537216
of O 0 0.008127991110086441
onset O 1 0.9999991655349731
. O 0 0.003885026555508375

The O 0 0.012114221230149269
trinucleotide O 1 0.9980996251106262
repeat O 0 0.028528738766908646
instability O 0 0.07496744394302368
mechanisms O 0 0.0016116772312670946
involved O 0 0.0007347618811763823
in O 0 0.0014262539334595203
DM B-Disease 1 1.0
and O 0 0.0005258701858110726
other O 0 0.00024289265275001526
human O 0 0.0316447839140892
genetic B-Disease 1 0.999995231628418
diseases I-Disease 1 1.0
are O 0 0.000318237638566643
unknown O 0 0.002961541526019573
. O 0 0.0008247708901762962

We O 0 0.0014789601555094123
studied O 0 0.0016087512485682964
somatic O 0 0.00412589218467474
instability O 0 0.0034784222953021526
by O 0 0.00025256667868234217
measuring O 0 0.0026687749195843935
the O 0 0.0013652899069711566
CTG O 1 0.9974107146263123
repeat O 0 0.0018618999747559428
length O 0 0.00017961273260880262
at O 0 0.0002703165228012949
several O 0 4.9692116590449587e-05
ages O 0 0.0002089691552100703
in O 0 9.348192543257028e-05
various O 0 0.00012372068886179477
tissues O 0 0.0013597437646239996
of O 0 0.0009908505016937852
transgenic O 0 0.016197748482227325
mice O 0 0.0005929481121711433
carrying O 0 0.00032309439848177135
a O 0 0.00023263602633960545
( O 0 0.0003538029850460589
CTG O 1 0.7104446887969971
) O 0 0.0003921973111573607
55expansion O 0 0.009672015905380249
surrounded O 0 0.002931992057710886
by O 0 8.946041634771973e-05
45 O 0 0.00023751567641738802
kb O 0 0.0010430167894810438
of O 0 0.00021451986685860902
the O 0 0.000620528997387737
human O 0 0.0025028344243764877
DM B-Disease 1 1.0
region O 0 0.0010887094540521502
, O 0 0.00015346401778515428
using O 0 7.165142596932128e-05
small O 0 0.00017898068472277373
- O 0 0.0008607750642113388
pool O 0 0.0028603258542716503
PCR O 0 0.0038830928970128298
. O 0 0.000557335268240422

These O 0 0.0014895314816385508
mice O 0 0.001855981070548296
have O 0 9.505647176411003e-05
been O 0 0.0001655501255299896
shown O 0 0.00014668087533209473
to O 0 0.0001102756432374008
reproduce O 0 0.00040812615770846605
the O 0 0.0002912034105975181
intergenerational O 0 0.002536266576498747
and O 0 0.0002878373197745532
somatic O 0 0.0021558785811066628
instability O 0 0.0021503199823200703
of O 0 0.0006347503513097763
the O 0 0.0010491306893527508
55 O 0 0.002114723203703761
CTG O 1 0.9975008368492126
repeat O 0 0.0019161544041708112
suggesting O 0 0.0003823097504209727
that O 0 3.316292350064032e-05
surrounding O 0 0.0005462905392050743
sequences O 0 9.812953794607893e-05
and O 0 7.504088716814294e-05
the O 0 0.0002895680663641542
chromatin O 0 0.002779676578938961
environment O 0 0.00026115920627489686
are O 0 1.9523577066138387e-05
involved O 0 0.00012622108624782413
in O 0 0.0002906542213167995
instability O 1 0.8302844762802124
mechanisms O 0 0.013367871753871441
. O 0 0.002021299907937646

As O 0 0.001719346852041781
observed O 0 0.00036463350988924503
in O 0 0.00012075898848706856
some O 0 6.531050166813657e-05
of O 0 0.00017508890596218407
the O 0 0.0006191360298544168
tissues O 0 0.03906955569982529
of O 1 0.7565675377845764
DM B-Disease 1 1.0
patients O 0 0.4404803514480591
, O 0 0.00014991786156315356
there O 0 7.671540515730157e-05
is O 0 4.1748109651962295e-05
a O 0 0.00013767917698714882
tendency O 0 0.00041312878602184355
for O 0 8.136175165418535e-05
repeat O 0 0.0009991531260311604
length O 0 0.00023624503228347749
and O 0 0.0002005473943427205
somatic O 0 0.0019917208701372147
mosaicism O 0 0.030277056619524956
to O 0 0.00012145927757956088
increase O 0 6.789658073103055e-05
with O 0 2.5882187401293777e-05
the O 0 9.722733375383541e-05
age O 0 0.00018701136286836118
of O 0 0.0003189605486113578
the O 0 0.0008545031305402517
mouse O 0 0.0037639900110661983
. O 0 0.0005651884130202234

Furthermore O 0 0.0056236619129776955
, O 0 0.0003795862721744925
we O 0 0.0001321658055530861
observed O 0 8.346809772774577e-05
no O 0 4.465529855224304e-05
correlation O 0 6.34377429378219e-05
between O 0 0.00014237075811251998
the O 0 0.0003117812448181212
somatic O 0 0.002200900577008724
mutation O 0 0.000712038017809391
rate O 0 0.0005277932505123317
and O 0 0.0005866740248166025
tissue O 1 0.9882388114929199
proliferation O 1 0.9877372980117798
capacity O 0 0.008262489922344685
. O 0 0.0008158257696777582

The O 0 0.005150298122316599
somatic O 0 0.00560715701431036
mutation O 0 0.0006757848896086216
rates O 0 0.0002052850613836199
in O 0 8.37413826957345e-05
different O 0 5.041332769906148e-05
tissues O 0 0.0014270383398979902
were O 0 0.00018437324615661055
also O 0 7.017934694886208e-05
not O 0 2.7526710255187936e-05
correlated O 0 0.00010532826854614541
to O 0 3.5659348213812336e-05
the O 0 9.491752280155197e-05
relative O 0 0.0003575896844267845
inter O 0 0.003547451924532652
- O 0 0.0022742622531950474
tissue O 0 0.0013447590172290802
difference O 0 0.00018391497724223882
in O 0 0.00010440689220558852
transcriptional O 0 0.00047542559332214296
levels O 0 0.00013258021499495953
of O 0 6.72570095048286e-05
the O 0 9.0769499365706e-05
three O 0 9.995985601563007e-05
genes O 0 0.00021342305990401655
( O 0 0.00038750714156776667
DMAHP O 1 0.9999074935913086
, O 0 0.0005339457420632243
DMPK O 1 0.9995918869972229
and O 0 0.00028307121829129755
59 O 0 0.0008552044746465981
) O 0 0.000165264806128107
surrounding O 0 0.0011482243426144123
the O 0 0.0006799737457185984
repeat O 0 0.0038004806265234947
. O 0 0.0003827818436548114
. O 0 0.0004783111799042672

A O 0 0.006352643482387066
novel O 0 0.003065625438466668
missense O 0 0.005140532739460468
mutation O 0 0.0005818010540679097
in O 0 0.00035941044916398823
patients O 0 0.0002954801020678133
from O 0 0.00031178153585642576
a O 0 0.0009921388700604439
retinoblastoma B-Disease 1 0.9943782687187195
pedigree O 0 0.007526080124080181
showing O 0 0.0011622814927250147
only O 0 0.00018748287402559072
mild O 0 0.0011847538407891989
expression O 0 0.00028149090940132737
of O 0 0.0005363466334529221
the O 0 0.005224897060543299
tumor B-Disease 1 0.9999982118606567
phenotype O 0 0.010280215181410313
. O 0 0.0009514563134871423

We O 0 0.0011600980069488287
have O 0 0.00011985726450802758
used O 0 0.00015480218280572444
single O 0 0.00017583038425073028
strand O 0 0.0006042602472007275
conformation O 0 0.0008138678385876119
polymorphism O 0 0.00017317981109954417
analysis O 0 1.5692572560510598e-05
to O 0 1.9207191144232638e-05
study O 0 2.79476516880095e-05
the O 0 0.00011270823597442359
27 O 0 0.0004406558000482619
exons O 0 0.000717360177077353
of O 0 0.0002488991303835064
the O 0 0.0007383592310361564
RB1 O 1 0.9999419450759888
gene O 0 0.0003791569615714252
in O 0 8.635641279397532e-05
individuals O 0 5.005061029805802e-05
from O 0 0.00013841092004440725
a O 0 0.0002877476217690855
family O 0 0.0005285522202029824
showing O 0 0.002126930747181177
mild O 0 0.006943515036255121
expression O 0 0.0005546435131691396
of O 0 0.000882471795193851
the O 0 0.0027540288865566254
retinoblastoma B-Disease 1 0.9999203681945801
phenotype O 0 0.01019115000963211
. O 0 0.0011154094245284796

In O 0 0.001191991730593145
this O 0 0.00025465316139161587
family O 0 0.000501356553286314
affected O 0 0.0005210392409935594
individuals O 0 9.904293256113306e-05
developed O 0 0.0017512008780613542
unilateral B-Disease 1 0.9996039271354675
tumors I-Disease 1 1.0
and O 0 0.0012311249738559127
, O 0 0.00015175087901297957
as O 0 9.676884656073526e-05
a O 0 8.56629412737675e-05
result O 0 9.955443238141015e-05
of O 0 0.0002001349930651486
linkage O 0 0.001686149393208325
analysis O 0 0.00010698656842578202
, O 0 0.00021111420937813818
unaffected O 0 0.0022493365686386824
mutation O 0 0.00038541844696737826
carriers O 0 0.00029420049395412207
were O 0 8.593194797867909e-05
also O 0 5.311649510986172e-05
identified O 0 7.907988037914038e-05
within O 0 0.0001318949944106862
the O 0 0.0005413935869000852
pedigree O 0 0.005462499335408211
. O 0 0.0009070719825103879

A O 0 0.007861933670938015
single O 0 0.0017194425454363227
band O 0 0.002083315746858716
shift O 0 0.0012473179958760738
using O 0 0.0001777632860466838
SSCP O 1 0.9993577599525452
was O 0 0.0008095090161077678
identified O 0 0.00017316329467575997
in O 0 9.646581747801974e-05
exon O 0 0.0013079741038382053
21 O 0 0.0005032851477153599
which O 0 6.120809848653153e-05
resulted O 0 0.00029585722950287163
in O 0 8.371376316063106e-05
a O 0 0.00019230741600040346
missense O 0 0.0010584414703771472
mutation O 0 0.00021350610768422484
converting O 0 0.0005211500101722777
a O 0 0.0005514078075066209
cys O 0 0.02421523630619049
- O 0 0.0013218510430306196
- O 0 0.0010042344219982624
> O 0 0.0013603785773739219
arg O 0 0.002229670761153102
at O 0 0.0003704451955854893
nucleotide O 0 0.0003650677390396595
position O 0 0.00019307801267132163
28 O 0 0.0004884792724624276
in O 0 0.00015345436986535788
the O 0 0.0005401024827733636
exon O 0 0.006702405866235495
. O 0 0.0009018978453241289

The O 0 0.003878819989040494
mutation O 0 0.0021318679209798574
destroyed O 0 0.016897208988666534
an O 0 0.0008665893110446632
NdeI O 1 0.9174383878707886
restriction O 0 0.0025637298822402954
enzyme O 0 0.0012799515388906002
site O 0 0.0017370450077578425
. O 0 0.0005197669379413128

Analysis O 0 0.00031870094244368374
of O 0 0.00031583383679389954
all O 0 0.00010922908404609188
family O 0 0.00022563201491720974
members O 0 0.00011227595678064972
demonstrated O 0 0.0004307748458813876
that O 0 5.4016956710256636e-05
the O 0 0.00026813519070856273
missense O 0 0.00234694080427289
mutation O 0 0.0006228761048987508
co O 0 0.0015858050901442766
- O 0 0.0012682030210271478
segregated O 0 0.0017323590582236648
with O 0 0.00018309926963411272
patients O 0 0.00041844986844807863
with O 0 0.000627715140581131
tumors B-Disease 1 1.0
or O 0 0.003475200617685914
who O 0 0.00041507018613629043
, O 0 0.00013089831918478012
as O 0 9.076637797988951e-05
a O 0 0.00011384239769540727
result O 0 0.00013318461424205452
of O 0 0.00024494921672157943
linkage O 0 0.0014474623603746295
analysis O 0 9.696660708868876e-05
had O 0 0.0002195780980400741
been O 0 0.00013880556798540056
predicted O 0 0.0002271516277687624
to O 0 6.650810973951593e-05
carry O 0 0.00017026238492690027
the O 0 0.0005808175774291158
predisposing O 0 0.012563806027173996
mutation O 0 0.00190652662422508
. O 0 0.0012122506741434336

These O 0 0.00046827204641886055
observations O 0 0.00029590519261546433
point O 0 0.00023026642156764865
to O 0 6.688265420962125e-05
another O 0 0.0001225012238137424
region O 0 0.0002881028049159795
of O 0 0.0003367379540577531
the O 0 0.0012175029842182994
RB1 O 1 0.999975323677063
gene O 0 0.0005006316350772977
where O 0 0.0002536161046009511
mutations O 0 9.128666715696454e-05
only O 0 2.960646088467911e-05
modify O 0 0.00011742750939447433
the O 0 8.370833529625088e-05
function O 0 3.8877129554748535e-05
of O 0 0.00012191553105367348
the O 0 0.0003310453030280769
gene O 0 0.00023844641691539437
and O 0 6.952336843824014e-05
raise O 0 0.00019362385501153767
important O 0 0.000141342738061212
questions O 0 8.143650484271348e-05
for O 0 4.2053667129948735e-05
genetic O 0 0.00022204681590665132
counseling O 0 0.0005994921084493399
in O 0 0.00016078479529824108
families O 0 0.00010543197277002037
with O 0 7.086299592629075e-05
these O 0 9.595919254934415e-05
distinctive O 0 0.0034084368962794542
phenotypes O 0 0.007189280353486538
. O 0 0.00045101711293682456
. O 0 0.0006589653203263879

Maternal B-Disease 1 0.9727498888969421
disomy I-Disease 1 0.9999579191207886
and O 0 0.07879018038511276
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.4162299633026123
with O 0 0.0014701054897159338
gamete O 1 0.9978923201560974
complementation O 1 0.9776025414466858
in O 0 0.00034665557905100286
a O 0 0.00021296224440447986
case O 0 0.00020045180281158537
of O 0 0.00022576328774448484
familial O 0 0.004842062946408987
translocation O 0 0.04555835947394371
( O 0 0.00039952259976416826
3 O 0 0.0003370729391463101
; O 0 4.868969335802831e-05
15 O 0 0.00021269255375955254
) O 0 9.554847201798111e-05
( O 0 0.00027310644509270787
p25 O 0 0.015476095490157604
; O 0 0.0002560884749982506
q11 O 0 0.022383183240890503
. O 0 0.0002451856853440404
2 O 0 0.0006815132219344378
) O 0 0.0002682190388441086
. O 0 0.0003433863748796284

Maternal B-Disease 1 0.9716055393218994
uniparental I-Disease 1 0.9999880790710449
disomy I-Disease 1 0.9999966621398926
( I-Disease 0 0.10340254753828049
UPD I-Disease 1 0.9999990463256836
) I-Disease 0 0.0004033709701616317
for I-Disease 0 0.00017110641056206077
chromosome I-Disease 0 0.000489241152536124
15 I-Disease 0 0.0004309903015382588
is O 0 7.594421185785905e-05
responsible O 0 0.00014359931810759008
for O 0 3.449475843808614e-05
an O 0 6.323143315967172e-05
estimated O 0 0.00011136238026665524
30 O 0 0.00015137283480726182
% O 0 3.618556002038531e-05
of O 0 0.0001117618303396739
cases O 0 0.0001671876962063834
of O 0 0.004040433559566736
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999967813491821
PWS B-Disease 1 1.0
) O 0 0.004415060859173536
. O 0 0.001254281378351152

We O 0 0.0008216104470193386
report O 0 0.0001194649885292165
on O 0 7.462046050932258e-05
an O 0 6.171836139401421e-05
unusual O 0 0.0002475258079357445
case O 0 0.00016805077029857785
of O 0 0.00040019009611569345
maternal B-Disease 0 0.058148935437202454
disomy I-Disease 1 0.9999527931213379
15 I-Disease 0 0.0038641011342406273
in O 0 0.001766682369634509
PWS B-Disease 1 1.0
that O 0 0.00015279412036761642
is O 0 4.619078026735224e-05
most O 0 3.1322175345849246e-05
consistent O 0 8.392157906200737e-05
with O 0 5.226253779255785e-05
adjacent O 0 0.001351702492684126
- O 0 0.0006964603089727461
1 O 0 0.00041518494253978133
segregation O 0 0.0010887240059673786
of O 0 0.00014509129687212408
a O 0 0.00022775430988986045
paternal O 0 0.0012219877680763602
t O 0 0.0012015135725960135
( O 0 0.0001034423548844643
3 O 0 0.0001503711100667715
; O 0 2.9448940040310845e-05
15 O 0 0.00022718541731592268
) O 0 9.887871419778094e-05
( O 0 0.0002209325903095305
p25 O 0 0.017961811274290085
; O 0 0.00028010443202219903
q11 O 0 0.012729082256555557
. O 0 0.000137034134240821
2 O 0 0.0002353852614760399
) O 0 3.410105637158267e-05
with O 0 5.430743476608768e-05
simultaneous O 0 0.0005722088390029967
maternal O 0 0.004717003088444471
meiotic O 1 0.9992233514785767
nondisjunction O 1 0.9993550181388855
for O 0 0.000602005748078227
chromosome O 0 0.002379016485065222
15 O 0 0.002225247211754322
. O 0 0.000891388684976846

The O 0 0.004115360789000988
patient O 0 0.0036415760405361652
( O 0 0.0009617378236725926
J O 1 0.5148816108703613
. O 0 0.0002136091497959569
B O 0 0.0006103127379901707
. O 0 4.9183840019395575e-05
) O 0 2.0954837964382023e-05
, O 0 2.150093496311456e-05
a O 0 8.414129843004048e-05
17 O 0 0.00047384932986460626
- O 0 0.00042751667206175625
year O 0 0.00027064731693826616
- O 0 0.0005030482425354421
old O 0 0.0008755080634728074
white O 0 0.0011500321561470628
male O 0 0.0005870157619938254
with O 0 0.0005142622394487262
PWS B-Disease 1 1.0
, O 0 0.0008241847972385585
was O 0 0.0008040507091209292
found O 0 7.248816109495237e-05
to O 0 4.109132714802399e-05
have O 0 2.1696570911444724e-05
47 O 0 0.0002083537692669779
chromosomes O 0 0.0001588909944985062
with O 0 5.5101412726799026e-05
a O 0 0.0004505031683947891
supernumerary O 0 0.3359560966491699
, O 0 0.00034797436092048883
paternal O 0 0.0025808229111135006
der O 0 0.08819123357534409
( O 0 0.0002853848272934556
15 O 0 0.0003841662546619773
) O 0 4.2906180169666186e-05
consisting O 0 6.871842924738303e-05
of O 0 0.00014219748845789582
the O 0 0.0003191576397512108
short O 0 0.0005250685499049723
arm O 0 0.002117492025718093
and O 0 0.00021525991905946285
the O 0 0.0006640538340434432
proximal O 1 0.999278724193573
long O 0 0.0018753436161205173
arm O 0 0.010472970083355904
of O 0 0.0016304097371175885
chromosome O 0 0.005388339981436729
15 O 0 0.0026976317167282104
, O 0 0.00037576298927888274
and O 0 0.0005279243341647089
distal O 1 0.9971743822097778
chromosome O 1 0.9839089512825012
arm O 1 0.9999510049819946
3p O 1 0.99996018409729
. O 0 0.002775311702862382

The O 0 0.002767779864370823
t O 0 0.0029899487271904945
( O 0 0.00020908055012114346
3 O 0 0.0003351295890752226
; O 0 6.929421942913905e-05
15 O 0 0.00029254748369567096
) O 0 6.895711703691632e-05
was O 0 0.00028256268706172705
present O 0 0.0001293792884098366
in O 0 8.2159269368276e-05
the O 0 0.00012130938557675108
balanced O 0 0.0001497442863183096
state O 0 4.427528983796947e-05
in O 0 6.409653724404052e-05
the O 0 0.00027623845380730927
patients O 0 0.0004224104050081223
father O 0 0.0024368311278522015
and O 0 0.0004748466017190367
a O 0 0.0012023928575217724
sister O 0 0.004903006367385387
. O 0 0.0012895112158730626

Fluorescent O 0 0.017296332865953445
in O 0 0.001452918048016727
situ O 0 0.008065108209848404
hybridization O 0 0.0006439206190407276
analysis O 0 0.00010692313662730157
demonstrated O 0 0.0007955529144965112
that O 0 0.00010669641778804362
the O 0 0.0008278503664769232
PWS B-Disease 1 0.9999992847442627
critical O 0 0.0016205103602260351
region O 0 0.000546140072401613
resided O 0 0.0009595712763257325
on O 0 0.00015001939027570188
the O 0 0.00016578596842009574
derivative O 0 0.00038774326094426215
chromosome O 0 0.0004143111582379788
3 O 0 0.0002451349573675543
and O 0 6.78105279803276e-05
that O 0 3.8365411455743015e-05
there O 0 5.31012010469567e-05
was O 0 0.00021991983521729708
no O 0 8.11984355095774e-05
deletion O 0 0.000289955671178177
of O 0 0.000339391699526459
the O 0 0.0015328718582168221
PWS B-Disease 1 1.0
region O 0 0.0013812141260132194
on O 0 0.0004105044063180685
the O 0 0.0003260836820118129
normal O 0 0.0003020329459104687
pair O 0 0.0002662873885128647
of O 0 0.0003869962238240987
15s O 0 0.035664163529872894
present O 0 0.001023479737341404
in O 0 0.001075147301889956
J O 1 0.7359269261360168
. O 0 0.0010695367818698287

B O 0 0.038932885974645615
. O 0 0.003778572892770171

Methylation O 0 0.0017370583955198526
analysis O 0 0.00017991592176258564
at O 0 0.0004891719436272979
exon O 0 0.0010724375024437904
alpha O 0 0.0002494890650268644
of O 0 7.822992483852431e-05
the O 0 0.00014656397979706526
small O 0 0.00016425906505901366
nuclear O 0 0.0014991695061326027
ribonucleoprotein O 0 0.035008784383535385
- O 0 0.0006785346777178347
associated O 0 0.00013385122292675078
polypeptide O 0 0.0019488418474793434
N O 0 0.002003928180783987
( O 0 0.0004996024654246867
SNRPN O 1 0.998434841632843
) O 0 0.00024637565365992486
gene O 0 0.0002338502526981756
showed O 0 0.0003163494111504406
a O 0 0.0001839169126469642
pattern O 0 0.0006794212386012077
characteristic O 0 0.0007429944816976786
of O 0 0.0004843127680942416
only O 0 0.00012562898336909711
the O 0 0.00026232184609398246
maternal O 0 0.0016308905323967338
chromosome O 0 0.0006420377758331597
15 O 0 0.0006566200172528625
in O 0 0.0006701958482153714
J O 0 0.3348444402217865
. O 0 0.0007293833768926561

B O 0 0.053946174681186676
. O 0 0.003883738536387682

Maternal B-Disease 1 0.7420697212219238
disomy I-Disease 1 0.9991424083709717
was O 0 0.004020388703793287
confirmed O 0 0.0007498672348447144
by O 0 0.00013356434646993876
polymerase O 0 0.0008933042990975082
chain O 0 0.0005366232944652438
reaction O 0 0.00020639668218791485
analysis O 0 2.939271325885784e-05
of O 0 0.00017465572454966605
microsatellite O 0 0.0028026695363223553
repeats O 0 0.0007344762561842799
at O 0 0.00038922985550016165
the O 0 0.00024627044331282377
gamma O 0 0.0007913067820481956
- O 0 0.0008846441633068025
aminobutyric O 0 0.008601679466664791
acid O 0 0.0012945453636348248
receptor O 0 0.00044456784962676466
beta3 O 0 0.00675018597394228
subunit O 0 0.0010951326694339514
( O 0 0.0007009759428910911
GABRB3 O 1 0.9977160692214966
) O 0 0.0008030720637179911
locus O 0 0.005330811254680157
. O 0 0.0010404076892882586

A O 0 0.010608578100800514
niece O 0 0.21037307381629944
( O 0 0.0011022052494809031
B O 0 0.0018296411726623774
. O 0 0.0001372356346109882
B O 0 0.0005279638571664691
. O 0 4.3060343159595504e-05
) O 0 2.3972015696926974e-05
with O 0 2.3330587282544002e-05
45 O 0 0.00017844545072875917
chromosomes O 0 0.00014958516112528741
and O 0 3.979964094469324e-05
the O 0 0.0001248258340638131
derivative O 0 0.00020801076607313007
3 O 0 0.00018354655185248703
but O 0 3.407674012123607e-05
without O 0 3.0291315852082334e-05
the O 0 0.0001324672339251265
der O 0 0.0036114274989813566
( O 0 0.00018450057541485876
15 O 0 0.00028103557997383177
) O 0 7.224869477795437e-05
demonstrated O 0 0.00034908231464214623
a O 0 0.00024366345314774662
phenotype O 0 0.0005511235212907195
consistent O 0 0.00026553875068202615
with O 0 5.830877853441052e-05
that O 0 5.025904829381034e-05
reported O 0 0.000163359654834494
for O 0 7.13531844667159e-05
haploinsufficiency O 0 0.008640565909445286
of O 0 0.0007698351982980967
distal O 1 0.9967105388641357
3 O 0 0.005848052445799112
p O 0 0.005504312459379435
. O 0 0.0007092907326295972

Uniparental B-Disease 1 0.9999986886978149
disomy I-Disease 1 0.9999946355819702
associated O 0 0.002860954264178872
with O 0 0.0006377078825607896
unbalanced O 0 0.013690069317817688
segregation O 0 0.08985065668821335
of O 0 0.001890098094008863
non O 0 0.014328690245747566
- O 0 0.02944866009056568
Robertsonian O 1 0.99886155128479
translocations O 0 0.003607015125453472
has O 0 0.0002051107003353536
been O 0 9.702617535367608e-05
reported O 0 0.00013932911679148674
previously O 0 0.0001248554908670485
but O 0 3.90450659324415e-05
has O 0 3.137829480692744e-05
not O 0 2.0002915334771387e-05
, O 0 3.121342888334766e-05
to O 0 5.153059464646503e-05
our O 0 0.0001716615370241925
knowledge O 0 0.00044048065319657326
, O 0 9.517619764665142e-05
been O 0 8.026508294278756e-05
observed O 0 7.715589163126424e-05
in O 0 5.8409896155353636e-05
a O 0 0.0001797218428691849
case O 0 0.000491012295242399
of O 0 0.0025022760964930058
PWS B-Disease 1 1.0
. O 0 0.004341845866292715

Furthermore O 0 0.005314195994287729
, O 0 0.0005435865023173392
our O 0 0.0004353391705080867
findings O 0 0.00016001882613636553
are O 0 1.7741103874868713e-05
best O 0 0.00012194367445772514
interpreted O 0 0.000162824711878784
as O 0 0.00017592799849808216
true O 0 0.001126350718550384
gamete O 0 0.03836725279688835
complementation O 1 0.9881640672683716
resulting O 0 0.005698610562831163
in O 0 0.002224768977612257
maternal B-Disease 1 0.9973725080490112
UPD I-Disease 1 1.0
15 I-Disease 0 0.19401133060455322
and O 0 0.007107042707502842
PWS B-Disease 1 0.9999995231628418

Schwartz B-Disease 0 0.3009648621082306
- I-Disease 1 0.8860868215560913
Jampel I-Disease 1 0.9999945163726807
syndrome I-Disease 1 0.9999995231628418
type I-Disease 0 0.014593018218874931
2 I-Disease 0 0.003430598182603717
and O 0 0.0010203525889664888
Stuve B-Disease 1 0.9999980926513672
- I-Disease 1 0.9989446997642517
Wiedemann I-Disease 1 0.999991774559021
syndrome I-Disease 1 0.9999998807907104
: O 0 0.0005837111966684461
a O 0 0.0004765558405779302
case O 0 0.000495963147841394
for O 0 0.00014240659947972745
" O 0 0.0010528693674132228
lumping O 0 0.007952907122671604
" O 0 0.0033423632849007845
. O 0 0.0009223163360729814

Recent O 0 0.002173306653276086
studies O 0 0.0002273286518175155
demonstrated O 0 0.0005731449346058071
the O 0 0.00019035486911889166
existence O 0 0.0002967136970255524
of O 0 0.0001635251974221319
a O 0 0.0002556771505624056
genetically O 0 0.00031041924376040697
distinct O 0 0.0001092742895707488
, O 0 6.157997268019244e-05
usually O 0 4.539799556368962e-05
lethal O 0 0.00023793500440660864
form O 0 7.793878467055038e-05
of O 0 0.0002164689067285508
the O 0 0.0007536393241025507
Schwartz B-Disease 0 0.04990917071700096
- I-Disease 1 0.9403334259986877
Jampel I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 1 0.8667498826980591
SJS B-Disease 1 0.9999924898147583
) O 0 0.0007386410725302994
of O 0 0.002643937710672617
myotonia B-Disease 1 1.0
and O 1 0.9856239557266235
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.20887012779712677
which O 0 0.0003516232536640018
we O 0 0.0001908526464831084
called O 0 0.0007257781689986587
SJS B-Disease 1 0.9716352224349976
type I-Disease 0 0.0012188147520646453
2 I-Disease 0 0.001471040304750204
. O 0 0.0005610059015452862

This O 0 0.003502990584820509
disorder O 1 0.9999929666519165
is O 0 0.000909032707568258
reminiscent O 0 0.04766162112355232
of O 0 0.001223913161084056
another O 0 0.0016374781262129545
rare O 0 0.0016342464368790388
condition O 0 0.0019073280273005366
, O 0 0.00017629709327593446
the O 0 0.0009408523910678923
Stuve B-Disease 1 0.999997615814209
- I-Disease 1 0.9996378421783447
Wiedemann I-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
( O 1 0.9602958559989929
SWS B-Disease 1 0.999990701675415
) O 0 0.00030515508842654526
, O 0 0.00010037402535090223
which O 0 5.346663965610787e-05
comprises O 0 0.0006132865673862398
campomelia B-Disease 1 0.7922201156616211
at O 0 0.003223415929824114
birth O 0 0.0026629227213561535
with O 0 0.001390698947943747
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999369382858276
contractures B-Disease 1 1.0
, O 0 0.0014512365451082587
and O 0 0.0004800271417479962
early B-Disease 0 0.001416245591826737
death I-Disease 0 0.005775406025350094
. O 0 0.0009045380284078419

To O 0 0.0010149648878723383
test O 0 0.00036219533649273217
for O 0 0.00011436923523433506
possible O 0 0.0003858715353999287
nosologic O 0 0.07142352312803268
identity O 0 0.0006158221513032913
between O 0 0.0008887901203706861
these O 0 0.0003854715032503009
disorders O 1 0.9999992847442627
, O 0 0.0004547479038592428
we O 0 0.0001313888787990436
reviewed O 0 7.646409358130768e-05
the O 0 5.762735600001179e-05
literature O 0 6.994949944783002e-05
and O 0 3.231001028325409e-05
obtained O 0 4.5478722313418984e-05
a O 0 9.8719414381776e-05
follow O 0 0.00012018276902381331
- O 0 0.00012943247565999627
up O 0 7.887337415013462e-05
of O 0 8.597809937782586e-05
the O 0 0.00013355060946196318
only O 0 4.050907227792777e-05
two O 0 6.032831879565492e-05
surviving O 0 0.0015132251428440213
patients O 0 0.00026307825464755297
, O 0 7.445796654792503e-05
one O 0 6.215022585820407e-05
with O 0 8.2324659160804e-05
SJS B-Disease 1 0.9784846901893616
type I-Disease 0 0.0004886388196609914
2 I-Disease 0 0.0003660913498606533
at O 0 0.00028147909324616194
age O 0 0.00013743233284913003
10 O 0 0.00011253533739363775
years O 0 7.31642940081656e-05
and O 0 4.453711153473705e-05
another O 0 0.00010157257202081382
with O 0 0.00011175106919836253
SWS B-Disease 1 0.9980181455612183
at O 0 0.0009886546758934855
age O 0 0.0005871125031262636
7 O 0 0.0015258132480084896
years O 0 0.000826576491817832
. O 0 0.0005320649361237884

Patients O 0 0.008447356522083282
reported O 0 0.0011555167147889733
as O 0 0.0003929154481738806
having O 0 0.0005948675679974258
either O 0 0.0012454285752028227
neonatal O 1 0.9999997615814209
SJS B-Disease 1 0.9999997615814209
or O 0 0.0032745911739766598
SWS B-Disease 1 0.9347428679466248
presented O 0 0.0004897575126960874
a O 0 0.0002355509641347453
combination O 0 0.00029370756237767637
of O 0 0.00029931709286756814
a O 0 0.0010171933099627495
severe O 1 0.9999781847000122
, O 0 0.0024115911219269037
prenatal O 1 0.9996178150177002
- O 1 0.9999480247497559
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999967813491821
with O 1 0.9998276233673096
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999955892562866
respiratory O 1 1.0
and O 1 0.9882815480232239
feeding O 1 0.9700161814689636
difficulties O 1 0.9589266777038574
, O 0 0.0004387859080452472
tendency O 0 0.0014372720615938306
to O 0 0.0005525447195395827
hyperthermia B-Disease 1 0.999993085861206
, O 0 0.0004320009611546993
and O 0 0.00020347120880614966
frequent O 0 0.000535191735252738
death O 0 0.0027798463124781847
in O 0 0.0004499201604630798
infancy O 0 0.002966310130432248
) O 0 6.692668102914467e-05
with O 0 4.0983471990330145e-05
a O 0 0.00023402622900903225
distinct O 0 0.0009414253290742636
campomelic B-Disease 1 0.9999985694885254
- I-Disease 1 0.9998347759246826
metaphyseal I-Disease 1 0.9999990463256836
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.0144418990239501

The O 0 0.0016487056855112314
similarity O 0 0.0008320552296936512
of O 0 0.0008557876572012901
the O 0 0.0009270148002542555
clinical O 0 0.001637716661207378
and O 0 0.0005542841390706599
radiographic O 0 0.30205824971199036
findings O 0 0.0005488528404384851
is O 0 9.808789764065295e-05
so O 0 7.0592672273051e-05
extensive O 0 0.00034709388273768127
that O 0 0.00012178424367448315
these O 0 0.00018690263095777482
disorders O 1 0.9999047517776489
appear O 0 0.0006084170308895409
to O 0 0.00016007546219043434
be O 0 8.178078132914379e-05
a O 0 0.0002061390405287966
single O 0 0.00038039986975491047
entity O 0 0.0011252256808802485
. O 0 0.000627899426035583

The O 0 0.0014424544060602784
follow O 0 0.0005581572186201811
- O 0 0.0006165298400446773
up O 0 0.00022026228543836623
observation O 0 0.00033325431286357343
of O 0 0.0001336252607870847
an O 0 0.00011653088586172089
identical O 0 0.00018729385919868946
and O 0 0.00011228388029849157
unique O 0 0.00019070383859798312
pattern O 0 0.0013692002976313233
of O 1 0.6751907467842102
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.008454912342131138
the O 0 0.0008423769613727927
two O 0 0.0001319918956141919
patients O 0 9.877750562736765e-05
( O 0 5.178577339393087e-05
one O 0 4.363322295830585e-05
with O 0 0.00010277387627866119
SJS B-Disease 1 0.9955841898918152
type I-Disease 0 0.0008568312623538077
2 I-Disease 0 0.0005696963053196669
, O 0 7.727687625447288e-05
one O 0 6.989936082391068e-05
with O 0 0.00013886993110645562
SWS B-Disease 1 0.9959828853607178
) O 0 0.00040048317168839276
surviving O 0 0.002277775900438428
beyond O 0 0.0020961929112672806
infancy O 0 0.002625219989567995
adds O 0 0.00037209736183285713
to O 0 4.775135312229395e-05
the O 0 0.00013641927216667682
evidence O 0 0.000145335026900284
in O 0 8.68640054250136e-05
favor O 0 0.00010786868369905278
of O 0 0.00026917768991552293
identity O 0 0.0006444848258979619
. O 0 0.0008563509327359498

The O 0 0.003177614649757743
hypothesis O 0 0.00197967910207808
that O 0 0.0003649677091743797
SWS B-Disease 1 0.970562219619751
and O 0 0.0007841472397558391
SJS B-Disease 1 0.9991633892059326
type I-Disease 0 0.001304545090533793
2 I-Disease 0 0.0004253386287018657
are O 0 2.0935684005962685e-05
the O 0 0.00019189018348697573
same O 0 0.00041051203152164817
disorder O 1 0.99996018409729
should O 0 0.0002900087565649301
be O 0 0.00011013030598405749
testable O 0 0.00046952225966379046
by O 0 5.390693695517257e-05
molecular O 0 0.0002727679384406656
methods O 0 0.00021749608276877552
. O 0 0.00011884462583111599
. O 0 0.0002929147449322045

A O 0 0.007864671759307384
mouse O 0 0.0024476395919919014
model O 0 0.000532044970896095
of O 0 0.0012010826030746102
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999990463256836
defects O 1 1.0
in O 1 0.915972888469696
hemostasis O 1 0.9999998807907104
and O 0 0.2228984832763672
thrombosis B-Disease 1 0.9999996423721313
. O 0 0.004507849458605051

von B-Disease 1 0.986816942691803
Willebrand I-Disease 1 0.9999969005584717
factor I-Disease 1 0.9347273707389832
( I-Disease 0 0.022480124607682228
vWf I-Disease 1 0.9998123049736023
) I-Disease 0 0.12719306349754333
deficiency I-Disease 1 1.0
causes O 1 0.9999998807907104
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9999082088470459
humans O 0 0.021957959979772568
. O 0 0.00043270981404930353

We O 0 0.0007214503712020814
generated O 0 0.00032195175299420953
a O 0 0.00022400419402401894
mouse O 0 0.000437146401964128
model O 0 0.0001935609325300902
for O 0 6.730037421220914e-05
this O 0 0.00013998430222272873
disease O 0 0.47019892930984497
by O 0 0.00016179861268028617
using O 0 0.00017568006296642125
gene O 0 0.0003316015063319355
targeting O 0 0.0009189598495140672
. O 0 0.00037607047124765813

vWf B-Disease 1 0.9880417585372925
- I-Disease 1 0.5927305817604065
deficient I-Disease 1 0.9444518089294434
mice O 0 0.002169396262615919
appeared O 0 0.0008107665344141424
normal O 0 0.000537219806574285
at O 0 0.0007656184025108814
birth O 0 0.0006345222936943173
; O 0 5.3935425967210904e-05
they O 0 4.03377998736687e-05
were O 0 0.00012564289500005543
viable O 0 0.0010333458194509149
and O 0 0.00038345716893672943
fertile O 0 0.011691631749272346
. O 0 0.0014025724958628416

Neither O 0 0.023731885477900505
vWf O 0 0.06515457481145859
nor O 0 0.008235100656747818
vWf O 0 0.07415590435266495
propolypeptide O 1 0.9867454171180725
( O 0 0.0015983401099219918
von B-Disease 0 0.39231863617897034
Willebrand I-Disease 1 0.9999992847442627
antigen O 1 0.9950700998306274
II O 1 0.9999996423721313
) O 0 0.0003588828258216381
were O 0 0.00017834798200055957
detectable O 0 0.0012366333976387978
in O 0 0.0001807822845876217
plasma O 0 0.0013733520172536373
, O 0 0.00024231044517364353
platelets O 0 0.00402142945677042
, O 0 0.0002542026631999761
or O 0 0.0004521647351793945
endothelial O 0 0.3433143198490143
cells O 0 0.0004881545901298523
of O 0 0.00027577613946050406
the O 0 0.000794692081399262
homozygous O 0 0.0027041013818234205
mutant O 0 0.008725396357476711
mice O 0 0.003580149495974183
. O 0 0.0005963924922980368

The O 0 0.008992734365165234
mutant O 1 0.9815074801445007
mice O 1 0.6780279278755188
exhibited O 1 0.9906541705131531
defects O 1 0.9999963045120239
in O 0 0.003525982378050685
hemostasis O 1 0.9998703002929688
with O 0 0.0005211435491219163
a O 0 0.0014187550405040383
highly O 0 0.004088964778929949
prolonged O 1 0.9999918937683105
bleeding O 1 1.0
time O 0 0.002462940290570259
and O 0 0.0008285732474178076
spontaneous O 0 0.09707935899496078
bleeding O 1 0.9999042749404907
events O 0 0.000526882940903306
in O 0 0.00015111020184122026
approximately O 0 0.0002259114116895944
10 O 0 0.0001808543602237478
% O 0 6.345117435557768e-05
of O 0 0.00035997951636090875
neonates O 0 0.011780905537307262
. O 0 0.00086981151252985

As O 0 0.0011983144795522094
in O 0 0.0002932607021648437
the O 0 0.0007607126608490944
human O 0 0.0016456084558740258
disease O 1 0.9997907280921936
, O 0 0.00017705380741972476
the O 0 0.0004365176719147712
factor O 0 0.001202314393594861
VIII O 1 0.9984807372093201
level O 0 0.0011364731471985579
in O 0 0.000204939249670133
these O 0 6.132313865236938e-05
mice O 0 0.0003512584080453962
was O 0 0.0004144332488067448
reduced O 0 0.0002343379455851391
strongly O 0 0.00010459522309247404
as O 0 4.910983989248052e-05
a O 0 7.822948100510985e-05
result O 0 9.676911577116698e-05
of O 0 0.00013642876001540571
the O 0 0.0003036656999029219
lack O 0 0.0005972525686956942
of O 0 0.0007572291069664061
protection O 0 0.006333247292786837
provided O 0 0.0008205206249840558
by O 0 0.000638442812487483
vWf O 0 0.02363012544810772
. O 0 0.0012493642279878259

Defective O 1 0.9999986886978149
thrombosis B-Disease 1 0.999998927116394
in O 0 0.02806086279451847
mutant O 1 0.9951683282852173
mice O 0 0.004303995054215193
was O 0 0.0008217400754801929
also O 0 0.00011058006202802062
evident O 0 0.00041417055763304234
in O 0 6.493843829957768e-05
an O 0 7.977929635671899e-05
in O 0 0.0001749817602103576
vivo O 0 0.0014125879388302565
model O 0 0.0006348707247525454
of O 0 0.017490431666374207
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.010777967050671577

In O 0 0.0011621020967140794
this O 0 0.0002658373850863427
model O 0 0.0005494163488037884
, O 0 0.00018823734717443585
the O 0 0.0008504432626068592
exteriorized O 1 0.942264199256897
mesentery O 1 0.953055202960968
was O 0 0.014830667525529861
superfused O 1 0.9984365105628967
with O 0 0.001996585400775075
ferric O 1 0.9999997615814209
chloride O 1 0.6852977871894836
and O 0 0.0005100804264657199
the O 0 0.0006950400420464575
accumulation O 0 0.007303241174668074
of O 0 0.0033776797354221344
fluorescently O 1 0.9996277093887329
labeled O 0 0.2292742133140564
platelets O 0 0.08420182019472122
was O 0 0.0013043463695794344
observed O 0 0.0003424597380217165
by O 0 0.000293063378194347
intravital O 0 0.10753247886896133
microscopy O 0 0.005336417816579342
. O 0 0.000817563442979008

We O 0 0.0016147269634529948
conclude O 0 0.0024505334440618753
that O 0 0.00014229080989025533
these O 0 8.410375448875129e-05
mice O 0 0.0005000202218070626
very O 0 0.0001741737505653873
closely O 0 0.0005901605472899973
mimic O 0 0.16504885256290436
severe O 1 0.9999973773956299
human O 1 0.99994957447052
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9672191739082336
will O 0 0.0004379751917440444
be O 0 7.226344314403832e-05
very O 0 3.912364263669588e-05
useful O 0 3.250036752433516e-05
for O 0 1.7518557797302492e-05
investigating O 0 0.00013587869761977345
the O 0 0.00017901277169585228
role O 0 0.0004489774291869253
of O 0 0.0006551871774718165
vWf O 0 0.008767920546233654
in O 0 0.0006220141076482832
normal O 0 0.0012294573243707418
physiology O 0 0.1782654970884323
and O 0 0.00037550789420492947
in O 0 0.0009826369350776076
disease O 1 0.999982476234436
models O 0 0.0016807080246508121
. O 0 0.000375030271243304
. O 0 0.0004304769972804934

Oral O 0 0.05780388414859772
contraceptives O 0 0.01959579810500145
and O 0 0.00041223381413146853
the O 0 0.0006942279869690537
risk O 0 0.0010879547335207462
of O 1 0.7541456818580627
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.11053367704153061

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Clinical O 1 0.9516066908836365
Study O 0 0.0022535899188369513
Group O 0 0.0012428008485585451
. O 0 0.0007330752559937537

BACKGROUND O 0 0.011970195919275284
Women O 0 0.0013802475295960903
with O 0 0.00014591334911528975
mutations O 0 0.00016966454859357327
in O 0 0.00012203207734273747
either O 0 0.0001337703288299963
the O 0 0.00031630630837753415
BRCA1 O 0 0.04623812437057495
or O 0 0.00030989383230917156
the O 0 0.00046210267464630306
BRCA2 O 0 0.007767295464873314
gene O 0 8.853190956870094e-05
have O 0 2.246155600005295e-05
a O 0 0.00011829558934550732
high O 0 0.0004129515727981925
lifetime O 0 0.0011231573298573494
risk O 0 0.001380468369461596
of O 1 0.9994503855705261
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00793448742479086

Oral O 0 0.08564823865890503
contraceptives O 1 0.9273077845573425
protect O 1 0.744037389755249
against O 1 0.9998953342437744
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0015740336384624243
general O 0 0.0017574647208675742
, O 0 9.839226549956948e-05
but O 0 3.29718241118826e-05
it O 0 2.3968656023498625e-05
is O 0 2.7431535272626206e-05
not O 0 1.3385553756961599e-05
known O 0 0.00010035096056526527
whether O 0 8.117923425743356e-05
they O 0 3.92179936170578e-05
also O 0 8.750800770940259e-05
protect O 0 0.0004524540563579649
against O 0 0.0005218857550062239
hereditary B-Disease 1 0.9995532631874084
forms I-Disease 1 0.9988967180252075
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.006496657617390156

METHODS O 0 0.003603233490139246
We O 0 0.0005607978673651814
enrolled O 0 0.0012063024332746863
207 O 0 0.0036049748305231333
women O 0 0.000780319154728204
with O 0 0.0009249326540157199
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.001574522233568132
161 O 0 0.0023755456786602736
of O 0 0.00042132861563004553
their O 0 0.00011548552720341831
sisters O 0 0.000812854093965143
as O 0 0.00011019365774700418
controls O 0 0.00010495730384718627
in O 0 5.50727236259263e-05
a O 0 0.00013245095033198595
case O 0 0.0003419431741349399
- O 0 0.0007834156858734787
control O 0 0.00047089019790291786
study O 0 0.000212467581150122
. O 0 0.0003120012697763741

All O 0 0.0007781318854540586
the O 0 0.000902203842997551
patients O 0 0.0004285048635210842
carried O 0 0.00027499973657540977
a O 0 0.0002805587719194591
pathogenic O 0 0.001227018074132502
mutation O 0 0.0001250235945917666
in O 0 0.00011074278154410422
either O 0 0.00019536020408850163
BRCA1 O 0 0.004040160216391087
( O 0 0.0002391846210230142
179 O 0 0.0010978836799040437
women O 0 0.00024055891844909638
) O 0 0.00010982209641952068
or O 0 0.0003340654948260635
BRCA2 O 0 0.041103824973106384
( O 0 0.0005642620380967855
28 O 0 0.0031114197336137295
women O 0 0.0008707863162271678
) O 0 0.0004723878810182214
. O 0 0.00042774659232236445

The O 0 0.0032159509137272835
control O 0 0.002152719534933567
women O 0 0.00040237646317109466
were O 0 0.00013573442993219942
enrolled O 0 0.00025872347760014236
regardless O 0 0.00010277466935804114
of O 0 0.00013223919086158276
whether O 0 0.00013098683848511428
or O 0 0.0001051389190251939
not O 0 3.518048470141366e-05
they O 0 2.5908168026944622e-05
had O 0 0.00022529451234731823
either O 0 0.0002508632023818791
mutation O 0 0.00048662774497643113
. O 0 0.0004873272846452892

Lifetime O 0 0.008092203177511692
histories O 0 0.0016713166842237115
of O 0 0.0015125595964491367
oral O 0 0.043148212134838104
- O 0 0.0075296140275895596
contraceptive O 0 0.0024586059153079987
use O 0 6.368924368871376e-05
were O 0 4.9338537792209536e-05
obtained O 0 6.37342527625151e-05
by O 0 6.291841418715194e-05
interview O 0 0.0004122864338569343
or O 0 9.124437201535329e-05
by O 0 5.3562795073958114e-05
written O 0 3.515070420689881e-05
questionnaire O 0 8.497034286847338e-05
and O 0 5.6879318435676396e-05
were O 0 7.587030995637178e-05
compared O 0 0.00020770376431755722
between O 0 0.00028513569850474596
patients O 0 0.0002871525939553976
and O 0 0.00015360808174591511
control O 0 0.0009028250933624804
women O 0 0.00033099573920480907
, O 0 0.00010101322550326586
after O 0 0.0002977911790367216
adjustment O 0 0.000742772244848311
for O 0 8.45327231218107e-05
year O 0 0.000221431371755898
of O 0 0.0004425878869369626
birth O 0 0.0019174696644768119
and O 0 0.0008467281586490571
parity O 0 0.05588351562619209
. O 0 0.001286472543142736

RESULTS O 0 0.0034983763471245766
The O 0 0.001515705487690866
adjusted O 0 0.0029099942184984684
odds O 0 0.002639369573444128
ratio O 0 0.0016220655525103211
for O 0 0.0012578848982229829
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 0.0006073990953154862
with O 0 0.0001371054822811857
any O 0 0.00011136195826111361
past O 0 0.00028234347701072693
use O 0 7.318125426536426e-05
of O 0 0.0002949312620330602
oral O 0 0.0039891451597213745
contraceptives O 0 0.046448882669210434
was O 0 0.002175177214667201
0 O 0 0.0007063923985697329
. O 0 0.00048186417552642524

5 O 0 0.0025878511369228363
( O 0 0.0004311978118494153
95 O 0 0.0005338724586181343
percent O 0 0.00023692175454925746
confidence O 0 0.0006276476196944714
interval O 0 0.0002164788165828213
, O 0 4.803434421774e-05
0 O 0 5.14026905875653e-05
. O 0 1.4332637874758802e-05
3 O 0 4.68798607471399e-05
to O 0 3.0530518415616825e-05
0 O 0 8.591703954152763e-05
. O 0 4.856707892031409e-05
8 O 0 0.0005221200408414006
) O 0 0.0002109097840730101
. O 0 0.00042671256233006716

The O 0 0.005031423177570105
risk O 0 0.002181742340326309
decreased O 0 0.001766776666045189
with O 0 8.899201930034906e-05
increasing O 0 0.00014446153363678604
duration O 0 0.00018113704572897404
of O 0 0.00017083760758396238
use O 0 9.205102105624974e-05
( O 0 0.0001620700495550409
P O 0 0.001047366065904498
for O 0 5.650913590216078e-05
trend O 0 0.00024875300005078316
, O 0 6.138098979135975e-05
< O 0 0.0004900191561318934
0 O 0 0.00010586073767626658
. O 0 4.9473146646050736e-05
001 O 0 0.002235681051388383
) O 0 5.1522238209145144e-05
; O 0 1.4810135326115415e-05
use O 0 1.2986874935450032e-05
for O 0 1.929851532622706e-05
six O 0 5.416530621005222e-05
or O 0 5.390071601141244e-05
more O 0 2.8625730919884518e-05
years O 0 0.00013585355191025883
was O 0 0.0002743010991252959
associated O 0 5.1272956625325605e-05
with O 0 2.0938958186889067e-05
a O 0 0.00010975770419463515
60 O 0 0.000213560662814416
percent O 0 0.0002224610943812877
reduction O 0 0.000557186605874449
in O 0 0.00038462248630821705
risk O 0 0.0007549529545940459
. O 0 0.0006180538330227137

Oral O 0 0.025968896225094795
- O 0 0.009448528289794922
contraceptive O 0 0.004936968442052603
use O 0 0.0003259425866417587
protected O 0 0.004150510299950838
against O 1 0.9795138835906982
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
both O 0 0.0003145516093354672
for O 0 0.00010094408207805827
carriers O 0 0.00014053666382096708
of O 0 0.00012334798520896584
the O 0 0.00045284544466994703
BRCA1 O 0 0.04396246373653412
mutation O 0 0.00029977780650369823
( O 0 0.0001533382455818355
odds O 0 0.0004012480203527957
ratio O 0 9.412650251761079e-05
, O 0 2.59855150943622e-05
0 O 0 3.83535552828107e-05
. O 0 1.798164885258302e-05
5 O 0 7.802400068612769e-05
; O 0 1.8544882550486363e-05
95 O 0 0.00017734948778524995
percent O 0 0.00011088786413893104
confidence O 0 0.00038353080162778497
interval O 0 0.00015135854482650757
, O 0 5.046119258622639e-05
0 O 0 4.139575321460143e-05
. O 0 1.4877985449857078e-05
3 O 0 4.283512316760607e-05
to O 0 2.135165050276555e-05
0 O 0 5.606898048426956e-05
. O 0 2.6644278477760963e-05
9 O 0 0.0002080502308672294
) O 0 3.0648778192698956e-05
and O 0 2.9234826797619462e-05
for O 0 3.184594970662147e-05
carriers O 0 0.00011854851618409157
of O 0 0.0001464117522118613
the O 0 0.0005850183661095798
BRCA2 O 0 0.030184393748641014
mutation O 0 0.00032440893119201064
( O 0 0.00016382390458602458
odds O 0 0.0005415448104031384
ratio O 0 0.00011672318214550614
, O 0 3.5254772228654474e-05
0 O 0 3.670070509542711e-05
. O 0 1.6724055967642926e-05
4 O 0 8.010480087250471e-05
; O 0 2.2511627321364358e-05
95 O 0 0.00016998760111164302
percent O 0 0.00013784835755359381
confidence O 0 0.0003866879269480705
interval O 0 0.00015343725681304932
, O 0 4.344870103523135e-05
0 O 0 3.856981493299827e-05
. O 0 1.4832808119535912e-05
2 O 0 5.2313193009467795e-05
to O 0 2.7895328457816504e-05
1 O 0 0.00014536605158355087
. O 0 5.32081576238852e-05
1 O 0 0.00039460722473450005
) O 0 0.0002150219661416486
. O 0 0.0003937510191462934

CONCLUSIONS O 0 0.012267819605767727
Oral O 0 0.017839672043919563
- O 0 0.006513664964586496
contraceptive O 0 0.0030412478372454643
use O 0 0.00014353744336403906
may O 0 0.00012905891344416887
reduce O 0 0.00014407344860956073
the O 0 0.00022034000721760094
risk O 0 0.000715569534804672
of O 1 0.996604323387146
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0034214062616229057
women O 0 0.0004071853472851217
with O 0 0.000101307341537904
pathogenic O 0 0.0010484872618690133
mutations O 0 0.00018030748469755054
in O 0 0.00016661162953823805
the O 0 0.0007691914797760546
BRCA1 O 1 0.9786832332611084
or O 0 0.002034749137237668
BRCA2 O 0 0.2947218120098114
gene O 0 0.003200842998921871

A O 0 0.010821929201483727
Japanese O 0 0.011418979614973068
family O 0 0.0018892093794420362
with O 0 0.0006296217907220125
adrenoleukodystrophy B-Disease 1 0.9999991655349731
with O 0 0.0004920078790746629
a O 0 0.0009022896992973983
codon O 0 0.001427461626008153
291 O 0 0.0014322535134851933
deletion O 0 0.000621277664322406
: O 0 0.00010649760952219367
a O 0 0.0001791210233932361
clinical O 0 0.00045876309741288424
, O 0 0.00028439078596420586
biochemical O 0 0.007515061181038618
, O 0 0.0006250378210097551
pathological O 1 0.9955247640609741
, O 0 0.0005416307249106467
and O 0 0.0004298435233067721
genetic O 0 0.001109195058234036
report O 0 0.0008955431403592229
. O 0 0.0006510181119665504

We O 0 0.0007215775549411774
report O 0 0.00022655227803625166
a O 0 0.0002551100042182952
Japanese O 0 0.0019365481566637754
family O 0 0.0009910940425470471
with O 0 0.0009269759757444263
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9997259974479675
ALD B-Disease 1 1.0
) O 0 0.00033375094062648714
with O 0 7.08679945091717e-05
a O 0 0.00012904044706374407
three O 0 0.0001224928128067404
base O 0 0.0006672636372968554
pair O 0 0.0007244120934046805
deletion O 0 0.001977713080123067
( O 0 0.0006473077810369432
delGAG O 0 0.02601311355829239
291 O 0 0.0031175133772194386
) O 0 0.00013820886670146137
in O 0 0.00017936747462954372
the O 0 0.00125643250066787
ALD B-Disease 1 0.9999998807907104
gene O 0 0.0030183293856680393
. O 0 0.0010211402550339699

A O 0 0.004262298345565796
variety O 0 0.0006858925335109234
of O 0 0.0008583908202126622
phenotypes O 0 0.001386284944601357
were O 0 0.00020666370983235538
observed O 0 0.00015005801105871797
within O 0 0.00012577115558087826
this O 0 0.00012088272342225537
family O 0 0.0005475290818139911
. O 0 0.0004923346568830311

While O 0 0.0010946397669613361
the O 0 0.0009324228158220649
proband O 1 0.9950593709945679
( O 0 0.0007446059607900679
patient O 0 0.0007356927380897105
1 O 0 0.0004954490577802062
) O 0 7.89236364653334e-05
was O 0 0.00033224993967451155
classified O 0 0.00028432352701202035
as O 0 0.00010068038682220504
having O 0 0.00013030973786953837
a O 0 0.00015651274588890374
rare O 0 0.0005152192316018045
intermediate O 0 0.0011902296682819724
type O 0 0.0005472301272675395
of O 0 0.0008078361279331148
adult O 0 0.0020191820804029703
cerebral O 1 0.999983549118042
and O 0 0.004193459637463093
cerebello O 1 0.9999998807907104
- O 1 0.9999058246612549
brain O 1 0.9989444613456726
stem O 0 0.0014774370938539505
forms O 0 0.000299085775623098
, O 0 0.00011900327081093565
his O 0 0.0005372118321247399
younger O 0 0.0021942423190921545
brother O 0 0.004838909022510052
( O 0 0.00033843694836832583
patient O 0 0.0006199339986778796
2 O 0 0.0005745911039412022
) O 0 8.521125710103661e-05
and O 0 9.839095582719892e-05
nephew O 0 0.009653882123529911
( O 0 0.00040091254049912095
patient O 0 0.0005822197999805212
3 O 0 0.0007095317123457789
) O 0 0.00015815335791558027
had O 0 0.0003905697667505592
a O 0 0.0010679548140615225
childhood O 1 0.9997137188911438
ALD B-Disease 1 1.0
type O 1 0.9989771842956543
. O 0 0.003192082280293107

Another O 0 0.007941990159451962
nephew O 1 0.7075690627098083
( O 0 0.001248999615199864
patient O 0 0.0008851450402289629
4 O 0 0.0006346632144413888
) O 0 9.054161637322977e-05
of O 0 0.0001707459014141932
patient O 0 0.00044735358096659184
1 O 0 0.0004340582527220249
was O 0 0.0005573740927502513
classified O 0 0.00041915092151612043
as O 0 0.00015503157919738442
having O 0 0.00027567148208618164
an O 0 0.0002739409392233938
adolescent O 0 0.005905002821236849
form O 0 0.0012595009757205844
. O 0 0.0007612888584844768

The O 0 0.0033189496025443077
tau O 0 0.0056663258001208305
level O 0 0.0007470549317076802
in O 0 0.00020764458167832345
the O 0 0.0007560169906355441
cerebrospinal O 1 0.9980307221412659
fluid O 1 0.9950802326202393
( O 0 0.002549088327214122
CSF O 1 0.9994269609451294
) O 0 0.00011353926674928516
in O 0 8.114115917123854e-05
patient O 0 0.00024516487610526383
1 O 0 0.0002494669461157173
was O 0 0.00042584657785482705
as O 0 0.0001297692215302959
high O 0 0.00023553725623060018
as O 0 6.684599065920338e-05
that O 0 2.579672946012579e-05
of O 0 0.00020987306197639555
patients O 0 0.000680622411891818
with O 0 0.0019265476148575544
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.807794451713562
AD B-Disease 0 0.019946476444602013
) O 0 0.0005469126044772565
. O 0 0.0003432763915043324

His O 0 0.020423855632543564
brain O 1 0.9973561763763428
magnetic O 0 0.009443530812859535
resonance O 0 0.0047361236065626144
image O 0 0.005143850110471249
( O 0 0.001694693579338491
MRI O 1 0.9915933609008789
) O 0 0.0006007046904414892
showed O 0 0.0018986253999173641
abnormalities B-Disease 0 0.055475864559412
in I-Disease 0 0.0005352802691049874
the I-Disease 0 0.0014795103343203664
bilateral I-Disease 1 0.7391718029975891
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9998816251754761
and O 1 0.7145682573318481
brain O 1 0.9999997615814209
stem O 1 0.9843407273292542
, O 0 0.00015043838357087225
but O 0 4.267659460310824e-05
not O 0 1.8008027836913243e-05
in O 0 6.912551907589659e-05
the O 0 0.0005680355825461447
cerebral O 1 0.9999091625213623
white O 0 0.3224593997001648
matter O 0 0.0006338463281281292
, O 0 0.00012584697105921805
where O 0 0.00014301731425803155
marked O 0 0.0009491727687418461
reductions O 0 0.00092179054627195
of O 0 0.00044879302731715143
the O 0 0.0020390839781612158
cerebral O 1 0.9999984502792358
blood O 1 0.9997594952583313
flow O 0 0.014347006566822529
and O 0 0.0010016780579462647
oxygen O 0 0.01743791624903679
metabolism O 0 0.0024595579598098993
were O 0 0.00012867135228589177
clearly O 0 0.0001535704650450498
demonstrated O 0 0.00028208622825331986
by O 0 5.4180236475076526e-05
positron O 0 0.0012423120206221938
emission O 0 0.0007944952812977135
tomography O 0 0.000739575014449656
( O 0 0.0007878569886088371
PET O 0 0.009030771441757679
) O 0 0.00043659735820256174
. O 0 0.000432436412665993

In O 0 0.0025226790457963943
patients O 0 0.0008511948981322348
2 O 0 0.0006618144107051194
and O 0 0.00018745427951216698
3 O 0 0.00030276778852567077
, O 0 0.00011386954429326579
the O 0 0.0001813957787817344
autopsy O 0 0.0013619023375213146
findings O 0 0.00043742070556618273
showed O 0 0.0014106823364272714
massive O 1 0.8140575289726257
demyelination B-Disease 1 0.9999997615814209
of I-Disease 1 0.6575188040733337
the I-Disease 1 0.9960349202156067
cerebral I-Disease 1 0.9999986886978149
white I-Disease 0 0.087223581969738
matter I-Disease 0 0.0003745566646102816
with O 0 8.171740046236664e-05
sparing O 0 0.000779025605879724
of O 0 0.0003119299071840942
the O 0 0.0014413148164749146
U O 1 0.9999899864196777
- O 0 0.2683500051498413
fibers O 1 0.516058623790741
, O 0 0.0002054963551927358
compatible O 0 0.0001413352001691237
with O 0 5.365870310924947e-05
the O 0 0.00017031743482220918
findings O 0 0.0003111754194833338
of O 0 0.0011749290861189365
childhood O 1 0.9999475479125977
ALD B-Disease 1 1.0
. O 0 0.009313377551734447

Oleic O 0 0.4110201895236969
and O 0 0.005186179187148809
erucic O 1 0.9939285516738892
acids O 0 0.00284101371653378
( O 0 0.0012827090686187148
Lorenzos O 1 0.9903542995452881
Oil O 0 0.004788869991898537
) O 0 0.0001279810821870342
were O 0 7.101323717506602e-05
administered O 0 0.00013832937111146748
to O 0 5.066616358817555e-05
patients O 0 0.00010903260408667848
1 O 0 0.0001736981066642329
and O 0 9.790987678570673e-05
4 O 0 0.00030926454928703606
, O 0 8.172526577254757e-05
but O 0 6.599031621590257e-05
sufficient O 0 0.00034571808646433055
effectiveness O 0 0.00043146920506842434
was O 0 0.0005397563218139112
not O 0 8.917458035284653e-05
obtained O 0 0.00028405420016497374
. O 0 0.0004350229864940047

The O 0 0.0022854243870824575
findings O 0 0.0005645821220241487
in O 0 0.00019238298409618437
this O 0 9.107555524678901e-05
family O 0 0.00024835485965013504
suggest O 0 0.00030306470580399036
that O 0 0.00010654614015948027
delGAG291 O 0 0.019760852679610252
is O 0 0.00011589988571358845
part O 0 0.000237494838074781
of O 0 0.0002630079980008304
the O 0 0.0006684312247671187
cause O 0 0.006460645701736212
of O 0 0.0026147793978452682
Japanese O 1 0.9998782873153687
ALD B-Disease 1 1.0
with O 0 0.0012302023824304342
phenotypic O 0 0.0071879057213664055
variations O 0 0.0011853623436763883
. O 0 0.0008023488335311413

Moreover O 0 0.003863197984173894
, O 0 0.0002688104286789894
although O 0 5.9800324379466474e-05
the O 0 0.00010194402420893312
scale O 0 0.0003207037225365639
of O 0 0.0001866557722678408
the O 0 0.00025269194156862795
study O 0 0.00010055546590592712
is O 0 4.623903805622831e-05
limited O 0 4.7900128265609965e-05
, O 0 3.0339477234520018e-05
there O 0 3.184655724908225e-05
is O 0 4.1151841287501156e-05
a O 0 0.0001178634338430129
possibility O 0 0.0003115750150755048
that O 0 9.406691970070824e-05
PET O 0 0.0029104379937052727
can O 0 0.00013082678196951747
detect O 0 0.0005457300576381385
an O 0 0.0005254431162029505
insidious B-Disease 1 0.9980787038803101
lesion I-Disease 1 0.9999576807022095
which O 0 0.00043247666326351464
is O 0 0.0002635095443110913
undetectable O 0 0.003972299862653017
by O 0 0.00015890553186181933
computed O 0 0.0004758899158332497
tomogram O 0 0.11811330914497375
( O 0 0.000748434744309634
CT O 0 0.01206557359546423
) O 0 0.0001680876302998513
or O 0 0.0001849775726441294
MRI O 0 0.002674926072359085
analysis O 0 7.220612314995378e-05
, O 0 7.984215335454792e-05
and O 0 5.005586353945546e-05
that O 0 2.672041409823578e-05
the O 0 0.0001344193733530119
higher O 0 0.00017314149590674788
level O 0 0.00022043036005925387
of O 0 0.00018737476784735918
tau O 0 0.0016682777786627412
reflects O 0 0.0003679307992570102
the O 0 0.00018677576736081392
process O 0 0.00026681830058805645
of O 0 0.0011109557235613465
neuronal B-Disease 1 0.9994850158691406
degeneration I-Disease 1 1.0
in O 1 0.9996803998947144
ALD B-Disease 1 1.0
. O 0 0.005467630457133055

Lorenzos O 1 0.9991106390953064
Oil O 0 0.011135988868772984
should O 0 0.00018472940428182483
be O 0 3.313251363579184e-05
given O 0 2.6724594135885127e-05
in O 0 4.8542166041443124e-05
the O 0 0.00016781986050773412
early O 0 0.000632367969956249
stage O 0 0.0033773090690374374
. O 0 0.00028751612990163267
. O 0 0.0003128406242467463

Nonsense O 0 0.019543340429663658
mutation O 0 0.0009026784682646394
in O 0 0.00035021748044528067
exon O 0 0.002837530802935362
4 O 0 0.000648452085442841
of O 0 0.00033872746280394495
human O 0 0.0005788749549537897
complement O 0 0.0025305477902293205
C9 O 1 0.9999005794525146
gene O 0 0.0003485404304228723
is O 0 6.540018512168899e-05
the O 0 0.00018569754320196807
major O 0 0.0011445856653153896
cause O 0 0.001336039393208921
of O 0 0.0014758866745978594
Japanese O 1 0.9982800483703613
complement B-Disease 1 0.999470055103302
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0032867875415831804

Deficiency B-Disease 1 0.9999784231185913
of I-Disease 0 0.005215181037783623
the I-Disease 0 0.004431816749274731
ninth I-Disease 1 0.9986653327941895
component I-Disease 0 0.0020552854984998703
of I-Disease 0 0.0005454231868498027
human I-Disease 0 0.0006077016005292535
complement I-Disease 0 0.002154518850147724
( O 0 0.0010320666478946805
C9 O 1 0.9997678399085999
) O 0 0.0002274576690979302
is O 0 6.174061127239838e-05
the O 0 0.00013369151565711945
most O 0 0.00012534612324088812
common O 0 0.0004579382366500795
complement B-Disease 1 0.9996944665908813
deficiency I-Disease 1 1.0
in O 0 0.11837688833475113
Japan O 0 0.49879589676856995
but O 0 0.00012038463319186121
is O 0 6.299070082604885e-05
rare O 0 0.00020209280773997307
in O 0 0.00012192076974315569
other O 0 7.707683107582852e-05
countries O 0 5.711744597647339e-05
. O 0 0.0004141102253925055

We O 0 0.0006228695856407285
studied O 0 0.000332221738062799
the O 0 0.00019586790585890412
molecular O 0 0.00021156721049919724
basis O 0 0.00015933765098452568
of O 0 0.001176166464574635
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
in O 0 0.0012084990739822388
four O 0 0.000717551854904741
Japanese O 1 0.5920031070709229
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9863353967666626
deficient I-Disease 1 0.9683179259300232
patients O 0 0.0005249499808996916
who O 0 0.0004517386551015079
had O 0 0.0033727316185832024
suffered O 1 0.9999998807907104
from O 1 0.9999544620513916
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.12478768080472946

Direct O 0 0.0023011115845292807
sequencing O 0 0.0017490724567323923
of O 0 0.0012012107763439417
amplified O 0 0.008998770266771317
C9 O 1 0.9809387922286987
cDNA O 0 0.0034452409017831087
and O 0 0.0002899523242376745
DNA O 0 0.00038876524195075035
revealed O 0 0.0005454107304103673
a O 0 0.00027147718355990946
nonsense O 0 0.0023996615782380104
substitution O 0 0.0014106660382822156
( O 0 0.0004782468604389578
CGA O 0 0.007610322441905737
- O 0 0.001319830771535635
- O 0 0.0010927623370662332
> O 0 0.0012432732619345188
TGA O 0 0.0065830363892018795
) O 0 0.00011082591663580388
at O 0 0.00028506043599918485
codon O 0 0.0005085341981612146
95 O 0 0.00024274492170661688
in O 0 8.535927918273956e-05
exon O 0 0.0009420571150258183
4 O 0 0.0002553317171987146
in O 0 7.661356357857585e-05
the O 0 0.00021463072334881872
four O 0 0.0006551516707986593
C9 B-Disease 1 0.9999972581863403
- I-Disease 1 0.8828815221786499
deficient I-Disease 0 0.08649512380361557
individuals O 0 0.00035227820626460016
. O 0 0.0007119722431525588

An O 0 0.0010876577580347657
allele O 0 0.0008246278739534318
- O 0 0.0005737768369726837
specific O 0 0.00013838321319781244
polymerase O 0 0.001511727343313396
chain O 0 0.0011980690760537982
reaction O 0 0.0005857917130924761
system O 0 0.000290112744551152
designed O 0 0.0003500247548799962
to O 0 0.00011673308472381905
detect O 0 0.0003645850229077041
exclusively O 0 0.00010041577479569241
only O 0 1.6894777218112722e-05
one O 0 2.492246130714193e-05
of O 0 8.377573249163106e-05
the O 0 0.00027408465393818915
normal O 0 0.0003617527545429766
and O 0 0.00014971272321417928
mutant O 0 0.0011097381357103586
alleles O 0 0.00018372570048086345
indicated O 0 0.00011337245814502239
that O 0 1.4118564649834298e-05
all O 0 2.0716935978271067e-05
the O 0 0.00011041074321838096
four O 0 0.00013395158748608083
patients O 0 0.00015572972188238055
were O 0 8.066638110904023e-05
homozygous O 0 0.00020937557565048337
for O 0 2.7701571525540203e-05
the O 0 0.00010085931717185304
mutation O 0 6.766679871361703e-05
in O 0 8.140373392961919e-05
exon O 0 0.0011822308879345655
4 O 0 0.0002580870932433754
and O 0 3.696537532960065e-05
that O 0 1.6561672964598984e-05
the O 0 6.433310045395046e-05
parents O 0 5.77475038880948e-05
of O 0 0.00019519001943990588
patient O 0 0.0008480706601403654
2 O 0 0.001111689256504178
were O 0 0.0003883755416609347
heterozygous O 0 0.0009737960644997656
. O 0 0.00040836981497704983

The O 0 0.0031131505966186523
common O 0 0.0005471456679515541
mutation O 0 0.0004369193338789046
at O 0 0.0006008879281580448
codon O 0 0.0007239262340590358
95 O 0 0.0002810382575262338
in O 0 9.710947051644325e-05
exon O 0 0.0016090866411104798
4 O 0 0.0004928898415528238
might O 0 0.00016314111417159438
be O 0 3.02055268548429e-05
responsible O 0 0.00015776506916154176
for O 0 8.38791747810319e-05
most O 0 0.00040488230297341943
Japanese O 1 0.9956316947937012
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0017873469041660428
. O 0 0.0009947816142812371

BRCA1 O 0 0.027501992881298065
required O 0 0.0005498926620930433
for O 0 0.00021750769519712776
transcription O 0 0.0024895246606320143
- O 0 0.0032956877257674932
coupled O 0 0.002561241155490279
repair O 1 0.9943268895149231
of O 0 0.006984067615121603
oxidative O 1 0.9999507665634155
DNA O 1 0.7877321243286133
damage O 1 0.9998317956924438
. O 0 0.0025221151299774647

The O 0 0.03882432356476784
breast B-Disease 1 0.9999955892562866
and I-Disease 1 0.9975202679634094
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999167919158936
gene O 0 0.0032069343142211437
BRCA1 O 0 0.010733582079410553
encodes O 0 0.0005625059129670262
a O 0 0.0005060613621026278
zinc O 0 0.08073854446411133
finger O 0 0.002981562865898013
protein O 0 0.00034223010879941285
of O 0 0.0004564720729831606
unknown O 0 0.00110901752486825
function O 0 0.00044562260154634714
. O 0 0.00033431683550588787

Association O 0 0.00254974071867764
of O 0 0.0007872138521634042
the O 0 0.0011470370227470994
BRCA1 O 0 0.006927868817001581
protein O 0 0.00032458093483000994
with O 0 7.753137469990179e-05
the O 0 0.0003427216724958271
DNA O 0 0.001641593873500824
repair O 1 0.996737539768219
protein O 0 0.00230661709792912
Rad51 O 1 0.9522373080253601
and O 0 0.0002413825859548524
changes O 0 0.00011314760922687128
in O 0 7.77601744630374e-05
the O 0 0.00016297369438689202
phosphorylation O 0 0.00022830608941148967
and O 0 0.00011234823614358902
cellular O 0 0.00045079062692821026
localization O 0 0.0006852264632470906
of O 0 0.0001422785862814635
the O 0 0.00020349719852674752
protein O 0 0.0001641738781472668
after O 0 0.00028620471130125225
exposure O 0 0.0002981650468427688
to O 0 8.423876715824008e-05
DNA O 0 0.0008425098494626582
- O 0 0.0015467421617358923
damaging O 0 0.006155240349471569
agents O 0 0.00022804090986028314
are O 0 1.874520421552006e-05
consistent O 0 8.51070653880015e-05
with O 0 3.9750484575051814e-05
a O 0 0.00015646305109839886
role O 0 0.0005901774275116622
for O 0 0.00016675722145009786
BRCA1 O 0 0.02109501138329506
in O 0 0.0008130147471092641
DNA O 0 0.0037373744416981936
repair O 1 0.9993945360183716
. O 0 0.0021630486007779837

Here O 0 0.003825591644272208
, O 0 0.0004408598178997636
it O 0 8.759123738855124e-05
is O 0 5.233844422036782e-05
shown O 0 0.00010392989497631788
that O 0 8.785625686869025e-05
mouse O 0 0.0013492663856595755
embryonic O 0 0.006081965286284685
stem O 0 0.009089136496186256
cells O 0 0.0025435294955968857
deficient B-Disease 0 0.01219397783279419
in I-Disease 0 0.0005033485358580947
BRCA1 I-Disease 0 0.03608405217528343
are O 0 7.939671195345e-05
defective O 0 0.00469952030107379
in O 0 0.00013906019739806652
the O 0 0.00016023444186430424
ability O 0 8.670875104144216e-05
to O 0 4.149036612943746e-05
carry O 0 7.367510988842696e-05
out O 0 0.00011420120426919311
transcription O 0 0.000788989185821265
- O 0 0.0008622723980806768
coupled O 0 0.0014596293913200498
repair O 0 0.10220485925674438
of O 0 0.0015188927063718438
oxidative O 1 0.9999513626098633
DNA O 1 0.9429009556770325
damage O 1 0.9999827146530151
, O 0 0.000262481247773394
and O 0 0.00012232545122969896
are O 0 5.083414725959301e-05
hypersensitive O 0 0.006024335511028767
to O 0 0.0009548827074468136
ionizing O 1 0.9484086632728577
radiation O 0 0.1100575253367424
and O 0 0.0006206676480360329
hydrogen O 0 0.0035134325735270977
peroxide O 0 0.008967765606939793
. O 0 0.0011633038520812988

These O 0 0.0007763803005218506
results O 0 0.00039440792170353234
suggest O 0 0.00032603141153231263
that O 0 0.000152718392200768
BRCA1 O 0 0.010443638078868389
participates O 0 0.0009294978226535022
, O 0 0.00016803618927951902
directly O 0 0.00022630312014371157
or O 0 0.0001780417951522395
indirectly O 0 0.00046539423055946827
, O 0 0.00015157836605794728
in O 0 0.0001426559902029112
transcription O 0 0.0012121465988457203
- O 0 0.0014295874862000346
coupled O 0 0.0025902818888425827
repair O 1 0.5858039259910583
of O 0 0.005126442760229111
oxidative O 1 0.9999358654022217
DNA O 1 0.7930417060852051
damage O 1 0.9999215602874756
. O 0 0.0007370228413492441
. O 0 0.0007464911905117333

Truncation O 0 0.04507070407271385
mutations O 0 0.0010175780626013875
in O 0 0.00031489095999859273
the O 0 0.0005660709575749934
transactivation O 0 0.007346309721469879
region O 0 0.0007219008402898908
of O 0 0.0010137964272871614
PAX6 O 1 0.999972939491272
result O 0 0.0009317806106992066
in O 0 0.0005468401941470802
dominant O 0 0.0033966945484280586
- O 0 0.0019419610034674406
negative O 0 0.0007563013350591063
mutants O 0 0.0042379978112876415
. O 0 0.0007891011773608625

PAX6 O 1 0.9736675024032593
is O 0 0.000572694989386946
a O 0 0.0005021961987949908
transcription O 0 0.0006011365330778062
factor O 0 0.00022702710703015327
with O 0 3.2623524020891637e-05
two O 0 5.668119410984218e-05
DNA O 0 0.00029680508305318654
- O 0 0.00031372890225611627
binding O 0 0.00013386145292315632
domains O 0 0.00040680356323719025
( O 0 0.00025666336296126246
paired O 0 0.0007737222476862371
box O 0 0.001428141607902944
and O 0 0.0002821561647579074
homeobox O 0 0.007617002818733454
) O 0 0.00013024377403780818
and O 0 0.00011163061572005972
a O 0 0.0004137860087212175
proline O 0 0.004114700015634298
- O 0 0.0015935486881062388
serine O 0 0.0021076309494674206
- O 0 0.001288250437937677
threonine O 0 0.004779915791004896
( O 0 0.001093294587917626
PST O 1 0.9110954403877258
) O 0 0.0005099876434542239
- O 0 0.0014393094461411238
rich O 0 0.0014677756698802114
transactivation O 0 0.01365612167865038
domain O 0 0.0017706293147057295
. O 0 0.0008469530148431659

PAX6 O 1 0.9999382495880127
regulates O 0 0.07875054329633713
eye O 0 0.10712880641222
development O 0 0.0010389882372692227
in O 0 0.00031981157371774316
animals O 0 0.00018610488041304052
ranging O 0 0.0002969786000903696
from O 0 0.00018279103096574545
jellyfish O 0 0.00044647534377872944
to O 0 9.08052534214221e-05
Drosophila O 0 0.0008696126169525087
to O 0 0.0002770672144833952
humans O 0 0.0007006086525507271
. O 0 0.0003599788178689778

Heterozygous O 0 0.00355877005495131
mutations O 0 0.0005961679271422327
in O 0 0.0002542068250477314
the O 0 0.0005288054817356169
human O 0 0.0009679298964329064
PAX6 O 1 0.9998993873596191
gene O 0 0.0003480738669168204
result O 0 0.00015990536485332996
in O 0 0.00011782703222706914
various O 0 0.00013538206985685974
phenotypes O 0 0.0010104466928169131
, O 0 0.0001800439495127648
including O 0 0.0005732919089496136
aniridia B-Disease 1 1.0
, O 0 0.0037232753820717335
Peters B-Disease 1 0.9999948740005493
anomaly I-Disease 1 0.9999967813491821
, O 0 0.002002280903980136
autosomal B-Disease 1 0.9364376068115234
dominant I-Disease 1 0.9999549388885498
keratitis I-Disease 1 1.0
, O 0 0.007160212378948927
and O 0 0.0026890658773481846
familial B-Disease 1 0.9999985694885254
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.660392165184021

It O 0 0.0007116211345419288
is O 0 0.00027356305508874357
believed O 0 0.0004458233597688377
that O 0 5.3916650358587503e-05
the O 0 0.0001826849183999002
mutated O 0 0.0007471320568583906
allele O 0 0.0003415241662878543
of O 0 0.0004437760799191892
PAX6 O 1 0.9983377456665039
produces O 0 0.0004438354808371514
an O 0 0.00017858008504845202
inactive O 0 0.0010603979462757707
protein O 0 0.0003970966790802777
and O 0 0.00027566123753786087
aniridia B-Disease 1 0.9999921321868896
is O 0 0.0004508924321271479
caused O 0 0.007671103347092867
due O 0 0.001117523293942213
to O 0 0.0004750654916279018
genetic O 0 0.002075116615742445
haploinsufficiency O 1 0.9998123049736023
. O 0 0.0017637130804359913

However O 0 0.0017006793059408665
, O 0 0.00029158289544284344
several O 0 0.00022139272186905146
truncation O 0 0.007782634813338518
mutations O 0 0.0005050435429438949
have O 0 6.176393799250945e-05
been O 0 6.583231152035296e-05
found O 0 4.2106355977011845e-05
to O 0 4.209671897115186e-05
occur O 0 5.4194861149881035e-05
in O 0 4.667132452595979e-05
the O 0 0.00023485574638471007
C O 0 0.0009947464568540454
- O 0 0.0008816720801405609
terminal O 0 0.0010415720753371716
half O 0 0.00017971945635508746
of O 0 0.0002746994432527572
PAX6 O 1 0.9943400025367737
in O 0 0.0005165737820789218
patients O 0 0.00029722985345870256
with O 0 0.0001897266338346526
Aniridia B-Disease 1 0.9999998807907104
resulting O 0 0.0025978372432291508
in O 0 0.00047433830332010984
mutant O 0 0.0011394958710297942
proteins O 0 9.371703345095739e-05
that O 0 3.4864664485212415e-05
retain O 0 0.00015094317495822906
the O 0 0.0001373305422021076
DNA O 0 0.0003239641955588013
- O 0 0.0003236807824578136
binding O 0 8.247599907917902e-05
domains O 0 0.00020532379858195782
but O 0 3.640531576820649e-05
have O 0 1.949864235939458e-05
lost O 0 0.00023261293245013803
most O 0 3.7117551983101293e-05
of O 0 0.00012327957665547729
the O 0 0.0006168519612401724
transactivation O 0 0.02104334719479084
domain O 0 0.0017426111735403538
. O 0 0.0008610746008343995

It O 0 0.0007108129793778062
is O 0 0.00018561858450993896
not O 0 4.4547265133587644e-05
clear O 0 0.00012239287025295198
whether O 0 8.104139851639047e-05
such O 0 9.775464423000813e-05
mutants O 0 0.0024190545082092285
really O 0 0.0007501145009882748
behave O 0 0.0004307308990973979
as O 0 0.00019087377586402
loss O 0 0.0010558979120105505
- O 0 0.0005339378258213401
of O 0 0.000306652975268662
- O 0 0.0008881992544047534
function O 0 0.00029240024741739035
mutants O 0 0.0015783982817083597
as O 0 0.0002986182225868106
predicted O 0 0.0007291188812814653
by O 0 0.00024783588014543056
haploinsufficiency O 0 0.1141028180718422
. O 0 0.0015393324429169297

Contrary O 0 0.0029667953494936228
to O 0 0.00021658906189259142
this O 0 9.677447087597102e-05
theory O 0 0.0003915991692338139
, O 0 0.0001478204212617129
our O 0 0.00018138762970920652
data O 0 7.227791502373293e-05
showed O 0 0.00021946527704130858
that O 0 4.385435750009492e-05
these O 0 2.8052700145053677e-05
mutants O 0 0.0008041809196583927
are O 0 2.7635393053060398e-05
dominant O 0 0.0007460666238330305
- O 0 0.0005157152772881091
negative O 0 9.632261208025739e-05
in O 0 0.00023735358263365924
transient O 0 0.003892159555107355
transfection O 0 0.011660157702863216
assays O 0 0.0006241298979148269
when O 0 0.00016183548723347485
they O 0 3.630992796388455e-05
are O 0 1.6701134882168844e-05
coexpressed O 0 0.0033350090961903334
with O 0 0.00013041253259871155
wild O 0 0.0014612629311159253
- O 0 0.004800684284418821
type O 0 0.005154680926352739
PAX6 O 1 0.9994878768920898
. O 0 0.0019791675731539726

We O 0 0.0007117110071703792
found O 0 0.00013457969180308282
that O 0 4.25818761868868e-05
the O 0 0.000188294259714894
dominant O 0 0.001823736703954637
- O 0 0.0006902269669808447
negative O 0 0.0002380647638347
effects O 0 0.00040717466617934406
result O 0 0.00014193644165061414
from O 0 0.00013787530770059675
the O 0 0.00018823286518454552
enhanced O 0 0.0005518763209693134
DNA O 0 0.00025725230807438493
binding O 0 9.876977856038138e-05
ability O 0 0.0001082426097127609
of O 0 0.00018634246953297406
these O 0 0.00013409739767666906
mutants O 0 0.0063926177099347115
. O 0 0.0008753605070523918

Kinetic O 0 0.006897256709635258
studies O 0 0.0002505517622921616
of O 0 0.0004475587629713118
binding O 0 0.00036564821493811905
and O 0 0.00025916812592186034
dissociation O 0 0.002125747036188841
revealed O 0 0.0007096304907463491
that O 0 6.538359593832865e-05
various O 0 0.00010283347364747897
truncation O 0 0.0036708172410726547
mutants O 0 0.0013108353596180677
have O 0 4.552410973701626e-05
3 O 0 0.00021778620430268347
- O 0 0.0002724646183196455
5 O 0 0.00023718482407275587
- O 0 0.00030115764820948243
fold O 0 0.00043315760558471084
higher O 0 7.805853238096461e-05
affinity O 0 6.0779530031140894e-05
to O 0 1.925153446791228e-05
various O 0 3.2318144803866744e-05
DNA O 0 0.00017602932348381728
- O 0 0.00023840642825234681
binding O 0 4.876338061876595e-05
sites O 0 5.8677876950241625e-05
when O 0 5.313037399901077e-05
compared O 0 6.591849523829296e-05
with O 0 2.392925671301782e-05
the O 0 0.000161370582645759
wild O 0 0.001212304225191474
- O 0 0.002875122707337141
type O 0 0.004150898661464453
PAX6 O 1 0.9995400905609131
. O 0 0.0025310604833066463

These O 0 0.00033728062408044934
results O 0 0.00022516309400089085
provide O 0 7.600674143759534e-05
a O 0 9.189770207740366e-05
new O 0 0.00010292039951309562
insight O 0 0.0004981036763638258
into O 0 0.00011547275062184781
the O 0 0.00017992347420658916
role O 0 0.00041495668119750917
of O 0 0.0006689318106509745
mutant O 0 0.08477021008729935
PAX6 O 1 0.9999840259552002
in O 0 0.0038797452580183744
causing O 1 0.9999765157699585
aniridia B-Disease 1 0.9999998807907104
. O 0 0.0011564954183995724
. O 0 0.000744181452319026

Reversal O 1 0.7310239672660828
of O 1 0.9507714509963989
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999845027923584
excellent O 1 0.9975087642669678
neuropsychologic O 1 0.9999524354934692
outcome O 0 0.0006546573713421822
in O 0 0.0001062690353137441
very B-Disease 0 9.839770063990727e-05
- I-Disease 0 0.00029615696985274553
long I-Disease 0 0.0001657007960602641
- I-Disease 0 0.0005047134472988546
chain I-Disease 0 0.0010059131309390068
acyl I-Disease 0 0.0018273305613547564
- I-Disease 0 0.001444248715415597
coenzyme I-Disease 0 0.0041807349771261215
A I-Disease 0 0.12957870960235596
dehydrogenase I-Disease 1 0.9998644590377808
deficiency I-Disease 1 0.9999997615814209
. O 0 0.004295756109058857

Very B-Disease 0 0.002660357393324375
- I-Disease 0 0.003247293410822749
long I-Disease 0 0.0011087750317528844
- I-Disease 0 0.0014773026341572404
chain I-Disease 0 0.0011667845537886024
acyl I-Disease 0 0.0015159567119553685
- I-Disease 0 0.0006437686970457435
coenzyme I-Disease 0 0.0009035444818437099
A I-Disease 0 0.0016329459613189101
dehydrogenase I-Disease 0 0.013657053001224995
( I-Disease 0 0.0019330610521137714
VLCAD I-Disease 1 0.9999996423721313
) I-Disease 0 0.003663437208160758
deficiency I-Disease 1 0.9999978542327881
is O 0 0.0003828404296655208
a O 0 0.0012993097770959139
disorder O 1 0.9999992847442627
of O 1 0.9979615211486816
fatty O 1 0.999944806098938
acid O 0 0.1280406415462494
beta O 0 0.0006602564826607704
oxidation O 0 0.0003573795547708869
that O 0 4.374191848910414e-05
reportedly O 0 0.0003202292718924582
has O 0 8.365726534975693e-05
high O 0 0.00025152519810944796
rates O 0 0.0001019636620185338
of O 0 0.000297281687380746
morbidity O 0 0.07751721143722534
and O 0 0.0010851605329662561
mortality O 0 0.011204657144844532
. O 0 0.0016573683824390173

We O 0 0.0005603587487712502
describe O 0 0.00024167433730326593
the O 0 0.0001159410021500662
outcome O 0 6.650557043030858e-05
of O 0 7.712609658483416e-05
a O 0 0.00021512449893634766
5 O 0 0.00042705237865448
- O 0 0.00043823328451253474
year O 0 0.0002665761858224869
- O 0 0.0005067192250862718
old O 0 0.0013305506436154246
girl O 0 0.00427978066727519
with O 0 0.0015497133135795593
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0037227447610348463
was O 0 0.002777906134724617
first O 0 0.00040350810741074383
seen O 0 0.00040951749542728066
at O 0 0.0002019389212364331
5 O 0 0.0001437205501133576
months O 0 0.00010745750478236005
of O 0 0.00017681591270957142
age O 0 0.0006664444226771593
with O 0 0.0014996920945122838
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999992847442627
encephalopathy B-Disease 1 1.0
, O 0 0.06906414031982422
and O 0 0.004771953448653221
hypotonia B-Disease 1 0.9999479055404663
. O 0 0.0023474814370274544

Biochemical O 0 0.022646449506282806
studies O 0 0.002157175447791815
indicated O 1 0.6056952476501465
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999983310699463
by O 0 0.0006398853147402406
a O 0 0.0007763521280139685
stable O 0 0.00265380903147161
yet O 0 0.0005747215473093092
inactive O 0 0.002511912491172552
enzyme O 0 0.0013210386969149113
. O 0 0.0004901775391772389

Molecular O 0 0.002956629963591695
genetic O 0 0.0004408808017615229
analysis O 0 8.062985580181703e-05
of O 0 0.0002975241222884506
her O 0 0.0013160287635400891
VLCAD O 1 0.9999994039535522
gene O 0 0.0008057586965151131
revealed O 0 0.0009127028752118349
a O 0 0.0006137274904176593
T1372C O 1 0.994223415851593
( O 0 0.001094832899980247
F458L O 1 0.6503193378448486
) O 0 0.0004459829651750624
missense O 0 0.00183587905485183
mutation O 0 0.0002837071951944381
and O 0 0.0001993045152630657
a O 0 0.0010649433825165033
1668 O 1 0.9973737001419067
ACAG O 1 0.9999792575836182
1669 O 1 0.9864081144332886
splice O 0 0.03405708819627762
site O 0 0.008852323517203331
mutation O 0 0.0019986408296972513
. O 0 0.0008827210986055434

After O 0 0.005754806566983461
initial O 0 0.0027239215560257435
treatment O 0 0.003176879370585084
with O 0 0.0007665199227631092
intravenous O 1 0.9972930550575256
glucose O 1 0.5623703002929688
and O 0 0.0007809734670445323
carnitine O 1 0.9981572031974792
, O 0 0.00024973347899504006
the O 0 0.00025455825380049646
patient O 0 0.00034232475445605814
has O 0 0.00012541140313260257
thrived O 0 0.001144428737461567
on O 0 0.0001717519189696759
a O 0 0.00037665312993340194
low O 0 0.0007362418109551072
- O 0 0.0010347077623009682
fat O 0 0.0013490017736330628
diet O 0 0.0006857729749754071
supplemented O 0 0.00027190535911358893
with O 0 7.370363891823217e-05
medium O 0 0.0004718301061075181
- O 0 0.0011199942091479897
chain O 0 0.001824294333346188
triglyceride O 0 0.0065041836351156235
oil O 0 0.002582124201580882
and O 0 0.0005703993956558406
carnitine O 0 0.20220215618610382
and O 0 0.0007641197298653424
avoidance O 0 0.05337746813893318
of O 0 0.008571315556764603
fasting O 0 0.11284911632537842
. O 0 0.0011965123703703284

Her O 1 0.9379720091819763
ventricular O 1 1.0
hypertrophy O 1 0.9999995231628418
resolved O 0 0.013338658958673477
significantly O 0 0.0006463731988333166
over O 0 0.00019738385162781924
1 O 0 0.00036117847776040435
year O 0 0.00024551269598305225
, O 0 0.00012908833741676062
and O 0 0.00026517341029830277
cognitively O 0 0.01004179660230875
, O 0 0.0002093945658998564
she O 0 0.00014684909547213465
is O 0 6.217357440618798e-05
in O 0 7.979360088938847e-05
the O 0 0.00024928193306550384
superior O 0 0.0011077398667111993
range O 0 0.00025110921706072986
for O 0 0.00013983635290060192
age O 0 0.001227357191964984
. O 0 0.0008169790380634367

Clinical O 0 0.005896907765418291
recognition O 0 0.004679813981056213
of O 1 0.9994550347328186
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.007048764266073704
important O 0 0.0007604854763485491
because O 0 0.00010050140554085374
it O 0 3.417727202759124e-05
is O 0 2.5060500774998218e-05
one O 0 3.0097584385657683e-05
of O 0 8.463217818643898e-05
the O 0 0.00020671772654168308
few O 0 0.0003412979422137141
directly O 0 0.0008952504140324891
treatable O 1 0.9999934434890747
causes O 1 0.9990838766098022
of O 1 0.9999576807022095
cardiomyopathy B-Disease 1 1.0
in O 1 0.9997474551200867
children O 0 0.003101946087554097
. O 0 0.0003776211815420538
. O 0 0.0004520716902334243

Cloning O 0 0.004537548404186964
of O 0 0.00045870733447372913
a O 0 0.00034872975083999336
novel O 0 0.00026226782938465476
member O 0 0.00014029297744855285
of O 0 0.00012974558921996504
the O 0 0.00026854072348214686
low O 0 0.0005586254992522299
- O 0 0.000813234131783247
density O 0 0.00042250423575751483
lipoprotein O 0 0.015943240374326706
receptor O 0 0.0007689971826039255
family O 0 0.0004304421890992671
. O 0 0.00037737234379164875

A O 0 0.004256063606590033
gene O 0 0.00043998859473504126
encoding O 0 0.0001261651486856863
a O 0 0.00016316726396325976
novel O 0 0.0003580008924473077
transmembrane O 0 0.0011091531487181783
protein O 0 0.00029500917298719287
was O 0 0.0003210922877769917
identified O 0 6.593515718122944e-05
by O 0 2.059845792246051e-05
DNA O 0 6.899433356011286e-05
sequence O 0 4.507321500568651e-05
analysis O 0 1.4863477190374397e-05
within O 0 4.702067235484719e-05
the O 0 0.0003456376725807786
insulin B-Disease 0 0.11325883865356445
- I-Disease 0 0.004796603228896856
dependent I-Disease 0 0.0015810951590538025
diabetes I-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999998807907104
( O 0 0.16461274027824402
IDDM B-Disease 1 0.999996542930603
) O 0 0.0009446420008316636
locus O 0 0.0041440511122345924
IDDM4 O 1 0.9965097308158875
on O 0 0.0023722006008028984
chromosome O 0 0.008725284598767757
11q13 O 1 0.9965341091156006
. O 0 0.002066476969048381

Based O 0 0.0004447195678949356
on O 0 0.0003277804935351014
its O 0 0.00020469087758101523
chromosomal O 0 0.0024914119858294725
position O 0 0.0007519237697124481
, O 0 0.00016630005848128349
this O 0 5.9408703236840665e-05
gene O 0 9.651458094595e-05
is O 0 3.9638354792259634e-05
a O 0 9.040116856340319e-05
candidate O 0 0.00012682638771366328
for O 0 8.128566696541384e-05
conferring O 0 0.0028819001745432615
susceptibility O 1 0.727777361869812
to O 0 0.0032491139136254787
diabetes B-Disease 1 0.999996542930603
. O 0 0.002634831005707383

The O 0 0.003317098133265972
gene O 0 0.0011012139730155468
, O 0 0.00030345848063006997
termed O 0 0.0020870044827461243
low O 0 0.0008605151670053601
- O 0 0.0007699519628658891
density O 0 0.00029732336406596005
lipoprotein O 0 0.0029340586625039577
receptor O 0 0.00022884288046043366
related O 0 9.55820141825825e-05
protein O 0 0.00021709725842811167
5 O 0 0.0005296130548231304
( O 0 0.00045893320930190384
LRP5 O 1 0.9975433349609375
) O 0 0.0001582535041961819
, O 0 5.958043766440824e-05
encodes O 0 0.00011323438229737803
a O 0 0.00011670903768390417
protein O 0 0.00016415368008892983
of O 0 0.00042224815115332603
1615 O 0 0.012140008620917797
amino O 0 0.0005556089454330504
acids O 0 0.00014681911852676421
that O 0 3.167533577652648e-05
contains O 0 0.000105101520603057
conserved O 0 0.00025666385772638023
modules O 0 0.00034280531690455973
which O 0 3.066971476073377e-05
are O 0 5.974251962470589e-06
characteristic O 0 7.298437412828207e-05
of O 0 0.0001347052602795884
the O 0 0.0003403170558158308
low O 0 0.0007137571810744703
- O 0 0.000872905133292079
density O 0 0.0005868168664164841
lipoprotein O 0 0.3864057660102844
( O 0 0.0010744755854830146
LDL O 1 0.9688114523887634
) O 0 0.0003412912483327091
receptor O 0 0.0004594992788042873
family O 0 0.0004289155767764896
. O 0 0.00042601392487995327

These O 0 0.0007606028812006116
modules O 0 0.0019308250630274415
include O 0 0.0003179965424351394
a O 0 0.00046021773596294224
putative O 0 0.002815036103129387
signal O 0 0.001188977505080402
peptide O 0 0.0007255832315422595
for O 0 7.381068280665204e-05
protein O 0 0.0002490938059054315
export O 0 0.00043402769370004535
, O 0 9.519579180050641e-05
four O 0 0.00022999959765002131
epidermal O 0 0.026036696508526802
growth O 0 0.0015717765782028437
factor O 0 0.0013810232048854232
( O 0 0.0007165881688706577
EGF O 1 0.9501210451126099
) O 0 0.0003053337859455496
repeats O 0 0.0007163771078921854
with O 0 0.00014674689737148583
associated O 0 0.0002710974949877709
spacer O 0 0.0035114965867251158
domains O 0 0.0006658590282313526
, O 0 0.00017790212586987764
three O 0 0.0002971513895317912
LDL O 1 0.9980202913284302
- O 0 0.0016401882749050856
receptor O 0 0.0006474377005361021
( O 0 0.0003328885359223932
LDLR O 1 0.9931776523590088
) O 0 0.00013398632290773094
repeats O 0 0.0003536083095241338
, O 0 5.850556044606492e-05
a O 0 0.00013263014261610806
single O 0 0.0002669618115760386
transmembrane O 0 0.002634698059409857
spanning O 0 0.003246889216825366
domain O 0 0.0006397945107892156
, O 0 0.0002025324502028525
and O 0 0.00016283807053696364
a O 0 0.0006397365359589458
cytoplasmic O 0 0.0027948615606874228
domain O 0 0.0018211579881608486
. O 0 0.0010416613658890128

The O 0 0.0017054829513654113
encoded O 0 0.0004511989827733487
protein O 0 0.0003246673149988055
has O 0 6.0366070101736113e-05
a O 0 8.391445589950308e-05
unique O 0 0.00010933454177575186
organization O 0 0.0001411864795954898
of O 0 0.0005183269968256354
EGF O 1 0.9994612336158752
and O 0 0.0013642292469739914
LDLR O 1 0.9999972581863403
repeats O 0 0.003105615498498082
; O 0 0.00015238091873470694
therefore O 0 0.00020434589532669634
, O 0 0.00021064793691039085
LRP5 O 1 0.9990584254264832
likely O 0 0.0003673213941510767
represents O 0 0.00022898954921402037
a O 0 0.00012019903806503862
new O 0 0.00010280485003022477
category O 0 0.00019946230167988688
of O 0 0.0002735838934313506
the O 0 0.001354099134914577
LDLR O 1 0.999994158744812
family O 0 0.004104165825992823
. O 0 0.0014518062816932797

Both O 0 0.0016586341662332416
human O 0 0.0016128960996866226
and O 0 0.0012068552896380424
mouse O 0 0.37530943751335144
LRP5 O 1 0.9999996423721313
cDNAs O 1 0.999890923500061
have O 0 0.00022492663993034512
been O 0 0.00015271168376784772
isolated O 0 0.0004355088749434799
and O 0 0.00011170558718731627
the O 0 0.00020856167247984558
encoded O 0 0.00015241432993207127
mature O 0 0.00022370452643372118
proteins O 0 6.135839794296771e-05
are O 0 1.1492941666801926e-05
95 O 0 0.00011549267946975306
% O 0 4.657639510696754e-05
identical O 0 0.00010867905803024769
, O 0 5.776016405434348e-05
indicating O 0 0.0002206768112955615
a O 0 0.00010427306551719084
high O 0 0.0002722007629927248
degree O 0 0.00015102897305041552
of O 0 0.00026562201674096286
evolutionary O 0 0.0014839449431747198
conservation O 0 0.0008138860575854778
. O 0 0.0001494938915129751
. O 0 0.000341226055752486

The O 0 0.0063767023384571075
APC B-Disease 1 0.989766538143158
variants O 0 0.004171783570200205
I1307K O 1 0.9980490207672119
and O 0 0.0009586210362613201
E1317Q O 1 0.9844101667404175
are O 0 0.00011487684241728857
associated O 0 0.0007627771119587123
with O 1 0.6529937982559204
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.04265344887971878
but O 0 0.00021302461391314864
not O 0 4.117739445064217e-05
always O 0 5.6608598242746666e-05
with O 0 2.9819200790370815e-05
a O 0 0.0001690320495981723
family O 0 0.000476688495837152
history O 0 0.0017903178231790662
. O 0 0.0009807037422433496

Classical O 0 0.04449072480201721
familial B-Disease 1 0.9999964237213135
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998132586479187
FAP B-Disease 1 0.9999985694885254
) O 0 0.0005949101760052145
is O 0 0.00018374109640717506
a O 0 0.00043954947614111006
high O 0 0.0024007451720535755
- O 0 0.005414233077317476
penetrance O 1 0.8115448355674744
autosomal B-Disease 1 0.9340596795082092
dominant I-Disease 1 0.999995231628418
disease I-Disease 1 1.0
that O 0 0.0005787197151221335
predisposes O 1 0.9687777757644653
to O 0 0.00022233980416785926
hundreds O 0 0.0005474028876051307
or O 0 0.00015861730207689106
thousands O 0 0.0007527647539973259
of O 0 0.37411192059516907
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999984860420227
carcinoma I-Disease 1 1.0
and O 0 0.0013138239737600088
that O 0 0.00010590011515887454
results O 0 9.084925841307268e-05
from O 0 9.545849752612412e-05
truncating O 0 0.001523320679552853
mutations O 0 0.00010653457138687372
in O 0 0.00011509030446177348
the O 0 0.0006876859115436673
APC B-Disease 1 0.993739128112793
gene O 0 0.0014256733702495694
. O 0 0.0004920308711007237

A O 0 0.0071350890211761
variant O 0 0.0041812751442193985
of O 0 0.0023717787116765976
FAP B-Disease 1 0.9998077750205994
is O 0 0.0018409840995445848
attenuated B-Disease 1 0.9981300234794617
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999992847442627
, O 0 0.0005798015045002103
which O 0 9.827702160691842e-05
results O 0 0.00014173195813782513
from O 0 0.000292627839371562
germ O 1 0.9994909763336182
- O 0 0.0019691186025738716
line O 0 0.000706863182131201
mutations O 0 5.816776683786884e-05
in O 0 3.761753032449633e-05
the O 0 0.0001112556055886671
5 O 0 0.00014395178004633635
and O 0 4.299292777432129e-05
3 O 0 0.0001145960995927453
regions O 0 7.50780527596362e-05
of O 0 0.00020022869284730405
the O 0 0.0009283538674935699
APC B-Disease 1 0.9994305968284607
gene O 0 0.0016726895701140165
. O 0 0.0009686310077086091

Attenuated B-Disease 1 0.9999179840087891
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.44025397300720215
have O 0 0.00030197619344107807
" O 0 0.0010791204404085875
multiple O 0 0.0014092683559283614
" O 1 0.9956432580947876
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.0012431115610525012
typically O 0 0.00012064319889759645
fewer O 0 8.404642721870914e-05
than O 0 3.258186552557163e-05
100 O 0 0.0001761572784744203
) O 0 4.65851480839774e-05
without O 0 7.57448942749761e-05
the O 0 0.00024072479573078454
florid O 0 0.01180005818605423
phenotype O 0 0.0018138970481231809
of O 0 0.0016087848925963044
classical O 0 0.021202202886343002
FAP B-Disease 1 0.9998874664306641
. O 0 0.003008184488862753

Another O 0 0.002965438412502408
group O 0 0.0004402057675179094
of O 0 0.0007396398577839136
patients O 0 0.0008910311735235155
with O 0 0.00036722945515066385
multiple O 0 0.008401752449572086
adenomas B-Disease 1 0.9999973773956299
has O 0 0.00044628707109950483
no O 0 0.0002458195376675576
mutations O 0 9.666564437793568e-05
in O 0 0.00011641893070191145
the O 0 0.0006035793921910226
APC B-Disease 1 0.9994754195213318
gene O 0 0.0003806149761658162
, O 0 7.845479558454826e-05
and O 0 6.491731619462371e-05
their O 0 5.128380871610716e-05
phenotype O 0 0.00044562260154634714
probably O 0 0.0002998360723722726
results O 0 3.978522363468073e-05
from O 0 3.429274511290714e-05
variation O 0 0.00010839941387530416
at O 0 0.0002650692767929286
a O 0 0.00020141663844697177
locus O 0 0.0007050560088828206
, O 0 0.00011452989565441385
or O 0 0.00015967863146215677
loci O 0 0.0007309535285457969
, O 0 0.00012609633267857134
elsewhere O 0 0.00013558128557633609
in O 0 7.325365004362538e-05
the O 0 0.00027512721135281026
genome O 0 0.0008422004175372422
. O 0 0.0004466262471396476

Recently O 0 0.006081752013415098
, O 0 0.0005839784862473607
however O 0 0.00016862669144757092
, O 0 8.366955444216728e-05
a O 0 0.0001724541070871055
missense O 0 0.001222669961862266
variant O 0 0.0009469520300626755
of O 0 0.0009276748169213533
APC B-Disease 1 0.9999816417694092
( O 0 0.00225734687410295
I1307K O 1 0.9996285438537598
) O 0 0.0001777683646650985
was O 0 0.0004591778269968927
described O 0 0.0001570060121593997
that O 0 2.262401358166244e-05
confers O 0 0.0003028775390703231
an O 0 7.97594475443475e-05
increased O 0 0.00034348233020864427
risk O 0 0.0007593890186399221
of O 1 0.999860405921936
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0839209035038948
including O 0 0.0011558656115084887
multiple O 0 0.002603809116408229
adenomas B-Disease 1 0.999995231628418
, O 0 0.0006744523416273296
in O 0 0.0008743935613892972
Ashkenazim O 0 0.07569805532693863
. O 0 0.001467126770876348

We O 0 0.0007215898367576301
have O 0 6.406611646525562e-05
studied O 0 0.00021438184194266796
a O 0 0.0001445683155907318
set O 0 0.00017727813974488527
of O 0 0.00026010535657405853
164 O 0 0.0026112860068678856
patients O 0 0.0005787144182249904
with O 0 0.0005445647402666509
multiple O 1 0.9968100190162659
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9996740818023682
/ I-Disease 1 0.9999798536300659
or I-Disease 0 0.3682454824447632
carcinoma I-Disease 1 1.0
and O 0 0.0007059324416331947
analyzed O 0 0.0004952281014993787
codons O 0 0.0018462040461599827
1263 O 0 0.014722899533808231
- O 0 0.002440341282635927
1377 O 0 0.039697419852018356
( O 0 0.0006417505792342126
exon O 0 0.003857576521113515
15G O 0 0.00852547399699688
) O 0 9.597493044566363e-05
of O 0 0.00014212117821443826
the O 0 0.00036522894515655935
APC B-Disease 0 0.26743820309638977
gene O 0 0.0003932221152354032
for O 0 0.0002884493733290583
germ O 1 0.9999402761459351
- O 0 0.004805178381502628
line O 0 0.0018052876694127917
variants O 0 0.0009433419327251613
. O 0 0.0003434780810493976

Three O 0 0.0027269097045063972
patients O 0 0.0009174236329272389
with O 0 0.00016806776693556458
the O 0 0.0008331206627190113
I1307K O 1 0.9954973459243774
allele O 0 0.0005861242534592748
were O 0 0.0001647299068281427
detected O 0 0.0003928897494915873
, O 0 4.535329935606569e-05
each O 0 2.185535413445905e-05
of O 0 0.0002648883673828095
Ashkenazi O 0 0.004805679898709059
descent O 0 0.005515647120773792
. O 0 0.0013706418685615063

Four O 0 0.004703362938016653
patients O 0 0.0014382387744262815
had O 0 0.0007789392257109284
a O 0 0.0012185507221147418
germ O 1 0.9998828172683716
- O 0 0.004428977146744728
line O 0 0.0023160430137068033
E1317Q O 0 0.021802568808197975
missense O 0 0.002150909276679158
variant O 0 0.0008517035166732967
of O 0 0.000647299864795059
APC O 1 0.9996955394744873
that O 0 0.0001905682438518852
was O 0 0.0005132285878062248
not O 0 3.105632640654221e-05
present O 0 0.00010335726983612403
in O 0 9.230223076883703e-05
controls O 0 0.0001989134179893881
; O 0 2.989659333252348e-05
one O 0 3.803742947638966e-05
of O 0 8.512216300005093e-05
these O 0 3.619552808231674e-05
individuals O 0 4.106637425138615e-05
had O 0 0.00015944706683512777
an O 0 0.00012864780728705227
unusually O 0 0.000772512867115438
large O 0 0.00015171240374911577
number O 0 6.169423431856558e-05
of O 0 0.0005766606773249805
metaplastic B-Disease 1 0.999937891960144
polyps I-Disease 1 0.7954052686691284
of I-Disease 0 0.0019848723895847797
the I-Disease 0 0.005391571670770645
colorectum I-Disease 1 0.999715268611908
. O 0 0.001911225263029337

There O 0 0.0012271266896277666
is O 0 0.00027978571597486734
increasing O 0 0.0002208338410127908
evidence O 0 0.00022701217676512897
that O 0 5.6279612181242555e-05
there O 0 0.0001227059547090903
exist O 0 0.00022639744565822184
germ O 1 0.9630305767059326
- O 0 0.001311065861955285
line O 0 0.0005211411044001579
variants O 0 0.00015520375745836645
of O 0 0.00018356600776314735
the O 0 0.0007768250070512295
APC B-Disease 1 0.9714615345001221
gene O 0 0.00031865263008512557
that O 0 7.497451588278636e-05
predispose O 0 0.0010516283800825477
to O 0 0.00010102352098328993
the O 0 0.0002771602012217045
development O 0 0.0005201484891586006
of O 0 0.0012308188015595078
multiple O 1 0.9995189905166626
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
, O 0 0.0032164978329092264
but O 0 0.00019430874090176076
without O 0 8.485172293148935e-05
the O 0 0.0001748515060171485
florid O 0 0.0068590822629630566
phenotype O 0 0.0008821754017844796
of O 0 0.00063227245118469
classical O 0 0.005658244714140892
FAP B-Disease 1 0.9999759197235107
, O 0 0.0003421663714107126
and O 0 0.00012160680489614606
possibly O 0 0.00025368985370732844
with O 0 8.262359915534034e-05
importance O 0 0.0018650363199412823
for O 0 0.017524903640151024
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.013306966982781887
in O 0 0.000186939345439896
the O 0 0.0003173014847561717
general O 0 0.0004410924739204347
population O 0 8.420760423177853e-05
. O 0 0.00013792792742606252
. O 0 0.0002775134926196188

Genomic O 0 0.004020167514681816
structure O 0 0.0030721842776983976
of O 0 0.0012774517526850104
the O 0 0.012987721711397171
human O 1 0.9999792575836182
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999994039535522
CLD B-Disease 1 1.0
) O 0 0.0013908564578741789
gene O 0 0.0008718469180166721
. O 0 0.00038504661642946303

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999997615814209
CLD B-Disease 1 1.0
) O 0 0.001657238113693893
is O 0 0.0002245083887828514
caused O 0 0.002426896709948778
by O 0 0.00012467976193875074
mutations O 0 0.0001120543311117217
in O 0 9.049242362380028e-05
a O 0 0.00021989172091707587
gene O 0 0.0001798732264433056
which O 0 8.855411579133943e-05
encodes O 0 0.0004574029298964888
an O 0 0.000889335700776428
intestinal O 1 0.9999998807907104
anion O 1 0.9985129237174988
transporter O 1 0.995244562625885
. O 0 0.0016829201485961676

We O 0 0.0013533125165849924
report O 0 0.0002910313487518579
here O 0 0.000131399036035873
the O 0 0.00011338650801917538
complete O 0 0.00030506198527291417
genomic O 0 0.00026373498258180916
organization O 0 8.480271208100021e-05
of O 0 0.00017077747907023877
the O 0 0.000591596937738359
human O 0 0.0010623869020491838
CLD B-Disease 1 0.9999511241912842
gene O 0 0.0004226377932354808
which O 0 0.00010998620564350858
spans O 0 0.0010369039373472333
approximately O 0 0.00046916850260458887
39kb O 1 0.7668377161026001
, O 0 0.0001655152445891872
and O 0 0.00015219503256957978
comprises O 0 0.0008922077831812203
21 O 0 0.0030223815701901913
exons O 0 0.008211829699575901
. O 0 0.0012461862061172724

All O 0 0.0017095275688916445
exon O 0 0.010020029731094837
/ O 0 0.004228880163282156
intron O 0 0.004367714282125235
boundaries O 0 0.0002311238058609888
conform O 0 0.0004436039016582072
to O 0 0.00012587096716742963
the O 0 0.0006886940100230277
GT O 1 0.9972814321517944
/ O 0 0.18244273960590363
AG O 1 0.9968364238739014
rule O 0 0.0031872170511633158
. O 0 0.0008851408492773771

An O 0 0.0007717744447290897
analysis O 0 0.00015221188368741423
of O 0 0.0003543648635968566
the O 0 0.0007252776995301247
putative O 0 0.0031725044827908278
promoter O 0 0.011245552450418472
region O 0 0.0007019024342298508
sequence O 0 0.00026145289302803576
shows O 0 0.0002161216107197106
a O 0 0.00043729646131396294
putative O 0 0.010954554192721844
TATA O 1 0.9999909400939941
box O 0 0.003147862385958433
and O 0 0.0003790886839851737
predicts O 0 0.0011056250659748912
multiple O 0 0.00023697211872786283
transcription O 0 0.0011189342476427555
factor O 0 0.0007747510098852217
binding O 0 0.00034967405372299254
sites O 0 0.0006961293984204531
. O 0 0.000358757097274065

The O 0 0.0022575538605451584
genomic O 0 0.0015983583871275187
structure O 0 0.0015946461353451014
was O 0 0.000954956456553191
determined O 0 0.00021499778085853904
using O 0 3.9053480577422306e-05
DNA O 0 0.00011787197581725195
from O 0 4.1241059079766273e-05
several O 0 4.44939432782121e-05
sources O 0 5.582958328886889e-05
including O 0 5.978572880849242e-05
multiple O 0 0.00014768433175049722
large O 0 0.0005100493435747921
- O 0 0.002130389679223299
insert O 0 0.00399754336103797
libaries O 0 0.01274965237826109
and O 0 0.00019979331409558654
genomic O 0 0.0005246984073892236
DNA O 0 0.0006140797049738467
from O 0 0.0008046010043472052
Finnish O 1 0.9939079284667969
CLD B-Disease 1 0.9999997615814209
patients O 0 0.00409125117585063
and O 0 0.0007157751242630184
controls O 0 0.002015197416767478
. O 0 0.0007206532172858715

Exon O 0 0.03786791115999222
- O 0 0.004199074115604162
specific O 0 0.0002459972456563264
primers O 0 0.0015699205687269568
developed O 0 0.0003801755083259195
in O 0 0.00010689152986742556
this O 0 7.461988570867106e-05
study O 0 7.836357690393925e-05
will O 0 6.329712778097019e-05
facilitate O 0 0.00018646723765414208
mutation O 0 0.00013827583461534232
screening O 0 0.00012451995280571282
studies O 0 5.189373769098893e-05
of O 0 0.00019810449157375842
patients O 0 0.0003042252501472831
with O 0 0.00025457621086388826
the O 1 0.8232172727584839
disease O 1 0.9999998807907104
. O 0 0.002622660482302308

Genomic O 0 0.002466821111738682
sequencing O 0 0.0010964745888486505
of O 0 0.0006252492894418538
a O 0 0.0016527449479326606
BAC O 1 0.9991590976715088
clone O 1 0.9868647456169128
H O 1 0.9999085664749146
_ O 0 0.0011623811442404985
RG364P16 O 0 0.052735693752765656
revealed O 0 0.0010916158789768815
the O 0 0.00022520341735798866
presence O 0 0.00028235584613867104
of O 0 0.00023556083033327013
another O 0 0.00043725810246542096
, O 0 0.00014309125253930688
highly O 0 0.00023738299205433577
homologous O 0 0.0005006035207770765
gene O 0 8.094008080661297e-05
3 O 0 0.00013972267333883792
of O 0 0.00017754339205566794
the O 0 0.0007353498949669302
CLD B-Disease 1 0.9999833106994629
gene O 0 0.0003906902566086501
, O 0 6.688488065265119e-05
with O 0 2.6324532882426865e-05
a O 0 0.00012615624291356653
similar O 0 8.123591396724805e-05
genomic O 0 0.00040154304588213563
structure O 0 0.0008610064396634698
, O 0 0.00012277370842639357
recently O 0 0.00023918964143376797
identified O 0 0.00010763862519524992
as O 0 0.00014934572391211987
the O 0 0.0013865978689864278
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9258654117584229
( O 0 0.230807363986969
PDS B-Disease 1 0.9999995231628418
) O 0 0.0009090023231692612
. O 0 0.00033072923542931676
. O 0 0.000469216174678877

The O 0 0.006099672056734562
APCI1307K O 1 0.9999847412109375
allele O 0 0.004210322629660368
and O 0 0.0008114041993394494
cancer B-Disease 1 0.9962269067764282
risk O 0 0.000296582467854023
in O 0 0.00018467607151251286
a O 0 0.00021477097470778972
community O 0 0.0001652944483794272
- O 0 0.0002215316635556519
based O 0 2.1224399461061694e-05
study O 0 2.4775985366431996e-05
of O 0 0.00022677553351968527
Ashkenazi O 0 0.003979226108640432
Jews O 0 0.004124523140490055
. O 0 0.0010679332772269845

Mutations O 0 0.0051852441392838955
in O 0 0.0022847047075629234
APC O 1 0.9982934594154358
are O 0 0.00023826166579965502
classically O 0 0.003879387630149722
associated O 0 0.0005561360158026218
with O 0 0.00042349781142547727
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999979734420776
FAP B-Disease 1 1.0
) O 0 0.0006150947883725166
, O 0 0.0002024019486270845
a O 0 0.0005339238559827209
highly O 0 0.00448613753542304
penetrant O 1 0.9999905824661255
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999995231628418
by O 1 0.9759542942047119
multiple O 1 0.9999821186065674
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.004659291822463274
, O 0 0.00037360822898335755
without O 0 0.0002964705054182559
surgical O 1 0.7778306603431702
intervention O 0 0.0038823073264211416
, O 0 0.00013868148380424827
the O 0 0.00024032119836192578
development O 0 0.0006482814205810428
of O 1 0.9554201364517212
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9997001886367798
CRC B-Disease 1 0.9999892711639404
) O 0 0.0010052885627374053
. O 0 0.0006136157317087054

APC B-Disease 1 0.5755829215049744
is O 0 0.0009053912945091724
a O 0 0.0026113467756658792
tumour O 1 1.0
- O 1 0.5792751312255859
suppressor O 0 0.23640665411949158
gene O 0 0.00041176873492076993
, O 0 0.00011111353524029255
and O 0 0.00016866000078152865
somatic O 0 0.003289764514192939
loss O 0 0.44085344672203064
occurs O 0 0.0018772896146401763
in O 0 0.001470081158913672
tumours B-Disease 1 0.9999994039535522
. O 0 0.002541828900575638

The O 0 0.007825716398656368
germline O 1 0.9923827052116394
T O 1 0.9418226480484009
- O 0 0.0011267366353422403
to O 0 0.00015239004278555512
- O 0 0.0004685997555498034
A O 0 0.0008154751849360764
transversion O 0 0.012714504264295101
responsible O 0 0.00036089387140236795
for O 0 0.00010554726759437472
the O 0 0.0005897855735383928
APC O 1 0.5979470610618591
I1307K O 0 0.2542870044708252
allele O 0 0.0007094986503943801
converts O 0 0.00022866968356538564
the O 0 0.00014235745766200125
wild O 0 0.00027658528415486217
- O 0 0.00025857725995592773
type O 0 0.00015519605949521065
sequence O 0 8.005966810742393e-05
to O 0 0.00010714502423070371
a O 0 0.0007354736444540322
homopolymer O 1 0.9999234676361084
tract O 1 0.9999977350234985
( O 0 0.01848594844341278
A8 O 1 0.9999920129776001
) O 0 0.0004354514239821583
that O 0 9.852989751379937e-05
is O 0 0.00019303748558741063
genetically O 0 0.0013277081307023764
unstable O 0 0.36952319741249084
and O 0 0.0006709637818858027
prone O 0 0.41424062848091125
to O 0 0.0010687699541449547
somatic O 0 0.009535149671137333
mutation O 0 0.001601522439159453
. O 0 0.001105605042539537

The O 0 0.005771300755441189
I1307K O 1 0.7010896801948547
allele O 0 0.0017630759393796325
was O 0 0.0007930985884740949
found O 0 0.00015786605945322663
in O 0 0.00026130935293622315
6 O 0 0.001476920093409717
. O 0 0.0005676972796209157

1 O 0 0.0018884786404669285
% O 0 0.0002951214264612645
of O 0 0.0006581486668437719
unselected O 0 0.07404305785894394
Ashkenazi O 0 0.004789833910763264
Jews O 0 0.0012525842757895589
and O 0 0.00023306228104047477
higher O 0 0.0003318263916298747
proportions O 0 0.0009670264553278685
of O 0 0.0006289578159339726
Ashkenazim O 0 0.015468540601432323
with O 0 0.00033793525653891265
family O 0 0.0007156800129450858
or O 0 0.0003351554914843291
personal O 0 0.0005425020935945213
histories O 0 0.0007248931215144694
of O 0 0.0025566054973751307
CRC B-Disease 1 0.9999958276748657
( O 0 0.0024588655214756727
ref O 1 0.7774444222450256
. O 0 0.00019775156397372484
2 O 0 0.0004622240667231381
) O 0 0.00020241255697328597
. O 0 0.00024436513194814324

To O 0 0.0006209058337844908
evaluate O 0 0.0003846551408059895
the O 0 0.0002883709967136383
role O 0 0.0005488384631462395
of O 0 0.0007695895619690418
I1307K O 1 0.9999035596847534
in O 0 0.0035921961534768343
cancer B-Disease 1 0.9986708164215088
, O 0 0.0002316130994586274
we O 0 0.0002711210399866104
genotyped O 0 0.03186905384063721
5 O 0 0.0008924892754293978
, O 0 0.0002716514572966844
081 O 0 0.018268276005983353
Ashkenazi O 0 0.0029789924155920744
volunteers O 0 0.0007463841466233134
in O 0 0.00014646367344539613
a O 0 0.00024071606458164752
community O 0 0.00023570528719574213
survey O 0 0.00021001561253797263
. O 0 0.00028287750319577754

Risk O 0 0.0042899842374026775
of O 0 0.00481516495347023
developing O 1 0.9995166063308716
colorectal B-Disease 1 1.0
, I-Disease 1 0.8516299724578857
breast I-Disease 1 0.9999454021453857
and I-Disease 0 0.000768379308283329
other I-Disease 0 0.00030898131080903113
cancers I-Disease 1 0.7227206230163574
were O 0 0.00032996077788993716
compared O 0 0.0003456062404438853
between O 0 0.0006906641647219658
genotyped O 1 0.9977220892906189
I1307K O 1 0.9991521835327148
carriers O 0 0.001161349704489112
and O 0 0.00022892362903803587
non O 0 0.0005936226807534695
- O 0 0.0007127971039153636
carriers O 0 0.00023447831335943192
and O 0 3.479597216937691e-05
their O 0 2.501112612662837e-05
first O 0 0.0001951636077137664
- O 0 0.000492792169097811
degree O 0 0.0005026485305279493
relatives O 0 0.0008601610315963626
. O 0 0.000531381752807647

Sperm O 0 0.0018891276558861136
DNA O 0 0.0009121716138906777
analysis O 0 6.97274663252756e-05
in O 0 0.00021435182134155184
a O 0 0.0015439387643709779
Friedreich B-Disease 1 0.9999651908874512
ataxia I-Disease 1 0.9999973773956299
premutation O 1 0.9999988079071045
carrier O 0 0.058557383716106415
suggests O 0 0.0012464069295674562
both O 0 0.0003423660236876458
meiotic O 0 0.177315354347229
and O 0 0.0006104581989347935
mitotic O 0 0.005794983357191086
expansion O 0 0.001261142548173666
in O 0 0.0002281252818647772
the O 0 0.0009040379081852734
FRDA B-Disease 1 0.9999254941940308
gene O 0 0.0012145539512857795
. O 0 0.0006614209269173443

Friedreich B-Disease 1 0.9999983310699463
ataxia I-Disease 1 0.9999990463256836
is O 0 0.003779495367780328
usually O 0 0.0007633817149326205
caused O 0 0.02032923698425293
by O 0 0.00014043338887859136
an O 0 0.0001526414998807013
expansion O 0 0.0007469843258149922
of O 0 0.00030042638536542654
a O 0 0.0007095649489201605
GAA O 0 0.013765489682555199
trinucleotide O 0 0.10473719239234924
repeat O 0 0.0011589769273996353
in O 0 0.0001492921874159947
intron O 0 0.0016241819830611348
1 O 0 0.0002508125326130539
of O 0 0.00038469256833195686
the O 0 0.0012680593645200133
FRDA B-Disease 1 0.9999713897705078
gene O 0 0.001685937400907278
. O 0 0.0006718516233377159

Occasionally O 0 0.003960480913519859
, O 0 0.00043788671609945595
a O 0 0.00038816159940324724
fully O 0 0.0007293066009879112
expanded O 0 0.0004760237643495202
allele O 0 0.0002842487010639161
has O 0 5.61256856599357e-05
been O 0 4.36994741903618e-05
found O 0 5.545850581256673e-05
to O 0 6.840701098553836e-05
arise O 0 0.00022243607963901013
from O 0 0.00015200069174170494
a O 0 0.0004887810791842639
premutation O 0 0.012507131323218346
of O 0 0.0006821787101216614
100 O 0 0.0011036992073059082
or O 0 0.000259603897575289
less O 0 0.0002977185067720711
triplet O 0 0.012331093661487103
repeats O 0 0.003655936336144805
. O 0 0.0006365739391185343

We O 0 0.0008148125489242375
have O 0 7.565941632492468e-05
examined O 0 0.00025001485482789576
the O 0 0.0001467316469643265
sperm O 0 0.00015194433217402548
DNA O 0 0.00016818221774883568
of O 0 0.0002711605920922011
a O 0 0.0009540210012346506
premutation O 1 0.9985395669937134
carrier O 0 0.005266115069389343
. O 0 0.0007137181237339973

This O 0 0.0012942719040438533
mans O 0 0.01065332442522049
leucocyte O 0 0.07328089326620102
DNA O 0 0.0013537355698645115
showed O 0 0.0009133622515946627
one O 0 0.00014595563698094338
normal O 0 0.0004915892495773733
allele O 0 0.0001886792160803452
and O 0 5.029443491366692e-05
one O 0 6.092583134886809e-05
allele O 0 8.787108527030796e-05
of O 0 0.00011786006507463753
approximately O 0 0.00038094783667474985
100 O 0 0.000791471975389868
repeats O 0 0.0021834103390574455
. O 0 0.0005589413922280073

His O 0 0.004524789284914732
sperm O 0 0.0008656023419462144
showed O 0 0.0004715234972536564
an O 0 9.198152110911906e-05
expanded O 0 0.0002864286070689559
allele O 0 0.0001257226977031678
in O 0 5.8378936955705285e-05
a O 0 0.0001609022874617949
tight O 0 0.0006325602298602462
range O 0 0.00010460499470354989
centering O 0 0.0005982047878205776
on O 0 0.0001248528715223074
a O 0 0.0001139207961387001
size O 0 0.0001094359322451055
of O 0 0.00017884999397210777
approximately O 0 0.0005967216566205025
320 O 0 0.0032287242356687784
trinucleotide O 0 0.11379601806402206
repeats O 0 0.004517379682511091
. O 0 0.0007418715977109969

His O 0 0.011948649771511555
affected O 0 0.010148980654776096
son O 0 0.12451447546482086
has O 0 0.0004896944155916572
repeat O 0 0.0013907996471971273
sizes O 0 0.0002623634063638747
of O 0 0.0005837294738739729
1040 O 0 0.029690563678741455
and O 0 0.0009135502623394132
540 O 0 0.014776094816625118
. O 0 0.0010489359265193343

These O 0 0.00040344326407648623
data O 0 0.00016974077152553946
suggest O 0 0.00023279512242879719
that O 0 5.460218744701706e-05
expansion O 0 0.0007101362571120262
occurs O 0 0.00017627252964302897
in O 0 5.5997592426138e-05
two O 0 5.004001650377177e-05
stages O 0 0.0005215008277446032
, O 0 7.530067523475736e-05
the O 0 0.0001744242326822132
first O 0 0.00030237319879233837
during O 0 0.0006527875084429979
meiosis O 0 0.0031545537058264017
followed O 0 0.0004658039251808077
by O 0 7.191929034888744e-05
a O 0 0.0002464329591020942
second O 0 0.0011431848397478461
mitotic O 0 0.012538590468466282
expansion O 0 0.006182591896504164
. O 0 0.0006916967686265707

We O 0 0.0009996240260079503
also O 0 0.00020592294458765537
show O 0 0.0002674677816685289
that O 0 2.342194420634769e-05
in O 0 4.7758639993844554e-05
all O 0 3.9159021980594844e-05
informative O 0 0.00018997247389052063
carrier O 0 0.0005723100039176643
father O 0 0.000768539379350841
to O 0 0.00023391311697196215
affected O 0 0.0008974949596449733
child O 0 0.001367042656056583
transmissions O 0 0.0007893230649642646
, O 0 9.073263208847493e-05
with O 0 4.2563846363918856e-05
the O 0 0.00010575036139925942
notable O 0 0.00017539234249852598
exception O 0 0.00019294291269034147
of O 0 0.00024039360869210213
the O 0 0.0008905070717446506
premutation O 1 0.9958534240722656
carrier O 0 0.0015246092807501554
, O 0 0.00011687318328768015
the O 0 0.00015986694779712707
expansion O 0 0.0008566414471715689
size O 0 0.0007508060079999268
decreases O 0 0.0010480538476258516
. O 0 0.00015376209921669215
. O 0 0.00032501851092092693

The O 0 0.004971497226506472
R496H O 0 0.4523300230503082
mutation O 0 0.0010076971957460046
of O 0 0.001009626779705286
arylsulfatase O 1 0.9996427297592163
A O 0 0.05330317094922066
does O 0 0.0004855115548707545
not O 0 0.0002660110767465085
cause O 1 0.9673397541046143
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999998807907104
. O 0 0.0048537543043494225

Deficiency B-Disease 1 0.9999984502792358
of I-Disease 0 0.14186681807041168
arylsulfatase I-Disease 1 0.999993085861206
A I-Disease 1 0.9961607456207275
( O 0 0.004421473015099764
ARSA O 1 0.9984391331672668
) O 0 0.000560175278224051
enzyme O 0 0.0012600349728018045
activity O 0 0.0018571526743471622
causes O 1 0.9528932571411133
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9888699054718018
MLD B-Disease 1 0.9999998807907104
) O 0 0.0023306303191930056
. O 0 0.0010548533173277974

A O 0 0.0038609420880675316
number O 0 0.0004044440865982324
of O 0 0.0012636501342058182
ARSA O 1 0.9997081160545349
gene O 0 0.0009253055904991925
mutations O 0 0.0004260001005604863
responsible O 0 0.0007514459430240095
for O 0 0.0005432601901702583
MLD B-Disease 1 0.9999997615814209
have O 0 0.0003400696150492877
been O 0 0.00029164575971663
identified O 0 0.0003713119658641517
. O 0 0.0003779807884711772

Recently O 0 0.004469775594770908
, O 0 0.00031420838786289096
the O 0 0.0005694813444279134
R496H O 0 0.10517467558383942
mutation O 0 0.0006825070595368743
of O 0 0.001077017281204462
ARSA O 1 0.9999778270721436
was O 0 0.0014853557804599404
proposed O 0 0.00017506853328086436
to O 0 3.618797563831322e-05
be O 0 3.592322173062712e-05
a O 0 0.00016041359049268067
cause O 0 0.0010665191803127527
of O 0 0.0023536349181085825
MLD B-Disease 1 1.0
( O 0 0.003414740087464452
Draghia O 1 0.9994887113571167
et O 0 0.007555424701422453
al O 0 0.00290456460788846
. O 0 0.0001160479587269947
, O 0 0.00014654261758551002
1997 O 0 0.0013618323719128966
) O 0 0.000326983310515061
. O 0 0.0005309817497618496

We O 0 0.0009092772379517555
have O 0 0.0001055579268722795
investigated O 0 0.0007138344226405025
the O 0 0.0005923279095441103
R496H O 1 0.9584487676620483
mutation O 0 0.00045687780948355794
and O 0 0.000110330329334829
found O 0 5.987473559798673e-05
this O 0 3.1617000786354765e-05
mutation O 0 9.244668763130903e-05
at O 0 0.00019564539252314717
a O 0 0.0001345573691651225
relatively O 0 8.339490159414709e-05
high O 0 0.0001422771019861102
frequency O 0 2.7570324164116755e-05
in O 0 2.4311784727615304e-05
an O 0 2.801067785185296e-05
African O 0 0.00018081814050674438
American O 0 0.00015528692165389657
population O 0 2.355508695472963e-05
( O 0 4.8726848035585135e-05
f O 0 0.0001323679753113538
= O 0 0.00020090374164283276
0 O 0 7.71773120504804e-05
. O 0 5.8291487221140414e-05
09 O 0 0.0019073733128607273
, O 0 0.00018767049186863005
n O 0 0.0006336158257909119
= O 0 0.0008423429098911583
61 O 0 0.0016792494570836425
subjects O 0 0.0016835476271808147
) O 0 0.00044140248792245984
. O 0 0.0007022692007012665

The O 0 0.01072534266859293
ARSA O 1 0.9970220923423767
enzyme O 0 0.002578685525804758
activity O 0 0.0006570506957359612
in O 0 0.0001509702269686386
subjects O 0 0.0003631992731243372
with O 0 7.087529229465872e-05
and O 0 9.008267807075754e-05
without O 0 9.53222406678833e-05
the O 0 0.0004266454780008644
R496H O 1 0.9986787438392639
mutation O 0 0.00044238645932637155
was O 0 0.0006986456573940814
determined O 0 0.00024358583323191851
and O 0 6.90564775140956e-05
found O 0 8.872114267433062e-05
to O 0 0.00011304341751383618
be O 0 0.00018254577298648655
normal O 0 0.0007928322884254158
. O 0 0.00039186247158795595

It O 0 0.0007004336803220212
is O 0 0.00016071827849373221
therefore O 0 0.00013562421372625977
concluded O 0 0.00039342083618976176
that O 0 5.538530240301043e-05
the O 0 0.00041091046296060085
R496H O 0 0.3072044551372528
mutation O 0 0.0008949588518589735
of O 0 0.0012201290810480714
ARSA O 1 0.999975323677063
does O 0 0.0003345154400449246
not O 0 6.53933166177012e-05
negatively O 0 0.0001855847949627787
influence O 0 0.00022975234605837613
the O 0 0.0001972969330381602
activity O 0 0.0003526629589032382
of O 0 0.0007114119944162667
ARSA O 1 0.9999878406524658
and O 0 0.0003772712661884725
is O 0 9.592991409590468e-05
not O 0 4.095475378562696e-05
a O 0 0.0003272605827078223
cause O 0 0.004091643262654543
of O 0 0.014950253069400787
MLD B-Disease 1 0.9999998807907104

Down O 0 0.027666721493005753
- O 0 0.0028945226222276688
regulation O 0 0.0007807992515154183
of O 0 0.0008293457212857902
transmembrane O 0 0.015314404852688313
carbonic O 1 0.9933382272720337
anhydrases O 1 0.9999617338180542
in O 0 0.43271133303642273
renal B-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 1 0.9618916511535645
lines O 0 0.0009160544723272324
by O 0 0.00010018621105700731
wild O 0 0.0004898571642115712
- O 0 0.0008966760942712426
type O 0 0.0009285723208449781
von B-Disease 0 0.027801357209682465
Hippel I-Disease 1 0.9980949759483337
- I-Disease 0 0.038689348846673965
Lindau I-Disease 1 0.8953783512115479
transgenes O 0 0.1285504549741745
. O 0 0.0025771530345082283

To O 0 0.0013233210192993283
discover O 0 0.0009020550642162561
genes O 0 0.00016628991579636931
involved O 0 0.0002861526154447347
in O 0 0.00031788466731086373
von B-Disease 0 0.01840565726161003
Hippel I-Disease 1 0.9994626641273499
- I-Disease 0 0.1033678874373436
Lindau I-Disease 1 0.9978495836257935
( O 0 0.003569073975086212
VHL B-Disease 1 0.9999392032623291
) O 0 0.0011892742477357388
- O 0 0.0043030655942857265
mediated O 0 0.009080741554498672
carcinogenesis O 1 0.9985053539276123
, O 0 0.000718359078746289
we O 0 0.0006754100904799998
used O 0 0.0023698853328824043
renal B-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 1 0.9967899918556213
lines O 0 0.002864817390218377
stably O 0 0.00850616954267025
transfected O 0 0.0052470555528998375
with O 0 0.0001321144081884995
wild O 0 0.0008392943418584764
- O 0 0.0015895768301561475
type O 0 0.003024067496880889
VHL O 1 0.9999926090240479
- O 0 0.007884982973337173
expressing O 0 0.0029478941578418016
transgenes O 0 0.0286495890468359
. O 0 0.0011413112515583634

Large O 0 0.0031918471213430166
- O 0 0.002557990839704871
scale O 0 0.0020951242186129093
RNA O 0 0.0008917753002606332
differential O 0 0.0006559953326359391
display O 0 0.0009165119263343513
technology O 0 0.0003630582068581134
applied O 0 8.535203232895583e-05
to O 0 6.21155631961301e-05
these O 0 5.135613901074976e-05
cell O 0 0.0004368506488390267
lines O 0 0.00022181213716976345
identified O 0 5.406668424257077e-05
several O 0 4.9057412979891524e-05
differentially O 0 0.0006237743073143065
expressed O 0 0.00015403373981826007
genes O 0 9.323444101028144e-05
, O 0 4.697513941209763e-05
including O 0 5.7735935115488246e-05
an O 0 0.00015627087850589305
alpha O 0 0.0018203719519078732
carbonic O 0 0.02054566703736782
anhydrase O 1 0.9188395142555237
gene O 0 0.0009393235086463392
, O 0 0.0005112947546876967
termed O 0 0.010902496054768562
CA12 O 1 0.9999300241470337
. O 0 0.0025905678048729897

The O 0 0.0026697686407715082
deduced O 0 0.0016076244646683335
protein O 0 0.0002720290212891996
sequence O 0 0.0001675349340075627
was O 0 0.0003745795402210206
classified O 0 0.00012297123612370342
as O 0 6.73485264996998e-05
a O 0 8.697175508132204e-05
one O 0 0.00010751039371825755
- O 0 0.0004710997745860368
pass O 0 0.0008244384662248194
transmembrane O 0 0.005831747315824032
CA O 0 0.004705327562987804
possessing O 0 0.0012042042799293995
an O 0 0.00020081565889995545
apparently O 0 0.0009168897522613406
intact O 0 0.0012602006318047643
catalytic O 0 0.0009808879112824798
domain O 0 0.00014709446986671537
in O 0 0.00010319929424440488
the O 0 0.00043083890341222286
extracellular O 0 0.008346975781023502
CA O 0 0.05943932756781578
module O 0 0.019865328446030617
. O 0 0.0008054525242187083

Reintroduced O 0 0.021386664360761642
wild O 0 0.0043972330167889595
- O 0 0.004181649535894394
type O 0 0.0029085048008710146
VHL B-Disease 1 0.9995658993721008
strongly O 0 0.0010080947540700436
inhibited O 0 0.001347607234492898
the O 0 0.00017131178174167871
overexpression O 0 0.0006446565384976566
of O 0 0.0002881885156966746
the O 0 0.0011042283149436116
CA12 O 1 0.9998262524604797
gene O 0 0.0002635025011841208
in O 0 0.0001391655096085742
the O 0 0.0007201043772511184
parental O 0 0.006182375364005566
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999322891235352
lines O 0 0.008052700199186802
. O 0 0.0008401424274779856

Similar O 0 0.0012227467959746718
results O 0 0.00033688245457597077
were O 0 0.00014866543642710894
obtained O 0 0.00018173146236222237
with O 0 0.0002010823809541762
CA9 O 1 0.9912092685699463
, O 0 0.0003471883828751743
encoding O 0 0.00017667438078206033
another O 0 0.0005328802508302033
transmembrane O 0 0.004168326035141945
CA O 0 0.0020462749525904655
with O 0 0.0001231381029356271
an O 0 0.0003069460508413613
intact O 0 0.004306092858314514
catalytic O 0 0.006794239394366741
domain O 0 0.0017696458380669355
. O 0 0.0006279198569245636

Although O 0 0.000914853357244283
both O 0 0.00016272104403469712
domains O 0 0.0005936733214184642
of O 0 0.0005135363317094743
the O 0 0.001297044102102518
VHL B-Disease 1 0.9999734163284302
protein O 0 0.0007251763599924743
contribute O 0 0.00037983315996825695
to O 0 9.446279727853835e-05
regulation O 0 0.00015861276187933981
of O 0 0.0003955003630835563
CA12 O 1 0.9999924898147583
expression O 0 0.0006938867154531181
, O 0 0.000116531657113228
the O 0 0.0002691735571715981
elongin O 0 0.007872316986322403
binding O 0 0.00023951871844474226
domain O 0 0.0004072699521202594
alone O 0 0.0004658642574213445
could O 0 0.0002399695076746866
effectively O 0 0.0009205885580740869
regulate O 0 0.00262842676602304
CA9 O 1 0.9984873533248901
expression O 0 0.0020054469350725412
. O 0 0.0008462422410957515

We O 0 0.003986487630754709
mapped O 0 0.007642123382538557
CA12 O 1 0.9972321391105652
and O 0 0.0028523399960249662
CA9 O 1 0.9964017868041992
loci O 0 0.004731414839625359
to O 0 0.0009558348101563752
chromosome O 0 0.0034978275652974844
bands O 0 0.009488356299698353
15q22 O 1 0.9997419714927673
and O 0 0.003096067113801837
17q21 O 1 0.9974195957183838
. O 0 0.0018932941602542996

2 O 0 0.004292257595807314
respectively O 0 0.0015509998193010688
, O 0 0.00026213983073830605
regions O 0 0.0003560108889359981
prone O 0 0.002518830355256796
to O 0 0.00027063084417022765
amplification O 0 0.0014340353664010763
in O 0 0.0002825729316100478
some O 0 0.00032226904295384884
human O 0 0.001837267423979938
cancers B-Disease 1 0.9984667897224426
. O 0 0.0015186079544946551

Additional O 0 0.001344800810329616
experiments O 0 0.0006798584363423288
are O 0 3.9419570384779945e-05
needed O 0 0.00016888351819943637
to O 0 6.37464108876884e-05
define O 0 0.0001442271313862875
the O 0 0.00012211310968268663
role O 0 0.0004878803447354585
of O 0 0.0007350357482209802
CA O 1 0.9827994704246521
IX O 1 0.9999903440475464
and O 0 0.0011562950676307082
CA O 0 0.05295003205537796
XII O 1 0.9958464503288269
enzymes O 0 0.00043874469702132046
in O 0 6.728222069796175e-05
the O 0 9.084570046979934e-05
regulation O 0 0.00014211400412023067
of O 0 0.00019552494632080197
pH O 0 0.0012241231743246317
in O 0 0.00015500749577768147
the O 0 0.0003961802867706865
extracellular O 0 0.0021878944244235754
microenvironment O 0 0.006466846447438002
and O 0 0.0001554245682200417
its O 0 9.980746835935861e-05
potential O 0 0.00037964669172652066
impact O 0 0.000702591787558049
on O 0 0.0014598163543269038
cancer B-Disease 1 0.9998693466186523
cell O 0 0.38213926553726196
growth O 0 0.0036842592526227236
. O 0 0.0007587221334688365

A O 0 0.0044627198949456215
gene O 0 0.0004408066743053496
encoding O 0 0.0001931907027028501
a O 0 0.00031648908043280244
transmembrane O 0 0.0018075610278174281
protein O 0 0.00035526565625332296
is O 0 0.0001186244044220075
mutated O 0 0.0006138438475318253
in O 0 0.00037749033072032034
patients O 0 0.000845781178213656
with O 0 0.0024602741468697786
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.010010512545704842
. O 0 0.0016289519844576716

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997231364250183
WFS B-Disease 1 0.9999996423721313
; O 0 0.007478171028196812
OMIM O 1 0.9999986886978149
222300 O 1 0.999934196472168
) O 0 0.0007345021585933864
is O 0 0.000322851468808949
an O 0 0.000586374313570559
autosomal B-Disease 1 0.9980556964874268
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9970020651817322
by O 0 0.0024885893799364567
young O 0 0.06005354970693588
- O 0 0.04822404310107231
onset O 1 0.999915599822998
non O 0 0.44205787777900696
- O 1 0.9925099611282349
immune O 1 0.9999338388442993
insulin B-Disease 1 0.9988489151000977
- I-Disease 0 0.44197484850883484
dependent I-Disease 0 0.006335630547255278
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999823570251465
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.781082272529602

Linkage O 0 0.00873121339827776
to O 0 0.0006324707064777613
markers O 0 0.001907163648866117
on O 0 0.0008658785955049098
chromosome O 0 0.004056261852383614
4p O 1 0.9997127652168274
was O 0 0.0017087708692997694
confirmed O 0 0.0002427502622595057
in O 0 0.00010456810559844598
five O 0 0.00017060643585864455
families O 0 0.00022981633082963526
. O 0 0.00038900060462765396

On O 0 0.0010583007242530584
the O 0 0.00042692231363616884
basis O 0 0.000196195745957084
of O 0 0.0007374678971245885
meiotic O 1 0.9999895095825195
recombinants O 1 0.9999997615814209
and O 1 0.7183008790016174
disease O 1 0.9999998807907104
- O 1 0.6295137405395508
associated O 0 0.0007197005907073617
haplotypes O 0 0.0014248236548155546
, O 0 0.00021329123410396278
the O 0 0.0005752440774813294
WFS B-Disease 1 0.9988031387329102
gene O 0 0.0005973948864266276
was O 0 0.0007101771188899875
localized O 0 0.0004966519773006439
to O 0 9.87234670901671e-05
a O 0 0.0005203086766414344
BAC O 1 0.9974465370178223
/ O 0 0.006228034850209951
P1 O 0 0.14186334609985352
contig O 0 0.013256474398076534
of O 0 0.0005102413706481457
less O 0 0.00016137644706759602
than O 0 0.00012633921869564801
250 O 0 0.0007896444294601679
kb O 0 0.005323885474354029
. O 0 0.0008490658947266638

Mutations O 0 0.0018589087994769216
in O 0 0.0005324094090610743
a O 0 0.0007614992209710181
novel O 0 0.001342696719802916
gene O 0 0.0006668182904832065
( O 0 0.0005777940386906266
WFS1 O 1 0.9945333003997803
) O 0 0.0001586309081176296
encoding O 0 8.191689994418994e-05
a O 0 0.00016566176782362163
putative O 0 0.001835805713199079
transmembrane O 0 0.001760411076247692
protein O 0 0.00030774716287851334
were O 0 8.626635826658458e-05
found O 0 6.353012577164918e-05
in O 0 5.095485539641231e-05
all O 0 5.4936768719926476e-05
affected O 0 0.0002080821868730709
individuals O 0 3.5252720408607274e-05
in O 0 0.00014983840810600668
six O 0 0.0006916495622135699
WFS B-Disease 1 0.9999465942382812
families O 0 0.00023005728144198656
, O 0 0.0001259989949176088
and O 0 9.976388537324965e-05
these O 0 5.031174805480987e-05
mutations O 0 0.00019146288104820997
were O 0 0.0001367281802231446
associated O 0 0.00020003940153401345
with O 0 0.0002825494739226997
the O 0 0.2375907450914383
disease O 1 0.9999998807907104
phenotype O 1 0.9608598351478577
. O 0 0.0017365359235554934

WFS1 O 1 0.9999134540557861
appears O 0 0.0038573823403567076
to O 0 0.00031023434712551534
function O 0 0.0001909392885863781
in O 0 0.0001577313814777881
survival O 0 0.0008325230446644127
of O 0 0.0004928889102302492
islet O 0 0.009792943485081196
beta O 0 0.002756253583356738
- O 0 0.0021956991404294968
cells O 0 0.0007330773514695466
and O 0 0.0002092460636049509
neurons O 0 0.0015790353063493967
. O 0 0.00022021797485649586
. O 0 0.00037221304955892265

Stable O 0 0.012944565154612064
interaction O 0 0.0006918575963936746
between O 0 0.0005347182741388679
the O 0 0.0005363262025639415
products O 0 0.00043278245721012354
of O 0 0.00041506896377541125
the O 0 0.0011004761327058077
BRCA1 O 1 0.9477187991142273
and O 0 0.001072659739293158
BRCA2 O 1 0.999589741230011
tumor B-Disease 1 0.999988317489624
suppressor O 1 0.5997555255889893
genes O 0 0.0005474200006574392
in O 0 0.0003685962874442339
mitotic O 0 0.010167200118303299
and O 0 0.0011984771117568016
meiotic O 1 0.9999018907546997
cells O 0 0.005343129392713308
. O 0 0.0006353662465699017

BRCA1 O 1 0.9961563944816589
and O 0 0.00198863516561687
BRCA2 O 0 0.016978638246655464
account O 0 0.00015260367945302278
for O 0 4.6517056034645066e-05
most O 0 4.558849468594417e-05
cases O 0 7.280363934114575e-05
of O 0 0.00037164075183682144
familial O 1 0.8489673137664795
, O 0 0.0010483174119144678
early O 0 0.00883430615067482
onset O 1 0.9999994039535522
breast B-Disease 1 0.999991774559021
and I-Disease 0 0.0930369570851326
/ I-Disease 1 0.999995231628418
or I-Disease 1 0.9999537467956543
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.0005972764338366687
encode O 0 0.00037700694520026445
products O 0 0.0002452193293720484
that O 0 2.9764310966129415e-05
each O 0 2.1832813217770308e-05
interact O 0 0.0001650478079682216
with O 0 0.00019315311510581523
hRAD51 O 1 0.8215470314025879
. O 0 0.0017837918130680919

Results O 0 0.0022410142701119184
presented O 0 0.0014832300366833806
here O 0 0.0005429050070233643
show O 0 0.0005253516719676554
that O 0 0.00018713658209890127
BRCA1 O 0 0.049385424703359604
and O 0 0.0007904793601483107
BRCA2 O 0 0.07643235474824905
coexist O 0 0.0011941451812162995
in O 0 0.0002582185552455485
a O 0 0.0004949113936163485
biochemical O 0 0.0027803785633295774
complex O 0 0.0029862525407224894
and O 0 0.0006367607857100666
colocalize O 1 0.9091896414756775
in O 0 0.0009422581060789526
subnuclear O 1 0.9649565815925598
foci O 0 0.0071648843586444855
in O 0 0.000812708109151572
somatic O 0 0.0027148250956088305
cells O 0 0.0004131216846872121
and O 0 6.132600537966937e-05
on O 0 9.089560626307502e-05
the O 0 0.0001244616723852232
axial O 0 0.0004916377947665751
elements O 0 0.0004272485966794193
of O 0 0.0008631388191133738
developing O 0 0.0036396803334355354
synaptonemal O 1 0.999935507774353
complexes O 0 0.13566169142723083
. O 0 0.0008742769132368267

Like O 0 0.021379249170422554
BRCA1 O 1 0.9961677193641663
and O 0 0.003174966899678111
RAD51 O 1 0.99998939037323
, O 0 0.0024821211118251085
BRCA2 O 0 0.023458823561668396
relocates O 0 0.01708700694143772
to O 0 0.0012627815594896674
PCNA O 1 0.8210330009460449
+ O 0 0.0018749679438769817
replication O 0 0.0006139067700132728
sites O 0 0.00016686838353052735
following O 0 0.00015915694530121982
exposure O 0 0.0004792074323631823
of O 0 0.00043304034625180066
S O 0 0.39795437455177307
phase O 0 0.024453239515423775
cells O 0 0.0008158062701113522
to O 0 0.00035891361767426133
hydroxyurea O 0 0.048963382840156555
or O 0 0.002405978972092271
UV O 1 0.9868687987327576
irradiation O 0 0.009541167877614498
. O 0 0.0012077050050720572

Thus O 0 0.010088191367685795
, O 0 0.002535591134801507
BRCA1 O 1 0.7723999619483948
and O 0 0.0007699283887632191
BRCA2 O 0 0.027462385594844818
participate O 0 0.0004147640138398856
, O 0 0.00011877109500346705
together O 0 0.00011783646914409474
, O 0 5.0634185754461214e-05
in O 0 8.591662481194362e-05
a O 0 0.00024845669395290315
pathway O 0 0.001781506696715951
( O 0 0.0002814855251926929
s O 0 0.0012096459977328777
) O 0 5.5772696214262396e-05
associated O 0 4.727596387965605e-05
with O 0 2.982136356877163e-05
the O 0 0.00018425268353894353
activation O 0 0.0004131953464820981
of O 0 0.0003657437046058476
double O 0 0.002340271370485425
- O 0 0.001267187763005495
strand O 0 0.0009790484327822924
break O 0 0.0021571468096226454
repair O 1 0.6620258092880249
and O 0 0.0007249414338730276
/ O 0 0.004329248797148466
or O 0 0.0008556261891499162
homologous O 0 0.0050582196563482285
recombination O 0 0.004363784566521645
. O 0 0.0007535743643529713

Dysfunction O 1 0.9998363256454468
of O 0 0.003194073447957635
this O 0 0.0006668420974165201
pathway O 0 0.1633845865726471
may O 0 0.00020408013369888067
be O 0 3.376168751856312e-05
a O 0 8.653380064060912e-05
general O 0 0.0002475888468325138
phenomenon O 0 0.00019439583411440253
in O 0 3.713008118211292e-05
the O 0 6.54025498079136e-05
majority O 0 3.831455251201987e-05
of O 0 9.68238600762561e-05
cases O 0 0.00017799274064600468
of O 0 0.0016078462358564138
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9993483424186707
/ I-Disease 1 0.9999997615814209
or I-Disease 1 0.9999984502792358
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0009318663505837321
. O 0 0.0007232525967992842

A O 0 0.012515958398580551
novel O 0 0.0066267456859350204
Arg362Ser O 0 0.11165795475244522
mutation O 0 0.0006137157906778157
in O 0 0.0001663573202677071
the O 0 0.00040472278487868607
sterol O 0 0.006308915559202433
27 O 0 0.0016896541928872466
- O 0 0.0017381467623636127
hydroxylase O 0 0.0042571090161800385
gene O 0 0.0003605456731747836
( O 0 0.00031675651553086936
CYP27 O 1 0.9991344809532166
) O 0 0.0001855325826909393
: O 0 8.616802369942889e-05
its O 0 5.932542262598872e-05
effects O 0 0.0002802214294206351
on O 0 0.00016229877655860037
pre O 0 0.0012323145056143403
- O 0 0.0005090885679237545
mRNA O 0 0.0003261981182731688
splicing O 0 0.00041249088826589286
and O 0 9.993260027840734e-05
enzyme O 0 0.0005675712018273771
activity O 0 0.0007217811071313918
. O 0 0.0003308345330879092

A O 0 0.004364306572824717
novel O 0 0.001564142992720008
C O 0 0.0009533973061479628
to O 0 8.938453538576141e-05
A O 0 0.00043347483733668923
mutation O 0 8.12069556559436e-05
in O 0 6.259107613004744e-05
the O 0 0.00022919749608263373
sterol O 0 0.004748763516545296
27 O 0 0.002029741881415248
- O 0 0.001993985613808036
hydroxylase O 0 0.006998805794864893
gene O 0 0.0006306919967755675
( O 0 0.00045255370787344873
CYP27 O 1 0.9995549321174622
) O 0 0.00022290910419542342
was O 0 0.0006011256482452154
identified O 0 0.00017971842316910625
by O 0 8.736692689126357e-05
sequencing O 0 0.000760270282626152
amplified O 0 0.0032493285834789276
CYP27 O 1 0.998842179775238
gene O 0 0.000547764531802386
products O 0 0.0002750422281678766
from O 0 0.00010114516771864146
a O 0 0.00026747494121082127
patient O 0 0.0006471314118243754
with O 0 0.00054208654910326
cerebrotendinous B-Disease 1 0.9999998807907104
xanthomatosis I-Disease 1 1.0
( O 1 0.5490018129348755
CTX B-Disease 1 0.9999985694885254
) O 0 0.001790028647519648
. O 0 0.0008873372571542859

The O 0 0.0028315316885709763
mutation O 0 0.0010334444232285023
changed O 0 0.0006866283365525305
the O 0 0.0006588233518414199
adrenodoxin O 0 0.028225580230355263
cofactor O 0 0.009083779528737068
binding O 0 0.0004945527762174606
residue O 0 0.004539637826383114
362Arg O 0 0.022749274969100952
to O 0 0.0007397565641440451
362Ser O 1 0.9398429989814758
( O 0 0.0017892818432301283
CGT O 1 0.9996095299720764
362Arg O 1 0.9326500296592712
to O 0 0.002117754891514778
AGT O 1 0.9999985694885254
362Ser O 1 0.9998975992202759
) O 0 0.00041942010284401476
, O 0 9.394752123625949e-05
and O 0 8.969062764663249e-05
was O 0 0.0007800125167705119
responsible O 0 0.0007734873797744513
for O 0 0.0003793267533183098
deficiency O 1 0.9999902248382568
in O 0 0.0004440917691681534
the O 0 0.0006993938004598022
sterol O 0 0.015660149976611137
27 O 0 0.00260491413064301
- O 0 0.0012779063545167446
hydroxylase O 0 0.0037204462569206953
activity O 0 0.00027339800726622343
, O 0 6.0406833654269576e-05
as O 0 6.620121712330729e-05
confirmed O 0 0.0001220798003487289
by O 0 4.023890141979791e-05
expression O 0 0.00011654633999569342
of O 0 0.00021493526583071798
mutant O 0 0.0012457328848540783
cDNA O 0 0.001415640115737915
into O 0 0.0004982821410521865
COS O 1 0.9985211491584778
- O 0 0.0032339522149413824
1 O 0 0.0015673425514250994
cells O 0 0.0011674626730382442
. O 0 0.0004421103512868285

Quantitative O 0 0.0020758267492055893
analysis O 0 0.00015282764798030257
showed O 0 0.0004069393326062709
that O 0 5.322328433976509e-05
the O 0 0.00014974871010053903
expression O 0 0.00022654082567896694
of O 0 0.00035811829729937017
CYP27 O 1 0.9998362064361572
gene O 0 0.0002756807080004364
mRNA O 0 0.0001848971878644079
in O 0 5.426219286164269e-05
the O 0 0.00011282221385044977
patient O 0 0.00025887475931085646
represented O 0 0.0002811963786371052
52 O 0 0.0013459796318784356
. O 0 0.0005253434064798057

5 O 0 0.002095763338729739
% O 0 0.00029044042457826436
of O 0 0.00034318366670049727
the O 0 0.0006338586681522429
normal O 0 0.0012043569004163146
level O 0 0.0013141162926331162
. O 0 0.00048315286403521895

As O 0 0.0014603552408516407
the O 0 0.000801163143478334
mutation O 0 0.00044309336226433516
occurred O 0 0.001220341888256371
at O 0 0.0003237857308704406
the O 0 0.00017381242651026696
penultimate O 0 0.003336117137223482
nucleotide O 0 0.000152721579070203
of O 0 0.00011286484368611127
exon O 0 0.0011163832386955619
6 O 0 0.0005700277397409081
( O 0 0.00014265802747104317
- O 0 0.0002251175610581413
2 O 0 9.779939864529297e-05
position O 0 8.509960025548935e-05
of O 0 9.50099783949554e-05
exon O 0 0.0015595253789797425
6 O 0 0.0009308294393122196
- O 0 0.0005644229240715504
intron O 0 0.002546207746490836
6 O 0 0.0006810353952459991
splice O 0 0.0014188834466040134
site O 0 0.0002853918995242566
) O 0 2.5346518668811768e-05
of O 0 9.765812137629837e-05
the O 0 0.00018275532056577504
gene O 0 0.00019418909505475312
, O 0 0.0001081518130376935
we O 0 8.558105037081987e-05
hypothesized O 0 0.00023017993953544647
that O 0 3.8612502976320684e-05
the O 0 0.0002323075314052403
mutation O 0 0.00040253435145132244
may O 0 0.0003036686102859676
partially O 0 0.001310689956881106
affect O 0 0.00020681117894127965
the O 0 0.00019045725639443845
normal O 0 0.0002793643216136843
splicing O 0 0.0004009538097307086
efficiency O 0 0.00036157245631329715
in O 0 9.876620606519282e-05
exon O 0 0.0012250504223629832
6 O 0 0.0008616851409897208
and O 0 0.00021140325407031924
cause O 0 0.0009819322731345892
alternative O 0 0.00034695013891905546
splicing O 0 0.0005455927457660437
elsewhere O 0 0.00022010777320247144
, O 0 5.012120527680963e-05
which O 0 2.759852031886112e-05
resulted O 0 0.00030025659361854196
in O 0 0.00020766162197105587
decreased O 0 0.001771420007571578
transcript O 0 0.0006634785095229745
in O 0 0.00016582771786488593
the O 0 0.00048294616863131523
patient O 0 0.0015525395283475518
. O 0 0.0008867117576301098

Transfection O 0 0.044481340795755386
of O 0 0.0033079986460506916
constructed O 0 0.496823787689209
minigenes O 1 0.9998171925544739
, O 0 0.00022493329015560448
with O 0 6.653177115367725e-05
or O 0 8.614765101810917e-05
without O 0 5.0259237468708307e-05
the O 0 0.00012134444114053622
mutation O 0 0.0001297427515964955
, O 0 6.901052256580442e-05
into O 0 0.00025242753326892853
COS O 1 0.998336911201477
- O 0 0.0012061254819855094
1 O 0 0.0005611154483631253
cells O 0 0.0002133929665433243
confirmed O 0 6.977988232392818e-05
that O 0 2.537157342885621e-05
the O 0 0.0001813053386285901
mutant O 0 0.0025536264292895794
minigene O 1 0.728239893913269
was O 0 0.0014351473655551672
responsible O 0 0.0004269361379556358
for O 0 5.819706348120235e-05
a O 0 0.0001681607391219586
mRNA O 0 0.00022132668527774513
species O 0 2.0121804482187144e-05
alternatively O 0 0.000138153787702322
spliced O 0 0.0003433062229305506
at O 0 0.00021372793707996607
an O 0 0.00012472161324694753
activated O 0 0.0014420452062040567
cryptic O 0 0.001069913967512548
5 O 0 0.0002351735020056367
splice O 0 0.0012225920800119638
site O 0 0.0007419465691782534
88 O 0 0.0007783796172589064
bp O 0 0.0009851340437307954
upstream O 0 0.00028252493939362466
from O 0 4.31522166763898e-05
the O 0 8.991961658466607e-05
3 O 0 0.00018262675439473242
end O 0 0.0003385477466508746
of O 0 0.0003333610948175192
exon O 0 0.005391725338995457
6 O 0 0.0024840575642883778
. O 0 0.0006398566765710711

Our O 0 0.0029147572349756956
data O 0 0.00019918254110962152
suggest O 0 0.000210513811907731
that O 0 2.8697808375000022e-05
the O 0 0.00011565436579985544
C O 0 0.0003708821313921362
to O 0 5.9115056501468644e-05
A O 0 0.00037407776108011603
mutation O 0 0.000189064972801134
at O 0 0.00020194548415020108
the O 0 0.00014007376739755273
penultimate O 0 0.0036119006108492613
nucleotide O 0 0.0002913081261795014
of O 0 0.00018088608339894563
exon O 0 0.0013956570765003562
6 O 0 0.0003840384597424418
of O 0 0.00024004180158954114
the O 0 0.0008321559871546924
CYP27 O 1 0.9999372959136963
gene O 0 0.0003808530746027827
not O 0 4.514427564572543e-05
only O 0 8.321402128785849e-05
causes O 0 0.0009309970191679895
the O 0 0.0014909030869603157
deficiency B-Disease 1 0.9999978542327881
in I-Disease 0 0.0004671607748605311
the I-Disease 0 0.0008241604664362967
sterol I-Disease 0 0.013268892653286457
27 I-Disease 0 0.0029690260998904705
- I-Disease 0 0.0017059068195521832
hydroxylase I-Disease 0 0.0049208481796085835
activity I-Disease 0 0.00046932577970437706
, O 0 0.00012439153215382248
but O 0 6.617572216782719e-05
also O 0 0.00010359823500039056
partially O 0 0.0007905387901701033
leads O 0 0.00038847903488203883
to O 0 0.00010817924339789897
alternative O 0 0.00027703394880518317
pre O 0 0.001360202324576676
- O 0 0.000476673012599349
mRNA O 0 0.00021179647592362016
splicing O 0 0.00024658150505274534
of O 0 0.0001654732768656686
the O 0 0.0004661963030230254
gene O 0 0.0007547983550466597
. O 0 0.0005389207508414984

To O 0 0.0008398920181207359
our O 0 0.00048822761164046824
knowledge O 0 0.00038586673326790333
, O 0 7.796703721396625e-05
this O 0 3.163313522236422e-05
is O 0 4.0835690015228465e-05
the O 0 9.196800965582952e-05
first O 0 0.00016428099479526281
report O 0 6.811273487983271e-05
regarding O 0 0.00012713052274193615
effects O 0 0.0002882231492549181
on O 0 0.00020792073337361217
pre O 0 0.0009749026503413916
- O 0 0.00021313635807018727
mRNA O 0 9.647796105127782e-05
splicing O 0 9.334243804914877e-05
of O 0 3.2635845855111256e-05
a O 0 7.418517634505406e-05
mutation O 0 6.423348531825468e-05
at O 0 0.00015469800564460456
the O 0 0.00015570150571875274
- O 0 0.0002343310188734904
2 O 0 0.00010141713573830202
position O 0 6.887627387186512e-05
of O 0 7.556582568213344e-05
a O 0 0.00021501682931557298
5 O 0 0.0006755595095455647
splice O 0 0.005837834905833006
site O 0 0.0030914887320250273
. O 0 0.0007860024925321341

ATM O 0 0.20591022074222565
germline O 0 0.036421168595552444
mutations O 0 0.000725260004401207
in O 0 0.0006989394314587116
classical O 0 0.020908186212182045
ataxia B-Disease 1 1.0
- I-Disease 1 0.999985933303833
telangiectasia I-Disease 1 0.9999992847442627
patients O 0 0.0010958261555060744
in O 0 0.00022867927327752113
the O 0 0.000633563322480768
Dutch O 0 0.0022214348427951336
population O 0 0.00018149110837839544
. O 0 0.00032999381073750556

Germline O 0 0.22391285002231598
mutations O 0 0.0010667945025488734
in O 0 0.00027010138728655875
the O 0 0.0007615507929585874
ATM O 0 0.003974043298512697
gene O 0 0.00016363529721274972
are O 0 1.9882187189068645e-05
responsible O 0 0.000212466562516056
for O 0 0.0001297378184972331
the O 0 0.0018716896884143353
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9973873496055603
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999380111694336
T I-Disease 1 0.9999542236328125
) O 0 0.00047127139987424016
. O 0 0.0004549547447822988

In O 0 0.001679660170339048
our O 0 0.0006868724594824016
study O 0 0.00016395798593293875
, O 0 9.721342212287709e-05
we O 0 3.483621549094096e-05
have O 0 1.6471654816996306e-05
determined O 0 5.981195863569155e-05
the O 0 0.0001682896981947124
ATM O 0 0.0020187986083328724
mutation O 0 0.00024160108296200633
spectrum O 0 0.00021574238780885935
in O 0 8.685157808940858e-05
19 O 0 0.00047317592543549836
classical O 0 0.000929750211071223
A B-Disease 1 0.9998307228088379
- I-Disease 1 0.999698281288147
T I-Disease 1 0.9999963045120239
patients O 0 0.0004182351112831384
, O 0 6.766982551198453e-05
including O 0 5.798539859824814e-05
some O 0 4.905077730654739e-05
immigrant O 0 0.00022585024998988956
populations O 0 9.507114737061784e-05
, O 0 6.760333781130612e-05
as O 0 7.451592682627961e-05
well O 0 9.178245818475261e-05
as O 0 0.00011459828965598717
12 O 0 0.00023695200798101723
of O 0 0.00029790247208438814
Dutch O 0 0.0016471054404973984
ethnic O 0 0.00047657627146691084
origin O 0 0.0005310126580297947
. O 0 0.0005874707130715251

Both O 0 0.0006095878197811544
the O 0 0.0006009417702443898
protein O 0 0.0006120016914792359
truncation O 0 0.004457101225852966
test O 0 0.0006295922794379294
( O 0 0.0004440119955688715
PTT O 0 0.006144975312054157
) O 0 6.978200690355152e-05
and O 0 5.357515692594461e-05
the O 0 0.00011029824963770807
restriction O 0 0.0003422585141379386
endonuclease O 0 0.002031318610534072
fingerprinting O 0 0.0019271800993010402
( O 0 0.000664445455186069
REF O 1 0.980604887008667
) O 0 7.134406769182533e-05
method O 0 4.318359060562216e-05
were O 0 3.808657493209466e-05
used O 0 3.387398101040162e-05
and O 0 4.388896195450798e-05
compared O 0 6.207949627423659e-05
for O 0 2.0698293155874126e-05
their O 0 3.61117854481563e-05
detection O 0 0.0003828143235296011
efficiency O 0 0.0004993631737306714
, O 0 6.949777889531106e-05
identifying O 0 0.00017234265396837145
76 O 0 0.0004401383630465716
% O 0 4.337108111940324e-05
and O 0 3.612522050389089e-05
60 O 0 0.0001056285182130523
% O 0 3.581348937586881e-05
of O 0 0.00012315783533267677
the O 0 0.00048454038915224373
mutations O 0 0.0005830136360600591
, O 0 0.0003027796628884971
respectively O 0 0.0008609719225205481
. O 0 0.0006002548616379499

Most O 0 0.002509711543098092
patients O 0 0.0009308320586569607
were O 0 0.00024869226035661995
found O 0 0.00010972745803883299
to O 0 0.00014864106196910143
be O 0 0.00019828739459626377
compound O 0 0.010693869553506374
heterozygote O 0 0.013715907000005245
. O 0 0.0010401936015114188

Seventeen O 0 0.013880130834877491
mutations O 0 0.0006968582165427506
were O 0 0.0001470118877477944
distinct O 0 8.973450894700363e-05
, O 0 5.8064739278052e-05
of O 0 0.0001836722658481449
which O 0 9.415854583494365e-05
10 O 0 0.00015943124890327454
were O 0 8.019889355637133e-05
not O 0 4.649084439733997e-05
reported O 0 0.0002818840730469674
previously O 0 0.0005452537443488836
. O 0 0.00048740857164375484

Mutations O 0 0.0032030390575528145
are O 0 9.46156942518428e-05
small O 0 0.00025292381178587675
deletions O 0 0.0016636468935757875
or O 0 0.0004461650096345693
point O 0 0.00122361711692065
mutations O 0 0.000531418772879988
frequently O 0 0.0005911333719268441
affecting O 0 0.0014433179749175906
splice O 0 0.008539494127035141
sites O 0 0.001500359852798283
. O 0 0.0006125533836893737

Moreover O 0 0.003863686230033636
, O 0 0.0004541022644843906
a O 0 0.0008554701926186681
16 O 0 0.0027309847064316273
. O 0 0.0011584266321733594

7 O 0 0.008616704493761063
- O 0 0.0030180930625647306
kb O 0 0.0033749856520444155
genomic O 0 0.0004963698447681963
deletion O 0 0.0004099319048691541
of O 0 0.00020585051970556378
the O 0 0.0004054087330587208
3 O 0 0.0002901857369579375
end O 0 0.0004730753425974399
of O 0 0.00019900637562386692
the O 0 0.00025957467732951045
gene O 0 0.00019687767780851573
, O 0 5.037103619542904e-05
most O 0 3.8388614484574646e-05
likely O 0 7.971540617290884e-05
a O 0 7.4558294727467e-05
result O 0 7.51473126001656e-05
of O 0 0.00013806451170239598
recombination O 0 0.0002786811674013734
between O 0 0.00013289181515574455
two O 0 9.964104538084939e-05
LINE O 0 0.003371649654582143
elements O 0 0.0007494157762266695
, O 0 0.00021511013619601727
was O 0 0.0011058514937758446
identified O 0 0.0008670787210576236
. O 0 0.0005083006108179688

The O 0 0.001986987190321088
most O 0 0.00029417022597044706
frequently O 0 0.00021341961110010743
found O 0 0.00011992289364570752
mutation O 0 0.00013231094635557383
, O 0 5.4545613238587976e-05
identified O 0 5.640329618472606e-05
in O 0 4.981870733899996e-05
three O 0 6.674636824754998e-05
unrelated O 0 0.0004380267928354442
Turkish O 0 0.0015465004835277796
A B-Disease 1 0.9992233514785767
- I-Disease 1 0.9865868091583252
T I-Disease 1 0.9999344348907471
individuals O 0 0.00011726078082574531
, O 0 0.00012447757762856781
was O 0 0.0004836463776882738
previously O 0 0.0002197827270720154
described O 0 0.00014889342128299177
to O 0 4.924396853311919e-05
be O 0 3.4435695852153e-05
a O 0 7.86900709499605e-05
Turkish O 0 0.0008498964598402381
A B-Disease 1 0.9622924327850342
- I-Disease 1 0.9834308624267578
T I-Disease 1 0.999971866607666
founder O 0 0.05358481407165527
mutation O 0 0.0013773087412118912
. O 0 0.0006322326371446252

The O 0 0.001785988686606288
presence O 0 0.0008348057745024562
of O 0 0.0004221451235935092
a O 0 0.0008966393652372062
founder O 0 0.013929290696978569
mutation O 0 0.000357823126250878
among O 0 0.00010489588021300733
relatively O 0 6.364886212395504e-05
small O 0 3.173229924868792e-05
ethnic O 0 4.8781526857055724e-05
population O 0 1.901738141896203e-05
groups O 0 1.1216075108677614e-05
in O 0 4.723906022263691e-05
Western O 0 0.0004564923292491585
Europe O 0 0.0003886114282067865
could O 0 8.104495645966381e-05
indicate O 0 0.0001390764955431223
a O 0 0.00012659029744099826
high O 0 0.0004114811308681965
carrier O 0 0.0004671841743402183
frequency O 0 7.712683145655319e-05
in O 0 6.715037307003513e-05
such O 0 6.960668542888016e-05
communities O 0 0.00029961089603602886
. O 0 0.0003864686586894095

In O 0 0.0021826934535056353
patients O 0 0.0009028727654367685
of O 0 0.00038283035974018276
Dutch O 0 0.0012575429864227772
ethnic O 0 0.00022654773783870041
origin O 0 0.00012183744547655806
, O 0 9.090011735679582e-05
however O 0 6.821172428317368e-05
, O 0 4.311552766012028e-05
no O 0 9.811287600314245e-05
significant O 0 0.00039116147672757506
founder O 0 0.007592582143843174
effect O 0 0.0006436972762458026
could O 0 0.00027159060118719935
be O 0 9.156993473879993e-05
identified O 0 0.0002196255954913795
. O 0 0.00037671116297133267

The O 0 0.0032244855538010597
observed O 0 0.0009968879166990519
genetic O 0 0.0005919768591411412
heterogeneity O 0 0.0008710866677574813
including O 0 0.00018290574371349066
the O 0 0.00028222586843185127
relative O 0 0.00027367574512027204
high O 0 0.0005361416842788458
percentage O 0 0.00015881223953329027
of O 0 0.00022336140682455152
splice O 0 0.006027620285749435
- O 0 0.001407602452673018
site O 0 0.0010563075775280595
mutations O 0 0.00024450657656416297
had O 0 0.00021006727183703333
no O 0 0.00018129029194824398
reflection O 0 0.0007034668233245611
on O 0 0.00035774908610619605
the O 0 0.0011061918921768665
phenotype O 0 0.0027359607629477978
. O 0 0.00063215201953426

All O 0 0.0030343597754836082
patients O 0 0.0021859705448150635
manifested O 0 0.007594033610075712
classical O 0 0.0035405124071985483
A B-Disease 1 0.999904990196228
- I-Disease 1 0.9898089170455933
T I-Disease 1 0.9987473487854004
and O 0 0.00030034477822482586
increased O 0 0.0005722988280467689
cellular O 0 0.0023427403066307306
radioresistant O 1 0.6209473013877869
DNA O 0 0.0023422585800290108
synthesis O 0 0.0025493649300187826
. O 0 0.000608303991612047

Determination O 0 0.005276951938867569
of O 0 0.0007837844896130264
the O 0 0.0004670394700951874
genomic O 0 0.0004600615648087114
structure O 0 0.0005421529640443623
of O 0 0.00044720989535562694
the O 0 0.0011294505093246698
COL4A4 O 1 0.999995231628418
gene O 0 0.0003347754536662251
and O 0 0.00011393688328098506
of O 0 0.00041671309736557305
novel O 0 0.00353973894380033
mutations O 0 0.019783375784754753
causing O 1 0.9999953508377075
autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9974148273468018

Autosomal B-Disease 1 0.9999783039093018
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9032551050186157
a O 1 0.9574611186981201
progressive O 1 0.9999964237213135
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9979433417320251
by O 0 0.005379128269851208
glomerular B-Disease 1 0.9999998807907104
basement I-Disease 1 0.9999998807907104
membrane I-Disease 1 0.9998387098312378
abnormalities I-Disease 1 0.9999513626098633
and O 0 0.0002731254789978266
associated O 0 0.00020397470507305115
with O 0 0.00011655977868940681
mutations O 0 0.00011797700426541269
in O 0 9.517130092717707e-05
either O 0 0.0001325354678556323
the O 0 0.0003303854027763009
COL4A3 O 1 0.9999147653579712
or O 0 0.00041089928708970547
the O 0 0.0006775938090868294
COL4A4 O 1 0.9999507665634155
gene O 0 0.00030067338957451284
, O 0 5.864867125637829e-05
which O 0 2.8685522920568474e-05
encode O 0 0.00010405693319626153
the O 0 0.0002997583360411227
alpha3 O 0 0.01764131337404251
and O 0 0.0006067750509828329
alpha4 O 1 0.9986968636512756
type O 1 0.9869493842124939
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9994115829467773
, O 0 0.0008194189867936075
respectively O 0 0.0012426243629306555
. O 0 0.0005388801218941808

To O 0 0.001149599440395832
date O 0 0.0011719067115336657
, O 0 0.00018035668472293764
mutation O 0 0.00016673971549607813
screening O 0 0.0001237336837220937
in O 0 5.948193938820623e-05
the O 0 0.00010583913535811007
two O 0 4.702085425378755e-05
genes O 0 9.004979074234143e-05
has O 0 8.533087384421378e-05
been O 0 0.00012942185276187956
hampered O 0 0.0022723576985299587
by O 0 0.00010667953756637871
the O 0 0.00031361464061774313
lack O 0 0.0006238670321181417
of O 0 0.0006190540734678507
genomic O 0 0.001458519953303039
structure O 0 0.004559960216283798
information O 0 0.0004480436909943819
. O 0 0.0004893561126664281

We O 0 0.0012076601851731539
report O 0 0.0002569236094132066
here O 0 0.00023218840942718089
the O 0 0.00013340817531570792
complete O 0 0.0003848170454148203
characterization O 0 0.0007126585114747286
of O 0 0.000249999575316906
the O 0 0.00027290292200632393
48 O 0 0.00033983151661232114
exons O 0 0.0005454164347611368
of O 0 0.00020702304027508944
the O 0 0.0007123114774003625
COL4A4 O 1 0.999983549118042
gene O 0 0.0003048410580959171
, O 0 7.298227865248919e-05
a O 0 0.0001090332298190333
comprehensive O 0 0.00045397455687634647
gene O 0 0.0002589660871308297
screen O 0 0.00034673287882469594
, O 0 6.946200301172212e-05
and O 0 3.731715332833119e-05
the O 0 9.372739441459998e-05
subsequent O 0 0.0002491940394975245
detection O 0 0.00027001305716112256
of O 0 0.00022192724281921983
10 O 0 0.0003977234591729939
novel O 0 0.0004831247788388282
mutations O 0 0.00020030871382914484
in O 0 0.0002484538417775184
eight O 0 0.0015962199540808797
patients O 0 0.07450591027736664
diagnosed O 1 0.9999988079071045
with O 0 0.2640381157398224
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9973639845848083

Furthermore O 0 0.005874470341950655
, O 0 0.00044852422433905303
we O 0 0.00011353731679264456
identified O 0 0.00012816245725844055
a O 0 0.00022790439834352583
glycine O 0 0.0011819899082183838
to O 0 0.00019399698066990823
alanine O 0 0.001307893544435501
substitution O 0 0.0006552652921527624
in O 0 0.00015558351879008114
the O 0 0.0003564168291632086
collagenous O 1 0.7921777367591858
domain O 0 0.00032387461396865547
that O 0 4.130528759560548e-05
is O 0 5.918652095715515e-05
apparently O 0 0.00022446599905379117
silent O 0 0.0006033481331542134
in O 0 8.461764082312584e-05
the O 0 0.0001878120965557173
heterozygous O 0 0.00016155026969499886
carriers O 0 0.00014294016000349075
, O 0 3.9750033465679735e-05
in O 0 0.00010282719449605793
11 O 0 0.0010193557245656848
. O 0 0.0005154229002073407

5 O 0 0.0015229767886921763
% O 0 0.00017574522644281387
of O 0 0.00016696244711056352
all O 0 0.00011523911234689876
control O 0 0.0005200324812904
individuals O 0 5.132793739903718e-05
, O 0 8.067669114097953e-05
and O 0 7.085758988978341e-05
in O 0 7.62486961320974e-05
one O 0 9.603791841072962e-05
control O 0 0.00029377336613833904
individual O 0 8.315610466524959e-05
homozygous O 0 0.00029286788776516914
for O 0 6.71379457344301e-05
this O 0 0.00013663721620105207
glycine O 0 0.0028336800169199705
substitution O 0 0.0024629670660942793
. O 0 0.0006241507944650948

There O 0 0.0011951704509556293
has O 0 0.00028642176766879857
been O 0 9.901808516588062e-05
no O 0 8.30070857773535e-05
previous O 0 0.00011968368198722601
finding O 0 8.063930727075785e-05
of O 0 0.0001716220867820084
a O 0 0.0003750913601834327
glycine O 0 0.0015308158472180367
substitution O 0 0.0008252197876572609
that O 0 6.897374987602234e-05
is O 0 5.3242161811795086e-05
not O 0 2.1242016373435035e-05
associated O 0 5.8127618103753775e-05
with O 0 4.6597990149166435e-05
any O 0 0.00015073288523126394
obvious O 0 0.0014889473095536232
phenotype O 0 0.001514857867732644
in O 0 0.0005395724438130856
homozygous O 0 0.0010364081244915724
individuals O 0 0.00020148081239312887
. O 0 0.0006044235778972507

Founder O 1 0.998508870601654
BRCA1 O 1 0.998588502407074
and O 0 0.002058937679976225
BRCA2 O 1 0.576103150844574
mutations O 0 0.0004738746501971036
in O 0 0.00045717708417214453
French O 0 0.015188713558018208
Canadian O 1 0.9982598423957825
breast B-Disease 1 0.9999990463256836
and I-Disease 1 0.9996893405914307
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.004165035672485828
. O 0 0.0013456579763442278

We O 0 0.0009519450250081718
have O 0 8.652785618323833e-05
identified O 0 0.00013968802522867918
four O 0 9.858705016085878e-05
mutations O 0 7.94755615061149e-05
in O 0 3.993461359641515e-05
each O 0 2.2380709197022952e-05
of O 0 0.00023269327357411385
the O 0 0.0019629604648798704
breast B-Disease 1 0.9999967813491821
cancer I-Disease 1 0.9999974966049194
- O 1 0.8549614548683167
susceptibility O 0 0.03663451969623566
genes O 0 0.0004693871014751494
, O 0 0.0003363599826116115
BRCA1 O 1 0.534509539604187
and O 0 0.00046238466165959835
BRCA2 O 0 0.03745509311556816
, O 0 0.00017481998656876385
in O 0 0.00020543384016491473
French O 0 0.004934003576636314
Canadian O 1 0.9034937620162964
breast B-Disease 1 0.9999969005584717
cancer I-Disease 1 0.9999988079071045
and O 1 0.9917014241218567
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.0008445964194834232
from O 0 0.0010980446822941303
Quebec O 0 0.011393643915653229
. O 0 0.0015650950372219086

To O 0 0.0013372410321608186
identify O 0 0.0013050464913249016
founder O 0 0.31755974888801575
effects O 0 0.013194344006478786
, O 0 0.00022570646251551807
we O 0 0.00011358129268046468
examined O 0 0.0004499924252741039
independently O 0 0.0001304595498368144
ascertained O 0 0.0014522430719807744
French O 0 0.002233924577012658
Canadian O 0 0.003597295843064785
cancer B-Disease 0 0.0049378094263374805
families O 0 7.930310675874352e-05
for O 0 2.955912350444123e-05
the O 0 9.36819997150451e-05
distribution O 0 4.682941653300077e-05
of O 0 0.00013197853695601225
these O 0 6.238964851945639e-05
eight O 0 0.0006059396546334028
mutations O 0 0.0006637870683334768
. O 0 0.0004104261752218008

Mutations O 0 0.0019005691865459085
were O 0 0.00025951603311114013
found O 0 0.00011454735795268789
in O 0 0.0001158464074251242
41 O 0 0.00038931742892600596
of O 0 0.00038498896174132824
97 O 0 0.0029038493521511555
families O 0 0.0006465399055741727
. O 0 0.0005680064205080271

Six O 0 0.001348834834061563
of O 0 0.0006517202127724886
eight O 0 0.0007632202468812466
mutations O 0 0.00022850275854580104
were O 0 0.00013298980775289237
observed O 0 0.0001481946965213865
at O 0 0.0002975105307996273
least O 0 0.0002553400117903948
twice O 0 0.0005273658316582441
. O 0 0.00030560785671696067

The O 0 0.009576525539159775
BRCA1 O 1 0.9886445999145508
C4446T O 1 0.998437225818634
mutation O 0 0.0011230941163375974
was O 0 0.0007989244186319411
the O 0 0.00023220834555104375
most O 0 6.480667070718482e-05
common O 0 9.568186214892194e-05
mutation O 0 0.00014239191659726202
found O 0 9.828011388890445e-05
, O 0 0.00010027155803982168
followed O 0 0.0003146781527902931
by O 0 0.00012724866974167526
the O 0 0.0009478366118855774
BRCA2 O 1 0.9335836172103882
8765delAG O 1 0.9990845918655396
mutation O 0 0.004325090441852808
. O 0 0.001257705269381404

Together O 0 0.002682577120140195
, O 0 0.0003626928955782205
these O 0 5.4744319641031325e-05
mutations O 0 0.00012531253742054105
were O 0 5.439399683382362e-05
found O 0 3.4074659197358415e-05
in O 0 4.9155758460983634e-05
28 O 0 0.00024028957705013454
of O 0 0.00014471866597887129
41 O 0 0.00040135515155270696
families O 0 7.788871153024957e-05
identified O 0 6.236515037016943e-05
to O 0 6.125755317043513e-05
have O 0 5.471811527968384e-05
a O 0 0.00032587291207164526
mutation O 0 0.0007476232131011784
. O 0 0.0005755723104812205

The O 0 0.0018683891976252198
odds O 0 0.0012082079192623496
of O 0 0.00031085399677976966
detection O 0 0.0003545456856954843
of O 0 0.00015736241766717285
any O 0 9.729421435622498e-05
of O 0 0.00020566981402225792
the O 0 0.0004925181274302304
four O 0 0.0006960668251849711
BRCA1 O 0 0.04626820608973503
mutations O 0 0.0005164753529243171
was O 0 0.001245369901880622
18 O 0 0.0016542059602215886
. O 0 0.0006491247331723571

7x O 1 0.9107552766799927
greater O 0 0.001217721146531403
if O 0 0.00010279180423822254
one O 0 5.2539668104145676e-05
or O 0 4.333267133915797e-05
more O 0 3.273609036114067e-05
cases O 0 0.00014044021372683346
of O 1 0.888241708278656
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.000821641820948571
also O 0 0.00011039263335987926
present O 0 9.371577471029013e-05
in O 0 7.702760922256857e-05
the O 0 0.0002760623465292156
family O 0 0.0008064654539339244
. O 0 0.0006782217533327639

The O 0 0.002330747665837407
odds O 0 0.0015397039242088795
of O 0 0.0003898297727573663
detection O 0 0.0004346170462667942
of O 0 0.00016105240501929075
any O 0 7.683290459681302e-05
of O 0 0.0002525498275645077
the O 0 0.0004622353008016944
four O 0 0.00047716082190163434
BRCA2 O 0 0.012933706864714622
mutations O 0 0.0004791882529389113
was O 0 0.001839353353716433
5 O 0 0.0016408242518082261
. O 0 0.0005812941817566752

3x O 0 0.06566823273897171
greater O 0 0.0013127513229846954
if O 0 0.00014028976147528738
there O 0 7.70404003560543e-05
were O 0 5.6438700994476676e-05
at O 0 0.00010291107173543423
least O 0 2.4340923118870705e-05
five O 0 2.8100223062210716e-05
cases O 0 5.13817576575093e-05
of O 0 0.0006455988041125238
breast B-Disease 1 0.999998927116394
cancer I-Disease 1 0.9998923540115356
in O 0 0.0006069216760806739
the O 0 0.0006960498867556453
family O 0 0.0008791737491264939
. O 0 0.00040033753612078726

Interestingly O 0 0.007299519143998623
, O 0 0.0003091192338615656
the O 0 0.00023516902001574636
presence O 0 0.000575544370803982
of O 0 0.0004661392595153302
a O 0 0.002040776889771223
breast B-Disease 1 0.9999552965164185
cancer I-Disease 1 0.9908363819122314
case O 0 0.0006938973092474043
< O 0 0.0013553693424910307
36 O 0 0.00029825998353771865
years O 0 9.79657270363532e-05
of O 0 0.00017693667905405164
age O 0 0.0003059815790038556
was O 0 0.00046672436292283237
strongly O 0 0.00013776439300272614
predictive O 0 0.00010551888408372179
of O 0 0.00010337481216993183
the O 0 0.00015215917665045708
presence O 0 0.0001894320157589391
of O 0 0.00016153333126567304
any O 0 6.410448986571282e-05
of O 0 0.0001737060520099476
the O 0 0.0004153173940721899
eight O 0 0.0007934179157018661
mutations O 0 0.0006230458966456354
screened O 0 0.0013474200386554003
. O 0 0.0005582221201620996

Carriers O 0 0.0015026538167148829
of O 0 0.0003124060749541968
the O 0 0.0003666261909529567
same O 0 0.00020002279779873788
mutation O 0 0.0001320538140134886
, O 0 4.74056250823196e-05
from O 0 4.343585897004232e-05
different O 0 2.377771306782961e-05
families O 0 5.081617200630717e-05
, O 0 6.476973067037761e-05
shared O 0 0.00019355742551852018
similar O 0 0.00017230173398274928
haplotypes O 0 0.0015231160214170814
, O 0 0.00021136477880645543
indicating O 0 0.00042171578388661146
that O 0 5.990923091303557e-05
the O 0 0.00026415346655994654
mutant O 0 0.0016236323863267899
alleles O 0 0.00029723753686994314
were O 0 9.584707004250959e-05
likely O 0 9.304773266194388e-05
to O 0 5.4132466175360605e-05
be O 0 2.3242559109348804e-05
identical O 0 4.5192951802164316e-05
by O 0 2.5054670913959853e-05
descent O 0 0.00018976355204358697
for O 0 3.7993093428667635e-05
a O 0 0.00016686537128407508
mutation O 0 7.422358612529933e-05
in O 0 8.69778887135908e-05
the O 0 0.0003039634320884943
founder O 0 0.003774823620915413
population O 0 0.00018037283734884113
. O 0 0.00028758085682056844

The O 0 0.0014366713585332036
identification O 0 0.0005191131494939327
of O 0 0.0009293672628700733
common O 0 0.004672672133892775
BRCA1 O 1 0.9999591112136841
and O 0 0.0019185743294656277
BRCA2 O 1 0.9363619089126587
mutations O 0 0.0004941194783896208
will O 0 0.00013386194768827409
facilitate O 0 0.0003373200015630573
carrier O 0 0.000499740126542747
detection O 0 0.00022491933486890048
in O 0 0.00017854024190455675
French O 0 0.0022810203954577446
Canadian O 0 0.050081707537174225
breast B-Disease 1 0.999983549118042
cancer I-Disease 1 0.9999969005584717
and O 1 0.989624559879303
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0030197217129170895
. O 0 0.001066718716174364

Are O 0 0.002049069618806243
Dp71 O 1 0.9979178309440613
and O 0 0.00536810327321291
Dp140 O 1 0.9999927282333374
brain O 1 0.9999186992645264
dystrophin O 1 0.8824471831321716
isoforms O 0 0.001237755175679922
related O 0 0.0007775670965202153
to O 0 0.0008995556272566319
cognitive B-Disease 1 0.9994865655899048
impairment I-Disease 1 0.9999996423721313
in O 1 0.9999818801879883
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999768733978271

Molecular O 0 0.004938822239637375
study O 0 0.0003065419150516391
and O 0 0.00022974380408413708
neuropsychological O 0 0.0012570465914905071
analysis O 0 5.9984919062117115e-05
were O 0 9.495625999988988e-05
performed O 0 0.0004616360238287598
concurrently O 0 0.0005849826848134398
on O 0 0.0002648722438607365
49 O 0 0.0014243758050724864
patients O 0 0.0010866863885894418
with O 0 0.0020174484234303236
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DMD B-Disease 1 1.0
) O 0 0.0005814470932818949
in O 0 0.00016394157137256116
order O 0 0.00011732509301509708
to O 0 3.7325338780647144e-05
find O 0 4.4326065108180046e-05
a O 0 6.443913298426196e-05
molecular O 0 8.227938087657094e-05
explanation O 0 0.00015037384582683444
for O 0 4.938862912240438e-05
the O 0 0.000468753045424819
cognitive B-Disease 0 0.24218665063381195
impairment I-Disease 1 0.9993392825126648
observed O 0 0.0010604474227875471
in O 0 0.0007355858106166124
most O 0 0.0014093969948589802
DMD B-Disease 1 0.9999998807907104
patients O 0 0.008370465599000454
. O 0 0.0012118973536416888

Complete O 0 0.0025004714261740446
analysis O 0 0.00015931576490402222
of O 0 0.0003338622918818146
the O 0 0.0010361041640862823
dystrophin O 1 0.8709976673126221
gene O 0 0.0006112814298830926
was O 0 0.001199010876007378
performed O 0 0.000572522054426372
to O 0 8.13294027466327e-05
define O 0 0.00021889620984438807
the O 0 0.0003443096939008683
localization O 0 0.0015496460255235434
of O 0 0.0003843631420750171
deletions O 0 0.0016383889596909285
and O 0 0.00022079425980336964
duplications O 0 0.002666160464286804
in O 0 0.0001871956483228132
relation O 0 0.0003122083726339042
to O 0 0.00010856336302822456
the O 0 0.0004038380866404623
different O 0 0.0003150855773128569
DMD B-Disease 1 0.9999979734420776
promoters O 1 0.5139107704162598
. O 0 0.0020305824000388384

Qualitative O 0 0.0018237282056361437
analysis O 0 0.00014873745385557413
of O 0 0.00029855361208319664
the O 0 0.0008734059520065784
Dp71 O 1 0.9960353970527649
transcript O 0 0.001933775027282536
and O 0 0.00017210420628543943
testing O 0 0.00011775537132052705
for O 0 2.365603177167941e-05
the O 0 5.4564188758376986e-05
specific O 0 2.621830572024919e-05
first O 0 0.00019682869606185704
exon O 0 0.0015222331276163459
of O 0 0.0005410030717030168
Dp140 O 1 0.9828604459762573
were O 0 0.00038192179636098444
also O 0 0.0001512812013970688
carried O 0 0.0003616417234297842
out O 0 0.0004202549753244966
. O 0 0.0004916798789054155

Neuropsychological O 0 0.027311528101563454
analysis O 0 0.000709629850462079
assessed O 0 0.0014614270767197013
verbal O 0 0.00284161907620728
and O 0 0.0008866493008099496
visuospatial O 1 0.9937159419059753
intelligence O 0 0.0024119431618601084
, O 0 0.00036107300547882915
verbal O 0 0.0037160550709813833
memory O 1 0.9959050416946411
, O 0 0.000508997414726764
and O 0 0.00041178485844284296
reading O 0 0.0025820801965892315
skills O 0 0.004017098341137171
. O 0 0.0008964608423411846

Comparison O 0 0.001837800838984549
of O 0 0.0013873018324375153
molecular O 0 0.0015570385148748755
and O 0 0.000507187913171947
psychometric O 0 0.0070936125703155994
findings O 0 0.0005887869629077613
demonstrated O 0 0.000871900119818747
that O 0 9.481693268753588e-05
deletions O 0 0.0010592126054689288
and O 0 0.00017578010738361627
duplications O 0 0.0029327813535928726
that O 0 9.130511898547411e-05
were O 0 0.00010868092067539692
localized O 0 0.0003817671095021069
in O 0 0.00010686879977583885
the O 0 0.00019259772670920938
distal O 0 0.003140382468700409
part O 0 0.0004012681310996413
of O 0 0.0003262456739321351
the O 0 0.0005950264167040586
gene O 0 0.00027291697915643454
seemed O 0 0.0004763196629937738
to O 0 6.045006011845544e-05
be O 0 5.349765342543833e-05
preferentially O 0 0.0004767089558299631
associated O 0 0.00025514818844385445
with O 0 0.00044529649312607944
cognitive B-Disease 1 0.9975122213363647
impairment I-Disease 1 0.9999938011169434
. O 0 0.005151752382516861

Two O 0 0.0027508719358593225
altered O 0 0.008487281389534473
Dp71 O 0 0.4182620048522949
transcripts O 0 0.002657476579770446
and O 0 0.0002197944704676047
two O 0 9.474606486037374e-05
deleted O 0 0.0007734841201454401
Dp140 O 0 0.006077141966670752
DNA O 0 0.00025496535818092525
sequences O 0 0.0001084169780369848
were O 0 6.24172535026446e-05
found O 0 4.436844028532505e-05
in O 0 7.607236329931766e-05
four O 0 0.00028830254450440407
patients O 0 0.0011124780867248774
with O 0 0.005743721034377813
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9987162351608276

These O 0 0.0006101289764046669
findings O 0 0.0004030941636301577
suggest O 0 0.0002392521419096738
that O 0 3.620426286943257e-05
some O 0 3.217324410798028e-05
sequences O 0 6.855819810880348e-05
located O 0 0.00017563767323736101
in O 0 6.797050446039066e-05
the O 0 0.00019000055908691138
distal O 0 0.002605539746582508
part O 0 0.0003665175463538617
of O 0 0.00034980641794390976
the O 0 0.0005759767955169082
gene O 0 0.0002018068771576509
and O 0 9.147995297098532e-05
, O 0 5.255756332189776e-05
in O 0 6.449618376791477e-05
particular O 0 9.252871677745134e-05
, O 0 0.00010429862595628947
some O 0 0.00013866853259969503
DMD B-Disease 1 0.99954754114151
isoforms O 0 0.0002535186940804124
expressed O 0 0.00014719535829499364
in O 0 0.0001815617288229987
the O 0 0.0009623546502552927
brain O 1 0.9993839263916016
may O 0 0.00030561862513422966
be O 0 6.0375514294719324e-05
related O 0 8.168304339051247e-05
to O 0 0.0001114621409215033
the O 0 0.0008976240060292184
cognitive B-Disease 1 0.9881324172019958
impairment I-Disease 1 0.9999816417694092
associated O 0 0.007145899813622236
with O 0 0.005777010694146156
DMD B-Disease 1 1.0
. O 0 0.001955609302967787
. O 0 0.0010563990799710155

I1307K O 1 0.9994955062866211
APC O 1 0.9987666606903076
and O 0 0.0019904719665646553
hMLH1 O 1 0.9956870675086975
mutations O 0 0.00041934437467716634
in O 0 0.00021013178047724068
a O 0 0.0003819764533545822
non O 0 0.0007327703642658889
- O 0 0.00044118010555393994
Jewish O 0 0.00048135092947632074
family O 0 0.00034167562262155116
with O 0 0.00025594711769372225
hereditary B-Disease 1 0.9999823570251465
non I-Disease 1 0.9999886751174927
- I-Disease 1 0.9999997615814209
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.011291277594864368

We O 0 0.0008499702089466155
describe O 0 0.0008866493008099496
a O 0 0.0005613599787466228
French O 0 0.0027377570513635874
Canadian O 0 0.006345165893435478
hereditary B-Disease 1 0.9999076128005981
non I-Disease 1 0.9992033839225769
- I-Disease 1 0.9999978542327881
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999853372573853
HNPCC B-Disease 1 1.0
) O 0 0.0013666675658896565
kindred O 0 0.013299090787768364
which O 0 0.00021432031644508243
carries O 0 0.0002595820988062769
a O 0 0.0002606574271339923
novel O 0 0.0008942997665144503
truncating O 0 0.007463228423148394
mutation O 0 0.0010141743114218116
in O 0 0.0008010246092453599
hMLH1 O 1 0.9717065095901489
. O 0 0.001150135649368167

Interestingly O 0 0.010726516135036945
, O 0 0.0008291138801723719
the O 0 0.0010007537202909589
I1307K O 1 0.9955249428749084
APC O 1 0.9975099563598633
polymorphism O 0 0.0014547283062711358
, O 0 0.00018347606237512082
associated O 0 0.0001252400252269581
with O 0 5.2909323130734265e-05
an O 0 0.00014920807734597474
increased O 0 0.00043223495595157146
risk O 0 0.0011273769196122885
of O 1 0.9998866319656372
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.002320619998499751
is O 0 0.00010027529788203537
also O 0 4.7150075261015445e-05
present O 0 9.020861762110144e-05
in O 0 0.0001161271138698794
this O 0 8.272608101833612e-05
family O 0 0.0006360432598739862
. O 0 0.0005662733456119895

The O 0 0.005709977354854345
I1307K O 1 0.91245436668396
polymorphism O 0 0.0019288301700726151
has O 0 0.00021247689437586814
previously O 0 0.0001520044606877491
only O 0 3.3637570595601574e-05
been O 0 4.6184130042092875e-05
identified O 0 5.814668838866055e-05
in O 0 5.453027551993728e-05
individuals O 0 3.8004614907549694e-05
of O 0 0.0003496298741083592
self O 0 0.019451303407549858
- O 0 0.006086232140660286
reported O 0 0.0007797267753630877
Ashkenazi O 0 0.0021531006786972284
Jewish O 0 0.001276428927667439
origins O 0 0.0027810558676719666
. O 0 0.0006650155992247164

In O 0 0.001245536026544869
addition O 0 0.00030403301934711635
, O 0 9.543156193103641e-05
in O 0 6.67997301206924e-05
this O 0 4.051880750921555e-05
family O 0 0.00016097500338219106
, O 0 8.859145600581542e-05
there O 0 7.703863229835406e-05
appears O 0 0.00018340538372285664
to O 0 3.3248263207497075e-05
be O 0 3.094369458267465e-05
no O 0 5.810479342471808e-05
relationship O 0 0.00010599164670566097
between O 0 0.00017557288811076432
the O 0 0.0006240359507501125
I1307K O 1 0.879764199256897
polymorphism O 0 0.0005384993855841458
and O 0 0.0001098508873838
the O 0 0.00018076589913107455
presence O 0 0.0004706379259005189
or O 0 0.0002033726777881384
absence O 0 0.0019305860623717308
of O 0 0.49480652809143066
cancer B-Disease 1 0.9999971389770508
. O 0 0.0005456501967273653
. O 0 0.0007620364776812494

Identification O 0 0.0007532181916758418
of O 0 0.0006042384193278849
a O 0 0.00044679720303975046
novel O 0 0.0005136994295753539
mutation O 0 0.00020184111781418324
of O 0 0.0002886323200073093
the O 0 0.0007549544097855687
CPO O 1 0.6232204437255859
gene O 0 0.00016724670422263443
in O 0 0.00010884479706874117
a O 0 0.0003101018664892763
Japanese O 0 0.008414505049586296
hereditary B-Disease 1 0.9998496770858765
coproporphyria I-Disease 1 0.9999953508377075
family O 0 0.007220215164124966
. O 0 0.0017099326942116022

Hereditary B-Disease 1 0.9999862909317017
coproporphyria I-Disease 1 0.9999996423721313
( O 1 0.9674215316772461
HCP B-Disease 1 0.9999921321868896
) O 0 0.0006131001864559948
is O 0 0.0001883014483610168
an O 0 0.0002799586218316108
autosomal B-Disease 1 0.8313544988632202
dominant I-Disease 1 0.9999958276748657
disease I-Disease 1 1.0
characterized O 1 0.9956905245780945
by O 0 0.0007654611254110932
a O 0 0.009567420929670334
deficiency B-Disease 1 0.9999998807907104
of I-Disease 1 0.9669365882873535
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.949958860874176
( O 0 0.0009251512819901109
CPO O 1 0.9123228788375854
) O 0 0.00021124992053955793
caused O 0 0.0005397035856731236
by O 0 4.5324246457312256e-05
a O 0 0.0001512315939180553
mutation O 0 0.0001310480438405648
in O 0 0.00019063295621890575
the O 0 0.000866880058310926
CPO O 1 0.885188639163971
gene O 0 0.000942125276196748
. O 0 0.0005809720023535192

Only O 0 0.00080169050488621
11 O 0 0.0010814277920871973
mutations O 0 0.00014586436736863106
of O 0 0.00020921057148370892
the O 0 0.00035969860618934035
gene O 0 0.0001804152998374775
have O 0 4.608900781022385e-05
been O 0 9.628733823774382e-05
reported O 0 0.0003395946405362338
in O 0 0.0007786026690155268
HCP B-Disease 1 0.9999910593032837
patients O 0 0.00460354657843709
. O 0 0.0010253993095830083

We O 0 0.0010238181566819549
report O 0 0.00027058416162617505
another O 0 0.0002278826868860051
mutation O 0 0.00012863357551395893
in O 0 7.834325515432283e-05
a O 0 0.0002304205991094932
Japanese O 0 0.00289226695895195
family O 0 0.0011538929538801312
. O 0 0.0007397382287308574

Polymerase O 0 0.01503171119838953
chain O 0 0.005430764053016901
reaction O 0 0.001203159219585359
- O 0 0.000955421885009855
single O 0 0.00028547304100356996
strand O 0 0.0008373875170946121
conformational O 0 0.0006349887698888779
polymorphism O 0 0.0003341641859151423
and O 0 7.968159479787573e-05
direct O 0 7.316080154851079e-05
sequence O 0 0.00012184929801151156
analyses O 0 9.558748570270836e-05
demonstrated O 0 0.0003808524925261736
a O 0 0.00016661225527059287
C O 0 0.0005320580676198006
to O 0 0.00012317899381741881
T O 0 0.0014944587601348758
substitution O 0 0.0002848232688847929
in O 0 8.562872972106561e-05
exon O 0 0.0007854275172576308
1 O 0 0.00014978925173636526
of O 0 0.00011542563152033836
the O 0 0.00022823319886811078
CPO O 0 0.005990628153085709
gene O 0 0.00011477238149382174
at O 0 0.00026413207524456084
nucleotide O 0 0.0001684627786744386
position O 0 0.0001413076970493421
85 O 0 0.000349148060195148
, O 0 8.078369864961132e-05
which O 0 5.507052264874801e-05
lies O 0 0.0003204953100066632
in O 0 0.00011903912673005834
the O 0 0.00040721430559642613
putative O 0 0.0033043751027435064
presequence O 0 0.025596965104341507
for O 0 0.00019666660227812827
targeting O 0 0.0005809017457067966
to O 0 0.00042187844519503415
mitochondria O 0 0.004892481025308371
. O 0 0.0006353422650136054

This O 0 0.0009605528321117163
mutation O 0 0.00039489701157435775
changes O 0 0.00013044039951637387
the O 0 0.00019693512876983732
codon O 0 0.0007635869551450014
for O 0 3.9083213778212667e-05
glutamine O 0 0.0002890123287215829
to O 0 5.977832552161999e-05
a O 0 0.0001402426860295236
termination O 0 0.0007987965364009142
codon O 0 0.0010108009446412325
at O 0 0.0008367318660020828
amino O 0 0.0005062798736616969
acid O 0 0.0007063971133902669
position O 0 0.0006706284475512803
29 O 0 0.0026401784271001816
. O 0 0.0008098029065877199

MaeI O 1 0.5324117541313171
restriction O 0 0.0012166914530098438
analysis O 0 7.146023563109338e-05
showed O 0 0.0001752988900989294
two O 0 4.359154627309181e-05
other O 0 4.9776630476117134e-05
carriers O 0 0.00020533085626084358
in O 0 0.0001342437753919512
the O 0 0.0005748826079070568
family O 0 0.0012715079355984926
. O 0 0.0007953664171509445

The O 0 0.0031117598991841078
C O 0 0.01855950802564621
- O 0 0.010098224505782127
T O 0 0.026851333677768707
mutation O 0 0.00017409703286830336
is O 0 3.228610512451269e-05
located O 0 0.00022556661861017346
within O 0 0.00010094128811033443
a O 0 0.00018156242731492966
recently O 0 0.00026160303968936205
proposed O 0 0.00015906590851955116
putative O 0 0.0008489131578244269
alternative O 0 0.00021777043002657592
translation O 0 0.00033562551834620535
initiation O 0 0.0013435883447527885
codon O 0 0.0016604006523266435
( O 0 0.0004497852933127433
TIC O 0 0.07726091146469116
- O 0 0.001136536942794919
1 O 0 0.00034154290915466845
) O 0 6.806351302657276e-05
, O 0 5.0635248044272885e-05
supporting O 0 0.0001368937228107825
that O 0 0.00010075723548652604
TIC O 1 0.9100667834281921
- O 0 0.0010245450539514422
1 O 0 0.00031871951068751514
is O 0 4.9585229135118425e-05
the O 0 0.00015169777907431126
real O 0 0.000724875193554908
TIC O 0 0.10873641073703766
rather O 0 0.0002959684352390468
than O 0 0.0002551268262322992
TIC O 1 0.9938336610794067
- O 0 0.0013996229972690344
2 O 0 0.0007588688749819994
. O 0 0.0001830524706747383
. O 0 0.0002679190074559301

Human B-Disease 0 0.008200458250939846
complement I-Disease 0 0.015003284439444542
factor I-Disease 1 0.9323452115058899
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9537389278411865
with O 1 0.9998522996902466
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999316930770874

This O 0 0.00047889421693980694
study O 0 0.00012627971591427922
reports O 0 9.955064160749316e-05
on O 0 0.00012861541472375393
six O 0 0.00018363496928941458
cases O 0 0.00011849970178445801
of O 0 0.0013629475142806768
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.0009504102636128664
the I-Disease 0 0.0008214930421672761
human I-Disease 0 0.00021446852770168334
complement I-Disease 0 0.00036869346513412893
regulatory I-Disease 0 0.0002421940298518166
protein I-Disease 0 0.0002886246074922383
Factor I-Disease 0 0.0009642030345275998
H I-Disease 1 0.9996097683906555
( O 0 0.0006198137998580933
FH O 0 0.2545856237411499
) O 0 4.8458266974193975e-05
in O 0 3.9662256313022226e-05
the O 0 8.255988359451294e-05
context O 0 0.00016730857896618545
of O 0 0.0007318861316889524
an O 1 0.5226913690567017
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.999643087387085

Five O 0 0.0008470954489894211
of O 0 0.0005636966088786721
the O 0 0.0005323820514604449
cases O 0 0.00015913526294752955
were O 0 0.0001208880275953561
observed O 0 0.00014080815890338272
in O 0 0.00010831777035491541
children O 0 0.00016900965420063585
presenting O 0 0.0008969281334429979
with O 0 0.003571807174012065
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 0 0.3942709267139435
. O 0 0.002092661103233695

Two O 0 0.0006372525822371244
of O 0 0.0006618238985538483
the O 0 0.0011957058450207114
children O 0 0.0008093065698631108
exhibited O 0 0.009015779942274094
a O 0 0.011142783798277378
homozygous O 1 0.967574954032898
deficiency O 1 0.9999998807907104
characterized O 0 0.009824064560234547
by O 0 0.00024074038083199412
the O 0 0.0003647123812697828
absence O 0 0.000563696026802063
of O 0 0.000262027868302539
the O 0 0.0004064060340169817
150 O 0 0.0006777817034162581
- O 0 0.0005289674736559391
kD O 0 0.0029589589685201645
form O 0 0.0001277685514651239
of O 0 0.0002757592883426696
Factor O 0 0.0018096993444487453
H O 1 0.9966275095939636
and O 0 0.00017627354827709496
the O 0 0.00023128824250306934
presence O 0 0.0004432759014889598
, O 0 8.367370173800737e-05
upon O 0 0.00037608586717396975
immunoblotting O 0 0.011447153985500336
, O 0 7.414966967189685e-05
of O 0 0.00013941708311904222
the O 0 0.0002470639010425657
42 O 0 0.0008564178715460002
- O 0 0.0008786345133557916
kD O 0 0.007963588461279869
Factor O 0 0.0018850871128961444
H O 0 0.2808716595172882
- O 0 0.0006022916059009731
like O 0 0.0001493175223004073
protein O 0 0.0001801806502044201
1 O 0 0.00023305030481424183
( O 0 0.0002765315002761781
FHL O 0 0.09989075362682343
- O 0 0.0006741445977240801
1 O 0 0.00026810297276824713
) O 0 4.286265902919695e-05
and O 0 4.815460124518722e-05
other O 0 5.409948789747432e-05
FH O 0 0.15479709208011627
- O 0 0.0014759956393390894
related O 0 0.0006780169205740094
protein O 0 0.0010292988736182451
( O 0 0.0009921796154230833
FHR O 1 0.999980092048645
) O 0 0.0007704763556830585
bands O 0 0.0028160116635262966
. O 0 0.0007438679458573461

Southern O 0 0.009256741032004356
blot O 0 0.012202149257063866
and O 0 0.0005627903738059103
PCR O 0 0.000989670166745782
analysis O 0 5.353460437618196e-05
of O 0 0.0001371095422655344
DNA O 0 0.00023517372028436512
of O 0 0.00024807272711768746
one O 0 0.00029097669175826013
patient O 0 0.0009665106190368533
with O 0 0.0003689916920848191
homozygous O 0 0.21827563643455505
deficiency O 1 0.9999997615814209
ruled O 0 0.002761655952781439
out O 0 0.0002664268249645829
the O 0 0.00019223739218432456
presence O 0 0.0001735567202558741
of O 0 0.00013709529594052583
a O 0 0.0001422422647010535
large O 0 0.0001183137355837971
deletion O 0 0.0002936210366897285
of O 0 0.00016857816081028432
the O 0 0.000543366011697799
FH O 1 0.9735084176063538
gene O 0 0.0002338212652830407
as O 0 0.00015968564548529685
the O 0 0.00041006653918884695
underlying O 0 0.11601124703884125
defect O 1 0.9999836683273315
for O 0 0.001418188912793994
the O 1 0.9743331670761108
deficiency O 1 1.0
. O 0 0.004568255972117186

The O 0 0.001454586279578507
other O 0 0.00019490919657982886
four O 0 0.00026134971994906664
children O 0 0.00031299455440603197
presented O 0 0.0008001144742593169
with O 0 0.0004723912861663848
heterozygous O 0 0.008237889967858791
deficiency O 1 0.9999998807907104
and O 0 0.0011434686603024602
exhibited O 1 0.5522453784942627
a O 0 0.0018384098075330257
normal O 0 0.0012462051818147302
immunoblotting O 0 0.030319316312670708
pattern O 0 0.0006062406464479864
of O 0 0.0002235395077150315
proteins O 0 0.0001603180426172912
of O 0 0.0003957838052883744
the O 0 0.0016646594740450382
FH O 1 0.9991710186004639
family O 0 0.0021934437099844217
. O 0 0.0008080354891717434

Factor B-Disease 1 0.9976420998573303
H I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
is O 0 0.0005577210686169565
the O 0 0.0008591927471570671
only O 0 0.0007379469461739063
complement B-Disease 1 0.9994943141937256
deficiency I-Disease 1 1.0
associated O 0 0.10346435755491257
with O 0 0.05224870145320892
HUS B-Disease 1 1.0
. O 0 0.008854532614350319

These O 0 0.0004998715594410896
observations O 0 0.0003448585921432823
suggest O 0 0.0002529243065509945
a O 0 0.00021073651441838592
role O 0 0.0006383956642821431
for O 0 0.0003190903807990253
FH O 1 0.9960881471633911
and O 0 0.0007230560877360404
/ O 0 0.0114192645996809
or O 0 0.0011372388107702136
FH O 1 0.9788211584091187
receptors O 0 0.00044156069634482265
in O 0 0.00014358837506733835
the O 0 0.0004564370319712907
pathogenesis O 1 0.9901566505432129
of O 1 0.5449090600013733
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.01818554662168026
. O 0 0.002299523912370205

Further O 0 0.0018632049905136228
evidence O 0 0.0005513022188097239
for O 0 0.00011494346836116165
a O 0 0.00031054147984832525
major O 0 0.0015730852028355002
ancient O 0 0.009727970696985722
mutation O 0 0.010367657989263535
underlying O 1 0.9999663829803467
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9960558414459229
linkage O 1 0.9965638518333435
disequilibrium O 1 0.9450187087059021
studies O 0 0.00019304816669318825
in O 0 0.00016749629867263138
the O 0 0.00033790385350584984
Japanese O 0 0.0027178064920008183
population O 0 0.00020412099547684193
. O 0 0.0003103280905634165

The O 1 0.5105518698692322
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999570846557617
DM B-Disease 1 1.0
) O 0 0.0007448788383044302
mutation O 0 0.00025531588471494615
is O 0 5.543439692701213e-05
an O 0 0.00013527044211514294
unstable O 0 0.2991172969341278
( O 0 0.001104673370718956
CTG O 1 0.9987446069717407
) O 0 0.00020205641339998692
n O 0 0.0005186889902688563
repeat O 0 0.0007614564383402467
, O 0 6.481056334450841e-05
present O 0 9.69220491242595e-05
at O 0 0.0001883161603473127
a O 0 7.305023609660566e-05
copy O 0 7.167596049839631e-05
number O 0 1.3295505596033763e-05
of O 0 5.730359771405347e-05
5 O 0 0.00022599933436140418
- O 0 0.00029560914845205843
37 O 0 0.00035022315569221973
repeats O 0 0.0004108253924641758
on O 0 0.00019712411449290812
normal O 0 0.00029878169880248606
chromosomes O 0 0.00020428259449545294
but O 0 4.0517148590879515e-05
amplified O 0 0.00032699579605832696
to O 0 7.116000051610172e-05
50 O 0 0.0002739138435572386
- O 0 0.0005762606160715222
3000 O 0 0.0018658691551536322
copies O 0 0.00026474904734641314
on O 0 0.000731703476049006
DM B-Disease 1 0.9999676942825317
chromosomes O 0 0.005285719875246286
. O 0 0.001233955379575491

Previous O 0 0.0034426599740982056
findings O 0 0.0006566161755472422
in O 0 0.0002459287643432617
Caucasian O 0 0.0014959913678467274
populations O 0 0.0001111352612497285
of O 0 0.0002790379512589425
a O 0 0.0018649428384378552
DM B-Disease 1 1.0
founder O 1 0.9503581523895264
chromosome O 0 0.0010003614006564021
raise O 0 0.0003142095811199397
a O 0 0.00015610137779731303
question O 0 0.00010314381506759673
about O 0 5.2162547945044935e-05
the O 0 0.00014879449736326933
molecular O 0 0.00029363753856159747
events O 0 0.0002591975498944521
involved O 0 0.0002285798836965114
in O 0 0.00014762970386072993
the O 0 0.0003882881428580731
expansion O 0 0.003800282021984458
mutation O 0 0.0012651121942326427
. O 0 0.0005866793217137456

To O 0 0.0013219378888607025
investigate O 0 0.001377865090034902
whether O 0 0.00020464014960452914
a O 0 0.0004971649032086134
founder O 0 0.0034432110842317343
chromosome O 0 0.0008887604926712811
for O 0 0.0001525856350781396
the O 0 0.0012488823849707842
DM B-Disease 1 0.9999998807907104
mutation O 0 0.0006264353287406266
exists O 0 0.00015874076052568853
in O 0 7.980379450600594e-05
the O 0 0.00013863890490029007
Japanese O 0 0.0011443981202319264
population O 0 5.079494439996779e-05
, O 0 6.203044904395938e-05
we O 0 0.00011804588575614616
genotyped O 0 0.003969103097915649
families O 0 0.00010893346916418523
using O 0 6.598969048354775e-05
polymorphic O 0 0.0005577944102697074
markers O 0 0.0011533056385815144
near O 0 0.0031710637267678976
the O 0 0.001064914045855403
( O 0 0.0008803708478808403
CTG O 1 0.5361105799674988
) O 0 0.0003293325426056981
n O 0 0.0007994061452336609
repeat O 0 0.0020700169261544943
region O 0 0.0012260624207556248
and O 0 0.0005523646832443774
constructed O 0 0.011436313390731812
haplotypes O 0 0.011765693314373493
. O 0 0.0016405399655923247

Six O 0 0.0015940130688250065
different O 0 0.00016111107834149152
haplotypes O 0 0.0017646040068939328
were O 0 0.00019730070198420435
found O 0 0.0002802046074066311
and O 0 0.0004825023643206805
DM B-Disease 1 0.9999995231628418
alleles O 0 0.0010777685092762113
were O 0 0.0003649148275144398
always O 0 0.0005862502730451524
haplotype O 0 0.0024762763641774654
A O 0 0.003105909563601017
. O 0 0.0014528239844366908

To O 0 0.000768180179875344
find O 0 0.0003227747802156955
an O 0 7.660713890800253e-05
origin O 0 5.6282726291101426e-05
of O 0 0.00013571165618486702
the O 0 0.0004084040701854974
( O 0 0.0008393286843784153
CTG O 1 0.990933895111084
) O 0 0.0002890492614824325
n O 0 0.0007987417047843337
repeat O 0 0.0010970168514177203
mutation O 0 0.00016293296357616782
and O 0 5.194106779526919e-05
to O 0 5.5770622566342354e-05
investigate O 0 0.0002637563447933644
the O 0 0.00018342112889513373
mechanism O 0 0.00021503714378923178
of O 0 0.00015238062769640237
the O 0 0.0002457159571349621
expansion O 0 0.0006169213447719812
mutation O 0 7.165299030020833e-05
in O 0 4.3166375689907e-05
the O 0 0.00010799887968460098
Japanese O 0 0.0006825714372098446
population O 0 3.0184679417288862e-05
we O 0 1.9499013433232903e-05
have O 0 1.0065587048302405e-05
studied O 0 0.00010123482206836343
90 O 0 0.0003220797807443887
Japanese O 0 0.0037179836072027683
DM B-Disease 1 0.9999454021453857
families O 0 0.00043715641368180513
comprising O 0 0.0005582696758210659
190 O 0 0.0011863155523315072
affected O 0 0.0007782424800097942
and O 0 0.000290593015961349
130 O 0 0.0019339334685355425
unaffected O 0 0.004049265757203102
members O 0 0.0005534196388907731
. O 0 0.0006053416873328388

The O 0 0.0024794908240437508
results O 0 0.0004116877098567784
suggest O 0 0.00022381248709280044
that O 0 3.4484004572732374e-05
a O 0 0.00010383004700997844
few O 0 0.00014981695858296007
common O 0 0.00024091675004456192
ancestral O 0 0.008289928548038006
mutations O 0 0.0003363444411661476
in O 0 0.0001771824900060892
both O 0 0.00023360802151728421
Caucasian O 0 0.0037806357722729445
and O 0 0.00040051943506114185
Japanese O 0 0.004910388961434364
populations O 0 0.00010219806426903233
have O 0 1.8332541003474034e-05
originated O 0 0.00012444742606021464
by O 0 2.106654574163258e-05
expansion O 0 0.0001515410840511322
of O 0 8.194956899387762e-05
an O 0 9.471597877563909e-05
ancestral O 0 0.0013584463158622384
n O 0 0.0005318200564943254
= O 0 0.00025484772049821913
5 O 0 0.0001386504154652357
repeat O 0 0.00025798327988013625
to O 0 6.944530468899757e-05
n O 0 0.0002789241261780262
= O 0 0.0003723802219610661
19 O 0 0.0008181417360901833
- O 0 0.0007701250724494457
37 O 0 0.0010838411981239915
copies O 0 0.0008025556453503668
. O 0 0.0006171760032884777

These O 0 0.0006388043984770775
data O 0 0.00017491001926828176
support O 0 0.0001787899964256212
multistep O 0 0.0015811581397429109
models O 0 0.000363215891411528
of O 0 0.0005090768681839108
triplet O 1 0.8735173344612122
repeat O 0 0.0069962446577847
expansion O 0 0.001508734654635191
that O 0 6.411268259398639e-05
have O 0 1.7937394659384154e-05
been O 0 3.402562651899643e-05
proposed O 0 6.2624501879327e-05
for O 0 4.858051033806987e-05
both O 0 0.0002791146107483655
DM B-Disease 1 1.0
and O 0 0.010965832509100437
Friedreichs B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999984502792358
. O 0 0.002421635901555419
. O 0 0.001566635095514357

The O 0 0.0014416029443964362
molecular O 0 0.0006865498144179583
basis O 0 0.0003322600678075105
of O 0 0.0045729526318609715
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.001929107354953885
the O 0 0.000842402980197221
western O 0 0.0012107205111533403
Cape O 0 0.003393451916053891
, O 0 0.0002677816082723439
South O 0 0.0011866649147123098
Africa O 0 0.0016997187631204724
. O 0 0.0007349075167439878

Deficiency B-Disease 1 0.9999785423278809
of I-Disease 0 0.0032048572320491076
the I-Disease 0 0.0018929995130747557
sixth I-Disease 0 0.4260881841182709
component I-Disease 0 0.0013795916456729174
of I-Disease 0 0.0002849112788680941
human I-Disease 0 0.0002773872984107584
complement I-Disease 0 0.001176186720840633
( O 0 0.0009336060029454529
C6 O 1 0.9999977350234985
) O 0 0.00013118631613906473
has O 0 3.937689325539395e-05
been O 0 3.2716492569306865e-05
reported O 0 5.429170050774701e-05
in O 0 2.1214647858869284e-05
a O 0 5.179623985895887e-05
number O 0 2.2667683879262768e-05
of O 0 7.821784674888477e-05
families O 0 5.769983181380667e-05
from O 0 0.00011137832188978791
the O 0 0.00025402632309123874
western O 0 0.000924616411793977
Cape O 0 0.0040763006545603275
, O 0 0.00045158452121540904
South O 0 0.002102307043969631
Africa O 0 0.00316030764952302
. O 0 0.0012003467418253422

Meningococcal B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999998807907104
is O 0 0.0016906100790947676
endemic O 0 0.0038882591761648655
in O 0 0.00037876912392675877
the O 0 0.0005041109980084002
Cape O 0 0.0018548646476119757
and O 0 0.00011409344006096944
almost O 0 0.00012456330296117812
all O 0 4.323109533288516e-05
pedigrees O 0 0.0004949481808580458
of O 0 0.0005371345323510468
total O 0 0.2877441644668579
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9993728995323181
C6Q0 O 1 1.0
) O 0 0.00045937334652990103
have O 0 8.037997031351551e-05
been O 0 0.00013691617641597986
ascertained O 0 0.0013553875032812357
because O 0 0.00039139128057286143
of O 0 0.0021903919987380505
recurrent O 1 0.9999997615814209
disease O 1 1.0
. O 0 0.04195581376552582

We O 0 0.0014809098793193698
have O 0 0.00014550112246070057
sequenced O 0 0.0005567624466493726
the O 0 0.00018416716193314642
expressed O 0 0.00018775195349007845
exons O 0 0.0008884387789294124
of O 0 0.0003197329060640186
the O 0 0.0008632988319732249
C6 O 1 0.9999839067459106
gene O 0 0.00035493544419296086
from O 0 0.00013975276669953018
selected O 0 0.00018038350390270352
cases O 0 7.279322016984224e-05
and O 0 5.710895493393764e-05
have O 0 4.063946835231036e-05
found O 0 0.00010693445074139163
three O 0 0.0002023824636125937
molecular O 0 0.0012239901116117835
defects O 1 0.9998040795326233
leading O 0 0.008297842927277088
to O 0 0.0007118287030607462
total O 0 0.08896142244338989
deficiency O 1 1.0
879delG O 1 0.9999998807907104
, O 0 0.0003838849370367825
which O 0 5.982764923828654e-05
is O 0 2.610115370771382e-05
the O 0 0.0001322561874985695
common O 0 0.00027139621670357883
defect O 1 0.9993294477462769
in O 0 0.0007384711061604321
the O 0 0.0011509762844070792
Cape O 0 0.0052124750800430775
and O 0 0.0003486138884909451
hitherto O 0 0.002834356389939785
unreported O 0 0.0023586784955114126
, O 0 0.0002805724216159433
and O 0 0.0003395541862118989
1195delC O 1 0.9968558549880981
and O 0 0.0010300569701939821
1936delG O 1 0.9999681711196899
, O 0 0.0004114998155273497
which O 0 5.82277680223342e-05
have O 0 2.294730074936524e-05
been O 0 5.3482348448596895e-05
previously O 0 0.00013516098260879517
reported O 0 0.00012059648724971339
in O 0 0.00012467191845644265
African O 0 0.0015887945191934705
- O 0 0.0026775312144309282
Americans O 0 0.0006685305270366371
. O 0 0.0005475232028402388

We O 0 0.0009237176855094731
also O 0 0.00022368320787791163
show O 0 0.00027686788234859705
that O 0 6.701538222841918e-05
the O 0 0.0005273733986541629
879delG O 1 0.9988573789596558
and O 0 0.003033534623682499
1195delC O 1 0.9999988079071045
defects O 1 0.9999961853027344
are O 0 0.00016588241851422936
associated O 0 0.00033194507705047727
with O 0 0.0003518058219924569
characteristic O 1 0.997306227684021
C6 O 1 1.0
/ O 1 0.9999057054519653
C7 O 1 0.9999932050704956
region O 0 0.0017750931438058615
DNA O 0 0.001044519362039864
marker O 0 0.0032419345807284117
haplotypes O 0 0.0015833631623536348
, O 0 0.00017449822917114943
although O 0 0.000115343886136543
small O 0 0.00013088520790915936
variations O 0 0.0002641715982463211
were O 0 0.00021341229148674756
observed O 0 0.0005881189717911184
. O 0 0.00047125769197009504

The O 0 0.011684856377542019
1936delG O 1 0.999934196472168
defect O 1 0.9999678134918213
was O 0 0.007380077149719
observed O 0 0.000385035207727924
only O 0 7.070356514304876e-05
once O 0 0.00018992935656569898
in O 0 9.217575279762968e-05
the O 0 0.00024027720792219043
Cape O 0 0.0017859939252957702
, O 0 0.00016357914137188345
but O 0 6.493627006420866e-05
its O 0 0.00010388451482867822
associated O 0 0.00023955754295457155
haplotype O 0 0.001530901761725545
could O 0 0.0004600264655891806
be O 0 0.00022263170103542507
deduced O 0 0.0027071493677794933
. O 0 0.0007476630271412432

The O 0 0.0010882946662604809
data O 0 0.00012792095367331058
from O 0 0.00010103199747391045
the O 0 0.0002972754882648587
haplotypes O 0 0.0006850433419458568
indicate O 0 0.00018506050400901586
that O 0 2.506738564989064e-05
these O 0 1.6786307242000476e-05
three O 0 0.00011024387640645728
molecular O 0 0.001226108055561781
defects O 1 0.9970056414604187
account O 0 0.0001758924190653488
for O 0 0.00014671499957330525
the O 0 0.0014846374979242682
defects O 1 0.9995561242103577
in O 0 0.0002169786748709157
all O 0 0.00010687684698496014
the O 0 0.0003625334065873176
38 O 0 0.0011862523388117552
unrelated O 0 0.003487147158011794
C6Q0 O 1 0.9999897480010986
individuals O 0 0.00013722582662012428
we O 0 5.961590068181977e-05
have O 0 2.259943175886292e-05
studied O 0 0.00013678921095561236
from O 0 0.00016377674182876945
the O 0 0.00045617850264534354
Cape O 0 0.006154091563075781
. O 0 0.0009054064285010099

We O 0 0.0010468943510204554
have O 0 0.00014067314623389393
also O 0 8.079479448497295e-05
observed O 0 0.0001015693778754212
the O 0 0.00035717058926820755
879delG O 1 0.9869778752326965
defect O 1 0.9814091920852661
in O 0 0.0005033063353039324
two O 0 0.00041345617501065135
Dutch O 1 0.7440420985221863
C6 B-Disease 1 1.0
- I-Disease 1 0.9970293045043945
deficient I-Disease 1 0.9996515512466431
kindreds O 0 0.014840616844594479
, O 0 0.0002698545577004552
but O 0 0.00013939235941506922
the O 0 0.00039226122316904366
879delG O 1 0.9991459846496582
defect O 1 0.9982483386993408
in O 0 0.0005204344051890075
the O 0 0.0007920550997368991
Cape O 0 0.0089552728459239
probably O 0 0.0005757023463957012
did O 0 8.175488619599491e-05
not O 0 1.4642314454249572e-05
come O 0 4.5065822632750496e-05
from O 0 4.721518780570477e-05
The O 0 0.00032308176741935313
Netherlands O 0 0.0011351738357916474
. O 0 0.00029826510581187904
. O 0 0.0004459442861843854

Complement B-Disease 1 0.9996719360351562
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.002202210947871208
seven O 0 0.0013439217582345009
further O 0 0.001284234574995935
molecular O 0 0.005424519069492817
defects O 1 0.9999710321426392
and O 0 0.0004139471857342869
their O 0 0.00028563584783114493
associated O 0 0.0007720444700680673
marker O 0 0.009523286484181881
haplotypes O 0 0.006995164789259434
. O 0 0.0009716255590319633

Seven O 0 0.0030416748486459255
further O 0 0.0006890074000693858
molecular O 0 0.001354471780359745
bases O 0 0.0036916688550263643
of O 1 0.9706249833106995
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0008933335775509477
described O 0 0.004074113443493843
. O 0 0.0011872815666720271

All O 0 0.0007726949988864362
these O 0 0.0001545200648251921
new O 0 0.00041776514262892306
molecular O 0 0.0018760041566565633
defects O 1 0.9954343438148499
involve O 0 0.0011705445358529687
single O 0 0.0007001900812610984
- O 0 0.0013780854642391205
nucleotide O 0 0.000462319643702358
events O 0 0.0002986595209222287
, O 0 0.00012033596431137994
deletions O 0 0.0011847787536680698
and O 0 0.00018272880697622895
substitutions O 0 0.0004553559992928058
, O 0 7.059994095470756e-05
some O 0 3.870271393680014e-05
of O 0 0.0001447556569473818
which O 0 9.862316801445559e-05
alter O 0 0.0008143266313709319
splice O 0 0.002805162686854601
sites O 0 0.00045463821152225137
, O 0 0.00018286792328581214
and O 0 0.00019113272719550878
others O 0 0.0004543563991319388
codons O 0 0.0035913221072405577
. O 0 0.0009481767774559557

They O 0 0.0004064535314682871
are O 0 4.2934014345519245e-05
distributed O 0 3.5968121665064245e-05
along O 0 0.00016557681374251842
the O 0 0.0005996510153636336
C7 O 1 0.9999905824661255
gene O 0 0.0005190891097299755
, O 0 9.271418821299449e-05
but O 0 3.2591866329312325e-05
predominantly O 0 8.861688547767699e-05
towards O 0 0.00023301584587898105
the O 0 0.0002120341086992994
3 O 0 0.0005687294760718942
end O 0 0.0016946839168667793
. O 0 0.00043647809070535004

All O 0 0.0009773391066119075
were O 0 0.00047613016795367
found O 0 0.0002626637287903577
in O 0 0.00042018629028461874
compound O 0 0.012701929546892643
heterozygous O 0 0.0010494741145521402
individuals O 0 0.0002257846063002944
. O 0 0.0007654987275600433

The O 0 0.050134483724832535
C6 O 1 0.9999986886978149
/ O 1 0.9983665347099304
C7 O 1 0.9999732971191406
marker O 0 0.027249088510870934
haplotypes O 0 0.007185863796621561
associated O 0 0.0009382424759678543
with O 0 0.0005730761913582683
most O 0 0.0037985837552696466
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999998807907104
are O 0 0.0005227011861279607
tabulated O 0 0.0036355771590024233
. O 0 0.00044418402831070125
. O 0 0.0006282011745497584

A O 0 0.009028897620737553
genome O 0 0.0021589600946754217
- O 0 0.0012141561601310968
wide O 0 0.00029454290051944554
search O 0 0.00022926676319912076
for O 0 0.00017655547708272934
chromosomal O 0 0.012854267843067646
loci O 0 0.010564455762505531
linked O 0 0.0317634679377079
to O 0 0.001131623750552535
mental O 1 0.9999963045120239
health O 1 0.5776218175888062
wellness O 1 0.9364776611328125
in O 0 0.0005278060561977327
relatives O 0 0.0009003282757475972
at O 0 0.000967274303548038
high O 0 0.001527173793874681
risk O 0 0.0010223141871392727
for O 0 0.00098442193120718
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9217265844345093
the O 0 0.12739083170890808
Old O 1 0.6448239684104919
Order O 0 0.0022076566237956285
Amish O 0 0.01223566010594368
. O 0 0.0010159623343497515

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999997615814209
BPAD B-Disease 1 1.0
; O 1 0.9973932504653931
manic B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.0011507372837513685
is O 0 0.0001545292034279555
characterized O 0 0.0005166850751265883
by O 0 9.342507109977305e-05
episodes O 0 0.0005877810181118548
of O 0 0.0015572489937767386
mania B-Disease 1 0.9999997615814209
and O 0 0.008752807974815369
/ O 1 0.9934008717536926
or O 0 0.0022344773169606924
hypomania B-Disease 1 0.9999547004699707
interspersed O 0 0.0017911616014316678
with O 0 0.00012294288899283856
periods O 0 0.001068471698090434
of O 0 0.0029033799655735493
depression B-Disease 1 0.9999996423721313
. O 0 0.0020564787555485964

Compelling O 0 0.006272852886468172
evidence O 0 0.0007356159621849656
supports O 0 0.00040567319956608117
a O 0 0.0003371883649379015
significant O 0 0.00032096498762257397
genetic O 0 0.000371199770597741
component O 0 0.0012843846343457699
in O 0 0.0002623418695293367
the O 0 0.0005552086513489485
susceptibility O 0 0.002160203643143177
to O 0 0.0007189394091255963
develop O 0 0.18587753176689148
BPAD B-Disease 1 1.0
. O 0 0.004045792855322361

To O 0 0.0009124227799475193
date O 0 0.0012532973196357489
, O 0 0.0002046975278062746
however O 0 0.00020667791250161827
, O 0 0.00012619869085028768
linkage O 0 0.0008815427427180111
studies O 0 0.00011093683133367449
have O 0 3.727379589690827e-05
attempted O 0 0.0005486839800141752
only O 0 6.713499897159636e-05
to O 0 8.497212547808886e-05
identify O 0 0.00023797672474756837
chromosomal O 0 0.01289692148566246
loci O 0 0.003251791000366211
that O 0 0.00018689870194066316
cause O 0 0.10734250396490097
or O 0 0.0003508054360281676
increase O 0 0.00023087799490895122
the O 0 0.00034689161111600697
risk O 0 0.000303639069898054
of O 0 0.0008952317293733358
developing O 0 0.15288329124450684
BPAD B-Disease 1 1.0
. O 0 0.0037237494252622128

To O 0 0.0007439827895723283
determine O 0 0.0002606449997983873
whether O 0 0.00011289798567304388
there O 0 0.00012903823517262936
could O 0 0.00016313583182636648
be O 0 0.0001419824839103967
protective O 0 0.003138978034257889
alleles O 0 0.00030070290085859597
that O 0 8.775335300015286e-05
prevent O 0 0.0008650877862237394
or O 0 0.00021959544392302632
reduce O 0 0.0002339287311770022
the O 0 0.0002273739519296214
risk O 0 0.00015370859182439744
of O 0 0.00041829198016785085
developing O 0 0.27470719814300537
BPAD B-Disease 1 1.0
, O 0 0.00028443033806979656
similar O 0 6.189011037349701e-05
to O 0 3.4572643926367164e-05
what O 0 4.9344092985847965e-05
is O 0 3.340510738780722e-05
observed O 0 6.115348514867947e-05
in O 0 9.192031575366855e-05
other O 0 0.0001692815712885931
genetic B-Disease 1 0.9999724626541138
disorders I-Disease 1 1.0
, O 1 0.7087947130203247
we O 0 0.0007402586634270847
used O 0 0.0006040912121534348
mental O 1 0.9999488592147827
health O 0 0.048861537128686905
wellness O 1 0.9978284239768982
( O 0 0.0006362047861330211
absence O 0 0.0009593547438271344
of O 0 0.0006259802612476051
any O 0 0.001338705187663436
psychiatric B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
) O 0 0.0010517280315980315
as O 0 0.00031723431311547756
the O 0 0.00025295658269897103
phenotype O 0 0.00032322038896381855
in O 0 0.00011626795458141714
our O 0 0.0003377795801497996
genome O 0 0.0004226550809107721
- O 0 0.0008312888676300645
wide O 0 0.0006228963029570878
linkage O 0 0.0019274005899205804
scan O 0 0.0006714422488585114
of O 0 0.00033494463423267007
several O 0 0.00021892416407354176
large O 0 0.0006615729071199894
multigeneration O 1 0.6736488342285156
Old O 0 0.006246682722121477
Order O 0 0.0011529217008501291
Amish O 0 0.006537802517414093
pedigrees O 0 0.0030961050651967525
exhibiting O 0 0.0021604893263429403
an O 0 0.00038668830529786646
extremely O 0 0.0011660857126116753
high O 0 0.002260924782603979
incidence O 0 0.01988481543958187
of O 0 0.027741508558392525
BPAD B-Disease 1 1.0
. O 0 0.005178024526685476

We O 0 0.0010112575255334377
have O 0 0.00010481628851266578
found O 0 8.561100548831746e-05
strong O 0 0.00012731226161122322
evidence O 0 0.00012373911158647388
for O 0 4.70430932182353e-05
a O 0 0.0001963188697118312
locus O 0 0.00046091052354313433
on O 0 0.00036084381281398237
chromosome O 0 0.0015548702795058489
4p O 1 0.9995365142822266
at O 0 0.004654734395444393
D4S2949 O 0 0.42015302181243896
( O 0 0.0007896848837845027
maximum O 0 0.0010088523849844933
GENEHUNTER O 1 0.9860575795173645
- O 0 0.002033074852079153
PLUS O 0 0.0015738147776573896
nonparametric O 0 0.002714575035497546
linkage O 0 0.0010430808179080486
score O 0 0.00023295253049582243
= O 0 0.00030986868659965694
4 O 0 0.00023766043887007982
. O 0 7.032538269413635e-05
05 O 0 0.002589220181107521
, O 0 0.00013148813741281629
P O 0 0.0013279798440635204
= O 0 0.00028170511359348893
5 O 0 0.00011125156743219122
. O 0 1.5927047570585273e-05
22 O 0 0.0001054042368195951
x O 0 0.00010286221368005499
10 O 0 0.0001871176646091044
( O 0 0.00012695681652985513
- O 0 0.0004345965280663222
4 O 0 0.00043471541721373796
) O 0 0.0001216660748468712
; O 0 0.00011852728493977338
SIBPAL O 0 0.06120821088552475
Pempirical O 0 0.014157350175082684
value O 0 0.0002859764208551496
< O 0 0.0005513235228136182
3 O 0 0.00013129645958542824
x O 0 0.00012717563367914408
10 O 0 0.00011987167818006128
( O 0 9.707161370897666e-05
- O 0 0.00023850145225878805
5 O 0 0.0001945857220562175
) O 0 7.883382204454392e-05
) O 0 4.9187641707248986e-05
and O 0 5.8955851272912696e-05
suggestive O 0 0.0006966375513002276
evidence O 0 0.00015260222426149994
for O 0 5.48712196177803e-05
a O 0 0.0002958014083560556
locus O 0 0.0009041521698236465
on O 0 0.0006629115086980164
chromosome O 0 0.0026405875105410814
4q O 1 0.7056905627250671
at O 0 0.002394199138507247
D4S397 O 0 0.3634546399116516
( O 0 0.0004396570147946477
maximum O 0 0.0007394783897325397
GENEHUNTER O 1 0.9971076846122742
- O 0 0.001955413958057761
PLUS O 0 0.001272246241569519
nonparametric O 0 0.002584842499345541
linkage O 0 0.0007963784737512469
score O 0 0.00021481521253008395
= O 0 0.00027161079924553633
3 O 0 0.00014750473201274872
. O 0 3.0711624276591465e-05
29 O 0 0.0002711341658141464
, O 0 8.291215635836124e-05
P O 0 0.0010583119001239538
= O 0 0.00038486329140141606
2 O 0 0.00016079154738690704
. O 0 2.282096647832077e-05
57 O 0 0.00011684400669764727
x O 0 0.0001419463224010542
10 O 0 0.00017052851035259664
( O 0 0.00012382726708892733
- O 0 0.000376956129912287
3 O 0 0.00034775451058521867
) O 0 9.8734388302546e-05
; O 0 9.321238758275285e-05
SIBPAL O 0 0.08028779923915863
Pempirical O 0 0.012058697640895844
value O 0 0.00029760500183328986
< O 0 0.0005492953932844102
1 O 0 0.0001454635348636657
x O 0 0.00013258893159218132
10 O 0 0.00010349829972255975
( O 0 9.654220048105344e-05
- O 0 0.00029613831429742277
3 O 0 0.00028210534946992993
) O 0 6.718199438182637e-05
) O 0 4.6599190682172775e-05
that O 0 2.7731332011171617e-05
are O 0 2.2852826077723876e-05
linked O 0 0.000819273351226002
to O 0 0.0007550676818937063
mental O 1 0.9999959468841553
health O 1 0.9984413981437683
wellness O 1 0.9999264478683472
. O 0 0.0022462871856987476

These O 0 0.0004643466672860086
findings O 0 0.0003453315293882042
are O 0 2.944955849670805e-05
consistent O 0 0.00017005049448926002
with O 0 6.767305603716522e-05
the O 0 0.0002745407691691071
hypothesis O 0 0.0001977653446374461
that O 0 3.0027917091501877e-05
certain O 0 6.512535037472844e-05
alleles O 0 0.00023505065473727882
could O 0 0.0002285484952153638
prevent O 0 0.0006963026244193316
or O 0 0.00018727582937572151
modify O 0 0.0003301715769339353
the O 0 0.00036613651900552213
clinical O 0 0.000897331687156111
manifestations O 0 0.14523693919181824
of O 1 0.7934335470199585
BPAD B-Disease 1 1.0
and O 0 0.0015123996417969465
perhaps O 0 0.0012157896999269724
other O 0 0.0002824646362569183
related O 0 0.009265019558370113
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.6960102915763855

Segregation O 1 0.9996825456619263
distortion O 1 0.9999765157699585
in O 1 0.97881019115448
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.03628423810005188

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999953508377075
DM B-Disease 1 1.0
) O 0 0.0012442837469279766
is O 0 0.00019850325770676136
an O 0 0.0002862341934815049
autosomal B-Disease 0 0.05792379379272461
dominant I-Disease 1 0.9999668598175049
disease I-Disease 1 1.0
which O 0 0.0004644258879125118
, O 0 0.00010430658585391939
in O 0 0.0001010832711472176
the O 0 0.0003325750876683742
typical O 0 0.0006262576789595187
pedigree O 0 0.0008393331081606448
, O 0 8.018658263608813e-05
shows O 0 0.0001016555106616579
a O 0 0.00016483612125739455
three O 0 0.00024161698820535094
generation O 0 0.003521003294736147
anticipation O 0 0.006185546517372131
cascade O 0 0.16150227189064026
. O 0 0.0011932015186175704

This O 0 0.0010213961359113455
results O 0 0.001255116774700582
in O 0 0.0013989859726279974
infertility B-Disease 1 0.9999938011169434
and O 1 0.9999244213104248
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
CDM B-Disease 1 0.9999991655349731
) O 0 0.00033851145417429507
with O 0 0.00010188434680458158
the O 0 0.00028273463249206543
disappearance O 0 0.0017621909501031041
of O 0 0.0011799221392720938
DM B-Disease 1 1.0
in O 0 0.0009515886777080595
that O 0 0.0002592121309135109
pedigree O 0 0.0032063047401607037
. O 0 0.000525375478900969

The O 0 0.0015246819239109755
concept O 0 0.001151738571934402
of O 0 0.0010419843019917607
segregation O 1 0.9998044371604919
distortion O 1 0.9997932314872742
, O 0 0.00023776399029884487
where O 0 0.00013524734822567552
there O 0 6.818460678914562e-05
is O 0 4.872433783020824e-05
preferential O 0 0.00031115286401472986
transmission O 0 0.0002691122645046562
of O 0 0.0001756747078616172
the O 0 0.0002632157120388001
larger O 0 0.0003055819252040237
allele O 0 0.00021815262152813375
at O 0 0.00034902693005278707
the O 0 0.0005004985141567886
DM B-Disease 1 0.9999998807907104
locus O 0 0.004321740474551916
, O 0 0.00017872349417302758
has O 0 7.634299254277721e-05
been O 0 7.699999696342275e-05
put O 0 0.00016124510148074478
forward O 0 0.00020450438023544848
to O 0 8.512200292898342e-05
explain O 0 0.00037328212056308985
partially O 0 0.0006576596642844379
the O 0 0.0002793051826301962
maintenance O 0 0.0024875577073544264
of O 0 0.001432807999663055
DM B-Disease 1 1.0
in O 0 0.0009372489876113832
the O 0 0.0006311640609055758
population O 0 0.0001591340551385656
. O 0 0.00025034614372998476

In O 0 0.0009467356139793992
a O 0 0.0004472107393667102
survey O 0 0.0001741000305628404
of O 0 0.0005049874889664352
DM B-Disease 1 0.9999983310699463
in O 0 0.0006703923572786152
Northern O 0 0.0011826036497950554
Ireland O 0 0.0006789693725295365
, O 0 0.00021222341456450522
59 O 0 0.0013408476952463388
pedigrees O 0 0.003608156694099307
were O 0 0.0008654406992718577
ascertained O 0 0.005911542102694511
. O 0 0.0008929332834668458

Sibships O 1 0.9439989924430847
where O 0 0.0007815168937668204
the O 0 0.0002648065856192261
status O 0 0.00013968322309665382
of O 0 9.590814443072304e-05
all O 0 6.219563510967419e-05
the O 0 0.0001875081070465967
members O 0 9.913741087075323e-05
had O 0 0.000191338243894279
been O 0 7.377353176707402e-05
identified O 0 7.450256816809997e-05
were O 0 6.175345333758742e-05
examined O 0 0.00011355454626027495
to O 0 3.866869883495383e-05
determine O 0 6.893672980368137e-05
the O 0 0.00025410333182662725
transmission O 0 0.000496340508107096
of O 0 0.00026547949528321624
the O 0 0.0011691589606925845
DM B-Disease 1 1.0
expansion O 0 0.0034287823364138603
from O 0 0.00038051739102229476
affected O 0 0.000300130108371377
parents O 0 8.060855907388031e-05
to O 0 5.9199792303843424e-05
their O 0 0.00010355200356571004
offspring O 0 0.0013758038403466344
. O 0 0.0006097595323808491

Where O 0 0.0030486653558909893
the O 0 0.0010659659747034311
transmitting O 0 0.00463038170710206
parent O 0 0.000981681514531374
was O 0 0.0014983458677306771
male O 0 0.0007539890939369798
, O 0 0.00019859563326463103
58 O 0 0.0017676422139629722
. O 0 0.0005193144897930324

3 O 0 0.0016691944329068065
% O 0 0.0001962818205356598
of O 0 0.0002856494393199682
the O 0 0.0005682529881596565
offspring O 0 0.0005421594250947237
were O 0 0.00012970490206498653
affected O 0 0.00024712138110771775
, O 0 5.2370749472174793e-05
and O 0 4.3338579416740686e-05
in O 0 6.913264223840088e-05
the O 0 9.695884364191443e-05
case O 0 0.00013491349818650633
of O 0 0.0001298794086324051
a O 0 0.0003838809207081795
female O 0 0.001603038632310927
transmitting O 0 0.004587927833199501
parent O 0 0.0008265466894954443
, O 0 0.0003558113530743867
68 O 0 0.00199308805167675
. O 0 0.0008179086144082248

7 O 0 0.006099446676671505
% O 0 0.0007063267985358834
were O 0 0.0006964387139305472
affected O 0 0.001915323780849576
. O 0 0.0007537692436017096

Studies O 0 0.0009748265147209167
on O 0 0.0012446190230548382
meiotic O 1 0.6256597638130188
drive O 0 0.00369802163913846
in O 0 0.0009032975067384541
DM B-Disease 1 0.9999991655349731
have O 0 0.00017447129357606173
shown O 0 0.00023808771220501512
increased O 0 0.00020994471560698003
transmission O 0 0.000288950017420575
of O 0 0.00015732491738162935
the O 0 0.00023124371364247054
larger O 0 0.00019503077783156186
allele O 0 0.000127547507872805
at O 0 0.0002782510709948838
the O 0 0.0004511807637754828
DM B-Disease 1 0.9999791383743286
locus O 0 0.002613711403682828
in O 0 0.0005214828415773809
non O 0 0.0023601120337843895
- O 0 0.010790052823722363
DM O 1 0.9999973773956299
heterozygotes O 0 0.02265406958758831
for O 0 0.001287091406993568
CTGn O 1 0.9821456074714661
. O 0 0.002340278122574091

This O 0 0.0005599107826128602
study O 0 0.0001152533950516954
provides O 0 8.049986354308203e-05
further O 0 8.720901678316295e-05
evidence O 0 0.00014462169201578945
that O 0 8.349086419912055e-05
the O 0 0.0008812671876512468
DM B-Disease 1 0.9999985694885254
expansion O 0 0.007306871470063925
tends O 0 0.0007588305743411183
to O 0 0.00018096355779562145
be O 0 0.00019582662207540125
transmitted O 0 0.0009806440211832523
preferentially O 0 0.001496418146416545
. O 0 0.0004383920750115067

Diagnosis O 1 0.9955871105194092
of O 1 0.9934727549552917
hemochromatosis B-Disease 1 1.0
. O 0 0.049894604831933975

If O 0 0.01433506328612566
untreated O 1 0.9999995231628418
, O 0 0.3607832193374634
hemochromatosis B-Disease 1 1.0
can O 0 0.026108302175998688
cause O 1 0.9999933242797852
serious O 1 0.9999996423721313
illness O 1 1.0
and O 0 0.006418464705348015
early B-Disease 0 0.04484668746590614
death I-Disease 0 0.2714463174343109
, O 0 0.00015712223830632865
but O 0 6.980742909945548e-05
the O 0 0.0004432401910889894
disease O 1 0.9994356036186218
is O 0 0.0002455918292980641
still O 0 0.00027656496968120337
substantially O 0 0.001367896911688149
under O 0 0.002285473048686981
- O 1 0.8865963220596313
diagnosed O 1 0.9996933937072754
. O 0 0.0014478685334324837

The O 0 0.004184306133538485
cornerstone O 0 0.07413496822118759
of O 0 0.0011971050407737494
screening O 0 0.0005431147292256355
and O 0 0.00011900281970156357
case O 0 0.0002524953742977232
detection O 0 0.00033012061612680554
is O 0 4.847083619097248e-05
the O 0 0.00010221325646853074
measurement O 0 0.00036830001045018435
of O 0 0.0008409265428781509
serum O 1 0.6713517308235168
transferrin O 1 0.8218199014663696
saturation O 0 0.00292874313890934
and O 0 0.0002766897086985409
the O 0 0.0008827610872685909
serum O 0 0.0249442458152771
ferritin O 1 0.8413546681404114
level O 0 0.0035068243741989136
. O 0 0.0008428547880612314

Once O 0 0.004927750211209059
the O 0 0.0014862288953736424
diagnosis O 0 0.004207648802548647
is O 0 0.00034046260407194495
suspected O 0 0.0027120893355458975
, O 0 0.00033286152756772935
physicians O 0 0.0005659188609570265
must O 0 0.0002059327671304345
use O 0 0.0003246815176680684
serum O 0 0.14338234066963196
ferritin O 1 0.9989884495735168
levels O 0 0.0044035715982317924
and O 0 0.0007534745382145047
hepatic O 1 0.9999915361404419
iron O 1 0.9999998807907104
stores O 0 0.003464127890765667
on O 0 0.0013413470005616546
liver O 1 0.9925857186317444
biopsy O 0 0.005351660773158073
specimens O 0 0.0006822157301940024
to O 0 0.00014745186490472406
assess O 0 0.00031560598290525377
patients O 0 0.00011696372530423105
for O 0 4.1753963159862906e-05
the O 0 0.0002039357932517305
presence O 0 0.0006808283505961299
of O 0 0.005714728031307459
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
. O 0 0.0034724045544862747

Liver O 1 0.9999992847442627
biopsy O 1 0.9993727803230286
is O 0 0.0005124082672409713
also O 0 0.00012158617028035223
used O 0 5.4629272199235857e-05
to O 0 4.9457910790806636e-05
establish O 0 0.0001485037646489218
the O 0 0.00015359152166638523
presence O 0 0.0004000527551397681
or O 0 0.0002092430804623291
absence O 0 0.001230046502314508
of O 0 0.007891845889389515
cirrhosis B-Disease 1 1.0
, O 0 0.0012793221976608038
which O 0 0.0003010850341524929
can O 0 0.0001116891871788539
affect O 0 0.0006986343651078641
prognosis O 1 0.7644525766372681
and O 0 0.0005475181969814003
management O 0 0.0030496548861265182
. O 0 0.0016264879377558827

A O 0 0.004822121001780033
DNA O 0 0.001675671897828579
- O 0 0.0008207622449845076
based O 0 5.418747241492383e-05
test O 0 7.566432759631425e-05
for O 0 4.469496343517676e-05
the O 0 0.0003931540995836258
HFE O 1 0.9994716048240662
gene O 0 0.00045609628432430327
is O 0 0.00012392565258778632
commercially O 0 0.0002771517320070416
available O 0 3.695170016726479e-05
, O 0 3.567740350263193e-05
but O 0 1.4325150004879106e-05
its O 0 1.7028156435117126e-05
place O 0 9.60362667683512e-05
in O 0 7.149219163693488e-05
the O 0 0.0002905051806010306
diagnosis O 0 0.0027522773016244173
of O 0 0.31160128116607666
hemochromatosis B-Disease 1 1.0
is O 0 0.014342152513563633
still O 0 0.0007320277509279549
being O 0 0.0005175977712497115
evaluated O 0 0.000740564486477524
. O 0 0.0004152629117015749

Currently O 0 0.001819751807488501
, O 0 0.00025265192380174994
the O 0 0.00016008722013793886
most O 0 6.219693750608712e-05
useful O 0 6.86127386870794e-05
role O 0 0.00021037293481640518
for O 0 5.548263288801536e-05
this O 0 3.88340704375878e-05
test O 0 5.6858654716052115e-05
is O 0 2.446953294565901e-05
in O 0 3.856679904856719e-05
the O 0 0.00012613399303518236
detection O 0 0.00047029400593601167
of O 0 0.0014513181522488594
hemochromatosis B-Disease 1 1.0
in O 0 0.001092520891688764
the O 0 0.0005451386678032577
family O 0 0.00017946807201951742
members O 0 7.244959124363959e-05
of O 0 0.00014818509225733578
patients O 0 0.00014641285815741867
with O 0 5.8186411479255185e-05
a O 0 0.0005096833338029683
proven O 0 0.002620941260829568
case O 0 0.00033629988320171833
of O 0 0.0005814877804368734
the O 0 0.004775657784193754
disease O 1 0.9999983310699463
. O 0 0.002167308470234275

It O 0 0.0008697568555362523
is O 0 0.0003561493649613112
crucial O 0 0.0016338977729901671
to O 0 0.0013688990147784352
diagnose O 1 0.999997615814209
hemochromatosis B-Disease 1 1.0
before O 1 0.9999994039535522
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999954700469971
because O 0 0.07429666817188263
phlebotomy O 1 0.9999898672103882
therapy O 1 0.9595047235488892
can O 0 0.0005391107988543808
avert O 1 0.9999270439147949
serious O 1 0.9999998807907104
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9997634291648865
can O 0 0.00023636603145860136
even O 0 0.00011132276995340362
lead O 0 0.00029093591729179025
to O 0 0.00010823042975971475
normal O 0 0.0005469293682835996
life O 0 0.0008747956017032266
expectancy O 0 0.0022436045110225677
. O 0 0.00028074203873984516
. O 0 0.0004400597244966775

Prevalence O 0 0.009654957801103592
of O 0 0.0016369807999581099
the O 0 0.0027880750130861998
I1307K O 1 0.9998326301574707
APC B-Disease 1 0.9985905289649963
gene O 0 0.0008475944632664323
variant O 0 0.0006121921469457448
in O 0 0.00012128821254009381
Israeli O 0 0.000585781061090529
Jews O 0 0.0003216523618903011
of O 0 0.00010819585440913215
differing O 0 4.7982513933675364e-05
ethnic O 0 9.226156544173136e-05
origin O 0 0.00012131089169997722
and O 0 0.00023667562345508486
risk O 0 0.0036638930905610323
for O 0 0.1789882928133011
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.010714774020016193

BACKGROUND O 0 0.03481481969356537
& O 0 0.0798296332359314
AIMS O 0 0.008325564675033092
Israeli O 0 0.001714529818855226
Jews O 0 0.0007353636319749057
of O 0 0.00024358606606256217
European O 0 0.000276905600912869
birth O 0 0.0008086624438874424
, O 0 0.00015975296264514327
i O 0 0.00031127812690101564
. O 0 7.520007784478366e-05
e O 0 0.00012224404781591147
. O 0 3.10749928758014e-05
, O 0 9.67901578405872e-05
Ashkenazim O 0 0.0027162842452526093
, O 0 0.00012515381968114525
have O 0 6.481241143774241e-05
the O 0 0.0007318237330764532
highest O 1 0.9996030926704407
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.999267041683197
of O 0 0.0020407456904649734
any O 0 0.00028599935467354953
Israeli O 0 0.0011303009232506156
ethnic O 0 0.00047839072067290545
group O 0 0.00024115346604958177
. O 0 0.00037834057002328336

The O 0 0.005668977741152048
I1307K O 1 0.9985393285751343
APC B-Disease 1 0.9963048696517944
gene O 0 0.0010944767855107784
variant O 0 0.0012388156028464437
was O 0 0.0007350531523115933
found O 0 0.00011304600775474682
in O 0 0.0002135891845682636
6 O 0 0.001222374732606113
. O 0 0.0003703519469127059

1 O 0 0.0014031121972948313
% O 0 0.00011408843420213088
of O 0 0.00020345607481431216
American O 0 0.00037771317875012755
Jews O 0 0.0005703162169083953
, O 0 0.0001090977166313678
28 O 0 0.00022987680858932436
% O 0 4.3852600356331095e-05
of O 0 0.00016765049076639116
their O 0 0.00042423949344083667
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9689347743988037
, O 0 0.0003847336338367313
but O 0 5.934596265433356e-05
not O 0 2.7355668862583116e-05
in O 0 6.40887810732238e-05
non O 0 0.0004566696297843009
- O 0 0.0009453276870772243
Jews O 0 0.0015915624098852277
. O 0 0.0005335445748642087

We O 0 0.0013921447098255157
assessed O 0 0.0012684131506830454
the O 0 0.0009532783296890557
I1307K O 1 0.6015388369560242
prevalence O 0 0.0014190381625667214
in O 0 0.0001580231182742864
Israeli O 0 0.0007320137810893357
Jews O 0 0.0003214635362382978
of O 0 0.0001439498591935262
differing O 0 6.936892896192148e-05
ethnic O 0 9.804235014598817e-05
origin O 0 0.0001372368133161217
and O 0 0.00036629452370107174
risk O 0 0.0036828822921961546
for O 0 0.12681105732917786
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.012433172203600407

METHODS O 0 0.0025187344290316105
DNA O 0 0.0007379040471278131
samples O 0 0.0002577647101134062
from O 0 0.00023494714696425945
500 O 0 0.001108689932152629
unrelated O 0 0.0006357290549203753
Jews O 0 0.00038030414725653827
of O 0 0.00026268375222571194
European O 0 0.0003219296922907233
or O 0 0.0002770526916719973
non O 0 0.00036953232483938336
- O 0 0.00023795198649168015
European O 0 5.593413152382709e-05
origin O 0 3.846861363854259e-05
, O 0 2.560213215474505e-05
with O 0 2.1734967958764173e-05
or O 0 8.180496661225334e-05
without O 0 5.53503014089074e-05
a O 0 0.0001708921481622383
personal O 0 0.0006575337029062212
and O 0 0.00031551902065984905
/ O 0 0.0035778058227151632
or O 0 0.00024090758233796805
family O 0 0.00035908681456930935
history O 0 0.0005251162219792604
of O 0 0.00143752945587039
neoplasia B-Disease 1 0.9999926090240479
, O 0 0.0004047659458592534
were O 0 0.00015791798068676144
examined O 0 0.0003028047503903508
for O 0 7.301074947463349e-05
the O 0 0.0003538988239597529
I1307K O 0 0.43455079197883606
variant O 0 0.0007677290122956038
by O 0 8.854474435793236e-05
the O 0 0.00016356995911337435
allele O 0 0.00019631924806162715
- O 0 0.0002461410767864436
specific O 0 5.742487701354548e-05
oligonucleotide O 0 0.001839228207245469
( O 0 0.0006512945983558893
ASO O 1 0.9996451139450073
) O 0 0.0004027654358651489
method O 0 0.0005496795638464391
. O 0 0.000604459026362747

RESULTS O 0 0.0022943224757909775
In O 0 0.0003895435365848243
persons O 0 0.000265985174337402
at O 0 0.00043637744965963066
average O 0 0.00028219626983627677
risk O 0 0.00033939609420485795
for O 0 0.0005962466238997877
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.003093014471232891
I1307K O 1 0.999951958656311
was O 0 0.0017789688427001238
found O 0 0.00012475706171244383
in O 0 0.00012468879867810756
5 O 0 0.0005481160478666425
. O 0 0.0003892265085596591

0 O 0 0.000760129711125046
% O 0 0.0001274898531846702
of O 0 0.0001669696212047711
120 O 0 0.000411482120398432
European O 0 0.0002485542790964246
and O 0 0.00023209347273223102
1 O 0 0.0009939834708347917
. O 0 0.0005384196410886943

6 O 0 0.0026714415289461613
% O 0 0.00016700959531590343
of O 0 0.00031358597334474325
188 O 0 0.001240501063875854
non O 0 0.0006675517070107162
- O 0 0.0003605735255405307
European O 0 8.72691671247594e-05
Jews O 0 0.0002843685506377369
( O 0 0.00015641786740161479
P O 0 0.0012640859931707382
= O 0 0.0004798354930244386
0 O 0 0.00022295117378234863
. O 0 0.00013004646461922675
08 O 0 0.004387544933706522
) O 0 0.00035527581349015236
. O 0 0.00044334647827781737

It O 0 0.001185863628052175
occurred O 0 0.003224289044737816
in O 0 0.0005273205460980535
15 O 0 0.0012804715661332011
. O 0 0.0006289772572927177

4 O 0 0.0019632596522569656
% O 0 0.00019655261712614447
of O 0 0.0002485426957719028
52 O 0 0.0006571778212673962
Ashkenazi O 0 0.0015081154415383935
Israelis O 0 0.0004883359652012587
with O 0 0.00020444374240469187
familial O 1 0.8170338273048401
cancer B-Disease 1 0.9998767375946045
( O 0 0.001290330197662115
P O 0 0.013393566943705082
= O 0 0.0007462807116098702
0 O 0 0.000188114820048213
. O 0 7.311296212719753e-05
02 O 0 0.004269711673259735
) O 0 8.962966239778325e-05
and O 0 7.894501322880387e-05
was O 0 0.0002697999880183488
not O 0 3.2024356187321246e-05
detected O 0 0.00016564408724661916
in O 0 0.00010386748908786103
51 O 0 0.000374086870579049
non O 0 0.0004581596003845334
- O 0 0.0002713930734898895
European O 0 0.00013304878666531295
Jews O 0 0.0005104544688947499
at O 0 0.001547404914163053
increased O 0 0.0014443760737776756
cancer B-Disease 1 0.9988024234771729
risk O 0 0.002204064978286624
. O 0 0.0011172142112627625

Colorectal B-Disease 1 0.9999990463256836
neoplasia I-Disease 1 0.9999978542327881
occurred O 1 0.9994390606880188
personally O 0 0.013153158128261566
or O 0 0.00022842345060780644
in O 0 8.573772356612608e-05
the O 0 7.865630323067307e-05
families O 0 2.8625405320781283e-05
of O 0 7.937467307783663e-05
13 O 0 0.0002454949135426432
of O 0 0.00024278707860503346
20 O 0 0.0007957511115819216
Ashkenazi O 0 0.0034238556399941444
I1307K O 1 0.961554229259491
carriers O 0 0.0005753013538196683
, O 0 9.859682904789224e-05
8 O 0 0.0002707229577936232
of O 0 0.0002173495158785954
whom O 0 0.0003491866809781641
also O 0 0.00011674265988403931
had O 0 0.00016788020730018616
a O 0 0.0002380579971941188
personal O 0 0.0005797805497422814
or O 0 0.0001801895850803703
family O 0 0.0004005877999588847
history O 0 0.0011559438426047564
of O 0 0.006970845628529787
noncolonic O 1 0.9999997615814209
neoplasia B-Disease 1 0.9999992847442627
. O 0 0.0036280525382608175

CONCLUSIONS O 0 0.007898147217929363
The O 0 0.0039095813408494
I1307K O 1 0.9992468357086182
APC O 1 0.9987707734107971
variant O 0 0.004544476047158241
may O 0 0.0002866850991267711
represent O 0 0.00016412566765211523
a O 0 0.0002770315622910857
susceptibility O 0 0.0013424564385786653
gene O 0 0.0004883384681306779
for O 0 0.00043077056761831045
colorectal B-Disease 1 1.0
, I-Disease 0 0.000738896953407675
or I-Disease 0 0.00034124814555980265
other I-Disease 0 0.00012178516772110015
, I-Disease 0 0.00034373588277958333
cancers I-Disease 0 0.01943700574338436
in O 0 0.0004057897604070604
Ashkenazi O 0 0.00619350653141737
Jews O 0 0.0019515390740707517
, O 0 0.00025491139967925847
and O 0 0.0002585491456557065
partially O 0 0.0019475790904834867
explains O 0 0.0004601260006893426
the O 0 0.0003615686728153378
higher O 0 0.0007846816442906857
incidence O 0 0.07164385914802551
of O 1 0.999574601650238
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0039307610131800175
European O 0 0.0007557680946774781
Israelis O 0 0.0016019706381484866
. O 0 0.000420145399402827

Systematic O 0 0.004419101867824793
analysis O 0 0.00046383417793549597
of O 0 0.0019731223583221436
coproporphyrinogen O 1 0.9999713897705078
oxidase O 1 0.7978641390800476
gene O 0 0.004694362170994282
defects O 1 0.9998846054077148
in O 0 0.002252398058772087
hereditary B-Disease 1 0.9999991655349731
coproporphyria I-Disease 1 0.9999998807907104
and O 0 0.004177630878984928
mutation O 0 0.0015402523567900062
update O 0 0.002878729719668627
. O 0 0.0005700531764887273

Hereditary B-Disease 1 0.999980092048645
coproporphyria I-Disease 1 0.9999974966049194
( O 1 0.7096281051635742
HC B-Disease 1 0.9999995231628418
) O 0 0.0018653166480362415
is O 0 0.0005537626566365361
an O 0 0.002041367581114173
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9981988072395325
autosomal O 1 0.9999465942382812
dominant O 1 0.9999918937683105
inheritance O 1 0.9995567202568054
caused O 1 0.999983549118042
by O 0 0.0007076147012412548
deficient B-Disease 0 0.017985578626394272
activity I-Disease 0 0.0005925001460127532
of I-Disease 0 0.0007090782164596021
coproporphyrinogen I-Disease 1 0.9999673366546631
III I-Disease 1 0.9999994039535522
oxidase I-Disease 0 0.16437199711799622
( O 0 0.0019958578050136566
CPO O 0 0.2920549809932709
) O 0 0.0004828228265978396
. O 0 0.0004780841991305351

Clinical O 0 0.011996393091976643
manifestations O 1 0.824591875076294
of O 0 0.08549275994300842
the O 1 0.999131977558136
disease O 1 0.9999998807907104
are O 0 0.00011775514576584101
characterized O 0 0.0012788712047040462
by O 0 0.0003231153532397002
acute O 1 0.9999973773956299
attacks O 1 0.9447103142738342
of O 1 0.99998939037323
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9730864763259888
precipitated O 1 0.9999996423721313
by O 0 0.0005635063862428069
drugs O 0 0.0012217642506584525
, O 0 0.0002671716210898012
fasting O 0 0.0016980940708890557
, O 0 0.0002760220959316939
cyclical O 0 0.48127979040145874
hormonal O 1 0.9992146492004395
changes O 0 0.0018613896099850535
, O 0 0.0012298556976020336
or O 0 0.4902983009815216
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.006360149942338467

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.12396286427974701
also O 0 0.0005444929120130837
be O 0 0.0001523230894235894
present O 0 0.00041995864012278616
. O 0 0.0005781327490694821

The O 0 0.0018468801863491535
seven O 0 0.0010682996362447739
exons O 0 0.001484024222008884
, O 0 0.00017299794126302004
the O 0 0.00038919312646612525
exon O 0 0.004262909758836031
/ O 0 0.0023704625200480223
intron O 0 0.0040032146498560905
boundaries O 0 0.00014734729484189302
and O 0 7.969685975695029e-05
part O 0 0.0001368236553389579
of O 0 0.00021701116929762065
3 O 0 0.00037146260729059577
noncoding O 0 0.0008424753323197365
sequence O 0 8.769596752244979e-05
of O 0 0.00022469663235824555
the O 0 0.0004996512434445322
CPO O 0 0.49898871779441833
gene O 0 0.00018769572488963604
were O 0 7.562666723970324e-05
systematically O 0 0.00028081113123334944
analyzed O 0 6.722687248839065e-05
by O 0 2.547534131736029e-05
an O 0 6.716957432217896e-05
exon O 0 0.0015837672399356961
- O 0 0.0006004236056469381
by O 0 0.00014118431136012077
- O 0 0.0010536882327869534
exon O 0 0.004866669420152903
denaturing O 0 0.017402322962880135
gradient O 0 0.006705111358314753
gel O 0 0.02588825486600399
electrophoresis O 0 0.007822743616998196
( O 0 0.0013382527977228165
DGGE O 1 0.9988601207733154
) O 0 0.00026191797223873436
strategy O 0 0.0003784061991609633
followed O 0 0.00024323980323970318
by O 0 3.9962724258657545e-05
direct O 0 7.635085785295814e-05
sequencing O 0 0.000151743515743874
in O 0 9.87782550510019e-05
seven O 0 0.00034588866401463747
unrelated O 0 0.0011228786315768957
heterozygous O 0 0.0009829486953094602
HC B-Disease 1 0.9999920129776001
patients O 0 0.0030726459808647633
from O 0 0.0005675482098013163
France O 0 0.003384734969586134
, O 0 0.00032564843422733247
Holland O 0 0.002014961326494813
, O 0 0.00017401207878720015
and O 0 0.00014194159302860498
Czech O 0 0.003021495183929801
Republic O 0 0.004128510598093271
. O 0 0.0018664969829842448

Seven O 0 0.00415913388133049
novel O 0 0.0015333665069192648
mutations O 0 0.000290003779809922
and O 0 0.0001290420477744192
two O 0 9.189525007968768e-05
new O 0 0.00035807289532385767
polymorphisms O 0 0.0015388898318633437
were O 0 0.0005118030239827931
detected O 0 0.0021242513321340084
. O 0 0.0006132474518381059

Among O 0 0.0013140635564923286
these O 0 0.00010297026165062562
mutations O 0 0.00016630513709969819
two O 0 4.483345037442632e-05
are O 0 2.428288644296117e-05
missense O 0 0.0010165025014430285
( O 0 0.000379282224457711
G197W O 1 0.997201681137085
, O 0 0.0005867052241228521
W427R O 1 0.9896682500839233
) O 0 0.00022162715322338045
, O 0 6.678239878965542e-05
two O 0 5.030421743867919e-05
are O 0 3.4477787266951054e-05
nonsense O 0 0.002089990070089698
( O 0 0.0007443091017194092
Q306X O 1 0.9806023836135864
, O 0 0.0007526263361796737
Q385X O 1 0.9832218289375305
) O 0 0.00024133332772180438
, O 0 8.652752876514569e-05
two O 0 3.430992001085542e-05
are O 0 1.8187951354775578e-05
small O 0 0.00011674977577058598
deletions O 0 0.0022774594835937023
( O 0 0.0007946168188937008
662de14bp O 1 0.9850597381591797
; O 0 0.0005051696789450943
1168del3bp O 0 0.026287464424967766
removing O 0 0.0026203515008091927
a O 0 0.00048668222734704614
glycine O 0 0.0009731042664498091
at O 0 0.00048451413749717176
position O 0 0.0003112140402663499
390 O 0 0.001758373575285077
) O 0 9.121984476223588e-05
, O 0 5.996513573336415e-05
and O 0 3.312707849545404e-05
one O 0 3.8385976949939504e-05
is O 0 3.2306710636476055e-05
a O 0 0.00014906912110745907
splicing O 0 0.0006787516176700592
mutation O 0 0.0004746038175653666
( O 0 0.00044647621689364314
IVS1 O 1 0.9990618824958801
- O 0 0.003048876766115427
15c O 0 0.015622134320437908
- O 0 0.0012645934475585818
- O 0 0.001039645867422223
> O 0 0.0011399383656680584
g O 0 0.0008661220781505108
) O 0 8.383663225686178e-05
which O 0 4.871337296208367e-05
creates O 0 0.000289243325823918
a O 0 0.0002474524371791631
new O 0 0.000389506749343127
acceptor O 0 0.0012735545169562101
splice O 0 0.00836949236690998
site O 0 0.00491741206496954
. O 0 0.0009821323910728097

The O 0 0.0027754874899983406
pathological O 0 0.00785629078745842
significance O 0 0.001273590954951942
of O 0 0.0006223574746400118
the O 0 0.000804733659606427
point O 0 0.0009638723568059504
mutations O 0 0.0007836369914002717
G197W O 1 0.9966608285903931
, O 0 0.0004188595339655876
W427R O 1 0.9814291000366211
, O 0 0.00016065529780462384
and O 0 0.00010333263344364241
the O 0 0.00019377071294002235
in O 0 0.0002874109195545316
- O 0 0.0014529195614159107
frame O 0 0.004070571158081293
deletion O 0 0.003417418571189046
390delGly O 1 0.755734384059906
were O 0 0.00030843011336401105
assessed O 0 0.0002573156089056283
by O 0 3.2448901038151234e-05
their O 0 3.4460663300706074e-05
respective O 0 0.00018276157788932323
expression O 0 0.0001816947478801012
in O 0 0.00011288733367109671
a O 0 0.0002408662112429738
prokaryotic O 0 0.0010932008735835552
system O 0 0.00025859157904051244
using O 0 0.00012533440894912928
site O 0 0.0009036301635205746
- O 0 0.0008676180150359869
directed O 0 0.000591456366237253
mutagenesis O 0 0.003932863939553499
. O 0 0.0005219827289693058

These O 0 0.0005110533093102276
mutations O 0 0.0004107796121388674
resulted O 0 0.000594879558775574
in O 0 0.00018591119442135096
the O 0 0.000387297390261665
absence O 0 0.0007415676955133677
or O 0 0.00012881522707175463
a O 0 0.0002680815232452005
dramatic O 0 0.002023058943450451
decrease O 0 0.001644787611439824
of O 0 0.0016700942069292068
CPO O 1 0.9949814677238464
activity O 0 0.001741684041917324
. O 0 0.0005970425554551184

The O 0 0.002715512178838253
two O 0 0.0005938269896432757
polymorphisms O 0 0.001432520104572177
were O 0 0.0002200484013883397
localized O 0 0.000858429295476526
in O 0 0.00013036566087976098
noncoding O 0 0.0007138153887353837
part O 0 0.00020217358542140573
of O 0 0.00014506543811876327
the O 0 0.0001722845045151189
gene O 0 0.00010365019988967106
1 O 0 0.00013017251330893487
) O 0 3.308449231553823e-05
a O 0 0.0001340548333246261
C O 0 0.0008587311604060233
/ O 0 0.0009563594940118492
G O 0 0.0017673637485131621
polymorphism O 0 0.0004694577946793288
in O 0 0.00016014004359021783
the O 0 0.0004990208544768393
promotor O 0 0.027387501671910286
region O 0 0.0009334129863418639
, O 0 0.00033505994360893965
142 O 0 0.002224506111815572
bp O 0 0.002563381101936102
upstream O 0 0.0006851190701127052
from O 0 8.860243542585522e-05
the O 0 0.00018957255815621465
transcriptional O 0 0.0008384717511944473
initiation O 0 0.001425503520295024
site O 0 0.0008368307026103139
( O 0 0.0002453643537592143
- O 0 0.0007238078978843987
142C O 0 0.10808690637350082
/ O 0 0.0028796757105737925
G O 0 0.002246501389890909
) O 0 8.063016866799444e-05
, O 0 4.302151137380861e-05
and O 0 3.900889350916259e-05
2 O 0 0.00012399778643157333
) O 0 4.2983989260392264e-05
a O 0 0.00012652028817683458
6 O 0 0.0005924368742853403
bp O 0 0.0016271723434329033
deletion O 0 0.00041517068166285753
polymorphism O 0 0.00014615090913139284
in O 0 7.797231955919415e-05
the O 0 0.00014838897914160043
3 O 0 0.000332184717990458
noncoding O 0 0.0010145684937015176
part O 0 0.00028198809013701975
of O 0 0.0003060971212107688
the O 0 0.0006925878114998341
CPO O 1 0.6616712808609009
gene O 0 0.0002566765761002898
, O 0 0.00020393657905515283
574 O 0 0.005160558968782425
bp O 0 0.0021428659092634916
downstream O 0 0.0006534959538839757
of O 0 9.679560753284022e-05
the O 0 0.00013921914796810597
last O 0 0.00015853172226343304
base O 0 0.00022914461442269385
of O 0 0.00011634392285486683
the O 0 0.0002484008145984262
normal O 0 0.0005173089448362589
termination O 0 0.001649591256864369
codon O 0 0.001375968917272985
( O 0 0.0004234432999510318
+ O 0 0.0018434487283229828
574 O 0 0.020506782457232475
delATTCTT O 1 0.9612447619438171
) O 0 0.001052588690072298
. O 0 0.0006634215242229402

Five O 0 0.008952086791396141
intragenic O 1 0.9997088313102722
dimorphisms O 1 0.9982587695121765
are O 0 0.00017571038915775716
now O 0 0.00020749021496158093
well O 0 0.00016344459436368197
characterized O 0 0.0004216773668304086
and O 0 9.127326484303921e-05
the O 0 0.0003103796043433249
high O 0 0.00051873893244192
degree O 0 0.00040126239764504135
of O 0 0.0005930435727350414
allelic O 0 0.006616238038986921
heterogeneity O 0 0.0032131546176970005
in O 0 0.0007592526380904019
HC B-Disease 1 0.999984860420227
is O 0 0.0004971094895154238
demonstrated O 0 0.00040181545773521066
with O 0 4.299767897464335e-05
seven O 0 7.384546188404784e-05
new O 0 4.00882308895234e-05
different O 0 1.0841529729077592e-05
mutations O 0 3.78612894564867e-05
making O 0 5.8247365814168006e-05
a O 0 8.16437168396078e-05
total O 0 0.00010215519432676956
of O 0 0.0002434678899589926
nineteen O 0 0.007900740019977093
CPO O 1 0.999478280544281
gene B-Disease 0 0.004065818153321743
defects I-Disease 1 0.9998666048049927
reported O 0 0.000977514311671257
so O 0 0.00018694221216719598
far O 0 0.00019992957822978497
. O 0 0.0001379950117552653
. O 0 0.00026392689323984087

Coincidence O 0 0.00720624253153801
of O 0 0.0008592533995397389
two O 0 0.000331067421939224
novel O 0 0.0012210988206788898
arylsulfatase O 0 0.4487324059009552
A O 0 0.002207676414400339
alleles O 0 0.0004279448476154357
and O 0 0.0002479351533111185
mutation O 0 0.0006451538065448403
459 O 0 0.01132117584347725
+ O 0 0.003817203687503934
1G O 0 0.14756985008716583
> O 0 0.0014326130039989948
A O 0 0.0006269988953135908
within O 0 0.00014832630404271185
a O 0 0.00017743406351655722
family O 0 0.00034582422813400626
with O 0 0.0004589400195982307
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 0.9999995231628418
: O 0 0.0006120229954831302
molecular O 0 0.0003909285005647689
basis O 0 0.0001346060016658157
of O 0 0.0004585956339724362
phenotypic O 0 0.006504190154373646
heterogeneity O 0 0.010385402478277683
. O 0 0.0015812487108632922

In O 0 0.0010505910031497478
a O 0 0.0005460973479785025
family O 0 0.0003863868478219956
with O 0 0.00010365139314671978
three O 0 0.00022384557814802974
siblings O 0 0.0011143824085593224
, O 0 0.00015189479745458812
one O 0 0.00015845570305828005
developed O 0 0.00042932588257826865
classical O 0 0.0019100542413070798
late O 0 0.03535477817058563
infantile O 1 0.9999982118606567
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.7051264047622681
MLD B-Disease 1 0.9999997615814209
) O 0 0.0006965628126636147
, O 0 0.0003121738263871521
fatal O 1 0.7973823547363281
at O 0 0.0008910825126804411
age O 0 0.0003665105323307216
5 O 0 0.00029367199749685824
years O 0 0.00020349060650914907
, O 0 7.078748603817075e-05
with O 0 0.00010999313235515729
deficient O 0 0.2035820633172989
arylsulfatase O 1 0.9993276596069336
A O 0 0.22161442041397095
( O 0 0.0011987551115453243
ARSA O 1 0.997229278087616
) O 0 0.0002283393987454474
activity O 0 0.00025476099108345807
and O 0 0.00016719057748559862
increased O 0 0.0008770402637310326
galactosylsulfatide O 1 0.9994146823883057
( O 0 0.005249595269560814
GS O 1 0.9999994039535522
) O 0 0.0018435269594192505
excretion O 0 0.010748275555670261
. O 0 0.00100785365793854

The O 0 0.0022014311980456114
two O 0 0.00032973059569485486
other O 0 0.0001815049326978624
siblings O 0 0.0014998832484707236
, O 0 0.0002371943264734
apparently O 0 0.0007393146515823901
healthy O 0 0.0003514772979542613
at O 0 0.00025440973695367575
12 O 0 0.00022813116083852947
( O 0 6.65926345391199e-05
1 O 0 0.00020853122987318784
/ O 0 0.0005037089576944709
2 O 0 0.00018117712170351297
) O 0 3.5788631066679955e-05
and O 0 4.020216147182509e-05
15 O 0 0.00016644364222884178
years O 0 0.00014863029355183244
, O 0 0.0001083316165022552
respectively O 0 0.00022857684234622866
, O 0 6.40977086732164e-05
and O 0 6.973205745453015e-05
their O 0 5.658506415784359e-05
father O 0 0.0018863846780732274
, O 0 0.00032461402588523924
apparently O 0 0.0013741865986958146
healthy O 0 0.0011582243023440242
as O 0 0.000224041155888699
well O 0 0.00013022214989177883
, O 0 0.00010702922736527398
presented O 0 0.0008054897771216929
ARSA O 1 0.9997650980949402
and O 0 0.0007714802632108331
GS O 1 0.9999715089797974
values O 0 0.00021220157213974744
within O 0 8.974016236606985e-05
the O 0 0.00018981602624990046
range O 0 0.0003017385024577379
of O 0 0.0018236041069030762
MLD B-Disease 1 1.0
patients O 0 0.009093467146158218
. O 0 0.001154834870249033

Mutation O 0 0.0025295994710177183
screening O 0 0.0005517300451174378
and O 0 0.0001459671912016347
sequence O 0 0.0001127228606492281
analysis O 0 3.582469071261585e-05
disclosed O 0 0.00040969616384245455
the O 0 0.00011862678366014734
involvement O 0 0.00043816064135171473
of O 0 0.00026706160861067474
three O 0 0.00014738409663550556
different O 0 0.0001099073706427589
ARSA O 1 0.9996947050094604
mutations O 0 0.0003111683181487024
being O 0 0.0001646940945647657
the O 0 0.00016286695608869195
molecular O 0 0.00025899868342094123
basis O 0 0.00011384088429622352
of O 0 0.000614290707744658
intrafamilial O 1 0.979233980178833
phenotypic O 0 0.017089305445551872
heterogeneity O 0 0.011967488564550877
. O 0 0.0014156010001897812

The O 0 0.005472654942423105
late O 0 0.02331455796957016
infantile O 1 0.9999884366989136
patient O 0 0.4525107145309448
inherited O 1 0.9999071359634399
from O 0 0.0014691028045490384
his O 0 0.0025000241585075855
mother O 0 0.001531074522063136
the O 0 0.0003415551036596298
frequent O 0 0.00026258258731104434
0 O 0 0.00020029475854244083
- O 0 0.00041416543535888195
type O 0 0.00035529330489225686
mutation O 0 0.00033326318953186274
459 O 0 0.005501973908394575
+ O 0 0.002641255734488368
1G O 0 0.23365609347820282
> O 0 0.001292987959459424
A O 0 0.0006822001305408776
, O 0 9.346766455564648e-05
and O 0 5.8971087128156796e-05
from O 0 0.00013335490075405687
his O 0 0.0005136808031238616
father O 0 0.0017718228045850992
a O 0 0.000671325484290719
novel O 0 0.0007434275466948748
, O 0 0.0001965380070032552
single O 0 0.00041843552025966346
basepair O 0 0.0169561468064785
microdeletion O 0 0.011970940977334976
of O 0 0.0007705824682489038
guanine O 0 0.0018198825418949127
at O 0 0.0003605994861572981
nucleotide O 0 0.00023206624609883875
7 O 0 0.00018804342835210264
in O 0 7.918560731923208e-05
exon O 0 0.0015782025875523686
1 O 0 0.000779820722527802
( O 0 0.0005500889383256435
7delG O 0 0.4310545027256012
) O 0 0.0007451344863511622
. O 0 0.0004976444761268795

The O 0 0.0031272172927856445
two O 0 0.0009906672639772296
clinically O 0 0.039876602590084076
unaffected O 0 0.008306318894028664
siblings O 0 0.0015812094788998365
carried O 0 0.0005238792509771883
the O 0 0.0004663450235966593
maternal O 0 0.0034215981140732765
mutation O 0 0.001331600360572338
459 O 0 0.020362654700875282
+ O 0 0.004729134496301413
1G O 0 0.485512375831604
> O 0 0.0019957388285547495
A O 0 0.0009250428411178291
and O 0 0.00017221501911990345
, O 0 7.022245699772611e-05
on O 0 8.317649189848453e-05
their O 0 7.29959283489734e-05
paternal O 0 0.0012578885070979595
allele O 0 0.00026873534079641104
, O 0 7.46592486393638e-05
a O 0 0.00022610838641412556
novel O 0 0.0005983618902973831
cytosine O 0 0.001142101245932281
to O 0 0.0001664566370891407
thymidine O 0 0.0019916847813874483
transition O 0 0.0014601112343370914
at O 0 0.0010744915343821049
nucleotide O 0 0.0011160587891936302
2435 O 0 0.014841802418231964
in O 0 0.00023623736342415214
exon O 0 0.001447639660909772
8 O 0 0.0004975114134140313
, O 0 0.00012331540347076952
resulting O 0 0.000195868662558496
in O 0 8.415342017542571e-05
substitution O 0 0.00036356112104840577
of O 0 0.0003113760321866721
alanine O 0 0.0016193946357816458
464 O 0 0.005983948241919279
by O 0 0.0003484274784568697
valine O 0 0.033531222492456436
( O 0 0.0013071221765130758
A464V O 1 0.9901054501533508
) O 0 0.0007610091706737876
. O 0 0.0007410053513012826

The O 0 0.004955163691192865
fathers O 0 0.005635401234030724
genotype O 0 0.0029746703803539276
thus O 0 0.0007617045775987208
was O 0 0.0034265199210494757
7delG O 1 0.9994297623634338
/ O 1 0.7634615898132324
A464V O 1 0.9978927969932556
. O 0 0.002137022092938423

Mutation O 0 0.008493037894368172
A464V O 1 0.994131863117218
was O 0 0.0022716333623975515
not O 0 0.00010363044566474855
found O 0 9.845251770457253e-05
in O 0 0.00024019909324124455
18 O 0 0.0017711939290165901
unrelated O 0 0.015951117500662804
MLD B-Disease 1 0.9999998807907104
patients O 0 0.0035081543028354645
and O 0 0.0005111448699608445
50 O 0 0.0009954775450751185
controls O 0 0.0009688985883258283
. O 0 0.0006128571112640202

A464V O 1 0.9989731311798096
, O 0 0.0016006341902539134
although O 0 0.0007106526754796505
clearly O 0 0.0010798403527587652
modifying O 0 0.006554461549967527
ARSA O 1 0.999964714050293
and O 0 0.00717743206769228
GS O 1 1.0
levels O 0 0.005681201349943876
, O 0 0.00022813442046754062
apparently O 0 0.0005786514957435429
bears O 0 0.0006446667248383164
little O 0 0.0004877596802543849
significance O 0 0.000542868918273598
for O 0 0.00011107147292932495
clinical O 0 0.0011942292330786586
manifestation O 1 0.9982201457023621
of O 1 0.9604682922363281
MLD B-Disease 1 1.0
, O 0 0.002658169250935316
mimicking O 0 0.0076291440054774284
the O 0 0.001191602204926312
frequent O 0 0.0026607292238622904
ARSA O 1 0.9998317956924438
pseudodeficiency O 1 0.9974561333656311
allele O 0 0.006529003847390413
. O 0 0.001209937734529376

Our O 0 0.0028305586893111467
results O 0 0.00045973650412634015
demonstrate O 0 0.00038128625601530075
that O 0 4.3353255023248494e-05
in O 0 8.574802632210776e-05
certain O 0 0.00013756607950199395
genetic O 0 0.0006570099503733218
conditions O 1 0.9462621212005615
MLD B-Disease 1 1.0
- O 1 0.9857221841812134
like O 0 0.004071274306625128
ARSA O 1 0.9998263716697693
and O 0 0.001142548630014062
GS O 1 0.9999880790710449
values O 0 0.00030852213967591524
need O 0 0.00010594545892672613
not O 0 2.7518783099367283e-05
be O 0 2.954131196020171e-05
paralleled O 0 0.000615480646956712
by O 0 0.00015049475769046694
clinical O 0 0.004232616163790226
disease O 1 0.9999979734420776
, O 0 0.0003488521324470639
a O 0 0.0003436736005824059
finding O 0 0.0002618830476421863
with O 0 0.00017160475545097142
serious O 0 0.15167886018753052
diagnostic O 0 0.008008045144379139
and O 0 0.0016683634603396058
prognostic O 1 0.99661785364151
implications O 0 0.011717170476913452
. O 0 0.0013507477706298232

Moreover O 0 0.008754909038543701
, O 0 0.0009301077225245535
further O 0 0.0017241330351680517
ARSA O 1 0.9792006015777588
alleles O 0 0.0011936811497434974
functionally O 0 0.001810541027225554
similar O 0 0.00014311909035313874
to O 0 0.00027391541516408324
A464V O 1 0.9966075420379639
might O 0 0.0005552653456106782
exist O 0 0.00011188093776581809
which O 0 2.9735942007391714e-05
, O 0 2.7969939765171148e-05
together O 0 3.566060695447959e-05
with O 0 4.0363349398830906e-05
0 O 0 0.00027106545167043805
- O 0 0.0008258686866611242
type O 0 0.0007824632339179516
mutations O 0 0.0004387206572573632
, O 0 0.00030752253951504827
may O 0 0.0009069363004527986
cause O 1 0.559107780456543
pathological O 1 0.9999816417694092
ARSA O 1 0.9999998807907104
and O 1 0.6192069053649902
GS O 1 1.0
levels O 0 0.005129741504788399
, O 0 0.00011195224215043709
but O 0 2.411967216175981e-05
not O 0 1.7871654563350603e-05
clinical O 0 0.00025559228379279375
outbreak O 0 0.006689231377094984
of O 0 0.0011933209607377648
the O 1 0.9924049973487854
disease O 1 1.0
. O 0 0.0005471023614518344
. O 0 0.0006150583503767848

Human O 1 0.9991685152053833
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999967813491821
to O 0 0.052104003727436066
hematological B-Disease 1 0.9999985694885254
malignancy I-Disease 1 0.9999998807907104
and O 0 0.16618092358112335
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9893119931221008
1 I-Disease 0 0.014431905001401901
. O 0 0.000841447152197361

Heterozygous O 0 0.01166438963264227
germ O 1 0.9994297623634338
- O 0 0.0053522647358477116
line O 0 0.0013636628864333034
mutations O 0 0.00015208245895337313
in O 0 9.692796447779983e-05
the O 0 0.00030436072847805917
DNA O 0 0.0017048513982445002
mismatch O 1 0.9992781281471252
repair O 1 0.9998781681060791
genes O 0 0.0008845237898640335
lead O 0 0.0012466029729694128
to O 0 0.001039461581967771
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.008115875534713268

The O 0 0.02578773908317089
disease O 1 0.9999982118606567
susceptibility O 1 0.9407849907875061
of O 0 0.014101694338023663
individuals O 0 0.00045783299719914794
who O 0 0.0008395854383707047
constitutionally O 0 0.0026268360670655966
lack O 0 0.0006910707452334464
both O 0 0.0001727869239402935
wild O 0 0.0008278900641016662
- O 0 0.00120490079279989
type O 0 0.0006427287007682025
alleles O 0 0.0003380228881724179
is O 0 0.00017228972865268588
unknown O 0 0.0010542626259848475
. O 0 0.0006155704031698406

We O 0 0.0008488832390867174
have O 0 7.288032793439925e-05
identified O 0 9.328334272140637e-05
three O 0 0.0001413581194356084
offspring O 0 0.0003307979495730251
in O 0 0.00015658319171052426
a O 0 0.0010301150614395738
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.8003930449485779
who O 0 0.0018513225950300694
developed O 0 0.009341911412775517
hematological B-Disease 1 0.9999854564666748
malignancy I-Disease 1 0.9999986886978149
at O 0 0.006010708399116993
a O 0 0.00026021446683444083
very O 0 6.340411346172914e-05
early O 0 0.00017191265942528844
age O 0 0.00012714338663499802
, O 0 6.260730151552707e-05
and O 0 7.191038457676768e-05
at O 0 0.00018813167116604745
least O 0 4.660461127059534e-05
two O 0 2.150753789464943e-05
of O 0 6.98271396686323e-05
them O 0 5.191264790482819e-05
displayed O 0 0.0009234859026037157
signs O 0 0.0011392902815714478
of O 0 0.0009444602765142918
neurofibromatosis B-Disease 1 0.9999946355819702
type I-Disease 0 0.3163564205169678
1 I-Disease 0 0.030752217397093773
( O 0 0.0012424339074641466
NF1 B-Disease 1 0.9971188306808472
) O 0 0.0005224665510468185
. O 0 0.0004890253185294569

DNA O 0 0.001083139213733375
sequence O 0 0.00026471976889297366
analysis O 0 4.754551991936751e-05
and O 0 8.691198308952153e-05
allele O 0 0.0002673484559636563
- O 0 0.0003200891660526395
specific O 0 6.409012712538242e-05
amplification O 0 0.0002621683233883232
in O 0 7.57268353481777e-05
two O 0 0.00011143185110995546
siblings O 0 0.0008803674718365073
revealed O 0 0.0009377608075737953
a O 0 0.0008925802540034056
homozygous O 0 0.002603575587272644
MLH1 O 1 0.9991094470024109
mutation O 0 0.0009314455674029887
( O 0 0.0006950571550987661
C676T O 1 0.9957016110420227
- O 0 0.008454296737909317
- O 0 0.004400925245136023
> O 0 0.005576401483267546
Arg226Stop O 1 0.8772264719009399
) O 0 0.0008189490181393921
. O 0 0.0005445582792162895

Thus O 0 0.0028813162352889776
, O 0 0.0006099544698372483
a O 0 0.0007584315026178956
homozygous O 0 0.004488014150410891
germ O 1 0.9999110698699951
- O 0 0.021376950666308403
line O 0 0.00821453332901001
MLH1 O 1 0.9998776912689209
mutation O 0 0.001565801678225398
and O 0 0.0007373769185505807
consequent O 1 0.9999231100082397
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.0022433525882661343
in O 0 0.000497891684062779
a O 0 0.001028355909511447
mutator O 1 0.9974341988563538
phenotype O 0 0.002508512232452631
characterized O 0 0.001986120594665408
by O 0 0.0007522046798840165
leukemia B-Disease 1 0.9999998807907104
and O 1 0.7241559624671936
/ O 1 0.9999903440475464
or O 1 0.9903861284255981
lymphoma B-Disease 1 1.0
associated O 0 0.001543189282529056
with O 0 0.0010062429355457425
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9977999329566956
1 I-Disease 0 0.0165274478495121
. O 0 0.00031441639293916523
. O 0 0.00034956273157149553

Missense O 0 0.021013524383306503
mutations O 0 0.0006702821119688451
in O 0 0.00019992880697827786
the O 0 0.00016933403094299138
most O 0 7.967148849274963e-05
ancient O 0 0.000583367480430752
residues O 0 0.00038422600482590497
of O 0 0.00035100828972645104
the O 0 0.0009205858805216849
PAX6 O 1 0.9991955161094666
paired O 0 0.0020216931588947773
domain O 0 0.0006985551444813609
underlie O 0 0.0031268843449652195
a O 0 0.0007217556121759117
spectrum O 0 0.002160470699891448
of O 0 0.2437100112438202
human O 1 0.9999992847442627
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9950516819953918

Mutations O 0 0.002415154594928026
of O 0 0.001144414534792304
the O 0 0.002086021937429905
human O 0 0.0037386510521173477
PAX6 O 1 0.9999881982803345
gene O 0 0.011758987791836262
underlie O 1 0.99998939037323
aniridia B-Disease 1 1.0
( O 1 0.9990237951278687
congenital B-Disease 1 1.0
absence I-Disease 1 0.995166540145874
of I-Disease 0 0.33907923102378845
the I-Disease 1 0.9129546284675598
iris I-Disease 1 0.999294638633728
) O 0 0.0002283846988575533
, O 0 0.00011572959192562848
a O 0 0.00024050960200838745
rare O 0 0.0013412805274128914
dominant O 0 0.19000206887722015
malformation B-Disease 1 0.9999994039535522
of I-Disease 1 0.6821439266204834
the I-Disease 1 0.9937427639961243
eye I-Disease 1 0.9999359846115112
. O 0 0.0024696984328329563

The O 0 0.0033491114154458046
spectrum O 0 0.0029490201268345118
of O 0 0.001557222567498684
PAX6 O 1 0.9999874830245972
mutations O 0 0.002040398307144642
in O 0 0.0026125742588192225
aniridia B-Disease 1 1.0
patients O 0 0.0016225388972088695
is O 0 0.00013701713760383427
highly O 0 0.0002450057363603264
biased O 0 0.00014182929589878768
, O 0 4.5799752115271986e-05
with O 0 4.540042209555395e-05
92 O 0 0.0005940466071479023
% O 0 6.032336750649847e-05
of O 0 0.0001304249744862318
all O 0 0.00012973298726137727
reported O 0 0.0003423335438128561
mutations O 0 0.00019226268341299146
leading O 0 0.000836424995213747
to O 0 0.00023190829961095005
premature O 0 0.001515118172392249
truncation O 0 0.001553368871100247
of O 0 0.00026879404322244227
the O 0 0.0004585956339724362
protein O 0 0.0004907016409561038
( O 0 0.0002346346154808998
nonsense O 0 0.002315952442586422
, O 0 0.00019731384236365557
splicing O 0 0.0008427383145317435
, O 0 0.00018082986935041845
insertions O 0 0.0016221852274611592
and O 0 0.00020314283028710634
deletions O 0 0.0013600740348920226
) O 0 7.916514005046338e-05
and O 0 5.6443106586812064e-05
just O 0 0.00014350746641866863
2 O 0 0.000144610385177657
% O 0 3.156650564051233e-05
leading O 0 0.00017221056623384356
to O 0 3.502890103845857e-05
substitution O 0 0.00011910465400433168
of O 0 0.00011903038830496371
one O 0 7.513713353546336e-05
amino O 0 0.00015964821795932949
acid O 0 0.00033377701765857637
by O 0 6.73994145472534e-05
another O 0 0.00046833540545776486
( O 0 0.00029661640292033553
missense O 0 0.003003594698384404
) O 0 0.0005327058606781065
. O 0 0.0006503533222712576

The O 0 0.0021686421241611242
extraordinary O 0 0.003114023944362998
conservation O 0 0.0007333596586249769
of O 0 0.00041923366370610893
the O 0 0.0008602200541645288
PAX6 O 1 0.8065841794013977
protein O 0 0.0005306645180098712
at O 0 0.000437292706919834
the O 0 0.0002642653416842222
amino O 0 0.0003267517895437777
acid O 0 0.0006651676376350224
level O 0 0.0005594235262833536
amongst O 0 0.0013271390926092863
vertebrates O 0 0.0025802929885685444
predicts O 0 0.0009358627139590681
that O 0 0.00011940053082071245
pathological O 0 0.005030551925301552
missense O 0 0.004058810882270336
mutations O 0 0.00034617140772752464
should O 0 0.00010711845970945433
in O 0 7.53773347241804e-05
fact O 0 0.0001236739772139117
be O 0 5.112959479447454e-05
common O 0 9.794760262593627e-05
even O 0 0.00011088426981586963
though O 0 7.691133941989392e-05
they O 0 2.4208506147260778e-05
are O 0 2.024664900091011e-05
hardly O 0 0.0005357351037673652
ever O 0 0.0008062127162702382
seen O 0 0.0008950970368459821
in O 0 0.0010849367827177048
aniridia B-Disease 1 0.9999983310699463
patients O 0 0.004897077567875385
. O 0 0.0013811205280944705

This O 0 0.0007218773826025426
indicates O 0 0.0006132701528258622
that O 0 5.382253584684804e-05
there O 0 6.283836410148069e-05
is O 0 3.913498221663758e-05
a O 0 0.00018058501882478595
heavy O 0 0.004276683088392019
ascertainment O 1 0.854877769947052
bias O 0 0.0008740491466596723
in O 0 0.0001705213653622195
the O 0 0.00021821042173542082
selection O 0 0.0003113870043307543
of O 0 0.00028135458705946803
patients O 0 0.00033278504270128906
for O 0 0.00019874241843353957
PAX6 O 1 0.9996267557144165
mutation O 0 0.0003381685819476843
analysis O 0 3.465959525783546e-05
and O 0 5.293072172207758e-05
that O 0 4.2205250792903826e-05
the O 0 0.0002538577828090638
missing O 0 0.0035181636922061443
PAX6 O 1 0.9998151659965515
missense O 0 0.018596738576889038
mutations O 0 0.001070972764864564
frequently O 0 0.000628122768830508
may O 0 0.0008180442964658141
underlie O 0 0.013973589055240154
phenotypes O 0 0.0020556540694087744
distinct O 0 0.0005065876757726073
from O 0 0.0010037272004410625
textbook O 1 0.5123959183692932
aniridia B-Disease 1 0.9999974966049194
. O 0 0.0021913405507802963

Here O 0 0.0030171633698046207
we O 0 0.0003212827432435006
present O 0 0.00034244536072947085
four O 0 0.0002368372806813568
novel O 0 0.0019878915045410395
PAX6 O 1 0.9988030195236206
missense O 0 0.007671629544347525
mutations O 0 0.00040342347347177565
, O 0 9.618327749194577e-05
two O 0 6.72641908749938e-05
in O 0 0.00014847813872620463
association O 0 0.0003914388653356582
with O 0 0.0002326672984054312
atypical O 1 0.9996532201766968
phenotypes O 1 0.9967549443244934
ectopia B-Disease 1 0.9999992847442627
pupillae I-Disease 1 0.9999969005584717
( O 0 0.001546256011351943
displaced B-Disease 0 0.00413490878418088
pupils I-Disease 0 0.0035041728988289833
) O 0 0.0008190930238924921
and O 0 0.0021289873402565718
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999997615814209
( O 0 0.009135465137660503
searching B-Disease 0 0.003974528517574072
gaze I-Disease 0 0.30925923585891724
) O 0 0.00020979504915885627
, O 0 8.403064566664398e-05
and O 0 4.8929217882687226e-05
two O 0 5.105714444653131e-05
in O 0 0.00015462530427612364
association O 0 0.00029927032301202416
with O 0 0.00012682081433013082
more O 0 0.0002988258493132889
recognizable O 1 0.904708981513977
aniridia B-Disease 1 0.9999996423721313
phenotypes O 0 0.1976041942834854
. O 0 0.0019042794592678547

Strikingly O 0 0.009917241521179676
, O 0 0.0003792692150454968
all O 0 0.00011037347576348111
four O 0 0.00016655285435263067
mutations O 0 0.00012273660104256123
are O 0 1.2775503819284495e-05
located O 0 0.0002993390953633934
within O 0 0.00024137843865901232
the O 0 0.0005764288362115622
PAX6 O 1 0.9196511507034302
paired O 0 0.0015680798096582294
domain O 0 0.0005290685803629458
and O 0 0.00019139132928103209
affect O 0 0.00036959664430469275
amino O 0 0.0002453156921546906
acids O 0 0.00014920182002242655
which O 0 3.892364475177601e-05
are O 0 1.056907967722509e-05
highly O 0 0.00012023685849271715
conserved O 0 0.00015627207176294178
in O 0 9.901836892822757e-05
all O 0 6.155262235552073e-05
known O 0 0.0003015032852999866
paired O 0 0.0007065230747684836
domain O 0 0.00048578748828731477
proteins O 0 0.0004817126027774066
. O 0 0.00043095863657072186

Our O 0 0.0018943939357995987
results O 0 0.00034299673279747367
support O 0 0.00011955866648349911
the O 0 0.00016372176469303668
hypothesis O 0 0.00013891614798922092
that O 0 2.2659598471364006e-05
the O 0 6.820236012572423e-05
under O 0 0.0002718758478295058
- O 0 0.00036630779504776
representation O 0 0.00012739106023218483
of O 0 0.0003013917594216764
missense O 0 0.002946054795756936
mutations O 0 0.0005134438397362828
is O 0 0.00020580516138579696
caused O 0 0.01222087163478136
by O 0 0.00042135448893532157
ascertainment O 1 0.9993245601654053
bias O 0 0.0023684187326580286
and O 0 0.0003192966978531331
suggest O 0 0.00022250224719755352
that O 0 3.1341238354798406e-05
a O 0 0.0001313648244831711
substantial O 0 0.00045401070383377373
burden O 0 0.0019655742216855288
of O 0 0.004115520976483822
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9996849298477173
related I-Disease 0 0.047914158552885056
disease I-Disease 1 0.9999889135360718
remains O 0 0.01022721640765667
to O 0 0.00015224787057377398
be O 0 9.210000280290842e-05
uncovered O 0 0.0024627845268696547
. O 0 0.0002231081307400018
. O 0 0.0003494462580420077

The O 0 0.002380269579589367
chromosomal O 0 0.006312219426035881
order O 0 0.0007448859396390617
of O 0 0.00037614701432175934
genes O 0 0.0002802700037136674
controlling O 0 0.000750567065551877
the O 0 0.00048602346214465797
major O 0 0.07854141294956207
histocompatibility O 1 0.9999997615814209
complex O 0 0.07852005958557129
, O 0 0.0004134372575208545
properdin O 0 0.37641632556915283
factor O 0 0.0008295677835121751
B O 0 0.0011963311117142439
, O 0 0.00017693247355055064
and O 0 0.00033362559042871
deficiency B-Disease 1 0.9999351501464844
of I-Disease 0 0.0010578230721876025
the I-Disease 0 0.0014615287072956562
second I-Disease 0 0.0019500423222780228
component I-Disease 0 0.0013993344036862254
of I-Disease 0 0.00046533040585927665
complement I-Disease 0 0.0022338235285133123
. O 0 0.0006865773466415703

The O 0 0.0020334627479314804
relationship O 0 0.0007546598208136857
of O 0 0.0003887210914399475
the O 0 0.0004114772309549153
genes O 0 0.00024047658371273428
coding O 0 0.0005297472816891968
for O 0 0.00018505731713958085
HLA O 0 0.13172435760498047
to O 0 0.00011210318916710094
those O 0 6.267354910960421e-05
coding O 0 0.00037681765388697386
for O 0 0.00015106152568478137
properdin O 1 0.7434733510017395
Factor O 0 0.0031075694132596254
B O 0 0.00421551987528801
allotypes O 1 0.642673134803772
and O 0 0.00046767963794991374
for O 0 0.0002977440890390426
deficiency B-Disease 1 0.9995656609535217
of I-Disease 0 0.0005352644366212189
the I-Disease 0 0.0006574231083504856
second I-Disease 0 0.0008540863636881113
component I-Disease 0 0.0006171382847242057
of I-Disease 0 0.0002574417449068278
complement I-Disease 0 0.0014699040912091732
( O 0 0.0007059311610646546
C2 O 1 0.9986147880554199
) O 0 0.00012949494703207165
was O 0 0.00021848149481229484
studied O 0 0.00010568200377747416
in O 0 4.719956632470712e-05
families O 0 5.7578799896873534e-05
of O 0 0.0003646027180366218
patients O 0 0.007544222753494978
with O 1 0.6791992783546448
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9936754107475281

Patients O 0 0.00437403516843915
were O 0 0.0005723190261051059
selected O 0 0.0005460761021822691
because O 0 0.00012496256385929883
they O 0 3.897133865393698e-05
were O 0 0.00012533619883470237
heterozygous O 0 0.00037834563408978283
or O 0 0.000392731191823259
homozygous O 0 0.0036747462581843138
for O 0 0.0030751267913728952
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.009655779227614403

12 O 0 0.0030639469623565674
families O 0 0.00029966773581691086
with O 0 0.000186365723493509
15 O 0 0.001175450743176043
matings O 0 0.0071107083931565285
informative O 0 0.003343955846503377
for O 0 0.002586308168247342
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.0036864341236650944
found O 0 0.001176019199192524
. O 0 0.0008730585686862469

Of O 0 0.0036859349347651005
57 O 0 0.0043870373629033566
informative O 0 0.0026437488850206137
meioses O 0 0.11322415620088577
, O 0 0.0003736981889232993
two O 0 0.00012713090109173208
crossovers O 0 0.0007410032558254898
were O 0 0.00014994674711488187
noted O 0 0.00023020054504740983
between O 0 0.0003932138788513839
the O 0 0.0054738568142056465
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0009112308616749942
and O 0 0.000273502548225224
the O 0 0.0011826645350083709
HLA O 1 0.9999786615371704
- O 0 0.0033943417947739363
B O 0 0.0012418931582942605
gene O 0 0.00013075709284748882
, O 0 3.501246828818694e-05
with O 0 2.4607765226392075e-05
a O 0 0.00012567693192977458
recombinant O 0 0.0007667493191547692
fraction O 0 0.000430993182817474
of O 0 0.00033866093144752085
0 O 0 0.0005938122631050646
. O 0 0.0003651739389169961

035 O 1 0.9452255368232727
. O 0 0.008034013211727142

A O 0 0.005361597053706646
lod O 0 0.010114248842000961
score O 0 0.0003436882107052952
of O 0 0.00031702121486887336
13 O 0 0.0008626003400422633
was O 0 0.0004727996711153537
calculated O 0 0.00013810045493301004
for O 0 0.00011063353304052725
linkage O 0 0.002643364481627941
between O 0 0.1125117689371109
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9843868613243103
HLA O 1 0.9999998807907104
- O 0 0.014537014998495579
B O 0 0.001059641595929861
at O 0 0.00018181085761170834
a O 0 7.336719136219472e-05
maximum O 0 5.477632294059731e-05
likelihood O 0 7.789895607857034e-05
value O 0 2.5639248633524403e-05
of O 0 6.349596515065059e-05
the O 0 0.00014868217112962157
recombinant O 0 0.0005588582716882229
fraction O 0 0.0003009403881151229
of O 0 0.00026702365721575916
0 O 0 0.0004447013488970697
. O 0 0.0002960626734420657

04 O 1 0.9213548898696899
. O 0 0.005200674757361412

18 O 0 0.0035112432669848204
families O 0 0.0004138594085816294
with O 0 0.0001691208890406415
21 O 0 0.0011691648978739977
informative O 0 0.0008794712484814227
matings O 0 0.0015620831400156021
for O 0 0.00011192340753041208
both O 0 0.0002530101337470114
properdin O 0 0.2430257946252823
Factor O 0 0.0024392700288444757
B O 0 0.0037761973217129707
allotype O 1 0.9154125452041626
and O 0 0.0007750866352580488
HLA O 1 0.9999772310256958
- O 0 0.006939446087926626
B O 0 0.002545394469052553
were O 0 0.0003321169351693243
found O 0 0.000456636626040563
. O 0 0.0004950102302245796

Of O 0 0.003798191901296377
72 O 0 0.006033880170434713
informative O 0 0.002644916297867894
meioses O 0 0.1442399024963379
, O 0 0.00027113573742099106
three O 0 0.00024195284640882164
recombinants O 0 0.27230915427207947
were O 0 0.00017766599194146693
found O 0 0.0001045975077431649
, O 0 5.6486511311959475e-05
giving O 0 9.770561155164614e-05
a O 0 0.0001673764199949801
recombinant O 0 0.0008367254631593823
fraction O 0 0.0003668496501632035
of O 0 0.00040299544343724847
0 O 0 0.0007859253673814237
. O 0 0.000489882891997695

042 O 1 0.9956645369529724
. O 0 0.0074671003967523575

A O 0 0.004201515577733517
lod O 0 0.009230378083884716
score O 0 0.00027885896270163357
of O 0 0.00025926600210368633
16 O 0 0.0008276168373413384
between O 0 0.0006835114327259362
HLA O 1 0.9997598528862
- O 0 0.0017630852526053786
B O 0 0.0011499910615384579
and O 0 0.00012447329936549067
Factor O 0 0.0006025854963809252
B O 0 0.001687938580289483
allotypes O 0 0.040631748735904694
was O 0 0.0007296951371245086
calculated O 0 0.0001695825339993462
at O 0 0.00016492132272105664
a O 0 8.311813871841878e-05
maximum O 0 8.378484199056402e-05
likelihood O 0 9.02626634342596e-05
value O 0 3.6510486097540706e-05
of O 0 7.953879685373977e-05
the O 0 0.00016061286441981792
recombinant O 0 0.0009654252207837999
fraction O 0 0.00044296582927927375
of O 0 0.0003299658128526062
0 O 0 0.0006277322536334395
. O 0 0.0004848692042287439

04 O 1 0.9115695953369141
. O 0 0.006103760562837124

A O 0 0.006578524596989155
crossover O 0 0.005255166441202164
was O 0 0.0017134331865236163
shown O 0 0.00023406484979204834
to O 0 5.6707682233536616e-05
have O 0 3.378809924470261e-05
occurred O 0 0.000560287619009614
between O 0 7.897813338786364e-05
genes O 0 6.101670442149043e-05
for O 0 4.53008251497522e-05
Factor O 0 0.00043465406633913517
B O 0 0.001040724921040237
and O 0 0.0002863769477698952
HLA O 1 0.9998464584350586
- O 0 0.0035673193633556366
D O 0 0.001839948701672256
, O 0 6.999728066148236e-05
in O 0 6.661626684945077e-05
which O 0 0.00012588404933921993
HLA O 1 0.9943526983261108
- O 0 0.0020010846201330423
D O 0 0.004191346932202578
segregared O 0 0.0141494395211339
with O 0 0.00038276377017609775
HLA O 1 0.9999146461486816
- O 0 0.0023360736668109894
A O 0 0.0015613946598023176
and O 0 0.0004099748912267387
B O 0 0.002945051994174719
. O 0 0.000606292043812573

These O 0 0.00043393418309278786
studies O 0 8.042352419579402e-05
suggest O 0 0.00011624854960246012
that O 0 2.516995846235659e-05
the O 0 7.981809903867543e-05
genes O 0 6.230474537005648e-05
for O 0 6.50679285172373e-05
Factor O 0 0.001174285775050521
B O 0 0.07437600940465927
and O 0 0.007312591653317213
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0001229550689458847
located O 0 0.00048286421224474907
outside O 0 0.00029448786517605186
those O 0 4.6000746806384996e-05
for O 0 0.0001248796470463276
HLA O 1 0.9997028708457947
, O 0 0.0001045678072841838
that O 0 3.3017007808666676e-05
the O 0 9.115184366237372e-05
order O 0 0.00014034489868208766
of O 0 0.0002812146267388016
genese O 1 0.9325205683708191
is O 0 0.0005028140731155872
HLA O 1 0.9991018772125244
- O 0 0.0007871643756516278
A O 0 0.000526872172486037
, O 0 0.0001295466790907085
- O 0 0.00039128120988607407
B O 0 0.0006312952027656138
, O 0 0.0001050335995387286
- O 0 0.0005288583342917264
D O 0 0.001419934444129467
, O 0 0.00014542941062245518
Factor O 0 0.001289330655708909
B O 0 0.005441225599497557
allotype O 1 0.9999752044677734
, O 0 0.04981065168976784
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.0006651321891695261
that O 0 9.107799269258976e-05
the O 0 0.00022823580366093665
genes O 0 0.0002894513017963618
coding O 0 0.0013343887403607368
for O 0 0.001360202324576676
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.004171581473201513
Factor O 0 0.008329308591783047
B O 0 0.002561835804954171
allotypes O 0 0.00659870496019721
are O 0 1.3673893590748776e-05
approximately O 0 6.353648495860398e-05
3 O 0 0.0001244547893293202
- O 0 0.00022036206792108715
- O 0 0.00025533779989928007
5 O 0 0.00018703259411267936
centimorgans O 0 0.0019471545238047838
from O 0 0.00016031513223424554
the O 0 0.0003532232076395303
HLA O 1 0.997973620891571
- O 0 0.0008704988285899162
A O 0 0.0010244713630527258
and O 0 0.00033878558315336704
HLA O 1 0.9999055862426758
- O 0 0.0035417459439486265
B O 0 0.002549119759351015
loci O 0 0.0014154647942632437
, O 0 0.00012526796490419656
and O 0 5.0408132665324956e-05
that O 0 4.510761209530756e-05
the O 0 0.00022997283667791635
apparent O 0 0.0014029305893927813
lack O 0 0.0008740785415284336
of O 0 0.0008248777594417334
recombinants O 1 0.9984232187271118
between O 0 0.0007403182098641992
the O 0 0.0009163844515569508
Factor O 0 0.001248184242285788
B O 0 0.0025743208825588226
gene O 0 0.0007895352900959551
and O 0 0.00173408561386168
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0019802292808890343
suggests O 0 0.00031250319443643093
that O 0 3.38096906489227e-05
these O 0 1.3405661775323097e-05
two O 0 3.58074794348795e-05
genes O 0 9.024338214658201e-05
lie O 0 0.00043660547817125916
in O 0 0.00011681236355798319
close O 0 0.0004054054734297097
proximity O 0 0.0003902676107827574
to O 0 0.00011071944027207792
one O 0 0.00016775938274804503
another O 0 0.0007256008684635162
. O 0 0.000588090333621949

Distribution O 0 0.001987762749195099
of O 0 0.002125106519088149
emerin O 1 0.9997437596321106
and O 0 0.0009324467391707003
lamins O 0 0.35026025772094727
in O 0 0.0007052812143228948
the O 0 0.0012008465128019452
heart O 1 0.9948769211769104
and O 0 0.00039286931860260665
implications O 0 0.0010901474161073565
for O 0 0.0004017400788143277
Emery B-Disease 1 0.9976338148117065
- I-Disease 1 0.9999394416809082
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.04653326794505119

Emerin O 1 0.9455676078796387
is O 0 0.0007324317120946944
a O 0 0.0006385694141499698
nuclear O 0 0.001864604651927948
membrane O 0 0.0007908914121799171
protein O 0 0.00023416575277224183
which O 0 5.585018152487464e-05
is O 0 5.1583192544057965e-05
missing O 0 0.0005621411837637424
or O 0 0.0003833414812106639
defective O 1 0.6345599889755249
in O 0 0.0010731922229751945
Emery B-Disease 1 0.9970685839653015
- I-Disease 1 0.9996351003646851
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999997615814209
EDMD B-Disease 1 1.0
) O 0 0.0044454531744122505
. O 0 0.0013138533104211092

It O 0 0.0003757697995752096
is O 0 0.00010218987881671637
one O 0 7.034162263153121e-05
member O 0 7.841799379093572e-05
of O 0 0.00012631101708393544
a O 0 0.00019060386694036424
family O 0 0.0004634843207895756
of O 0 0.0012242315569892526
lamina O 1 0.9999960660934448
- O 0 0.049722298979759216
associated O 0 0.00043464702321216464
proteins O 0 0.00025398124125786126
which O 0 8.378995698876679e-05
includes O 0 0.00023982195125427097
LAP1 O 1 0.9999227523803711
, O 0 0.0004895387683063745
LAP2 O 1 0.9991427659988403
and O 0 0.0006752833141945302
lamin O 0 0.0188539270311594
B O 0 0.007612037472426891
receptor O 0 0.0019440378528088331
( O 0 0.0013396019348874688
LBR O 1 0.9991986155509949
) O 0 0.0011245935456827283
. O 0 0.0005789839196950197

A O 0 0.0032182903960347176
panel O 0 0.000988268293440342
of O 0 0.000615519646089524
16 O 0 0.0019629267044365406
monoclonal O 0 0.002625133842229843
antibodies O 0 0.0016103879315778613
( O 0 0.000697938259691
mAbs O 0 0.007215920835733414
) O 0 0.00012116983998566866
has O 0 4.7810590331209823e-05
been O 0 4.456995884538628e-05
mapped O 0 0.00016811264504212886
to O 0 6.024483809596859e-05
six O 0 0.00010029537952505052
specific O 0 3.8623846194241196e-05
sites O 0 0.00011909612658200786
throughout O 0 0.0001883646473288536
the O 0 0.00042070046765729785
emerin O 0 0.01897302269935608
molecule O 0 0.0006483203615061939
using O 0 0.00018553099653217942
phage O 0 0.0034813096281141043
- O 0 0.0009111223625950515
displayed O 0 0.0012242087395861745
peptide O 0 0.0009327372536063194
libraries O 0 0.00016234569193329662
and O 0 4.938260099152103e-05
has O 0 6.008442142046988e-05
been O 0 7.053237641230226e-05
used O 0 5.862887701368891e-05
to O 0 0.00011638475552899763
localize O 0 0.00815618596971035
emerin O 1 0.9366180896759033
in O 0 0.0008553022053092718
human O 0 0.000657627999316901
and O 0 0.0008441777317784727
rabbit O 1 0.9979676604270935
heart O 1 0.9999840259552002
. O 0 0.0027202321216464043

Several O 0 0.0028765255119651556
mAbs O 0 0.015433577820658684
against O 0 0.0014547526370733976
different O 0 0.0003155087761115283
emerin O 1 0.9787994623184204
epitopes O 0 0.010112377814948559
did O 0 0.0006558147724717855
not O 0 8.951094059739262e-05
recognize O 0 0.0005514335935004056
intercalated O 0 0.017616862431168556
discs O 0 0.0020176491234451532
in O 0 0.00024226792447734624
the O 0 0.0008991250651888549
heart O 1 0.9998947381973267
, O 0 0.00015856906247790903
though O 0 6.175263115437701e-05
they O 0 2.2868174710310996e-05
recognized O 0 0.00027081978623755276
cardiomyocyte O 0 0.20281793177127838
nuclei O 0 0.0019538772758096457
strongly O 0 0.0002884086570702493
, O 0 7.691736391279846e-05
both O 0 4.6901997848181054e-05
at O 0 0.0002975715324282646
the O 0 0.0003167239192407578
rim O 0 0.006705457344651222
and O 0 0.0003090426616836339
in O 0 0.0006464312318712473
intranuclear O 1 0.9983019828796387
spots O 0 0.004373765084892511
or O 0 0.0008970837225206196
channels O 0 0.0007427247473970056
. O 0 0.0006018324056640267

A O 0 0.019380686804652214
polyclonal O 0 0.05288247764110565
rabbit O 0 0.018367644399404526
antiserum O 0 0.028175007551908493
against O 0 0.004120765719562769
emerin O 1 0.9963145852088928
did O 0 0.0009746899595484138
recognize O 0 0.0005852542817592621
both O 0 0.00026356830494478345
nuclear O 0 0.002534857951104641
membrane O 0 0.001644281903281808
and O 0 0.00040357752004638314
intercalated O 0 0.10678980499505997
discs O 0 0.0035373098216950893
but O 0 0.0001187560337712057
, O 0 7.738291606074199e-05
after O 0 0.00020698001026175916
affinity O 0 0.00035567907616496086
purification O 0 0.005014174617826939
against O 0 0.0006549028330482543
a O 0 0.00045630784006789327
pure O 0 0.004294263198971748
- O 0 0.0019911504350602627
emerin O 0 0.03412841260433197
band O 0 0.0008312397985719144
on O 0 0.00015144255303312093
a O 0 0.00017912716430146247
western O 0 0.0006275835912674665
blot O 0 0.006797164678573608
, O 0 0.0003382645081728697
it O 0 0.0001673598017077893
stained O 0 0.023426303640007973
only O 0 0.00017850294534582645
the O 0 0.0006975618889555335
nuclear O 0 0.004537501372396946
membrane O 0 0.0028621326200664043
. O 0 0.00047467483091168106

These O 0 0.0006212841253727674
results O 0 0.000316935678711161
would O 0 7.178321538958699e-05
not O 0 2.7666243113344535e-05
be O 0 3.808879046118818e-05
expected O 0 0.00013107228733133525
if O 0 0.00010216074588242918
immunostaining O 0 0.010849579237401485
at O 0 0.0013885932276025414
intercalated O 0 0.027763746678829193
discs O 0 0.0022983774542808533
were O 0 0.00015277416969183832
due O 0 0.00016506039537489414
to O 0 6.291733734542504e-05
a O 0 0.00014397224003914744
product O 0 0.0001257699477719143
of O 0 0.0001970508455997333
the O 0 0.0005716086598113179
emerin O 1 0.9991772770881653
gene O 0 0.0005881323595531285
and O 0 0.00013782775204163045
, O 0 9.422142466064543e-05
therefore O 0 7.878527685534209e-05
, O 0 4.40865260316059e-05
cast O 0 0.0001337682770099491
some O 0 5.846719068358652e-05
doubt O 0 0.0002850003947969526
upon O 0 0.00028014686540700495
the O 0 0.00044403207721188664
hypothesis O 0 0.0008684483473189175
that O 0 0.0005904526333324611
cardiac B-Disease 1 0.9999998807907104
defects I-Disease 1 1.0
in O 1 0.9992409944534302
EDMD B-Disease 1 1.0
are O 0 0.0002744481316767633
caused O 0 0.004943623207509518
by O 0 0.00015556869038846344
absence O 0 0.001143150613643229
of O 0 0.001532678958028555
emerin O 1 0.999966025352478
from O 0 0.004134443588554859
intercalated O 1 0.9960101842880249
discs O 0 0.029295209795236588
. O 0 0.001547645078971982

Although O 0 0.0049031442031264305
emerin O 1 0.9780826568603516
was O 0 0.0030889459885656834
abundant O 0 0.0012337220832705498
in O 0 0.0002355720498599112
the O 0 0.0003918181755580008
membranes O 0 0.001519885379821062
of O 0 0.0010425676591694355
cardiomyocyte O 1 0.9999450445175171
nuclei O 0 0.015950273722410202
, O 0 0.00023068831069394946
it O 0 7.4781448347494e-05
was O 0 0.00033394061028957367
absent O 0 0.0007125497795641422
from O 0 0.00013228142051957548
many O 0 0.00010742913582362235
non O 0 0.001116601168178022
- O 0 0.0034467587247490883
myocyte O 1 0.9960907101631165
cells O 0 0.0011799054918810725
in O 0 0.00039879849646240473
the O 0 0.0014646684285253286
heart O 1 0.9965971112251282
. O 0 0.0011391349835321307

This O 0 0.0005386084667406976
distribution O 0 0.00024230813141912222
of O 0 0.0004355697310529649
emerin O 1 0.9984942674636841
was O 0 0.0013528778217732906
similar O 0 7.622369594173506e-05
to O 0 3.633421511040069e-05
that O 0 1.2678879102168139e-05
of O 0 0.00013297876284923404
lamin O 0 0.0038464644458144903
A O 0 0.0007240590639412403
, O 0 0.0001092938837246038
a O 0 0.00011955969239352271
candidate O 0 0.00022458461171481758
gene O 0 9.08174624782987e-05
for O 0 3.439007923589088e-05
an O 0 0.0001052104271366261
autosomal O 0 0.0008018864318728447
form O 0 0.001162313506938517
of O 1 0.9883005619049072
EDMD B-Disease 1 1.0
. O 0 0.005616925191134214

In O 0 0.004229301121085882
contrast O 0 0.004601805470883846
, O 0 0.0021645515225827694
lamin O 1 0.5689848065376282
B1 O 1 0.9997989535331726
was O 0 0.005703932140022516
absent O 0 0.003686815733090043
from O 0 0.0011001534294337034
cardiomyocyte O 1 0.9981196522712708
nuclei O 0 0.007376403547823429
, O 0 0.00045566741027869284
showing O 0 0.0011178198037669063
that O 0 0.00043343970901332796
lamin O 1 0.5891708731651306
B1 O 1 0.9994934797286987
is O 0 0.00027832615887746215
not O 0 6.764668069081381e-05
essential O 0 0.0002368781279074028
for O 0 7.180129614425823e-05
localization O 0 0.0009113698033615947
of O 0 0.0003780355618800968
emerin O 1 0.5342437028884888
to O 0 0.0002916813245974481
the O 0 0.000835712009575218
nuclear O 0 0.008797693066298962
lamina O 1 0.773548424243927
. O 0 0.0016364292241632938

Lamin O 1 0.9981447458267212
B1 O 1 0.9998301267623901
is O 0 0.0007555150077678263
also O 0 0.00045460183173418045
almost O 0 0.0005918031674809754
completely O 0 0.00231345696374774
absent O 0 0.003519390942528844
from O 0 0.0030975225381553173
skeletal O 1 0.9999995231628418
muscle O 1 0.9999995231628418
nuclei O 1 0.9995205402374268
. O 0 0.003048053476959467

In O 0 0.008515400812029839
EDMD B-Disease 1 0.9999986886978149
, O 0 0.0006460942677222192
the O 0 0.0004440291377250105
additional O 0 0.000250031502218917
absence O 0 0.0010513549204915762
of O 0 0.0014332366408780217
lamin O 1 0.9989746809005737
B1 O 1 0.9999947547912598
from O 0 0.03023567423224449
heart O 1 0.9999991655349731
and O 0 0.3892446756362915
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.9998385906219482
which O 0 0.0006449991487897933
already O 0 0.00041516550118103623
lack O 0 0.0012373292120173573
emerin O 1 0.9994196891784668
may O 0 0.0002480353869032115
offer O 0 7.35289795557037e-05
an O 0 5.452590630738996e-05
alternative O 0 0.00011065400758525357
explanation O 0 0.0001919198257382959
of O 0 0.0002463225682731718
why O 0 0.00047283415915444493
these O 0 0.00012594492000062019
tissues O 0 0.004804868251085281
are O 0 6.956805736990646e-05
particularly O 0 0.0006530298851430416
affected O 0 0.0011539359111338854
. O 0 0.00023029452131595463
. O 0 0.00041821057675406337

Genetic O 0 0.002473121974617243
mapping O 0 0.0012076051207259297
of O 0 0.0009908745996654034
the O 0 0.003388193668797612
copper B-Disease 1 0.9999877214431763
toxicosis I-Disease 1 0.9998526573181152
locus O 0 0.00376126985065639
in O 0 0.0007653656066395342
Bedlington O 0 0.027718696743249893
terriers O 0 0.004906127694994211
to O 0 0.00030303059611469507
dog O 0 0.002319594379514456
chromosome O 0 0.0006407720502465963
10 O 0 0.00024482968728989363
, O 0 6.372495408868417e-05
in O 0 6.670996663160622e-05
a O 0 0.0001784709602361545
region O 0 0.0006438132259063423
syntenic O 0 0.029144609346985817
to O 0 0.00037603353848680854
human O 0 0.0005095063243061304
chromosome O 0 0.001361214555799961
region O 0 0.0034683512058109045
2p13 O 1 0.9999687671661377
- O 0 0.02712182141840458
p16 O 0 0.057101015001535416
. O 0 0.0011174590326845646

Abnormal O 1 0.9999940395355225
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999998807907104
accumulation I-Disease 1 0.9999300241470337
is O 0 0.0003381737624295056
recognized O 0 0.00020896138448733836
as O 0 0.00021019690029788762
an O 0 0.0004768753133248538
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9975576400756836
man O 1 0.99950110912323
, O 0 0.0006849336205050349
mouse O 0 0.002055738354101777
, O 0 0.00039990406366996467
rat O 0 0.06753746420145035
and O 0 0.0007816848810762167
dog O 0 0.01033646147698164
. O 0 0.0012881015427410603

The O 0 0.004222768824547529
major O 0 0.016548791900277138
cause O 1 0.9516605734825134
of O 1 0.9701974987983704
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999780654907227
in O 0 0.001251477049663663
man O 0 0.002681436948478222
is O 0 8.838892972562462e-05
a O 0 0.00021957475109957159
dysfunctional O 0 0.028763918206095695
ATP7B O 1 0.9999954700469971
gene O 0 0.0010297986445948482
, O 0 0.0005902658449485898
causing O 1 0.9995482563972473
Wilson B-Disease 1 0.9999642372131348
disease I-Disease 1 1.0
( O 1 0.8755548596382141
WD B-Disease 1 0.9999926090240479
) O 0 0.0013943552039563656
. O 0 0.0007782928878441453

Mutations O 0 0.002048533409833908
in O 0 0.00063372339354828
the O 0 0.0012177558382973075
ATP7B O 1 0.9999901056289673
genes O 0 0.00033941600122489035
have O 0 4.165537393419072e-05
also O 0 5.2335548389237374e-05
been O 0 0.00010259937698720023
demonstrated O 0 0.0005425419076345861
in O 0 0.0003682440146803856
mouse O 0 0.0013387614162638783
and O 0 0.0005515723605640233
rat O 0 0.24487967789173126
. O 0 0.0013167496072128415

The O 0 0.008422250859439373
ATP7B O 1 0.9999933242797852
gene O 0 0.001146530150435865
has O 0 0.00017315075092483312
been O 0 0.00010789326188387349
excluded O 0 0.0003794024814851582
in O 0 9.853074880084023e-05
the O 0 0.0003375110973138362
much O 0 0.0006697917124256492
rarer O 0 0.12407991290092468
human O 0 0.34130293130874634
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 0.9999997615814209
non B-Disease 0 0.3287719786167145
- I-Disease 0 0.0055175358429551125
Indian I-Disease 0 0.0019117819610983133
childhood I-Disease 1 0.9920404553413391
cirrhosis I-Disease 1 0.9999998807907104
, O 0 0.000952527450863272
indicating O 0 0.0037961627822369337
genetic O 0 0.0012326232390478253
heterogeneity O 0 0.007134528830647469
. O 0 0.0013452330604195595

By O 0 0.0011108180042356253
investigating O 0 0.001468371250666678
the O 0 0.0014187550405040383
common O 0 0.0012684083776548505
autosomal O 1 0.9816688895225525
recessive O 1 0.9999992847442627
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 0.4216553568840027
CT B-Disease 1 0.7542465329170227
) O 0 0.00015862031432334334
in O 0 0.00021491335064638406
Bedlington O 1 0.6207269430160522
terriers O 0 0.025074893608689308
, O 0 0.00021362016559578478
we O 0 5.358552516554482e-05
have O 0 1.9019538740394637e-05
identified O 0 5.6435037549817935e-05
a O 0 8.933792560128495e-05
new O 0 0.00015451743092853576
locus O 0 0.0009976944420486689
involved O 0 0.0006674543838016689
in O 0 0.0031324552837759256
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.7240986824035645

We O 0 0.0013293757801875472
examined O 0 0.0007593152695335448
whether O 0 0.0001503281237091869
the O 0 0.0005728626274503767
WD B-Disease 1 0.9914331436157227
gene O 0 0.002341028768569231
ATP7B O 1 0.9999637603759766
was O 0 0.002695071278139949
also O 0 0.00025351287331432104
causative O 0 0.0022383311297744513
for O 0 0.0002464085118845105
CT B-Disease 0 0.00476714177057147
by O 0 0.00010231780470348895
investigating O 0 0.00040876262937672436
the O 0 0.0005980181158520281
chromosomal O 0 0.034365568310022354
co O 0 0.004480249248445034
- O 0 0.0019221898401156068
localization O 0 0.003848059568554163
of O 0 0.0012415857054293156
ATP7B O 1 0.9999923706054688
and O 0 0.000902552914340049
C04107 O 1 0.9099348187446594
, O 0 0.00020860742370132357
using O 0 7.014629227342084e-05
fluorescence O 0 0.00027444734587334096
in O 0 0.0001066380282281898
situ O 0 0.0023884745314717293
hybridization O 0 0.0005664417403750122
( O 0 0.00048143486492335796
FISH O 0 0.0018463085871189833
) O 0 0.00028979312628507614
. O 0 0.0003112635458819568

C04107 O 1 0.9823675155639648
is O 0 0.0004562717513181269
an O 0 0.00025396625278517604
anonymous O 0 0.0009010440553538501
microsatellite O 0 0.006189076229929924
marker O 0 0.003141681430861354
closely O 0 0.000522268412169069
linked O 0 0.001658930443227291
to O 0 0.0011334237642586231
CT B-Disease 0 0.40339788794517517
. O 0 0.0010024866787716746

However O 0 0.004982406739145517
, O 0 0.0029458808712661266
BAC O 1 0.9754579663276672
clones O 0 0.021949943155050278
containing O 0 0.004082763567566872
ATP7B O 1 0.9999525547027588
and O 0 0.0006923377513885498
C04107 O 0 0.03404504433274269
mapped O 0 0.0006776567897759378
to O 0 0.00011824641842395067
the O 0 0.00036693571018986404
canine O 0 0.0053508891724050045
chromosome O 0 0.0016139891231432557
regions O 0 0.0011842161184176803
CFA22q11 O 1 0.9999372959136963
and O 0 0.0015398323303088546
CFA10q26 O 1 0.9999403953552246
, O 0 0.0006091005052439868
respectively O 0 0.0007626888109371066
, O 0 0.00021526010823436081
demonstrating O 0 0.0016248255269601941
that O 0 0.0002121222496498376
WD B-Disease 1 0.9457629323005676
cannot O 0 0.00044615287333726883
be O 0 0.00010726882464950904
homologous O 0 0.0010435982840135694
to O 0 0.000507908349391073
CT B-Disease 0 0.03200332820415497
. O 0 0.0011866489658132195

The O 0 0.009630750864744186
copper O 1 0.9992107152938843
transport O 0 0.012395290657877922
genes O 0 0.002031630137935281
CTR1 O 1 0.9999831914901733
and O 0 0.0011593964882194996
CTR2 O 1 0.9999934434890747
were O 0 0.00032656340044923127
also O 0 9.50744142755866e-05
excluded O 0 0.000390221452107653
as O 0 0.00011869285663124174
candidate O 0 0.00015295110642910004
genes O 0 0.0001165989160654135
for O 0 0.00016374190454371274
CT B-Disease 0 0.02423582784831524
since O 0 0.00030015353695489466
they O 0 3.530201138346456e-05
both O 0 4.447544415597804e-05
mapped O 0 0.0003793319338001311
to O 0 0.00025406747590750456
canine O 0 0.00907026045024395
chromosome O 0 0.004349095746874809
region O 0 0.006062832660973072
CFA11q22 O 1 0.9999134540557861
. O 0 0.002102120313793421

2 O 0 0.006084894761443138
- O 0 0.003985913936048746
22 O 0 0.003722666995599866
. O 0 0.0007660982082597911

5 O 0 0.013284465298056602
. O 0 0.0028858657460659742

A O 0 0.004238082095980644
transcribed O 0 0.0010216808877885342
sequence O 0 0.00018501991871744394
identified O 0 0.0001128131989389658
from O 0 7.726574403932318e-05
the O 0 0.0003037039132323116
C04107 O 1 0.9159904718399048
- O 0 0.0018708807183429599
containing O 0 0.0008814969332888722
BAC O 1 0.5439841151237488
was O 0 0.0006334545905701816
found O 0 7.602963887620717e-05
to O 0 3.82495709345676e-05
be O 0 2.7868023607879877e-05
homologous O 0 0.00020960309484507889
to O 0 4.364080086816102e-05
a O 0 0.00010090183059219271
gene O 0 7.775772246532142e-05
expressed O 0 6.644852692261338e-05
from O 0 0.0001553935871925205
human O 0 0.0004403396451380104
chromosome O 0 0.0034761386923491955
2p13 O 1 0.999953031539917
- O 0 0.007931279018521309
p16 O 0 0.009498543106019497
, O 0 0.00013272375508677214
a O 0 0.00019871666154358536
region O 0 0.00044182027340866625
devoid O 0 0.0018970970995724201
of O 0 0.00035020880750380456
any O 0 0.000285553076537326
positional O 0 0.004435613751411438
candidate O 0 0.0014596128603443503
genes O 0 0.0008881221292540431
. O 0 0.000685816106852144

Molecular O 0 0.001295676571317017
analysis O 0 0.00010126359120476991
of O 0 0.0002534978848416358
the O 0 0.000577261729631573
APC B-Disease 0 0.49980273842811584
gene O 0 0.00022669251484330744
in O 0 9.74647919065319e-05
205 O 0 0.0007043327786959708
families O 0 7.615017239004374e-05
: O 0 9.74533541011624e-05
extended O 0 0.0003603958757594228
genotype O 0 0.0010560427326709032
- O 0 0.001214189687743783
phenotype O 0 0.0007928881095722318
correlations O 0 0.00059836934087798
in O 0 0.00059152563335374
FAP B-Disease 1 0.9887270927429199
and O 0 0.00021687628759536892
evidence O 0 0.0001824523351388052
for O 0 5.271552799968049e-05
the O 0 0.00016302138101309538
role O 0 0.00030840569525025785
of O 0 0.00043145232484675944
APC B-Disease 1 0.9893450140953064
amino O 0 0.0008822939125820994
acid O 0 0.001279374468140304
changes O 0 0.000511653779540211
in O 0 0.013773654587566853
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.999996542930603
. O 0 0.007640871684998274

BACKGROUND O 0 0.030699944123625755
/ O 0 0.010488159954547882
AIMS O 0 0.005383622366935015
The O 0 0.0008898989181034267
development O 0 0.0014504491118714213
of O 1 0.9699921011924744
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.000729849620256573
a O 0 0.0004366645298432559
variable O 0 9.201643842970952e-05
range O 0 0.00015721304225735366
of O 0 0.0004944202955812216
extracolonic O 1 0.9960373044013977
manifestations O 0 0.40303221344947815
in O 0 0.0024821702390909195
familial B-Disease 1 0.9999995231628418
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998669624328613
FAP B-Disease 1 0.9999995231628418
) O 0 0.0002920851402450353
is O 0 8.366875408682972e-05
the O 0 0.00014529551845043898
result O 0 8.824643737170845e-05
of O 0 0.00015093079127836972
the O 0 0.0004398563760332763
dominant O 0 0.0017585541354492307
inheritance O 0 0.0026313834823668003
of O 0 0.08674430847167969
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9883596897125244
APC B-Disease 1 0.9999902248382568
) O 0 0.0006086400826461613
gene O 0 0.0007445499650202692
mutations O 0 0.0005532253417186439
. O 0 0.00042365811532363296

In O 0 0.0013700858689844608
this O 0 0.0001465074165025726
study O 0 7.410958642140031e-05
, O 0 4.5834352931706235e-05
direct O 0 5.37327432539314e-05
mutation O 0 6.0373437008820474e-05
analysis O 0 1.3777169442619197e-05
of O 0 8.640302257845178e-05
the O 0 0.00047720817383378744
APC B-Disease 1 0.9977890253067017
gene O 0 0.0003814160299953073
was O 0 0.0007495236350223422
performed O 0 0.00045190058881416917
to O 0 9.190225682687014e-05
determine O 0 0.00018911994993686676
genotype O 0 0.0009271035087294877
- O 0 0.0010131881572306156
phenotype O 0 0.0009938295697793365
correlations O 0 0.000498773530125618
for O 0 0.00017208945064339787
nine O 0 0.0010906272800639272
extracolonic O 1 0.9980887770652771
manifestations O 0 0.18210358917713165
and O 0 0.0002996334806084633
to O 0 0.00017301573825534433
investigate O 0 0.00061306037241593
the O 0 0.00047883164370432496
incidence O 0 0.00152022042311728
of O 0 0.001520733698271215
APC B-Disease 1 0.9999575614929199
mutations O 0 0.000759670278057456
in O 0 0.0006497164722532034
non O 0 0.0502864308655262
- O 1 0.9997517466545105
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.003956051543354988

METHODS O 0 0.003975332714617252
The O 0 0.0022576688788831234
APC B-Disease 1 0.9837629795074463
gene O 0 0.0005224857595749199
was O 0 0.0006428456981666386
analysed O 0 0.000387036066967994
in O 0 0.00017973796639125794
190 O 0 0.0012747073778882623
unrelated O 0 0.0027323386166244745
FAP B-Disease 0 0.3918635845184326
and O 0 0.0004898094921372831
15 O 0 0.0022329704370349646
non O 0 0.056436844170093536
- O 1 0.9998577833175659
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.007603138219565153
using O 0 0.0006851250072941184
denaturing O 0 0.23820006847381592
gradient O 0 0.011796582490205765
gel O 0 0.010835658758878708
electrophoresis O 0 0.0019754525274038315
, O 0 0.00010046269017038867
the O 0 0.00017294581630267203
protein O 0 0.00039743297384120524
truncation O 0 0.003189320443198085
test O 0 0.00045015590148977935
, O 0 0.00010194529022555798
and O 0 9.094233973883092e-05
direct O 0 0.0001888642436824739
sequencing O 0 0.0010776766575872898
. O 0 0.00048008645535446703

RESULTS O 0 0.00739608658477664
Chain O 0 0.005441643297672272
terminating O 0 0.003251089481636882
signals O 0 0.0006524697528220713
were O 0 0.00011218166764592752
only O 0 3.921350435120985e-05
identified O 0 9.585813677404076e-05
in O 0 9.374124783789739e-05
patients O 0 0.00011002921382896602
belonging O 0 0.00026083120610564947
to O 0 0.0001351416576653719
the O 0 0.000617703830357641
FAP B-Disease 1 0.9566457867622375
group O 0 0.00039098222623579204
( O 0 0.00047274644020944834
105 O 0 0.0033182762563228607
patients O 0 0.0010851728729903698
) O 0 0.00043299206299707294
. O 0 0.0007102143717929721

Amino O 0 0.004980785306543112
acid O 0 0.002674712333828211
changes O 0 0.0001836031151469797
were O 0 7.434259896399453e-05
identified O 0 7.402434130199254e-05
in O 0 8.703090861672536e-05
four O 0 0.00017234824190381914
patients O 0 0.0001603817945579067
, O 0 5.779487401014194e-05
three O 0 6.976204895181581e-05
of O 0 0.0001760612358339131
whom O 0 0.0004502964729908854
belonged O 0 0.0015649236738681793
to O 0 0.00020568392938002944
the O 0 0.0004050182178616524
non O 0 0.0013329661451280117
- O 0 0.002050400245934725
FAP O 1 0.9737435579299927
group O 0 0.0005041883559897542
of O 1 0.9596676230430603
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9994679093360901
. O 0 0.0020910752937197685

Genotype O 0 0.0322732999920845
- O 0 0.008566183969378471
phenotype O 0 0.003015059744939208
correlations O 0 0.0007588096195831895
identified O 0 0.00021364334679674357
significant O 0 0.000197131434106268
differences O 0 0.00017660498269833624
in O 0 0.0001736219273880124
the O 0 0.00032099493546411395
nature O 0 0.0004709063214249909
of O 0 0.00040979066397994757
certain O 0 0.0008020068635232747
extracolonic O 1 0.9999531507492065
manifestations O 1 0.9995658993721008
in O 0 0.007393272593617439
FAP B-Disease 1 0.9999898672103882
patients O 0 0.0010350976372137666
belonging O 0 0.0010932695586234331
to O 0 0.00023528966994490474
three O 0 0.00035585431032814085
mutation O 0 0.0007420745678246021
subgroups O 0 0.0023594205267727375
. O 0 0.0009421890135854483

CONCLUSIONS O 0 0.008626437745988369
Extended O 0 0.004131922964006662
genotype O 0 0.004171351436525583
- O 0 0.0021398416720330715
phenotype O 0 0.001014932058751583
correlations O 0 0.0005214476259425282
made O 0 0.0001923906966112554
in O 0 9.538453014101833e-05
this O 0 4.623692075256258e-05
study O 0 5.997216794639826e-05
may O 0 7.023223588475958e-05
have O 0 1.67946818692144e-05
the O 0 6.920017767697573e-05
potential O 0 8.545807213522494e-05
to O 0 3.013112655025907e-05
determine O 0 4.972188617102802e-05
the O 0 0.00010319132707081735
most O 0 7.248616020660847e-05
appropriate O 0 0.00015153053391259164
surveillance O 0 0.0005108594195917249
and O 0 0.00040863698814064264
prophylactic O 1 0.5236567854881287
treatment O 1 0.7194394469261169
regimens O 0 0.06956881284713745
for O 0 0.00034025023342110217
those O 0 0.0002139907592209056
patients O 0 0.00027561813476495445
with O 0 0.00018051115330308676
mutations O 0 0.0003973129205405712
associated O 0 0.00029629477648995817
with O 0 0.00030961856828071177
life O 0 0.03595004603266716
threatening O 1 0.9997510313987732
conditions O 0 0.2102280855178833
. O 0 0.0011732265120372176

This O 0 0.0005025910213589668
study O 0 0.00018585094949230552
also O 0 9.053799294633791e-05
provided O 0 8.022665861062706e-05
evidence O 0 0.00010194869537372142
for O 0 5.60453518119175e-05
the O 0 0.0002827637072186917
pathological O 0 0.006490473169833422
nature O 0 0.001202313811518252
of O 0 0.0008261954062618315
amino O 0 0.0006185887032188475
acid O 0 0.000835204089526087
changes O 0 0.0002302967186551541
in O 0 0.00025137417833320796
APC O 0 0.22725804150104523
associated O 0 0.0002868086448870599
with O 0 0.00010347649367759004
both O 0 0.0003103352210018784
FAP B-Disease 1 0.9994348883628845
and O 0 0.0011399443028494716
non O 1 0.898911714553833
- O 1 0.9999901056289673
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9973153471946716
. O 0 0.0008471225155517459
. O 0 0.0007393238483928144

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.999832034111023
cancer B-Disease 1 0.9999984502792358
risk O 0 0.0024252417497336864
of O 0 0.0018968497170135379
the O 0 0.043466322124004364
APC O 1 0.9999809265136719
I1307K O 1 0.9997634291648865
polymorphism O 0 0.004363869316875935
. O 0 0.0009150730911642313

Germ O 1 0.9999740123748779
- O 0 0.021059591323137283
line O 0 0.0026445738039910793
and O 0 0.0004181051626801491
somatic O 0 0.002014441881328821
truncating O 0 0.005230776499956846
mutations O 0 0.0002285432565258816
of O 0 0.00037746658199466765
the O 0 0.0008872044854797423
APC B-Disease 1 0.994932234287262
gene O 0 0.0003060104791074991
are O 0 2.0897385184071027e-05
thought O 0 0.00022080687631387264
to O 0 0.00024213768483605236
initiate O 0 0.007486335933208466
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999994039535522
formation O 1 0.99991774559021
in O 1 0.6843119263648987
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999948740005493
sporadic O 1 0.9999998807907104
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.0041231028735637665
respectively O 0 0.0027973398100584745
. O 0 0.0007061349460855126

Recently O 0 0.003756851889193058
, O 0 0.0005118835251778364
an O 0 0.0005030477768741548
isoleucine O 0 0.316032737493515
- O 0 0.004111884161829948
- O 0 0.0016830748645588756
> O 0 0.0016674560029059649
lysine O 0 0.0013356119161471725
polymorphism O 0 0.00038706636405549943
at O 0 0.000670662266202271
codon O 0 0.0025340744759887457
1307 O 0 0.02257736586034298
( O 0 0.0007835048600099981
I1307K O 0 0.010355180129408836
) O 0 0.00011458211520221084
of O 0 0.00018648749392013997
the O 0 0.0006609426345676184
APC B-Disease 1 0.9945971965789795
gene O 0 0.00031045061768963933
has O 0 5.589163993136026e-05
been O 0 3.86203100788407e-05
identified O 0 3.713199475896545e-05
in O 0 3.4747830795822665e-05
6 O 0 0.00022964154777582735
% O 0 5.584666723734699e-05
- O 0 0.00022209741291590035
7 O 0 0.0002959779812954366
% O 0 4.591423930833116e-05
of O 0 0.00011579119018279016
the O 0 0.00036373810144141316
Ashkenazi O 0 0.002246505580842495
Jewish O 0 0.0012622842332348228
population O 0 0.0002529030607547611
. O 0 0.00034468062222003937

To O 0 0.0009034382528625429
assess O 0 0.0009570212569087744
the O 0 0.0003705762210302055
risk O 0 0.00022557092597708106
of O 0 0.00015216716565191746
this O 0 0.0001194597571156919
common O 0 0.0005624793702736497
APC B-Disease 1 0.9913206696510315
allelic O 0 0.1396113485097885
variant O 0 0.09201257675886154
in O 0 0.05189158022403717
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 0 0.000610171933658421
we O 0 0.00013089031563140452
have O 0 1.4170469512464479e-05
analyzed O 0 6.611037679249421e-05
a O 0 8.229209925048053e-05
large O 0 0.00010221025149803609
cohort O 0 0.0007636392838321626
of O 0 0.0003460600564721972
unselected O 0 0.03293916955590248
Ashkenazi O 0 0.005032454151660204
Jewish O 0 0.0017137969844043255
subjects O 0 0.0015728934668004513
with O 0 0.0005524578737094998
adenomatous B-Disease 1 0.9999978542327881
polyps I-Disease 1 0.9999809265136719
and O 0 0.0013973088935017586
. O 0 0.000713684072252363
or O 1 0.9985765218734741
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0005027443985454738
for O 0 0.00016277380927931517
the O 0 0.0012257295893505216
APC O 1 0.9992783665657043
I1307K O 1 0.997280478477478
polymorphism O 0 0.0035390884149819613
. O 0 0.0012326091527938843

The O 0 0.0078018466010689735
APC O 1 0.9927229285240173
I1307K O 1 0.9558910131454468
allele O 0 0.0010265675373375416
was O 0 0.0004606500151567161
identified O 0 5.802992018288933e-05
in O 0 5.7765893870964646e-05
48 O 0 0.00016410437820013613
( O 0 8.006676944205537e-05
10 O 0 9.298645454691723e-05
. O 0 2.6374436856713146e-05
1 O 0 9.760820830706507e-05
% O 0 4.424506551004015e-05
) O 0 5.387394048739225e-05
of O 0 0.0002907002635765821
476 O 0 0.06979259848594666
patients O 0 0.003349913517013192
. O 0 0.001479312893934548

Compared O 0 0.0015535539714619517
with O 0 0.00013809003576170653
the O 0 0.00018329211161471903
frequency O 0 5.909522224101238e-05
in O 0 3.1677420338382944e-05
two O 0 1.6068413970060647e-05
separate O 0 3.4105869417544454e-05
population O 0 3.2558506063651294e-05
control O 0 0.00013132223102729768
groups O 0 2.985004539368674e-05
, O 0 7.974924665177241e-05
the O 0 0.0005329049308784306
APC O 1 0.9980393052101135
I1307K O 1 0.9987465143203735
allele O 0 0.0011262744665145874
is O 0 0.0001375806168653071
associated O 0 9.709613368613645e-05
with O 0 4.7403995267814025e-05
an O 0 7.93680883361958e-05
estimated O 0 0.0002987466286867857
relative O 0 0.0003625793324317783
risk O 0 0.0002506011805962771
of O 0 0.000445498590124771
1 O 0 0.0017229089280590415
. O 0 0.000695299357175827

5 O 0 0.005235179793089628
- O 0 0.0037955620791763067
1 O 0 0.0016771497903391719
. O 0 0.0006354746292345226

7 O 0 0.009725655429065228
for O 0 0.003013325622305274
colorectal B-Disease 1 0.9999994039535522
neoplasia I-Disease 1 0.9999707937240601
( O 0 0.0017617471748962998
both O 0 0.0006673386669717729
P O 0 0.018263347446918488
= O 0 0.00191679282579571
. O 0 0.0004103823157493025
01 O 0 0.014616637490689754
) O 0 0.0004600567335728556
. O 0 0.00040102453203871846

Furthermore O 0 0.005165633279830217
, O 0 0.0005395287880674005
compared O 0 0.00045620082528330386
with O 0 0.000240966139244847
noncarriers O 1 0.998820960521698
, O 0 0.001004706253297627
APC O 1 0.9994485974311829
I1307K O 1 0.9995537400245667
carriers O 0 0.0009423883748240769
had O 0 0.0003699336957652122
increased O 0 0.00024417691747657955
numbers O 0 8.528678154107183e-05
of O 0 0.0005980748101137578
adenomas B-Disease 1 0.9999806880950928
and O 0 0.030269792303442955
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999771118164062
per O 0 0.0005944243748672307
patient O 0 0.0005681501352228224
( O 0 0.00022626967984251678
P O 0 0.002203214680776
= O 0 0.00045079729170538485
. O 0 8.519021503161639e-05
03 O 0 0.0036525630857795477
) O 0 0.00011420686496421695
, O 0 5.971530481474474e-05
as O 0 6.575789302587509e-05
well O 0 4.5993205276317894e-05
as O 0 7.993273175088689e-05
a O 0 0.00021329347509890795
younger O 0 0.001087071606889367
age O 0 0.0008716018637642264
at O 0 0.004676958546042442
diagnosis O 0 0.11016049981117249
. O 0 0.0009924707701429725

We O 0 0.0011611549416556954
conclude O 0 0.0016689830226823688
that O 0 0.00014823256060481071
the O 0 0.0005668540834449232
APC O 1 0.6308242678642273
I1307K O 1 0.9906877875328064
variant O 0 0.0025442750193178654
leads O 0 0.0013119501527398825
to O 0 0.0004576235660351813
increased O 0 0.0024651107378304005
adenoma B-Disease 1 0.9999998807907104
formation O 1 0.9678760766983032
and O 0 0.0003352692583575845
directly O 0 0.00016489822883158922
contributes O 0 0.0001657809189055115
to O 0 3.4913638955913484e-05
3 O 0 0.00011192041711183265
% O 0 2.7727945052902214e-05
- O 0 0.00010344758629798889
4 O 0 9.522321488475427e-05
% O 0 2.4186883820220828e-05
of O 0 9.52937116380781e-05
all O 0 0.00015634196461178362
Ashkenazi O 0 0.010882142931222916
Jewish O 1 0.996704638004303
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.003935106564313173

The O 0 0.002611021511256695
estimated O 0 0.0009947039652615786
relative O 0 0.0006547396187670529
risk O 0 0.00034424432669766247
for O 0 0.0001535316405352205
carriers O 0 0.0005630854866467416
may O 0 0.00016062527720350772
justify O 0 0.000427330523962155
specific O 0 4.818142406293191e-05
clinical O 0 0.0001575461938045919
screening O 0 9.934893751051277e-05
for O 0 3.749615643755533e-05
the O 0 0.00017501747061032802
360 O 0 0.000770876940805465
, O 0 9.974314161809161e-05
000 O 0 0.0005002943798899651
Americans O 0 9.939147275872529e-05
expected O 0 8.831024751998484e-05
to O 0 5.1450158935040236e-05
harbor O 0 0.0011489575263112783
this O 0 8.414676267420873e-05
allele O 0 0.0001628576428629458
, O 0 5.006492938264273e-05
and O 0 7.333032408496365e-05
genetic O 0 0.0001656646199990064
testing O 0 0.00018330992315895855
in O 0 7.735760300420225e-05
the O 0 0.00010836096771527082
setting O 0 0.00024151566321961582
of O 0 0.00014866939454805106
long O 0 0.00030347181018441916
- O 0 0.0005383560201153159
term O 0 0.0003899277071468532
- O 0 0.00041250954382121563
outcome O 0 0.00018484692554920912
studies O 0 5.451415927382186e-05
may O 0 0.0001328484941041097
impact O 0 0.0004585388523992151
significantly O 0 0.0009140195325016975
on O 0 0.006278417073190212
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9998490810394287
in O 0 0.0007024164078757167
this O 0 0.00015132823318708688
population O 0 0.00010571850725682452
. O 0 0.00017127045430243015

Localization O 0 0.016389628872275352
of O 0 0.001499377773143351
human O 0 0.0011146558681502938
BRCA1 O 0 0.018049461767077446
and O 0 0.0001420144399162382
its O 0 8.9505389041733e-05
loss O 0 0.00046892912359908223
in O 0 0.00013918835611548275
high O 0 0.0009469164069741964
- O 0 0.0009616086026653647
grade O 0 0.002598504303023219
, O 0 0.00028793970705009997
non B-Disease 0 0.001813560607843101
- I-Disease 0 0.24223469197750092
inherited I-Disease 1 0.9999984502792358
breast I-Disease 1 0.9999996423721313
carcinomas I-Disease 1 1.0
. O 0 0.005052099470049143

Although O 0 0.0008573249797336757
the O 0 0.0005742662469856441
link O 0 0.0009211431024596095
between O 0 0.00043366930913180113
the O 0 0.0019892393611371517
BRCA1 O 1 0.9999852180480957
tumour B-Disease 1 1.0
- O 1 0.943641185760498
suppressor O 1 0.6895608305931091
gene O 0 0.0005034587229602039
and O 0 0.0004445890663191676
hereditary B-Disease 1 0.9999988079071045
breast I-Disease 1 1.0
and I-Disease 1 0.9999983310699463
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.00038844379014335573
established O 0 0.0002724687510635704
, O 0 5.1677136070793495e-05
the O 0 0.0001104754046536982
role O 0 0.0003418033302295953
, O 0 7.649383769603446e-05
if O 0 4.543719842331484e-05
any O 0 4.3558640754781663e-05
, O 0 6.539456808241084e-05
of O 0 0.00024155685969162732
BRCA1 O 0 0.1397256702184677
in O 0 0.0008826000266708434
non B-Disease 0 0.017539646476507187
- I-Disease 1 0.6019284725189209
familial I-Disease 1 0.9997972846031189
cancers I-Disease 1 0.9999842643737793
is O 0 0.0008114598458632827
unclear O 0 0.001242126221768558
. O 0 0.0005639746086671948

BRCA1 O 1 0.9916092753410339
mutations O 0 0.0013205531286075711
are O 0 7.311784429475665e-05
rare O 0 0.0005219048471190035
in O 0 0.00042857270454987884
sporadic B-Disease 1 0.9180883169174194
cancers I-Disease 1 0.999752938747406
, O 0 0.00026210135547444224
but O 0 9.819523256737739e-05
loss O 0 0.0008674865821376443
of O 0 0.000597455189563334
BRCA1 O 1 0.9857115149497986
resulting O 0 0.0016606488497927785
from O 0 0.0003389842459000647
reduced O 0 0.0005272580310702324
expression O 0 0.00027541458257474005
or O 0 0.0001209635374834761
incorrect O 0 0.0005286560044623911
subcellular O 0 0.00330938259139657
localization O 0 0.0024365379940718412
is O 0 0.0001650072226766497
postulated O 0 0.0008236076682806015
to O 0 8.125489694066346e-05
be O 0 3.16407713398803e-05
important O 0 9.354978828923777e-05
in O 0 0.0001736088452162221
non B-Disease 0 0.0011729913530871272
- I-Disease 0 0.008644850924611092
familial I-Disease 1 0.9998910427093506
breast I-Disease 1 1.0
and I-Disease 1 0.999997615814209
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.010602193884551525

Epigenetic O 1 0.8144282698631287
loss O 1 0.9968035221099854
, O 0 0.0006365390727296472
however O 0 0.00021843794093001634
, O 0 9.76210503722541e-05
has O 0 4.153803092776798e-05
not O 0 1.6820891687530093e-05
received O 0 6.815262167947367e-05
general O 0 0.00028552146977744997
acceptance O 0 0.0007049224223010242
due O 0 0.0006332482444122434
to O 0 0.00018340398673899472
controversy O 0 0.0010402005864307284
regarding O 0 0.00032624657615087926
the O 0 0.00039527571061626077
subcellular O 0 0.003970653750002384
localization O 0 0.003000452183187008
of O 0 0.0009057092247530818
BRCA1 O 0 0.2204291969537735
proteins O 0 0.0002530786441639066
, O 0 7.278378325281665e-05
reports O 0 6.370375922415406e-05
of O 0 8.568148768972605e-05
which O 0 5.070309271104634e-05
have O 0 2.720021439017728e-05
ranged O 0 0.00030509952921420336
from O 0 0.00010981560626532882
exclusively O 0 0.00029867206467315555
nuclear O 0 0.0006230351864360273
, O 0 6.483968172688037e-05
to O 0 6.067459980840795e-05
conditionally O 0 0.0011144101154059172
nuclear O 0 0.0003803414583671838
, O 0 3.7333884392865e-05
to O 0 3.669737998279743e-05
the O 0 0.00044231500942260027
ER O 1 0.999413013458252
/ O 0 0.007730653043836355
golgi O 0 0.19690409302711487
, O 0 0.00021931089577265084
to O 0 0.00016426517686340958
cytoplasmic O 0 0.0007086545811034739
invaginations O 0 0.014768275432288647
into O 0 0.0006431729416362941
the O 0 0.001079078298062086
nucleus O 0 0.0067963143810629845
. O 0 0.000993541325442493

In O 0 0.001042919815517962
an O 0 0.0003002039447892457
attempt O 0 0.0009353279019705951
to O 0 0.00016745159518904984
resolve O 0 0.001120157539844513
this O 0 0.00014117748651187867
issue O 0 0.0003304713754914701
, O 0 0.000106830193544738
we O 0 5.335571040632203e-05
have O 0 5.0445647502783686e-05
comprehensively O 0 0.002711618784815073
characterized O 0 0.0011688614031299949
19 O 0 0.004403746221214533
anti O 1 0.9222337007522583
- O 1 0.6744493842124939
BRCA1 O 1 0.9885335564613342
antibodies O 0 0.002602553926408291
. O 0 0.0006476188427768648

These O 0 0.0009247696143575013
reagents O 0 0.0033921084832400084
detect O 0 0.0008283245842903852
a O 0 0.00039531546644866467
220 O 0 0.0016973739257082343
- O 0 0.001182821113616228
kD O 0 0.00585287855938077
protein O 0 0.00031618779757991433
localized O 0 0.0005663159536197782
in O 0 0.00011776143219321966
discrete O 0 0.00026336783776059747
nuclear O 0 0.0010320800356566906
foci O 0 0.0015262489905580878
in O 0 0.00020891914027743042
all O 0 0.00028002989711239934
epithelial O 1 0.9979902505874634
cell O 0 0.005110227037221193
lines O 0 0.0005267935921438038
, O 0 7.782426109770313e-05
including O 0 8.551154314773157e-05
those O 0 6.328486779239029e-05
derived O 0 0.0003375284723006189
from O 0 0.0015368302119895816
breast B-Disease 1 0.9999009370803833
malignancies I-Disease 1 0.999543309211731
. O 0 0.002478770213201642

Immunohistochemical O 1 0.6896201968193054
staining O 0 0.04709753766655922
of O 0 0.007916109636425972
human O 0 0.3518824577331543
breast O 1 0.9996466636657715
specimens O 0 0.0017479952657595277
also O 0 0.0006629210547544062
revealed O 0 0.002257766667753458
BRCA1 O 0 0.04148287698626518
nuclear O 0 0.004964835941791534
foci O 0 0.008910322561860085
in O 0 0.0013621196849271655
benign O 1 0.9999966621398926
breast O 1 0.9999933242797852
, O 0 0.004752934444695711
invasive B-Disease 1 0.9999980926513672
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999990463256836
and O 0 0.0035066993441432714
low B-Disease 0 0.30283859372138977
- I-Disease 1 0.5107641816139221
grade I-Disease 1 0.9984574317932129
ductal I-Disease 1 0.9999991655349731
carcinomas I-Disease 1 0.999997615814209
. O 0 0.0029701567254960537

Conversely O 0 0.016987746581435204
, O 0 0.0014560915296897292
BRCA1 O 0 0.036651648581027985
expression O 0 0.0013060803757980466
was O 0 0.0015866417670622468
reduced O 0 0.0008272092090919614
or O 0 0.00028472498524934053
undetectable O 0 0.001611046027392149
in O 0 7.659632683498785e-05
the O 0 5.413473991211504e-05
majority O 0 2.9638777050422505e-05
of O 0 0.00011424280819483101
high O 0 0.0011088305618613958
- O 0 0.00314611685462296
grade O 0 0.1755692958831787
, O 0 0.0007915346068330109
ductal B-Disease 1 0.9999996423721313
carcinomas I-Disease 1 0.9999997615814209
, O 0 0.0006165122031234205
suggesting O 0 0.0005392675520852208
that O 0 4.963736864738166e-05
absence O 0 0.0006615880411118269
of O 0 0.0010208592284470797
BRCA1 O 1 0.9991462230682373
may O 0 0.0006146880332380533
contribute O 0 0.00032916743657551706
to O 0 8.33463273011148e-05
the O 0 0.00026330663240514696
pathogenesis O 0 0.007088442798703909
of O 0 0.0003044326731469482
a O 0 0.0003477994177956134
significant O 0 0.00037537075695581734
percentage O 0 0.0003466681228019297
of O 0 0.0007240090635605156
sporadic B-Disease 1 0.9970935583114624
breast I-Disease 1 0.9999996423721313
cancers I-Disease 1 0.9999912977218628
. O 0 0.000765029457397759
. O 0 0.0008110223570838571

